-DOCSTART- -X- N

pain NN Pain
, , None
medications NNS Other
, , None
and CC None
postoperative JJ Pain
pain NN Pain
( ( None
1 CD None
) ) None
pain NN Pain
with IN Pain
cough NN Pain
, , None
( ( None
2 CD None
) ) None
narcotic JJ Pain
medication NN Pain
intake NN Pain
, , None
( ( None
3 CD None
) ) None
FVC NNP Physical
, , None
( ( None
4 CD None
) ) None
FEV1 NNP Physical
, , None
and CC None
( ( None
5 CD None
) ) None
PEFR NNP Physical
pain VBP Pain
at IN Pain
rest NN Pain
pain NN Pain
and CC None
medication NN Pain
intake NN Pain
pulmonary JJ Physical
functions NNS Physical
pain NN Other
management NN Other
pulmonary JJ Physical
dysfunction NN Physical
. . None
-DOCSTART- -X- N

Muscle NNP Physical
relaxation NN Physical
prolongation NN Other
of IN Other
the DT Other
duration NN Other
of IN Other
action NN Other
mean JJ Other
increase NN Other
shortest JJ Other
time NN Other
depression NN Mental
EMG-response NNP Physical
. . None
clinically RB Pain
relevant JJ Pain
interactions NNS Pain
muscle NN Pain
relaxants NNS Pain
. . None
-DOCSTART- -X- N

efficacy NN Other
severity NN Physical
of IN Physical
SDB NNP Physical
( ( Physical
polysomnography NN Physical
) ) Physical
, , Physical
subjective JJ Physical
and CC Physical
objective JJ Physical
loudness NN Physical
of IN Physical
snoring VBG Physical
( ( None
visual JJ None
analog NN None
scale NN None
and CC None
SNAP NNP None
recording NN None
) ) None
, , None
sleepiness NN Physical
( ( Physical
Epworth NNP Physical
Sleepiness NNP Physical
Scale NNP Physical
) ) Physical
anatomic JJ Physical
changes NNS Physical
( ( Physical
upper JJ Physical
airway RB Physical
endoscopy NN Physical
) ) Physical
snoring NN Physical
snoring NN Physical
-DOCSTART- -X- N

standing VBG Other
stress NN Other
test NN Other
Sandvik NNP Other
questionnaire NN Other
Incontinence NNP Other
Quality NNP Other
of IN Other
Life NNP Other
( ( Other
I-QOL NNP Other
) ) Other
questionnaire NN Other
International NNP Other
Consultation NNP Other
on IN Other
Incontinence NNP Other
Questionnaire-Female NNP Other
Lower NNP Other
Urinary NNP Other
Tract NNP Other
Symptoms NNP Other
( ( Other
ICIQ-FLUTS NNP Other
) ) Other
. . None
satisfaction NN Other
complications NNS Adverse
stress JJ Other
test NN Other
Sandvik NNP Other
questionnaire NN Other
surgical JJ None
outcomes NNS None
Objective JJ Other
cure NN Other
rates NNS Other
Subjective JJ Other
cure NN Other
rates NNS Other
I-QOL NNP Other
and CC Other
domain NN Other
scores NNS Other
of IN Other
the DT Other
ICIQ-FLUTS NNP Other
( ( Other
filling VBG Other
and CC Other
incontinence NN Other
sum NN Other
, , Other
QOL NNP Other
score NN Other
) ) Other
patients NNS Mental
' POS Mental
satisfaction NN Mental
intraoperative JJ Physical
vaginal JJ Physical
wall NN Physical
perforation NN Physical
increased VBN Adverse
bleeding NN Adverse
temporary JJ Physical
postoperative JJ Physical
retention NN Physical
. . None
cure NN Other
rates NNS Other
QOL NNP Other
treatment NN Other
satisfaction NN Other
-DOCSTART- -X- N

effects NNS Other
Childhood NNP Physical
Autism NNP Physical
Rating NNP Physical
Scale NNP Physical
( ( Physical
CARS NNP Physical
) ) Physical
Clinical JJ Mental
Global NNP Mental
Impressions NNP Mental
Autism NNP Physical
Diagnostic NNP Physical
Observation NNP Physical
Schedule NNP Physical
values NNS Physical
Side JJ None
effects NNS None
occasional JJ None
mild NN None
hypokalaemia NN None
improved VBN None
accuracy NN None
in IN None
facial JJ None
emotional JJ None
labelling NN None
, , None
and CC None
increased VBD None
brain NN None
activation NN None
in IN None
areas NNS None
involved VBN None
in IN None
social JJ None
and CC None
emotional JJ None
perception NN None
( ( None
Hadjikhani NNP None
-DOCSTART- -X- N

values NNS Physical
for IN Physical
plasma NN Physical
amprenavir NN Physical
( ( Physical
APV NNP Physical
) ) Physical
area NN Physical
under IN Other
the DT Other
concentration-time JJ Other
profile NN Other
over IN None
the DT None
dosing VBG None
interval NN None
( ( None
tau NN None
) ) None
at IN None
steady JJ None
state NN None
maximum JJ Other
concentration NN Other
of IN Other
drug NN Other
in IN Other
plasma NN Other
( ( Other
C NNP Other
( ( Other
max NN Other
) ) Other
) ) Other
, , None
and CC None
plasma JJ Physical
concentration NN Physical
at IN Physical
the DT Physical
end NN Physical
of IN Physical
tau NN Physical
at IN Physical
steady JJ Physical
state NN Physical
( ( Other
C NNP Other
( ( Other
tau NN Other
) ) Other
) ) Other
values NNS Physical
for IN Physical
plasma NN Physical
RTV NNP Physical
AUC NNP Physical
( ( Physical
0-tau JJ Physical
) ) Physical
, , None
C NNP Other
( ( Other
max NN Other
) ) Other
, , None
and CC None
C NNP Other
( ( Other
tau NN Other
) ) Other
values NNS Physical
for IN Physical
plasma NN Physical
APV NNP Physical
AUC NNP Physical
( ( Physical
0-tau JJ Physical
) ) Physical
, , None
C NNP Other
( ( Other
max NN Other
) ) Other
, , None
and CC None
C NNP Other
( ( Other
tau NN Other
) ) Other
plasma NN Physical
RTV NNP Physical
AUC NNP Physical
( ( Physical
0-tau JJ Physical
) ) Physical
, , None
C NNP Physical
( ( Physical
max NN Physical
) ) Physical
, , None
and CC None
C NNP Physical
( ( Physical
tau NN Physical
) ) Other
rate NN Physical
of IN Physical
marked VBN Physical
hepatic JJ Physical
transaminase NN Physical
elevations NNS Physical
lack NN Other
of IN Other
pharmacokinetic JJ Other
advantage NN Other
. . Other
-DOCSTART- -X- N

antibacterial JJ Physical
and CC Physical
antifungal JJ Physical
properties NNS Physical
antibacterial JJ Physical
and CC Physical
antifungal JJ Physical
activity NN Physical
saliva NN None
samples NNS None
aerobic JJ None
and CC None
anaerobic JJ None
bacteria NNS None
Candida NNP None
albicans NNS None
. . None
aerobic JJ Physical
bacterial JJ Physical
counts NNS Physical
anaerobic JJ Physical
bacterial JJ Physical
counts NNS Physical
Candida NNP None
albicans NNS None
eradicating VBG Physical
completely RB Physical
aerobic JJ Physical
and CC Physical
anaerobic JJ Physical
bacteria NNS Physical
reduction NN Other
-DOCSTART- -X- N

Response NN Mental
to TO Mental
familiar JJ Mental
faces VBZ Mental
ERP NNP Mental
responses NNS Mental
to TO Mental
a DT Mental
familiar JJ Mental
repeated VBN Mental
face NN Mental
( ( Mental
Familiar NNP Mental
) ) Mental
unfamiliar JJ Mental
repeated JJ Mental
face NN Mental
( ( Mental
Other JJ Mental
) ) Mental
and CC Mental
novel JJ Mental
faces VBZ Mental
( ( Mental
Novels NNP Mental
) ) Mental
processing NN Mental
of IN Mental
facial JJ Mental
familiarity NN Mental
and CC Mental
repetition NN Mental
face NN Mental
memory NN Mental
. . None
-DOCSTART- -X- N

comparative JJ Other
study NN Other
of IN Other
the DT Other
pharmacokinetics NNS Other
pharmacokinetic JJ Other
profile NN Other
bioavailability NN Other
for IN Other
S NNP Other
( ( Other
+ NNP Other
) ) Other
-ibuprofen NN Other
. . None
maximum JJ Other
concentration NN Other
( ( Other
C NNP Other
( ( Other
max NN Other
) ) Other
) ) Other
time NN Other
to TO Other
peak VB Other
concentration NN Other
( ( Other
T NNP Other
( ( Other
max NN Other
) ) Other
) ) Other
-DOCSTART- -X- N

Mean NNP Physical
postoperative JJ Physical
intraocular JJ Physical
pressure NN Physical
intraocular JJ Physical
pressure NN Physical
surgical JJ Physical
complications NNS Physical
. . None
-DOCSTART- -X- N

egg NN Physical
negative JJ Physical
conversion NN Physical
rates NNS Physical
of IN Physical
hookworm NN Physical
, , Physical
Ascaris NNP Physical
and CC Physical
Trichuris NNP Physical
egg NN Other
reduction NN Other
rates NNS Other
of IN Other
hookworm NN Other
larval JJ Physical
negative JJ Physical
conversion NN Physical
rates NNS Physical
of IN Physical
Ancylostoma NNP Physical
duodenale NN Physical
and CC Physical
Necator NNP Physical
americanus VBP Physical
egg NN Other
negative JJ Other
conversion NN Other
rates NNS Other
egg NN Other
reduction NN Other
rate NN Other
of IN Other
hookworm NN Other
egg NN Other
negative JJ Other
conversion NN Other
rates NNS Other
-DOCSTART- -X- N

-DOCSTART- -X- N

higher JJR None
pH NN None
( ( None
24 CD None
) ) None
and CC None
lower JJR None
cooking NN None
loss NN None
and CC None
thiobarbituric JJ None
acid NN None
reacting VBG None
substance NN None
values NNS None
at IN None
had VBD None
higher JJR None
cortisol NN None
levels NNS None
, , None
creatine NN None
kinase NN None
activities NNS None
, , None
white JJ None
blood NN None
cell NN None
counts NNS None
, , None
neutrophil JJ None
percentage NN None
, , None
neutrophil NN None
: : None
lymphocyte NN None
ratio NN None
and CC None
lower JJR None
T NNP None
( ( None
3 CD None
) ) None
, , None
T NNP None
( ( None
4 CD None
) ) None
levels NNS None
, , None
lymphocyte NN None
percentage NN None
than IN None
growth NN None
performance NN None
, , None
welfare NN None
, , None
and CC None
meat NN None
quality NN None
of IN None
-DOCSTART- -X- N

maternal JJ Physical
erythropoietin NN Physical
response NN Physical
Serial JJ Physical
hemoglobin NN Physical
, , None
hematocrit NN Physical
, , None
and CC None
serum NN Physical
erythropoietin NN Physical
Serum NNP Physical
ferritin NN Physical
mean JJ Physical
hemoglobin NN Physical
mean JJ Physical
serum NN Physical
ferritin NN Physical
mean JJ Physical
hemoglobin NN Physical
and CC Physical
hematocrit NN Physical
mean JJ Physical
maternal JJ Physical
serum NN Physical
erythropoietin NN Physical
mean JJ Physical
cord NN Physical
blood NN Physical
hematologic NN Physical
values NNS Physical
Maternal NNP Physical
serum NN Physical
erythropoietin NN Physical
-DOCSTART- -X- N

Parents NNS Other
' POS Other
checklist NN Other
ratings NNS Other
( ( Other
ABC NNP Other
) ) Other
clinicians NNS Other
' POS Other
ratings NNS Other
( ( Other
CGI NNP Other
) ) Other
ABC NNP Other
social JJ Other
withdrawal NN Other
subscale NN Other
. . Other
children NNS Mental
's POS Mental
play NN Mental
behavior NN Mental
social JJ Mental
interaction NN Mental
between IN Mental
child NN Mental
and CC Mental
experimenter NN Mental
. . Mental
Gaze NNP Mental
coordination NN Mental
-DOCSTART- -X- N

mortality NN Mortality
All-cause NNP Other
hospitalization NN Other
Matched VBN Physical
HR NNP Physical
for IN Physical
cardiovascular JJ Physical
and CC Physical
HF NNP Physical
hospitalization NN Physical
HR NNP Physical
for IN Physical
all-cause JJ Physical
hospitalization NN Physical
for IN Physical
GFR NNP Physical
HR NNP Mortality
for IN Mortality
all-cause JJ Mortality
death NN Mortality
for IN Mortality
GFR NNP Mortality
45-59 CD Mortality
and CC Mortality
< $ Mortality
45 CD Mortality
ml/min/1.73 NN Mortality
m NN Mortality
( ( Mortality
2 CD Mortality
) ) Mortality
BSA NNP Mortality
Matched VBN Mortality
HR NNP Mortality
for IN Mortality
death NN Mortality
due JJ Mortality
to TO Mortality
cardiovascular JJ Mortality
causes NNS Mortality
and CC Mortality
progressive JJ Mortality
HF NNP Mortality
mortality NN Mortality
and CC None
hospitalization NN Other
kidney NN Physical
function NN Physical
. . Physical
-DOCSTART- -X- N

non-recurrence JJ Other
rates NNS Other
Time NN Physical
to TO Physical
recurrence VB Physical
for IN Physical
tumors NNS Physical
larger JJR Physical
than IN Physical
1 CD Physical
cm NN Physical
Time NN Physical
to TO Physical
recurrence VB Physical
for IN Physical
single JJ Physical
and CC Physical
grade VBD Physical
1+2 CD Physical
tumors NNS Physical
adverse JJ Adverse
effects NNS Adverse
effective JJ Other
single JJ Physical
, , Physical
low JJ Physical
grade NN Physical
lesions NNS Physical
larger JJR Physical
than IN Physical
1 CD Physical
cm NN Physical
-DOCSTART- -X- N

progression NN Other
rates NNS Other
( ( Physical
appearance NN Physical
of IN Physical
metastases NNS Physical
in IN Physical
bone NN Physical
scan NN Physical
) ) Physical
frequency NN Physical
of IN Physical
thromboembolic JJ Physical
and CC Physical
other JJ Physical
cardiovascular JJ Physical
complications NNS Physical
bowel NN Physical
or CC Physical
bladder NN Physical
complications NNS Physical
. . None
-DOCSTART- -X- N

in IN None
progression-free JJ Mortality
survival NN Mortality
, , None
of IN None
PTK2 NNP None
gene NN None
expression NN None
PTK2 NNP None
inhibition NN None
blunted VBD None
R-dependent NNP Physical
cell NN Physical
death NN Physical
in IN None
vitro NN None
. . None
increased VBD None
PTK2 NNP None
expression NN None
-DOCSTART- -X- N

arterial JJ Physical
stiffness NN Physical
and CC None
central JJ Physical
haemodynamics NNS Physical
: : None
Aortic JJ Physical
pulse NN Physical
wave NN Physical
velocity NN Physical
( ( Physical
PWV NNP Physical
) ) Physical
augmentation NN Physical
index NN Physical
( ( Physical
AIx NNP Physical
) ) Physical
cardiovascular JJ Physical
risk NN Physical
and CC None
mortality NN Mortality
arterial JJ Physical
stiffness NN Physical
( ( Physical
aortic JJ Physical
and CC Physical
brachial JJ Physical
PWV NNP Physical
) ) Physical
, , None
and CC None
on IN Physical
central JJ Physical
haemodynamics NNS Physical
[ VBP Physical
including VBG Physical
augmented VBN Physical
pressure NN Physical
( ( Physical
AP NNP Physical
) ) Physical
, , Physical
AIx NNP Physical
] NNP Physical
, , None
and CC None
aortic JJ Physical
reservoir NN Physical
components NNS Physical
[ VBP None
including VBG None
reservoir NN Physical
and CC Physical
excess JJ Physical
pressures NNS Physical
( ( Physical
P NNP Physical
ex NN Physical
) ) Physical
] NN None
. . None
. . None
Supine JJ None
resting VBG None
measures NNS None
were VBD None
change NN None
in IN None
brachial JJ None
blood NN None
pressure NN None
between IN None
control VB None
, , None
AP NNP None
AIx NNP None
time NN None
to TO None
maximum VB None
P NNP None
ex FW None
change NN None
in IN None
aortic JJ None
PWV NNP None
) ) None
or CC None
brachial JJ None
PWV NNP None
increases VBZ None
central JJ None
haemodynamic JJ None
stress NN None
and CC None
alters NNS None
timing NN None
of IN None
peak JJ None
aortic JJ None
in-flow NN None
without IN None
affecting VBG None
arterial JJ None
stiffness NN None
. . None
-DOCSTART- -X- N

number NN Other
of IN Other
preemptively RB Other
treated VBN Other
HCMV NNP Physical
infection NN Physical
number NN Other
of IN Other
patients NNS Other
treated VBN Other
HCMV NNP Physical
disease NN Physical
. . None
-DOCSTART- -X- N

erythropoiesis NN Physical
erythropoietic JJ Physical
response NN Physical
serum NN Other
iron NN Other
level NN Other
significantly RB Other
rose VBD Other
new JJ Physical
red JJ Physical
blood NN Physical
cells NNS Physical
increase NN Physical
of IN Physical
hemoglobin NN Physical
effective JJ Other
-DOCSTART- -X- N

number NN Physical
and CC Physical
character NN Physical
of IN Physical
each DT Physical
stool NN Physical
stool NN Physical
specimens NNS Physical
for IN Physical
weight NN Physical
and CC None
oocyst NN Physical
excretion NN Physical
. . None
oocyst JJ Physical
excretion NN Physical
Oocyst NNP Physical
excretion NN Physical
Stool NNP Other
frequency NN Other
stool NN Physical
weight NN Physical
, , Physical
stool JJ Physical
character NN Physical
, , None
and CC None
Karnofsky NNP Other
score NN Other
. . None
-DOCSTART- -X- N

Blood NNP Physical
pressure NN Physical
behaviour NN Physical
blood NN Physical
pressure NN Physical
or CC Physical
plasma NN Physical
volume NN Physical
. . Physical
blood NN Physical
pressure NN Physical
Cardiac NNP Physical
output NN Physical
cardiac JJ Physical
output NN Physical
myocardial JJ Physical
or CC Physical
venous JJ Physical
angiotensin NN Physical
effects NNS Physical
. . Physical
blood NN Physical
pressure NN Physical
heart NN Physical
rate NN Physical
effect NN Physical
Blood NN Physical
pressure NN Physical
and CC Physical
total JJ Physical
peripheral JJ Physical
resistance NN Physical
responses NNS Physical
heart NN Physical
rate NN Physical
cardiac JJ Physical
output NN Physical
-DOCSTART- -X- N

survival JJ Physical
advantage NN Physical
rates NNS Physical
of IN Physical
disease-free JJ Physical
survival NN Physical
One-year JJ Mortality
and CC Mortality
4-year JJ Mortality
overall JJ Mortality
survival NN Mortality
rates NNS Mortality
survival JJ Mortality
rates NNS Mortality
disease-free JJ Mortality
survival NN Mortality
rates NNS Mortality
overall JJ Mortality
survival NN Mortality
rates NNS Mortality
at IN Other
least JJS Other
as RB Other
effective JJ Other
as IN Other
-DOCSTART- -X- N

effectiveness NN Other
of IN Other
therapy NN Other
. . Other
lower JJR Mental
levels NNS Mental
of IN Mental
symptom NN Mental
distress NN Mental
liked VBD Other
their PRP$ Other
therapist NN Other
more RBR Other
. . Other
-DOCSTART- -X- N

arterial JJ Physical
pressure NN Physical
arterial JJ Physical
gas NN Physical
measurements NNS Physical
. . Physical
Cardiovascular NNP Physical
( ( Physical
heart NN Physical
rate NN Physical
and CC Physical
arterial JJ Physical
pressure NN Physical
) ) Physical
and CC None
respiratory NN Physical
( ( Physical
respiratory JJ Physical
rate NN Physical
and CC Physical
presence/absence NN Physical
of IN Physical
apnoea NN Physical
) ) Physical
effects NNS Physical
-DOCSTART- -X- N

toe-brachial JJ Physical
pressure NN Physical
indices NNS Physical
( ( Physical
TBPI NNP Physical
) ) Physical
effect NN Other
TBPI NNP Physical
TBPI NNP Physical
peak NN Physical
TBPI NNP Physical
TBPI NNP Physical
Restenosis NNP Physical
TBPI NNP Physical
TBPI NNP None
-DOCSTART- -X- N

rate NN Physical
of IN Physical
induction NN Physical
of IN Physical
labour NN Physical
prolonged JJ Physical
pregnancy NN Physical
rate NN Other
of IN Other
induction NN Physical
of IN Physical
labour NN Physical
prolonged JJ Physical
pregnancy NN Physical
. . None
The DT Other
rate NN Other
of IN Other
induction NN Physical
of IN Physical
labour NN Physical
for IN Other
prolonged JJ Physical
pregnancy NN Physical
. . None
rate NN Physical
of IN Physical
induction NN Physical
prolonged JJ Physical
pregnancy NN Physical
rate NN Other
of IN Other
induction NN Other
of IN Other
labour NN Other
prolonged JJ Physical
pregnancy NN Physical
-DOCSTART- -X- N

parental JJ Mental
mental JJ Mental
health NN Mental
parenting VBG Physical
stress NN Physical
and CC None
maternal JJ Physical
depressive NN Physical
symptoms NNS Physical
parental JJ Mental
stress NN Mental
and CC None
maternal JJ Mental
depressive NN Mental
symptoms NNS Mental
. . None
parental JJ Mental
stress NN Mental
depressive JJ Mental
symptoms NNS Mental
depressive NN Mental
symptoms NNS Mental
parenting VBG Mental
stress NN Mental
depressive JJ Mental
symptoms NNS Mental
-DOCSTART- -X- N

incidence NN Physical
of IN Physical
ventricular JJ Physical
fibrillation NN Physical
or CC None
sustained VBN Physical
ventricular JJ Physical
tachycardia NN Physical
sustained JJ Physical
ventricular JJ Physical
tachycardia NN Physical
number NN Physical
of IN Physical
patients NNS Physical
with IN Physical
warning VBG Physical
arrhythmias NNS Physical
average JJ Physical
plasma JJ Physical
lidocaine JJ Physical
level NN Physical
minutes NNS Other
after IN Other
mean JJ Physical
plasma NN Physical
lidocaine JJ Physical
level NN Physical
incidence NN Adverse
of IN Adverse
central JJ Adverse
nervous JJ Adverse
system NN Adverse
side NN Adverse
effects NNS Adverse
hypotension NN Physical
died VBD Mortality
-DOCSTART- -X- N

professional JJ Other
competence NN Other
and CC Other
quality NN Other
of IN Other
interaction NN Other
-DOCSTART- -X- N

identical JJ Other
analgetic JJ Pain
efficiency NN Pain
. . None
adverse JJ Adverse
side NN Adverse
effects NNS Adverse
obstetrical JJ Pain
analgesia NN Pain
inhibitory JJ Physical
effects NNS Physical
-DOCSTART- -X- N

improvement NN Physical
in IN Physical
time NN Physical
to TO Physical
progression NN Physical
, , Physical
overall JJ Mortality
and CC Mortality
cancer NN Mortality
specific JJ Mortality
survival NN Mortality
objective VB Physical
progression NN Physical
, , Physical
overall JJ Mortality
and CC Mortality
cancer NN Mortality
specific JJ Mortality
survival NN Mortality
-DOCSTART- -X- N

Clinical NNP None
and CC None
instrumental JJ None
evaluation NN None
of IN None
postoperative JJ None
outcomes NNS None
. . None
nasal JJ Physical
polyposis NN Physical
relapses NNS Physical
. . Physical
early-stage JJ Physical
relapse NN Physical
grades NNS Physical
of IN Physical
chronic JJ Physical
hyperplastic JJ Physical
sinusitis NN Physical
with IN Physical
nasal JJ Physical
polyposis NN Physical
-DOCSTART- -X- N

event NN Mental
free JJ Mental
survival NN Mental
Methotrexate NNP Other
clearance NN Other
rate NN Physical
of IN Physical
leukaemia NN Physical
relapse NN Physical
survival NN Mortality
-DOCSTART- -X- N

amount NN Physical
of IN Physical
bifidobacteria NN Physical
lactobacilli NN Physical
gastrointestinal JJ Physical
symptoms NNS Physical
, , Physical
defecation NN Physical
frequency NN Physical
, , Physical
consistency NN Physical
of IN Physical
stools NNS Physical
or CC Physical
ease NN Physical
of IN Physical
defecation NN Physical
bifidobacteria NN Physical
-DOCSTART- -X- N

death NN Mortality
rate NN Mortality
TE NNP Physical
event NN Physical
rate NN Physical
-DOCSTART- -X- N

tobacco NN Mental
dependency NN Mental
. . Mental
abstinent JJ Mental
abstinent JJ Mental
after IN Mental
a DT Mental
year NN Mental
. . Mental
abstinent JJ None
not RB Mental
smoking VBG Mental
after IN Mental
a DT Mental
year NN Mental
. . Mental
-DOCSTART- -X- N

EFficacy NNP Other
and CC Other
tolerability NN Other
low-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
( ( Physical
LDL-C NNP Physical
) ) Physical
. . None
high-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
( ( Physical
HDL-C NNP Physical
) ) Physical
LDL-C NNP Physical
efficacy NN Other
and CC Other
safety NN Other
profile NN Other
percent JJ Other
change NN Other
from IN Other
baseline NN Physical
in IN Physical
LDL-C NNP Physical
and CC None
the DT None
safety NN Other
and CC Other
tolerability NN Other
of IN None
anacetrapib NN None
. . None
blood NN Physical
pressure NN Physical
and CC None
electrolytes NNS Physical
. . None
Lipid JJ Physical
results NNS Physical
, , None
clinical JJ Physical
CV NNP Physical
events NNS Physical
, , None
and CC None
safety NN Other
outcomes RB Other
-DOCSTART- -X- N

ongoing VBG Mental
participation NN Mental
in IN Mental
rates NNS Mental
of IN Mental
regular JJ Mental
breast NN Mental
cancer NN Mental
screening NN Mental
continued JJ Mental
participation NN Mental
in IN Mental
mammography NN Mental
screening NN Mental
. . None
mammogram NN Mental
received VBN Mental
after IN Mental
the DT Mental
intervention NN Mental
period NN Mental
and CC Mental
within IN Mental
2 CD Mental
years NNS Mental
of IN Mental
the DT Mental
initial JJ Mental
mammogram NN Mental
date NN Mental
. . None
subsequent JJ Mental
mammogram NN Mental
participation NN None
mammography NN Mental
screening NN Mental
mammography NN Mental
screening NN Mental
-DOCSTART- -X- N

diagnostic JJ Other
yield NN Other
diagnostic JJ Physical
yield NN Physical
diagnostic JJ Physical
yield NN Physical
yield NN Other
in IN Other
the DT Other
EBUS-TBNA JJ Other
higher RBR Physical
diagnostic JJ Physical
yield NN Physical
highest JJS Physical
diagnostic JJ Physical
yield NN Physical
diagnostic JJ Physical
yield NN Physical
of IN Physical
TBNA NNP Physical
adverse JJ Adverse
effects NNS Adverse
diagnostic JJ Physical
yield NN Physical
diagnostic JJ Other
advantage NN Other
-DOCSTART- -X- N

efficacy NN None
behavior JJ None
training NN None
therapeutic JJ Mental
effect NN Mental
developing VBG Mental
level NN Mental
of IN Mental
with IN Mental
CARS NNP Mental
and CC Mental
PEP NNP Mental
. . None
total JJ Other
effective JJ Other
rate NN Other
CARS NNPS Mental
scores NNS Mental
PEP NNP Mental
scores NNS Mental
scores NNS Mental
of IN Mental
cognitive JJ Mental
understanding NN Mental
and CC Mental
cognitive JJ Mental
expression NN Mental
enhancing VBG Mental
cognition NN Mental
understanding NN Mental
and CC Mental
cognition NN Mental
expression NN Mental
. . Mental
-DOCSTART- -X- N

Efficacy NN Other
antitumor NN Other
activity NN Other
response NN Other
rates NNS Other
( ( None
CR NNP None
+ NNP None
PR NNP None
) ) None
response NN Other
rate NN Other
with IN Other
I-MEC NNP Other
therapy NN Other
I-MEC NNP Other
therapy NN Other
thrombocytopenia NN Physical
antitumor NN Other
effects NNS Other
. . Other
-DOCSTART- -X- N

safety NN Other
cardiovascular JJ Adverse
effects NNS Adverse
safety NN Other
efficacy NN Other
frequency NN Adverse
of IN Adverse
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
( ( None
safety NN Physical
) ) None
changes NNS Physical
in IN Physical
6-minute JJ Physical
walk NN Physical
test NN Physical
Minnesota NNP Other
Living NNP Other
With IN Other
HF NNP Other
score NN Other
( ( None
efficacy NN Other
) ) None
Ventricular JJ Physical
tachycardia NN Physical
responsive NN Physical
functional JJ Mental
capacity NN Mental
Minnesota NNP None
Living NNP None
With IN None
HF NNP None
scores NNS None
-DOCSTART- -X- N

survival NN Mortality
and CC None
quality NN Physical
of IN Physical
life NN Physical
. . None
died VBN Mortality
non-significant JJ Mortality
survival NN Mortality
benefit NN Mortality
Median JJ Mortality
survival NN Mortality
survival JJ Mortality
advantage NN Mortality
median JJ Mortality
survival NN Mortality
survival JJ Mortality
benefit NN Mortality
quality-of-life NN Physical
subscales NNS Physical
( ( Physical
physical JJ Physical
functioning NN Physical
, , Physical
pain NN Physical
, , Physical
dyspnoea NN Physical
, , Physical
and CC Physical
global JJ Physical
health NN Physical
status NN Physical
) ) Physical
survival NN Mortality
or CC Mental
quality NN Physical
of IN Physical
life NN Physical
. . None
-DOCSTART- -X- N

physical JJ Other
activity NN Other
physical JJ Physical
activity NN Physical
physical JJ Other
activity NN Other
dietary JJ Mental
intake NN Mental
Canada NNP None
's POS None
Guides NNP None
to TO None
Physical NNP Mental
Activity NNP Mental
Healthy NNP Mental
Eating NNP Mental
hypertension NN Physical
diabetes VBZ Physical
. . None
-DOCSTART- -X- N

no DT Mortality
mortality NN Mortality
mean VB Other
operative JJ Other
time NN Other
( ( Other
OpT NNP Other
) ) Other
left JJ Other
adrenalectomy JJ Other
mean JJ Other
OpT NNP Other
mean JJ Physical
blood NN Physical
loss NN Physical
mean JJ Other
hospital NN Other
stay NN Other
short JJ Physical
operating NN Physical
time NN Physical
and CC Physical
blood NN Physical
loss NN Physical
. . None
-DOCSTART- -X- N

Histologic NNP Other
conversion NN Other
complete JJ Physical
response NN Physical
rate NN Physical
( ( Physical
CR NNP Physical
) ) Physical
achieved VBD Mental
a DT Mental
CR NNP Mental
relapsed VBN Mental
. . Mental
achieve VB Physical
a DT Physical
CR NNP Physical
achieved VBD Physical
a DT Physical
CR NNP Physical
relapsed VBN Physical
. . Physical
Histologic NNP Physical
conversion NN Physical
actuarial JJ Other
risk NN Other
for IN Other
conversion NN Other
greater JJR Mental
median JJ Mental
time NN Mental
to TO Mental
documentation NN Mental
of IN Mental
conversion NN Mental
most RBS Other
common JJ Other
histologic JJ Physical
conversion NN Physical
histiocytic JJ Other
lymphoma NN Other
. . Other
histologic JJ Other
conversion NN Other
aggressive JJ Mental
clinical JJ Mental
behavior NN Mental
median JJ Physical
survival NN Physical
conversion NN Physical
achieved VBD Other
a DT Other
CR NNP Other
conversion NN Physical
favorable JJ Mental
outcome NN Mental
( ( Mental
actuarial JJ Mental
survival NN Mental
risk NN Other
factors NNS Other
histologic JJ Physical
conversion NN Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

lengthening NN Physical
of IN Physical
remission NN Physical
duration NN Physical
and CC None
an DT None
improved JJ Physical
quality NN Physical
of IN Physical
life NN Physical
and CC None
survival NN Mortality
. . None
-DOCSTART- -X- N

shock NN Physical
conversion NN Physical
efficacy NN Physical
of IN Physical
spontaneous JJ Physical
arrhythmias NNS Physical
. . Other
implant JJ Physical
indications NNS Physical
and CC Physical
baseline VB Physical
antiarrhythmic JJ Physical
drug NN Physical
use NN Physical
percentage NN Physical
of IN Physical
dual-chamber JJ Physical
ICDs NNP Physical
implanted VBD Physical
energy NN Physical
safety NN Physical
margins NNS Physical
. . Other
-DOCSTART- -X- N

anxiety NN Mental
quality NN Mental
of IN Mental
life NN Mental
quality NN Other
of IN Other
life NN Other
( ( None
QoL NNP None
) ) None
state NN Mental
anxiety NN Mental
State-Trait NNP Mental
Anxiety NNP Mental
Inventory NNP Mental
, , Mental
QoL NNP Mental
with IN Mental
the DT Mental
IBD NNP Mental
Questionnaire NNP Mental
Visual NNP Other
Analogue NNP Other
Scale NNP Other
pain NN Pain
, , None
depression NN Mental
, , None
stress NN Mental
mood NN Mental
anxiety NN None
levels NNS None
QoL NNP None
and CC None
mood NN None
pain NN None
and CC None
stress NN None
-DOCSTART- -X- N

usefulness NN Other
Response NNP Physical
to TO Physical
ovarian JJ Physical
stimulation NN Physical
and CC Physical
occurrence NN Physical
of IN Physical
spontaneous JJ Physical
luteinizing VBG Physical
hormone NN Physical
( ( Physical
LH NNP Physical
) ) Physical
surges VBZ Physical
ovulation NN Physical
induction NN Physical
, , Physical
fertilization NN Physical
, , Physical
and CC Physical
pregnancy NN Physical
rates NNS Physical
LH NNP Physical
surge NN Physical
-DOCSTART- -X- N

sensory JJ Mental
and CC Mental
self-regulatory JJ Mental
disturbances NNS Mental
. . None
sensory JJ Mental
impairment NN Mental
, , None
digestion NN Physical
, , None
and CC None
sleep NN Physical
social JJ Mental
and CC Mental
language NN Mental
skills NNS Mental
reduction NN Mental
in IN Mental
autistic JJ Mental
behavior NN Mental
gains NNS Other
sensory JJ Mental
and CC Mental
self-regulation JJ Mental
problems NNS Mental
-DOCSTART- -X- N

peripheral JJ Physical
blood NN Physical
progenitor NN Physical
cells NNS Physical
median JJ Physical
CD34+ NNP Physical
cell NN Physical
yield/pheresis NN Physical
minimum JJ Physical
yield NN Physical
of IN Physical
CD34+ NNP Physical
CD34+ NNP Physical
cell NN Physical
values NNS Physical
. . None
platelet NN Physical
recovery NN Physical
. . None
PBPC NNP Physical
leukapheresis NN Physical
-DOCSTART- -X- N

survival NN Mortality
efficacy NN Other
and CC Other
tolerability NN Other
efficacy NN Other
time NN Physical
to TO Physical
disease VB Physical
progression NN Physical
( ( Physical
TTP NNP Physical
) ) Physical
overall JJ Mortality
survival NN Mortality
objective JJ Physical
tumor NN Physical
response NN Physical
rate NN Physical
Gastrointestinal JJ Adverse
side NN Adverse
effects NNS Adverse
and CC Adverse
hand-foot JJ Adverse
syndrome NN Adverse
myalgia NN Adverse
, , Adverse
arthralgia NN Adverse
neutropenic JJ Adverse
fever/sepsis NN Adverse
grade JJ Adverse
3 CD Adverse
adverse JJ Adverse
events NNS Adverse
grade VBP Adverse
4 CD Adverse
events NNS Adverse
TTP NNP Mortality
and CC Mortality
survival NN Mortality
toxicity NN Physical
profile NN Physical
-DOCSTART- -X- N

rates NNS Physical
of IN Physical
in IN Physical
vitro JJ Physical
oocyte JJ Physical
maturation NN Physical
, , Physical
fertilization NN Physical
and CC Physical
cleavage NN Physical
implantation NN Physical
rate NN Physical
and CC Physical
pregnancy NN Physical
rate NN Physical
percentage NN Other
of IN Other
oocytes NNS Other
reaching VBG Other
metaphase NN Other
II NNP Other
rates NNS Other
of IN Other
oocyte JJ Other
fertilization NN Other
and CC Other
cleavage NN Other
pregnancies NNS Physical
clinical JJ Other
pregnancies NNS Other
implantations NNS Physical
healthy JJ Physical
singleton NN Physical
children NNS Physical
born VBN Physical
spontaneous JJ Adverse
abortions NNS Adverse
maturational JJ Other
potential NN Other
of IN Other
the DT Other
oocytes NNS Other
and CC Other
the DT Other
implantation NN Other
rate NN Other
of IN Other
the DT Other
cleaved JJ Other
embryos NN Other
. . Physical
-DOCSTART- -X- N

motivational JJ Mental
interviewing NN Mental
skills NNS Mental
, , Mental
knowledge NN Mental
, , Mental
and CC Mental
confidence NN Mental
skills NNS Mental
, , Mental
knowledge NN Mental
confidence NN Mental
attitudes NNS Mental
Motivational JJ Mental
interviewing NN Mental
skills NNS Mental
, , Mental
knowledge NN Other
, , Mental
confidence NN Other
, , Mental
and CC Mental
attitudes NNS Mental
skills NNS Mental
, , Mental
knowledge NN Mental
, , Mental
and CC Mental
confidence NN Mental
. . Mental
skills NNS Mental
knowledge NN Other
recognition NN Mental
for IN Mental
the DT Mental
value NN Mental
of IN Mental
motivational JJ Mental
interviewing NN Mental
. . Mental
motivational JJ Mental
interviewing NN Mental
-DOCSTART- -X- N

inattention NN Mental
, , Mental
impulsivity NN Mental
, , Mental
and CC Mental
hyperactivity NN Mental
effective JJ Other
Teacher PRP$ Other
ratings NNS Other
on IN Other
the DT Other
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
irritability NN Mental
, , Mental
stereotypy NN Mental
, , Mental
hyperactivity NN Mental
, , Mental
and CC Mental
inappropriate JJ Mental
speech NN Mental
factors NNS Mental
Comprehensive NNP Mental
Teacher NNP Mental
's POS Mental
Rating NNP Mental
Scale NNP Mental
ratings NNS Mental
Parent NN Mental
Conners NNPS Mental
Abbreviated NNP Mental
Parent-Teacher NNP Mental
Questionnaire NNP Mental
ratings NNS Mental
side NN Adverse
effects NNS Adverse
of IN Adverse
drowsiness NN Adverse
and CC Adverse
decreased JJ Adverse
activity NN Adverse
. . None
( ( None
Children NNP Mental
's POS Mental
Psychiatric NNP Mental
Rating NNP Mental
Scale NNP Mental
Autism NNP Mental
, , Mental
Hyperactivity NNP Mental
, , Mental
Anger NNP Mental
and CC Mental
Speech NNP Mental
Deviance NNP Mental
factors NNS Mental
; : None
Children NNP Mental
's POS Mental
Global NNP Mental
Assessment NNP Mental
Scale NNP Mental
; : None
Clinical NNP Mental
Global NNP Mental
Impressions NNP Mental
efficacy NN Mental
) ) None
irritability NN Mental
and CC Mental
hyperactivity NN Mental
-DOCSTART- -X- N

stimuli NNS Physical
-DOCSTART- -X- N

Comparable JJ Other
clinical JJ Other
benefits NNS Other
and CC None
adverse JJ Adverse
effects NNS Adverse
-DOCSTART- -X- N

Health NNP Physical
status NN Physical
was VBD None
measured VBN None
using VBG None
the DT None
SF12 NNP Physical
physical JJ Physical
and CC Physical
mental JJ Physical
summary JJ Physical
component NN Physical
T-scores NNS Physical
and CC None
pain NN Pain
was VBD None
measured VBN None
with IN None
a DT None
100 CD None
mm NN None
visual JJ Other
analogue NN Other
pain NN Other
scale NN Other
. . None
health NN Physical
utility NN Physical
and CC Physical
perceived VBD Physical
health NN Physical
both DT None
measured VBN None
with IN None
the DT None
EuroQol NNP None
instrument NN None
, , None
mental JJ None
health NN None
measured VBN None
with IN None
the DT None
Hospital NNP None
Anxiety NNP Mental
and CC Mental
Depression NNP Mental
scale NN Mental
, , None
disability NN Physical
with IN None
the DT None
modified JJ None
Health NNP None
Assessment NNP None
Questionnaire NNP None
and CC None
economic JJ None
costs NNS None
measured VBN None
from IN None
a DT None
societal JJ None
perspective NN None
. . None
Mean NNP Other
waiting VBG Other
times NNS Other
mean JJ None
[ JJ None
95 CD None
% NN None
confidence NN None
interval NN None
( ( None
CI NNP None
) ) None
] NN None
scores NNS None
for IN None
pain NN Pain
: : None
physical JJ Physical
health NN Physical
status NN Physical
: : None
mental JJ Mental
health NN Mental
status NN Mental
: : None
health NN Physical
utility NN Physical
: : None
-DOCSTART- -X- N

utilising VBG Other
the DT Other
guidebook NN Other
patient JJ Mental
participation NN Mental
-DOCSTART- -X- N

behavioral JJ Mental
improvement NN Mental
. . None
daily JJ Physical
diary NN Physical
; : Physical
daily JJ Physical
visual JJ Physical
analogue NN Physical
scales NNS Physical
of IN Physical
affection NN Physical
, , Physical
reciting VBG Physical
, , Physical
or CC Physical
aspects NNS Physical
of IN Physical
social JJ Physical
interaction NN Physical
; : None
Aberrant NNP Physical
Behavior NNP Physical
Checklists NNP Physical
( ( Physical
ABC NNP Physical
, , Physical
Aman NNP Physical
) ) Physical
; : None
and CC None
Clinical NNP Physical
Global NNP Physical
Improvement NNP Physical
scales NNS Physical
. . None
-DOCSTART- -X- N

heterotopic NN Physical
ossification NN Physical
( ( None
HO NNP None
) ) None
side NN Adverse
effects NNS Adverse
NSAIDs NNP Other
on IN None
heterotopic NN Physical
ossification NN Physical
( ( None
HO NNP None
) ) None
HO NNP Physical
was VBD None
graded VBN None
-DOCSTART- -X- N

in IN Physical
vivo NN Physical
biofilm NN Physical
accumulation NN Physical
Biofilm NNP Physical
accumulation NN Physical
on IN None
provisional JJ Physical
restorations NNS Physical
Biofilm NNP Physical
, , Physical
250 CD Physical
Mum NNP Physical
thick NN Physical
bacterial JJ Physical
accumulation NN Physical
biofilm NN Physical
biofilm NN Physical
formation NN Physical
-DOCSTART- -X- N

IOP-reducing JJ Physical
intraocular JJ Physical
pressure NN Physical
( ( Physical
IOP NNP Physical
) ) Physical
IOP NNP Physical
IOP NNP Physical
IOP NNP Physical
IOP NNP Physical
IOP NNP Physical
IOP NNP Physical
-DOCSTART- -X- N

coagulation NN Physical
and CC Physical
fibrinolysis NN Physical
Plasma NNP Physical
lipids NNS Physical
, , Physical
glucose JJ Physical
homeostasis NN Physical
markers NNS Physical
hemostasic JJ Physical
variables NNS Physical
plasma JJ Physical
levels/activity NN Physical
of IN Physical
fibrinogen NN Physical
factor NN None
VII NNP None
plasminogen JJ None
activator NN None
inhibitor-1 NN None
von NN None
Willebrand NNP None
factor NN None
levels NNS None
prothrombin NN None
and CC None
partial JJ None
thromboplastin NN None
times NNS None
coagulation NN None
and CC None
fibrinolysis NN None
-DOCSTART- -X- N

acute JJ None
postoperative JJ None
pressure NN None
intraocular JJ Physical
pressure NN Physical
( ( Physical
IOP NNP Physical
) ) Physical
IOPs NNP Physical
average NN Physical
of IN Physical
the DT Physical
maximum JJ Physical
pressure NN Physical
rises VBZ Physical
IOP NNP Physical
rises VBZ Physical
IOP NNP Physical
rises VBZ Physical
pressure NN Physical
rise NN Physical
> VBZ Physical
20 CD Physical
mm NN Physical
Hg NNP Physical
rises NNS Physical
> VBP Physical
6 CD Physical
mm NN Physical
Hg NNP Physical
rises NNS Physical
> VBP Physical
6 CD Physical
acute JJ Physical
pressure NN Physical
rises NNS Physical
acute JJ Physical
IOP NNP Physical
-DOCSTART- -X- N

Emotional NNP Mental
, , Mental
motivational JJ Mental
and CC Mental
interpersonal JJ Mental
responsiveness NN Mental
events NNS Mental
of IN Mental
'joy NNP Mental
' POS Mental
, , Mental
'emotional JJ Mental
synchronicity NN Mental
' POS Mental
and CC Mental
'initiation NN Mental
of IN Mental
engagement NN Mental
' '' Mental
behaviours NNS Mental
'compliant NNP Mental
( ( Mental
positive JJ Mental
) ) Mental
responses NNS Mental
' POS None
'no POS Other
responses NNS Other
' POS Other
social JJ Mental
, , Mental
emotional JJ Mental
and CC Mental
motivational JJ Mental
development NN Mental
-DOCSTART- -X- N

the DT None
survival NN None
rate NN None
the DT None
condition NN None
of IN None
the DT None
peri-implant JJ None
tissues NNS None
The DT None
five-year JJ None
survival NN None
rate NN None
is VBZ None
group NN None
. . None
Mean NNP None
scores VBZ None
on IN None
indices NNS None
for IN None
plaque NN None
, , None
calculus NN None
, , None
gingiva NN None
and CC None
bleeding NN None
were VBD None
periods NNS None
. . None
Mean NNP None
marginal JJ None
bone NN None
loss NN None
over IN None
a DT None
period NN None
of IN None
5 CD None
years NNS None
, , None
was VBD None
-DOCSTART- -X- N

Aberrant NNP Other
Behavior NNP Other
Checklist-Community NNP Other
( ( Other
ABC-C NNP Other
) ) Other
Rating VBG Other
Scale NNP Other
. . None
reduction NN Other
in IN Other
ABC-C NNP Other
subscale NN Other
scores NNS Other
for IN Other
irritability NN Other
, , None
stereotypic JJ Physical
behavior NN Physical
and CC None
hyperactivity/noncompliance NN Mental
. . None
-DOCSTART- -X- N

effectiveness NN Other
skills NNS Mental
social JJ Mental
interaction NN Mental
and CC Mental
communication NN Mental
. . None
social JJ Mental
communication NN Mental
skills NNS Mental
outcome NN Mental
of IN Mental
therapy NN Mental
cost-effectiveness NN Other
. . None
standardised JJ Other
scales NNS Other
( ( Mental
Autism NNP Mental
Diagnostic NNP Mental
Observation NNP Mental
Schedule NNP Mental
, , Mental
ADOS NNP Mental
) ) Mental
and CC None
parents NNS Mental
( ( Mental
Social NNP Mental
Responsiveness NNP Mental
Scale NNP Mental
, , Mental
SRS NNP Mental
) ) Mental
Cost NNP Other
effectiveness NN Other
session NN Mental
frequency NN Mental
therapy NN None
outcome NN None
. . None
-DOCSTART- -X- N

effects NNS Other
feedlot NN Other
performance NN Other
and CC Mental
carcass NN Other
characteristics NNS Other
dietary JJ Other
CP NNP Other
Urea-N NNP Other
dietary JJ Physical
CP NNP Physical
and CC Physical
level NN Physical
of IN Physical
RPLM NNP Physical
carcass NN Other
characteristics NNS Other
. . Mental
Feedlot NNP Other
performance NN Other
feedlot JJ Other
performance NN Other
fat JJ Physical
thickness NN Physical
) ) Physical
fat VBZ Physical
thickness JJ Physical
RPLM NNP Physical
cubic JJ Other
( ( Other
P NNP Other
< NNP Other
.10 NNP Other
) ) Other
responses VBZ Other
gain NN Physical
: : Physical
feed VBN Physical
-DOCSTART- -X- N

Efficacy NNP Other
plasma JJ Other
mefloquine NN Other
levels NNS Other
Mefloquine NNP Physical
AUC NNP Physical
time NN Other
to TO Other
reach VB Other
peak JJ Other
concentration NN Other
mefloquine NN Physical
plasma NN Physical
levels NNS Physical
Mefloquine NNP Other
AUC NNP Other
-DOCSTART- -X- N

Recognition NNP Mental
, , Mental
awareness NN Mental
, , Mental
comprehension NN Mental
, , Mental
and CC Mental
acceptance NN Mental
of IN Mental
health NN Mental
messages NNS Mental
-DOCSTART- -X- N

pharmacokinetics NNS Other
relative JJ Other
bioavailability NN Other
of IN Physical
morphine NN Physical
and CC Physical
naltrexone NN Physical
when WRB None
MS-sNT NNP None
is VBZ None
administered VBN None
( ( None
under IN None
fasting VBG None
conditions NNS None
) ) None
with IN None
increasing VBG None
doses NNS Physical
of IN Physical
alcohol NN Physical
. . None
drug NN Physical
interaction NN Physical
overall JJ Other
morphine NN Other
exposure NN Other
C NNP Other
( ( Other
max NN Other
) ) Other
t NN Other
( ( Other
max NN Other
) ) Other
Naltrexone CD Other
sequestering NN Other
was VBD Other
successful JJ Other
-DOCSTART- -X- N

death NN Mortality
, , None
new JJ Physical
myocardial JJ Physical
infarction NN Physical
, , None
and CC None
new JJ Physical
coronary JJ Physical
angioplasty NN Physical
or CC None
coronary JJ Physical
artery NN Physical
bypass NN Physical
procedures NNS Physical
. . None
symptom NN Other
and CC Other
employment NN Other
status NN Other
, , None
quality NN Other
of IN Other
life NN Other
, , None
exercise NN Physical
tolerance NN Physical
, , None
and CC None
left VBD Physical
ventricular JJ Physical
function NN Physical
. . None
-DOCSTART- -X- N

Hamilton NNP Physical
Rating NNP Physical
Scale NNP Physical
for IN Physical
Depression NNP Physical
overall JJ None
assessment NN None
of IN None
efficacy NN None
Zung NNP Other
Self-rating NNP Other
Scale NNP Other
better RBR Other
tolerated VBN Other
-DOCSTART- -X- N

Perioperative JJ Mortality
morbidity NN Mortality
, , None
including VBG None
cervical JJ Physical
wound NN Physical
hematoma NN Physical
, , None
transient JJ Physical
ischemic JJ Physical
attack NN Physical
, , None
and CC None
stroke NN Physical
, , None
and CC None
perioperative JJ Mortality
mortality NN Mortality
Suture NNP Physical
line NN Physical
bleeding VBG Physical
at IN Physical
3 CD Physical
minutes NNS Physical
Suture JJ Physical
line NN Physical
bleeding NN Physical
evaluated VBD Physical
at IN Physical
4 CD Physical
minutes NNS Physical
Net JJ Physical
+/- JJ Physical
SEM NNP Physical
sponge NN Physical
weight NN Physical
( ( Physical
total JJ Physical
intraoperative JJ Physical
suture NN Physical
line NN Physical
bleeding VBG Physical
) ) Physical
Total JJ Physical
suture NN Physical
line NN Physical
bleeding NN Physical
bleeding NN Physical
-DOCSTART- -X- N

change NN Physical
of IN Physical
the DT Physical
size NN Physical
of IN Physical
the DT Physical
thrombus NN Physical
incidence NN Adverse
of IN Adverse
major JJ Adverse
bleeding VBG Adverse
clot NN Physical
size NN Physical
evolution NN Physical
incidence NN Adverse
of IN Adverse
overall JJ Adverse
recurrent JJ Adverse
thromboembolic JJ Adverse
events NNS Adverse
serious JJ Adverse
bleeding VBG Adverse
complications NNS Adverse
-DOCSTART- -X- N

-DOCSTART- -X- N

sensory JJ Mental
impairment NN Mental
social JJ Mental
skills NNS Mental
basic JJ Mental
living NN Mental
skills NNS Mental
-DOCSTART- -X- N

overall JJ Mortality
survival NN Mortality
( ( Mortality
OS NNP Mortality
) ) Mortality
Three-year JJ None
OS NNP None
did VBD None
3-year JJ None
disease-free JJ None
survival NN None
, , None
response NN None
rates NNS None
, , None
toxicity NN None
, , None
or CC None
postoperative JJ None
mortality NN None
. . None
Pathological NNP None
complete JJ None
response NN None
Although IN None
quality NN None
of IN None
life NN None
chemotherapy NN None
compliance NN None
between IN None
GP NNP None
and CC None
TC NNP None
3-year JJ None
OS NNP None
or CC None
response NN None
rates NNS None
. . None
regimens NNS None
' POS None
toxicity NN None
in IN None
survival NN None
the DT None
pathological JJ None
response NN None
-DOCSTART- -X- N

effectiveness NN Other
effectiveness NN Other
physical JJ Mental
activity NN Mental
productivity NN Mental
at IN Mental
work NN Mental
and CC None
sickness JJ Mental
absence NN Mental
, , None
and CC None
healthcare NN Mental
costs NNS Mental
. . None
change NN Other
in IN Other
physical JJ Other
activity NN Other
measured VBN Other
in IN Other
MET NNP Other
minutes NNS Other
per IN Other
week NN Other
, , Other
work NN Other
productivity NN Other
and CC Other
sickness NN Other
absence NN Other
, , Other
and CC Other
healthcare JJ Other
utilisation NN Other
. . Other
various JJ Physical
physiological JJ Physical
measures NNS Physical
. . Physical
Cost-effectiveness JJ Other
questionnaires NNS Other
sickness JJ Mental
absence NN Mental
cost-effectiveness NN Other
-DOCSTART- -X- N

oxygen NN Physical
consumption NN Physical
and CC Physical
energy NN Physical
expenditure NN Physical
. . None
oxygen NN Physical
consumption NN Physical
energy NN Physical
expenditure NN Physical
VO2 NNP Physical
and CC Physical
EE NNP Physical
Cardiovascular JJ Physical
responses NNS Physical
Plasma NNP Physical
drug NN Physical
concentrations NNS Physical
visual JJ Physical
analog NN Physical
scale NN Physical
( ( Physical
VAS NNP Physical
) ) Physical
heart NN Physical
rate NN Physical
pressure NN Physical
rate NN Physical
quotient NN Physical
( ( Physical
PRQ NNP Physical
) ) Physical
heart NN Physical
rate NN Physical
increase NN Physical
in IN Physical
PRQ NNP Physical
. . None
VO2 NNP Physical
and CC Physical
EE NNP Physical
VO2 NNP Physical
. . None
metabolic JJ Physical
variables NNS Physical
. . None
sedation NN Physical
-DOCSTART- -X- N

Coronary NNP Physical
Artery NNP Physical
efficacy NN Other
and CC None
safety NN Other
occurrence NN Mortality
of IN Mortality
cardiovascular JJ Mortality
death NN Mortality
or CC None
nonfatal JJ Physical
myocardial JJ Physical
infarction NN Physical
through IN None
postoperative JJ None
day NN None
30 CD None
. . None
short- JJ Physical
and CC Physical
intermediate-term JJ Physical
morbidity NN Physical
and CC None
mortality NN Mortality
-DOCSTART- -X- N

Absorption NN Other
of IN Other
intramuscular JJ Other
phenobarbitone NN Other
absorption NN Physical
of IN Physical
intramuscular JJ Other
phenobarbitone NN Physical
repeated VBN Physical
convulsions NNS Physical
uncomplicated JJ Physical
recovery NN Physical
. . Physical
convulsions NNS Physical
toxicity NN Other
level NN Physical
of IN Physical
coma NN Physical
become VB Physical
sleepy NN Physical
febrile JJ Physical
convulsions NNS Physical
. . Physical
-DOCSTART- -X- N

tissue NN Physical
trace NN Physical
element NN Physical
concentrations NNS Physical
. . Physical
antioxidant JJ None
status NN None
clinical JJ Physical
outcome NN Physical
Plasma NNP Physical
TE NNP Physical
concentrations NNS Physical
skin JJ Physical
contents NNS Physical
of IN Physical
both DT Physical
selenium NN Physical
zinc NN None
Plasma NNP None
and CC None
tissue NN None
antioxidant NN None
status NN None
number NN Physical
of IN Physical
infections NNS Physical
pulmonary JJ None
Wound IN None
healing NN None
requirements NNS None
for IN None
regrafting VBG None
circulating NN None
plasma NN None
and CC None
skin JJ None
tissue NN None
contents NNS None
of IN None
selenium NN None
and CC None
zinc NN None
antioxidant JJ None
status NN None
. . None
clinical JJ None
outcome NN None
, , None
including VBG None
fewer JJR None
pulmonary JJ None
infections NNS None
and CC None
better JJR None
wound NN None
healing NN None
. . None
-DOCSTART- -X- N

Feasibility NN Other
and CC Other
effects NNS Other
feasibility NN Other
and CC Other
effect NN Other
level NN Mental
of IN Mental
advice NN Mental
recorded VBN Mental
drug NN Mental
compliance NN Mental
, , Mental
adverse JJ Mental
drug NN Mental
effects NNS Mental
, , Mental
driving VBG Mental
, , Mental
alcohol NN Mental
intake NN Mental
, , Mental
and CC Mental
self PRP Mental
help VBP Mental
feasible JJ Other
and CC Other
well RB Other
attended VBD Other
. . None
improve VB Mental
the DT Mental
level NN Mental
of IN Mental
advice NN Mental
and CC Mental
drug NN Mental
management NN Mental
-DOCSTART- -X- N

weight JJ Physical
loss NN Physical
Weight NNP Physical
change NN Physical
Weight NNP Physical
loss NN Physical
weight NN Physical
loss NN Physical
Weight NNP Physical
loss NN Physical
weight JJ Physical
loss NN Physical
weight JJ Physical
loss NN Physical
-DOCSTART- -X- N

emotion NN Mental
recognition NN Mental
Reading VBG Mental
the DT Mental
Mind NNP Mental
in IN Mental
the DT Mental
Eyes NNP Mental
Task NNP Mental
emotion NN Mental
recognition NN Mental
. . None
performance NN Mental
on IN Mental
the DT Mental
Reading VBG Mental
the DT Mental
Mind NNP Mental
in IN Mental
the DT Mental
Eyes NNP Mental
Task NNP Mental
. . None
emotion NN Mental
recognition NN Mental
-DOCSTART- -X- N

cost-effectiveness NN Other
cost-effectiveness NN Other
costs NNS Other
costs NNS Other
9.4 CD None
% NN None
of IN None
patients NNS Other
correctly RB Other
treated VBN Other
incremental JJ Other
cost NN Other
Cost-effectiveness NNP Other
-DOCSTART- -X- N

Rehabilitation NNP Physical
outcomes VBZ Physical
risk NN Mental
factors NNS Mental
, , None
psychological JJ Mental
well-being NN Mental
, , None
functional JJ Mental
capacity NN Mental
, , None
and CC None
work NN Mental
resumption NN Mental
serum NN Physical
cholesterol NN Physical
levels NNS Physical
exercise JJ Physical
participation NN Physical
exercise NN Physical
participation NN Physical
body NN Physical
mass NN Physical
index NN Physical
( ( Physical
BMI NNP Physical
) ) Physical
psychological JJ Physical
well-being NN Physical
functional JJ Physical
capacity NN Physical
returned VBN Mental
to TO Mental
work VB Mental
risk NN Other
factor NN Other
profiles NNS Other
and CC Other
work NN Other
resumption NN Other
patterns NNS Other
-DOCSTART- -X- N

reach NN Other
and CC Other
attrition NN Other
between IN Other
Web-based JJ Other
and CC Other
print-delivered JJ Other
tailored JJ Other
interventions NNS Other
user JJ Other
characteristics NNS Other
related VBN Other
to TO Other
participation NN Other
and CC Other
attrition NN Other
user NN Mental
characteristics NNS Mental
dropout NN Other
rate NN Other
higher JJR Mental
participation NN Mental
rate NN Mental
dropout NN Other
rate NN Other
intention NN Mental
to TO Mental
be VB Mental
physically RB Mental
active JJ Mental
dropout NN Other
dropout NN Other
rate NN None
tailored JJ Mental
physical JJ Mental
activity NN Mental
( ( Mental
PA NNP Mental
) ) Mental
dropout NN Other
rate NN Other
dropout NN Other
rates NNS Other
rate NN Other
of IN Other
dropout NN Other
-DOCSTART- -X- N

effect NN Mental
on IN Mental
relatives NNS Mental
burden NN Mental
on IN Mental
the DT Mental
relatives NNS Mental
satisfied JJ Mental
burden NN Mental
on IN Mental
their PRP$ Mental
relatives NNS Mental
-DOCSTART- -X- N

sustained VBN Other
remission NN Other
rates NNS Physical
of IN Physical
sustained JJ Physical
remission NN Physical
low-level JJ Physical
disease NN Physical
activity NN Physical
Disease NNP Physical
flares NNS Physical
relative JJ Physical
risk NN Physical
of IN Physical
disease NN Physical
flares NNS Physical
severe JJ Adverse
or CC Adverse
life-threatening JJ Adverse
adverse JJ Adverse
event NN Adverse
or CC None
died VBN Mortality
Solid JJ Physical
cancers NNS Physical
Durable JJ Physical
remissions NNS Physical
-DOCSTART- -X- N

disease NN Physical
scores NNS Physical
owner NN Physical
mobility NN Physical
veterinary JJ Physical
lameness NN Physical
Owner NNP Physical
mobility NN Physical
scores NNS Physical
owner-assessed JJ Physical
scores NNS Physical
( ( Physical
mobility NN Physical
activity NN Physical
temperament JJ Physical
lifestyle CC Physical
mobility NN Physical
and CC None
activity NN Physical
levels NNS Physical
owner NN Physical
assessment NN Physical
scores VBZ Physical
-DOCSTART- -X- N

index NN None
of IN None
portal-systemic JJ None
encephalopathy NN None
Casein-treated JJ None
patients NNS None
given VBN None
branched-chain JJ None
amino NN None
acids NNS None
improved VBN Physical
. . Physical
semiquantitative JJ None
nitrogen NN None
balance NN None
nutritional JJ None
parameters NNS None
liver JJ None
function NN None
nitrogen JJ None
supply NN None
mental JJ None
state NN None
-DOCSTART- -X- N

relative JJ Other
efficacy NN Other
response NN Other
rate NN Other
survival NN Mortality
and CC Physical
time NN Physical
to TO Physical
progression NN Physical
. . None
inferior JJ Other
-DOCSTART- -X- N

ovulation NN Physical
rate NN Physical
the DT None
ovulation NN None
rates NNS None
for IN None
the DT None
cumulative JJ None
ovulation NN None
rates NNS None
over IN None
ovulation NN None
rates NNS None
in IN None
-DOCSTART- -X- N

Growth NNP Physical
hormone NN Physical
( ( Physical
GH NNP Physical
) ) Physical
responses VBZ Physical
hypothalamic-pituitary-adrenal JJ Physical
axis NN Physical
[ NNP Physical
urinary JJ Physical
free JJ Physical
cortisol NN Physical
( ( Physical
UFC NNP Physical
) ) Physical
excretion NN Physical
, , None
serum NN Physical
cortisol NN Physical
at IN Physical
0800 CD Physical
h NN Physical
, , None
plasma JJ Physical
ACTH NNP Physical
at IN Physical
0800 CD Physical
h NN Physical
, , None
morning NN Physical
cortisol NN Physical
after IN Physical
overnight JJ Physical
1 CD Physical
mg NN Physical
dexamethasone NN Physical
] NN None
. . None
abnormalities NNS Physical
of IN Physical
the DT Physical
hypothalamic-pituitary-adrenal JJ Physical
axis NN Physical
borderline NN Physical
or CC Physical
increased VBN Physical
UFC JJ Physical
excretion NN Physical
UFC NNP Physical
excretion NN Physical
and CC None
lower JJR Physical
ACTH NNP Physical
concentrations NNS Physical
GH NNP Physical
release NN Physical
after IN Physical
GHRH NNP Physical
treatment NN Physical
GH NNP Physical
peaks NNS Physical
after IN Physical
GHRH NNP Physical
plus CC Physical
arginine NN Physical
and CC None
after IN None
GHRH NNP Physical
plus CC Physical
saline NN Physical
GH NNP Physical
response NN Physical
somatostatinergic NN Physical
tone NN Physical
-DOCSTART- -X- N

nocturia NNS Physical
and CC Physical
urgency NN Physical
sensation NN Physical
of IN Physical
incomplete JJ Physical
voiding NN Physical
Residual JJ Physical
urine JJ Physical
volume NN Physical
maximum NN Physical
and CC Physical
average JJ Physical
flow JJ Physical
rates NNS Physical
Average NNP Physical
flow JJ Physical
rate NN Physical
orthostatic JJ Adverse
hypotension NN Adverse
blood NN Adverse
pressure NN Adverse
irritative JJ Physical
and CC Physical
obstructive JJ Physical
symptoms NNS Physical
benign JJ Physical
prostatic JJ Physical
hypertrophy NN Physical
urodynamic JJ Physical
studies NNS Physical
-DOCSTART- -X- N

composite NN Physical
of IN Physical
cardiovascular JJ Physical
mortality NN Physical
, , None
heart NN Physical
failure NN Physical
, , None
thrombo-embolic JJ Physical
complications NNS Physical
( ( Physical
TECs NNP Physical
) ) Physical
, , None
bleeding VBG Physical
, , None
serious JJ Adverse
adverse JJ Adverse
effects NNS Adverse
of IN Adverse
antiarrhythmic JJ Adverse
drugs NNS Adverse
and CC None
pacemaker NN Adverse
implants NNS Adverse
) ) None
coronary JJ Physical
artery NN Physical
disease NN Physical
, , None
heart NN None
failure NN None
, , None
and CC None
digitalis RB Physical
Chronic NNP Physical
sinus NN Physical
rhythm NN Physical
-DOCSTART- -X- N

passive JJ Physical
torque NN Physical
, , Physical
mobility NN Physical
, , Physical
and CC Physical
isometric JJ Physical
muscle NN Physical
force NN Physical
. . Physical
lower-limb JJ Physical
function NN Physical
and CC Physical
flexibility NN Physical
: : Physical
static JJ Physical
passive NN Physical
torque NN Physical
( ( Physical
SPT NNP Physical
) ) Physical
, , Physical
dynamic JJ Physical
passive JJ Physical
torque NN Physical
( ( Physical
DPT NNP Physical
) ) Physical
, , Physical
stiffness NN Physical
, , Physical
straight VBD Physical
leg NN Physical
raise NN Physical
( ( Physical
SLR NNP Physical
) ) Physical
, , Physical
and CC Physical
isometric JJ Physical
muscle NN Physical
force NN Physical
. . Physical
Static JJ Physical
passive JJ Physical
torque NN Physical
Static JJ Physical
passive JJ Physical
torque NN Physical
DPT NNP Physical
and CC Physical
stiffness NN Physical
SLR NNP None
Straight NNP Physical
leg NN Physical
raise NN Physical
higher JJR None
Isometric JJ Physical
muscle NN Physical
force NN Physical
significantly RB Physical
decreased VBN Physical
SPT NNP Physical
SLR NNP None
. . None
DPT NNP Physical
and CC Physical
stiffness NN Physical
isometric JJ None
muscle NN None
force NN None
-DOCSTART- -X- N

cortical JJ Physical
bone NN Physical
dimensions NNS Physical
bone NN Physical
mass NN Physical
. . None
improved VBN Physical
bone NN Physical
strength NN Physical
. . None
GH NNP Physical
on IN None
cortical JJ Physical
bone NN Physical
dimensions NNS Physical
. . None
months NNS None
. . None
Cortical NNP None
bone NN None
dimensions NNS None
were VBD None
evaluated VBN None
by IN None
digital JJ None
x-ray JJ None
radiogrammetry NN None
of IN None
the DT None
months NNS None
, , None
cortical JJ None
thickness NN None
was VBD None
increased VBN None
0.0001 CD None
) ) None
and CC None
metacarpal JJ None
index NN None
( ( None
MCI NNP None
) ) None
while IN None
the DT None
endosteal JJ None
diameter NN None
decreased VBN None
( ( None
-4.64 CD None
) ) None
. . None
Total JJ None
bone NN None
width NN None
did VBD None
seen VBN None
on IN None
bone NN None
width NN None
endosteal JJ None
diameter NN None
( ( None
p JJ None
cortical JJ None
thickness NN None
( ( None
p JJ None
< NNP None
the DT None
cortical JJ None
thickness NN None
through IN None
leads VBZ None
to TO None
a DT None
higher JJR None
peak NN None
bone NN None
mass NN None
and CC None
reduce VB None
the DT None
risk NN None
of IN None
cortical JJ None
bone NN None
fragility NN None
-DOCSTART- -X- N

progressed VBN Physical
died VBN Mortality
Median JJ Mortality
overall JJ Mortality
survival NN Mortality
prostrate NN Physical
specific JJ Physical
antigen NN Physical
Progression-free JJ Mortality
survival NN Mortality
Toxicity NN Physical
-DOCSTART- -X- N

rate NN Physical
of IN Physical
posterior JJ Physical
capsule NN Physical
opacification NN Physical
( ( Physical
PCO NNP Physical
) ) Physical
. . None
rate NN Physical
of IN Physical
PCO NNP Physical
capsulorhexis NN Physical
optics NNS Physical
of IN Physical
the DT Physical
IOL NNP Physical
totally RB Physical
on IN Physical
the DT Physical
IOL NNP Physical
PCO NNP Physical
PCO NNP Physical
PCO NNP Physical
-DOCSTART- -X- N

Psychological NNP Mental
well-being NN Mental
was VBD None
assessed VBN None
with IN None
General NNP Mental
Health NNP Mental
Questionnaire-12 NNP Mental
( ( Mental
GHQ-12 NNP Mental
) ) Mental
, , None
Thyroid NNP Mental
Symptom NNP Mental
Questionnaire NNP Mental
, , None
and CC None
Hospital NNP Mental
Anxiety NNP Mental
and CC Mental
Depression NNP Mental
Scale NNP Mental
. . None
GHQ-12 NNP None
scores NNS None
GHQ NNP None
scores NNS None
and CC None
fT3 NN None
Thyroid NNP Physical
Symptom NNP Physical
Questionnaire NNP Physical
Hospital NNP Physical
Anxiety NNP Physical
and CC Physical
Depression NNP Physical
Scale NNP Physical
scores NNS Physical
. . None
-DOCSTART- -X- N

Serum NNP Physical
concentrations NNS Physical
of IN Physical
leptin NN Physical
, , None
insulin NN Physical
, , None
cortisol NN Physical
, , None
T4 NNP Physical
, , None
T3 NNP Physical
, , None
insulin-like JJ Physical
growth NN Physical
factor NN Physical
( ( Physical
IGF NNP Physical
) ) Physical
-I NN Physical
, , None
IGF-binding JJ Physical
protein-3 NN Physical
and CC None
the DT None
acid-labile JJ Physical
subunit NN Physical
( ( Physical
ALS NNP Physical
) ) Physical
Baseline NNP Physical
leptin NN Physical
levels NNS Physical
leptin NN Physical
. . None
leptin NN Physical
levels NNS Physical
maximal JJ Physical
leptin JJ Physical
increase NN Physical
leptin NN Physical
leptin NN Physical
within IN Physical
12 CD Physical
h NN None
leptin NN Physical
increased VBN Physical
IGF-I NNP Physical
circulating VBG Physical
leptin NN Physical
levels NNS Physical
leptin NN Physical
levels NNS Physical
-DOCSTART- -X- N

Anthropometric NNP Physical
and CC Physical
blood NN Physical
biochemical JJ Physical
parameters NNS Physical
body NN Physical
weight NN Physical
, , Physical
body NN Physical
mass NN Physical
index NN Physical
, , Physical
waist NN Physical
circumference NN Physical
, , Physical
body NN Physical
fat NN Physical
, , Physical
total JJ Physical
fat JJ Physical
area NN Physical
and CC Physical
subcutaneous JJ Physical
fat JJ Physical
area NN Physical
in IN Physical
the DT Physical
abdomen NNS Physical
and CC Physical
serum NN Physical
triglycerides NNS Physical
, , Physical
low-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
, , Physical
apolipoprotein NN Physical
B NNP Physical
, , Physical
C2 NNP Physical
, , Physical
C3 NNP Physical
and CC Physical
E NNP Physical
these DT Other
parameters NNS Other
body NN Physical
weight NN Physical
body NN Physical
fat NN Physical
blood NN Physical
lipid JJ Physical
profiles NNS Other
-DOCSTART- -X- N

significant JJ None
difference NN None
between IN None
the DT None
two CD None
groups NNS None
of IN None
patients NNS None
with IN None
respect NN None
to TO None
age NN Other
, , Other
sex NN Other
ratio NN Other
, , Other
chest JJS Other
drainage NN Other
duration NN Other
, , None
postprocedural JJ Other
hospital NN Other
stay NN Other
, , None
parenteral JJ Mental
narcotics NNS Mental
requirement NN Mental
, , None
complications NNS Adverse
, , None
or CC None
procedure NN Other
failure NN Other
( ( Other
ie NN Other
, , Other
recurrence NN Other
) ) None
. . None
-DOCSTART- -X- N

relief NN Physical
in IN Physical
more RBR Other
effective JJ Other
wheal NN Physical
and CC Physical
flare NN Physical
reactions NNS Physical
antihistamine NN Physical
activity NN Physical
effect NN Physical
on IN Physical
the DT Physical
flare JJ Physical
reaction NN Physical
changes NNS None
Safety NN Other
antihistamine NN Physical
; : None
-DOCSTART- -X- N

cardiovascular JJ Physical
morbidity NN Physical
. . Physical
myocardial JJ Physical
normal JJ Physical
left JJ Physical
ventricular NN Physical
( ( Physical
LV NNP Physical
) ) Physical
systolic JJ Physical
function NN Physical
impaired JJ Physical
diastolic JJ Physical
function NN Physical
subclinical JJ Physical
LV NNP Physical
systolic NN Physical
and CC Physical
diastolic JJ Physical
dysfunction NN Physical
impaired JJ Physical
circumferential NN Physical
and CC Physical
longitudinal JJ Physical
strain NN Physical
and CC Physical
strain NN Physical
rate NN Physical
improvement NN Physical
in IN Physical
LV NNP Physical
systolic NN Physical
and CC Physical
diastolic JJ Physical
function NN Physical
systolic VB Physical
and CC Physical
diastolic JJ Physical
dysfunction NN Physical
-DOCSTART- -X- N

weight JJ Physical
loss NN Physical
improvement NN Physical
of IN Physical
ventricular JJ Physical
systolic JJ Physical
function NN Physical
left VBD Physical
ventricular JJ Physical
ejection NN Physical
fraction NN Physical
( ( Physical
LVEF NNP Physical
) ) Physical
right JJ Physical
ventricular NN Physical
systolic JJ Physical
function NN Physical
Weight NNP Physical
loss NN Physical
during IN Physical
index NN Physical
admission NN Physical
and CC None
cardiac JJ None
index/cardiac NN None
output NN None
ischemic JJ Physical
or CC Physical
nonischemic JJ Physical
, , Physical
systolic JJ Physical
function NN Physical
of IN Physical
the DT Physical
ventricles NNS Physical
Weight NNP Physical
loss NN Physical
cardiac JJ Physical
index/output NN Physical
LVEF NNP Physical
. . Physical
-DOCSTART- -X- N

fluence NN Pain
, , Pain
pain NN Pain
using VBG Pain
the DT Pain
visual JJ Pain
analog NN Pain
scale NN Pain
, , Other
time NN Other
, , Other
laser NN Other
spot NN Other
spread NN Other
retinal JJ Physical
sensitivity NN Physical
average JJ Other
fluence NN Other
Average JJ Other
time NN Other
required VBN Other
per IN Other
sitting VBG Other
Average NNP Other
visual JJ Other
analog NN Other
scale NN Other
reading NN Other
spot NN Physical
spread NN Physical
average JJ Physical
retinal JJ Physical
sensitivity NN Physical
regression NN Physical
of IN Physical
retinopathy JJ Physical
-DOCSTART- -X- N

rate NN Physical
of IN Physical
ischemic JJ Physical
stroke NN Physical
stroke NN Physical
or CC Physical
systemic JJ Physical
embolism NN Physical
. . None
Major JJ Physical
and CC Physical
nonmajor JJ Physical
clinically RB Physical
relevant JJ Physical
bleeding NN Physical
intracranial JJ Physical
hemorrhage NN Physical
fatal JJ Physical
bleeding NN Physical
major JJ Physical
bleeding NN Physical
intracranial JJ Physical
and CC Physical
fatal JJ Physical
bleeding NN Physical
-DOCSTART- -X- N

quality NN Physical
of IN Physical
pain NN Physical
control NN Physical
, , Physical
the DT Physical
amount NN Physical
and CC Physical
character NN Physical
of IN Physical
the DT Physical
drain NN Physical
fluid NN Physical
, , Physical
incidence NN Physical
of IN Physical
nausea NN Physical
and CC Physical
vomiting NN Physical
, , Physical
length NN Physical
of IN Physical
stay NN Physical
in IN Physical
the DT Physical
postoperative JJ Physical
care NN Physical
unit NN Physical
, , Physical
and CC Physical
amount NN Physical
of IN Physical
morphine NN Physical
quality NN Pain
of IN Pain
pain NN Pain
control NN Pain
incidence NN Physical
of IN Physical
nausea NN Physical
drain NN Physical
output NN Physical
effective JJ Other
efficacy NN Other
-DOCSTART- -X- N

( ( None
all DT None
determined VBN None
surgically RB None
) ) None
response NN Physical
rate NN Physical
survival NN Mortality
median JJ Mortality
survival NN Mortality
time NN Mortality
Hematologic NNP Physical
toxicity NN Physical
Gastrointestinal NNP Adverse
toxicity NN Adverse
Other JJ Adverse
toxicities NNS Adverse
-DOCSTART- -X- N

reduced JJ Physical
drug NN Physical
exposure NN Physical
EVR NNP Physical
and CC None
SVR NNP Physical
Mean NNP Other
ribavirin NN Other
exposure NN Other
EVR NNP Physical
and CC None
SVR NNP Physical
rates NNS Physical
EVR NNP Physical
and CC None
SVR NNP Physical
-DOCSTART- -X- N

visual JJ Physical
field NN Physical
( ( Physical
VF NNP Physical
) ) Physical
progression NN Physical
reduce VB Physical
intraocular JJ Physical
pressure NN Physical
( ( Physical
IOP NNP Physical
) ) Physical
Visual NNP Physical
field NN Physical
progression NN Physical
, , Physical
measured VBN Physical
by IN Physical
Humphrey NNP Physical
24-2 JJ Physical
full-threshold JJ Physical
testing NN Physical
and CC Physical
assessed VBN Physical
by IN Physical
the DT Physical
change NN Physical
in IN Physical
the DT Physical
mean JJ Physical
deviation NN Physical
( ( Physical
MD NNP Physical
) ) Physical
an DT Physical
indicator NN Physical
of IN Physical
substantial JJ Physical
worsening NN Physical
of IN Physical
the DT Physical
VF NNP Physical
MD NNP Physical
. . None
worsening NN Physical
( ( Physical
> CD Physical
or CC Physical
=3 VB Physical
dB NN Physical
) ) Physical
of IN Physical
MD NNP Physical
from IN Physical
baseline NN Physical
VF NNP Physical
loss NN Physical
VF NNP Physical
progression NN Physical
VF JJ Physical
loss NN Physical
lowering NN Physical
of IN Physical
IOP NNP Physical
-DOCSTART- -X- N

intracranial JJ Physical
pressure NN Physical
, , None
cerebral JJ Physical
blood NN Physical
flow NN Physical
, , None
and CC None
cerebral JJ Physical
metabolism NN Physical
effects NNS Other
on IN None
intracranial JJ Physical
pressure NN Physical
( ( Physical
ICP NNP Physical
) ) Physical
, , None
cerebral JJ Physical
blood NN Physical
flow NN Physical
( ( Physical
CBF NNP Physical
) ) Physical
, , None
and CC None
cerebral JJ Physical
metabolism NN Physical
. . None
ICP NNP Physical
CBF NNP Physical
and CC None
the DT None
arteriovenous JJ Physical
difference NN Physical
of IN Physical
oxygen NN Physical
( ( None
AVDO2 NNP None
) ) None
ICP NNP Physical
CBF NNP Physical
AVDO2 NNP Physical
. . None
cerebral JJ Physical
metabolic JJ Physical
rate NN Physical
of IN Physical
oxygen NN Physical
, , None
the DT Physical
arteriovenous JJ Physical
difference NN Physical
of IN Physical
lactate NN Physical
, , Physical
or CC None
the DT None
lactate/oxygen NN Physical
index NN Physical
dura NN Physical
dura NN Physical
cerebral JJ Physical
swelling VBG Physical
. . None
dural JJ Physical
tightness NN Physical
. . None
-DOCSTART- -X- N

recurrence NN Physical
Recurrence NNP Physical
immunosuppression NN None
in IN None
large JJ None
genital JJ None
warts NNS None
. . None
recurrence NN Physical
of IN Physical
large JJ Physical
CA NNP Physical
recurred JJ Physical
lesions NNS Physical
. . None
patients NNS None
' POS None
Treg NNP None
cells NNS None
function NN Physical
of IN Physical
HPV-specific NNP Physical
T NNP Physical
cells NNS Physical
and CC Physical
NK NNP Physical
cells NNS Physical
immune JJ Physical
milieu NN Physical
of IN Physical
the DT Physical
lesion NN Physical
site NN Physical
elimination NN None
of IN None
remnant JJ None
viruses NNS None
. . None
treatment NN None
of IN None
CA NNP None
. . None
-DOCSTART- -X- N

system NN None
, , None
diarrhoeal JJ None
morbidity NN None
data NNS None
( ( None
severity NN None
, , None
duration NN None
, , None
compliance NN None
) ) None
were VBD None
analysing VBG None
cumulative JJ None
probability NN None
of IN None
cure NN None
by IN None
testing VBG None
Cox NNP None
proportional JJ None
hazards NNS None
models NNS None
and CC None
relative JJ None
risk NN None
( ( None
The DT None
cumulative JJ None
probability NN None
of IN None
cure NN None
was VBD None
both DT None
acute JJ None
[ NNP None
and CC None
prolonged VBD None
diarrhoea NNS None
[ NNP None
The DT None
recovery NN None
rates NNS None
of IN None
children NNS None
with IN None
acute JJ None
diarrhoea NN None
receiving VBG None
higher JJR None
recovery NN None
rates NNS None
by IN None
diet NN None
hastened VBD None
recovery NN None
of IN None
-DOCSTART- -X- N

plasma JJ Physical
cytokine NN Physical
levels NNS Physical
. . None
cytokine JJ Physical
production NN Physical
IL-6 NNP Physical
and CC Physical
TNF-alpha NNP Physical
levels NNS Physical
IL-1beta NNP Physical
and CC Physical
IFN-gamma NNP Physical
IL-1beta NNP Physical
IL-1beta NNP Physical
IFN-gamma NNP Physical
IL-1beta NNP Physical
IFN-gamma NNP Physical
IL-2 NNP Physical
IL-2 NNP Physical
-DOCSTART- -X- N

circulating VBG Physical
levels NNS Physical
of IN Physical
proinflammatory NN Physical
cytokines NNS Physical
proinflammatory NN Physical
circulating VBG Physical
levels NNS Physical
of IN Physical
the DT Physical
proinflammatory NN Physical
cytokines NNS Physical
Interleukin-6 NNP Physical
( ( Physical
IL-6 NNP Physical
) ) Physical
, , None
tumor JJ Physical
necrosis NN Physical
factor-alpha NN Physical
( ( Physical
TNF-alpha NNP Physical
) ) Physical
, , None
soluble JJ Physical
tumor NN Physical
necrosis NN Physical
factor-receptor-55 JJ Physical
( ( Physical
sTNF-R55 JJ Physical
) ) Physical
, , None
and CC None
soluble JJ Physical
tumor NN Physical
necrosis NN Physical
factor-receptor-75 JJ Physical
( ( Physical
sTNF-R75 JJ Physical
) ) Physical
concentrations NNS Physical
Clinical JJ Other
, , Other
demographic JJ Other
, , Other
and CC Other
cytokine NN Other
data NNS Other
primary JJ Physical
diagnoses NNS Physical
; : None
clinical JJ Physical
characteristics NNS Physical
; : None
and CC None
IL-6 NNP Physical
, , Physical
sTNF-R55 NN Physical
, , Physical
and CC Physical
sTNF-R75 JJ Physical
levels NNS Physical
TNF-alpha JJ Physical
levels NNS Physical
28-day JJ Mortality
survival NN Mortality
gender NN Other
difference NN Other
survival NN Mortality
or CC None
cytokine NN Physical
levels NNS Physical
. . None
-DOCSTART- -X- N

inhibin NN None
A NNP None
( ( None
analysis NN None
the DT None
Wilcoxon NNP None
rank NN None
sum NN None
test NN None
RESULTS VB None
The DT None
concentration NN None
of IN None
inhibin NN None
A NNP None
showed VBD None
differences NNS None
in IN None
inhibin NN None
A NNP None
concentrations NNS None
between IN None
-DOCSTART- -X- N

beneficial JJ Other
effects NNS Other
Detailed JJ Other
assessment NN Other
drug NN Physical
safety NN Physical
, , Physical
biochemical JJ Physical
and CC Physical
haematological JJ Physical
parameters NNS Physical
efficacy NN Other
tolerate VB Other
metronidazole NN Other
side NN Adverse
effects NNS Adverse
lack NN Other
of IN Other
efficacy NN Other
overall JJ Physical
improvement NN Physical
in IN Physical
articular JJ Physical
index NN Physical
and CC None
morning NN Adverse
stiffness NN Adverse
improvement NN Other
laboratory JJ Physical
indices NNS Physical
of IN Physical
disease NN Physical
activity NN Physical
disease NN Physical
modifying VBG Physical
properties NNS Physical
unacceptably RB Adverse
toxic JJ Adverse
. . Adverse
-DOCSTART- -X- N

migration NN Physical
incidence NN Other
of IN Other
inward JJ Other
migration NN Other
position NN Other
catheter NN Physical
migration NN Physical
-DOCSTART- -X- N

overall JJ Mortality
survival NN Mortality
( ( Mortality
OS NNP Mortality
) ) Mortality
rate NN Mortality
after IN Mortality
9 CD Mortality
months NNS Mortality
. . Mortality
9-month JJ Mortality
OS NNP Mortality
rate NN Mortality
median JJ Mortality
survival NN Mortality
times NNS Mortality
intent-to-treat JJ Physical
response NN Physical
rate NN Physical
Median JJ Mortality
progression-free JJ Mortality
survival NN Mortality
Grade $ Adverse
3/4 CD Adverse
haematological JJ Adverse
toxicities NNS Adverse
grade NN Adverse
3/4 CD Adverse
febrile NN Adverse
neutropaenia NN Adverse
-DOCSTART- -X- N

essential JJ Physical
tremor NN Physical
. . Physical
hand NN Physical
tremor NN Physical
-DOCSTART- -X- N

weight NN Physical
mean JJ Physical
+/- JJ Physical
SD NNP Physical
triglyceride NN Physical
level NN Physical
triglyceride NN Physical
levels NNS Physical
. . None
phase NN Physical
separation NN Physical
layering VBG Physical
out IN Physical
of IN Physical
the DT Physical
emulsion NN Physical
agglutination NN Physical
clots NNS Physical
layering VBG Physical
out RP Physical
, , Physical
agglutination NN Physical
, , Physical
and CC Physical
clot NN Physical
formation NN Physical
-DOCSTART- -X- N

Symptom NNP Physical
Distress NNP Physical
Scale NNP Physical
( ( Physical
SDS NNP Physical
) ) Physical
, , None
Revised VBN Physical
Piper NNP Physical
Fatigue NNP Physical
Scale NNP Physical
( ( Physical
PFS NNP Physical
) ) Physical
, , Physical
and CC None
the DT None
State NNP Mental
Anxiety NNP Mental
Inventory NNP Mental
( ( Mental
SAI NNP Mental
) ) None
decrease NN Other
SAI NNP Mental
SDS NNP Physical
or CC Physical
PFS NNP Physical
values NNS Physical
. . None
improved VBN Physical
symptoms NNS Physical
cybersickness NN Physical
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
baseline NN Physical
median JJ Physical
plasma NN Physical
HIV-1 NNP Physical
RNA NNP Physical
level NN Physical
plasma NN Physical
HIV-1 NNP Physical
RNA NNP Physical
level NN Physical
infrequency NN Physical
of IN Physical
virologic JJ Physical
failure NN Physical
emergence NN Physical
of IN Physical
resistance NN Physical
mutations NNS Physical
, , Physical
CD4 NNP Physical
cell NN Physical
increases NNS Physical
from IN Physical
baseline NN Physical
safety NN Physical
profile NN Physical
, , None
and CC None
incidence NN Physical
of IN Physical
ABC-related NNP Physical
hypersensitivity NN Physical
reactions NNS Physical
-DOCSTART- -X- N

neuropathic JJ Pain
pain NN Pain
. . None
pain NN Pain
in IN Pain
absence NN Pain
of IN Pain
and CC Pain
during IN Pain
a DT Pain
migraine JJ Pain
attack NN Pain
. . None
arterial JJ Pain
pain NN Pain
arterial JJ Pain
pain NN Pain
-DOCSTART- -X- N

Ratings NNS Other
of IN Other
videotapes NNS Other
live JJ Other
ratings NNS Other
. . None
live JJ Other
ratings NNS Other
ratings NNS Other
of IN Other
videotapes NNS Other
. . None
live JJ Other
or CC None
videotape JJ Other
ratings NNS Other
. . None
-DOCSTART- -X- N

fitness NN Physical
parameters NNS Physical
training NN Other
responses NNS Other
fitness NN Physical
measures NNS Physical
. . Physical
VO2max NNP Physical
, , Physical
running VBG Other
time NN Other
to TO Other
exhaustion NN Other
( ( Other
RTE NNP Other
) ) Other
, , Physical
and CC Physical
anthropometry NN Physical
VO2max NNP Physical
Run VB Physical
time NN Physical
to TO Physical
exhaustion NN Physical
anthropometry NN Physical
RTE NNP None
cardiovascular JJ Physical
endurance NN Physical
. . Physical
-DOCSTART- -X- N

absolute NN Other
risk NN Other
difference NN Other
short-term JJ Other
prevention NN Other
. . None
'ipsilateral JJ Physical
ischemic JJ Physical
stroke NN Physical
or CC Physical
vascular JJ Physical
death NN Physical
between IN Physical
randomisation NN Physical
and CC Physical
6 CD Physical
months NNS Physical
' POS None
Instent JJ Physical
restenoses NNS Physical
periprocedural JJ Adverse
complication NN Adverse
rate NN Adverse
. . None
-DOCSTART- -X- N

creatinine JJ Physical
clearance NN Physical
from IN Physical
serum JJ Physical
creatinine NN Physical
glomerular JJ Physical
filtration NN Physical
rate NN Physical
prediction NN None
of IN None
Clcr NNP Physical
from IN Physical
serum JJ Physical
creatinine NN Physical
( ( Physical
Scr NNP Physical
) ) None
correlation NN Physical
predict VB None
Clcr NNP None
from IN None
Scr NNP None
-DOCSTART- -X- N

Fasting VBG Physical
blood NN Physical
samples NNS Physical
Blood NNP Physical
lipoprotein JJ Physical
lipid JJ Physical
levels NNS Physical
Serum NNP Physical
total JJ Physical
cholesterol NN Physical
did VBD None
not RB None
change VB None
serum JJ Physical
triglyceride NN Physical
increased VBN Physical
HDL-cholesterol NNP Physical
by IN None
14 CD None
% NN None
8 CD None
% NN None
in IN None
the DT None
GTD NNP Physical
and CC Physical
DSG NNP Physical
serum NN Physical
LDL NNP Physical
level NN Physical
decreased VBN None
no DT None
further JJ None
significant JJ None
changes NNS None
small JJ None
and CC None
probably RB None
favorable JJ None
effects NNS None
on IN None
serum NN Physical
lipoprotein NN Physical
lipid JJ Physical
levels NNS Physical
. . None
-DOCSTART- -X- N

acute NN Physical
and CC Physical
chronic JJ Physical
electrophysiological JJ Physical
behavior NN Physical
Pacing VBG Other
impedance NN Other
values NNS Other
threshold JJ Other
threshold NN Physical
threshold JJ Physical
chronic JJ Physical
pacing NN Physical
threshold NN Physical
acute JJ Physical
pacing NN Physical
threshold JJ Physical
-DOCSTART- -X- N

Freedom-from-treatment-failure NNP Physical
( ( Physical
FFTF NNP Physical
) ) Physical
and CC None
survival NN Mortality
( ( Mortality
SV NNP Mortality
) ) Mortality
curves VBZ Mortality
acute JJ Physical
toxicities NNS Physical
Analysis NN Physical
of IN Physical
relapse NN Physical
patterns NNS Physical
risk NN Physical
for IN Physical
relapse NN Physical
radiotherapy NN Physical
dose JJ Physical
effect NN Physical
-DOCSTART- -X- N

Hemostatic JJ Physical
function NN Physical
hemostatic JJ Physical
function NN Physical
Postoperative JJ Physical
blood NN Physical
loss NN Physical
shear-induced JJ Physical
hemostasis NN Physical
shear-induced JJ Physical
pathway NN Physical
of IN Physical
aspirin-treated JJ Physical
platelets NNS Physical
thromboxane NN Physical
production NN Physical
and CC Physical
on IN Physical
collagen-induced JJ Physical
platelet NN Physical
aggregation NN Physical
aggregation NN Physical
capacity NN Physical
-DOCSTART- -X- N

cardiovascular JJ Mortality
morbidity NN Mortality
and CC Mortality
mortality NN Mortality
cardiovascular JJ Physical
morbidity NN Physical
and CC Physical
mortality NN Mortality
cardiovascular JJ Physical
death NN Physical
, , Physical
stroke VBD Physical
or CC Physical
myocardial JJ Physical
infarction NN Physical
. . None
Blood NNP Physical
pressure NN Physical
Relative JJ Physical
risk NN Physical
reduction NN Physical
Cardiovascular JJ Physical
mortality NN Physical
mortality NN Mortality
cardiovascular JJ Physical
morbidity NN Physical
and CC Physical
mortality NN Mortality
-DOCSTART- -X- N

Efficacy NN Other
efficacy NN Other
eyelid JJ Physical
debris NN Physical
, , None
eyelid JJ Physical
redness NN Physical
, , None
eyelid JJ Physical
swelling NN Physical
, , None
meibomian JJ Physical
gland NN Physical
( ( Physical
MG NNP Physical
) ) Physical
plugging NN Physical
, , None
and CC None
the DT None
quality NN Physical
of IN Physical
MG NNP Physical
secretion NN Physical
. . None
overall JJ Other
symptomatic JJ Other
relief NN Other
. . None
significant JJ Mental
improvements NNS Mental
MG NNP Physical
plugging NN Physical
, , None
MG NNP Physical
secretions NNS Physical
, , None
and CC None
eyelid JJ Physical
redness NN Physical
MG NNP Physical
plugging VBG Physical
MG NNP Physical
secretion NN Physical
returned VBD Physical
to TO Physical
normal JJ Physical
overall JJ Physical
symptomatic JJ Physical
relief NN Physical
Visual JJ Other
acuity NN Other
measurements NNS Other
and CC Other
biomicroscopic JJ Other
evaluation NN Other
no DT Other
ocular JJ Other
safety NN Other
issues NNS Other
. . None
significantly RB None
greater JJR None
clinical JJ None
benefit NN None
signs NNS Physical
and CC Physical
symptoms NNS Physical
of IN Physical
posterior JJ Physical
blepharitis NN Physical
. . None
-DOCSTART- -X- N

cognitive JJ Mental
, , Mental
language NN Mental
, , Mental
adaptive JJ Mental
, , Mental
social JJ Mental
, , Mental
and CC Mental
academic JJ Mental
measures NNS Mental
rapid JJ Mental
learning NN Mental
average JJ Mental
posttreatment JJ Mental
scores NNS Mental
pretreatment JJ Mental
imitation NN Mental
, , Mental
language NN Mental
, , Mental
and CC Mental
social JJ Mental
responsiveness NN Mental
. . None
-DOCSTART- -X- N

intestinal JJ Physical
absorption NN Physical
was VBD Physical
determined VBN Physical
by IN Physical
H2-exhalation NNP Physical
tests NNS Physical
clinical JJ Physical
symptoms NNS Physical
rate NN Physical
of IN Physical
malabsorption NN Physical
intestinal JJ Physical
absorption NN Physical
carbohydrate JJ Physical
malabsorption NN Physical
-DOCSTART- -X- N

blood NN Physical
loss NN Physical
early JJ Physical
clinical JJ Physical
outcomes NNS Physical
blood NN Physical
loss NN Physical
early JJ Physical
outcomes NNS Physical
blood NN None
loss NN None
early JJ Physical
clinical JJ Physical
outcomes NNS Physical
Hb NNP Physical
loss NN Physical
Transfusion NN Physical
requirements NNS Physical
surgical JJ Other
time NN Other
Knee NNP Physical
Society NNP Physical
Scores NNP Physical
( ( Physical
KSS NNP Physical
) ) Physical
, , Physical
knee JJ Physical
flexion NN Physical
, , Physical
knee VB Physical
swelling VBG Physical
and CC Physical
pain NN Physical
drainage NN Physical
of IN Physical
blood NN Physical
loss NN Physical
of IN Physical
Hb NNP Physical
Surgical JJ None
time NN None
KSS NNP None
Knee NNP Physical
flexion NN Physical
knee VB Physical
swelling VBG Physical
pain NN Physical
blood NN None
drainage NN None
Hb NNP None
loss NN None
transfusion NN None
rate NN None
Surgical JJ None
time NN None
early JJ Physical
clinical JJ Physical
outcomes NNS Physical
-DOCSTART- -X- N

occurrence NN Physical
of IN Physical
neutralizing VBG Physical
anti-erythro JJ Physical
poietin NN Physical
antibodies NNS Physical
, , None
tolerability NN Other
, , None
and CC None
adverse JJ Adverse
events NNS Adverse
( ( Adverse
AEs NNP Adverse
) ) Adverse
Mean NNP Physical
( ( Physical
range NN Physical
) ) Physical
Hb NNP Physical
levels NNS Physical
Mean NNP Other
( ( Other
range NN Other
) ) Other
weekly JJ Other
doses NNS Other
infections NNS Physical
and CC Adverse
infestations NNS Physical
neutralizing VBG Other
anti-erythropoietin JJ Other
antibodies NNS Other
. . None
-DOCSTART- -X- N

median JJ Mortality
survival NN Mortality
survival NN Mortality
rates NNS Mortality
alive JJ Mortality
local JJ Physical
distant NN Physical
recurrences NNS Physical
. . Physical
Severe NNP Adverse
and CC Adverse
life-threatening JJ Adverse
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

less RBR Other
positive JJ Other
attitudes NNS Other
behavioral JJ Mental
intentions NNS Mental
lower JJR Other
ratings NNS Other
attitudes NNS Mental
or CC Mental
behavioral JJ Mental
intentions NNS Mental
-DOCSTART- -X- N

effectiveness NN Other
The DT Physical
Family NNP Physical
Received NNP Physical
Index NNP Physical
Family JJ Physical
End-of-study NNP Physical
Up-to-date NNP Physical
Index NNP Physical
Family NNP Physical
Received NNP Physical
Index NNP Physical
Family NNP Physical
End-of-study NNP Physical
Up-to-date NNP Physical
indices NNS Physical
-DOCSTART- -X- N

complete JJ Physical
regression NN Physical
PDR NNP Physical
complete JJ Physical
regression NN Physical
rate NN Physical
proliferative JJ Physical
diabetic JJ Physical
retinopathy NN Physical
recurrence NN Physical
rapid JJ Physical
recurrence NN Physical
. . None
-DOCSTART- -X- N

Periodontal JJ Physical
probing VBG Physical
depth NN Physical
( ( Physical
PPD NNP Physical
) ) Physical
, , Physical
clinical JJ Physical
probing VBG Physical
attachment JJ Physical
level NN Physical
( ( Physical
CPAL NNP Physical
) ) Physical
, , Physical
and CC Physical
tooth DT Physical
mobility NN Physical
decrease NN Other
in IN Other
PPD NNP Other
tooth DT Physical
mobility NN Physical
gain NN Other
of IN Other
CPAL NNP Other
PPD NNP Other
and CC None
tooth JJ Physical
mobility NN Physical
significantly RB None
reduced VBN None
reductions NNS None
in IN None
tooth DT Physical
mobility NN Physical
and CC None
PPD NNP Other
smaller JJR None
gain NN None
CPAL NNP Other
loss NN Physical
of IN Physical
BRG NNP Physical
material NN Physical
tooth DT Physical
mobility NN Physical
. . None
overall JJ Physical
clinical JJ Physical
success NN Physical
. . Physical
-DOCSTART- -X- N

cured JJ Other
rate NN Other
-DOCSTART- -X- N

blood NN Physical
ammonia NN Physical
and CC None
psychometric NN Physical
abnormalities NNS Physical
ammonia NN Physical
and CC None
improve VB None
psychometric JJ Mental
function NN Mental
Mean NNP Physical
basal NN Physical
ammonia NN Physical
Basal NNP Physical
CRT NNP Physical
2 CD Physical
ammonia NNS Physical
psychometric JJ Mental
function NN Mental
CRT NNP Physical
psychometric JJ Mental
function NN Mental
psychometric JJ Mental
effects NNS Mental
-DOCSTART- -X- N

analgesic JJ Other
efficacy NN Other
post-tonsillectomy JJ Pain
pain NN Pain
management NN Pain
. . None
pain NN Pain
levels NNS Pain
twice RB Pain
daily RB Pain
visual JJ Pain
analogue NN Pain
scale NN Pain
. . None
Mean NNP Pain
postoperative JJ Pain
days NNS Pain
of IN Pain
pain NN Pain
Mean JJ Other
postoperative JJ Other
days NNS Other
of IN Other
analgesic JJ Other
postoperative JJ Adverse
hemorrhage NN Adverse
analgesic JJ Other
effect NN Other
post-tonsillectomy JJ Pain
pain NN Pain
relief NN Pain
-DOCSTART- -X- N

Antihypertensive JJ Other
efficacy NN Other
antihypertensive JJ Other
efficacy NN Other
and CC Other
safety NN Other
diastolic JJ Physical
blood NN Physical
pressure NN Physical
and CC Physical
heart NN Physical
rate NN Physical
supine JJ Physical
systolic/diastolic JJ Physical
blood NN Physical
pressure NN Physical
changes NNS Physical
in IN Physical
standing VBG Physical
( ( Physical
stabilized VBN Physical
) ) Physical
systolic NN Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
-DOCSTART- -X- N

bacteriological JJ Other
effectiveness NN Other
baseline NN Other
characteristics NNS Other
Clinical JJ Physical
cure NN Physical
Urine NNP Physical
bacteriological JJ Physical
eradication NN Physical
adverse JJ Adverse
effects NNS Adverse
effective JJ Other
well-tolerated JJ Other
-DOCSTART- -X- N

Weal NNP Physical
size NN Physical
time NN Physical
from IN Physical
stinging VBG Physical
to TO Physical
removal NN Physical
of IN Physical
the DT Physical
sting NN Physical
stings NNS Other
scraped VBD Other
or CC Other
pinched VBD Other
off RP Other
-DOCSTART- -X- N

renal JJ Physical
and CC Physical
hepatic JJ Physical
function NN Physical
. . None
blood NN Physical
volume NN Physical
, , None
glomerular JJ Physical
filtration NN Physical
rate NN Physical
, , None
renal JJ Physical
plasma NN Physical
flow NN Physical
, , None
plasma VBP Physical
aldosterone JJ Physical
concentration NN Physical
, , None
renin JJ Physical
substrate NN Physical
concentration NN Physical
, , None
and CC None
plasma JJ Physical
renin NN Physical
activity NN Physical
. . None
filtration NN Physical
fraction NN Physical
glomerular JJ Physical
filtration NN Physical
rate NN Physical
, , None
renal JJ Physical
plasma NN Physical
flow NN Physical
, , None
and CC None
urine JJ Physical
flow NN Physical
Plasma NNP Physical
aldosterone NN Physical
levels NNS Physical
glomerular JJ Physical
filtration NN Physical
rate NN Physical
and CC None
renal JJ Physical
plasma NN Physical
flow NN Physical
urinary JJ Physical
excretion NN Physical
of IN Physical
sodium NN Physical
and CC Physical
potassium NN Physical
intraperitoneal JJ None
pressure NN None
glomerular JJ Physical
filtration NN Physical
rate NN Physical
, , None
renal JJ Physical
plasma NN Physical
flow NN Physical
, , None
pressure NN Physical
in IN Physical
the DT Physical
vena NN Physical
cava NN Physical
, , None
hepatic JJ Physical
vein NN Physical
free JJ Physical
flow NN Physical
, , None
and CC None
hepatic JJ Physical
vein NNS Physical
wedged VBD Physical
pressure NN Physical
Venous JJ Physical
pressures NNS Physical
ascitic JJ Physical
fluid NN Physical
pressures NNS Physical
glomerular JJ Physical
filtration NN Physical
rate NN Physical
, , None
renal JJ Physical
plasma NN Physical
flow NN Physical
, , None
and CC None
urine JJ Physical
flow NN Physical
vascular JJ Physical
volume NN Physical
, , None
urine JJ Physical
flow NN Physical
, , Physical
glomerular JJ Physical
filtration NN Physical
rate NN Physical
, , None
and CC None
renal JJ Physical
plasma NN Physical
flow NN Physical
glomerular JJ Physical
filtration NN Physical
rate NN Physical
and CC None
renal JJ Physical
plasma NN Physical
flow NN Physical
and CC None
clinical JJ Physical
condition NN Physical
hepatic JJ Physical
function NN Physical
-DOCSTART- -X- N

Median JJ Mortality
survival NN Mortality
Overall JJ Other
response NN Other
Two- JJ Mortality
and CC Mortality
3-year JJ Mortality
survival NN Mortality
Grade VB Adverse
> NN Adverse
or CC Adverse
= $ Adverse
3 CD Adverse
toxicities NNS Adverse
slow JJ Physical
accrual NN Physical
, , Physical
logistics NNS Physical
of IN Physical
HART NNP Physical
, , Physical
mucosal NN Physical
toxicity NN Physical
-DOCSTART- -X- N

blood NN Physical
triglycerides NNS Physical
blood NN Physical
cholesterol NN Physical
pre-beta-lipoprotein JJ Physical
fraction NN Physical
platelet NN Physical
aggregation NN Physical
platelet NN Physical
adhesiveness NN Physical
nor CC Physical
aggregation NN Physical
rate NN Physical
Tolerance NN Other
palpebral JJ Physical
xanthelasmas NN Physical
heartburn NN Adverse
urticarial JJ Adverse
rash NN Adverse
renal JJ Physical
, , Physical
hepatic JJ Physical
or CC Physical
hematological JJ Physical
malfunctions NNS Physical
GOT NNP None
, , None
GPT NNP None
and CC None
LDH NNP None
thromboembolic JJ Physical
risk NN Physical
-DOCSTART- -X- N

significant JJ Other
difference NN Other
between IN Other
idarubicin NN Other
and CC Other
daunorubicin NN Other
. . Other
survival NN Mortality
analysis NN Mortality
advantage NN Other
of IN Other
idarubicin NNS Other
-DOCSTART- -X- N

positive JJ Other
and CC Other
negative JJ Other
priming NN Other
effects NNS Other
object-based JJ Other
representations NNS Other
excitatory NN Other
and CC Other
inhibitory JJ Other
guidance NN Other
mechanisms NNS Other
visual JJ Physical
search NN Physical
priming NN Other
effects NNS Other
excitatory NN Other
and CC Other
inhibitory NN Other
control NN Other
operate NN Other
comparably RB Other
normal JJ Physical
development NN Physical
. . Physical
-DOCSTART- -X- N

lymphocyte JJ Physical
cell-surface NN Physical
antigen NN Physical
expression NN Physical
mitogen-stimulated JJ Physical
interferon-gamma JJ Physical
and CC None
interleukin-2 JJ Physical
production NN Physical
CD4+ NNP Physical
lymphocytes NNS Physical
CD8+ NNP Physical
lymphocytes NNS Physical
mitogen-stimulated JJ Physical
interferon-gamma JJ Physical
production NN Physical
interleukin-2 JJ Physical
production NN Physical
or CC None
circulating VBG Physical
B-cell NNP Physical
concentrations NNS Physical
-DOCSTART- -X- N

response NN Mental
error NN Mental
monitoring NN Mental
and CC None
post-error JJ Mental
response NN Mental
correction NN Mental
. . None
error NN Mental
processing NN Mental
behavioral JJ Mental
correction NN Mental
event-related JJ Mental
potentials NNS Mental
( ( Mental
ERP NNP Mental
) ) Mental
fronto-central JJ Mental
error-related JJ Mental
negativity NN Mental
( ( Mental
ERN NNP Mental
) ) Mental
, , None
and CC None
the DT None
error-related JJ Mental
positivity NN Mental
( ( None
Pe NNP None
) ) None
. . None
reaction NN None
time NN None
( ( None
RT NNP None
) ) None
, , None
error NN None
rate NN None
, , None
post-error JJ None
RT NNP None
change NN None
, , None
ERN NNP None
, , None
and CC None
Pe NNP None
behavioral JJ Mental
and CC Mental
ERP NNP Mental
measures NNS Mental
. . Mental
Baseline NNP Mental
and CC Mental
post-TMS/or JJ Mental
WTL NNP Mental
EEG NNP Mental
ERN NNP Mental
omission JJ Mental
errors NNS Mental
RT NNPS Mental
post-error JJ None
RT NNP None
RT NNP Mental
, , None
error NN None
rate NN None
, , None
post-error NN None
RT NNP None
slowing NN None
, , None
nor CC None
in IN None
ERN/Pe NNP None
measures NNS None
response-locked JJ Mental
ERP NNP Mental
ERN NNP Mental
ERN NNP Mental
and CC None
Pe NNP Mental
-DOCSTART- -X- N

peripheral VBP Physical
venous JJ Physical
cannulation NN Physical
. . Other
success NN Other
rate NN Other
for IN Other
insertion NN Other
of IN Other
18 CD Other
gauge NN Other
cannula NN Other
into IN Other
vein NN Other
on IN Other
back NN Other
of IN Other
hand NN Other
. . Other
time NN Other
required VBN Other
for IN Other
successful JJ Other
cannulation NN Other
. . Other
insert VB Other
a DT Other
cannula NN Other
failed VBN Other
insertion NN Other
time NN Other
failure NN Other
rates NNS Other
at IN Other
first JJ Other
attempt NN Other
insertion NN Other
of IN Other
peripheral JJ Other
venous JJ Other
cannulas NNS Other
time NN Other
and CC Other
number NN Other
of IN Other
attempts NNS Other
required VBN Other
. . Other
time NN Other
inserting VBG Other
cannulas NN Other
supply NN Other
costs NNS Other
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
relieving VBG Pain
pain NN Pain
0-to-10 JJ Pain
points NNS Pain
visual JJ Pain
analogue JJ Pain
scale NN Pain
( ( Pain
VAS NNP Pain
) ) Pain
unbearable JJ Pain
pain NN Pain
serum NN Physical
PSA NNP Physical
, , Physical
prostate NN Physical
volume NN Physical
, , Physical
and CC Physical
cancer NN Physical
detection NN Physical
rate NN Physical
. . None
procedural JJ Pain
pain NN Pain
. . None
probe-related JJ Pain
pain NN Pain
relieving VBG None
sampling-related JJ None
pain NN None
( ( None
two CD None
pain NN None
sources NNS None
. . None
Complications NNS None
probe-related JJ None
pain NN None
, , None
improve VB None
pain NN None
control NN None
during IN None
-DOCSTART- -X- N

efficacy NN Other
6-year JJ Physical
isolated JJ Physical
central JJ Physical
nervous JJ Physical
system-relapse JJ Physical
rate NN Physical
isolated JJ Physical
bone NN Physical
marrow NN Physical
relapses VBZ Physical
6-year JJ Mortality
event-free JJ Mortality
survival NN Mortality
( ( Mortality
EFS NNP Mortality
) ) Mortality
survival NN Mortality
after IN Mortality
relapse NN Mortality
. . Mortality
-DOCSTART- -X- N

Mental NNP Mental
Development NNP Mental
Index NNP Mental
( ( Mental
MDI NNP Mental
) ) Mental
MDI NNP Mental
The DT None
Psychomotor NNP None
Development NNP None
Index NNP None
was VBD None
higher RBR None
benefits NNS None
on IN None
cognitive NN None
and CC None
psychomotor NN None
outcomes NNS None
. . None
MDI NNP None
and CC None
Psychomotor NNP None
Development NNP None
Index NNP None
scores NNS None
of IN None
both DT None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
safety NN Other
and CC Other
efficacy NN Other
rate NN Physical
of IN Physical
biopsy-confirmed JJ Physical
acute JJ Physical
rejection NN Physical
( ( Physical
BCAR NNP Physical
) ) Physical
and CC Physical
renal JJ Physical
function NN Physical
, , Physical
as IN Physical
measured VBN Physical
by IN Physical
serum JJ Physical
creatinine NN Physical
. . None
BCAR NNP Physical
Mean NNP Physical
serum JJ Physical
creatinine NN Physical
creatinine JJ None
clearance NN None
( ( None
?SEM NNP None
respectively RB None
. . None
Patient NNP None
and CC None
graft NN None
survival NN Mortality
exceeded VBD None
differences NNS None
in IN None
infection NN Physical
or CC Physical
malignancy NN Physical
were VBD None
excellent JJ None
12-month JJ None
patient NN None
and CC None
graft NN None
survival NN None
, , None
a DT None
low JJ None
incidence NN None
of IN None
BCAR NNP None
, , None
and CC None
improved VBD None
renal JJ None
function NN None
in IN None
renal JJ None
adequate JJ None
immunosuppression NN None
while IN None
the DT None
nephrotoxic JJ None
effects NNS None
of IN None
cyclosporine NN None
. . None
These DT None
-DOCSTART- -X- N

toxicity NN None
. . None
Total JJ None
CR NNP None
was VBD None
response NN None
. . None
that IN None
AMLs NNP None
with IN None
a DT None
RASGRP1/APTX NNP None
ratio NN None
of IN None
-DOCSTART- -X- N

effectiveness NN Other
improvements NNS Mental
in IN Mental
social JJ Mental
skills NNS Mental
social JJ Mental
functioning NN Mental
emotion-management JJ Mental
strategies NNS Mental
facial JJ Mental
expression NN Mental
and CC None
body-posture NN Mental
recognition NN Mental
measures NNS Mental
social JJ Mental
skills NNS Mental
and CC None
emotional JJ Mental
understanding NN Mental
-DOCSTART- -X- N

psychotic JJ Mental
symptoms NNS Mental
. . None
extrapyramidal NN Physical
symptoms NNS Physical
neuroendocrinological JJ Physical
effect NN Physical
plasma NN Physical
prolactin NN Physical
level NN Physical
plasma NN Physical
cortisol NN Physical
level NN Physical
. . None
-DOCSTART- -X- N

deep JJ Physical
sedation NN Physical
time NN Other
to TO Other
response NN Other
to TO Other
verbal JJ Other
command NN Other
, , None
Aldrete NNP Physical
score VBD Physical
= JJ Physical
9 CD Physical
, , None
Postanesthesia NNP Other
Discharge NNP Other
Scoring NNP Other
System NNP Other
= VBD Physical
7 CD Physical
, , None
and CC None
assessment NN Physical
by IN Physical
the DT Physical
Digit NNP Physical
Symbol NNP Physical
Substitution NNP Physical
Test NNP Physical
. . None
induction NN Physical
maintenance NN Other
of IN Other
deep JJ Other
sedation NN Other
rapid JJ Other
recovery NN Other
-DOCSTART- -X- N

safety NN Other
tolerability NN Other
safety NN Other
Safety NN Other
and CC Other
tolerability NN Other
measures NNS Physical
of IN Physical
function NN Physical
, , Physical
muscle NN Physical
strength NN Physical
and CC Physical
endurance NN Physical
. . Physical
tolerated VBN Other
dizziness PDT Adverse
serum JJ Physical
concentration NN Physical
of IN Physical
riluzole NN Physical
. . Physical
ALSFRS-R NNP Physical
, , Physical
Maximum NNP Physical
Minute NNP Physical
Ventilation NNP Physical
, , Physical
and CC Physical
Nasal NNP Physical
Inspiratory NNP Physical
Pressure NNP Physical
. . Physical
safely RB Other
multiple JJ None
exploratory JJ None
outcome NN None
measures NNS None
-DOCSTART- -X- N

synergistic JJ Adverse
effects NNS Adverse
synergistic JJ Adverse
effects NNS Adverse
visual JJ Other
analog NN Other
scale NN Other
( ( Other
VAS NNP Other
) ) Other
score NN Other
and CC Other
Lysholm NNP Physical
knee VBD Physical
score NN Physical
VAS NNP Other
score NN Other
Lysholm NNP Physical
score NN Physical
VAS NNP Other
score NN Other
Lysholm NNP Physical
score NN Physical
limp NN Physical
, , None
pain NN Pain
, , None
swelling VBG Adverse
, , None
stair NN Physical
activity NN Physical
and CC None
squat NN Physical
interlocking VBG Physical
and CC Physical
instability NN Physical
clinical JJ Physical
symptoms NNS Physical
motor NN Physical
function NN Physical
of IN Physical
knee NN Physical
joints NNS Physical
-DOCSTART- -X- N

microcirculatory NN Other
blood NN Other
flow NN Other
microcirculatory NN Physical
response NN Physical
Changes NNS Mortality
in IN Mortality
skin JJ Mortality
microcirculatory NN Mortality
volume NN Mortality
and CC Mortality
flux NN Mortality
blood NN Mental
flow NN Mental
baseline NN Mental
blood NN Mental
flow NN Mental
flux NN Mental
blood NN Other
flow NN Other
microcirculatory JJ Other
volume NN Other
and CC Other
flux NN Other
. . Other
-DOCSTART- -X- N

testicular JJ Physical
functions NNS Physical
fertility NN Physical
parameters NNS Physical
testis NN Physical
, , Physical
epididymis NN Physical
, , Physical
prostate NN Physical
, , Physical
and CC Physical
seminal JJ Physical
vesicles NNS Physical
were VBD Physical
weighed VBN Physical
and CC Physical
subjected VBN Physical
to TO Physical
histological JJ Physical
examination NN Physical
. . Physical
spermiogram NN Physical
, , Physical
testicular JJ Physical
enzyme NN Physical
markers NNS Physical
, , Physical
intratesticular JJ Physical
steroid JJ Physical
hormonal NN Physical
profile NN Physical
and CC Physical
testicular JJ Physical
antioxidant NN Physical
status NN Physical
fertility NN Physical
parameters NNS Physical
and CC Physical
testicular JJ Physical
antioxidants NNS Physical
together RB Physical
decrease NN Physical
in IN Physical
malondialdehyde NN Physical
and CC Physical
testicular JJ Physical
pathological JJ Physical
signs NNS Physical
including VBG Physical
degenerative JJ Physical
changes NNS Physical
of IN Physical
the DT Physical
seminiferous JJ Physical
tubules NNS Physical
. . Physical
infertility NN Physical
-DOCSTART- -X- N

mucosal NN Physical
Peri-implant JJ Physical
mucosal NN Physical
response NN Physical
and CC Physical
papilla NN Physical
index NN Physical
Prosthodontic NNP Physical
and CC Physical
aesthetic JJ Physical
age NN None
, , None
gender NN None
, , None
bone NN Other
quality NN Other
or CC Other
quantity NN Other
, , Other
implant JJ Other
stability NN Other
measurements NNS Other
at IN Other
surgery NN Other
implant JJ Other
length NN Other
. . None
implant JJ Other
success NN Other
rate NN Other
bone NN Physical
loss NN Physical
prosthodontic JJ Other
maintenance NN Other
, , Physical
peri-implant JJ Physical
mucosal NN Physical
response NN Physical
, , Physical
and CC Physical
papilla NN Physical
index NN Physical
-DOCSTART- -X- N

caregiver NN Other
burden NN Other
caregiver JJ Other
satisfaction NN Other
caregiver NN None
burden NN None
satisfaction NN None
caregiver JJ Other
burden NN Other
and CC None
satisfaction NN Other
. . None
Demand NNP Other
and CC Other
control VB Other
patient- JJ Other
and CC Other
caregiver-derived JJ Other
measures NNS Other
. . Other
caregiver NN Other
burden NN Other
control NN None
higher JJR None
burden NN None
. . None
caregiver NN Other
satisfaction NN Other
. . None
caregiver NN None
burden NN None
satisfaction NN None
caregiver NN Other
burden NN Other
caregiver JJ None
satisfaction NN None
-DOCSTART- -X- N

recovery NN Other
absolute JJ Physical
neutrophil NN Physical
count NN Physical
red JJ Other
cell NN Other
transfusion NN Other
requirements NNS Other
, , Other
platelet JJ Physical
recovery NN Physical
or CC None
duration NN Other
of IN Other
hospitalization NN Other
. . None
incidence NN Physical
of IN Physical
rash NN Physical
-DOCSTART- -X- N

basal NN Physical
or CC Physical
Oxo NNP Physical
meal NN Physical
stimulated VBD Physical
gastrin JJ Physical
concentrations NNS Physical
resting VBG Physical
serum JJ Physical
gastrin NN Physical
or CC None
calcium NN Physical
stimulated JJ Physical
increase NN Physical
in IN Physical
gastrin NN Physical
-DOCSTART- -X- N

overall JJ Mental
outcome NN Mental
, , None
specific JJ Mental
symptoms NNS Mental
, , None
and CC None
side JJ Adverse
effects NNS Adverse
improvement NN Physical
side NN Adverse
effects NNS Adverse
and CC None
efficacy NN Other
or CC None
behavior NN Mental
problems NNS Mental
. . None
autistic JJ Mental
symptom NN Mental
severity NN Mental
irritability NN Mental
and CC Mental
hyperactivity NN Mental
. . None
-DOCSTART- -X- N

grading NN Physical
of IN Physical
acute NN Physical
and CC Physical
late JJ Physical
nonhematologic NN Physical
toxicities NNS Physical
( ( None
mucositis NN Physical
, , None
dysphagia NN Physical
, , None
xerostomia NN Physical
) ) None
treatment NN Physical
duration NN Physical
, , None
hematologic JJ Physical
toxicity NN Physical
, , None
and CC None
clinical JJ Physical
outcome NN Physical
. . None
treatment NN Other
duration NN Other
Acute NNP Physical
toxicities NNS Physical
( ( None
mucositis NN Physical
and CC None
dysphagia NN Physical
) ) None
Grade NNP Physical
2 CD Physical
mucositis NN Physical
Grade NNP Physical
4 CD Physical
mucositis NN Physical
dysphagia NN Physical
. . None
Grade NNP Physical
2 CD Physical
xerostomia NN Physical
proportion NN Physical
of IN Physical
patients NNS Physical
with IN Physical
Grade NNP Physical
2 CD Physical
xerostomia NN Physical
-DOCSTART- -X- N

seasonal JJ Physical
allergic JJ Physical
conjunctivitis NN Physical
. . Physical
Bulbar NNP Physical
conjunctival NN Physical
injection NN Physical
( ( Physical
primary JJ Physical
sign NN Physical
) ) Physical
and CC Physical
itching VBG Physical
( ( Physical
primary JJ Physical
symptom NN Physical
) ) Physical
reduction NN Physical
in IN Physical
severity NN Physical
bulbar NN Physical
conjunctival NN Physical
injection NN Physical
proportion NN Other
of IN Other
patients NNS Other
with IN Other
signs NNS Other
or CC Other
symptoms VBZ Other
no DT Other
longer RBR Other
present JJ Other
) ) Other
tolerated VBN Other
. . None
elevation NN Physical
of IN Physical
intraocular JJ Physical
pressure NN Physical
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
heart NN Physical
rate NN Physical
and CC None
urinary JJ Physical
noradrenaline NN Physical
output NN Physical
systolic JJ Physical
or CC Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
. . None
Body NNP Physical
weight VBD Physical
urinary JJ Physical
sodium NN Physical
excretion NN Physical
urinary JJ Physical
sodium NN Physical
output NN Physical
weight JJ Physical
loss NN Physical
Systolic NNP Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressures NNS Physical
heart NN Physical
rate NN Physical
urinary JJ Physical
noradrenaline NN Physical
excretion NN Physical
. . None
sympathetic JJ Physical
nervous JJ Physical
system NN Physical
activity NN Physical
. . None
blood NN Physical
pressure NN Physical
-DOCSTART- -X- N

Lethality NNP Adverse
was VBD Physical
56 CD Adverse
% NN Adverse
in IN Physical
the DT Physical
sepsis NN Physical
group NN Physical
; : None
in IN Mental
the DT Mental
therapy NN Mental
group NN Mental
lethality NN Mortality
was VBD Mental
significantly RB Mental
lower JJR Mental
in IN Mental
patients NNS Mental
with IN Mental
plasmapheresis NN Mental
, , None
even RB None
though IN None
in IN None
this DT None
population NN None
the DT None
organic JJ None
failure NN None
rate NN None
was VBD None
higher JJR None
. . None
the DT Mental
dependency NN Mental
of IN Mental
lethality NN Mental
and CC Mental
age NN Mental
was VBD Mental
similar JJ Mental
in IN Mental
both DT Mental
groups NNS Mental
. . None
Lethality NNP Adverse
at IN Physical
22 CD Adverse
% NN Adverse
in IN Physical
the DT Physical
plasmapheresis NN Physical
group NN Physical
with IN None
double JJ Physical
organ JJ Physical
failure NN Physical
was VBD Physical
significantly RB Physical
lower JJR Physical
( ( Physical
P NNP Physical
> NNP Physical
0.01 CD Physical
) ) Physical
than IN Physical
in IN Physical
controls NNS Physical
. . None
Reduction NN None
of IN None
lethality NN None
seemed VBD None
to TO None
be VB None
as RB None
high JJ None
as IN None
18 CD None
% NN None
in IN None
patients NNS None
with IN None
sepsis NN None
, , None
while IN None
patients NNS None
with IN None
SIRS NNP None
did VBD None
not RB None
profit NN None
from IN None
the DT None
additional JJ None
therapy NN None
. . None
-DOCSTART- -X- N

activation NN Physical
levels NNS Physical
of IN Physical
the DT Physical
hand NN Physical
muscles NNS Physical
Elbow NNP Physical
muscle NN Physical
activation NN Physical
intrinsic JJ Physical
thumb NN Physical
flexor NN Physical
activation NN Physical
elbow JJ Physical
muscle NN Physical
activation NN Physical
intermuscular JJ Physical
coherence NN Physical
between IN Physical
distal JJ Physical
muscle NN Physical
pairs NNS Physical
-DOCSTART- -X- N

Apparent JJ Physical
cure NN Physical
parasitological JJ Physical
cure NN Physical
Ultimate NNP Physical
cure NN Physical
ultimate JJ Other
cure NN Other
adverse JJ Adverse
events NNS Adverse
( ( Adverse
rise NN Adverse
in IN Adverse
serum JJ Adverse
creatinine NN Adverse
and CC Adverse
fall NN Adverse
in IN Adverse
serum JJ Adverse
potassium NN Adverse
, , Adverse
loss NN Adverse
of IN Adverse
appetite NN Adverse
and CC Adverse
shivering NN Adverse
, , None
rigor NN None
and CC None
fever NN None
during IN None
infusion NN None
indicative NN None
of IN None
renal JJ None
, , None
GIT NNP None
and CC None
infusion NN None
related JJ None
toxicities NNS None
respectively RB None
) ) None
relapses NNS Physical
development NN Physical
drug NN Other
unresponsiveness NN Other
. . Physical
-DOCSTART- -X- N

no DT Physical
reaction NN Physical
. . None
tachycardia NN Physical
, , None
mild JJ Physical
hypotension NN Physical
after IN Physical
20 CD Physical
minutes NNS Physical
, , None
sneezing VBG Physical
, , None
itching NN Physical
of IN Physical
the DT Physical
nose NN Physical
, , None
and CC None
rhinorrhea NN Physical
after IN Physical
60 CD Physical
minutes NNS Physical
. . None
diarrhea NN Physical
( ( Physical
4x CD Physical
) ) Physical
, , None
flatulence NN Physical
( ( Physical
3x CD Physical
) ) Physical
, , None
headache NN Physical
( ( Physical
3x CD Physical
) ) Physical
, , None
pruritus NN Physical
( ( Physical
2x CD Physical
) ) Physical
and CC None
ocular JJ Physical
symptoms NNS Physical
histamine NN Physical
and CC Physical
DAO NNP Physical
levels NNS Physical
-DOCSTART- -X- N

Complete JJ Physical
responses NNS Physical
( ( Physical
CR NNP Physical
) ) Physical
severe JJ Physical
toxicity NN Physical
overall JJ Mortality
median JJ Mortality
survival NN Mortality
median JJ Mortality
survival NN Mortality
CR NNP Physical
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
change NN Physical
blood NN Physical
pressure NN Physical
( ( Physical
BP NNP Physical
) ) Physical
. . None
total JJ Physical
fat JJ Physical
intake NN Physical
BP NNP Physical
systolic JJ Physical
( ( Physical
SBP NNP Physical
) ) Physical
and CC Physical
diastolic JJ Physical
( ( Physical
DBP NNP Physical
) ) Physical
blood NN Physical
pressure NN Physical
BP NNP Physical
change NN Physical
. . None
body NN Physical
weight NN Physical
, , Physical
total JJ Physical
fat JJ Physical
intake NN Physical
, , Physical
urinary JJ Physical
sodium NN Physical
and CC Physical
potassium NN Physical
BP NNP Physical
. . None
-DOCSTART- -X- N

disease-free JJ Mortality
survival NN Mortality
disease-free JJ Mortality
survival NN Mortality
. . None
-DOCSTART- -X- N

nicotine NN None
regional JJ Physical
cerebral JJ Physical
glucose JJ Physical
metabolism NN Physical
positron NN Other
emission NN Other
tomographic JJ Other
images NNS Other
cerebral JJ Physical
metabolism NN Physical
of IN Physical
glucose JJ Physical
[ JJ None
18F CD None
] NNS None
fluorodeoxyglucose JJ None
Peak NNP Physical
plasma JJ Physical
nicotine NN Physical
levels NNS Physical
global JJ Physical
cerebral JJ Physical
metabolism NN Physical
of IN Physical
glucose NN Physical
increases NNS None
in IN None
activity NN None
. . None
regional JJ Physical
cerebral JJ Physical
metabolism NN Physical
of IN Physical
glucose NN Physical
decrease NN None
in IN None
regional JJ Physical
cerebral JJ Physical
metabolism NN Physical
of IN Physical
glucose NN Physical
( ( Physical
pepper JJ Physical
nicotine NN Physical
) ) None
cognitive JJ None
effects NNS None
of IN None
nicotine NN None
. . None
-DOCSTART- -X- N

bradycardia NN Physical
and CC None
postoperative JJ Physical
nausea NN Physical
and CC Physical
vomiting NN Physical
( ( Physical
PONV NNP Physical
) ) Physical
prophylaxis NN Physical
of IN Physical
PONV NNP Physical
. . Physical
moderate JJ Physical
peroperative JJ Physical
bradycardia NN Physical
intravenous JJ Physical
atropine NN Physical
. . None
PONV NNP Physical
. . None
droperidol NN Other
droperidol NN None
. . None
mean JJ Other
numbers NNS Other
of IN Other
doses NNS Other
of IN Other
droperidol NN Other
mild JJ Adverse
central JJ Adverse
anticholinergic JJ Adverse
syndrome NN Adverse
. . None
prophylaxis NN Other
against IN Physical
PONV NNP Physical
( ( Physical
auriculoemetic JJ Physical
reflex NN Physical
) ) Physical
bradycardia NN Physical
( ( Physical
auriculocardiac JJ Physical
reflex NN Physical
) ) Physical
side NN Adverse
effects NNS Adverse
. . None
-DOCSTART- -X- N

Recurrence NN Physical
of IN Physical
Clinical NNP Other
eradication NN Other
of IN Other
condylomata NN Other
for IN Other
six CD Other
months NNS Other
following VBG None
adjuvant JJ Other
chemotherapy NN Other
. . None
recurrences NNS Physical
. . None
experienced VBD Other
recurrences NNS Other
. . None
free JJ Physical
of IN Physical
recurrences NNS Physical
-DOCSTART- -X- N

Benefits NNS Other
, , None
morbidity NN Physical
, , None
and CC None
mortality NN Mortality
patient NN Mortality
mortality NN Mortality
, , None
morbidity NN Physical
and CC None
bypass NN Physical
patency NN Physical
rates NNS Physical
bypass JJ Physical
patency NN Physical
, , None
and CC None
mortality NN Mortality
and CC None
morbidity NN Physical
deaths NNS Mortality
deaths NNS Mortality
Major JJ Physical
hemorrhagic JJ Physical
events NNS Physical
patency NN Other
rate NN Other
patency NN Other
rate NN Other
patency NN Other
rate NN Other
bypass NN Other
patency NN Other
risk NN Physical
of IN Physical
morbidity NN Physical
and CC None
mortality NN Mortality
. . None
-DOCSTART- -X- N

ventricular JJ Physical
size NN Physical
Evans NNP Physical
Index NNP Physical
preshunt NN Physical
damage NN Physical
of IN Physical
the DT Physical
brain NN Physical
hydrocephalic JJ Physical
aspects NNS Physical
. . Physical
subdural JJ Physical
effusions NNS Physical
overdrainage NN Physical
. . None
IVP NNP Physical
possible JJ Physical
unphysiological JJ Physical
IVP NNP Physical
variations NNS Physical
level NN Physical
of IN Physical
implantation NN Physical
, , Physical
subcutaneous JJ Physical
pressure NN Physical
or CC Physical
CSF NNP Physical
flow VBP Physical
through IN Physical
the DT Physical
valve NN Physical
. . Physical
-DOCSTART- -X- N

cord NN Physical
complications NNS Physical
. . Physical
Reliability NNP Other
ppv RB Physical
npv RB Physical
sensitivity NN Other
specificity NN Other
level NN Other
of IN Other
agreement NN Other
intraobserver NN Other
variability NN Other
detection NN Physical
of IN Physical
cord NN Physical
complications NNS Physical
. . Physical
-DOCSTART- -X- N

Efficacy NN Other
and CC Other
safety NN Other
blood NN Physical
pressure NN Physical
lowering VBG Physical
efficacy NN Other
and CC Other
safety NN Other
blood NN Physical
pressure NN Physical
lowering VBG Physical
efficacy NN Other
and CC Other
safety NN Other
blood NN Physical
pressure NN Physical
lowering VBG Physical
composite NN Physical
of IN Physical
major JJ Physical
macrovascular NN Physical
and CC Physical
microvascular JJ Physical
disease NN Physical
. . None
relative JJ Physical
risk NN Physical
reductions NNS Physical
primary JJ None
outcome NN None
, , None
major JJ Physical
macrovascular JJ Physical
disease NN Physical
, , None
death NN Physical
and CC None
renal JJ Physical
events NNS Physical
primary JJ None
outcome NN None
tolerability NN Other
blood NN Physical
pressure NN Physical
risk NN None
side NN Adverse
effects NNS Adverse
. . None
-DOCSTART- -X- N

spring NN Physical
seasonal JJ Physical
allergic JJ Physical
rhinitis NN Physical
. . None
seasonal JJ Physical
allergic JJ Physical
rhinitis NN Physical
. . None
symptoms NNS Mental
daytime NN Physical
nasal NN Physical
symptoms NNS Physical
score NN Physical
nighttime NN Physical
symptoms NNS Physical
and CC Physical
daytime JJ Physical
eye NN Physical
symptoms NNS Physical
, , Physical
patient NN Physical
and CC Physical
physician JJ Physical
global JJ Physical
evaluations NNS Physical
of IN Physical
allergic JJ Physical
rhinitis NN Physical
, , Physical
and CC Physical
rhinoconjunctivitis VBP Physical
quality NN Physical
of IN Physical
life NN Physical
. . None
well RB Other
tolerated VBN Other
. . None
symptom JJ Physical
severity NN Physical
quality-of-life JJ Physical
parameters NNS Physical
-DOCSTART- -X- N

efficacy NN None
and CC None
safety NN None
safety NN None
and CC None
efficacy NN None
CMV NNP Other
infection NN Other
, , Other
CMV NNP Other
disease NN Other
, , Other
rejection NN Other
, , Other
opportunistic JJ Other
infections NNS Other
, , Other
and CC Other
possible JJ Other
drug NN Other
toxicity NN Other
. . Other
6-month JJ Other
incidence NN Other
of IN Other
CMV NNP Other
disease NN Other
incidence NN Other
of IN Other
CMV NNP Other
disease NN Other
CMV NNP Other
disease NN Other
incidence NN Other
of IN Other
CMV NNP Other
infection NN Other
symptomatic JJ Other
herpes-simplex JJ Other
infections NNS Other
-DOCSTART- -X- N

Acute NNP Other
and CC Other
long-term JJ Other
safety NN Other
and CC Other
tolerability NN Other
adverse JJ Adverse
events NNS Adverse
safety NN Other
and CC Other
tolerability NN Other
: : None
laboratory NN Other
blood NN Physical
assessments NNS Physical
( ( Other
CBC NNP Other
with IN Other
differential JJ Other
, , Other
electrolytes NNS Other
, , Other
and CC Other
liver JJ Other
function NN Other
tests NNS Other
) ) Other
and CC Other
urinalyses NNS Other
vital NN Physical
signs NNS Physical
Side NNP Adverse
Effects NNP Adverse
Review NNP Adverse
of IN Adverse
AEs NNP Adverse
sleep NN Physical
records NNS Physical
Simpson NNP Physical
Angus NNP Physical
Neurological NNP Physical
Rating NNP Physical
Scale NNP Physical
( ( Physical
SARS NNP Physical
) ) Physical
Abnormal NNP Physical
Involuntary NNP Physical
Movement NNP Physical
Scale NNP Physical
( ( Physical
AIMS NNP Physical
) ) Physical
height NN Physical
and CC Physical
weight NN Physical
. . None
Somnolence NN Adverse
enuresis NN Adverse
excessive JJ Adverse
appetite NN Adverse
rhinitis NN Adverse
difficulty NN Adverse
waking NN Adverse
constipation NN Adverse
Difficulty NN Mental
falling VBG Mental
asleep JJ Mental
and CC Mental
anxiety NN Mental
AEs NNP Adverse
weight NN Physical
and CC Physical
body NN Physical
mass NN Physical
index NN Physical
( ( Physical
BMI NNP Physical
) ) Physical
Extrapyramidal NNP Physical
symptoms NNS Physical
seizures NNS Physical
somnolence NN Adverse
and CC None
weight JJ Adverse
gain NN Adverse
. . None
-DOCSTART- -X- N

brain NN Physical
activity NN Physical
EEG NNP Physical
activity NN Physical
. . Physical
EEG NNP Physical
activity NN Physical
( ( Physical
event-related JJ Physical
potentials NNS Physical
and CC Physical
spectral JJ Physical
power NN Physical
) ) Physical
autism NN Mental
symptoms NNS Mental
, , Mental
IQ NNP Mental
, , Mental
language NN Mental
, , Mental
and CC Mental
adaptive JJ Mental
and CC Mental
social JJ Mental
behaviors NNS Mental
shorter NN None
Nc NNP None
latency NN None
and CC None
increased VBD None
cortical JJ None
activation NN None
( ( None
decreased VBN None
? . None
power NN None
and CC None
increased VBD None
? . None
power NN None
) ) None
when WRB None
shorter JJ None
latency NN None
event-related JJ None
potential JJ None
[ NN None
ERP NNP None
] NNP None
and CC None
greater JJR None
cortical JJ None
activation NN None
when WRB None
objects NNS None
) ) None
. . None
Greater NNP None
cortical JJ None
activation NN None
while IN None
with IN None
improved VBN None
social JJ None
behavior NN None
. . None
with IN None
normalized JJ None
patterns NNS None
of IN None
brain NN None
activity NN None
, , None
with IN None
improvements NNS None
in IN None
social JJ None
behavior NN None
, , None
-DOCSTART- -X- N

Body NNP None
weight VBD None
gain NN None
, , None
feed JJ None
intake NN None
, , None
and CC None
G NNP None
: : None
F NN None
Eimeria NNP None
maxima JJ None
schizonts NNS None
Weights NNS None
of IN None
cecal JJ None
digesta NN None
Expression NN None
of IN None
interleukin-12 NN None
in IN None
ileal JJ None
mucosa NN None
interferon-? JJ None
expression NN None
was VBD None
-DOCSTART- -X- N

BSE NNP Mental
and CC Mental
CARS NNP Mental
rating NN Mental
scales NNS Mental
autistic JJ Mental
symptomatology NN Mental
T-helper-inducers NNP Physical
( ( Physical
CD4+CD8- NNP Physical
) ) Physical
T-cytotoxic-suppressor NNP Physical
( ( Physical
CD4-CD8+ NNP Physical
) ) Physical
CD4/CD8 NNP Physical
ratio NN Physical
. . Physical
natural JJ Physical
killer NN Physical
cells NNS Physical
and CC Physical
activity NN Physical
-DOCSTART- -X- N

blood NN Physical
sugar NN Physical
profile NN Physical
and CC None
insulin NN Physical
consumption NN Physical
STH NNP Physical
, , Physical
ACTH NNP Physical
, , Physical
cortisol NN Physical
, , Physical
and CC Physical
catecholamines NNS Physical
. . None
-DOCSTART- -X- N

duodenal JJ Physical
ulcer NN Physical
recurrence NN Physical
-- : Physical
a DT Physical
eradication NN Other
DU NNP Physical
recurrence NN Physical
. . None
Gram NNP Other
stained VBD Other
mucosal JJ Other
smear NN Other
, , Physical
specific JJ Other
culture NN Other
, , None
biopsy NN Other
urease JJ Other
test NN Other
, , None
histology NN Other
of IN Other
H NNP Other
& CC Other
E NNP Other
staining-were JJ Other
DU NNP Physical
recurrence NN Physical
gastroscopy NN Other
eradication NN Other
rate NN Other
eradication NN Other
of IN Physical
H. NNP Physical
pylori NN Physical
. . None
recurrence NN Physical
rate NN Physical
recurrence NN Physical
rate NN Physical
recurrence NN Physical
of IN Physical
DU NNP Physical
. . None
-DOCSTART- -X- N

Sleep NNP Physical
difficulties NNS Physical
insomnia NN Physical
. . Physical
sleep JJ Physical
parameters NNS Physical
change NN Physical
in IN Physical
sleep JJ Physical
latency NN Physical
. . Physical
age NN Physical
, , Physical
gender NN Physical
, , Physical
socioeconomic JJ Physical
status NN Physical
, , Physical
total JJ Physical
Children NNP Physical
's POS Physical
Sleep NNP Physical
Habits NNP Physical
Questionnaire NNP Physical
score NN Physical
, , Physical
or CC Physical
actigraphy NN Physical
parameters NNS Physical
Mean JJ Physical
change NN Physical
in IN Physical
sleep-onset JJ Physical
latency NN Physical
information NN Other
-DOCSTART- -X- N

SADQ NNP Mental
scores NNS Mental
and CC None
Rand NNP Mental
definite VBP Mental
alcoholism NN Mental
personal JJ Mental
persuasion NN Mental
-DOCSTART- -X- N

concurrent JJ Other
validity NN Other
of IN Other
the DT Other
ADS NNP Other
as IN Other
a DT Other
general JJ Other
measure NN Other
of IN Other
severity NN Other
and CC Other
the DT Other
screening VBG Other
accuracy NN Other
Analyses NNS Mental
of IN Mental
variance NN Mental
tested VBN Mental
differences NNS Mental
between IN Mental
ADS NNP Mental
quartiles NNS Mental
on IN Mental
alcohol- JJ Mental
related JJ Mental
measures NNS Mental
. . Mental
proportion NN Mental
with IN Mental
DSM-IV NNP Mental
physiological JJ Mental
dependence NN Mental
accuracy NN Other
DSMIV NNP Mental
physiological JJ Mental
dependence NN Mental
Screening VBG Other
accuracy NN Other
-DOCSTART- -X- N

vigorous JJ Other
proportion NN None
of IN None
sleep NN None
in IN None
light JJ Physical
sleep NN Physical
( ( None
stage NN None
proportion NN None
of IN None
rapid JJ Physical
eye NN Physical
movement NN Physical
sleep JJ Physical
with IN Physical
increased JJ Physical
exercise NN Physical
intensity NN Physical
( ( None
P NNP None
increase VB None
sleep JJ None
need NN None
; : None
however RB None
increased VBN None
light JJ None
sleep NN None
. . None
-DOCSTART- -X- N

anterior JJ None
approach NN None
with IN None
the DT None
conventional JJ None
liver JJ None
resection NN None
technique NN None
with IN None
regard NN None
to TO None
intraoperative VB None
haematogenous JJ None
tumor NN None
cell NN None
dissemination NN None
. . None
five CD Mortality
year NN Mortality
survival NN Mortality
rates NNS Mortality
( ( Mortality
OS NNP Mortality
and CC Mortality
DFS NNP Mortality
) ) Mortality
, , Mortality
blood NN Physical
loss NN Physical
, , None
duration NN Other
of IN Other
operation NN Other
, , None
requirement NN Other
of IN Other
blood NN Other
transfusions NNS Other
, , None
morbidity NN Mortality
rate NN Mortality
, , None
prognostic JJ Other
relevance NN Other
of IN Other
tumor NN Other
cell NN Other
detection NN Other
in IN Other
blood NN Other
and CC Other
bone NN Other
marrow NN Other
and CC None
the DT None
comparison NN None
of IN None
tumor NN None
cell NN None
detection NN None
by IN None
different JJ None
detection NN None
methods NNS None
. . None
-DOCSTART- -X- N

efficacy NN Other
tolerance NN Other
overall JJ Physical
response NN Physical
rate NN Physical
( ( Physical
CR+PR NNP Physical
) ) Physical
mean JJ Physical
duration NN Physical
of IN Physical
remission NN Physical
mean JJ Mortality
survival NN Mortality
time NN Mortality
WHO NNP Adverse
grade VBD Adverse
4 CD Adverse
toxicity NN Adverse
cardiotoxicity NN Adverse
death NN Mortality
antitumor NN Physical
activity NN Physical
. . None
Toxicity NN Adverse
-DOCSTART- -X- N

drug NN None
release NN None
-DOCSTART- -X- N

healthcare NN Other
resource NN Other
use NN Other
patterns NNS Other
questionnaire NN Physical
establishing VBG Physical
typical JJ Physical
pre-trial JJ Physical
, , Physical
COPD-related JJ Physical
RU NNP Physical
Interactive JJ Other
Voice NNP Other
Response NNP Other
System NNP Other
( ( Other
IVRS NNP Other
) ) Other
RU NNP Physical
inpatient JJ Other
hospital NN Other
care NN Other
) ) None
resource NN Other
use NN Other
proportion NN Other
of IN Other
cases NNS Other
attending VBG Other
the DT Other
physician NN Other
doubled VBD Other
and CC Other
with IN Other
a DT Other
trip NN Other
to TO Other
the DT Other
Emergency NNP Other
Room NNP Other
( ( Other
ER NNP Other
) ) Other
-DOCSTART- -X- N

Protocol-defined JJ Other
cardiotoxicity NN Physical
Median JJ Other
cumulative JJ Other
doxorubicin NN Other
dose NN Other
at IN Other
onset NN Other
of IN Other
cardiotoxicity NN Physical
overall JJ Other
response NN Other
rate NN Other
median JJ Other
TTP NNP Other
Median JJ Mortality
survival NN Mortality
Clinical JJ None
toxicities NNS Physical
palmar-plantar JJ Physical
erythrodysesthesia NN Physical
-DOCSTART- -X- N

average JJ Other
number NN Other
of IN Other
horizontal JJ Other
overlaps NNS Other
for IN Other
the DT Other
loop NN Other
and CC Other
holder NN Other
techniques NNS Other
overlapping VBG Other
highest JJS Other
percentage NN Other
of IN Other
teeth NNS Other
showing VBG Other
the DT Other
alveolar JJ Other
crest NN Other
by IN Other
the DT Other
loop NN Other
technique NN Other
improper JJ Other
positioning NN Other
minimal JJ Other
cone NN Other
cutting NN Other
-DOCSTART- -X- N

treating VBG Physical
AWS NNP Physical
. . None
AWS NNP Physical
symptoms NNS Physical
( ( None
tremor NN Physical
, , None
sweating VBG Physical
, , None
nausea NN Physical
, , None
restlessness NN Physical
) ) None
additional JJ Other
medication NN Other
AWS NNP Physical
score NN None
outcome NN Physical
duration NN Other
of IN Other
ICU NNP Other
stay NN Other
. . None
No DT Adverse
serious JJ Adverse
side NN Adverse
effects NNS Adverse
controls VBZ None
AWS NNP Physical
symptoms NNS Physical
duration NN Physical
of IN Physical
patient NN Physical
withdrawal NN Physical
. . None
-DOCSTART- -X- N

milk NN Physical
yield NN Physical
artificial JJ Other
methods NNS Other
of IN Other
expression NN Other
milk NN Other
expression NN Other
. . None
milk NN Other
yield NN Other
and CC Other
prolactin NN Other
and CC Other
oxytocin NN Other
release NN Other
prolactin NN Other
responses VBZ Other
prolactin JJ Other
elevations NNS Other
. . None
oxytocin JJ Other
response NN Other
. . None
acute NN Other
and CC Other
sustained VBD Other
prolactin NNS Other
rise NN Other
-DOCSTART- -X- N

bone NN Physical
turnover NN Physical
markers NNS Physical
incidence NN Adverse
of IN Adverse
side NN Adverse
effects NNS Adverse
. . None
side JJ Adverse
effects NNS Adverse
, , None
C-telopeptide NNP Physical
, , None
osteocalcin NN Physical
and CC None
urine JJ Physical
hydroxyproline NN Physical
pyrosis NN Physical
( ( Physical
heartburn NN Physical
) ) Physical
nausea NN Physical
: : None
headache NN Physical
C-telopeptide NNP Physical
hydroxyproline NN Physical
osteocalcin $ Physical
heartburn NN Physical
and CC Physical
nausea NN Physical
. . None
biochemical JJ Physical
markers NNS Physical
. . None
-DOCSTART- -X- N

pulmonary JJ Physical
arterial JJ Physical
wedge NN Physical
pressure NN Physical
( ( Physical
PAWP NNP Physical
) ) Physical
mean JJ Physical
arterial JJ Physical
pressures NNS Physical
( ( Physical
MAP NNP Physical
) ) Physical
mean JJ Physical
exercise NN Physical
PAWP NNP Physical
and CC Mental
MAP NNP Physical
PAWP NNP Physical
PAWP NNP Physical
and CC Mental
MAP NNP Physical
-DOCSTART- -X- N

low-level JJ Physical
viral JJ Physical
replication NN Physical
2-long JJ Physical
terminal JJ Physical
repeat NN Physical
median JJ Physical
duration NN Physical
of IN Physical
ART NNP Physical
suppression NN Physical
was VBD None
level NN Physical
of IN Physical
2-LTR JJ Physical
circles NNS Physical
, , None
compared VBN None
group NN None
. . None
Intensification NNP None
also RB None
D-dimer NNP None
level NN None
, , None
compared VBN None
level NN None
of IN None
2-LTR JJ None
circles NNS None
in IN None
D-dimer NNP None
level NN None
, , None
a DT None
-DOCSTART- -X- N

survival NN Mortality
in IN Mortality
stress NN Physical
reduction NN Physical
use NN Physical
of IN Physical
aspirin NN Physical
, , Physical
beta-blockers NNS Physical
, , Physical
angiotensin-converting JJ Physical
enzyme NN Physical
inhibitors NNS Physical
, , Physical
calcium-channel JJ Physical
blockers NNS Physical
, , Physical
and CC Physical
statins VBZ Physical
-DOCSTART- -X- N

pain NN Pain
relief NN Pain
postoperative JJ Pain
pain NN Pain
postoperative JJ Pain
pain NN Pain
visual JJ Other
analogue NN Other
scale NN Other
verbal JJ Mental
rating NN Mental
score NN Mental
. . None
metamizol NN Physical
patient-controlled JJ Other
analgesia NN Other
( ( Other
PCA NNP Other
) ) Other
Pain NNP Pain
, , None
vital JJ Physical
signs NNS Physical
, , None
supplemental JJ Physical
analgesic JJ Physical
consumption NN Physical
and CC None
side-effects NNS Adverse
pain NN Pain
scores NNS Pain
Supplemental JJ Physical
consumption NN Physical
of IN Physical
metamizol NN Physical
cumulative JJ Other
doses NNS Other
analgesic JJ Physical
requirements NNS Physical
pain NN Pain
-DOCSTART- -X- N

synovial JJ Physical
fluid NN Physical
image NN Other
quality NN Other
-DOCSTART- -X- N

incidence NN Physical
of IN Physical
anuria NNS Physical
faster RBR Physical
recovery NN Physical
from IN Physical
hypertension NN Physical
incidence NN Physical
and CC Physical
severity NN Physical
of IN Physical
the DT Physical
histologic JJ Physical
lesions NNS Physical
. . None
blood NN Physical
pressure NN Physical
and CC None
creatinine JJ Physical
clearance NN Physical
values NNS Physical
heparin NN Physical
and CC None
dipyridamole NN Physical
benefit NN Other
over IN Other
symptomatic JJ Other
therapy NN Other
-DOCSTART- -X- N

quality NN Other
of IN Other
life NN Other
quality NN None
of IN None
life NN None
( ( None
QOL NNP None
) ) None
patient NN None
preference NN None
change NN None
of IN None
QOL NNP None
intensity NN None
of IN None
vomiting VBG None
, , None
nausea NN None
, , None
or CC None
time NN None
to TO None
onset VB None
of IN None
vomiting VBG None
global JJ None
QOL NNP None
other JJ None
patient JJ None
preference NN None
, , None
QOL NNP None
, , None
or CC None
symptoms NNS None
-DOCSTART- -X- N

success NN Other
correct JJ Other
assignment NN Other
correct JJ Other
assignment NN Other
Successful NNP Other
masking NN Other
Masking VBG Other
successful JJ Other
-DOCSTART- -X- N

mouth JJ Physical
leak NN Physical
Cephalometry NN Physical
mouth FW Physical
leak NN Physical
and CC None
the DT Other
arousal NN Other
index NN Other
total JJ Physical
sleep JJ Physical
time NN Physical
snoring VBG Physical
time NN Physical
arousal JJ Physical
index NN Physical
mouth NN Physical
leak NN Physical
. . None
Cephalometric JJ Physical
measures NNS Physical
anterior JJ Physical
lower JJR Physical
facial JJ Physical
height NN Physical
. . None
-DOCSTART- -X- N

liver NN Physical
volumes NNS Physical
liver NN Physical
and CC Physical
kidney NN Physical
volumes NNS Physical
Liver NNP Physical
volumes VBZ Physical
significantly RB Physical
decreased VBN Physical
Changes NNS Physical
in IN Physical
liver NN Physical
volumes NNS Physical
significantly RB Other
different JJ Other
Octreotide-induced JJ Physical
liver NN Physical
volume NN Physical
reduction NN Physical
parenchyma JJ Physical
volume NN Physical
Changes NNS Physical
in IN Physical
liver NN Physical
volumes NNS Physical
kidney NN Physical
volumes NNS Physical
Liver NNP Physical
and CC Physical
kidney NN Physical
volume NN Physical
changes NNS Physical
differed VBN Other
net JJ Physical
reductions NNS Physical
in IN Physical
liver NN Physical
kidney NN Physical
volume NN Physical
growth NN Physical
similar JJ Other
. . None
liver RB Physical
volumes NNS Physical
-DOCSTART- -X- N

reduced VBD None
lowlanders NNS None
' POS None
FMD NNP None
and CC None
GTN-induced JJ None
dilatation NN None
( ( None
16.6 CD None
raised VBD None
central JJ None
PWV NNP None
( ( None
6.0 CD None
lower JJR None
carotid NN Physical
wall NN Physical
: : Physical
lumen NNS Physical
ratio VBP Physical
( ( None
?19 CD None
LOOH NNP Physical
and CC None
NO2- NNP Physical
only RB None
LOOH NNP None
correlated VBD None
in IN None
GTN-induced NNP None
dilatation NN None
evident NN None
reduction NN None
in IN None
FMD NNP None
was VBD None
evident JJ None
decline NN None
in IN None
FMD NNP None
was VBD None
caused VBD None
persistent JJ None
impairment NN None
in IN None
vascular JJ None
function NN None
, , None
-DOCSTART- -X- N

beneficial JJ Other
effect NN Other
on IN Physical
clinical JJ Physical
symptoms NNS Physical
or CC Physical
laboratory JJ Physical
parameters NNS Physical
improvement NN Other
-DOCSTART- -X- N

Prevalence NN Physical
of IN Physical
metabolic JJ Physical
syndrome NN Physical
prevalence NN Physical
of IN Physical
metabolic JJ Physical
syndrome NN Physical
age-standardized JJ Physical
prevalences NNS Physical
of IN Physical
metabolic JJ Physical
syndrome NN Physical
risk NN Physical
factors NNS Physical
and CC Physical
higher JJR Physical
prevalence NN Physical
of IN Physical
the DT Physical
metabolic JJ Physical
syndrome NN Physical
Elevated VBN Physical
blood NN Physical
pressure NN Physical
central JJ Physical
obesity NN Physical
hyperglycemia NN Physical
-DOCSTART- -X- N

mean JJ Other
time NN Other
to TO Other
intubation NN Other
success NN Other
rate NN Other
oesophageal JJ Other
intubations NNS Other
mechanical JJ Other
or CC Other
technical JJ Other
errors NNS Other
such JJ Other
as IN Other
disconnection NN Other
feasibility NN Other
-DOCSTART- -X- N

social JJ Mental
responsiveness NN Mental
, , Mental
sensory JJ Mental
processing NN Mental
, , Mental
functional JJ Mental
motor NN Mental
skills NNS Mental
, , Mental
and CC Mental
social-emotional JJ Mental
factors NNS Mental
. . None
Goal NNP Mental
Attainment NNP Mental
Scaling NNP Mental
scores NNS Mental
autistic JJ Mental
mannerisms NNS Mental
-DOCSTART- -X- N

anthelmintic JJ Other
efficacy NN Other
faecal JJ Physical
egg NN Physical
count NN Physical
reduction NN Physical
test NN Physical
( ( Physical
FECRT NNP Physical
) ) Physical
failure NN Other
of IN Other
the DT Other
benzimidazole NN Other
, , Other
imidothiazole NN Other
, , Other
macrocyclic JJ Other
lactone NN Other
and CC Other
salicylanilide JJ Other
groups NNS Other
of IN Other
anthelmintics NNS Other
control VB None
H. NNP None
contortus JJ None
infections NNS None
-DOCSTART- -X- N

Immunogenicity NNP Physical
pertussis NN Physical
toxin NN Physical
, , Physical
filamentous JJ Physical
hemagglutinin NN Physical
, , Physical
pertactin NN Physical
and CC Physical
polioviruses VBZ Physical
1 CD Physical
, , Physical
2 CD Physical
and CC Physical
3 CD Physical
in IN Physical
the DT Physical
Pa NNP Physical
group NN Physical
. . Physical
geometric JJ Physical
mean NN Physical
concentrations NNS Physical
-DOCSTART- -X- N

overall JJ Mortality
survival NN Mortality
probability NN Mortality
recurrence VB Physical
multivariate NN Other
analysis NN Other
nodal JJ Physical
involvement NN Physical
age NN Other
distribution NN Other
sizofiran JJ Other
administration NN Other
primary JJ Physical
tumour NN Physical
size NN Physical
-DOCSTART- -X- N

autism NN Physical
abnormal JJ Mental
sensory JJ Mental
responses NNS Mental
self-regulation NN Mental
. . Mental
sensory JJ Mental
and CC Mental
self-regulatory JJ Mental
responses NNS Mental
-DOCSTART- -X- N

mean JJ Other
percent NN Other
decrease NN Other
in IN Other
frequency NN Other
of IN Other
hot JJ Other
flushes NNS Other
proportion NN Other
of IN Other
women NNS Other
with IN Other
at IN Other
least JJS Other
a DT Other
50 CD Other
% NN Other
reduction NN Other
in IN Other
hot JJ Other
flushes NNS Other
-DOCSTART- -X- N

anti-inflammatory JJ Pain
and CC Pain
analgesic JJ Pain
action NN Pain
Tolerance NN Other
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
mean JJ Physical
serum NN Physical
potassium NN Physical
hyperkalaemia NN Physical
. . None
adverse JJ Adverse
effects NNS Adverse
tolerated VBN Other
and CC Other
safe JJ Other
-DOCSTART- -X- N

ventricular JJ Physical
response NN Physical
Drug NNP Other
efficacy NN Other
ventricular JJ Physical
rate NN Physical
reduction NN Physical
conversion NN Physical
to TO Physical
sinus VB Physical
rhythm NN Physical
. . Physical
heart NN Physical
rate NN Physical
converted VBN Physical
to TO Physical
sinus VB Physical
rhythm NN Physical
Mild NNP Physical
hypotension NN Physical
efficacy NN Other
and CC Other
safety NN Other
acutely RB Physical
decreasing VBG Physical
ventricular JJ Physical
response NN Physical
conversion NN Physical
to TO Physical
sinus VB Physical
rhythm NN Physical
-DOCSTART- -X- N

serum JJ Physical
total JJ Physical
and CC Physical
LDL-cholesterol JJ Physical
concentrations NNS Physical
serum JJ Physical
N-acetyl-beta-glucosaminidase JJ Physical
activity NN Physical
ascorbic JJ Physical
acid NN Physical
plasminogen JJ Physical
activator NN Physical
inhibitor NN Physical
vonWillebrand FW Physical
factor NN Physical
E-selectin NNP Physical
vascular JJ Physical
endothelial JJ Physical
growth NN Physical
factor NN Physical
decrease NN None
in IN None
plasma NN Physical
glutathione NN Physical
( ( None
P NNP None
< NNP None
0.01 CD None
) ) None
levels NNS None
. . None
serum JJ Physical
triglyceride JJ Physical
concentration NN Physical
plasma NN Physical
malondialdehyde NN Physical
increase NN None
in IN None
plasma JJ Physical
PAI-1 NNP Physical
P-selectin NNP Physical
( ( None
P NNP None
< NNP None
0.05 CD None
) ) None
-DOCSTART- -X- N

loco-regional JJ Physical
recurrences NNS Physical
distant JJ Physical
metastases NNS Physical
recurrence-free JJ Mortality
survival NN Mortality
Overall JJ Mortality
survival NN Mortality
recurrence-free NN Mortality
or CC Mortality
overall JJ Mortality
survival NN Mortality
risk NN Physical
of IN Physical
a DT Physical
second JJ Physical
primary JJ Physical
malignancy NN Physical
second JJ Physical
lung NN Physical
cancers NNS Physical
cumulative JJ Physical
incidence NN Physical
at IN Physical
20 CD Physical
years NNS Physical
loco-regional JJ Physical
recurrences NNS Physical
-DOCSTART- -X- N

active JJ Physical
heart NN Physical
rate NN Physical
active JJ Physical
HR NNP Physical
in IN Physical
women NNS Physical
men NNS None
systolic JJ Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
above IN Physical
] NNP Physical
o2max NN Physical
resting VBG Physical
HR NNP Physical
systolic JJ Physical
and CC Physical
diastolic JJ Physical
BP NNP Physical
above IN None
] NNP None
o2max NN Physical
resting VBG Physical
HR NNP Physical
strength NN Physical
, , Physical
muscle NN Physical
endurance NN Physical
, , Physical
body NN Physical
composition NN Physical
, , Physical
and CC Physical
flexibility NN Physical
. . None
-DOCSTART- -X- N

effect NN Other
clinical JJ Physical
pregnancy NN Physical
rate NN Physical
overall JJ Physical
clinical JJ Physical
pregnancy NN Physical
rate NN Physical
did VBD None
not RB None
significantly RB None
alter VB None
the DT None
outcome NN Other
. . None
-DOCSTART- -X- N

mydriasis NN Physical
postoperative JJ Physical
inflammation NN Physical
. . Physical
Pupillary JJ Physical
diameter NN Physical
Inflammatory JJ Physical
indices NNS Physical
decrease NN Physical
in IN Physical
pupil JJ Physical
size NN Physical
anterior JJ Physical
chamber NN Physical
cells NNS Physical
redness NN Physical
in IN Physical
the DT Physical
eye NN Physical
anterior JJ Physical
chamber NN Physical
flare NN Physical
pain NN Pain
maintaining VBG Physical
mydriasis NN Physical
postoperative JJ Pain
pain NN Pain
anterior JJ Physical
chamber NN Physical
flare NN Physical
-DOCSTART- -X- N

dietary JJ Physical
[ NNP Physical
( ( Physical
Na+ NNP Physical
+ NNP Physical
K+ NNP Physical
) ) Physical
- : Physical
( ( Physical
Cl- JJ Physical
+ NNP Physical
SO4= NNP Physical
) ) Physical
] NN Physical
Plasma NNP Physical
calcium NN Physical
concentration NN Physical
and CC None
blood NN Physical
acid-base JJ Physical
parameters NNS Physical
urinary JJ Physical
calcium NN Physical
excretion NN Physical
urinary JJ Physical
pH NN Physical
and CC Physical
bicarbonate NN Physical
excretion NN Physical
-DOCSTART- -X- N

cardiovascular JJ Physical
parameters NNS Physical
( ( Physical
BP NNP Physical
and CC Physical
cardiac JJ Physical
frequency NN Physical
) ) Physical
, , None
respiratory JJ Physical
frequency NN Physical
and CC None
pain NN Pain
score NN Pain
Spontaneous JJ Pain
pain NN Pain
side JJ Adverse
effects NNS Adverse
-DOCSTART- -X- N

acute JJ Physical
blood NN Physical
loss NN Physical
total JJ Physical
blood NN Physical
volume NN Physical
. . None
mortality NN Mortality
rate NN Mortality
acute JJ Physical
blood NN Physical
loss NN Physical
mortality NN Mortality
rate NN Mortality
mortality NN Mortality
rate NN Mortality
acute JJ Physical
blood NN Physical
loss NN Physical
. . None
-DOCSTART- -X- N

efficient JJ Other
recruitment NN Other
method NN Other
-DOCSTART- -X- N

Safety NN Other
, , None
tolerability NN Other
, , None
and CC None
changes NNS Physical
in IN Physical
amyloid JJ Physical
beta NN Physical
concentrations NNS Physical
Abeta NNP Physical
in IN Physical
plasma NN Physical
and CC Physical
cerebrospinal JJ Physical
fluid NN Physical
( ( Physical
CSF NNP Physical
) ) Physical
Plasma NNP Physical
and CC Physical
CSF NNP Physical
concentrations NNS Physical
of IN Physical
LY450139 NNP Physical
, , Physical
Abeta NNP Physical
( ( Physical
1-40 JJ Physical
) ) Physical
Abeta NNP Physical
( ( Physical
1-X JJ Physical
) ) Physical
( ( Physical
Abeta NNP Physical
( ( Physical
total JJ Physical
) ) Physical
) ) Physical
Plasma NNP Physical
Abeta NNP Physical
concentrations NNS Physical
Abeta NNP Physical
concentrations NNS Physical
CSF NNP Physical
Abeta NNP Physical
concentrations NNS Physical
Adverse JJ Adverse
events NNS Adverse
plasma NN Physical
Abeta NNP Physical
plasma NN Physical
Abeta NNP Physical
-DOCSTART- -X- N

greater JJR None
reduction NN None
in IN None
PPD NNP Physical
and CC None
BOP NNP Physical
efficiency NN Physical
in IN Physical
plaque NN Physical
removal NN Physical
BOP NNP Physical
BOP NNP Physical
-DOCSTART- -X- N

Effectiveness NN Other
stimulating VBG Other
dental JJ Other
attendance NN Other
dental JJ Other
attendance NN Other
dental JJ Other
attendance NN Other
. . None
dental JJ Other
attendance NN Other
screening NN None
result NN None
dental JJ Other
attendance NN Other
Dental JJ Other
attendance NN Other
dental JJ Other
attendance NN Other
. . None
dental JJ Other
health NN Other
inequalities NNS Other
. . None
-DOCSTART- -X- N

The DT None
median JJ None
dose JJ None
per IN None
day NN None
was VBD None
achieved VBD None
major JJ None
molecular JJ None
remission NN None
and CC None
deep JJ None
molecular JJ None
remission NN None
achieved VBD None
remissions NNS None
much RB None
later RBR None
than IN None
Grades NNP None
3 CD None
and CC None
4 CD None
adverse JJ None
events NNS None
were VBD None
. . None
Five-year JJ None
relative JJ None
survival NN None
-DOCSTART- -X- N

frequency NN Physical
of IN Physical
recurrences NNS Physical
cumulative JJ Other
percentages NNS Other
of IN Other
patients NNS Other
with IN Other
recurrence NN Other
delayed JJ Physical
ulcer NN Physical
healing NN Physical
or CC None
ulcer JJ Physical
recurrence NN Physical
. . None
-DOCSTART- -X- N

quality NN Other
of IN Other
life NN Other
clinical JJ Other
gait JJ Physical
parameters NNS Physical
range NN Physical
of IN Physical
ankle JJ Physical
motion NN Physical
( ( Physical
ROAM NNP Physical
) ) Physical
, , Physical
gait NN Physical
, , Physical
pain NN Pain
, , Physical
perimeter NN Physical
of IN Physical
lower JJR Physical
limbs NN Physical
, , Physical
and CC Physical
quality NN Physical
of IN Physical
life NN Physical
MEASURES NNP None
ROAM NNP None
, , None
gait NN None
, , None
pain NN None
, , None
perimeter NN None
of IN None
right NN None
and CC None
left VBD None
lower JJR None
limb NN None
, , None
and CC None
quality NN None
of IN None
life NN None
were VBD None
RESULTS NNP None
Quality NNP None
of IN None
life NN None
was VBD None
both DT None
lower JJR None
limbs NN None
in IN None
gait JJ None
dorsiflexion NN None
ROAM NNP None
( ( None
1.02-2.49 JJ None
) ) None
, , None
cadence NN None
( ( None
3.45-1.47 NNP None
) ) None
, , None
stride JJ None
length NN None
( ( None
21.48-10.83 JJ None
) ) None
, , None
step JJ None
length NN None
( ( None
1.68-6.61 JJ None
) ) None
, , None
stance NN None
phase NN None
( ( None
and CC None
foot NN None
( ( None
and CC None
malleolus $ None
( ( None
1.15-1.63 JJ None
) ) None
circumference NN None
. . None
pain NN None
. . None
CONCLUSIONS NNP None
Ankle NNP None
dorsiflexion NN None
during IN None
gait NN None
, , None
walking VBG None
parameters NNS None
, , None
peripheral JJ None
edema NN None
, , None
venous JJ None
pain NN None
, , None
and CC None
quality NN None
of IN None
life NN None
remain VBP None
-DOCSTART- -X- N

complete JJ Physical
remission NN Physical
( ( Physical
CR NNP Physical
) ) Physical
partial JJ Physical
remission NN Physical
failed VBD Physical
to TO Physical
respond VB Physical
died VBD Mortality
overall JJ Physical
survival NN Physical
time NN Physical
to TO Physical
failure NN Physical
( ( Physical
TTF NNP Physical
) ) Physical
time NN Physical
to TO Physical
relapse VB Physical
( ( Physical
TTR NNP Physical
) ) Physical
survival NN Physical
relapse NN Physical
rate NN Physical
persistent JJ Physical
fibronecrotic JJ Physical
mass NN Physical
relapse NN Physical
rate NN Physical
. . Other
Toxicity NNP Adverse
neutropenia JJ Adverse
infection NN Physical
dying VBG Mortality
from IN Mortality
septic JJ Mortality
complications NNS Mortality
neutropenia NN Adverse
documented JJ Adverse
infection NN Adverse
-DOCSTART- -X- N

Serum NNP Physical
erythropoietin NN Physical
concentration NN Physical
, , None
absolute JJ Physical
reticulocyte NN Physical
count NN Physical
, , None
and CC None
adverse JJ Adverse
events NNS Adverse
. . None
Erythropoietin NNP Physical
exposure NN Physical
Mean NNP Physical
absolute JJ Physical
reticulocyte NN Physical
count NN Physical
adverse JJ Adverse
events NNS Adverse
pyrexia NNS Adverse
hypokalemia NN Adverse
hypophosphatemia NN Adverse
tolerated VBN Other
reticulocytosis NN Physical
pharmacodynamic JJ Physical
response NN Physical
-DOCSTART- -X- N

Blood NN Mental
samples NNS Mental
measurement NN Mental
of IN Mental
ionized JJ Mental
calcium NN Mental
, , Mental
ionized JJ Mental
magnesium NN Mental
, , Mental
and CC Mental
laboratory JJ Mental
indicators NNS Mental
of IN Mental
renal JJ Mental
function NN Mental
. . Mental
Hemodynamic NNP Physical
measurements NNS Physical
, , Physical
recovery NN Physical
adverse JJ Physical
events NNS Physical
clinical JJ Physical
efficacy NN Physical
or CC Physical
renal JJ Physical
function NN Physical
. . Physical
decrease NN Physical
from IN Physical
baseline NN Physical
in IN Physical
serum JJ Physical
concentrations NNS Physical
of IN Physical
ionized JJ Physical
calcium NN Physical
and CC Physical
magnesium NN Physical
during IN Physical
infusion NN Physical
Hemodynamic NNP Physical
measurements NNS Physical
systolic JJ Other
blood NN Other
pressure NN Other
, , Other
mean JJ Other
arterial JJ Other
pressure NN Other
, , Other
and CC Other
heart NN Other
rate NN Other
ionized JJ Other
calcium NN Other
ionized JJ Physical
calcium NN Physical
-DOCSTART- -X- N

Reperfusion NN Physical
arrhythmias NN Physical
, , Physical
CK NNP Other
and CC Other
CKMB NNP Other
, , Physical
corrected VBD Other
TIMI NNP Other
frame NN Other
count NN Other
( ( Other
CTFC NNP Other
) ) Other
, , Physical
wall JJ Other
motion NN Other
score NN Other
index NN Other
( ( Other
WMSI NNP Other
) ) Other
and CC Physical
left VBD Other
ventricular JJ Other
ejection NN Other
fraction NN Other
( ( Other
LVEF NNP Other
) ) Other
myocardial JJ Other
blush NN Other
grade NN Other
( ( Other
MBG NNP Other
) ) Other
incidence NN Adverse
of IN Adverse
reperfusion NN Adverse
arrhythmias-frequent JJ Adverse
ventricular JJ Adverse
premature NN Adverse
short JJ Physical
array NN Physical
ventricular JJ Physical
tachycardia NN Physical
beat NN Physical
peaks NNS Physical
CK NNP Physical
and CC None
infarction NN None
areas NNS None
determined VBN None
by IN None
ECG NNP None
all DT None
significantly RB None
lower JJR None
in IN None
significantly RB None
higher JJR None
in IN None
the DT None
-DOCSTART- -X- N

postoperative JJ Physical
perioperative JJ Physical
bleeding NN Physical
. . None
blood NN Physical
loss NN Physical
bleeding NN Physical
time NN Physical
. . None
vWF NN Physical
and CC Physical
factor NN Physical
VIII NNP Physical
: : Physical
C NNP Physical
levels NNS Physical
bleeding NN Physical
time NN Physical
vWF NN Physical
and CC Physical
factor NN Physical
VIII NNP Physical
: : Physical
C NN Physical
levels NNS Physical
Thrombin-antithrombin JJ Physical
III NNP Physical
complex NN Physical
, , Other
fibrinogen NN Physical
degradation NN Physical
product NN Physical
and CC Other
tissue NN Physical
plasminogen NN Physical
activator NN Physical
levels NNS Physical
activation NN Physical
of IN Physical
the DT Physical
coagulation NN Physical
and CC Physical
fibrinolytic JJ Physical
systems NNS Physical
blood NN Physical
loss NN Physical
or CC Physical
blood NN Physical
product NN Physical
requirements NNS Physical
-DOCSTART- -X- N

number NN Physical
and CC Physical
function NN Physical
of IN Physical
endothelial JJ Physical
progenitor NN Physical
cells NNS Physical
vascular JJ Physical
function NN Physical
cardiovascular NN Physical
risk NN Physical
. . Physical
adiponectin JJ Physical
levels NNS Physical
mean JJ Physical
high-sensitivity NN Physical
C-reactive JJ Physical
protein NN Physical
CD34 NNP Physical
( ( Physical
+ NNP Physical
) ) Physical
/kinase NN Physical
insert JJ Physical
domain NN Physical
receptor NN Physical
( ( Physical
+ NNP Physical
) ) Physical
EPCs NNP Physical
cultured VBD Physical
1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine-labeled JJ Physical
acetylated JJ Physical
LDL NNP Physical
( ( Physical
+ NNP Physical
) ) Physical
/lectin NN Physical
( ( Physical
+ NNP Physical
) ) Physical
EPCs NNP Physical
EPC JJ Physical
numbers NNS Physical
SDF-1-induced NNP Physical
migratory NN Physical
capacity NN Physical
clonogenic JJ Physical
potential NN Physical
of IN Physical
EPCs NNP Physical
the DT Physical
colony-forming JJ Physical
units NNS Physical
EPC NNP Physical
numbers NNS Physical
and CC Physical
migration NN Physical
and CC Physical
reduced JJ Physical
NADPH-oxidase NNP Physical
activity NN Physical
. . Physical
number NN Physical
and CC Physical
function NN Physical
of IN Physical
EPCs NNP Physical
-DOCSTART- -X- N

disposition NN Other
pharmacokinetic JJ Physical
properties NNS Physical
Serum NNP Physical
triazolam JJ Physical
concentrations NNS Physical
pharmacokinetic JJ Physical
values NNS Physical
disposition NN Physical
of IN Physical
intravenously RB Physical
administered VBN Physical
triazolam NN Physical
area NN Physical
under IN Physical
the DT Physical
serum JJ Physical
drug NN Physical
concentration-time JJ Physical
curve NN Physical
of IN Physical
oral JJ Physical
triazolam NN Physical
. . Physical
triazolam NN Physical
's POS Physical
terminal JJ Physical
elimination NN Physical
rate NN Physical
constant JJ Physical
time NN Physical
to TO Physical
reach VB Physical
maximum JJ Physical
serum JJ Physical
triazolam NN Physical
concentration NN Physical
. . Physical
systemic JJ Physical
availability NN Physical
of IN Physical
triazolam NN Physical
absorption NN Physical
. . Physical
-DOCSTART- -X- N

presence NN Physical
of IN Physical
exuberant JJ Physical
granulation NN Physical
tissue NN Physical
requiring VBG Physical
excision NN Physical
, , Physical
number NN Physical
of IN Physical
times NNS Physical
excision NN Physical
was VBD Physical
required VBN Physical
, , Physical
total JJ Physical
wound JJ Physical
area NN Physical
, , Physical
area NN Physical
of IN Physical
epithelialisation NN Physical
, , Physical
area NN Physical
of IN Physical
granulation NN Physical
, , Physical
and CC Physical
histological JJ Physical
evaluation NN Physical
of IN Physical
biopsy NN Physical
samples NNS Physical
of IN Physical
wounds NNS Physical
total JJ Physical
area NN Physical
of IN Physical
wounds NNS Physical
the DT Physical
area NN Physical
of IN Physical
granulation NN Physical
tissue NN Physical
the DT None
area NN Physical
of IN Physical
epithelialisation NN Physical
subjective JJ Physical
clinical JJ Physical
assessment NN Physical
of IN Physical
wounds NNS Physical
. . Physical
wound NN Physical
healing NN Physical
. . None
-DOCSTART- -X- N

susceptibility NN Physical
of IN Physical
LDL NNP Physical
to TO Physical
oxidation VB Physical
bioavailability NN Other
and CC Adverse
potential JJ Other
antioxidative JJ Other
effects NNS Other
urine JJ Physical
levels NNS Physical
of IN Physical
ferulic JJ Physical
acid NN Physical
urinary JJ Physical
excretion NN Physical
of IN Physical
ferulic JJ Physical
acid NN Physical
low-density NN Physical
lipoprotein NN Physical
( ( Physical
LDL NNP Physical
) ) Physical
susceptibility NN Physical
to TO Physical
copper VB Physical
oxidation NN Physical
ex FW Physical
vivo NN Physical
. . None
urinary JJ Physical
excretion NN Physical
of IN Physical
ferulic JJ Physical
acid NNS Physical
lag NN Physical
time NN Physical
or CC Physical
propagation NN Physical
rate NN Physical
of IN Physical
the DT Physical
LDL NNP Physical
oxidation NN Physical
antioxidative JJ Physical
effect NN Physical
intake NN Physical
of IN Physical
ferulic JJ Physical
acid NN Physical
-DOCSTART- -X- N

carbohydrate NN Physical
and CC Physical
lipoprotein JJ Physical
metabolism NN Physical
. . None
oral JJ Other
glucose NN Other
tolerance NN Other
test NN Other
fasting VBG Physical
plasma JJ Physical
concentrations NNS Physical
of IN Physical
total JJ Physical
cholesterol NN Physical
; : None
high-density JJ Physical
lipoprotein NN Physical
cholesterol NN Physical
, , None
including VBG Physical
the DT Physical
subfractions NNS Physical
high-density NN Physical
lipoprotein2 NN Physical
cholesterol NN Physical
and CC Physical
high-density NN Physical
lipoprotein3 NN Physical
cholesterol NN Physical
; : None
low-density JJ Physical
lipoprotein NN Physical
cholesterol NN Physical
; : None
very RB Physical
low-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
; : None
and CC None
triglycerides NNS Physical
. . None
transient JJ Physical
deterioration NN Physical
of IN Physical
glucose JJ Physical
tolerance NN Physical
insulin NN Physical
plasma VBP Physical
levels NNS Physical
of IN Physical
triglycerides NNS Physical
, , None
very RB Physical
low-density JJ Physical
lipoprotein NN Physical
cholesterol NN Physical
, , None
and CC None
high-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
increased VBD Physical
high-density NN Physical
lipoprotein NN Physical
cholesterol/total JJ Physical
cholesterol NN Physical
ratio NN Physical
low-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
carbohydrate NN Physical
or CC Physical
lipoprotein JJ Physical
metabolism NN Physical
-DOCSTART- -X- N

self-reported JJ None
3 CD None
months NNS None
prolonged VBN Mental
abstinence NN Mental
, , None
and CC None
1 CD None
month NN None
prolonged VBD None
abstinence NN None
, , None
7-day JJ None
and CC None
24-hour JJ None
point NN None
prevalence NN None
abstinence NN None
. . None
FINDINGS IN None
primary JJ None
outcome NN None
( ( None
9.1 CD None
the DT None
secondary JJ None
outcomes NNS None
-DOCSTART- -X- N

1-year JJ Other
freedom NN Other
from IN Other
efficacy NN Other
failure NN Other
patient JJ Mortality
survival NN Mortality
Mean NNP Physical
modification NN Physical
of IN Physical
diet NN Physical
in IN Physical
renal JJ Physical
disease NN Physical
( ( Physical
MDRD NNP Physical
) ) Physical
The DT None
incidence NN None
of IN None
CKD NNP None
stage NN None
? . None
3 CD None
( ( None
-DOCSTART- -X- N

?g/kg NNS None
. . None
Subject-rated JJ None
drug NN None
strength NN None
was VBD None
inhalation NN None
. . None
Orderly JJ None
time- JJ None
and CC None
dose-related JJ None
effects NNS None
were VBD None
observed VBN None
. . None
Drug NNP None
strength NN None
ratings NNS None
peaked VBD None
questionnaire NN None
measures NNS None
of IN None
mystical-type JJ None
experience NN None
( ( None
Mysticism NNP None
Scale NNP None
) ) None
and CC None
subjective JJ None
effects NNS None
associated VBN None
with IN None
classic JJ None
serotonergic NN None
( ( None
5-HT2 JJ None
( ( None
A NNP None
) ) None
) ) None
hallucinogens VBZ None
( ( None
Hallucinogen NNP None
Rating NNP None
Scale NNP None
) ) None
. . None
increase VB None
heart NN None
rate NN None
or CC None
blood NN None
change NN None
in IN None
spatial JJ None
orientation NN None
, , None
pressure NN None
on IN None
the DT None
body NN None
) ) None
and CC None
-DOCSTART- -X- N

materials NNS Other
efficacy NN Other
-DOCSTART- -X- N

Cost-effectiveness JJ Other
data NNS Other
-DOCSTART- -X- N

tracheal NN Physical
mucosa NN Physical
impaired JJ Physical
mucosal NN Physical
blood NN Physical
flow NN Physical
. . Physical
tracheal NN Physical
mucosal NN Physical
blood NN Physical
flow NN Physical
tracheal JJ Physical
morbidity NN Physical
cuff NN Physical
inflation NN Physical
pressure NN Physical
-DOCSTART- -X- N

Mastication NN None
and CC None
late JJ None
mandibular NN None
fracture NN None
mandibular JJ Physical
fracture NN Physical
mandibular JJ Physical
fracture NN Physical
limiting VBG Physical
mastication NN Physical
data NNS None
concerning VBG None
patients NNS None
' POS None
age NN None
and CC None
gender NN None
; : None
tooth CC None
position NN None
, , None
angulation NN None
, , None
and CC None
depth NN None
; : None
date NN None
and CC None
site NN None
of IN None
surgery NN None
; : None
and CC None
occurrence NN None
of IN None
late JJ None
mandibular JJ None
fracture NN None
were VBD None
recorded VBN None
late JJ Physical
mandibular JJ Physical
fracture NN Physical
severity NN Physical
of IN Physical
impaction NN Physical
late JJ Physical
mandibular JJ Physical
fracture NN Physical
late JJ Physical
fracture NN Physical
-DOCSTART- -X- N

humoral JJ Physical
immune NN Physical
response NN Physical
in IN Physical
vivo JJ Physical
anti-HBs JJ Physical
response NN Physical
in IN Physical
vitro NN Physical
cellular JJ Physical
immune JJ Physical
response NN Physical
dichotomous JJ Other
variables NNS Other
-DOCSTART- -X- N

efficacy NN Other
of IN None
including VBG None
stomatitis NN Physical
, , None
and CC None
laboratory NN None
parameters NNS None
, , None
such JJ None
as IN None
CD4 NNP None
( ( None
+ NNP None
) ) None
and CC None
CD8 NNP Physical
( ( Physical
+ NNP Physical
) ) Physical
counts NNS Physical
and CC None
serum NN Physical
FeLV NNP Physical
p VBZ Physical
27 CD Physical
antigen NN Physical
concentration NN Physical
, , None
were VBD None
period NN None
. . None
No DT None
significant JJ None
difference NN None
among IN None
anaemia NN Adverse
in IN None
one CD None
no DT None
adverse JJ None
effects NNS None
were VBD None
demonstrate VB None
efficacy NN None
of IN None
huIFN-?2a NN None
however RB None
, , None
no DT None
notable JJ None
side NN None
effects NNS None
were VBD None
-DOCSTART- -X- N

[ NN None
Specific NNP Physical
T NNP Physical
cell NN Physical
immune NN Physical
response NN Physical
specific JJ Physical
cellular JJ Physical
immunoresponse NN Physical
HBV NNP Physical
DNA NNP Physical
, , Physical
HBeAg NNP Physical
and CC Physical
liver JJ Physical
functions NNS Physical
secrete VBP Physical
IFN-gamma NNP Physical
ELISPOT NNP Physical
. . None
ELISPOT NNP Physical
positive JJ Physical
ratio NN Physical
ELISPOT NNP Physical
positive JJ Physical
HBV NNP Physical
DNA NNP Physical
HBeAg/Anti-HBe NNP Physical
seroconversion NN Physical
or CC Physical
HBeAg NNP Physical
undetectable JJ Physical
HBV NNP Physical
DNA NNP Physical
, , Physical
HBeAg/Anti-HBe NNP Physical
seroconversion NN Physical
or CC Physical
HBeAg NNP Physical
disappearance NN Physical
. . None
ELISPOT NNP Physical
positive JJ Physical
, , None
HBV NNP Physical
DNA NNP Physical
HBeAg/Anti-HBe NNP Physical
seroconversion NN Physical
or CC None
HBeAg NNP Physical
disappearance NN Physical
HBV NNP Physical
DNA NNP Physical
HBeAg/Anti-HBe NNP Physical
seroconversion NN Physical
. . None
function NN Physical
of IN Physical
specific JJ Physical
T NNP Physical
lymphocytes NNS Physical
-DOCSTART- -X- N

effectiveness JJ Other
exclusive JJ Physical
and CC Physical
appropriate JJ Physical
infant NN Physical
feeding NN Physical
at IN Physical
rate NN Physical
of IN Physical
exclusive JJ Physical
breastfeeding NN Physical
infant JJ Physical
weight NN Physical
and CC Physical
length-for-age JJ Physical
z-scores NNS Physical
HIV-free JJ Mortality
survival NN Mortality
. . None
take VB Physical
their PRP$ Physical
infant NN Physical
to TO Physical
the DT Physical
clinic NN Physical
within IN Physical
the DT Physical
first JJ Physical
week NN Physical
of IN Physical
life NN Physical
HIV-free NNP Physical
survival NN Physical
. . None
-DOCSTART- -X- N

GAI NNP Mental
scores NNS Mental
WAIS-III JJ Other
subtest NN Other
performance NN Other
. . None
Demographic JJ Physical
variables NNS Physical
included VBD None
age NN Physical
, , None
education NN None
, , None
ethnicity NN Physical
, , None
gender NN Physical
and CC None
region NN Physical
of IN Physical
country NN Physical
. . None
vocabulary JJ Mental
, , None
information NN Other
, , None
picture NN Mental
completion NN Mental
, , None
and CC None
matrix NN Other
reasoning VBG Other
raw JJ Other
scores NNS Other
. . None
GAI NNP Mental
. . None
GAI-Estimate NNP Physical
( ( Physical
GAI-E NNP Physical
) ) Physical
algorithms NN Physical
standard JJ Other
error NN Other
-DOCSTART- -X- N

prevention NN Physical
of IN Physical
fungal JJ Physical
infections NNS Physical
antifungal JJ Physical
prophylaxis NN Physical
proven JJ Physical
systemic JJ Physical
fungal JJ Physical
infections NNS Physical
deaths NNS Mortality
of IN Mortality
presumed JJ Mortality
fungal JJ Mortality
origin NN Mortality
aspergillosis NN Physical
mucosal NN Physical
candidal JJ Physical
infections NNS Physical
aspergillosis NN Mortality
. . Mortality
-DOCSTART- -X- N

enhance VB Other
analgesia NN Other
reduce VB Physical
the DT Physical
risk NN Physical
for IN Physical
unwanted JJ Physical
motor NN Physical
blockade NN Physical
. . Physical
pain-relieving JJ Pain
quality NN Pain
Objective JJ Pain
pain NN Pain
scale NN Pain
score NN Pain
and CC Pain
need NN Pain
for IN Pain
supplemental JJ Pain
analgesia NN Pain
Residual JJ Physical
postoperative JJ Physical
sedation NN Physical
supplemental JJ Physical
analgesia NN Physical
degree NN Physical
and CC Physical
the DT Physical
duration NN Physical
of IN Physical
postoperative JJ Physical
sedation NN Physical
postoperative JJ Physical
motor NN Physical
blockade NN Physical
improved JJ Other
quality NN Other
of IN Other
postoperative JJ Other
analgesia NN Other
improved JJ Other
analgesic JJ Other
quality NN Other
-DOCSTART- -X- N

resting VBG Physical
BP NNP Physical
, , Physical
reducing VBG Physical
systolic JJ Physical
( ( Physical
SBP NNP Physical
) ) Physical
and CC Physical
diastolic JJ Physical
( ( Physical
DBP NNP Physical
) ) Physical
blood NN Physical
pressure NN Physical
response NN Other
rate NN Other
BP NNP Physical
BP NNP Physical
BP NNP Physical
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
, , Physical
heart NN Physical
rate NN Physical
and CC Physical
S-FFA NNP Physical
concentrations NNS Physical
clinical JJ Physical
beta-blockade NN Physical
. . None
fasting NN Physical
blood NN Physical
glucose JJ Physical
level NN Physical
. . Physical
fasting VBG Physical
and CC Physical
glucagon-stimulated JJ Physical
serum NN Physical
C-peptide NNP Physical
concentration NN Physical
serum JJ Physical
insulin NN Physical
. . Physical
insulin NN Physical
binding NN Physical
to TO Physical
erythrocytes NNS Physical
glucose JJ Physical
disappearance NN Physical
rate NN Physical
KITT NNP Physical
glucose JJ Physical
metabolism NN Physical
endogenous JJ Physical
insulin NN Physical
secretion NN Physical
. . Physical
-DOCSTART- -X- N

blood VBP Physical
pressure NN Physical
and CC Physical
vascular JJ Physical
resistance NN Physical
hemodynamic JJ Physical
effects NNS Physical
( ( None
aortic JJ Physical
integral NN Physical
, , None
pulmonary JJ Physical
integral JJ Physical
, , None
end-systolic JJ Physical
and CC Physical
end-diastolic JJ Physical
diameters NNS Physical
) ) None
heart NN Physical
rate NN Physical
; : None
-DOCSTART- -X- N

melatonin JJ Physical
secretion NN Physical
melatonin JJ Physical
secretion NN Physical
melatonin NN Physical
secretion NN Physical
nocturnal JJ Physical
melatonin NN Physical
secretion NN Physical
melatonin JJ Physical
secretion NN Physical
urinary JJ Physical
excretion NN Physical
of IN Physical
melatonin NN Physical
GH NNP Physical
secretion NN Physical
nocturnal JJ Physical
melatonin NN Physical
secretion NN Physical
Urinary JJ Physical
excretion NN Physical
of IN Physical
melatonin NN Physical
total JJ Physical
nocturnal JJ Physical
secretion NN Physical
of IN Physical
TSH NNP Physical
nocturnal JJ Physical
secretion NN Physical
and CC None
urinary JJ Physical
excretion NN Physical
of IN Physical
melatonin NN Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
Endoscopic NNP Physical
healing NN Physical
complete JJ Physical
epithelialisation NN Physical
of IN Physical
all DT Physical
mucosal JJ Physical
lesions NNS Physical
. . None
Healing VBG Physical
rates NNS Physical
healing NN Physical
ulcer JJ Physical
size NN Physical
, , Physical
ulcer JJ Physical
number NN Physical
, , Physical
smoking VBG Physical
habits NNS Physical
and CC Physical
a DT Physical
disease NN Physical
duration NN Physical
Few JJ Adverse
side NN Adverse
effects NNS Adverse
effective JJ Other
-DOCSTART- -X- N

satisfaction NN Other
satisfaction NN Other
questionnaire NN Other
visual JJ Other
analog NN Other
scale NN Other
( ( Other
VAS NNP Other
, , Other
range VB Other
0-100 NNP Other
) ) Other
on IN None
overall JJ Other
satisfaction NN Other
questionnaire NN Other
and CC Other
VAS NNP Other
scores NNS Other
the DT Other
questionnaire NN Other
satisfaction NN Other
questionnaire NN Other
score NN Other
and CC Other
VAS NNP Other
score NN Other
Mean JJ Other
total JJ Other
satisfaction NN Other
questionnaire NN Other
scores NNS Other
waiting VBG Other
time NN Other
during IN Other
the DT Other
treatment NN Other
, , Other
autonomy NN Other
, , Other
coordination NN Other
, , Other
non-financial JJ Other
access NN Other
, , Other
and CC Other
quality NN Other
of IN Other
general JJ Other
information NN Other
satisfaction NN Other
questionnaire NN Other
satisfaction NN Other
-DOCSTART- -X- N

fasting VBG Physical
serum NN Physical
and CC Physical
red JJ Physical
cell NN Physical
folate NN Physical
levels NNS Physical
oral JJ None
status NN None
plaque NN Physical
index NN Physical
( ( Physical
P1I NNP Physical
) ) Physical
, , Physical
a DT Physical
gingival JJ Physical
index NN Physical
( ( Physical
GI NNP Physical
) ) Physical
, , Physical
and CC Physical
gingival JJ Physical
exudate NN Physical
flow NN Physical
meter NN Physical
( ( Physical
GEF NNP Physical
) ) Physical
. . None
dietary JJ Physical
folate NN Physical
. . None
GI NNP Physical
and CC Physical
P1I NNP Physical
GI NNP Physical
and CC Physical
GEF NNP Physical
. . None
GI NNP Physical
-DOCSTART- -X- N

[ JJ None
Therapeutic NNP Other
efficacy NN Other
HR-HPV NNP Physical
DNA NNP Physical
detection NN Physical
mRNA JJ Physical
expression NN Physical
of IN Physical
human JJ Physical
telomerase NN Physical
reverse NN Physical
transcriptase NN Physical
( ( Physical
hTERT NN Physical
) ) Physical
total JJ Other
effective JJ Other
rate NN Other
pathological JJ Physical
results NNS Physical
of IN Physical
the DT Physical
cervix NN Physical
mRNA JJ Physical
expression NN Physical
of IN Physical
hTERT NN Physical
mRNA JJ Physical
expression NN Physical
of IN Physical
hTERT NN Physical
cervix NN None
mRNA JJ Physical
expression NN Physical
of IN Physical
hTERT NN Physical
HR-HPV NNP None
infection NN None
cervical JJ Physical
precancerous JJ Physical
changes NNS Physical
-DOCSTART- -X- N

Ventilation NNP Physical
pattern NN Physical
leak NN Physical
volumes NNS Physical
leakage NN Physical
inspiratory NN Other
volumes NNS Other
delivered VBN Other
by IN Other
the DT Other
ventilator NN Other
leakage-induced JJ Physical
dyspnea NN Physical
. . Physical
Expiratory JJ Other
volume NN Other
-DOCSTART- -X- N

conventional JJ Other
services NNS Other
complementary JJ Other
and CC Other
alternative JJ Other
medicine NN Other
( ( Other
CAM NNP Other
) ) Other
CAM NNP Other
level NN Physical
of IN Physical
function NN Physical
, , Physical
immunization NN Physical
status NN Physical
, , Physical
and CC Physical
the DT Physical
presence NN Physical
of IN Physical
an DT Physical
identified VBN Physical
neurogenetic JJ Physical
disorder NN Physical
level NN Other
of IN Other
parental JJ Other
education NN Other
CAM NNP Other
-DOCSTART- -X- N

bleeding VBG Physical
esophageal JJ Physical
varices NNS Physical
bleeding VBG None
esophageal JJ None
varices NNS None
significant JJ Adverse
complications NNS Adverse
. . None
bleeding VBG None
varices NNS None
efficacy NN Other
and CC Other
safety NN Other
arresting VBG Physical
active JJ Physical
index NN Physical
bleeding NN Physical
achieving VBG Physical
variceal JJ Physical
eradication NN Physical
varices NNS Adverse
endoscopic NN Other
sessions NNS Other
rebleeding VBG Adverse
rate NN Adverse
rate NN Adverse
of IN Adverse
major JJ Adverse
complications NNS Adverse
esophageal JJ Adverse
variceal NN Adverse
recurrence NN Adverse
safe JJ Other
and CC Other
effective JJ Other
variceal JJ Physical
eradication NN Physical
rebleeding NN Physical
rate NN Physical
complications NNS Other
-DOCSTART- -X- N

core NN Mental
deficits NNS Mental
was VBD None
greater JJR None
play NN Mental
diversity NN Mental
on IN None
a DT None
standardized JJ None
assessment NN None
. . None
Effects NNS None
gestures NNS None
and CC None
spent VB None
less JJR None
time NN None
unengaged JJ None
. . None
These DT None
improve VB None
core NN None
-DOCSTART- -X- N

cardiac NN Physical
toxicity NN Physical
chronic JJ Physical
changes NNS Physical
in IN Physical
myocardium NN Physical
, , Physical
pericardium NN Physical
or CC Physical
cardiac JJ Physical
valves NNS Physical
haemodynamic JJ Physical
sequelae NN Physical
. . None
Maximal NNP Other
and CC Other
integrated VBN Other
early JJ Other
( ( Physical
E NNP Physical
, , Physical
Ei NNP Physical
) ) Physical
late JJ Other
( ( Other
A NNP Other
, , Other
Ai NNP Other
) ) Other
diastolic NN Other
flow NN Other
velocities NNS Other
and CC Other
their PRP$ Other
ratio NN Other
( ( Physical
E/A NNP Physical
, , Physical
Ei/Ai NNP Physical
) ) Physical
valvar NN Physical
thickening NN Physical
pericardial NN Physical
thickening NN Physical
reduced VBN Physical
fibre NN Physical
shortening VBG Physical
fraction NN Physical
, , Physical
the DT Physical
Doppler NNP Other
indices NNS Other
functional JJ Physical
and CC Physical
morphological JJ Physical
parameters NNS Physical
measurements NNS Physical
of IN Physical
diastolic JJ Physical
function NN Physical
-DOCSTART- -X- N

SICI NNP None
manual JJ None
motor NN Physical
performance NN Physical
Weak JJ None
resting-state JJ None
inhibition NN None
Better RBR None
event-related JJ None
modulation NN None
of IN None
inhibition NN None
Declining VBG None
resting-state JJ None
inhibition NN None
reduced VBD None
resting-state JJ None
-DOCSTART- -X- N

safety NN Other
tolerability NN Other
Beck NNP Mental
Depression NNP Mental
Inventory NNP Mental
( ( Mental
BDI NNP Mental
) ) Mental
, , Mental
the DT Mental
Hamilton NNP Mental
Depression NNP Mental
Rating NNP Mental
Scale NNP Mental
( ( Mental
HDRS NNP Mental
) ) Mental
depressive JJ Mental
symptoms NNS Mental
. . Mental
safety NN Other
and CC Other
tolerability NN Other
. . Physical
greater JJR Other
efficacy NN Other
effective JJ None
efficacy NN Physical
and CC Physical
lack NN Physical
of IN Physical
severe JJ Physical
side NN Physical
effects NNS Physical
. . Physical
-DOCSTART- -X- N

water NN None
turnover NN None
and CC None
thermobiological JJ None
variables NNS None
thermoregulative JJ Physical
responses NNS Physical
water NN Physical
turnover NN Physical
water NN Physical
turnover NN Physical
, , Physical
surface NN Physical
temperature NN Physical
, , Physical
and CC Physical
rectal JJ Physical
temperature NN Physical
, , None
as RB None
well RB None
as IN None
drinking VBG Mental
behavior NN Mental
of IN Mental
sheep NN Mental
Individual NNP None
feed NN None
and CC None
water NN None
intakes NNS None
Water NNP None
intake NN None
Ambient JJ None
temperature NN None
( ( None
T NNP None
( ( None
a DT None
) ) None
) ) None
, , None
relative JJ None
humidity NN None
, , None
and CC None
respiratory JJ None
rate NN None
whereas JJ None
BW NNP None
, , None
rectal NN None
and CC None
animal JJ None
surface NN None
temperatures NNS None
and CC None
wool JJ None
length NN None
in IN None
DMI NNP None
g?kg NN None
( ( None
-0.75 NNP None
) ) None
?d NN None
( ( None
-1 NNP None
) ) None
) ) None
, , None
water NN None
intake NN None
( ( None
165 CD None
-0.75 NNP None
) ) None
?d NN None
( ( None
-1 NNP None
) ) None
) ) None
, , None
respiratory JJ None
rate NN None
( ( None
66 CD None
, , None
rectal JJ None
temperature NN None
( ( None
39.3 CD None
? . None
0.2 CD None
and CC None
surface NN None
temperatures NNS None
same JJ None
trend NN None
in IN None
water NN None
intake NN None
between IN None
T NNP None
( ( None
a DT None
) ) None
and CC None
water NN None
intake NN None
, , None
respiratory NN None
rate NN None
, , None
and CC None
body NN None
surface NN None
temperatures NNS None
. . None
Even RB None
core NN None
body NN None
temperature NN None
, , None
water NN None
intake NN None
, , None
and CC None
respiratory NN None
rate NN None
heat NN None
-DOCSTART- -X- N

vigilance NN Other
Early JJ Mental
mental NN Mental
psychomotor NN Mental
recovery NN Mental
Heart NNP Physical
rate NN Physical
, , Physical
blood NN Physical
pressure NN Physical
, , Physical
arterial JJ Physical
oxygen NN Physical
saturation NN Physical
, , Physical
and CC Physical
blood NN Physical
gases NNS Physical
recovery NN Mental
tests NNS Mental
blood NN Physical
pressure NN Physical
, , Physical
heart NN Physical
rate NN Physical
, , Physical
arterial JJ Physical
blood NN Physical
gas NN Physical
analysis NN Physical
( ( Physical
Fig NNP Physical
. . Physical
6 CD Physical
) ) Physical
, , Physical
or CC Physical
oxygen NN Physical
saturation NN Physical
. . Physical
psychomotor NN Mental
and CC Mental
mental JJ Mental
impairment NN Mental
pCO2 NN Physical
hypercapnia RB Physical
postoperative JJ Adverse
nausea NN Adverse
and CC Adverse
vomiting NN Adverse
postoperative JJ Mental
recovery NN Mental
postoperative JJ Adverse
nausea NN Adverse
and CC Adverse
vomiting NN Adverse
-DOCSTART- -X- N

nosocomial JJ Physical
infections NNS Physical
Nosocomial NNP Physical
infections NNS Physical
Nosocomial JJ Physical
infections NNS Physical
of IN Physical
the DT Physical
blood NN Physical
, , Physical
meninges NNS Physical
, , Physical
or CC Physical
urinary JJ Physical
tract NN Physical
Septicemia NNP Physical
nosocomial JJ Physical
infections NNS Physical
Adverse JJ Adverse
reactions NNS Adverse
respiratory NN Physical
distress NN Physical
syndrome NN Physical
, , Physical
bronchopulmonary JJ Physical
dysplasia NN Physical
, , Physical
intracranial JJ Physical
hemorrhage NN Physical
, , None
the DT Other
duration NN Other
of IN Other
hospitalization NN Other
, , None
or CC None
mortality NN Mortality
. . None
necrotizing VBG Physical
enterocolitis NN Physical
hospital-acquired JJ Physical
infections NNS Physical
-DOCSTART- -X- N

Therapeutic JJ Physical
angiogenesis NN Physical
collateral JJ Physical
vessel NN Physical
formation NN Physical
. . None
efficacy NN Other
and CC Other
safety NN Other
safety NN Other
and CC Other
feasibility NN Other
of IN Other
treatment NN Other
ankle-brachial JJ Physical
index NN Physical
( ( Physical
ABI NNP Physical
) ) Physical
rest NN Pain
pain NN Pain
ABI NNP Physical
transcutaneous JJ Physical
oxygen NN Physical
pressure NN Physical
rest VBP Pain
pain NN Pain
pain-free JJ Pain
walking NN Pain
time NN Pain
improvements NNS None
improvements NNS None
died VBD Mortality
after IN Mortality
myocardial JJ Mortality
infarction NN Mortality
safe JJ Other
and CC Other
effective JJ Other
therapeutic JJ Physical
angiogenesis NN Physical
-DOCSTART- -X- N

language NN Mental
and CC Mental
social JJ Mental
interaction NN Mental
children NNS Mental
's POS Mental
behavior NN Mental
language NN Mental
and CC Mental
social JJ Mental
interaction NN Mental
stereotyped JJ Mental
behavior NN Mental
or CC Mental
motor NN Mental
function NN Mental
qEEG JJ Physical
spectral JJ Physical
amplitudes NNS Physical
language NN Mental
and CC Mental
social JJ Mental
functioning NN Mental
-DOCSTART- -X- N

Relapses NNPS Physical
3-year JJ Mortality
event-free JJ Mortality
survival NN Mortality
higher JJR Other
treatment NN Other
failure NN Other
rate NN Other
relative JJ Physical
failure NN Physical
rate NN Physical
( ( Physical
RFR NNP Physical
) ) Physical
RFRs NNP Physical
CNS NNP Physical
disease NN Physical
RFR NNP None
isolated JJ None
CNPs NNP None
nominally RB Other
worse JJR Other
outcome JJ Other
-DOCSTART- -X- N

absorption NN Physical
of IN Physical
digoxin NN Physical
digoxin NN Physical
Plasma NNP Physical
levels NNS Physical
, , Physical
areas NNS Physical
under IN Physical
24-hour JJ Physical
plasma NN Physical
concentration NN Physical
curves NNS Physical
and CC Physical
urinary JJ Physical
excretion NN Physical
digoxin NN Other
digoxin NN Other
bioavailability NN Other
-DOCSTART- -X- N

Treatment NN None
of IN None
-DOCSTART- -X- N

Simultaneous JJ Physical
measurements NNS Physical
from IN Physical
systemic JJ Other
haemodynamics NNS Other
, , Other
laser JJR Other
interferometry NN Other
of IN Other
ocular JJ Other
fundus NN Other
pulsations NNS Other
, , Other
systolic JJ Other
time NN Other
intervals NNS Other
from IN Other
mechanocardiography NN Other
, , Other
a/b VBP Other
ratio NN Other
from IN Other
oxymetric JJ Other
fingerplethysmography NN Other
and CC Other
Doppler NNP Other
sonography NN Other
of IN Other
the DT Other
radial JJ Other
artery NN Other
reproducibility NN Other
and CC Other
sensitivity NN Other
-DOCSTART- -X- N

anxiety NN Mental
symptoms NNS Mental
( ( None
Anxiety NNP None
Disorders NNP None
Interview NNP None
Schedule NNP None
? . None
Parent NNP None
Version NNP None
; : None
ADIS-P NNP None
) ) None
Clinician JJ None
Severity NNP None
Ratings NNP None
, , None
diagnostic JJ Mental
status NN Mental
, , None
and CC None
clinician JJ None
ratings NNS None
of IN None
global JJ None
improvement NN None
-DOCSTART- -X- N

nocturnal JJ Physical
sleep NN Physical
Changes NNS Other
in IN Other
sleep JJ Other
architecture NN Other
were VBD Physical
measured VBN Physical
using VBG Physical
centrally RB Other
scored VBN Other
nocturnal JJ Other
polysomnograms NNS Other
. . Physical
changes NNS Adverse
in IN Adverse
narcolepsy NN Adverse
symptoms NNS Adverse
and CC Adverse
adverse JJ Adverse
events NNS Adverse
. . Adverse
duration NN Other
of IN Other
stage NN Other
3 CD Other
and CC Other
4 CD Other
sleep NN Other
delta JJ Other
power NN Other
Stage NN Other
1 CD Other
sleep NN Other
and CC Other
the DT Other
frequency NN Other
of IN Other
nocturnal JJ Other
awakenings NNS Other
changes NNS Physical
in IN Physical
nocturnal JJ Physical
sleep NN Physical
severity NN Physical
and CC Physical
frequency NN Physical
of IN Physical
narcolepsy NN Physical
symptoms NNS Physical
. . Physical
slow JJ Physical
wave NN Physical
sleep NN Physical
, , Physical
wake VBP Physical
after IN Physical
sleep JJ Physical
onset NN Physical
, , Physical
awakenings NNS Physical
, , Physical
total JJ Other
sleep JJ Other
time NN Other
, , Physical
and CC Physical
stage NN Physical
1 CD Physical
sleep NN Physical
frequency NN Other
and CC Other
severity NN Other
of IN Other
narcolepsy NN Other
symptoms NNS Other
-DOCSTART- -X- N

efficacy NN Other
and CC None
tolerability NN Other
clinical JJ Other
signs NNS Other
number NN Physical
of IN Physical
positive JJ Physical
fungal NN Physical
cultures NNS Physical
tolerability NN Other
-DOCSTART- -X- N

decrease VB Mental
alcohol JJ Mental
intake NN Mental
lower JJR Physical
GGT NNP Physical
diarrhea VBN Adverse
-DOCSTART- -X- N

retention NN Mental
of IN Mental
social JJ Mental
cognition NN Mental
affective JJ Mental
speech NN Mental
comprehension NN Mental
assign VB Mental
emotional JJ Mental
significance NN Mental
to TO Mental
speech VB Mental
intonation NN Mental
social JJ Mental
recognition NN Mental
prosocial JJ Mental
behavior NN Mental
-DOCSTART- -X- N

levels NNS Physical
of IN Physical
damage NN Physical
complications NNS Adverse
-DOCSTART- -X- N

mortality NN Mortality
morbidity NN Other
total JJ Physical
cholesterol NN Physical
, , Physical
low JJ Physical
density NN Physical
lipoprotein NN Physical
( ( Physical
LDL NNP Physical
) ) Physical
cholesterol NN Physical
high JJ Physical
density NN Physical
lipoprotein NN Physical
( ( Physical
HDL NNP Physical
) ) Physical
cholesterol NN Physical
adverse JJ Adverse
effects NNS Adverse
. . Adverse
died VBD Mortality
Noncardiovascular JJ Adverse
causes NNS Adverse
deaths NNS Mortality
Major JJ Physical
coronary JJ Physical
events NNS Physical
risk NN Physical
reduction NN Physical
risk NN Physical
of IN Physical
undergoing VBG Physical
myocardial JJ Physical
revascularization NN Physical
procedures NNS Physical
. . Physical
-DOCSTART- -X- N

adherence NN Mental
Adherence NNP Mental
actual JJ Mental
administered VBN Mental
doses NNS Mental
Health-related JJ Mental
quality NN Mental
of IN Mental
life NN Mental
, , None
healthcare JJ Other
resource NN Other
utilization NN Other
, , None
and CC None
days NNS Mental
missed VBN Mental
from IN Mental
work NN Mental
or CC Mental
school NN Mental
mean JJ Other
adherence NN Mental
rates NNS Mental
Mean JJ Other
adherence NN Mental
rates NNS Mental
Adherence NN Mental
rates NNS Mental
Health-related JJ Mental
quality NN Mental
of IN Mental
life NN Mental
missed JJ Mental
work/school NN Mental
. . None
adherence NN Mental
rates NNS Mental
-DOCSTART- -X- N

safety NN Other
Immunogenicity NNP Physical
systemic JJ Physical
reactions NNS Physical
immune JJ Physical
success NN Physical
rates NNS Physical
of IN Physical
I PRP Physical
, , Physical
II NNP Physical
, , Physical
III NNP Physical
type NN Physical
GMTs NNP Physical
of IN Physical
I PRP Physical
, , Physical
II NNP Physical
, , Physical
III NNP Physical
type NN Physical
-DOCSTART- -X- N

Roll-off NNP Physical
median JJ Other
time NN Other
to TO Other
completion NN Other
of IN Other
treatment NN Other
total JJ Other
power NN Other
output NN Other
diameters NNS Physical
of IN Physical
RFA-induced JJ Physical
lesions NNS Physical
same JJ Other
therapeutic JJ Other
effects NNS Other
-DOCSTART- -X- N

Serum NNP Physical
C-peptide NNP Physical
Serum NNP Physical
C-peptide NNP Physical
Glycaemic NNP Physical
control NN Physical
C-peptide NNP Physical
-DOCSTART- -X- N

aberrant JJ Mental
behavior NN Mental
in IN Mental
treatment NN Mental
of IN Mental
autistic JJ Mental
disorder NN Mental
. . None
Aberrant NNP Mental
Behavior NNP Mental
Checklist-Community NNP Mental
( ( Mental
ABC-C NNP Mental
) ) Mental
. . Mental
ABC-C NNP Mental
subscale NN Mental
scores NNS Mental
for IN Mental
Irritability NNP Mental
, , Mental
Lethargy/Social NNP Mental
Withdrawal NNP Mental
, , Mental
Stereotypic NNP Mental
Behavior NNP Mental
, , Mental
Hyperactivity/Noncompliance NNP Mental
and CC Mental
Inappropriate NNP Mental
Speech NNP Mental
. . None
behavioral JJ Mental
problems NNS Mental
of IN Mental
-DOCSTART- -X- N

stage-matched JJ Other
expert NN Other
system NN Other
intervention NN Other
for IN Other
efficacy NN Other
prevalence NN Mental
abstinence NN Mental
cessation NN Mental
improvement NN Other
cessation NN Mental
rates NNS None
outperform VB Other
expert NN Other
system NN Other
cessation NN Mental
-DOCSTART- -X- N

-DOCSTART- -X- N

long-term JJ Mortality
survival NN Mortality
leucocyte-depleted JJ Physical
5-year JJ Mortality
overall JJ Mortality
survival NN Mortality
rate NN Mortality
of IN None
patients NNS None
with IN None
any DT None
type NN None
of IN None
gastrointestinal JJ None
cancer NN None
5-year JJ Mortality
disease-free JJ Mortality
survival NN Mortality
rates NNS Mortality
recurrence NN Physical
rates NNS Physical
long-term JJ Mortality
survival NN Mortality
and CC None
lower JJR Physical
recurrence NN Physical
rates NNS Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

postoperative JJ Mortality
mortality NN Mortality
and CC None
complications NNS Adverse
local JJ Other
and CC Other
distant JJ Other
recurrence NN Other
overall JJ Mortality
survival NN Mortality
. . None
postoperative JJ Mortality
mortality NN Mortality
-DOCSTART- -X- N

Blood NN Physical
and CC Physical
urine JJ Physical
samples NNS Physical
CYP1A2 NNP Physical
indices NNS Physical
, , None
oral JJ Physical
caffeine NN Physical
clearance NN Physical
6-h JJ Physical
paraxanthine NN Physical
to TO Physical
caffeine VB Physical
serum JJ Physical
concentration NN Physical
ratio NN Physical
unchanged JJ None
tolbutamide JJ Physical
oral JJ Physical
clearance NN Physical
tolbutamide JJ Physical
urinary JJ Physical
metabolic NN Physical
ratio NN Physical
dextromethorphan NN Physical
to TO None
dextrorphan VB Physical
urinary JJ Physical
ratio NN Physical
significantly RB Other
different JJ Other
vivo JJ Physical
catalytic JJ Physical
activity NN Physical
-DOCSTART- -X- N

supraspinal JJ Physical
diffuse NN Physical
noxious JJ Physical
inhibitory NN Physical
controls NNS Physical
( ( Physical
DNICs NNP Physical
) ) Physical
trigger VB None
DNICs NNP None
and CC None
induce VB None
counterirritation NN None
. . None
measured VBD None
ventilatory JJ None
variables NNS None
and CC None
end-tidal JJ None
CO2 NNP None
tension NN None
, , None
dyspnea NN None
intensity NN None
by IN None
visual JJ None
analog NN None
scale NN None
, , None
and CC None
the DT None
intensity NN None
of IN None
putative JJ None
chest NN None
pain NN None
. . None
The DT None
the DT None
amplitude NN None
of IN None
the DT None
RIII NNP None
component NN None
of IN None
the DT None
nociceptive JJ None
flexor NN None
reflex NN None
recorded VBN None
by IN None
biceps NNS None
femoris JJ None
electromyogram VBP None
in IN None
response NN None
to TO None
painful JJ None
electrical JJ None
sural JJ None
nerve NN None
stimulation NN None
( ( None
RIII NNP None
) ) None
, , None
taken VBN None
as IN None
a DT None
substitute NN None
for IN None
pain NN None
perception NN None
. . None
Placebo NNP None
induced VBD None
dyspnea NN None
, , None
hyperpnea NN None
, , None
tachycardia NN None
, , None
and CC None
significant JJ None
RIII NNP None
inhibition NN None
( ( None
24 CD None
temporal JJ None
dynamics NNS None
of IN None
adenosine-induced JJ None
dyspnea NN None
and CC None
RIII NNP None
inhibition NN None
differed VBD None
counterirritation NN None
, , None
fueling VBG None
adenosine-induced JJ None
dyspnea NN None
and CC None
RIII NNP None
inhibition NN None
suggests VBZ None
-DOCSTART- -X- N

renal JJ Physical
and CC Physical
respiratory JJ Physical
tolerance NN Physical
No DT Physical
acute JJ Physical
renal JJ Physical
failure NN Physical
extubated VBN Physical
died VBN Mortality
-DOCSTART- -X- N

effectiveness NN Other
Pain VB Pain
ratings NNS Pain
visual JJ Physical
analogue NN Physical
scale NN Physical
. . Physical
Side JJ Adverse
effects NNS Adverse
and CC Adverse
overall JJ Adverse
opinion NN Adverse
analgesic JJ Pain
properties NNS Pain
pain NN Pain
rating NN Pain
no DT Adverse
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

radial JJ Physical
artery NN Physical
spasm NN Physical
radial JJ Physical
artery NN Physical
spasm NN Physical
predictors NNS Physical
of IN Physical
arterial JJ Physical
spasm NN Physical
spasm NN Physical
. . None
spasm NN Physical
reduce VB Physical
the DT Physical
risk NN Physical
of IN Physical
spasm NN Physical
as RB None
effective JJ Other
as IN None
predicting VBG Physical
the DT Physical
occurrence NN Physical
of IN Physical
radial JJ Physical
spasm NN Physical
. . None
predicting VBG Physical
the DT Physical
occurrence NN Physical
of IN Physical
radial JJ Physical
spasm NN Physical
. . None
-DOCSTART- -X- N

migraine NN Pain
headaches NNS Pain
. . Physical
migraine NN Physical
headache NN Physical
Medical NNP Physical
Outcomes NNP Physical
Study NNP Physical
36-Item JJ Physical
Short NNP Physical
Form NNP Physical
Health NNP Physical
Survey NNP Physical
, , None
Migraine-Specific NNP Other
Quality NNP Other
of IN Other
Life NNP Other
, , None
and CC None
Migraine NNP Physical
Disability NNP Physical
Assessment NNP Physical
questionnaires VBZ Physical
positive JJ Physical
response NN Physical
complete JJ Other
elimination NN Other
of IN Other
migraine NN Other
headache NN Other
eliminate VB Other
or CC Other
reduce VB Other
the DT Other
frequency NN Other
, , Other
duration NN Other
, , Other
and CC Other
intensity NN Other
of IN Other
migraine NN Other
headache NN Other
-DOCSTART- -X- N

frequency NN Physical
severity NN Physical
of IN Physical
esophageal NN Physical
symptoms NNS Physical
, , Physical
extraesophageal JJ Physical
syndrome NN Physical
, , Physical
functional JJ Physical
dyspepsia NN Physical
degree NN Physical
of IN Physical
esophageal NN Physical
mucosal JJ Physical
injury NN Physical
relief NN Physical
of IN Physical
heartburn NN Physical
, , Physical
regurgitation NN Physical
, , Physical
chronic JJ Physical
cough NN Physical
, , Physical
sore RB Physical
throat NN Physical
, , Physical
and CC Physical
EBS NNP Physical
. . Physical
-DOCSTART- -X- N

Improvement NN Mental
in IN Mental
lifestyle NN Mental
supplementary JJ Physical
treatment NN Physical
with IN Physical
diuretics NNS Physical
. . None
-DOCSTART- -X- N

ovarian JJ Physical
follicular JJ Physical
dynamics NNS Physical
, , None
luteal JJ Physical
function NN Physical
, , None
onset NN Physical
of IN Physical
oestrus NN Physical
and CC None
reproductive JJ Physical
performance NN Physical
Concentrations NNS Physical
of IN Physical
CP NNP Physical
in IN Physical
pasture NN Physical
, , None
urea JJ Physical
in IN Physical
serum NN Physical
and CC None
progesterone NN Physical
in IN Physical
milk NN Physical
Ovarian JJ Physical
follicular NN Physical
and CC Physical
luteal JJ Physical
dynamics NNS Physical
Oestrous JJ Other
behaviour NN Other
and CC Other
the DT Other
number NN Other
, , Other
time NN Other
and CC Other
outcome NN Other
of IN Other
inseminations NNS Other
Mean JJ Physical
concentrations NNS Physical
of IN Physical
CP NNP Physical
in IN Physical
pasture NN Physical
and CC Other
urea NN Physical
in IN Physical
serum NN Physical
Intervals NNS Physical
between IN Physical
calving VBG Physical
and CC Physical
first JJ Physical
oestrus NN Physical
, , None
first JJ Physical
insemination NN Physical
and CC Physical
conception NN Physical
, , None
the DT Physical
time NN Physical
of IN Physical
first JJ Physical
emergence NN Physical
of IN Physical
a DT Physical
dominant JJ Physical
follicle NN Physical
, , None
milk NN Physical
progesterone NN Physical
concentration NN Physical
, , None
and CC None
the DT None
diameter NN Physical
of IN Physical
the DT Physical
corpus NN Physical
luteum NN Physical
( ( Physical
CL NNP Physical
) ) Physical
in IN Physical
the DT Physical
first JJ Physical
luteal JJ Physical
phase NN Physical
interval NN Physical
from IN Physical
calving VBG Physical
to TO Physical
first JJ Physical
ovulation NN Physical
diameter NN Physical
of IN Physical
the DT Physical
dominant JJ Physical
follicle NN Physical
of IN Physical
the DT Physical
oestrous JJ Physical
cycle NN Physical
at IN Physical
which WDT Physical
cows VBZ Physical
conceived VBN Other
concentrations NNS Physical
of IN Physical
CP NNP Physical
in IN Physical
pasture NN Physical
and CC Other
urea NN Physical
in IN Physical
serum NN Physical
reproductive JJ Physical
performance NN Physical
-DOCSTART- -X- N

CD34+ NNP Physical
cell NN Physical
yield NN Physical
CD34+ NNP Physical
cell NN Physical
yield NN Physical
, , Physical
or CC Physical
hematopoietic JJ Physical
recovery NN Physical
or CC Physical
immunoglobulin NN Physical
levels NNS Physical
-DOCSTART- -X- N

tolerability NN Other
and CC Other
efficacy NN Other
Headache NNP Physical
severity NN Physical
, , None
presence NN Physical
or CC Physical
absence NN Physical
of IN Physical
associated VBN Physical
symptoms NNS Physical
, , None
and CC None
functional JJ Physical
disability NN Physical
were VBD None
assessed VBN None
over IN None
a DT None
4-hour JJ None
postdose JJ None
period NN None
adverse JJ Adverse
events NNS Adverse
pain-free JJ Pain
status NN Pain
at IN Pain
2 CD Pain
hours NNS Pain
postdose RB Pain
. . None
adverse JJ Adverse
events NNS Adverse
dry JJ Adverse
mouth NN Adverse
, , Adverse
dizziness NN Adverse
, , Adverse
asthenia/fatigue NN Adverse
, , Adverse
nausea NN Adverse
, , Adverse
and CC Adverse
somnolence NN Adverse
. . None
pain-free JJ Pain
percentage NN Pain
of IN Pain
patients NNS Pain
with IN Pain
pain NN Pain
relief NN Pain
predose JJ Pain
pain NN Pain
intensity NN Pain
Placebo NNP Physical
response NN Physical
rates NNS Physical
functional JJ Physical
disability NN Physical
nausea NN Adverse
pain NN Pain
relief NN Pain
response NN Physical
rate NN Physical
tolerated VBN Other
and CC Other
effective JJ Other
-DOCSTART- -X- N

beta-adrenoceptor NN Physical
blockade NN Physical
. . Physical
heart NN Physical
rate NN Physical
dose-response JJ Physical
curves NNS Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
beta-adrenoceptor NN Physical
blockade NN Physical
-DOCSTART- -X- N

intent-to-treat NN Physical
( ( Physical
ITT NNP Physical
) ) Physical
clearance NN Physical
rate NN Physical
ITT NNP Physical
clearance NN Physical
rate NN Physical
effective JJ Other
eradicating VBG Physical
external JJ Physical
genital NN Physical
and CC Physical
perianal JJ Physical
warts NNS Physical
. . None
Imiquimod NNP None
wart NN Mental
treatment NN Mental
, , Mental
or CC Mental
tobacco NN Mental
use NN Mental
. . None
-DOCSTART- -X- N

response NN Other
rates NNS Other
overall JJ Other
response NN Other
rate NN Other
( ( Other
ORR NNP Other
) ) Other
underwent JJ Other
breast-conserving JJ Other
surgery NN Other
ORR NNP Other
clinical JJ Other
efficacy NN Other
Biomarker NNP Other
studies NNS Other
degree NN Other
of IN Other
ER NNP Other
positivity NN Other
expression NN Physical
from IN Physical
estrogen-regulated JJ Physical
genes NNS Physical
tumor NN Physical
proliferation NN Physical
-DOCSTART- -X- N

C-spine JJ Physical
motion NN Physical
C-spine JJ Physical
motion NN Physical
Time NN Other
C-spine JJ Physical
motion NN Physical
during IN Physical
bag-mask JJ Physical
ventilation NN Physical
C-spine JJ Physical
motion NN Physical
using VBG Physical
the DT Physical
Lightwand NNP Physical
time NN Other
to TO Other
intubate VB Other
C-spine JJ Physical
motion NN Physical
longer JJR Other
C-spine JJ Physical
movement NN Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

rehabilitation NN Physical
gait NN Physical
kinematics NNS Physical
gait NN Other
velocity NN Other
, , Other
cadence NN Other
, , Other
step NN Other
length NN Other
, , Other
and CC Other
stride JJ Other
length NN Other
range NN Other
of IN Other
motion NN Other
range NN Other
of IN Other
motion NN Other
pelvic JJ Other
tilt NN Other
Trendelenburg NNP Other
gait NN Other
-DOCSTART- -X- N

improving NN Mental
fitness NN Mental
and CC None
decreasing VBG Physical
cardiovascular JJ Physical
fitness NN Physical
( ( Physical
aerobic JJ Physical
power NN Physical
) ) Physical
, , None
general JJ Physical
muscular JJ Physical
strength NN Physical
( ( None
number NN Physical
of IN Physical
sit NN Physical
ups NNS Physical
per IN Physical
minute NN Physical
) ) None
, , None
and CC None
flexibility NN Physical
, , None
and CC None
lowered VBD Other
their PRP$ Other
body NN Other
fat NN Other
. . None
-DOCSTART- -X- N

the DT None
risk NN Physical
for IN Physical
falls VBZ Physical
gait NN Physical
and CC Physical
balance NN Physical
measures NNS Physical
, , None
self-reported JJ Physical
physical JJ Physical
function NN Physical
number NN Mental
of IN Mental
medications NNS Mental
being VBG Mental
taking VBG Mental
at IN Mental
baseline NN Mental
history NN Other
of IN Other
falling VBG Other
. . None
Falls NNS Physical
fall NN Physical
preventing VBG Other
falls NNS Other
risk NN Physical
for IN Physical
falls NNS Physical
risk NN Physical
for IN Physical
falls NNS Physical
-DOCSTART- -X- N

median JJ Mortality
follow-up NN Mortality
for IN Mortality
survivors NNS Mortality
frequency NN Physical
of IN Physical
complete JJ Physical
remission NN Physical
resistant JJ Physical
disease NN Physical
Induction NNP Mortality
deaths NNS Mortality
median JJ Mortality
survival NN Mortality
survival NN Mortality
rate NN Mortality
long-term JJ Other
outcomes NNS Other
. . None
-DOCSTART- -X- N

bruising VBG Physical
visual JJ Other
analog NN Other
scale NN Other
( ( Other
VAS NNP Other
) ) Other
percentage NN Physical
of IN Physical
bruising VBG Physical
occurrence NN Physical
size NN Physical
of IN Physical
the DT Physical
bruising NN Physical
Pain NNP Pain
intensity NN Pain
and CC Pain
pain NN Pain
period NN Pain
-DOCSTART- -X- N

motor NN Other
learning NN Other
. . Other
learning NN Physical
. . Physical
number NN Physical
of IN Physical
movements NNS Physical
target NN Physical
motion NN Physical
only RB Physical
direct JJ Physical
practice NN Physical
part NN Other
training NN Other
efficacy NN Other
. . Other
-DOCSTART- -X- N

recanalization NN Physical
of IN Physical
the DT Physical
infarct-related JJ Physical
artery NN Physical
myocardial JJ Physical
tissue NN Physical
reperfusion NN Physical
early JJ Physical
reperfusion NN Physical
in IN Physical
ST-elevation NNP Physical
myocardial JJ Physical
infarction NN Physical
pre-pPCI JJ Physical
ST-segment JJ Physical
resolution NN Physical
TIMI NNP Physical
flow NN Physical
grade VBD Physical
3 CD Physical
TIMI NNP Physical
frame NN Physical
count NN Physical
% NN Physical
diameter JJ Physical
stenosis NN Physical
myocardial JJ Physical
tissue NN Physical
perfusion NN Physical
cardiac JJ Physical
enzymes NNS Physical
rise NN Physical
of IN Physical
CK NNP Physical
QRS NNP Other
score RB Other
infarct NN Physical
size NN Physical
signs NNS Physical
of IN Physical
early JJ Physical
recanalization NN Physical
of IN Physical
the DT Physical
infarct-related JJ Physical
artery NN Physical
myocardial JJ Physical
tissue NN Physical
reperfusion NN Physical
. . None
-DOCSTART- -X- N

Antihypertensive JJ Physical
effect NN Physical
The DT Physical
mean JJ Physical
maximal JJ Physical
reduction NN Physical
in IN Physical
blood NN Physical
pressure NN Physical
heart NN Physical
rate NN Physical
. . Physical
symptomatic JJ Physical
hypotension NN Physical
. . None
incapacitating VBG Adverse
-DOCSTART- -X- N

Health NNP Other
advice NN Other
undertake VB Mental
lifestyle JJ Mental
changes NNS Mental
. . None
referred VBN Other
to TO Other
a DT Other
specialist NN Other
-DOCSTART- -X- N

Plasma NNP None
kinetics NNS None
of IN None
zeaxanthin NN None
and CC None
3'-dehydro-lutein JJ None
plasma NN Physical
kinetics NNS Physical
of IN Physical
synthetic JJ Physical
zeaxanthin NN Physical
plasma NN Physical
zeaxanthin NN Physical
concentrations NNS Physical
. . None
Plasma NNP Physical
concentration-time NN Physical
profiles NNS Physical
all-E-Zeaxanthin JJ Physical
concentrations NNS Physical
dose-normalized JJ Physical
bioavailability NN Physical
of IN Physical
all-E-zeaxanthin JJ Physical
kinetic JJ Physical
parameters NNS Physical
concentrations NNS Physical
terminal JJ Physical
elimination NN Physical
half-life NN Physical
time NN Physical
course NN Physical
of IN Physical
plasma JJ Physical
all-E-3-'dehydro-lutein JJ Physical
concentrations NNS Physical
all-E-3-'dehydro-lutein NN Physical
all-E-zeaxanthin JJ Physical
. . None
Concentrations NNS Physical
of IN Physical
other JJ Physical
carotenoids NNS Physical
plasma NN Physical
zeaxanthin JJ Physical
concentrations NNS Physical
all-E-3-dehydro-lutein NN Physical
-DOCSTART- -X- N

milk NN Physical
antibodies NNS Physical
optical JJ Other
density NN Other
ratios NNS Other
( ( Other
ODRs NNP Other
) ) Other
milk NN Physical
production NN Physical
ODR NNP Other
ODR NNP Physical
values NNS Physical
. . None
ODR NNP Other
values NNS Other
when WRB None
ODR NNP None
values NNS None
the DT None
ODR NNP None
values NNS None
-DOCSTART- -X- N

septic JJ Physical
complications NNS Physical
septic JJ Physical
complications NNS Physical
occurrence NN Physical
of IN Physical
infection NN Physical
of IN Physical
pancreatic JJ Physical
necrosis NN Physical
, , None
rate NN Physical
of IN Physical
extrapancreatic JJ Physical
infections NNS Physical
, , None
systemic JJ Adverse
and CC Adverse
local JJ Adverse
complications NNS Adverse
, , None
need VBP Other
for IN Other
surgery NN Other
, , None
mortality NN Mortality
rate NN Mortality
, , None
and CC None
length NN Other
of IN Other
hospitalization NN Other
septic JJ Physical
complication NN Physical
septic JJ Physical
complications NNS Physical
-DOCSTART- -X- N

cardiovascular NN Physical
( ( Physical
CV NNP Physical
) ) Physical
events NNS Physical
percent NN Physical
change NN Physical
of IN Physical
coronary JJ Physical
plaque NN Physical
volume NN Physical
. . None
inflammatory JJ Physical
markers NNS Physical
, , Physical
antioxidant JJ Physical
activity NN Physical
, , Physical
and CC Physical
incidence NN Physical
of IN Physical
composite JJ Physical
cardiovascular JJ Physical
events NNS Physical
. . None
coronary JJ Physical
plaque NN Physical
coronary JJ Physical
events NNS Physical
. . None
-DOCSTART- -X- N

T NNP Physical
and CC Physical
free- JJ Physical
T NNP Physical
levels NNS Physical
metabolic JJ Physical
parameters NNS Physical
Homeostasis NNP Physical
Model NNP Physical
Assessment NNP Physical
( ( Physical
HOMA NNP Physical
) ) Physical
index NN Physical
waist JJ Physical
circumference NN Physical
and CC Physical
fat JJ Physical
mass NN Physical
International NNP Other
Index NNP Other
of IN Other
Erectile NNP Other
Function-5 NNP Other
and CC Other
Aging NNP Other
Males NNP Other
' POS Other
Symptoms NNP Other
scores NNS Other
T NNP Physical
and CC Physical
free- JJ Physical
T NNP Physical
levels NNS Physical
metabolic JJ Physical
parameters NNS Physical
HOMA-index NNP Other
waist JJ Physical
circumference NN Physical
fat JJ Physical
mass NN Physical
T NNP Physical
levels NNS Physical
-DOCSTART- -X- N

Stability NNP Physical
, , Physical
segmental JJ Physical
maxillary JJ Physical
tipping NN Physical
and CC Physical
relapse NN Physical
Widening NNP Physical
Relapse NNP Physical
palatal JJ Physical
width NN Physical
, , Physical
at IN Physical
premolar JJ Physical
and CC Physical
molar JJ Physical
level NN Physical
Segmental NNP Physical
maxillary JJ Physical
tipping NN Physical
relapse NN Physical
. . None
retention NN Physical
period NN Physical
-DOCSTART- -X- N

relief NN Pain
of IN Pain
pain NN Pain
Analgesia NNP Mental
Postoperative JJ Mortality
respiratory NN Mortality
mechanics NNS Mortality
delayed VBN Mental
respiratory NN Mental
depression NN Mental
-DOCSTART- -X- N

effectiveness NN Other
and CC Other
complications NNS Physical
of IN Other
our PRP$ Other
adaptation NN Other
of IN Other
the DT Other
canalith NN Other
repositioning NN Other
procedure NN Other
( ( Other
CRP NNP Other
) ) Other
daily JJ Physical
grading NN Physical
of IN Physical
symptoms NNS Physical
and CC Physical
the DT Physical
amount NN Physical
of IN Physical
anti-vertiginous JJ Physical
drugs NNS Physical
( ( Physical
cinnarizine NN Physical
) ) Physical
taken VBN Physical
. . None
Objective JJ Other
and CC Other
subjective JJ Other
assessments NNS Other
nystagmus NN Physical
rates NNS Other
of IN Other
effectiveness NN Other
of IN Other
CRP NNP Other
treatment NN Other
used VBD Other
significantly RB Other
fewer JJR Other
drugs NNS Other
Complications NNS None
lateral JJ Adverse
canalithiasis NN Adverse
and CC Adverse
fainting NN Adverse
recovery NN Physical
dependence NN Mental
on IN Mental
medication NN Mental
. . Mental
Complications NNS Physical
-DOCSTART- -X- N

aldosterone JJ Physical
release NN Physical
angiotensin NN Physical
II NNP Physical
and CC Physical
ACTH NNP Physical
stimulated VBD Physical
aldosterone CD Physical
secretion NN Physical
plasma JJ Physical
aldosterone NN Physical
metoclopramide VB Other
plasma RB Physical
aldosterone NN Physical
rise NN None
in IN None
plasma NN None
aldosterone NN None
aldosterone NN Physical
release NN Physical
. . Physical
-DOCSTART- -X- N

The DT None
mean JJ None
number NN None
of IN None
chemotherapy NN None
cycles NNS None
was VBD None
developed VBD None
tumor NN None
recurrence NN None
. . None
The DT None
Median JJ None
Survival NNP None
time NN None
was VBD None
The DT None
proportion NN None
of IN None
patients NNS None
surviving VBG None
at IN None
any DT None
clinical JJ None
advantage NN None
over IN None
-DOCSTART- -X- N

intrinsic JJ Mental
motivation NN Mental
response NN Mental
rate NN Mental
response NN Mental
rate NN Mental
survival JJ Mortality
analysis NN Mortality
increase VB Mental
participation NN Mental
mail NN Other
questionnaire NN Other
motivation NN Mental
-DOCSTART- -X- N

effective JJ Other
and CC Other
safe JJ Other
Treatment NNP Other
efficacy NN Other
adverse JJ Adverse
events NNS Adverse
safety NN Other
and CC Other
tolerability NN Other
-DOCSTART- -X- N

motor NN Physical
symptoms NNS Physical
motor NN Physical
function NN Physical
motor NN Physical
impairment NN Physical
-DOCSTART- -X- N

Behavioral JJ Mental
ratings NNS Mental
of IN Mental
the DT Mental
roleplays NNS Mental
and CC None
participant JJ Mental
evaluations NNS Mental
of IN Mental
the DT Mental
motivational JJ Mental
interviewing NN Mental
video NN Mental
constituted VBD None
the DT None
outcome NN None
measures NNS None
. . None
empathy NN Mental
patient JJ Mental
defensiveness NN Mental
supporting VBG Mental
women NNS Mental
's POS Mental
beliefs NNS Mental
in IN Mental
their PRP$ Mental
ability NN Mental
to TO Mental
change VB Mental
. . None
-DOCSTART- -X- N

neutropenic JJ Physical
complications NNS Physical
neutropenic JJ Physical
complications NNS Physical
( ( Physical
NC NNP Physical
) ) Physical
NC NNP Physical
absolute NN Physical
neutrophil NN Physical
count NN Physical
< NNP None
or CC None
=1.5 NNP None
x VBP None
10 CD None
( ( None
9 CD None
) ) None
cells/L NN None
febrile JJ Physical
neutropenia NN Physical
or CC None
neutropenia NN Physical
with IN None
a DT None
documented JJ Physical
infection NN Physical
poor JJ Physical
performance NN Physical
status NN Physical
, , None
absolute VB Physical
neutrophil JJ Physical
count NN Physical
< NN None
or CC None
=2.0 VB None
x JJ None
10 CD None
( ( None
9 CD None
) ) None
cells/L NN None
age NN None
precycle NN Physical
risk NN Physical
score NN Physical
risk NN Other
NC NNP Physical
-DOCSTART- -X- N

improves VBZ Physical
self-evaluated JJ Mental
work NN Mental
ability NN Mental
: : None
LBP NNP Pain
and CC None
disability NN Physical
. . None
recurrence NN None
of IN None
LBP NNP Pain
and CC None
long-term JJ Physical
disability NN Physical
. . None
changes NNS None
in IN None
intensity NN None
of IN None
LBP NNP Pain
, , None
disability NN Physical
, , None
self-evaluated JJ Physical
future NN Physical
work NN Physical
ability NN Physical
, , None
and CC None
neuromuscular JJ Physical
fitness NN Physical
. . None
intensity NN Pain
of IN Pain
LBP NNP Pain
proportion NN Physical
of IN Physical
subjects NNS Physical
with IN Physical
negative JJ Physical
expectations NNS Physical
about IN Physical
their PRP$ Physical
future NN Physical
work NN Physical
ability NN Physical
disability NN Other
indexes NNS Other
and CC Other
fitness NN Other
-DOCSTART- -X- N

PGE NNP Physical
( ( Physical
2 CD Physical
) ) Physical
, , Physical
13-hydroxy-octadecadienoic JJ Physical
acids NNS Physical
, , Physical
and CC Physical
5- JJ Physical
, , Physical
12- JJ Physical
, , Physical
and CC Physical
15-hydroxyeicosatetraenoic JJ Physical
acid NN Physical
( ( Physical
5- JJ Physical
, , Physical
12- JJ Physical
, , Physical
and CC Physical
15-HETE JJ Physical
) ) Physical
Flexible JJ Physical
sigmoidoscopy NN Physical
eicosanoid JJ Physical
levels NNS Physical
mean JJ Physical
percent NN Physical
change NN Physical
eicosanoids NNS Physical
mean JJ Physical
percent NN Physical
change NN Physical
in IN Physical
PGE NNP Physical
( ( Physical
2 CD Physical
) ) Physical
5-HETE JJ None
12-HETE JJ Physical
15-HETE JJ None
free VB Physical
arachidonic JJ Physical
acid NN Physical
. . Physical
total JJ Adverse
adverse JJ Adverse
events NNS Adverse
eicosanoid JJ None
levels NNS None
tolerable JJ Other
and CC Other
safe JJ Other
. . Other
-DOCSTART- -X- N

myocardial JJ Physical
protection NN Physical
systolic JJ Physical
and CC Physical
early JJ Physical
diastolic JJ Physical
velocities NNS Physical
systolic JJ Physical
and CC Physical
diastolic JJ Physical
intramyocardial JJ Physical
velocities NNS Physical
functional JJ Physical
myocardial JJ Physical
impairment NN Physical
-DOCSTART- -X- N

dyspnoea NN Physical
psychodynamic JJ Mental
change NN Mental
; : Mental
psychiatric JJ Mental
symptoms NNS Mental
-DOCSTART- -X- N

creatinine NN Physical
( ( Physical
Cr NNP Physical
) ) Physical
rise NN None
serum NN Physical
Cr NNP Physical
levels NNS Physical
clinically RB Other
driven JJ Other
postprocedural JJ Other
observation NN Other
time NN Other
mean JJ Physical
maximum NN Physical
Cr NNP Physical
Cr NNP Physical
clearance NN Physical
Cr NNP Physical
Baseline NNP Physical
renal JJ Physical
function NN Physical
-DOCSTART- -X- N

empirical JJ Other
treatment NN Other
with IN Physical
antifungal JJ Other
drugs NNS Other
The DT None
numbers NNS None
of IN None
patients NNS None
who WP None
had VBD None
hepatotoxic NN None
and CC None
nephrotoxic JJ None
effects NNS None
hepatotoxic JJ None
effects NNS None
: : None
p=0?11 NN None
; : None
nephrotoxic JJ None
effects NNS None
: : None
52 CD None
reduced VBN None
use NN None
of IN None
empirical JJ None
antifungal JJ None
treatment NN None
. . None
This DT None
-DOCSTART- -X- N

symptoms NNS Physical
of IN Physical
menopausal VB Physical
symptoms NNS Physical
mean JJ Physical
monthly JJ Physical
hot JJ Physical
flush NN Physical
severity NN Physical
change NN Physical
in IN Physical
severity NN Physical
Sleep JJ Physical
disturbances NNS Physical
Mood NNP Mental
changes NNS Mental
relief NN Physical
of IN Physical
hot JJ Physical
flushes NNS Physical
and CC Physical
sleep JJ Physical
disturbances NNS Physical
. . None
-DOCSTART- -X- N

Blood NNP Physical
pressure NN Physical
reduction NN Physical
levels NNS Physical
of IN Physical
serum NN Physical
bilirubin NN Physical
, , None
uric JJ Physical
acid NN Physical
and CC None
triglycerides NNS Physical
Serum NNP Physical
cholesterol NN Physical
level NN Physical
mild NN Physical
to TO Physical
moderate VB Physical
hypertension NN Physical
-DOCSTART- -X- N

MRI NNP Physical
signal JJ Physical
hyperintensities NNS Physical
and CC Mental
failure NN Physical
to TO Physical
remit VB Physical
remission NN Physical
total JJ Physical
lesion NN Physical
volume NN Physical
. . Mental
lesion NN Physical
volume NN Physical
by IN Physical
region NN Physical
of IN Physical
interest NN Physical
( ( Physical
ROI NNP Physical
) ) Physical
. . Mental
DWMH NNP Physical
, , Mental
and CC Mental
PVH NNP Physical
volumes NNS Physical
Remission NN Mental
from IN Mental
depression NN Mental
Hamilton NNP Mental
Rating NNP Mental
Scale NNP Mental
for IN Mental
Depression NNP Mental
score NN Mental
remit VB None
following VBG None
whether IN None
remission NN None
from IN None
geriatric JJ None
depression NN None
depends VBZ None
lesion NN None
volume NN None
by IN None
ROI NNP None
in IN None
that IN None
lesion NN None
location NN None
may MD None
-DOCSTART- -X- N

education NN Mental
and CC Other
satisfaction NN Other
. . None
satisfied JJ Other
with IN Other
the DT Other
education NN Other
satisfied JJ Other
-DOCSTART- -X- N

translucency NN Other
Translucency NN Other
values NNS None
of IN None
translucency NN Other
Translucency NN Other
-DOCSTART- -X- N

Brief NNP Mental
Psychiatric NNP Mental
Rating NNP Mental
Scale NNP Mental
( ( Mental
BPRS NNP Mental
) ) Mental
total NN Mental
score NN Mental
. . None
plasma JJ Physical
level NN Physical
of IN Physical
haloperidol NN Physical
and CC None
clinical JJ Other
improvement NN Other
. . Other
side JJ Adverse
effects NNS Adverse
. . Adverse
-DOCSTART- -X- N

sweating NN Physical
threshold NN Physical
gain NN Physical
of IN Physical
sweating VBG Physical
. . None
increase NN Physical
in IN Physical
the DT Physical
reduce VB Physical
the DT Physical
Core NN Physical
temperature NN Physical
mean JJ Physical
skin NN Physical
temperature NN Physical
chest JJ Physical
sweating NN Physical
rate NN Physical
sweating NN Physical
core NN Physical
temperature NN Physical
Plasma NNP Physical
clonidine JJ Physical
concentrations NNS Physical
gain NN Physical
of IN Physical
sweating NN Physical
thermoregulatory JJ Physical
effects NNS Physical
-DOCSTART- -X- N

Blood NNP Physical
purification NN Physical
efficacy NN Other
indications NNS Other
, , None
efficacy NN Other
outcome JJ None
parameters NNS None
. . None
-DOCSTART- -X- N

effectiveness NN Other
and CC Other
safety NN Other
incidence NN Physical
of IN Physical
deep JJ Physical
venous JJ Physical
thrombosis NN Physical
hemorrhage NN Physical
. . Physical
deep JJ Physical
venous JJ Physical
thrombosis NN Physical
absolute NN Physical
risk NN Physical
difference NN Physical
absolute NN Physical
risk NN Physical
difference NN Physical
major JJ Physical
bleeding NN Physical
absolute NN Physical
risk NN Physical
difference NN Physical
-DOCSTART- -X- N

Intraperitoneal NNP Physical
distribution NN Physical
loculation NN Physical
free JJ Physical
intraperitoneal NN Physical
distribution NN Physical
pseudoloculation NN Physical
IDI NNP Physical
-DOCSTART- -X- N

cerebral JJ Physical
vasospasm NN Physical
delayed JJ Physical
ischemic JJ Physical
neurological JJ Physical
deficit NN Physical
3-month JJ Mental
dichotomized JJ Mental
Glasgow NNP Mental
Outcome NNP Mental
Score NNP Mental
( ( Mental
GOS NNP Mental
) ) Mental
, , None
development NN Mental
of IN Mental
delayed JJ Mental
ischemic JJ Mental
neurological JJ Mental
deficit NN Mental
( ( Mental
DIND NNP Mental
) ) Mental
, , None
occurrence NN Physical
of IN Physical
Transcranial NNP Physical
Doppler NNP Physical
( ( Physical
TCD NNP Physical
) ) Physical
vasospasm NN Physical
, , None
and CC None
length NN Other
of IN Other
stay NN Other
in IN Other
the DT Other
ICU NNP Other
incidence NN Mental
of IN Mental
DIND NNP Mental
pTBA NN Other
risk NN None
reduction NN None
relative JJ None
risk NN None
reduction NN None
absolute JJ None
and CC None
relative JJ None
risk NN None
reductions NNS None
Length NNP Other
of IN Other
stay NN Other
in IN Other
ICU NNP Other
procedure-related JJ Physical
vessel NN Physical
perforation NN Physical
vasospasm NN Physical
need NN Other
for IN Other
therapeutic JJ Other
angioplasty NN Other
. . Physical
-DOCSTART- -X- N

overall JJ Mental
first JJ Mental
response NN Mental
rate NN Mental
myelotoxic JJ Physical
non-haematological JJ Adverse
side-effects NNS Adverse
. . None
disease NN Other
control NN Other
. . None
Progression NN Physical
of IN Physical
disease NN Physical
duration NN Other
of IN Other
first JJ Other
response NN Physical
median JJ Other
duration NN Other
of IN Other
first JJ Other
response NN Physical
. . None
overall JJ Other
second JJ Other
response NN Physical
rate NN Other
Median JJ Other
survival NN Mortality
survival NN Mortality
first JJ Other
response NN Physical
second JJ Other
response NN Physical
side JJ Adverse
effects NNS Adverse
. . Adverse
-DOCSTART- -X- N

efficacies NNS Other
clinical JJ Other
scores NNS Other
colony-forming JJ Physical
units NNS Physical
external JJ Physical
ocular JJ Physical
disease NN Physical
ofloxacin JJ Other
eyedrops NN Other
was VBD Other
equally RB Other
effective JJ Other
when WRB Other
given VBN Other
BID NNP Other
or CC Other
QID NNP Other
. . None
-DOCSTART- -X- N

carcinogenic JJ Physical
effects NNS Physical
. . None
Total JJ Physical
iron-binding JJ Physical
capacity NN Physical
( ( Physical
TIBC NNP Physical
) ) Physical
Serum NNP Physical
iron NN Physical
metrics NNS Physical
GCC NNP Physical
GNCC NNP Physical
serum NN Physical
ferritin NN Physical
serum JJ Physical
iron NN Physical
transferrin JJ Physical
saturation NN Physical
. . None
TIBC NNP Physical
GNCC NNP Physical
Dietary NNP Physical
iron NN Physical
exposures NNS Physical
pathogenesis NN None
of IN None
GCC NNP Physical
. . None
-DOCSTART- -X- N

rate NN None
of IN None
brain NN None
metastases NNS None
overall JJ Mortality
survival NN Mortality
. . Mortality
neuropsychological JJ None
syndromes NNS None
and CC None
brain NN None
abnormalities NNS None
brain NN Mortality
metastasis NN Mortality
, , Mortality
overall JJ Mortality
survival NN Mortality
late-occurring JJ Adverse
toxic NN Adverse
effects NNS Adverse
2-year JJ Mental
cumulative JJ Mental
rate NN Mental
of IN Mental
brain NN Mental
metastasis NN Mental
relapse NN Mental
total JJ Physical
2-year JJ Physical
rate NN Physical
of IN Physical
brain NN Physical
metastasis NN Physical
2-year JJ Mortality
overall JJ Mortality
survival NN Mortality
rate NN Mortality
neuropsychological JJ Physical
function NN Physical
or CC Physical
abnormalities NNS Physical
overall JJ Mortality
survival NN Mortality
-DOCSTART- -X- N

economic JJ Other
productivity NN Other
hourly NN Other
wages NNS Other
tendency NN Other
for IN Other
hours NNS Other
worked VBN Other
annual JJ Other
incomes NNS Other
substantial JJ Other
increases NNS Other
in IN Other
wage NN Other
rates NNS Other
-DOCSTART- -X- N

number NN Other
of IN Other
transfusions NNS Other
number NN Other
of IN Other
transfusions NNS Other
, , None
the DT None
number NN Other
of IN Other
donor JJ Other
exposures NNS Other
, , None
and CC None
various JJ Other
clinical JJ Other
and CC Other
physiologic JJ Other
outcomes NNS Other
. . None
RBC JJ Physical
transfusions NNS Physical
number NN Physical
of IN Physical
donors NNS Physical
percentage NN Physical
of IN Physical
infants NNS Physical
who WP Physical
avoided VBD Physical
transfusions NNS Physical
altogether RB Physical
intraparenchymal JJ Physical
brain NN Physical
hemorrhage NN Physical
or CC Physical
periventricular JJ Physical
leukomalacia NN Physical
more RBR Physical
frequent JJ Physical
episodes NNS Physical
of IN Physical
apnea NN Physical
mild JJ Physical
and CC Physical
severe JJ Physical
episodes NNS Physical
. . None
major JJ Adverse
adverse JJ Adverse
neurologic NN Adverse
events NNS Adverse
-DOCSTART- -X- N

efficacy NN Other
improves NNS None
adult VBP None
height NN None
( ( None
AH NNP None
) ) None
evaluated VBD None
growth NN None
during IN None
puberty NN None
. . None
Median JJ None
height NN None
increased VBD None
better JJR None
AH NNP None
. . None
AH NNP None
improves VBZ None
AH NNP None
-DOCSTART- -X- N

mean JJ Physical
duration NN Other
of IN Other
therapeutic JJ Other
response NN Other
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
control NN Physical
, , None
quality NN Other
of IN Other
life NN Other
, , None
quality NN Other
of IN Other
care NN Other
, , None
and CC None
satisfaction NN Other
of IN Other
Systolic NNP Physical
blood NN Physical
pressure NN Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
quality NN Other
of IN Other
life NN Other
scores NNS Other
physical JJ Physical
functioning NN Physical
physical JJ Physical
role NN Physical
limitations NNS Physical
bodily RB Pain
pain NN Pain
Patient JJ Other
satisfaction NN Other
scores NNS Other
blood NN Physical
pressure NN Physical
control NN Physical
, , None
quality NN Other
of IN Other
life NN Other
, , None
and CC None
patient JJ Mental
satisfaction NN Mental
-DOCSTART- -X- N

AUC NNP Other
and CC Other
Cmax NNP Other
of IN Other
digoxin NN Other
. . Other
AUC- NNP Other
and CC Other
Cmax-ratios NNP Other
tolerated VBN Other
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

healed VBD Physical
. . None
remission NN Physical
time NN Physical
remained VBD Physical
healed VBN Physical
treatment NN Other
scalp JJ Physical
psoriasis NN Physical
minor JJ Physical
effect NN Physical
. . None
-DOCSTART- -X- N

[ JJ Physical
Acute NNP Physical
cardiovascular NN Physical
and CC Physical
metabolic JJ Physical
changes NNS Physical
acute NN Physical
changes NNS Physical
of IN Physical
cardiovascular NN Physical
and CC Physical
metabolic JJ Physical
reactions NNS Physical
training VBG Physical
heart NN Physical
rate NN Physical
acute JJ Physical
response NN Physical
of IN Physical
heart NN Physical
rate NN Physical
, , None
blood NN Physical
pressure NN Physical
, , None
rate-pressure JJ Physical
product NN Physical
, , None
glucose JJ Physical
, , None
lactate JJ Physical
and CC None
catecholamines NNS Physical
no DT None
significant JJ None
differences NNS None
in IN None
systolic JJ Other
and CC Other
diastolic JJ Other
pressure NN Other
, , None
rate-pressure JJ Other
product NN Other
, , None
in IN None
glucose NN Other
or CC None
catecholamine NN Other
levels NNS None
. . None
rate NN Physical
of IN Physical
lactate NN Physical
cardiac NN Physical
work NN Physical
-DOCSTART- -X- N

main JJ Mental
and CC Mental
interaction JJ Mental
effects NNS Mental
Speech NNP Mental
Alone NNP Mental
, , None
Sign NNP Mental
Alone NNP Mental
, , None
Simultaneous NNP Mental
Presentation NNP Mental
of IN Mental
Sign NNP Mental
and CC None
Speech NNP Mental
, , None
and CC None
Alternating NNP Mental
Presentation NNP Mental
of IN Mental
Sign NNP Mental
and CC Mental
Speech NNP Mental
training NN Mental
conditions NNS Mental
. . None
Speech NNP Mental
Alone RB Mental
, , None
Simultaneous JJ Mental
Presentation NNP Mental
, , None
and CC None
Alternating NNP Mental
Presentation NNP Mental
condition NN Mental
size NN Mental
of IN Mental
child-initiated JJ Mental
spoken JJ Mental
vocabulary JJ Mental
-DOCSTART- -X- N

overall JJ Pain
gut NN Pain
pain NN Pain
sensory JJ Physical
response NN Physical
to TO Physical
mechanical JJ Physical
stimulation NN Physical
thermal JJ Physical
sensitivity NN Physical
duodenum NN None
sensory JJ Physical
response NN Physical
to TO Physical
electrical JJ Physical
stimulation NN Physical
duodenum NN Physical
induced VBN Pain
somatic JJ Pain
referred VBD Pain
pain NN Pain
areas NNS Pain
somatic JJ Pain
referred VBD Pain
pain JJ Pain
areas NNS Pain
or CC None
self-reported JJ Physical
symptoms NNS Physical
. . None
-DOCSTART- -X- N

antihypertensives NNS None
Hypertension NN Physical
postoperative JJ Physical
myocardial JJ Physical
infraction NN Physical
bleeding NN Physical
, , Physical
Hemodynamic NNP Physical
effects NNS Physical
Hemodynamic JJ Physical
measurements NNS Physical
Mean NNP Physical
arterial JJ Physical
pressure NN Physical
heart NN Physical
rate NN Physical
hemodynamic JJ Physical
effects NNS Physical
myocardial JJ Physical
performance NN Physical
and CC None
more RBR None
effective JJ None
control NN None
of IN None
hypertension NN Physical
. . None
-DOCSTART- -X- N

durability NN Mental
of IN Mental
memory-based JJ Mental
automaticity NN Mental
response NN Mental
times NNS Mental
durability NN Mental
of IN Mental
memory-based JJ Mental
automaticity NN Mental
lag NN None
effect NN None
durability NN Mental
of IN Mental
memory-based JJ Mental
automaticity NN Mental
-DOCSTART- -X- N

clinical JJ None
outcome NN None
mortality NN Mortality
Q-wave NNP Physical
myocardial JJ Physical
infarction NN Physical
stroke NN Physical
. . None
five-year JJ Mortality
survival NN Mortality
rate NN Mortality
respective JJ Mortality
five-year JJ Mortality
survival NN Mortality
rates NNS Mortality
free VBP Mortality
from IN Mortality
Q-wave NNP Mortality
myocardial JJ Mortality
infarction NN Mortality
revascularization NN Other
procedures NNS Other
five-year JJ Mortality
survival NN Mortality
five-year JJ Mortality
survival NN Mortality
subsequent JJ Other
revascularization NN Other
five-year JJ Mortality
survival NN Mortality
-DOCSTART- -X- N

Generalizability NNP Other
and CC None
durability NN Other
of IN None
treatment NN None
effects NNS None
reliability NN Other
and CC None
durability NN Other
of IN Other
positive JJ Other
treatment NN Other
effects NNS Other
serum NN Physical
cholesterol NN Physical
levels NNS Physical
. . None
good JJ Other
maintenance NN Other
of IN Other
treatment NN Other
effects NNS Other
-DOCSTART- -X- N

Vascular JJ Physical
pedicle NN Physical
width NN Physical
( ( Physical
VPW NNP Physical
) ) Physical
VPW NNP Physical
and CC Physical
central JJ Physical
venous JJ Physical
pressure NN Physical
( ( Physical
CVP NNP Physical
) ) Physical
or CC Physical
pulmonary JJ Physical
artery NN Physical
occlusion NN Physical
pressure NN Physical
( ( Physical
PAOP NNP Physical
) ) Physical
relationships NNS Physical
between IN Physical
VPW NNP Physical
, , Physical
positive JJ Physical
end-expiratory JJ Physical
pressure NN Physical
( ( Physical
PEEP NNP Physical
) ) Physical
, , Physical
cumulative JJ Physical
fluid NN Physical
balance NN Physical
, , Physical
and CC Physical
PAOP NNP Physical
VPW NNP Physical
with IN None
PAOP NNP None
1.5-fold JJ None
PAOP NNP None
< NNP None
with IN None
VPW NNP None
?67 NNP None
, , None
VPW NNP None
-DOCSTART- -X- N

altered JJ Physical
perception NN Physical
. . Physical
Autism NNP Physical
Spectrum NNP Physical
Quotient NNP Physical
local JJ Physical
and CC Physical
global JJ Physical
processing NN Physical
cortical JJ Physical
response NN Physical
a DT Other
delay NN Other
identifying VBG Other
the DT Other
global JJ Other
components NNS Other
impaired JJ Other
global JJ Other
visual JJ Other
perception NN Other
behavioural JJ Physical
tendencies NNS Physical
-DOCSTART- -X- N

Skin NNP Physical
improvement NN Physical
serum NN Physical
androgen NN Physical
levels NNS Physical
serum NN Physical
androgen NN Physical
levels NNS Physical
skin NN Physical
parameters NNS Physical
serum NN Physical
androgen NN Physical
levels NNS Physical
, , Physical
grading NN Physical
of IN Physical
acne NN Physical
and CC Physical
hirsutism NN Physical
non-invasive JJ Physical
assessment NN Physical
of IN Physical
skin JJ Physical
hydration NN Physical
, , Physical
transepidermal JJ Physical
water NN Physical
loss NN Physical
( ( Physical
TEWL NNP Physical
) ) Physical
and CC Physical
skin JJ Physical
homogeneity NN Physical
skin NN Physical
and CC Physical
hormonal JJ Physical
parameters NNS Physical
acne NN Physical
and CC Physical
seborrhea NN Physical
. . Physical
effective JJ Other
and CC Other
safe JJ Other
treatment NN Other
potent JJ Other
therapeutic JJ Other
option NN Other
. . Other
-DOCSTART- -X- N

HCL NNP Physical
. . None
second JJ Physical
malignancy NN Physical
; : Physical
hematologic JJ Physical
malignancy NN Physical
excellent JJ Other
palliation NN Other
interferon NN Physical
chemotherapy NN Physical
. . None
second JJ Adverse
malignancies NNS Adverse
. . None
-DOCSTART- -X- N

maladaptive JJ Mental
and CC Mental
stereotypic JJ Mental
behaviors NNS Mental
maladaptive NN Mental
and CC Mental
stereotypic NN Mental
behaviors NNS Mental
maladaptive JJ Mental
and CC Mental
stereotypic JJ Mental
behaviors NNS Mental
maladaptive JJ Mental
and CC Mental
stereotypic JJ Mental
behaviors NNS Mental
-DOCSTART- -X- N

fibrinolytic JJ Physical
shutdown NN Physical
. . None
Fibrinogen NNP Physical
and CC Physical
plasminogen NN Physical
concentrations NNS Physical
in IN Physical
plasma NN Physical
, , None
plasminogen NN Physical
activator NN Physical
inhibitor NN Physical
activity NN Physical
in IN Physical
plasma NN Physical
and CC Physical
fibrinolytic JJ Physical
activity NN Physical
in IN Physical
concentrated JJ Physical
euglobulins NNS Physical
rise NN Physical
of IN Physical
fibrinogen NN Physical
concentration NN Physical
plasminogen NN Physical
level NN Physical
Fibrinolytic JJ Physical
activity NN Physical
in IN Physical
euglobulins NNS Physical
plasminogen NN Physical
activator NN Physical
inhibitor NN Physical
activity NN Physical
postoperative JJ Physical
fibrinolytic JJ Physical
shutdown NN Physical
fibrinolytic JJ Physical
activity NN Physical
plasminogen NN Physical
concentration NN Physical
-DOCSTART- -X- N

Regression NN Physical
of IN Physical
the DT Physical
ROP NNP Physical
ROP NNP Other
-DOCSTART- -X- N

Perioperative NNP Physical
data NN Physical
, , Physical
as RB Physical
well RB Physical
as IN Physical
symptom NN Physical
scores NNS Physical
, , Physical
Quality NNP Physical
of IN Physical
Life NNP Physical
( ( Physical
QoL NNP Physical
) ) Physical
scores VBZ Physical
, , Physical
and CC Physical
maximum JJ Physical
urinary JJ Physical
flow NN Physical
rates NNS Physical
( ( Physical
Qmax NNP Physical
) ) Physical
Post-void JJ Physical
residual JJ Physical
volumes NNS Physical
, , Physical
transrectal JJ Physical
ultrasound NN Physical
( ( Physical
TRUS NNP Physical
) ) Physical
volumes NNS Physical
, , Physical
and CC Physical
pressure NN Physical
flow NN Physical
studies NNS Physical
Continence NN Physical
and CC Physical
potency NN Physical
data NNS Physical
Mean JJ Physical
pre-operative JJ Physical
TRUS NNP Physical
volume NN Physical
catheter NN Other
times NNS Other
hospital NN Other
stays NNS Other
. . None
prostate JJ Physical
tissue NN Physical
urodynamically RB Physical
American NNP Physical
Urology NNP Physical
Association NNP Physical
scores NNS Physical
, , Physical
QoL NNP Physical
scores VBZ Physical
, , Physical
or CC Physical
Qmax NNP Physical
values NNS Physical
; : None
perioperative JJ Mortality
morbidity NN Mortality
urodynamic JJ Physical
outcomes NNS Physical
-DOCSTART- -X- N

response NN None
rates NNS None
( ( None
complete JJ None
response NN None
and CC None
partial JJ None
response NN None
) ) None
of IN None
=.99 NNP None
) ) None
. . None
Time NN None
to TO None
treatment NN None
failure NN None
( ( None
TTF NNP None
) ) None
was VBD None
TTF NNP None
was VBD None
overall JJ None
survival NN None
( ( None
30.0 CD None
-DOCSTART- -X- N

neural JJ Other
consequences NNS Other
of IN Other
emotional JJ Other
experiences NNS Other
on IN Other
place NN Other
memory NN Other
neural JJ Other
activity NN Other
parahippocampal JJ Other
activity NN Other
automatic JJ Other
enhancement NN Other
of IN Other
place NN Other
representations NNS Other
-DOCSTART- -X- N

short-term JJ Physical
postoperative JJ Physical
cure NN Physical
rates NNS Physical
: : None
surgical JJ Other
cure NN Other
rate NN Other
Cure NN Other
fasting VBG None
IGF1 NNP None
Cure NN Other
Surgical JJ Physical
morbidity NN Physical
postoperative JJ Other
hospital NN Other
stay NN Other
surgical JJ Other
cure NN Other
rates NNS Other
surgical JJ Adverse
complications NNS Adverse
duration NN Other
of IN Other
hospital NN Other
stay NN Other
-DOCSTART- -X- N

simple JJ Physical
test NN Physical
of IN Physical
blood NN Physical
coagulability NN Physical
normal JJ Physical
coagulability NN Physical
normal JJ Physical
clotting NN Physical
Local JJ Physical
tissue NN Physical
swelling NN Physical
local JJ Physical
necrosis NN Physical
-DOCSTART- -X- N

Mean JJ Physical
+/- JJ Physical
SD NNP Physical
baseline NN Physical
total NN Physical
cholesterol NN Physical
( ( Physical
TC NNP Physical
) ) Physical
and CC None
low-density JJ Physical
lipoprotein NN Physical
cholesterol NN Physical
( ( Physical
LDL-C NNP Physical
) ) Physical
levels NNS Physical
TC NNP Physical
and CC None
LDL-C NNP Physical
levels NNS Physical
Triglyceride NNP Physical
and CC Physical
high-density NN Physical
lipoprotein NNS Physical
cholesterol NN Physical
levels NNS Physical
adverse JJ Adverse
effects NNS Adverse
Serum NNP Physical
vitamin VBD Physical
A DT Physical
and CC Physical
25-hydroxyvitamin JJ Physical
D NNP Physical
levels NNS Physical
TC NNP Physical
and CC None
LDL-C NNP Physical
levels NNS Physical
-DOCSTART- -X- N

anti-ischemic JJ Physical
effect NN Physical
antiischemic JJ Physical
effects NNS Physical
. . None
ischemia NN Physical
antiischemic JJ Physical
effects NNS Physical
relief NN Other
of IN Other
symptoms NNS Other
ST-depression NNP Physical
myocardial JJ Physical
wall NN Physical
motion NN Physical
pathologically RB Physical
elevated VBN Physical
filling JJ Physical
pressure NN Physical
, , None
amelioration NN Physical
of IN Physical
coronary JJ Physical
blood NN Physical
flow NN Physical
myocard NN None
scintigraphy NN None
washout NN None
time NN None
ischemia-caused JJ Physical
mitral JJ Physical
regurgitation NN Physical
. . None
peripheral JJ Physical
effects NNS Physical
antiischemic JJ Physical
effects NNS Physical
synergistic JJ Physical
action NN Physical
Negative JJ Physical
dromotropic JJ Physical
effects NNS Physical
antiischemic JJ Physical
effects NNS Physical
Holter NNP Other
monitoring NN Other
ST-depression NNP Physical
number NN Physical
and CC Physical
duration NN Physical
of IN Physical
episodes NNS Physical
of IN Physical
silent JJ Physical
ischemia NN Physical
symptomatic JJ Physical
episodes NNS Physical
. . None
proarrhythmic JJ Physical
effects NNS Physical
-DOCSTART- -X- N

linear JJ Physical
height NN Physical
body NN Physical
mass NN Physical
index NN Physical
Mean JJ Other
muscle NN Other
volume NN Other
of IN Other
the DT Other
thigh NN Other
, , None
estimated VBN None
by IN None
computerised JJ None
tomography NN None
adipose JJ Physical
tissue NN Physical
volume NN Physical
of IN Physical
the DT Physical
thigh NN Physical
subscapular JJ Physical
skinfold NN Physical
thickness NN Physical
muscle NN Other
to TO Other
fat VB Other
ratio NN Other
of IN Other
the DT Other
thigh NN Other
mean JJ Other
isometric JJ Other
strength NN Other
of IN Other
the DT Other
quadriceps JJ Other
muscles NNS None
increased VBD None
Exercise NN Physical
capacity NN Physical
performed VBN None
on IN None
a DT None
bicycle NN None
ergometer NN None
adverse JJ Adverse
reactions NNS Adverse
hemoglobin NN Physical
A1c NNP Physical
-DOCSTART- -X- N

renal JJ Physical
function NN Physical
and CC Physical
urinary JJ Physical
output NN Physical
: : Physical
serum NN Physical
blood NN Physical
urea JJ Physical
nitrogen RB Physical
serum JJ Physical
creatinine NN Physical
creatinine JJ Physical
clearance NN Physical
indexed JJ Physical
urinary JJ Physical
output NN Physical
urinary JJ Physical
output NN Physical
but CC Physical
nonsignificant JJ Physical
renal JJ Physical
functional JJ Physical
deterioration NN Physical
. . Physical
-DOCSTART- -X- N

Electromyographic NNP Other
( ( Other
EMG NNP Other
) ) Other
activity NN Other
amplitude NN Other
of IN Other
the DT Other
movement NN Other
peak JJ Other
velocity NN Other
EMG NNP Other
pattern NN Other
step-tracking JJ Other
movement NN Other
. . None
initial JJ Physical
agonist NN Physical
burst NN Physical
( ( Physical
AG1 NNP Physical
) ) Physical
antagonist NN Physical
burst NN Physical
( ( Physical
ANT NNP Physical
) ) Physical
EMG NNP Other
response NN Other
-DOCSTART- -X- N

lesion NN Physical
counts NNS Physical
rash NN Physical
severity NN Physical
-DOCSTART- -X- N

age NN Mental
and CC Mental
sex NN Mental
magnitude JJ Mental
estimation NN Mental
ratings NNS Mental
of IN Mental
symptom JJ Mental
pathology NN Mental
-DOCSTART- -X- N

( ( None
FEV1 NNP Physical
) ) None
FEV1 NNP Physical
FEV1 NNP Physical
initial JJ Physical
FEV1 NNP Physical
airway NN Physical
response NN Physical
deltaFEV1 NN Physical
% NN Physical
init JJ Physical
mean JJ Physical
value NN Physical
-DOCSTART- -X- N

preventing VBG Physical
breast NN Physical
cancer NN Physical
cardiovascular JJ Physical
risk NN Physical
. . None
early JJ Physical
cardiovascular JJ Physical
events NNS Physical
cardiovascular JJ Adverse
effects NNS Adverse
cardiovascular JJ Adverse
effects NNS Adverse
Fatal NNP Physical
and CC Physical
nonfatal JJ Physical
myocardial JJ Physical
infarction NN Physical
, , None
unstable JJ Physical
angina NN Physical
, , Physical
and CC Physical
severe JJ Physical
angina NN Physical
Cardiovascular JJ Other
event NN Other
rates NNS Other
fatal JJ Physical
myocardial JJ Physical
infarction NN Physical
nonfatal JJ Physical
myocardial JJ Physical
infarction NN Physical
unstable JJ Physical
angina NN Physical
severe JJ Physical
angina NN Physical
. . None
risk JJ Other
ratios NNS Other
fatal JJ Physical
myocardial JJ Physical
infarction NN Physical
nonfatal JJ Physical
myocardial JJ Physical
infarction NN Physical
unstable JJ Physical
angina NN Physical
severe JJ Physical
angina NN Physical
. . None
cardiovascular JJ Physical
events NNS Physical
increase NN Physical
in IN Physical
risk NN Physical
cardiovascular JJ Adverse
effects NNS Adverse
. . None
-DOCSTART- -X- N

analgesic JJ Other
efficacy NN Other
adverse JJ Adverse
effects NNS Adverse
Analgesic JJ Other
efficacy NN Other
, , None
maternal JJ Adverse
side NN Adverse
effects NNS Adverse
, , None
changes NNS Physical
in IN Physical
the DT Physical
blood NN Physical
pressure NN Physical
, , None
heart NN Physical
rate NN Physical
, , None
and CC None
duration NN Physical
of IN Physical
labor NN Physical
pain VBP Pain
relief NN Pain
nausea NN Adverse
and CC Adverse
fatigue NN Adverse
decrease NN Physical
in IN Physical
systolic JJ Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
increase NN None
in IN None
heart NN Physical
rate NN Physical
duration NN Physical
of IN Physical
labor NN Physical
and CC Physical
Apgar NNP Physical
scores NNS Physical
. . None
respiratory JJ Physical
depression NN Physical
. . None
analgesic JJ Other
efficacy NN Other
maternal JJ Adverse
side NN Adverse
effects NNS Adverse
. . None
-DOCSTART- -X- N

overall JJ Physical
clinical JJ Physical
response NN Physical
rates NNS Physical
( ( None
complete JJ None
Median JJ Physical
progression-free JJ Physical
survival NN Physical
overall JJ Mortality
survival NN Mortality
Response JJ Physical
rates NNS Physical
response NN Physical
rate NN Physical
Median JJ Mortality
survival NN Mortality
response NN Physical
rates NNS Physical
, , None
progression-free JJ Mortality
interval NN Mortality
, , None
and CC None
overall JJ Mortality
survival NN Mortality
response NN Physical
rate NN Physical
survival NN Mortality
-DOCSTART- -X- N

Significant JJ Physical
improvement NN Physical
relieving VBG Physical
the DT Physical
problem NN Physical
-DOCSTART- -X- N

reduction NN Physical
ratio NN Physical
in IN Physical
plasma JJ Physical
cytokines NNS Physical
Other JJ Physical
clinical JJ Physical
parameters NNS Physical
reduction NN Physical
ratio NN Physical
in IN Physical
plasma JJ Physical
cytokine NN Physical
levels NNS Physical
VEGF NNP Physical
0.001 CD None
) ) None
, , None
IL-8 NNP None
( ( None
0.021 CD None
) ) None
, , None
IL-10 NNP None
( ( None
P NNP None
= NNP None
and CC None
tumor NN None
necrosis NN None
factor-? NN None
( ( None
P NNP None
= NNP None
0.029 CD None
differences NNS None
in IN None
intradialytic JJ Physical
blood NN Physical
pressures NNS Physical
. . None
Online NNP None
better RBR None
renal JJ None
recovery NN None
and CC None
shorter JJR None
length NN None
of IN None
hospitalization NN None
than IN None
high-flux JJ None
HD NNP None
. . None
In IN None
removal NN None
of IN None
VEGF NNP None
and CC None
other JJ None
cytokines NNS None
better JJR None
renal NN None
outcome NN None
-DOCSTART- -X- N

suppression NN Physical
of IN Physical
Dentin NNP Physical
sensitivity NN Physical
Tooth DT None
sensitivity NN None
suppression NN Physical
of IN Physical
cold JJ Physical
sensitivity NN Physical
temperature NN Physical
at IN Physical
which WDT Physical
teeth NN Physical
responded VBD Physical
temperature NN Physical
reductions NNS Physical
decrease NN Physical
in IN Physical
sensitivity NN Physical
to TO Physical
cold VB Physical
tooth DT Physical
root NN Physical
sensitivity NN Physical
-DOCSTART- -X- N

chemotherapy-induced JJ Physical
nausea NN Physical
chemotherapy-induced JJ Physical
nausea NN Physical
wrist VB Other
band NN Other
efficacy NN Other
( ( None
acute JJ Physical
nausea NN Physical
, , None
delayed VBN Physical
nausea NN Physical
, , None
vomiting VBG Physical
, , None
QOL NNP Mental
, , None
and CC None
total JJ Other
amount NN Adverse
of IN Adverse
antiemetic JJ Adverse
medication NN Adverse
used VBN Adverse
) ) None
severity NN Physical
of IN Physical
past JJ Physical
nausea NN Physical
. . None
chemotherapy-related JJ Physical
nausea NN Physical
-DOCSTART- -X- N

Neurocognitive JJ Physical
outcomes NNS Physical
growth NN Physical
modeling NN Physical
. . None
cognitive JJ Physical
test NN Physical
scores NNS Physical
incidence NN Physical
of IN Physical
cognitive JJ Physical
deficits NNS Physical
verbal JJ Mental
fluency NN Mental
pattern NN Physical
of IN Physical
cognitive JJ Physical
change NN Physical
over IN Physical
time NN Physical
verbal JJ Mental
fluency NN Mental
cognitive NN Physical
gains NNS Physical
-DOCSTART- -X- N

malignant JJ Physical
dysphagia NN Physical
mean JJ Physical
therapeutic JJ Physical
interval NN Physical
degree NN Physical
of IN Physical
dysphagia NN Physical
relief NN Physical
, , None
number NN Other
of IN Other
endoscopic JJ Other
procedures NNS Other
or CC Physical
survival JJ Mortality
times NNS Mortality
. . None
therapeutic JJ Physical
interval NN Physical
. . None
-DOCSTART- -X- N

daily JJ Mental
living NN Mental
skills NNS Mental
independence NN Mental
and CC Mental
self-help JJ Mental
skills NNS Mental
. . None
parental JJ Mental
intrusiveness NN Mental
total NN Mental
and CC Mental
personal JJ Mental
daily JJ Mental
living NN Mental
skills NNS Mental
involvement NN Mental
in IN Mental
their PRP$ Mental
children NNS Mental
's POS Mental
private JJ Mental
daily JJ Mental
routines NNS Mental
. . None
severity NN Other
. . None
independence NN Mental
and CC Mental
daily JJ Mental
living NN Mental
skills NNS Mental
-DOCSTART- -X- N

memory NN Mental
for IN Mental
emotional JJ Mental
experiences NNS Mental
: : None
memory NN Mental
for IN Mental
emotional JJ Mental
experiences NNS Mental
. . None
retrospective JJ Mental
frequency NN Mental
judgments NNS Mental
of IN Mental
emotions NNS Mental
. . None
CulturexType NNP Mental
of IN Mental
Event NNP Mental
congruence NN Mental
effect NN Mental
. . None
congruence NN Mental
effect NN Mental
personal JJ Mental
values NNS Mental
retrospective JJ Mental
frequency NN Mental
judgments NNS Mental
of IN Mental
emotion NN Mental
-DOCSTART- -X- N

effectiveness NN Other
therapeutic JJ Other
advantage NN Other
complete JJ Other
or CC Other
partial JJ Other
response NN Other
Response VB None
status NN None
development NN Physical
of IN Physical
progressive JJ Physical
disease NN Physical
or CC Other
survival NN Mortality
-DOCSTART- -X- N

complement JJ Physical
activation NN Physical
systemic VB Physical
complement JJ Physical
activation NN Physical
C4b/c NNP Physical
and CC Physical
C3b/c NNP Physical
levels NNS Physical
of IN Physical
microparticles NNS Physical
C3b/c NNP Physical
( ( Physical
but CC Physical
not RB Physical
C4b/c NNP Physical
) ) Physical
Concentrations NNS Physical
of IN Physical
fluid-phase JJ Physical
complement NN Physical
activation NN Physical
products NNS Physical
and CC Physical
microparticles NNS Physical
activation NN Physical
of IN Physical
the DT Physical
complement NN Physical
system NN Physical
systemic VB Physical
complement JJ Physical
activation NN Physical
. . None
-DOCSTART- -X- N

pain NN Pain
difficulty NN Other
in IN Other
wound NN Other
care NN Other
dressing VBG Other
interference NN Other
with IN Other
their PRP$ Other
daily JJ Other
functions NNS Other
. . Other
clinical JJ Adverse
infection NN Adverse
rate NN Adverse
and CC None
time NN Other
to TO Other
healing VBG Other
management NN Other
-DOCSTART- -X- N

attributions NNS Other
medical JJ Other
sounding VBG Other
term NN Other
attributions NNS Other
more RBR None
serious JJ None
, , None
disabling VBG None
illness NN None
. . None
-DOCSTART- -X- N

management NN Physical
of IN Physical
atrial JJ Physical
fibrillation NN Physical
. . Physical
rate NN Physical
control NN Physical
diltiazem-induced JJ Physical
hypotension NN Physical
[ NN Physical
defined VBN Physical
by IN Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
SBP NNP Physical
) ) Physical
< VBD Physical
90 CD Physical
mm NN Physical
Hg NNP Physical
] NNP Physical
hypotension NN Physical
hypotension NN Physical
SBP NNP Adverse
drop NN Adverse
heart NN Physical
rate NN Physical
adverse JJ Adverse
events NNS Adverse
tachycardic JJ Adverse
and CC Adverse
apneic NN Adverse
blunting NN Physical
of IN Physical
SBP NNP Physical
drop NN Physical
-DOCSTART- -X- N

progression NN Other
rate NN Other
and CC None
freedom NN Other
from IN Other
treatment NN Other
failure NN Other
( ( Other
FFTF NNP Other
) ) Other
24-month JJ Physical
FFTF NNP Physical
rate NN Physical
progressive JJ Physical
disease NN Physical
Differences NNS Mortality
in IN Mortality
survival NN Mortality
acute JJ Physical
toxicity NN Physical
of IN Physical
baseline NN Physical
BEACOPP NNP Physical
-DOCSTART- -X- N

tyrosine NN Physical
phenylalanine NN Physical
in IN None
plasma NN None
and CC None
urine NN None
. . None
Plasma NNP None
and CC None
urine JJ None
concentrations NNS None
of IN None
tyrosine NN Physical
and CC None
phenylalanine NN Physical
higher JJR None
catabolize VB Physical
tyrosine NN Physical
. . None
significantly RB None
higher JJR None
plasma JJ Physical
tyrosine NN Physical
concentrations NNS Physical
increased VBD None
plasma JJ Physical
tyrosine NN Physical
concentrations NNS Physical
-DOCSTART- -X- N

oxygen JJ Physical
uptake NN Physical
( ( Physical
VO2 NNP Physical
) ) Physical
pulmonary JJ Physical
ventilation NN Physical
( ( Physical
VE NNP Physical
) ) Physical
submaximal JJ Physical
response NN Physical
to TO Physical
exercise NN Physical
of IN Physical
experimental JJ Physical
subjects NNS Physical
HR NNP Physical
, , None
VO2 NNP Physical
VE NNP None
while IN None
VO2 NNP Physical
max NN None
physical JJ Physical
fitness NN Physical
submaximal JJ Physical
responses NNS Physical
-DOCSTART- -X- N

Transient NNP Physical
lower JJR Physical
esophageal NN Physical
sphincter NN Physical
relaxations NNS Physical
( ( Physical
TLESRs NNP Physical
) ) Physical
Basal NNP Physical
lower JJR Physical
esophageal NN Physical
pressure NN Physical
( ( Physical
LESP NNP Physical
) ) Physical
and CC None
swallow-induced JJ Physical
relaxation NN Physical
TLESRs NNP Physical
number NN Physical
of IN Physical
common JJ Physical
cavities NNS Physical
TLESRs NNP Physical
TLESRs NNP Physical
-DOCSTART- -X- N

fulminating VBG Physical
enteritis NN Physical
with IN Physical
typical JJ Physical
clinical JJ Physical
signs NNS Physical
and CC None
died VBD Mortality
died VBD Mortality
survived VBD Mortality
recovered VBN Physical
. . None
-DOCSTART- -X- N

exercise NN Physical
ECG NNP Physical
duration NN Other
of IN Other
exercise NN Other
ischaemia NN Physical
reduction NN None
number NN Physical
of IN Physical
anginal JJ Physical
attacks NNS Physical
Plasma NNP Physical
level NN Physical
of IN Physical
ISDN NNP Physical
and CC Physical
the DT Physical
mononitrates NNS Physical
frequency NN Physical
of IN Physical
angina NN Physical
and CC Physical
ischaemia NN Physical
parameters NNS Physical
anti-anginal JJ Physical
effect NN Physical
-DOCSTART- -X- N

86rubidium CD Physical
uptake NN Physical
86rubidium CD Physical
uptake NN Physical
sexual JJ Physical
maturation NN Physical
on IN Physical
cation NN Physical
handling NN Physical
of IN Physical
cells NNS Physical
. . None
sexual JJ Physical
maturation NN Physical
in IN Physical
capacity NN Physical
of IN Physical
sodium-potassium JJ Physical
pump NN Physical
-DOCSTART- -X- N

Penetration NN Mental
and CC Mental
accumulation NN Mental
eradicate VB Physical
the DT Physical
major JJ Physical
pathogens NNS Physical
Moxifloxacin NNP Physical
accumulated VBD Physical
in IN Physical
uterine JJ Physical
tissue NN Physical
and CC Physical
concentrations NNS Physical
Tissue NN Physical
to TO Physical
plasma VB Physical
ratios NNS Physical
safe JJ Other
and CC Other
well RB Other
tolerated VBN Other
. . None
uterine JJ Physical
tissue NN Physical
concentrations NNS Physical
-DOCSTART- -X- N

Pharmacokinetics NNS Other
half-life NN Physical
beta-blocking JJ Physical
activity NN Physical
. . None
metabolite NN Physical
-DOCSTART- -X- N

Posttransplant NNP Physical
hypertension NN Physical
blood NN Physical
pressure NN Physical
( ( Physical
BP NNP Physical
) ) Physical
24-hour JJ Physical
urine NN Physical
for IN Physical
sodium NN Physical
measurement NN Physical
, , Physical
BP NNP Physical
, , Physical
and CC Physical
allograft NN Physical
functions NNS Physical
sex NN None
, , None
serum JJ Physical
creatinine NN Physical
, , None
systolic JJ Physical
and CC None
diastolic JJ Physical
BP NNP Physical
, , None
antihypertensive JJ Physical
drugs NNS Physical
, , None
or CC None
24-hour JJ Physical
urinary JJ Physical
sodium NN Physical
levels NNS Physical
daily JJ Physical
urinary JJ Physical
sodium NN Physical
excretion NN Physical
systolic JJ Physical
BP NNP Physical
diastolic JJ Physical
BP NNP Physical
control NN Physical
BP NNP Physical
-DOCSTART- -X- N

feasibility NN Other
preliminary JJ Other
outcomes NNS Other
subject JJ Other
adherence NN Other
therapist JJ Other
fidelity NN Other
ASD NNP Mental
social JJ Mental
impairment NN Mental
anxiety NN Mental
symptoms NNS Mental
feasible JJ Other
-DOCSTART- -X- N

CPX NNP None
variables NNS None
oxygen NN Physical
uptake NN Physical
at IN Physical
peak NN Physical
exercise NN Physical
( ( Physical
peak JJ Physical
VO NNP Physical
( ( Physical
2 CD Physical
) ) Physical
) ) Physical
and CC Physical
the DT Physical
slope NN Physical
of IN Physical
the DT Physical
ventilation/carbon NN Physical
dioxide NN Physical
production NN Physical
ratio NN Physical
( ( Physical
VE/VCO NNP Physical
( ( Physical
2 CD Physical
) ) Physical
) ) Physical
Echocardiographic JJ None
measurements NNS None
LV NNP Physical
EF NNP Physical
, , None
the DT Physical
E/A NNP Physical
ratio NN Physical
, , None
filling VBG Physical
time NN Physical
, , None
cavity NN Physical
volumes NNS Physical
, , None
right JJ Physical
ventricular NN Physical
function NN Physical
, , None
and CC None
mitral JJ Physical
regurgitation NN Physical
. . None
use NN Other
of IN Other
beta NN Other
blockers NNS Other
or CC Physical
the DT Physical
incidence NN Physical
of IN Physical
coronary JJ Physical
artery NN Physical
disease NN Physical
. . Physical
E/A NNP Physical
ratios NNS Physical
filling VBG Physical
times NNS Physical
peak NN Physical
VO NNP Physical
( ( Physical
2 CD Physical
) ) Physical
VE/VCO NNP Physical
( ( Physical
2 CD Physical
) ) Physical
ratios NNS None
CPX NNP Physical
response NN Physical
peak VB Physical
VO NNP Physical
( ( Physical
2 CD Physical
) ) Physical
and CC Physical
ventilation NN Physical
-DOCSTART- -X- N

irritability NN Mental
efficacy NN Other
side NN None
effects NNS None
Aberrant NNP Mental
Behavior NNP Mental
Checklist-Irritability NNP Mental
subscale NN Mental
and CC Mental
Clinical JJ Mental
Global NNP Mental
Impression-Improvement NNP Mental
responders NNS Mental
ABC-Irritability NNP Mental
subscale NN Mental
valproate NN Physical
blood NN Physical
levels NNS Physical
efficacy NN Other
irritability NN Mental
-DOCSTART- -X- N

local JJ Physical
recurrence NN Physical
toxicities NNS Physical
anorexia JJ Physical
and CC Physical
neutropenia NN Physical
. . Physical
toxicities NNS Physical
recovery NN None
-DOCSTART- -X- N

mean JJ Other
range NN Other
of IN Other
movement NN Other
for IN Other
plantar NN Other
flexion NN Other
improved VBD Other
from IN Other
15.2 CD Other
degrees NNS Other
( ( Other
10.0 CD Other
degrees NNS Other
to TO Other
20.6 CD Other
degrees NNS Other
) ) Other
to TO Other
18.7 CD Other
degrees NNS Other
( ( Other
10.0 CD Other
degrees NNS Other
to TO Other
33.0 CD Other
degrees NNS Other
) ) Other
and CC None
for IN None
dorsiflexion NN Other
from IN Other
12.3 CD Other
degrees NNS Other
( ( Other
7.4 CD Other
degrees NNS Other
to TO Other
19.4 CD Other
degrees NNS Other
) ) Other
to TO Other
18.9 CD Other
degrees NNS Other
( ( Other
10.0 CD Other
degrees NNS Other
to TO Other
24.1 CD Other
degrees NNS Other
) ) Other
( ( None
both DT None
, , None
p NN None
= NNP None
0.0001 CD None
) ) None
when WRB None
the DT None
first JJ None
third NN None
of IN None
therapy NN None
was VBD None
compared VBN None
with IN None
the DT None
last JJ None
third JJ None
. . None
-DOCSTART- -X- N

straylight NN Other
measurements NNS Other
mean NN Physical
straylight NN Physical
values NNS Physical
Straylight NNP Other
values NNS Other
straylight NN Other
straylight NN Physical
value NN Physical
-DOCSTART- -X- N

overall JJ Mortality
survival NN Mortality
. . None
progression-free JJ Mortality
survival NN Mortality
, , None
the DT Physical
response NN Physical
rate NN Physical
, , None
the DT Physical
duration NN Physical
of IN Physical
the DT Physical
response NN Physical
, , None
safety NN Other
, , None
and CC None
the DT None
quality NN Physical
of IN Physical
life NN Physical
. . None
median JJ Mortality
duration NN Mortality
of IN Mortality
survival NN Mortality
median JJ Mortality
duration NN Mortality
of IN Mortality
progression-free JJ Mortality
survival NN Mortality
median JJ Physical
duration NN Physical
of IN Physical
the DT Physical
response NN Physical
Grade $ Physical
3 CD Physical
hypertension NN Physical
survival NN Mortality
-DOCSTART- -X- N

effect NN Other
therapeutic JJ Other
efficacy NN Other
vertebra NN Physical
basilar JJ Physical
artery NN Physical
ischemic JJ Physical
vertigo NN Physical
( ( Physical
VBIV NNP Physical
) ) Physical
. . Physical
clinical JJ Physical
syndromes NNS Physical
and CC Physical
the DT Physical
index NN Physical
of IN Physical
the DT Physical
transcranial JJ Physical
Doppler NNP Physical
( ( Physical
TCD NNP Physical
) ) Physical
hemorheology NN Physical
total JJ Other
effective JJ Other
rate NN Other
indexes NNS Physical
of IN Physical
TCD NNP Physical
and CC Physical
hemorheology NN Physical
effect NN Other
treating VBG Other
patients NNS Other
with IN Other
VBIV NNP Other
VBIV NNP None
. . None
-DOCSTART- -X- N

efficacy NN Physical
outcomes NNS Physical
Recurrence-free JJ Physical
survival NN Physical
and CC None
overall JJ Physical
survival NN Physical
adverse JJ Physical
events NNS Physical
recurrence NN None
. . None
recurrence-free JJ Physical
survival NN Physical
overall JJ Physical
survival NN Physical
deaths NNS None
recurrence-free JJ Physical
. . None
recurrence NN Physical
death NN Physical
rates NNS None
-DOCSTART- -X- N

effectiveness NN Other
diffusion NN Mental
of IN Mental
Smart NNP Mental
Choices NNP Mental
teachers NNS Mental
' POS Mental
implementation NN Mental
of IN Mental
Smart NNP Mental
Choices NNP Mental
completeness NN Mental
and CC Mental
fidelity NN Mental
of IN Mental
implementation NN Mental
-DOCSTART- -X- N

Influence NN None
heart NN Physical
rate NN Physical
and CC Physical
arrhythmic JJ Physical
pattern NN Physical
arrhythmogenic JJ Physical
action NN Physical
. . None
effect NN None
heart NN Physical
rate NN Physical
, , Physical
rhythm NN Physical
and CC Physical
electrical JJ Other
safety NN Other
. . None
Holter NNP Other
recordings NNS Other
heart NN Physical
rhythm NN Physical
maximum JJ Physical
heart NN Physical
rate NN Physical
medium JJ Physical
heart NN Physical
rate NN Physical
minimum JJ Physical
heart NN Physical
rate NN Physical
ectopic JJ Physical
supraventricular JJ Physical
beats NNS Physical
ectopic NN Physical
supraventricular JJ Physical
beats NNS Physical
ectopic JJ Physical
ventricular JJ Physical
beats NNS Physical
Lown JJ Physical
classification NN Physical
nor CC Physical
the DT Physical
Final NNP Physical
Score NN Physical
of IN Physical
the DT Physical
Italian JJ Physical
Lown NNP Physical
Classification NNP Physical
-DOCSTART- -X- N

survival JJ Mortality
rates NNS Mortality
of IN Mortality
complications NNS Mortality
, , None
types NNS Adverse
of IN Adverse
complications NNS Adverse
, , None
reasons NNS Other
for IN Other
failure NN Other
, , None
and CC None
clot NN Physical
salvageability NN Physical
. . None
-DOCSTART- -X- N

Aberrant NNP Mental
Behavioral NNP Mental
Checklist-Community NNP Mental
( ( Mental
ABC-C NNP Mental
) ) Mental
and CC Mental
adverse JJ Adverse
effects NNS Adverse
checklist NN Adverse
clinical JJ Mental
global JJ Mental
impression-improvement NN Mental
( ( Mental
CGI-I NNP Mental
) ) Mental
ABC-C NNP Mental
subscales NNS Mental
, , Mental
Hyperactivity NNP Mental
and CC Mental
Irritability NNP Mental
adverse JJ Adverse
effects NNS Adverse
CGI-I JJ Mental
scores NNS Mental
-DOCSTART- -X- N

included VBD None
pain-on-movement NN None
( ( None
POM NNP None
) ) None
, , None
pain-at-rest JJ None
( ( None
PAR NNP None
) ) None
, , None
functional JJ None
neck NN None
disability NN None
index NN None
( ( None
NDI NNP None
) ) None
and CC None
response NN None
to TO None
treatment NN None
( ( None
decrease NN None
, , None
POM NNP None
at IN None
48 CD None
h NN None
, , None
All DT None
POM NNP None
scores NNS None
were VBD None
. . None
Response NNP None
to TO None
treatment NN None
was VBD None
significantly RB None
were VBD None
no DT None
AEs NNP None
with IN None
over-the-counter JJ None
, , None
was VBD None
effective JJ None
and CC None
well RB None
tolerated VBN None
in IN None
the DT None
neck NN None
function NN None
. . None
-DOCSTART- -X- N

safety NN Physical
, , Physical
anti-plaque JJ Physical
, , Physical
and CC Physical
anti-gingivitis JJ Physical
effects NNS Physical
plaque NN Physical
reduction NN Physical
in IN Physical
gingivitis NN Physical
plaque JJ Physical
bleeding VBG Physical
on IN Physical
probing VBG Physical
adverse JJ Adverse
events NNS Adverse
shifts NNS Physical
in IN Physical
supragingival JJ Physical
microflora NN Physical
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
( ( Physical
BP NNP Physical
) ) Physical
systolic JJ Physical
BP NNP Physical
diastolic JJ Physical
BP NNP Physical
increased VBD Physical
BP NNP Physical
control NN Physical
increased VBD Physical
BP NNP Physical
control NN Physical
maximum JJ Physical
BP NNP Physical
control NN Physical
rate NN Physical
BP NNP Physical
became VBD Physical
normal JJ Physical
or CC Physical
optimal JJ Physical
BP NNP Physical
control NN Physical
. . None
-DOCSTART- -X- N

progression-free JJ Mortality
survival NN Mortality
clinical JJ Physical
benefit NN Physical
rate NN Physical
PFS NNP Mortality
HR NNP Mortality
median JJ Mortality
PFS NNP Mortality
the DT None
HR NNP Physical
CBRs NNP None
CBRs NNP None
-DOCSTART- -X- N

Impact NN Other
measure VB Physical
the DT Physical
impact NN Physical
of IN Physical
facial JJ Physical
acne NN Physical
health-related JJ Physical
quality NN Physical
of IN Physical
life NN Physical
( ( Physical
HRQL NNP Physical
) ) Physical
. . Physical
Acne-QoL NNP Physical
questionnaire NN Physical
mean JJ Physical
Acne-QoL NNP Physical
domain NN Physical
scores NNS Physical
HRQL NNP Physical
-DOCSTART- -X- N

global JJ Mental
anxiety NN Mental
scores NNS Mental
, , None
functioning VBG Mental
and CC Mental
well-being JJ Mental
, , None
patients NNS Mental
' POS Mental
reports NNS Mental
of IN Mental
global JJ Mental
improvements NNS Mental
-DOCSTART- -X- N

effects NNS Other
visceral JJ Pain
abdominal JJ Pain
pain NN Pain
visual JJ Pain
analogue NN Pain
and CC Other
verbal JJ Pain
rating NN Pain
pain NN Pain
scores NNS Pain
Analgesia NNP Physical
requirements NNS Physical
, , Physical
vital JJ Physical
signs NNS Physical
, , Physical
blood NN Physical
glucose NN Physical
, , Physical
and CC Physical
incidence NN Physical
of IN Physical
nausea NN Physical
and CC Physical
vomiting NN Physical
visual JJ Pain
analogue NN Pain
and CC Pain
verbal JJ Pain
rating NN Pain
pain NN Pain
scores NNS Pain
and CC None
analgesic JJ Other
consumption NN Other
controlled VBD Pain
pain NN Pain
Bowel NNP Physical
function NN Physical
recovery NN Physical
similar JJ None
visceral JJ Pain
abdominal NN Pain
pain NN Pain
-DOCSTART- -X- N

Mallampati NNP Physical
score NN Physical
tracheal NN Physical
intubation NN Physical
Cormack NNP Physical
's POS Physical
criteria NNS Physical
. . None
incidence NN Physical
of IN Physical
difficult JJ Physical
intubation NN Physical
upper JJ Other
lip NN Other
bite NN Other
test NN Other
specificity NN Other
and CC Other
accuracy NN Other
Mallampati NNP Physical
test NN Physical
sensitivity NN Other
, , Other
positive JJ Other
and CC Other
negative JJ Other
predictive NN Other
values NNS Other
-DOCSTART- -X- N

pain NN Pain
and CC None
power NN Other
pain NN Pain
and CC None
power NN Other
pain NN Pain
and CC None
power NN Other
pain NN Pain
power NN Other
-DOCSTART- -X- N

lymphocysts NNS Physical
. . None
no DT Other
significant JJ Other
differences NNS Other
fibrin JJ None
glue NN None
did VBD Physical
not RB Physical
reduce VB Physical
the DT Physical
rate NN Physical
of IN Physical
postoperative JJ Physical
lymphocysts NNS Physical
no DT Other
impact NN Other
follow-up JJ Other
parameter NN Other
. . None
-DOCSTART- -X- N

ischemic JJ Physical
postconditioning NN Physical
myocardial JJ Physical
protection NN Physical
ischemic JJ Physical
postconditioning VBG Physical
protection NN Physical
against IN Physical
myocardial JJ Physical
ischemia NN Physical
Cardiac NNP Physical
troponin NN Physical
I PRP Physical
postoperative JJ Other
peak NN Other
release NN Other
lower JJR None
peak NN None
inotropic NN None
score NN None
during IN None
) ) None
, , None
extubation JJ None
time NN None
and CC None
length NN None
of IN None
ICU NNP None
stay NN None
( ( None
43.4 CD None
higher JJR None
cardiac JJ None
output NN None
on IN None
-DOCSTART- -X- N

progression-free JJ Mortality
survival NN Mortality
progression-free JJ Mortality
survival NN Mortality
survival NN Mortality
account NN Physical
disease NN Physical
extent NN Physical
, , Physical
maintenance NN Physical
therapy NN Physical
, , Physical
Karnofsky NNP Physical
performance NN Physical
status NN Physical
( ( Physical
PS NNP Physical
) ) Physical
, , Physical
and CC Physical
absolute JJ Physical
dose-intensity NN Physical
( ( Physical
ADI NNP Physical
) ) Physical
of IN Physical
anthracycline NN Physical
limited JJ Physical
disease NN Physical
( ( Physical
LD NNP Physical
) ) Physical
and CC Physical
maintenance NN Physical
survival NN Mortality
. . Mortality
-DOCSTART- -X- N

efficacy NN Other
treatment NN Other
Autism NNP Mental
Diagnostic NNP Mental
Observation NNP Mental
Schedule NNP Mental
( ( Mental
ADOS NNP Mental
) ) Mental
pertinent JJ Mental
developmental JJ Mental
measures NNS Mental
ADOS NNP Mental
social-communication NN Mental
total JJ Mental
score NN Mental
treatment NN Physical
effect NN Physical
efficacy NN Other
-DOCSTART- -X- N

inhibition NN Physical
of IN Physical
neovascularization NN Physical
and CC Physical
maintenance NN Physical
of IN Physical
vision NN Physical
. . Physical
Best-corrected JJ Physical
visual JJ Physical
acuity NN Physical
( ( Physical
Early JJ Physical
Treatment NNP Physical
Diabetic NNP Physical
Retinopathy NNP Physical
Study NNP Physical
chart NN Physical
) ) Physical
, , Physical
intraocular JJ Physical
pressure NN Physical
measurement NN Physical
, , Physical
biomicroscopy NN Physical
, , Physical
funduscopy NN Physical
, , Physical
digital JJ Physical
fluorescein NN Physical
, , Physical
and CC Physical
indocyanine NN Physical
green JJ Physical
angiography NN Physical
mean JJ Physical
changes NNS Physical
in IN Physical
visual JJ Physical
acuity NN Physical
and CC Physical
lesion NN Physical
size NN Physical
at IN Physical
1 CD Physical
year NN Physical
. . Physical
detachment NN Physical
of IN Physical
the DT Physical
neurosensory JJ Physical
retina NN Physical
and CC Physical
retinal JJ Physical
pigment NN Physical
epithelium NN Physical
neovascular JJ Physical
lesions NNS Physical
increased VBD Physical
in IN Physical
size NN Physical
. . Physical
Vision NNP Physical
loss NN Physical
capillary JJ Physical
permeability NN Physical
neovascularization NN Physical
significant JJ None
loss NN Physical
of IN Physical
vision NN Physical
-DOCSTART- -X- N

effect NN Other
of IN Other
diet NN Other
and CC None
smoking VBG Other
intervention NN Other
dietary JJ Other
and CC Other
smoking VBG Other
counselling NN Other
. . Other
effect NN Physical
on IN Physical
serum NN Physical
cholesterol NN Physical
cigarette NN Mental
consumption NN Mental
. . Mental
effect NN Other
on IN Other
coronary JJ Physical
heart NN Physical
disease NN Physical
( ( None
fatal JJ None
and CC None
non-fatal JJ None
myocardial JJ None
infarction NN None
or CC None
sudden JJ None
death NN None
) ) None
-DOCSTART- -X- N

Mean NNP Mental
airway RB Mental
resistance NN Mental
specific JJ Mental
airway RB Mental
conductance NN Mental
mean JJ Mental
dynamic JJ Mental
pulmonary JJ Mental
compliance NN Mental
gain NN Physical
weight JJ Physical
gain NN Physical
Fluid NNP Physical
intake NN Physical
urine JJ Physical
output NN Physical
, , Physical
osmolal JJ Physical
clearance NN Physical
, , Physical
and CC Physical
potassium NN Physical
and CC Physical
phosphorus NN Physical
excretion NN Physical
retained VBD Physical
less JJR Physical
fluid NN Physical
excreted VBD Physical
less JJR Physical
calcium NN Physical
lung NN Physical
function NN Physical
-DOCSTART- -X- N

MEASURES NNP None
All-cause NNP None
mortality NN None
of IN None
women NNS None
related VBN None
to TO None
pregnancy NN None
, , None
stillbirth NN None
, , None
and CC None
infant JJ None
mortality NN None
the DT None
mortality NN None
outcomes RB None
, , None
of IN None
deaths NNS None
and CC None
all-cause NN None
, , None
pregnancy-related JJ None
mortality NN None
rates NNS None
for IN None
mortality NN None
of IN None
stillbirth NN None
and CC None
infant JJ None
mortality NN None
increased VBD None
plasma JJ None
retinol NN None
concentrations NNS None
eliminate VB None
, , None
gestational JJ None
night NN None
blindness NN None
( ( None
7.1 CD None
reduce VB None
all-cause JJ None
maternal NN None
, , None
fetal JJ None
, , None
or CC None
infant JJ None
mortality NN None
. . None
TRIAL NNP None
-DOCSTART- -X- N

neuromotor NN Physical
function NN Physical
shoulder NN Physical
and CC Physical
hip NN Physical
posture NN Physical
hip NN Physical
posture NN Physical
shoulder NN Physical
posture NN Physical
hip NN Physical
posture NN Physical
shoulder JJR Physical
posture NN Physical
-DOCSTART- -X- N

PTSD NNP Physical
symptom NN Physical
severity NN Physical
Depression NNP Physical
, , Mental
functioning NN Physical
, , None
perceived VBD Physical
quality NN Physical
of IN Physical
care NN Physical
, , Other
utilization NN Other
, , None
and CC None
costs NNS Other
symptoms NNS None
functioning VBG None
mental JJ Mental
health NN Mental
visit NN Mental
, , None
fill VB Other
an DT Other
antidepressant JJ Other
prescription NN Other
adequate VBN Other
antidepressant JJ Other
refills NNS Other
mental JJ Mental
health NN Mental
visits NNS Mental
outpatient NN Other
pharmacy NN Other
costs NNS Other
-DOCSTART- -X- N

structure NN Other
visualization NN Other
and CC Other
Doppler NNP Other
examination NN Other
imaging JJ Other
capability NN Other
nine CD Other
Doppler NNP Other
signals NNS Other
excellent JJ Other
visualization NN Other
of IN Other
cardiac JJ Other
structures NNS Other
Doppler NNP Other
signals NNS Other
number NN Other
of IN Other
attempts NNS Other
at IN Other
esophageal JJ Other
intubation NN Other
, , None
the DT Other
amount NN Other
of IN Other
sedation NN Other
used VBN Other
, , Other
and CC None
the DT Other
examination NN Other
time NN Other
. . None
number NN Other
of IN Other
complications NNS Other
was VBD None
similar JJ None
failed VBD Physical
intubations NNS Physical
-DOCSTART- -X- N

visual JJ Physical
function NN Physical
. . None
visual JJ Physical
function NN Physical
. . None
visual JJ Physical
acuity NN Physical
, , None
contrast NN Physical
sensitivity NN Physical
( ( Physical
with IN Physical
and CC Physical
without IN Physical
glare NN Physical
) ) Physical
, , None
visual JJ Physical
field NN Physical
, , None
and CC None
mesopic NN Physical
vision NN Physical
( ( Physical
with IN Physical
and CC Physical
without IN Physical
glare NN Physical
) ) Physical
. . None
Visual JJ Physical
acuity NN Physical
Goldmann NNP Physical
visual JJ Physical
field NN Physical
constriction NN Physical
of IN Physical
the DT Physical
isopters NNS Physical
: : None
Mesopic NNP Physical
vision NN Physical
without IN Physical
glare NN Physical
Contrast NNP Physical
sensitivity NN Physical
lens NNS Physical
wearing VBG Physical
comfort NN Physical
. . None
visual JJ Physical
functions NNS Physical
visual JJ Physical
acuity NN Physical
and CC None
contrast NN Physical
sensitivity NN Physical
. . None
-DOCSTART- -X- N

improve VB Mental
their PRP$ Mental
willingness NN Mental
to TO Mental
use VB Mental
the DT Mental
EAP NNP Mental
. . None
several JJ Mental
dimensions NNS Mental
of IN Mental
responsiveness NN Mental
own JJ Mental
help-seeking JJ Mental
behavior NN Mental
. . Mental
-DOCSTART- -X- N

intraocular JJ Physical
pressure NN Physical
. . None
mean JJ Physical
daily JJ Physical
intraocular JJ Physical
pressure NN Physical
mean JJ Physical
daily JJ Physical
intraocular JJ Physical
pressure NN Physical
Adverse JJ Adverse
event NN Adverse
adverse JJ Adverse
events NNS Adverse
adverse JJ Adverse
events NNS Adverse
burning VBG Physical
blurring NN Physical
of IN Physical
vision NN Physical
and CC Physical
light JJ Physical
sensitivity NN Physical
-DOCSTART- -X- N

Serum NNP Physical
LH NNP Physical
over IN Physical
time NN Physical
. . Physical
LH NNP Physical
levels NNS Physical
LH NNP Mental
LH NNP Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
toxicity NN Other
clinical JJ Physical
response NN Physical
clinical JJ Other
response NN Other
Nephrotoxicity NNP Physical
serum JJ Physical
creatinine NN Physical
nephrotoxicity NN Physical
Ototoxicity NNP Physical
ototoxicity NN Physical
toxicity NN Physical
-DOCSTART- -X- N

cardiovascular JJ Mortality
death NN Mortality
or CC None
rehospitalization NN Other
congestive JJ Physical
heart NN Physical
failure NN Physical
cardiovascular JJ Mortality
death NN Mortality
or CC None
hospital NN Physical
admission NN Physical
for IN None
congestive JJ Physical
heart NN Physical
failure NN Physical
Postprocedural NNP Physical
TIMI NNP Physical
3 CD Physical
flow NN Physical
Corrected VBN Physical
TIMI NNP Physical
frame NN Physical
count NN Physical
ST-segment JJ Physical
resolution NN Physical
> VBD Physical
50 CD Physical
% NN Physical
clinical JJ Physical
outcomes NNS Physical
cardiovascular JJ Physical
events NNS Physical
of IN Physical
long JJ Physical
duration NN Physical
and CC None
death NN Mortality
-DOCSTART- -X- N

pharmacokinetics NNS Physical
of IN Physical
cephalexin NN Physical
monohydrate NN Physical
. . Physical
pharmacokinetics NNS Physical
and CC Physical
pharmacodynamics NNS Physical
of IN Physical
cephalexin NN Physical
. . None
Time-concentration NN Other
pharmacokinetic JJ Physical
parameters NNS Physical
percentage NN Physical
of IN Physical
time NN Physical
that IN Physical
serum JJ Physical
concentrations NNS Physical
remain VBP Physical
above IN Physical
the DT Physical
MIC NNP Physical
( ( Physical
90 CD Physical
) ) Physical
during IN Physical
the DT Physical
dosing VBG Physical
interval NN Physical
( ( Physical
T NNP Physical
> NNP Physical
MIC NNP Physical
( ( Physical
90 CD Physical
) ) Physical
) ) Physical
for IN None
Streptococcus NNP Physical
pyogenes NNS Physical
and CC None
Staphylococcus NNP None
aureus RB None
associated VBD None
with IN None
the DT None
pharmacokinetic JJ None
profiles NNS None
was VBD None
calculated VBN None
. . None
C NNP Other
( ( Other
max NN Other
) ) Other
, , Physical
AUC NNP Other
( ( Other
infinity NN Other
) ) Other
, , Physical
t EX Other
( ( Other
1/2 CD Other
) ) Other
, , Physical
or CC Physical
CL/F NNP Other
. . None
t NN Physical
( ( Physical
max NN Physical
) ) Physical
Suboptimal NNP Physical
T NNP Physical
> NNP Physical
MIC NNP Physical
( ( Physical
90 CD Physical
) ) Physical
T NNP Physical
> NNP Physical
MIC NNP Physical
( ( Physical
90 CD Physical
) ) Physical
t NN Physical
( ( Physical
max NN Physical
) ) Physical
t NN Physical
( ( Physical
max NN Physical
) ) Physical
-DOCSTART- -X- N

therapeutic JJ Other
therapeutic JJ Other
failures NNS Other
Therapeutic JJ Other
failure NN Other
therapeutic JJ Other
failures NNS Other
efficacy NN Other
therapeutic JJ Other
failures NNS Other
-DOCSTART- -X- N

Sleep JJ Physical
variables NNS Physical
sleep JJ Other
duration NN Other
, , Other
sleep-onset JJ Other
time NN Other
, , Other
sleep-onset JJ Other
latency NN Other
time NN Other
, , Other
and CC Other
the DT Other
number NN Other
of IN Other
night NN Other
awakenings NNS Other
mean JJ Other
night NN Other
sleep NN Other
duration NN Other
mean JJ Other
sleep-onset JJ Other
latency NN Other
mean VB Other
sleep-onset JJ Other
time NN Other
-DOCSTART- -X- N

oxygen NN Physical
free JJ Physical
radical JJ Physical
production NN Physical
myocardial JJ Physical
free JJ Physical
radical JJ Physical
production NN Physical
Oxygen NNP Physical
free JJ Physical
radicals NNS Physical
spin-trapped JJ Physical
radicals NNS Physical
in IN Physical
arterial JJ Physical
blood NN Physical
arterial JJ Physical
values NNS Physical
were VBD Physical
the DT Physical
sinus NN Physical
values NNS Physical
Myocardial NNP None
free JJ None
radical JJ None
production NN None
myocardial JJ Physical
production NN Physical
of IN Physical
free JJ Physical
radicals NNS Physical
-DOCSTART- -X- N

anabolism NN Physical
Circulating NNP Physical
insulin NN Physical
, , None
C-peptide NNP Physical
, , None
GH NNP Physical
, , None
IGF-I NNP Physical
, , None
bioavailable JJ Physical
IGF-I JJ Physical
, , None
IGF-binding JJ Physical
protein NN Physical
( ( Physical
IGFBP NNP Physical
) ) Physical
-1 NN Physical
, , None
IGFBP-3 NNP Physical
, , None
and CC None
acid-labile JJ Physical
subunit NN Physical
cortisol NN Physical
glucagon NN Physical
C-peptide NNP Physical
circulating VBG Physical
GH NNP Physical
bioavailable JJ Physical
IGF-I NNP Physical
IGFBP-3 NNP Physical
acid-labile JJ Physical
subunit NN Physical
IGFBP-1 NNP Physical
urea/creatinine JJ Physical
ratio NN Physical
IGFBP-1 NNP Physical
cortisol NN Physical
and CC Physical
glucagon NN Physical
catabolic JJ Physical
state NN Physical
of IN Physical
critical JJ Physical
illness NN Physical
. . None
-DOCSTART- -X- N

response NN Other
rate NN Other
( ( Other
RR NNP Other
) ) Other
progression-free JJ Other
survival NN Other
( ( Other
PFS NNP Other
) ) Other
, , None
overall JJ Other
survival NN Other
( ( Other
OS NNP Other
) ) Other
, , None
and CC None
safety NN Other
. . None
RRs NNP Other
median JJ Other
OS NNP Other
incidence NN Physical
of IN Physical
grade NN Physical
3 CD Physical
or CC Physical
higher JJR Physical
haematological JJ Physical
toxicity NN Physical
incidence NN Adverse
of IN Adverse
grade NN Adverse
3 CD Adverse
or CC Adverse
higher JJR Adverse
non-haematological JJ Adverse
toxicity NN Adverse
-DOCSTART- -X- N

MRI-assessed JJ Other
indices NNS Other
( ( None
total JJ Other
vessel NN Other
area NN Other
, , Physical
wall JJ Other
area NN Other
, , Physical
wall NN Other
thickness NN Other
, , Physical
and CC Physical
normalised VBD Other
wall NN Other
index NN Other
MRI-derived JJ Other
change NN Other
in IN Other
total JJ Other
vessel JJ Other
area NN Other
PET/CT NNP None
measure NN None
of IN None
index NN None
vessel JJ None
most-diseased-segment JJ None
target-to-background NN None
ratio NN None
( ( None
TBR NNP None
) ) None
was VBD None
office NN None
blood NN None
pressure NN None
and CC None
the DT None
frequency NN None
of IN None
adverse JJ None
events NNS None
-DOCSTART- -X- N

the DT None
preferred JJ None
drug NN None
for IN None
treatment NN None
continuation NN None
at IN None
8 CD None
weeks NNS None
, , None
determined VBN None
by IN None
a DT None
patient-reported JJ None
questionnaire NN None
. . None
'good VBN None
efficacy NN None
' '' None
. . None
Incidence NN None
of IN None
adverse JJ None
effects NNS None
-DOCSTART- -X- N

The DT None
primary JJ None
endpoint NN None
was VBD None
polyp JJ None
number NN None
in IN None
the DT None
rectum NN None
and CC None
sigmoid JJ None
colon NN None
( ( None
at IN None
the DT None
end NN None
of IN None
intervention NN None
) ) None
, , None
and CC None
the DT None
major JJ None
secondary JJ None
endpoint NN None
was VBD None
size NN None
of IN None
the DT None
largest JJS None
polyp NN None
. . None
reduced VBN None
polyp NN None
count NN None
in IN None
the DT None
rectum NN None
and CC None
sigmoid JJ None
colon NN None
: : None
reduced JJ None
polyp NN None
load NN None
on IN None
adenomas NN None
. . None
-DOCSTART- -X- N

frequency NN Adverse
of IN Adverse
Nausea NN Adverse
and CC Adverse
vomiting NN Adverse
frequency NN Adverse
of IN Adverse
headache NN Adverse
postoperative JJ Other
analgesic NN Other
requirements NNS Other
Postoperative JJ Adverse
complaints NNS Adverse
analgesic JJ Other
requirement NN Other
vomiting VBG Adverse
. . None
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
blood NN Physical
pressure NN Physical
control NN Physical
baseline NN Physical
and CC Physical
quarterly JJ Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
SBP NNP Physical
) ) Physical
and CC None
diastolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
DBP NNP Physical
) ) Physical
blood NN Physical
pressures NNS Physical
SBP NNP Physical
and CC None
DBP NNP Physical
Mean NNP Physical
SBP NNP Physical
Mean NNP Physical
DBP NNP Physical
blood NN Physical
pressure NN Physical
-DOCSTART- -X- N

plasma NN Physical
total JJ Physical
cholesterol NN Physical
level NN Physical
plasma JJ Physical
triglyceride IN Physical
level NN Physical
very-low-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
level NN Physical
low-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
level NN Physical
high-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
level NN Physical
deterioration NN Physical
of IN Physical
glycemic JJ Physical
control NN Physical
mean JJ Physical
plasma NN Physical
glucose JJ Physical
concentrations NNS Physical
glycosylated JJ Physical
hemoglobin NN Physical
levels NNS Physical
marked JJ Physical
glycosuria NN Physical
plasma JJ Physical
uric JJ Physical
acid NN Physical
levels NNS Physical
lipid JJ Physical
and CC Physical
lipoprotein JJ Physical
concentrations NNS Physical
hyperglycemia NN Physical
hyperuricemia NN Physical
-DOCSTART- -X- N

TSH NNP Physical
and CC None
PRL NNP Physical
secretion NN Physical
TSH NNP Physical
and CC None
the DT None
stimulatory NN Physical
control NN Physical
of IN Physical
prolactin NN Physical
( ( Physical
PRL NNP Physical
) ) Physical
secretion NN Physical
Basal NNP Physical
TSH NNP Physical
levels NNS Physical
Normal NNP Physical
TSH NNP Physical
responses VBZ Physical
to TO Physical
TRH NNP Physical
TRH-induced NNP Physical
TSH NNP Physical
rise NN Physical
basal NN Physical
and CC Physical
TRH-stimulated JJ Physical
TSH NNP Physical
levels NNS Physical
. . None
Basal NNP Physical
PRL NNP Physical
concentrations NNS Physical
-DOCSTART- -X- N

radiation-induced JJ Physical
skin NN Physical
disease NN Physical
intensity NN Physical
of IN Physical
skin NN Physical
erythema NN Physical
erythema JJ Physical
time NN Physical
course NN Physical
skin JJ Adverse
reactions NNS Adverse
erythema NN Physical
-DOCSTART- -X- N

Burn NNP Physical
depth NN Physical
white JJ Physical
blood NN Physical
cell NN Physical
( ( Physical
WBC NNP Physical
) ) Physical
count NN Physical
plasma JJ Physical
cytokine NN Physical
inflammatory NN Physical
markers NNS Physical
WBC NNP None
count NN None
and CC None
serum NN None
interleukin NN None
( ( None
IL NNP None
) ) None
-1? NN None
, , None
IL-4 NNP None
, , None
IL-6 NNP None
, , None
IL-10 NNP None
and CC None
interferon-? NNS None
were VBD None
burn NN None
depth NN None
. . None
positive JJ None
bacterial JJ None
cultures NNS None
. . None
studied VBN None
. . None
Inflammatory JJ None
markers NNS None
were VBD None
-DOCSTART- -X- N

surface NN Physical
electromyographic JJ Physical
responses NNS Physical
dynamic JJ Physical
surface NN Physical
electromyographic JJ Physical
( ( Physical
EMG NNP Physical
) ) Physical
activities NNS Physical
surface NN Physical
EMG NNP Physical
dynamic JJ Physical
activities NNS Physical
dynamic JJ Physical
EMG NNP Physical
evaluation NN Physical
flexion-relaxation JJ Physical
ratio NN Physical
maximal JJ Physical
EMG NNP Physical
activity NN Physical
Concentric NNP Physical
( ( Physical
maximal JJ Physical
EMG NNP Physical
activity NN Physical
during IN Physical
extension NN Physical
) ) Physical
and CC Physical
eccentric JJ Physical
( ( Physical
maximal JJ Physical
EMG NNP Physical
activity NN Physical
during IN Physical
flexion NN Physical
) ) Physical
ratios NNS Physical
Disability NNP Physical
, , None
depression NN Physical
, , None
and CC None
visual JJ Physical
analog NN Physical
scale NN Physical
scores NNS Physical
concentric JJ Physical
ratio NN Physical
EMG NNP Physical
parameters NNS Physical
. . None
muscle NN Physical
symmetry NN Physical
; : Physical
flexion-relaxation NN Physical
phenomenon NN Physical
-DOCSTART- -X- N

Reactivation NN Physical
of IN Physical
clinical JJ Physical
events NNS Physical
, , Physical
including VBG Physical
reactivation NN Physical
of IN Physical
unstable JJ Physical
angina NN Physical
and CC Physical
myocardial JJ Physical
infarction NN Physical
occurring VBG Physical
within IN Physical
96 CD Physical
hours NNS Physical
after IN Physical
hospitalization NN Physical
Early JJ Physical
reactivation NN Physical
reactivations NNS Physical
myocardial JJ Physical
infarction NN Physical
Reactivations NNS Physical
reactivated VBN Physical
-DOCSTART- -X- N

Perceptual JJ Mental
learning NN Mental
of IN Mental
perceptual JJ Mental
learning NN Mental
perceptual JJ Mental
learning NN Mental
Perceptual JJ Mental
learning NN Mental
perceptual JJ Mental
learning NN Mental
-DOCSTART- -X- N

Gaze NNP Mental
duration NN Mental
and CC None
vocalization NN Mental
ESM NNP Physical
seeing VBG Mental
themselves PRP Mental
on IN Mental
the DT Mental
screen NN Mental
, , Mental
as RB Mental
well RB Mental
as IN Mental
for IN Mental
viewing VBG Mental
the DT Mental
VR NNP Mental
scenarios NNS Mental
-DOCSTART- -X- N

-DOCSTART- -X- N

glycemic JJ Physical
control NN Physical
long-term JJ Physical
glycemic JJ Physical
control NN Physical
changes NNS Physical
in IN Physical
HbA1c NNP Physical
impact NN Physical
of IN Physical
the DT Physical
two CD Physical
plans NNS Physical
on IN Physical
glycemic JJ Physical
control NN Physical
improvements NNS Physical
in IN Physical
HbA1c NNP Physical
HbA1c NNP Physical
levels NNS Physical
were VBD None
significantly RB None
lower JJR None
similar JJ Mental
improvements NNS Mental
in IN Mental
dietary JJ Mental
practices NNS Mental
increase NN None
consumption NN Mental
of IN Mental
green JJ Mental
vegetables NNS Mental
decrease NN Mental
in IN Mental
fruit NN Mental
consumption NN Mental
. . None
better RBR Physical
glycemic JJ Physical
control NN Physical
-DOCSTART- -X- N

safety NN Other
recovery NN Other
number NN Other
of IN Other
patients NNS Other
who WP Other
required VBD Other
a DT Other
continuous JJ Other
supply NN Other
of IN Other
oxygen NN Other
effectiveness NN Other
and CC None
safety NN Other
safety NN Physical
parameters NNS Physical
( ( None
hypotension NN Physical
, , None
hypoxia NN Physical
, , None
bradycardia NN Physical
) ) None
recovery NN Other
-DOCSTART- -X- N

safety NN Other
and CC Other
tolerability NN Other
well RB Other
tolerated VBN Other
and CC Other
safe JJ Other
Tolerability NNP Other
and CC Other
adverse JJ Adverse
event NN Adverse
frequency NN Adverse
-DOCSTART- -X- N

Spirometry NNP Physical
, , Physical
pulse NN Physical
and CC Physical
blood NN Physical
pressure NN Physical
mean JJ Physical
spirometric JJ Physical
values NNS Physical
. . Physical
mean JJ Physical
peak NN Physical
flow NN Physical
( ( Physical
PF NNP Physical
) ) Physical
forced JJ Physical
expiratory NN Physical
volume NN Physical
changes NNS Mental
in IN Mental
PF NNP Mental
and CC Mental
FEV1 NNP Mental
FEV1 NNP Physical
. . Physical
pulse NN Physical
or CC Physical
blood NN Physical
pressure NN Physical
mean NN Other
resting VBG Other
pulse NN Other
-DOCSTART- -X- N

mean NN Physical
eggs NNS Physical
per IN Physical
gram NN Physical
of IN Physical
feces NNS Physical
reduction NN Physical
in IN Physical
mean JJ Physical
post-treatment JJ Physical
eggs NNS Physical
per IN Physical
gram NN Physical
of IN Physical
feces NNS Physical
low JJ Other
efficacy NN Other
against IN Other
hookworm NN Other
infection NN Other
-DOCSTART- -X- N

endotracheal NN Physical
suction NN None
lung NN Physical
volume NN Physical
suctioning NN None
end-expiratory JJ Physical
lung NN Physical
volume NN Physical
( ( Physical
EELV NNP Physical
) ) Physical
CS NNP None
OS NNP None
Lung NNP Physical
impedance NN Physical
Oximetry NNP Physical
, , None
partial JJ Physical
pressure NN Physical
of IN Physical
oxygen NN Physical
in IN Physical
the DT Physical
alveoli/fraction NN Physical
of IN Physical
inspired JJ Physical
oxygen NN Physical
ratio NN Physical
and CC None
compliance NN Mental
impedance NN Physical
EELV NNP Physical
postsuctioning VBG None
. . None
-DOCSTART- -X- N

Absence NN None
of IN None
cervical JJ Physical
radiation NN Physical
myelitis NN Physical
risk NN Physical
of IN Physical
developing VBG Physical
radiation NN Physical
myelitis NN Physical
cervical JJ Physical
radiation NN Physical
myelitis NN Physical
. . Physical
potentially RB None
contributing VBG None
factors NNS None
occurrence NN Physical
of IN Physical
radiation NN Physical
myelitis NN Physical
interfraction NN Physical
interval NN Physical
, , Physical
cord NN Physical
length NN Physical
, , Physical
and CC Physical
administration NN Physical
of IN Physical
concurrent JJ Physical
CDDP NNP Physical
. . Physical
risks NNS None
of IN None
developing VBG None
cervical JJ Physical
radiation NN Physical
myelitis NN Physical
. . None
-DOCSTART- -X- N

Anthropometric JJ Physical
indices NNS Physical
anthropometric JJ Physical
indices NNS Physical
weight NN Physical
body JJ Physical
mass NN Physical
index NN Physical
waist NN Physical
hip NN Physical
circumferences NNS Physical
dietary JJ Other
calcium NN Other
intake NN Other
-DOCSTART- -X- N

Activity NN Physical
in IN Physical
activation NN Physical
of IN Physical
bilateral JJ Physical
SMA NNP Physical
and CC Physical
basal NN Physical
ganglia NN Physical
activity NN Mental
correlating VBG Mental
with IN Mental
temporal JJ Mental
complexity NN Mental
during IN Mental
initiate NN Mental
in IN Mental
bilateral JJ Mental
supplementary JJ Mental
and CC Mental
pre-supplementary JJ Mental
motor NN Mental
cortex NN Mental
( ( Mental
SMA NNP Mental
and CC Mental
preSMA NN Mental
) ) Mental
, , Mental
rostral JJ Mental
dorsal NN Mental
premotor NN Mental
cortex NN Mental
( ( Mental
PMC NNP Mental
) ) Mental
, , Mental
basal JJ Mental
ganglia NN Mental
, , Mental
and CC Mental
dorsolateral JJ Mental
prefrontal NN Mental
cortex NN Mental
( ( Mental
DLPFC NNP Mental
) ) Mental
, , Mental
among IN Mental
other JJ Mental
areas NNS Mental
. . Mental
correlated VBD Mental
activity NN Mental
preSMA NN None
and CC None
rostral JJ None
dorsal NN None
PMC NNP None
activities NNS None
selection NN Mental
of IN Mental
timing VBG Mental
parameters NNS Mental
temporal JJ Mental
error NN Mental
monitoring NN Mental
or CC Mental
correction NN Mental
. . Mental
activity NN Mental
significantly RB Mental
correlated VBN Mental
with IN Mental
temporal JJ Mental
complexity NN Mental
-DOCSTART- -X- N

posterior JJ Physical
retinal JJ Physical
detachment NN Physical
, , None
retinal JJ Physical
fold NN Physical
involving VBG Physical
the DT Physical
macula NN Physical
, , None
or CC None
retrolental JJ Physical
tissue NN Physical
. . None
unfavorable JJ None
outcome NN None
unexpected JJ Adverse
complications NNS Adverse
efficacy NN Other
-DOCSTART- -X- N

efficacy NN Other
and CC Other
toxicity NN Other
actuarial JJ Mortality
survival NN Mortality
curves NNS Mortality
CR NNP Physical
rate NN Physical
and CC Physical
toxicity NN Adverse
. . Physical
total JJ Other
relapses NNS Other
second JJ Physical
CR NNP Physical
CR NNP Physical
, , Other
low JJ Physical
risk NN Physical
of IN Physical
relapse NN Physical
and CC Other
an DT Other
acceptable JJ Physical
toxicity NN Physical
. . Other
-DOCSTART- -X- N

incidence NN Physical
of IN Physical
shivering VBG Physical
axillary JJ Physical
and CC Physical
calf JJ Physical
temperatures NNS Physical
. . Physical
incidence NN Physical
of IN Physical
shivering VBG Physical
shivering VBG Physical
thermoregulation NN Physical
. . Physical
-DOCSTART- -X- N

serum NN Physical
matrix RBS Physical
metalloproteinase-9 JJ Physical
tissue JJ Other
inhibitor NN Other
of IN Other
metalloproteinase-1 NN Other
serum NN Physical
matrix NN Physical
metalloproteinase-9 NN Physical
( ( Physical
MMP-9 NNP Physical
) ) Physical
tissue NN Physical
inhibitor NN Physical
of IN Physical
metalloproteinase NN Physical
( ( Physical
TIMP-1 NNP Physical
) ) Physical
forced JJ Physical
expiratory NN Physical
volume NN Physical
in IN Physical
one CD Physical
second NN Physical
( ( Physical
FEV1 NNP Physical
) ) Physical
forced VBN Physical
vital JJ Physical
capacity NN Physical
( ( Physical
FVC NNP Physical
) ) Physical
levels NNS Physical
of IN Physical
serum NN Physical
MMP-9 NNP Physical
and CC None
TIMP-1 NNP Physical
FEV1 NNP Physical
, , Physical
FVC NNP Physical
, , Physical
FEV1/FVC NNP Physical
( ( Physical
% NN Physical
) ) Physical
, , Physical
and CC Physical
FEV1 NNP Physical
% NN Physical
serum NN Physical
MMP-9 NNP Physical
, , Physical
TIMP-1 NNP Physical
, , Physical
and CC Physical
the DT Physical
ratio NN Physical
of IN Physical
MMP-9/TIMP-1 NNP Physical
serum NN Physical
MMP-9 NNP Physical
and CC Physical
TIMP-1 NNP Physical
and CC Physical
FEV1/FVC NNP Physical
( ( Physical
% NN Physical
) ) Physical
serum NN Physical
MMP-9 NNP Physical
and CC Physical
TIMP-1 NNP Physical
and CC Physical
FEV1 NNP Physical
% NN Physical
-DOCSTART- -X- N

pain NN Pain
urinary JJ Physical
urgency NN Physical
, , Physical
frequency NN Physical
, , Physical
and CC Physical
pain NN Physical
percent JJ Pain
change NN Pain
in IN Pain
pain NN Pain
score NN Pain
( ( Pain
11-point JJ Pain
analog NN Pain
pain VB Pain
scale NN Pain
) ) Pain
symptoms NNS Physical
12-hour JJ Physical
average JJ Physical
urgency NN Physical
reduction NN Physical
urgency NN Pain
and CC Pain
pain NN Pain
-DOCSTART- -X- N

score VB Other
cell NN Other
quantity NN Other
, , None
morphology NN Other
and CC None
cell NN Other
attachment NN Other
. . None
statistically RB None
analyzed VBN None
ANOVA NNP Other
with IN Other
Post NNP Other
Hoc NNP Other
Tukey NNP Other
HSD NNP Other
test NN Other
better JJR Other
adhesion NN Other
and CC None
spreading NN Other
of IN Other
cells NNS Other
biocompatibility NN Other
of IN Other
collagen NN Other
and CC Other
bioactive JJ Other
glass NN Other
improved VBD Other
the DT Other
biocompatibility NN Other
of IN Other
glass NN Other
ionomer NN Other
cement NN Other
-DOCSTART- -X- N

migraine NN Physical
attack NN Other
per IN Other
month NN Other
and CC Physical
normalization NN Physical
of IN Physical
high JJ Physical
urinary JJ Physical
serotonin NN Physical
, , None
5-HIAA JJ Physical
or CC Physical
histamine JJ Physical
levels NNS Physical
. . None
anti-serotonin JJ None
drugs NNS None
sedation NN Adverse
or CC None
dizziness NN Adverse
and CC None
hyperorexia NN Adverse
-DOCSTART- -X- N

patients NNS Mental
' POS Mental
preferences NNS Mental
quality NN Other
of IN Other
life NN Other
Mean JJ Physical
daily JJ Physical
nasal NN Physical
symptom NN Physical
scores NNS Physical
eye NN Physical
symptoms NNS Physical
nasal NN Adverse
and CC Adverse
non-nasal JJ Adverse
adverse JJ Adverse
events NNS Adverse
epistaxis JJ Adverse
headache NN Adverse
nasal JJ Adverse
irritation NN Adverse
quality NN Physical
of IN Physical
life NN Physical
safe JJ Other
efficacious JJ Other
-DOCSTART- -X- N

mean JJ Physical
arterial JJ Physical
pressure NN Physical
, , Physical
systemic JJ Physical
vascular NN Physical
resistance NN Physical
heart NN Physical
rate NN Physical
, , None
cardiac JJ Physical
index NN Physical
, , None
and CC None
norepinephrine JJ Other
requirement NN Other
. . None
plasma NN Physical
nitrite/nitrate NN Physical
nitric JJ Physical
oxide JJ Physical
formation NN Physical
reduction NN Physical
of IN Physical
vasopressor NN Physical
support NN Physical
. . Physical
inflammatory JJ Physical
response NN Physical
( ( Physical
interleukin-6 JJ Physical
and CC Physical
interleukin-8 JJ Physical
) ) Physical
, , Physical
endothelial JJ Physical
( ( Physical
soluble JJ Physical
E-selectin NN Physical
) ) Physical
and CC Physical
neutrophil JJ Physical
activation NN Physical
( ( Physical
expression NN Physical
of IN Physical
CD11b NNP Physical
, , Physical
CD64 NNP Physical
) ) Physical
, , Physical
and CC Physical
antiinflammatory JJ Physical
response NN Physical
( ( Physical
soluble JJ Physical
tumor NN Physical
necrosis NN Physical
factor NN Physical
receptors NNS Physical
I PRP Physical
and CC Physical
II NNP Physical
and CC Physical
interleukin-10 JJ Physical
) ) Physical
human JJ Physical
leukocyte VBD Physical
antigen-DR JJ Physical
expression NN Physical
in IN Physical
vitro JJ Physical
phagocytosis NN Physical
and CC Physical
the DT Physical
monocyte-activating JJ Physical
cytokine JJ Physical
interleukin-12 NN Physical
hemodynamic JJ Adverse
and CC Adverse
immunologic JJ Adverse
rebound NN Adverse
effects NNS Adverse
. . Adverse
hemodynamic JJ Physical
stability NN Physical
immunologic JJ Physical
response NN Physical
to TO Physical
stress VB Physical
-DOCSTART- -X- N

language NN Mental
development NN Mental
-DOCSTART- -X- N

pain RB Pain
, , None
additional JJ Pain
analgesic NN Pain
requirements NNS Pain
, , None
and CC None
incidence NN None
of IN None
postoperative JJ Adverse
nausea NN Adverse
and CC Adverse
vomiting NN Adverse
. . None
ineffective JJ Other
sole JJ None
analgesic JJ Pain
agents NNS None
-DOCSTART- -X- N

spinal JJ Physical
bone NN Physical
mass NN Physical
spinal JJ Physical
bone NN Physical
mass NN Physical
femoral JJ Physical
bone NN Physical
density NN Physical
bone NN Physical
resorption NN Physical
parathyroid JJ Physical
hormone NN Physical
-DOCSTART- -X- N

[ JJ None
Rapidity NNP Pain
of IN Pain
pain NN Pain
relief NN Pain
, , None
medication NN Other
requirement NN Other
and CC None
proton NN None
pump NN None
inhibitors NNS None
rapidity NN Pain
of IN Pain
pain NN Pain
relief NN Pain
single JJ Other
dose NN Other
, , None
effectiveness NN Other
and CC None
patient JJ Other
satisfaction NN Other
pain VB Pain
relief NN Pain
drug NN Physical
consumption NN Physical
. . None
amount NN Other
of IN Other
lansoprazole NN Other
consumed VBN Other
patient JJ Other
satisfaction NN Other
consumption NN Other
continuetreatment VB Other
patient JJ Other
satisfaction NN Other
faster RBR Pain
pain NN Pain
relief NN Pain
-DOCSTART- -X- N

clinical JJ Other
efficacy NN Other
nausea NN Physical
vomiting NN Physical
. . None
vomiting VBG Physical
nausea NN Physical
. . None
Nausea NN Physical
Vomiting NNP Physical
-DOCSTART- -X- N

Healing VBG Physical
of IN Physical
anal JJ Physical
fissure NN Physical
Rates NNPS Physical
of IN Physical
complete JJ Physical
healing NN Physical
of IN Physical
fissure NN Physical
Mean NNP Physical
( ( Physical
SD NNP Physical
) ) Physical
time NN Physical
taken VBN Physical
for IN Physical
complete JJ Physical
healing VBG Physical
with IN Physical
combination NN Physical
treatment NN Physical
Rates NNS Physical
of IN Physical
pain NN Pain
relief NN Pain
Stoppage NN Physical
of IN Physical
bleeding VBG Physical
systemic JJ Adverse
or CC Adverse
local JJ Adverse
side NN Adverse
effects NNS Adverse
. . None
-DOCSTART- -X- N

efficacy NN Other
intramammary JJ Physical
infections NNS Physical
( ( None
IMI NNP None
) ) None
rate NN Physical
of IN Physical
new JJ Physical
IMI NNP Physical
new JJ Physical
infection NN Physical
rates NNS Physical
new JJ Physical
IMI NNP Physical
new JJ Physical
IMI NNP Physical
linear JJ Physical
score NN Physical
somatic JJ Physical
cell NN Physical
count NN Physical
( ( Physical
SCC NNP Physical
) ) Physical
risk NN Physical
for IN Physical
new JJ Physical
IMI NNP Physical
prevention NN Physical
of IN Physical
new JJ Physical
IMI NNP Physical
; : Physical
-DOCSTART- -X- N

systolic NN Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
blood NN Physical
pressure NN Physical
antihypertensive JJ Physical
effect NN Physical
blood NN Physical
pressure NN Physical
blood NN Physical
pressure NN Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
-DOCSTART- -X- N

intraocular JJ Physical
pressure NN Physical
reduction NN Physical
nocturnal JJ Physical
intraocular JJ Physical
pressure NN Physical
( ( Physical
IOP NNP Physical
) ) Physical
reduction NN Physical
IOP NNP Physical
values NNS Physical
mean JJ Physical
nocturnal JJ Physical
IOPs NNP Physical
( ( Physical
Goldmann NNP Physical
's POS Physical
applanation NN Physical
tonometer NN Physical
) ) Physical
nocturnal JJ Physical
IOP NNP Physical
reductions NNS Physical
diurnal JJ Physical
and CC Physical
nocturnal JJ Physical
IOP NNP Physical
reductions NNS Physical
IOP NNP Physical
reduction NN Physical
-DOCSTART- -X- N

MPC NNP Physical
etiology NN None
, , None
clinical JJ Other
cure NN Other
rates NNS Other
, , None
adverse JJ Physical
events NNS Physical
( ( Physical
AEs NNP Physical
) ) Physical
, , None
and CC None
rates NNS Physical
of IN Physical
pelvic JJ Physical
inflammatory JJ Physical
disease NN Physical
. . None
cervicitis NN Physical
overall JJ Other
clinical JJ Other
failure NN Other
rate NN Other
clinical JJ Other
cure NN Other
rate NN Other
gastrointestinal JJ Physical
AEs NNP Physical
Clinical JJ Other
cure NN Other
rates NNS Other
Gastrointestinal JJ Physical
AEs NNP Physical
-DOCSTART- -X- N

efficacy NN Other
and CC None
safety NN Other
list NN Mental
of IN Mental
target NN Mental
behaviors NNS Mental
, , None
the DT Mental
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
, , None
and CC None
the DT None
Clinical NNP Mental
Global NNP Mental
Impression NNP Mental
Scale NNP Mental
. . None
failed VBD None
increased VBD None
the DT None
incidence NN Mental
of IN Mental
stereotypic JJ Mental
behavior NN Mental
on IN None
the DT None
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
significantly RB None
worse JJR None
Clinical NNP Mental
Global NNP Mental
Impression NNP Mental
Scale NNP Mental
. . None
-DOCSTART- -X- N

This DT None
model NN None
provides VBZ None
very RB None
promising JJ None
results NNS None
in IN None
that DT None
the DT None
employment NN Mental
outcomes NNS Mental
for IN None
youth NN None
in IN None
the DT None
treatment NN None
group NN None
were VBD None
much RB None
higher JJR None
in IN None
non-traditional JJ Other
jobs NNS Other
with IN None
higher JJR None
than IN None
minimum JJ None
wage NN None
incomes NNS None
than IN None
for IN None
youth NN None
in IN None
the DT None
control NN None
condition NN None
. . None
Specifically RB None
, , None
21 CD None
out IN None
of IN None
acquired VBD Mental
employment NN Mental
while IN None
1 CD None
of IN None
acquired VBD None
employment NN None
. . None
-DOCSTART- -X- N

cough NN Adverse
responses NNS Adverse
cough NN Physical
cough NN Physical
-DOCSTART- -X- N

recovery NN Other
times NNS Other
recovery NN Other
and CC Other
discharge NN Other
times NNS Other
time NN Other
to TO Other
emergence VB Other
and CC Other
time NN Other
to TO Other
meeting VBG Other
discharge JJ Other
criteria NNS Other
. . Other
intraoperative JJ Physical
vital JJ Physical
signs NNS Physical
and CC Physical
postoperative JJ Physical
emesis NN Physical
and CC Physical
opioid NN Physical
requirements NNS Physical
discharge NN Other
time NN Other
-DOCSTART- -X- N

CM NNP None
was VBD None
also RB None
significantly RB None
superior JJ None
to TO None
EC NNP None
during IN None
the DT None
first JJ None
attack NN None
for IN None
complete JJ Physical
headache NN Physical
relief NN Physical
( ( None
20 CD None
vs. FW None
8 CD None
% NN None
, , None
p NN None
= NNP None
0.006 CD None
) ) None
, , None
nausea NN Adverse
( ( None
42 CD None
vs. FW None
63 CD None
% NN None
, , None
p NN None
= VBD None
0 CD None
. . None
007 CD None
) ) None
and CC None
willingness NN Mental
to TO Mental
take VB Mental
the DT Mental
drug NN Mental
again RB Mental
( ( None
90 CD None
vs. FW None
80 CD None
% NN None
, , None
p NN None
= NNP None
0.043 CD None
) ) None
. . None
The DT None
global JJ Other
efficacy NN Other
evaluation NN Other
, , Other
rated VBN Other
by IN Other
the DT Other
investigators NNS Other
, , None
was VBD None
significantly RB None
more RBR None
favorable JJ None
to TO None
CM NNP None
for IN None
both DT None
attacks NNS None
( ( None
p VB None
= $ None
0.001 CD None
for IN None
the DT None
first JJ None
attack NN None
and CC None
p NN None
= VBP None
0.02 CD None
for IN None
the DT None
second JJ None
) ) None
. . None
The DT Other
patients NNS Other
' POS Other
evaluation NN Other
was VBD Other
significant JJ Other
for IN Other
the DT Other
first JJ Other
attack NN Other
( ( Other
p JJ Other
= NNP Other
0.002 CD Other
) ) Other
. . None
The DT None
global JJ Adverse
incidence NN Adverse
of IN Adverse
adverse JJ Adverse
events NNS Adverse
was VBD None
45 CD None
% NN None
higher JJR None
with IN None
EC NNP None
, , None
though IN None
not RB None
significant JJ None
( ( None
32 CD None
vs. FW None
22 CD None
% NN None
, , None
p NN None
= NNP None
0.075 CD None
) ) None
. . None
They PRP None
were VBD None
most RBS None
often RB None
unspecific JJ None
and CC None
mild JJ None
to TO None
moderate VB None
in IN None
intensity NN None
. . None
Gastrointestinal JJ Adverse
side NN Adverse
effects NNS Adverse
were VBD None
significantly RB None
less RBR None
frequent JJ None
with IN None
CM NNP None
than IN None
EC NNP None
( ( None
7 CD None
vs. FW None
21 CD None
% NN None
, , None
p NN None
= NNP None
0.001 CD None
) ) None
. . None
Thus RB Other
, , Other
CM NNP Other
is VBZ Other
more RBR Other
effective JJ Other
and CC Other
has VBZ Other
a DT Other
better JJR Other
gastrointestinal JJ Other
safety NN Other
than IN Other
EC NNP Other
in IN Other
the DT Other
acute JJ Other
treatment NN Other
of IN Other
migraine NN Other
attacks NNS Other
. . None
-DOCSTART- -X- N

prothrombin JJ Physical
time NN Physical
( ( Physical
PT NNP Physical
) ) Physical
ratio NN Physical
stable JJ Physical
PT NNP Physical
ratio NN Physical
number NN Other
of IN Other
days NNS Other
( ( Other
time NN Other
to TO Other
stabilization NN Other
) ) Other
stable JJ Physical
PT NNP Physical
ratio NN Physical
( ( None
stabilization JJ Other
dosage NN Other
) ) Other
stable JJ Other
PT NNP Other
ratio NN Other
mean JJ Physical
times NNS Physical
to TO Physical
stabilization NN Physical
-DOCSTART- -X- N

percentages NNS Physical
of IN Physical
CD3+ NNP Physical
, , Physical
CD4+ NNP Physical
, , Physical
CD56+ NNP Physical
, , Physical
CD3+CD56+ NNP Physical
cells NNS Physical
, , Physical
and CC Physical
CD4+/CD8+ NNP Physical
ratio VBP Physical
percentage NN Physical
of IN Physical
CD8 NNP Physical
cells NNS Physical
1-year JJ Physical
and CC Physical
18-month JJ Physical
recurrence NN Physical
rates NNS Physical
of IN Physical
the DT Physical
study NN Physical
group NN Physical
-DOCSTART- -X- N

reducing VBG Physical
the DT Physical
incidence NN Physical
of IN Physical
invasive JJ Physical
breast NN Physical
cancer NN Physical
, , None
2 CD None
) ) None
reducing VBG Mortality
breast NN Mortality
cancer NN Mortality
mortality NN Mortality
, , None
3 CD None
) ) None
reducing VBG Mortality
deaths NNS Mortality
from IN Mortality
cardiovascular JJ Mortality
disease NN Mortality
, , None
and CC None
4 CD None
) ) None
reducing VBG Physical
bone NN Physical
fractures NNS Physical
. . None
side NN Adverse
effects NNS Adverse
, , None
toxicity NN Mortality
, , None
and CC None
the DT None
quality NN Other
of IN Other
life NN Other
-DOCSTART- -X- N

Severity NNP Physical
of IN Physical
gagging NN Physical
less RBR Physical
gagging VBG Physical
gag NN Other
reflex NN Other
-DOCSTART- -X- N

pain NN Pain
and CC None
lumbar NN Physical
flexion NN Physical
range NN Physical
Pain NN Pain
visual JJ Pain
analogue NN Pain
scale NN Pain
( ( Pain
VAS NNP Pain
) ) Pain
and CC None
the DT None
lumbar NN Physical
flexion NN Physical
range NN Physical
pain NN Pain
and CC None
the DT None
lumbar NN Physical
flexion NN Physical
range NN Physical
VAS NNP Pain
score NN Pain
and CC None
the DT None
lumbar NN Physical
flexion NN Physical
range NN Physical
VAS NNP Pain
score NN Pain
and CC None
the DT None
lumbar NN Physical
flexion NN Physical
range NN Physical
pain NN Pain
and CC None
lumbar NN Physical
flexion NN Physical
range NN Physical
-DOCSTART- -X- N

distress-coping NN Mental
gatekeepers NNS Mental
with IN Mental
regard NN Mental
to TO Mental
self-destructive JJ Mental
behavior NN Mental
of IN Mental
peers NNS Mental
face NN Mental
validity NN Mental
social JJ Mental
validity NN Mental
. . None
attitudes NNS Mental
, , Mental
emotions NNS Mental
, , Mental
knowledge NN Mental
and CC Mental
awareness NN Mental
of IN Mental
distress NN Mental
coping VBG Mental
skills NNS Mental
. . None
face NN Mental
validity NN Mental
and CC Mental
social JJ Mental
validity NN Mental
cognitive-behavioral JJ Mental
, , Mental
school-based JJ Mental
prevention NN Mental
program NN Mental
-DOCSTART- -X- N

Safety NNP Other
and CC None
Performance NNP Other
safety NN Other
and CC None
efficacy NN Other
evaluates VBZ None
the DT None
bronchodilator NN None
efficacy NN None
. . None
The DT None
relative JJ None
safety NN None
and CC None
efficacy NN None
of IN None
the DT None
potential JJ None
dose-dependence NN None
of IN None
important JJ None
outcomes NNS None
and CC None
provide VB None
information NN None
on IN None
the DT None
clinical JJ None
epidemiology NN None
of IN None
COPD NNP None
in IN None
a DT None
large JJ None
international JJ None
patient NN None
cohort NN None
. . None
-DOCSTART- -X- N

Virologic NNP Physical
success NN Physical
Discontinuation NN Adverse
due JJ Adverse
to TO Adverse
adverse JJ Adverse
events NNS Adverse
Median JJ Physical
changes NNS Physical
in IN Physical
serum NN Physical
creatinine NN Physical
durable JJ Other
efficacy NN Other
long-term JJ Other
safety NN Other
-DOCSTART- -X- N

failure NN Other
rates NNS Other
total JJ Physical
number NN Physical
of IN Physical
treatments NNS Physical
for IN Physical
malaria NNS Physical
safe JJ Other
tolerated VBN Other
. . None
Clinical JJ Physical
treatment NN Physical
failure NN Physical
malaria NNS Physical
rate NN Physical
of IN Physical
subsequent JJ Physical
treatments NNS Physical
for IN Physical
malaria NN Physical
decrease VB Physical
the DT Physical
rate NN Physical
of IN Physical
subsequent JJ Physical
episodes NNS Physical
of IN Physical
malaria NN Physical
. . None
-DOCSTART- -X- N

patient JJ Other
satisfaction NN Other
long-term JJ Other
benefit NN Other
interview NN Other
by IN Other
an DT Other
independent JJ Other
, , Other
masked JJ Other
investigator NN Other
. . Other
outcome NN None
of IN None
their PRP$ None
surgery NN None
visual JJ Other
analogue NN Other
scale NN Other
overall JJ Other
satisfaction NN Other
-DOCSTART- -X- N

efficacy NN Other
return NN Physical
of IN Physical
sinus NN Physical
rhythm NN Physical
termination NN Physical
of IN Physical
persistent JJ Physical
AF NNP Physical
mean JJ Other
voltage NN Other
-DOCSTART- -X- N

Hemodynamic NNP Physical
and CC Physical
hormonal JJ Physical
measurements NNS Physical
circulating VBG Physical
beta-endorphin JJ Physical
, , Physical
norepinephrine JJ Physical
, , Physical
and CC Physical
endothelin-1 NN Physical
blood NN Physical
pressure NN Physical
circulating VBG Physical
norepinephrine NN Physical
plasma JJ Physical
atrial JJ Physical
natriuretic JJ Physical
factor NN Physical
systemic JJ Physical
vascular NN Physical
resistance NN Physical
blood NN Physical
pressure NN Physical
plasma JJ Physical
norepinephrine NN Physical
endothelin-1 JJ Physical
circulating VBG Physical
atrial JJ Physical
natriuretic JJ Physical
factor NN Physical
GH NNP Physical
IGF-I NNP Physical
hemodynamic JJ Physical
and CC Physical
hormonal JJ Physical
responses NNS Physical
-DOCSTART- -X- N

comfort NN Mental
and CC Other
local JJ Adverse
complications NNS Adverse
safety NN Physical
, , Physical
comfort NN Physical
, , Physical
and CC Physical
satisfaction NN Physical
levels NNS Physical
. . Physical
significant JJ Physical
bleeding NN Physical
. . Physical
complications NNS Physical
comfort NN Physical
levels NNS Physical
cost NN Other
of IN Other
the DT Other
outpatient JJ Other
procedure NN Other
. . Physical
-DOCSTART- -X- N

No DT Other
difference NN Other
in IN Other
efficacy NN Other
-DOCSTART- -X- N

Plasma NNP Physical
free JJ Physical
and CC Physical
total JJ Physical
tryptophan NN Physical
levels NNS Physical
whirling NN Mental
, , Mental
flapping NN Mental
, , Mental
pacing NN Mental
, , Mental
banging NN Mental
and CC Mental
hitting VBG Mental
self NN Mental
, , Mental
rocking NN Mental
, , Mental
and CC Mental
toe NN Mental
walking NN Mental
calm JJ Mental
and CC Mental
happy JJ Mental
anxious JJ Mental
social JJ Mental
relatedness NN Mental
or CC Mental
repetitive JJ Mental
thoughts NNS Mental
and CC Mental
behavior NN Mental
Plasma NNP Physical
total JJ Physical
and CC Physical
free JJ Physical
tryptophan NN Physical
levels NNS Physical
plasma IN Physical
total JJ Physical
tryptophan NN Physical
levels NNS Physical
Autism NNP Mental
Behavior NNP Mental
Checklist NNP Mental
scores NNS Mental
symptoms NNS Mental
-DOCSTART- -X- N

accelerates VBZ Physical
body JJ Physical
fat JJ Physical
loss NN Physical
, , Physical
exerts VBZ Physical
anabolic JJ Physical
effect NN Physical
and CC Physical
improves VBZ Physical
growth NN Physical
hormone NN Physical
secretory NN Physical
dysfunction NN Physical
accelerated JJ Physical
lipolysis NN Physical
. . None
lipolytic JJ Physical
effect NN Physical
of IN Physical
GH NNP Physical
. . None
increasing VBG None
insulin-like JJ Physical
growth NN Physical
factor NN Physical
( ( Physical
IGF NNP Physical
) ) Physical
-I NN Physical
. . None
lipolytic JJ Physical
and CC Physical
anabolic JJ Physical
actions NNS Physical
, , None
as RB None
well RB None
as IN None
the DT None
consequent NN None
changes NNS None
in IN None
insulin NN Physical
and CC None
GH NNP Physical
secretion NN Physical
in IN None
fraction NN Physical
of IN Physical
body NN Physical
weight NN Physical
lost VBD Physical
as IN Physical
fat NN Physical
and CC Physical
a DT Physical
greater JJR Physical
loss NN Physical
of IN Physical
visceral JJ Physical
fat JJ Physical
area NN Physical
lean JJ Physical
body NN Physical
mass NN Physical
negative JJ Physical
nitrogen NN Physical
balance NN Physical
lean JJ Physical
body NN Physical
mass NN Physical
positive JJ Physical
nitrogen NN Physical
balance NN Physical
increase NN Physical
in IN Physical
IGF-I NNP Physical
GH NNP Physical
response NN Physical
to TO Physical
L-dopa NNP Physical
stimulation NN Physical
blunted VBN None
insulin JJ Physical
levels NNS Physical
free JJ Physical
fatty JJ Physical
acid NN Physical
( ( Physical
FFA NNP Physical
) ) Physical
levels NNS Physical
FFA NNP Physical
area NN Physical
visceral JJ Physical
fat JJ Physical
loss NN Physical
. . Physical
body NN Physical
fat JJ Physical
loss NN Physical
, , None
exerts VBZ Physical
anabolic JJ Physical
effects NNS Physical
and CC None
improves NNS None
GH NNP Physical
secretion NN Physical
. . None
-DOCSTART- -X- N

health NN Physical
and CC Physical
nutritional JJ Physical
status NN Physical
outcome NN Physical
variables NNS Physical
growth NN Physical
, , Physical
biochemical JJ Physical
status NN Physical
, , None
mental JJ Mental
function NN Mental
, , None
and CC None
bone NN Physical
health NN Physical
beneficial JJ Other
. . None
-DOCSTART- -X- N

anxiety NN Mental
visibility NN Mental
. . Mental
bodily RB None
symptoms NNS None
social JJ Mental
evaluation NN Mental
anxiety NN Mental
visibility NN Mental
heart NN Physical
sound NN Physical
anxiety NN Mental
habituation NN Physical
in IN Physical
heart NN Physical
rate NN Physical
higher JJR Physical
heart NN Physical
rate NN Physical
anxiety NN Mental
worried JJ Mental
about IN Mental
their PRP$ Mental
heart NN Physical
rates NNS Physical
actual JJ Physical
heart NN Physical
rate NN Physical
differences NNS Physical
. . None
worried VBD None
bodily JJ Physical
anxiety NN Physical
symptom NN Physical
anxiety NN Mental
levels NNS Mental
-DOCSTART- -X- N

severe JJ Physical
hypoglycemia NN Physical
severe JJ Physical
hypoglycemia NN Physical
( ( Physical
SH NNP Physical
) ) Physical
clinical JJ Other
utility NN Other
continuous JJ Other
glucose JJ Other
monitoring NN Other
( ( Other
CGM NNP Other
) ) Other
CGM-derived JJ Physical
indices NNS Physical
of IN Physical
hypoglycemia NN Physical
SH NNP Physical
rate NN Physical
rate NN None
SH NNP Physical
SH NNP Physical
frequency NN Physical
CGM NNP Physical
values NNS Physical
the DT None
positive JJ None
predictive JJ None
value NN None
( ( None
PPV NNP None
) ) None
was VBD None
for IN None
hypoglycemic JJ None
area NN None
under IN None
the DT None
curve NN None
and CC None
the DT None
low JJ None
blood NN None
glucose NN None
index NN None
calculated VBN None
CGM NNP None
. . None
CONCLUSIONS NNP None
SH NNP None
in IN None
SH NNP None
during IN None
study NN None
. . None
CGM-measured JJ None
hypoglycemia NN None
over IN None
with IN None
SH NNP None
the DT None
the DT None
PPV NNP None
is VBZ None
-DOCSTART- -X- N

deep JJ Physical
vein NN Physical
thrombosis NN Physical
prophylaxis NN Physical
deep JJ Physical
vein NN Physical
thrombosis NN Physical
prophylaxis NN Physical
duplex JJ Physical
doppler NN Physical
scans NNS Physical
clinical JJ Physical
signs NNS Physical
and CC Physical
symptoms NNS Physical
of IN Physical
thromboembolic JJ Physical
disease NN Physical
. . Physical
asymptomatic JJ Physical
duplex JJ Other
scans NNS Other
venogram NN Physical
excessive JJ Physical
blood NN Physical
loss NN Physical
. . None
clinically RB Physical
detectable JJ Physical
proximal JJ Physical
deep JJ Physical
vein NN Physical
thrombosis NN Physical
duplex JJ Other
ultra-sonography NN Other
. . None
clinical JJ None
incidence NN None
deep JJ Physical
vein NN Physical
thrombosis NN Physical
thromboembolic JJ Physical
disease NN Physical
. . None
-DOCSTART- -X- N

cardiovascular JJ Physical
responses NNS Physical
cardiovascular JJ Physical
reactivity NN Physical
CSF NNP Physical
levels NNS Physical
CSF NNP Physical
5HIAA CD Physical
levels NNS Physical
blood NN Physical
pressure NN Physical
and CC Physical
heart NN Physical
rate NN Physical
responses NNS Physical
cardiovascular JJ Physical
reactivity NN Physical
-DOCSTART- -X- N

Emotional JJ Mental
reactivity NN Mental
emotional JJ Mental
reactivity NN Mental
writing NN Mental
personal JJ Mental
characteristics NNS Mental
social JJ Mental
rejection NN Mental
( ( Mental
negative JJ Mental
evaluation/social JJ Mental
rejection NN Mental
) ) Mental
. . None
emotional JJ Mental
reactivity NN Mental
reactivity NN Mental
of IN Mental
shame- JJ Mental
and CC Mental
anger-related JJ Mental
emotions NNS Mental
heightened VBN Mental
emotional JJ Mental
reactivity NN Mental
heightened JJ Mental
reactivity NN Mental
of IN Mental
irritability NN Mental
, , Mental
distress NN Mental
, , Mental
and CC Mental
shame NN Mental
-DOCSTART- -X- N

pain NN Pain
on IN Pain
IV NNP Pain
injection NN Pain
propofol-induced JJ Pain
pain NN Pain
. . None
Pain NN Physical
pain NN Physical
effective JJ Other
pain NN Physical
Pain NNP Physical
pain NN Physical
propofol NN Pain
pain NN Pain
-DOCSTART- -X- N

dose NN Other
antihypertensive JJ Physical
effects NNS Physical
. . None
The DT None
overall JJ None
incidence NN None
of IN None
side-effects NNS Adverse
was VBD None
similar JJ None
with IN None
atenolol NN None
, , None
metoprolol NN None
and CC None
pindolol NN None
but CC None
was VBD None
slightly RB None
less JJR None
with IN None
labetalol NN None
Sleep JJ Mental
disturbances NNS Mental
and CC None
abnormal JJ Mental
dreaming NN Mental
patterns NNS Mental
were VBD None
most RBS None
frequent JJ None
with IN None
pindolol NN None
There EX None
was VBD None
a DT None
significantly RB Physical
greater JJR Physical
fall NN Physical
in IN Physical
pulse JJ Physical
rate NN Physical
during IN None
atenolol NN None
and CC None
metoprolol NN None
treatment NN None
periods NNS None
-DOCSTART- -X- N

smooth JJ Physical
pursuit NN Physical
eye NN Physical
movement NN Physical
function NN Physical
. . Physical
-DOCSTART- -X- N

hemodynamic JJ Physical
response NN Physical
Mean NNP Physical
arterial JJ Physical
pressure NN Physical
and CC Physical
heart NN Physical
rate NN Physical
mean JJ Physical
arterial JJ Physical
pressure NN Physical
over IN Physical
time NN Physical
maximum JJ Physical
pressor NN Physical
response NN Physical
mean JJ Physical
arterial JJ Physical
pressure NN Physical
change NN Physical
hypertension NN Physical
heart NN Physical
rate NN Physical
over IN Physical
time NN Physical
hemodynamic JJ Physical
responses NNS Physical
-DOCSTART- -X- N

myocardial JJ Physical
myocardial JJ Physical
cardiac JJ Physical
troponin NN Physical
I PRP Physical
( ( Physical
CTnI NNP Physical
) ) Physical
and CC None
creatine JJ Physical
kinase NN Physical
isoenzyme NN Physical
MB NNP Physical
( ( Physical
CK-MB NNP Physical
) ) Physical
values NNS Physical
. . None
recovery NN Other
of IN Other
the DT Other
mean JJ Other
stroke NN Other
volume NN Other
index NN Other
( ( Other
SVI NNP Other
) ) Other
mean NN Other
SVI NNP Other
significant JJ None
reduction NN None
mean JJ Physical
heart NN Physical
rate NN Physical
( ( Physical
HR NNP Physical
) ) Physical
CTnI NNP Physical
level NN Physical
significantly RB None
lower JJR None
CK-MB JJ Physical
release NN Physical
duration NN Other
of IN Other
mechanical JJ Other
ventilation NN Other
, , Other
the DT Other
length NN Other
of IN Other
stay NN Other
ICU NNP None
use NN Other
of IN Other
inotropic JJ Other
medication NN Other
myocardial JJ Physical
enzyme NN Physical
HR NNP Physical
SVI NNP Physical
. . None
-DOCSTART- -X- N

total JJ Other
number NN Other
of IN Other
correct JJ Other
classifications NNS Other
. . None
number NN Other
of IN Other
correct JJ Other
classifications NNS Other
. . None
diagnostic JJ Other
decision NN Other
making NN Other
-DOCSTART- -X- N

section NN Physical
2D1 CD Physical
monoclonal JJ Physical
antibodies NNS Physical
. . None
-DOCSTART- -X- N

Scores NNS Physical
for IN Physical
cleansing VBG Physical
the DT Physical
entire JJ Physical
colon NN Physical
Scores NNS Physical
of IN Physical
left-colon NN Physical
cleansing NN Physical
for IN Physical
flexible JJ Physical
sigmoidoscopy NN Physical
Scores NNS Physical
for IN Physical
taste NN Physical
and CC Adverse
symptom JJ Adverse
side NN Adverse
effects NNS Adverse
signs NNS Physical
or CC Physical
symptoms NNS Physical
of IN Physical
hypocalcemia NN Physical
patient JJ Mental
savings NNS Mental
-DOCSTART- -X- N

Functional NNP Mental
Emotional NNP Mental
Assessment NNP Mental
Scale NNP Mental
( ( None
FEAS NNP None
) ) None
( ( None
F NNP None
= NNP None
Childhood NNP None
Autism NNP None
Rating NNP None
Scale NNP None
the DT None
Functional NNP None
Emotional NNP None
Questionnaires NNP None
( ( None
F NNP None
= NNP None
-DOCSTART- -X- N

completion NN Other
of IN Other
any DT Other
CRC NNP Other
screening NN Other
. . Other
CRC NNP None
screening NN None
completed VBN Physical
beneficial JJ Other
effect NN Other
FIT NNP Other
and CC Other
colonoscopy JJ Other
rates NNS Other
increased VBD Other
CRC NNP Other
screening VBG Other
rates NNS Other
-DOCSTART- -X- N

pain JJ Pain
relief NN Pain
analgesic JJ Other
efficacy NN Other
and CC Other
tolerability NN Other
if IN None
pain JJ None
intensity NN None
the DT None
proportion NN None
of IN None
patients NNS None
who WP None
achieved VBD None
pain NN None
relief NN None
the DT None
proportion NN None
of IN None
patients NNS None
in IN None
whom WP None
pain NN None
was VBD None
decreased VBN None
their PRP$ None
pain NN None
intensity NN None
experience VB None
pain NN None
relief NN None
. . None
pain NN None
any DT None
pain NN None
relief NN None
. . None
were VBD None
constipation NN None
dizziness NN None
vomiting VBG None
and CC None
dry JJ None
mouth NN None
efficacy NN None
and CC None
tolerability NN None
-DOCSTART- -X- N

SCORAD NNP Physical
score NN Physical
extent NN Physical
and CC Physical
severity NN Physical
of IN Physical
atopic NN Physical
eczema NN Physical
skin JJ Physical
condition NN Physical
SCORAD NNP Physical
CD4 NNP Physical
allergic JJ Physical
inflammation NN Physical
. . None
inflammatory JJ Physical
responses NNS Physical
-DOCSTART- -X- N

body NN Physical
weight NN Physical
or CC Physical
fat JJ Physical
mass NN Physical
in IN Physical
reduced JJ Physical
weight NN Physical
and CC Physical
fat JJ Physical
mass NN Physical
. . None
body NN Physical
weight NN Physical
and CC Physical
fat JJ Physical
mass NN Physical
in IN Physical
1-y JJ Physical
changes NNS Physical
in IN Physical
body NN Physical
weight NN Physical
( ( Physical
in IN Physical
kg NN Physical
) ) Physical
and CC Physical
fat JJ Physical
mass NN Physical
( ( Physical
in IN Physical
kg NN Physical
) ) Physical
intakes NNS Physical
of IN Physical
calcium NN Physical
mean JJ Physical
1-y JJ Physical
change NN Physical
in IN Physical
body NN Physical
weight NN Physical
mean JJ Physical
1-y JJ Physical
change NN Physical
in IN Physical
fat JJ Physical
mass NN Physical
body NN Physical
weight NN Physical
or CC Physical
fat JJ Physical
mass NN Physical
in IN Physical
over IN Physical
1 CD Physical
y NNS Physical
. . None
-DOCSTART- -X- N

attitudes NNS Mental
intentions NNS Mental
motivate VB Mental
donation NN Mental
. . None
anxiety NN Mental
, , Mental
attitudes NNS Mental
perceived VBD Mental
ability NN Mental
to TO Mental
cope VB Mental
with IN Mental
donation NN Mental
blood NN Mental
donation NN Mental
anxiety NN Mental
, , Mental
attitude NN Mental
, , Mental
self-efficacy NN Mental
, , Mental
and CC Mental
intention NN Mental
. . None
attitude NN Mental
, , Mental
anxiety NN Mental
, , Mental
self-efficacy NN Mental
, , Mental
and CC Mental
donation NN Mental
intention NN Mental
. . None
blood NN Mental
donation NN Mental
recruitment NN Mental
materials NNS Mental
. . None
-DOCSTART- -X- N

seizures NNS Physical
frequency NN Other
and CC Other
severity NN Other
. . None
-DOCSTART- -X- N

parieto-occipital JJ Physical
P50 NNP Physical
amplitude NN Physical
decreased VBD Physical
to TO Physical
novel JJ Physical
distracters NNS Physical
but CC Physical
not RB Physical
to TO Physical
targets NNS Physical
; : None
amplitude NN Physical
and CC Physical
latency NN Physical
to TO Physical
targets NNS Physical
increased VBN Physical
for IN Physical
the DT Physical
frontal JJ Physical
P50 NNP Physical
while IN Physical
decreasing VBG Physical
to TO Physical
non-target JJ Physical
stimuli NNS Physical
. . None
minimized VBD Physical
early JJ Physical
cortical JJ Physical
responses NNS Physical
to TO Physical
irrelevant VB Physical
stimuli JJ Physical
increased JJ Physical
responses NNS Physical
to TO Physical
relevant VB Physical
stimuli NN Physical
. . None
better JJR Physical
stimulus JJ Physical
differentiation NN Physical
at IN Physical
later-stage JJ Physical
responses NNS Physical
significant JJ Physical
change NN Physical
in IN Physical
early JJ Physical
, , Physical
middle-latency JJ Physical
and CC Physical
late JJ Physical
ERP NNP Physical
components NNS Physical
at IN Physical
the DT Physical
frontal JJ Physical
, , Physical
centro-parietal JJ Physical
, , Physical
and CC Physical
parieto-occipital JJ Physical
regions NNS Physical
of IN Physical
interest NN Physical
in IN Physical
response NN Physical
to TO Physical
target VB Physical
and CC Physical
distracter VB Physical
stimuli NNS Physical
-DOCSTART- -X- N

postoperative JJ Pain
painful NN Pain
and CC Pain
swollen JJ Physical
legs NNS Physical
deep JJ Physical
vein NN Physical
thrombosis NN Physical
-DOCSTART- -X- N

cellular JJ Physical
immune NN Physical
system NN Physical
concentration NN Physical
of IN Physical
plasma-TNF-alpha NN Physical
, , Physical
subpopulations NNS Physical
of IN Physical
blood NN Physical
mononuclear NN Physical
cells NNS Physical
, , Physical
the DT Physical
proliferative JJ Physical
responses NNS Physical
nor CC Physical
the DT Physical
natural JJ Physical
killer NN Physical
( ( Physical
NK NNP Physical
) ) Physical
, , Physical
and CC Physical
lymphokine NN Physical
activated VBN Physical
killer NN Physical
( ( Physical
LAK NNP Physical
) ) Physical
cell NN Physical
activities NNS Physical
. . Physical
weight NN Physical
, , Physical
temperature NN Physical
, , Physical
well RB Physical
being VBG Physical
, , Physical
or CC Physical
tiredness NN Physical
of IN Physical
the DT Physical
subjects NNS Physical
. . Physical
gastrointestinal JJ Adverse
side NN Adverse
effects NNS Adverse
. . Adverse
blood NN Other
mononuclear NN Other
cell NN Other
( ( Other
BMNC NNP Other
) ) Other
proliferative NN Other
responses NNS Other
, , None
NK NNP Physical
LAK NNP Physical
cell NN Physical
activities NNS Physical
. . None
-DOCSTART- -X- N

facial JJ Mental
expression NN Mental
photographs NN Mental
, , Other
cartoons NNS Mental
depicting VBG Mental
emotion-laden JJ Mental
situations NNS Mental
, , Other
and CC Other
non-literal JJ Mental
stories NNS Mental
. . None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
slit-lamp JJ Physical
characteristics NNS Physical
of IN Physical
the DT Physical
corneal NN Physical
ulceration NN Physical
, , Physical
corrected VBN Physical
distance NN Physical
visual JJ Physical
acuity NN Physical
, , Physical
duration NN Physical
until IN Physical
healing VBG Physical
, , Physical
and CC Physical
complications NNS Physical
time NN Physical
until IN Physical
healing VBG Physical
healing NN None
, , None
corrected VBN None
distance NN None
visual JJ None
acuity NN None
was VBD None
corneal JJ None
ulceration NN None
's POS None
width NN None
and CC None
length NN None
was VBD None
demonstrated VBD None
corneal JJ None
perforation NN None
; : None
infection NN None
time NN None
to TO None
corneal VB None
healing NN None
; : None
however RB None
perforation NN None
or CC None
recurrence NN None
of IN None
the DT None
infection NN None
in IN None
-DOCSTART- -X- N

weeks NNS None
. . None
Irritability NNP None
subscale JJ None
score NN None
of IN None
Aberrant NNP None
Behavior NNP None
Checklist NNP None
( ( None
measure NN None
. . None
Adverse JJ None
effects NNS None
were VBD None
The DT None
mean JJ None
score NN None
of IN None
irritability NN None
in IN None
most RBS None
common JJ None
adverse JJ None
effects NNS None
in IN None
were VBD None
constipation NN None
( ( None
16.1 CD None
% NN None
) ) None
, , None
increased VBN None
appetite NN None
( ( None
16.1 CD None
% NN None
) ) None
, , None
fatigue NN None
( ( None
12.9 CD None
% NN None
) ) None
, , None
nervousness RB None
( ( None
and CC None
daytime JJ None
drowsiness NN None
( ( None
fatal JJ None
adverse JJ None
effect NN None
. . None
decreased JJ None
irritability NN None
in IN None
the DT None
core NN None
symptoms NNS None
of IN None
autism NN None
. . None
Adverse JJ None
effects NNS None
were VBD None
generally RB None
tolerated VBN None
well RB None
-DOCSTART- -X- N

Heart NNP Physical
rate NN Physical
( ( Physical
HR NNP Physical
) ) Physical
, , None
mean JJ Physical
arterial JJ Physical
pressure NN Physical
, , None
oxygen NN Physical
saturation NN Physical
, , None
respiratory NN Physical
rate NN Physical
, , Physical
the DT None
Ramsay NNP Physical
sedation NN Physical
score NN Physical
( ( Physical
RSS NNP Physical
) ) Physical
, , Physical
and CC None
recovery NN Physical
time NN Physical
blood NN Physical
pressure NN Physical
and CC None
HR NNP Physical
measurements NNS Physical
respiratory JJ Physical
depression NN Physical
, , None
bradycardia NN Physical
, , Physical
hypotension NN Physical
, , None
nausea NN Physical
, , None
and CC None
vomiting VBG Physical
. . None
pain NN Pain
on IN Pain
the DT Pain
site NN Pain
of IN Pain
injection NN Pain
. . None
Myoclonus NNP Adverse
Recovery JJ Physical
time NN Physical
RSS NNP Physical
operation NN Other
time NN Other
. . None
Physician JJ Other
satisfaction NN Other
hemodynamic JJ Physical
responses NNS Physical
adverse JJ Adverse
effects NNS Adverse
anesthetic JJ Physical
effect NN Physical
-DOCSTART- -X- N

effect NN Physical
of IN Physical
smoking VBG Physical
acid JJ Physical
breath NN Physical
test NN Physical
excretion NN Physical
rate NN Physical
curve NN Physical
parameters NNS Other
of IN Other
k NN Other
and CC Other
beta NN Other
slower JJR Physical
( ( Physical
faster RBR Physical
) ) Physical
emptying VBG Physical
faster RBR None
( ( None
slower JJR None
) ) None
emptying VBG None
in IN None
half NN Physical
( ( Physical
13 CD Physical
) ) Physical
CO NNP Physical
( ( Physical
2 CD Physical
) ) Physical
excretion NN Physical
time NN Physical
time NN Physical
of IN Physical
maximal NN Physical
( ( Physical
13 CD Physical
) ) Physical
CO NNP Physical
( ( Physical
2 CD Physical
) ) Physical
excretion NN Physical
rate NN Physical
( ( Physical
t NN Physical
( ( Physical
max NN Physical
) ) Physical
k NN None
was VBD None
significantly RB None
increased VBN None
. . None
No DT None
significant JJ None
differences NNS None
beta NN Other
, , Other
t NN Other
( ( Other
1/2 CD Other
) ) Other
, , Other
and CC Other
t NN Other
( ( Other
max NN Other
) ) Other
increase NN Other
in IN Other
k JJ Other
-DOCSTART- -X- N

Glucosamine NNP Physical
in IN Physical
serum NN Physical
glucosamine JJ Physical
level NN Physical
in IN Physical
serum NN Physical
ventilatory NN Physical
threshold NN Physical
indices NNS Physical
of IN Physical
acid-base JJ Physical
balance NN Physical
, , Physical
lactate JJ Physical
level NN Physical
, , Physical
and CC Physical
glucose JJ Physical
level NN Physical
serum NN Physical
levels NNS Physical
of IN Physical
immunoreactive JJ Physical
insulin NN Physical
, , Physical
C-peptide NNP Physical
and CC Physical
glucosamine NN Physical
binding NN Physical
of IN Physical
125I-insulin JJ Physical
to TO Physical
erythrocyte VB Physical
receptors NNS Physical
. . None
physical JJ Physical
fitness NN Physical
glucosamine NN Physical
concentration NN Physical
, , Physical
insulinaemia NN Physical
and CC Physical
insulin NN Physical
resistance NN Physical
. . None
-DOCSTART- -X- N

complete VB Physical
care NN Physical
medication NN Mental
taking VBG Mental
behavior NN Mental
living VBG Mental
with IN Mental
both DT Mental
parents NNS Mental
sexual JJ Mental
intercourse NN Mental
speaking VBG Mental
mostly RB Mental
or CC Mental
only RB Mental
English JJ Mental
with IN Mental
parents NNS Mental
-DOCSTART- -X- N

Efficacy NN Other
safety NN Other
anesthetic JJ Other
efficacy NN Other
safety NN Other
profile NN Other
. . None
Success NNP None
rate NN None
, , None
onset VBN None
, , None
and CC None
duration NN None
of IN None
profound NN None
pulpal JJ None
anesthesia NN None
were VBD None
electrical JJ None
pulp NN None
tester NN None
, , None
while IN None
width NN None
of IN None
the DT None
anesthetic JJ None
field NN None
and CC None
duration NN None
of IN None
soft JJ None
tissue NN None
anesthesia NN None
were VBD None
pinprick NN None
testing NN None
. . None
A DT None
monitor NN None
was VBD None
cardiovascular JJ None
parameters NNS None
. . None
RESULTS VB None
dose-dependent JJ None
duration NN None
of IN None
pulpal JJ None
and CC None
soft JJ None
tissue NN None
anesthesia NN None
was VBD None
. . None
Success NNP None
rate NN None
, , None
duration NN Other
of IN Other
both DT Other
pulpal JJ Other
and CC Other
soft JJ Other
tissue NN Other
anesthesia NN Other
, , None
and CC None
its PRP$ None
width NN Other
were VBD None
significant JJ None
cardiovascular JJ None
changes NNS None
were VBD None
high JJ None
success NN None
rate NN None
and CC None
effective JJ None
clinical JJ None
parameters NNS None
of IN None
effectively RB None
and CC None
safely RB None
obtained VBN None
-DOCSTART- -X- N

behavioral JJ Mental
disturbances NNS Mental
-- : None
for IN None
hyperactivity NN Mental
and CC Mental
irritability NN Mental
-- : None
in IN None
Aberrant JJ Mental
Behavior NNP Mental
Checklist-Community NNP Mental
Version NNP Mental
( ( Mental
ABC-CV NNP Mental
) ) Mental
and CC Mental
Clinical JJ Mental
Global NNP Mental
Impressions NNP Mental
( ( Mental
CGI NNP Mental
) ) Mental
parent-rated JJ None
ABC-CV NNP None
ratings NNS None
of IN None
irritability NN Mental
and CC None
hyperactivity NN Mental
ABC-CVs NNP None
for IN None
hyperactivity NN Mental
inappropriate JJ Mental
speech NN Mental
CGI NNP Mental
scale JJ Mental
ratings NNS Mental
behavioral JJ Mental
change NN Mental
clinician-rated JJ None
improvements NNS None
in IN None
behavioral JJ Mental
ratings NNS Mental
-DOCSTART- -X- N

recommendations NNS Other
nature NN Physical
of IN Physical
the DT Physical
complications NNS Physical
risks NNS Physical
of IN Physical
specific JJ Adverse
complications NNS Adverse
-DOCSTART- -X- N

Treatment-induced JJ Physical
effects NNS Physical
Childhood NNP Mental
Autism NNP Mental
Rating NNP Mental
Scale NNP Mental
total JJ Mental
scores NNS Mental
of IN Mental
Childhood NNP Mental
Autism NNP Mental
Rating NNP Mental
Scale NNP Mental
social JJ Mental
interaction NN Mental
, , Mental
communication NN Mental
, , Mental
and CC Mental
stereotyped VBD Mental
behaviors NNS Mental
social JJ Mental
interaction NN Mental
score NN Mental
response NN Mental
of IN Mental
the DT Mental
social JJ Mental
interaction NN Mental
score NN Mental
and CC Mental
IQ NNP Mental
. . None
-DOCSTART- -X- N

ineffective JJ Physical
airway JJ Physical
clearance NN Physical
ineffective JJ Physical
airway JJ Physical
clearance NN Physical
the DT None
health NN None
status NN None
of IN None
choking VBG None
( ( None
and CC None
adventitious JJ None
breath NN None
sounds NNS None
( ( None
obstructive JJ None
symptoms NNS None
in IN None
-DOCSTART- -X- N

restenosis NN Physical
rate NN Physical
symptoms NNS Physical
improved VBN Other
symptom JJ Other
free JJ Other
; : None
angiographic JJ Physical
restenosis NN Physical
rate NN Physical
major JJ Adverse
bleeding NN Adverse
complications NNS Adverse
. . None
exercise NN Other
test NN Other
angiographic JJ Physical
restenosis NN Physical
rate NN Physical
angiographic JJ Physical
restenosis NN Physical
-DOCSTART- -X- N

weight NN Physical
change NN Physical
baseline VB Physical
values NNS Physical
both DT Physical
in IN Physical
systolic NN Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
minor JJ Adverse
side-effects NNS Adverse
-DOCSTART- -X- N

Efficacy NN Other
safety NN Other
efficacy NN Other
safety NN Other
HIV-RNA NNP Physical
, , Physical
CD4 NNP Physical
cells NNS Physical
, , Physical
and CC Physical
blood NN Physical
chemistry NN Physical
profiles VBZ Physical
HIV NNP Physical
RNA NNP Physical
HIV NNP Physical
RNA NNP Physical
CD4 NNP Physical
cells NNS Physical
Serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
antiviral JJ Physical
activity NN Physical
-DOCSTART- -X- N

chest NN Physical
pains NNS Physical
no DT Physical
symptomatic JJ Physical
relief NN Physical
number NN Physical
of IN Physical
episodes NNS Physical
of IN Physical
angina NN Physical
-DOCSTART- -X- N

employment NN Other
outcomes NNS Other
competitive JJ Other
employment NN Other
rates NNS Other
of IN Other
employment NN Other
earned VBD Other
significantly RB Other
less JJR Other
cost NN Other
significantly RB Other
more RBR Other
better RBR Other
vocational JJ Other
outcomes NNS Other
-DOCSTART- -X- N

immune JJ Physical
dysregulation NN Physical
. . None
subjective JJ Other
relief NN Other
side NN Adverse
effects NNS Adverse
. . None
relief NN Other
side NN Adverse
effects NNS Adverse
incidence NN Adverse
of IN Adverse
side NN Adverse
effects NNS Adverse
degree NN Other
of IN Other
relief NN Other
greater JJR Other
relief NN Other
immune JJ Physical
dysregulation NN Physical
beneficial JJ Other
-DOCSTART- -X- N

success NN Other
failure NN Physical
of IN Physical
osseointegration NN Physical
during IN Physical
healing VBG Physical
( ( Physical
stage NN Physical
I PRP Physical
) ) Physical
and CC Physical
at IN Physical
stage NN Physical
II NNP Physical
surgery NN Physical
( ( Physical
uncovering VBG Physical
) ) Physical
. . None
failures NNS Other
-DOCSTART- -X- N

Total JJ Physical
platelet NN Physical
and CC None
fibrin JJ Physical
deposition NN Physical
mean JJ Physical
inhibition NN Physical
of IN Physical
total JJ Physical
platelet NN Physical
deposition NN Physical
fibrin JJ Physical
deposition NN Physical
tolerated VBN Other
. . None
-DOCSTART- -X- N

Economic NNP Other
evaluation NN Other
Costs NNPS Other
of IN Other
initial JJ Other
and CC Other
follow-up JJ Other
economic JJ Other
evaluation NN Other
efficacies NNS None
primary JJ None
outcome NN None
variable NN None
symptomatic JJ None
, , None
sustained VBD Physical
ventricular JJ Physical
tachyarrhythmia NN Physical
recurrence NN Physical
( ( None
including VBG Physical
sudden JJ Physical
death NN Physical
) ) None
. . None
Initial JJ Other
hospitalization NN Other
costly JJ Other
follow-up JJ Other
hospital NN Other
costs NNS Other
total JJ Other
hospital NN Other
costs NNS Other
two-year JJ None
actuarial JJ None
probability NN None
of IN None
a DT None
recurrent NN None
, , None
sustained VBN None
, , None
symptomatic JJ Physical
ventricular NN Physical
tachyarrhythmia NN Physical
initial JJ Other
hospital NN Other
costs NNS Other
follow-up NN None
costs NNS None
. . None
costs NNS Other
antiarrhythmic JJ Physical
efficacy NN Physical
total JJ Other
hospital NN Other
costs NNS Other
. . None
-DOCSTART- -X- N

number NN Physical
and CC Physical
severity NN Physical
of IN Physical
infections NNS Physical
infectious JJ Physical
episodes NNS Physical
morbidity NN Mortality
scores NNS Mortality
( ( Mortality
infection/infusion NN Mortality
) ) Mortality
severity NN Physical
of IN Physical
infections NNS Physical
duration NN Physical
of IN Physical
infection-free JJ Physical
intervals NNS Physical
. . None
morbidity NN Mortality
-DOCSTART- -X- N

knee-specific JJ Physical
symptoms NNS Physical
functional JJ Physical
limitations NNS Physical
Western NNP Physical
Ontario NNP Physical
and CC Physical
McMaster NNP Physical
Universities NNP Physical
Osteoarthritis NNP Physical
Index NNP Physical
( ( Physical
WOMAC NNP Physical
) ) Physical
and CC Other
the DT Other
Activities NNS Physical
of IN Physical
Daily NNP Physical
Living NNP Physical
Scale NNP Physical
( ( Physical
ADLS NNP Physical
) ) Physical
. . None
knee NN Physical
extension NN Physical
strength NN Physical
Additionally RB None
, , None
total JJ None
knee NN None
range NN None
of IN None
motion NN None
was VBD None
less JJR None
pain NN None
while IN None
standing VBG None
greater JJR None
difficulty NN None
with IN None
going VBG None
downstairs NNS None
( ( None
OR NNP None
-DOCSTART- -X- N

emotion NN Mental
regulation NN Mental
measures NNS Mental
poorer JJR Mental
emotion NN Mental
regulation NN Mental
skills NNS Mental
, , None
fewer JJR Mental
percent NN Mental
days NNS Mental
abstinent NN Mental
, , None
greater JJR Mental
alcohol NN Mental
dependence NN Mental
severity NN Mental
, , None
and CC None
several JJ Mental
high-risk JJ Mental
drinking NN Mental
situations NNS Mental
. . None
-DOCSTART- -X- N

safety NN Other
and CC None
efficacy NN Other
Rates NNS Adverse
of IN Adverse
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
serious JJ Adverse
infections NNS Adverse
cancer NN Physical
and CC None
deaths NNS Mortality
response NN Other
rates NNS Other
Doses NNS Other
safety NN Other
profile NN Other
rates NNS Adverse
of IN Adverse
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

skill JJ Other
acquisition NN Other
. . Mental
performances NNS Other
Interrater NNP Physical
reliability NN Physical
posttest JJ Physical
performance NN Physical
scores NNS Physical
Interrater NNP Other
reliability NN Other
-DOCSTART- -X- N

HER2 NNP Physical
status NN Physical
HER2 NNP Physical
mRNA FW Physical
expression NN Physical
HER2 NNP Physical
overexpression/amplification NN Physical
Positive JJ Physical
HER2 NNP Physical
mRNA NN Physical
levels NNS Physical
correlation NN Physical
between IN Physical
central JJ Physical
HER2 NNP Physical
expression NN Physical
and CC None
HER2 NNP Physical
status NN Physical
measured VBN Physical
by IN Physical
kinetic JJ Physical
RT-PCR NNP Physical
central JJ None
HER2 NNP None
as RB None
well RB None
as IN None
HER2 NNP None
mRNA FW None
expression NN None
were VBD None
predictors NNS None
for IN None
a DT None
pathological JJ None
complete JJ None
response NN None
after IN None
neoadjuvant JJ None
anthracycline/taxane-based JJ None
primary JJ None
chemotherapy NN None
The DT None
predictive JJ None
value NN None
the DT None
central JJ None
HER2 NNP None
status NN None
The DT None
locally RB None
assessed VBN None
HER2 NNP None
status NN None
was VBD None
not RB None
predictive JJ None
of IN None
response NN None
to TO None
chemotherapy NN None
. . None
-DOCSTART- -X- N

3-yr JJ Mortality
survival NN Mortality
rate NN Mortality
complete JJ Other
response NN Other
rates NNS Other
median JJ Physical
time NN Physical
to TO Physical
progression NN Physical
( ( Physical
TTP NNP Physical
) ) Physical
and CC None
overall JJ Mortality
survival NN Mortality
( ( Mortality
OS NNP Mortality
) ) Mortality
median JJ Physical
TTP NNP Physical
median JJ Mortality
OS NNP Mortality
alive JJ Mortality
severe JJ Physical
hematological JJ Physical
toxicity NN Physical
. . None
severe JJ Adverse
nausea/vomiting NN Adverse
3-yr JJ Mortality
survival NN Mortality
and CC Mortality
median JJ Mortality
OS NNP Mortality
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
, , Physical
plasma NN Physical
lipid JJ Physical
profile NN Physical
and CC Physical
diet JJ Physical
pattern NN Physical
lower JJR Physical
diastolic NN Physical
and CC Physical
systolic JJ Physical
blood NN Physical
pressures NNS Physical
effect NN Other
plasma NN Physical
triglycerides NNS Physical
, , Physical
cholesterol NN Physical
, , Physical
HDL-cholesterol NNP Physical
and CC Physical
gamma-glutamyltranspeptidase NN Physical
plasma VBD Physical
free-EPA NN Physical
increased VBN None
significantly RB None
plasma JJ Physical
free-arachidonic JJ Physical
acid NN Physical
( ( Physical
AA NNP Physical
) ) Physical
decreased VBD None
plasma NN Physical
free JJ Physical
essential JJ Physical
fatty NN Physical
acid RB Physical
changed VBD None
HDL NNP Physical
: : Physical
cholesterol NN Physical
increased VBD None
slightly RB None
non-significantly RB None
increase NN None
EPA NNP Physical
and CC Physical
DHA NNP Physical
. . None
significant JJ None
changes NNS None
diet JJ Physical
pattern NN Physical
or CC Physical
body NN Physical
mass NN Physical
observed VBN None
. . None
lowering NN Physical
of IN Physical
plasma NN Physical
AA NNP Physical
. . None
-DOCSTART- -X- N

7-day JJ Mental
diary NN Mental
to TO Mental
record NN Mental
pain NN Mental
, , Mental
percussion NN Mental
pain NN Mental
, , Mental
and CC Mental
number NN Mental
and CC Mental
type NN Mental
of IN Mental
pain NN Mental
medication NN Mental
taken VBN Mental
. . None
reduce VB None
pain NN Pain
, , None
percussion NN Pain
pain NN Pain
, , None
or CC None
the DT None
number NN Other
of IN Other
analgesic JJ Other
medications NNS Other
significant JJ Pain
pain NN Pain
-DOCSTART- -X- N

10-year JJ Mortality
survival NN Mortality
rates NNS Mortality
survival NN Mortality
survival JJ Mortality
rates NNS Mortality
-DOCSTART- -X- N

performance NN Other
Gross NNP Physical
motor NN Physical
quotient NN Physical
scores NNS Physical
gross JJ Physical
motor NN Physical
quotient NN Physical
scores NNS Physical
TGMD-2 NNP Physical
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
( ( Physical
BP NNP Physical
) ) Physical
regression NN Physical
of IN Physical
LV NNP Physical
mass NN Physical
BP NNP Physical
BP NNP Physical
BP NNP Physical
-DOCSTART- -X- N

mucociliary JJ Mental
clearance NN Mental
times NNS Mental
restored VBN Physical
impaired JJ Physical
mucociliary JJ Physical
clearance NN Physical
in IN Physical
chronic JJ Physical
sinusitis NN Physical
patients NNS Physical
improved VBD Physical
mucociliary JJ Physical
clearance NN Physical
times NNS Physical
significantly RB Physical
mucociliary JJ Mental
clearance NN Mental
time NN Mental
-DOCSTART- -X- N

European JJ Other
Organisation NNP Other
for IN Other
Research NNP Other
and CC Other
Treatment NNP Other
of IN Other
Cancer NNP Other
Quality NNP Other
of IN Other
Life NNP Other
( ( Other
EORTC NNP Other
QOL NNP Other
) ) Other
-C30 VBP Other
questionnaire NN Other
pain NN Pain
, , None
anorexia NN Physical
, , None
diarrhoea NN Physical
, , None
fatigue NN Physical
, , None
nausea NN Physical
and CC None
vomiting NN Physical
, , None
dyspnea NN Physical
, , None
constipation NN Physical
and CC None
insomnia NN Physical
progression NN Physical
median JJ Mortality
survival NN Mortality
efficacy NN Other
survival NN Mortality
haematological JJ Physical
toxicity NN Physical
Non-haematological JJ Physical
toxicity NN Physical
-DOCSTART- -X- N

antihypertensive JJ Physical
clinical JJ Physical
response NN Physical
reduction NN Physical
in IN Physical
diastolic JJ Physical
pressure NN Physical
below IN Physical
90 CD Physical
mmHg NN Physical
or CC Physical
a DT Physical
fall NN Physical
of IN Physical
at IN Physical
least JJS Physical
10 CD Physical
mmHg NN Physical
from IN Physical
baseline NN Physical
. . Physical
blood NN Physical
pressure NN Physical
maintained VBD Physical
the DT Physical
reduction NN Physical
office NN Physical
measurements NNS Physical
first-dose JJ None
side NN None
effective JJ None
-DOCSTART- -X- N

pain JJ Pain
relief NN Pain
during IN Pain
the DT Pain
first JJ Pain
3 CD Pain
hours NNS Pain
after IN Pain
trial NN Pain
analgesia NN Pain
pain VBP Pain
relief NN Pain
after IN Pain
60 CD Pain
minutes NNS Pain
. . Pain
need VBN Physical
for IN Physical
resuscitation NN Physical
and CC Physical
Apgar NNP Physical
Score NNP Physical
< VBD Physical
7 CD Physical
at IN Physical
1 CD Physical
minute NN Physical
. . Physical
measure NN None
of IN None
pain NN None
relief NN None
, , None
maternal JJ None
sedation NN None
, , None
nausea NN None
and CC None
vomiting NN None
, , None
maternal JJ None
oxygen NN None
saturation NN None
, , None
satisfaction NN None
with IN None
analgesia NN None
, , None
whether IN None
method NN None
of IN None
analgesia NN None
would MD None
be VB None
used VBN None
again RB None
, , None
use NN None
of IN None
Entonox NNP None
, , None
umbilical JJ None
arterial NN None
and CC None
venous JJ None
pH NN None
, , None
fetal JJ None
heart NN None
rate NN None
, , None
meconium NN None
staining NN None
, , None
time NN None
from IN None
delivery NN None
to TO None
first JJ None
breath NN None
, , None
Apgar NNP None
scores VBZ None
at IN None
5 CD None
mins NNS None
, , None
naloxone JJ None
requirement NN None
, , None
transfer NN None
to TO None
neonatal JJ None
intensive JJ None
care NN None
unit NN None
, , None
neonatal JJ None
haemoglobin NN None
oxygen NN None
saturation NN None
at IN None
30 CD None
, , None
60 CD None
, , None
90 CD None
, , None
and CC None
120 CD None
mins NNS None
after IN None
delivery NN None
, , None
and CC None
neonatal JJ None
sedation NN None
and CC None
feeding VBG None
behaviour NN None
during IN None
first JJ None
2 CD None
hours NNS None
. . None
-DOCSTART- -X- N

eosinophilic JJ Physical
asthmatic JJ Physical
inflammation NN Physical
and CC Physical
atopic JJ Physical
disease NN Physical
expression NN Physical
. . Physical
mean JJ Physical
+/- JJ Physical
SEM NNP Physical
values NNS Physical
FEV1 NNP Physical
AMP NNP Physical
PC20 NNP Physical
Airway NNP Physical
calibre NN Physical
as IN Physical
prechallenge NN Physical
FEV1 NNP Physical
AMP NNP Physical
PC20 NNP Physical
AMP NNP Physical
PC20 NNP Physical
bronchial JJ Physical
hyper-responsiveness NN Physical
to TO Physical
AMP NNP Physical
asthma JJ Physical
exacerbations NNS Physical
. . Physical
-DOCSTART- -X- N

sodium NN Physical
burden NN Physical
ionic JJ Physical
mass NN Physical
balance NN Physical
Interdialytic JJ Physical
weight NN Physical
gain NN Physical
Predialysis NNP Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
reduction NN Other
in IN Other
convective JJ Physical
sodium NN Physical
removal NN Physical
diffusive JJ Physical
sodium NN Physical
removal NN Physical
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
( ( Physical
BP NNP Physical
) ) Physical
aortic JJ None
and CC None
large-artery JJ None
compliance NN None
arterial JJ Physical
wave NN Physical
reflections NNS Physical
[ VBP Physical
pulse JJ Physical
wave VBP Physical
velocity NN Physical
( ( Physical
PWV NNP Physical
) ) Physical
augmentation NN Physical
index NN Physical
( ( Physical
AI NNP Physical
) ) Physical
application NN Physical
tonometry NN Physical
] NNP Physical
cardiac JJ Physical
echocardiography NN Physical
body JJ Physical
weight NN Physical
, , Physical
BP NNP Physical
( ( Physical
mercury NN Physical
sphygmomanometer NN Physical
) ) Physical
, , Physical
serum JJ Physical
creatinine NN Physical
, , Physical
electrolytes VBZ Physical
, , Physical
complete JJ Physical
blood NN Physical
cell NN Physical
counts NNS Physical
, , Physical
urine JJ Physical
volume NN Physical
, , Physical
drainage NN Physical
volume NN Physical
, , Physical
and CC Physical
weekly JJ Physical
creatinine NN Physical
clearance NN Physical
Systolic NNP None
and CC None
diastolic JJ None
BP NNP None
LVMi NNP None
LVMi NNP None
PWV NNP Other
AI NNP None
LVMi NNP None
-DOCSTART- -X- N

change NN Physical
in IN Physical
CG NNP Physical
health NN Physical
status NN Physical
CG NNP Physical
burden NN Physical
and CC Physical
bother NN Physical
after IN Physical
the DT Physical
intervention NN Physical
. . None
self-rated JJ Physical
health NN Physical
, , None
sleep VBP Physical
quality NN Physical
, , None
physical JJ Physical
health NN Physical
, , None
and CC None
emotional JJ Mental
health NN Mental
depression NN Mental
physical JJ Physical
and CC None
emotional JJ Mental
health NN Mental
total JJ Mental
frustration NN Mental
with IN Mental
caregiving NN Mental
, , None
emotional JJ Mental
burden NN Mental
, , None
and CC None
CG-rated JJ Mental
bother NN Mental
self-reported JJ Physical
health NN Physical
status NN Physical
burden NN Mental
-DOCSTART- -X- N

stimulus JJ Mental
overselectivity NN Mental
accuracy NN Other
scores NNS Other
Accuracy NN Other
accuracy VB Other
accuracy NN Other
scores NNS Other
accuracy NN Other
stimulus JJ Mental
overselectivity NN Mental
lasting VBG Mental
benefits NNS Mental
. . Mental
-DOCSTART- -X- N

increased VBN Physical
risk NN Physical
subsequent JJ Mortality
death NN Mortality
cardiovascular JJ Physical
disease NN Physical
relationship NN Other
between IN Other
coronary JJ Other
thrombus NN Other
formation NN Other
and CC Other
acute JJ Other
Q-wave NNP Other
infarction NN Other
. . None
thrombus JJ Physical
formation NN Physical
events NNS Adverse
related VBN Adverse
to TO Adverse
thrombosis NN Adverse
. . Adverse
risk NN Physical
death NN Mortality
, , Mortality
reinfarction NN Mortality
thromboembolic JJ Physical
morbidity NN Physical
. . Physical
died VBD Mortality
risk NN Physical
reduction NN Physical
died VBD Mortality
risk NN Other
reduction NN Other
Relapsing VBG Physical
myocardial JJ Physical
infarction NN Physical
( ( Physical
fatal JJ Physical
and CC Physical
nonfatal JJ Physical
) ) Physical
incidence NN Physical
of IN Physical
cerebrovascular JJ Physical
attacks NNS Physical
Serious JJ Adverse
bleeding NN Adverse
-DOCSTART- -X- N

subclinical JJ Physical
brain NN Physical
infarct NN Physical
. . None
Subclinical NNP Physical
brain NN Physical
infarct NN Physical
( ( Physical
SBI NNP Physical
) ) Physical
SBI NNP Physical
. . None
development NN Physical
of IN Physical
brain NN Physical
infarct NN Physical
number NN Physical
of IN Physical
brain NN Physical
infarcts NNS Physical
number NN Physical
of IN Physical
new JJ Physical
brain NN Physical
infarcts NNS Physical
new JJ Physical
brain NN Physical
infarcts NNS Physical
brain NN Physical
infarcts NNS Physical
brain NN Physical
infarcts NNS Physical
SBIs NNP Physical
brain NN Physical
infarct NN Physical
. . None
-DOCSTART- -X- N

eosinophilia NNS Physical
specific JJ Physical
IgG NNP Physical
response NN Physical
. . Physical
IgE NNP Physical
responses NNS Physical
to TO Physical
the DT Physical
environmental JJ Physical
allergens NNS Physical
to TO Physical
which WDT Physical
the DT Physical
systemic JJ Physical
immune JJ Physical
regulation NN Physical
level NN Physical
of IN Physical
infection NN Physical
frequency NN Physical
of IN Physical
infection NN Physical
-DOCSTART- -X- N

Stability NNP Other
Corneal NNP Physical
curvature NN Physical
complications NNS Adverse
or CC Adverse
adverse JJ Adverse
events NNS Adverse
effective JJ Other
, , Other
predictable JJ Other
, , Other
stable JJ Other
, , Other
and CC Other
safe JJ Other
. . None
-DOCSTART- -X- N

overall JJ Mortality
survival JJ Mortality
overall JJ Mortality
survival NN Mortality
efficacy NN Other
and CC None
tolerability NN Other
died VBN Mortality
. . None
Prolonged NNP Mortality
survival NN Mortality
alive JJ Mortality
median JJ Mortality
overall JJ Mortality
survival NN Mortality
incidence NN Physical
of IN Physical
joint JJ Physical
disorders NNS Physical
-DOCSTART- -X- N

The DT None
accuracy NN Other
of IN Other
brushing VBG Other
cytology NN Other
in IN None
was VBD None
significantly RB None
higher JJR None
when WRB None
the DT None
brushing NN Other
was VBD None
performed VBN None
before IN None
biopsy NN None
than IN None
after IN None
biopsy NN None
The DT None
diagnostic JJ Other
yield NN Other
of IN None
the DT None
biopsy NN Other
was VBD None
not RB None
significantly RB None
different JJ None
diagnostic JJ Other
superiority NN Other
of IN None
brushings NNS Other
obtained VBN None
before IN None
biopsy NN None
did VBD None
not RB None
relate VB None
to TO None
the DT None
site NN None
or CC None
endoscopic JJ None
appearance NN None
of IN None
the DT None
tumor NN None
. . None
no DT Other
false-positive JJ Other
cytologic NN Other
or CC Other
histologic JJ Other
reports NNS Other
. . None
cumulative JJ Other
accuracy NN Other
( ( None
brushing VBG Other
cytology NN Other
plus CC Other
biopsy NN Other
) ) None
biopsy NN Other
alone RB None
cytology NN Other
alone RB None
combined JJ Other
application NN Other
of IN Other
brushing NN Other
and CC Other
biopsy NN Other
-DOCSTART- -X- N

success NN Other
rate NN Other
time NN Other
required VBN Other
to TO Other
pass VB Other
the DT Other
endotracheal NN Other
tube NN Other
through IN Other
the DT Other
nasal JJ Other
cavity NN Other
( ( Other
nasal JJ Other
passage NN Other
time NN Other
) ) Other
, , Other
success NN Other
rate NN Other
of IN Other
nasal JJ Other
passage NN Other
with IN Other
nasotracheal JJ Other
tube NN Other
, , Other
and CC Other
the DT Other
incidence NN Physical
and CC Physical
severity NN Physical
of IN Physical
nasal JJ Physical
bleeding VBG Physical
Success NNP Other
rate NN Other
for IN Other
nasal JJ Other
passage NN Other
Frequency NN Physical
of IN Physical
nasal JJ Physical
bleeding NN Physical
Severity NN Physical
of IN Physical
nasal JJ Physical
bleeding NN Physical
success NN Other
rate NN Other
incidence NN Physical
and CC Physical
severity NN Physical
-DOCSTART- -X- N

effectiveness NN Other
of IN Other
treatment NN Other
Plaque NNP Physical
, , None
BOP NNP Physical
, , None
and CC None
PPD NNP Physical
Bone NN Physical
levels NNS Physical
Oral NNP Physical
hygiene NN Physical
bleed VB Physical
. . None
PPD NNP Physical
and CC None
bone NN Physical
levels NNS Physical
. . None
number NN Physical
of IN Physical
sites NNS Physical
with IN Physical
BOP NNP Physical
-DOCSTART- -X- N

69-month JJ Mortality
survival NN Mortality
rate NN Mortality
survival NN Mortality
rates NNS Mortality
No DT None
significant JJ Adverse
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

safety NN Other
laxative JJ Physical
effect NN Physical
serious JJ Adverse
toxic NN Adverse
effects NNS Adverse
or CC Adverse
irritation NN Adverse
urge NN Physical
to TO Physical
defecate VB Physical
defecated VBD Physical
toxic JJ Adverse
side NN Adverse
effects NNS Adverse
laxative JJ Physical
effect NN Physical
-DOCSTART- -X- N

climacteric NN Physical
symptoms NNS Physical
, , Physical
short-term JJ Physical
memory NN Physical
, , Physical
lipid JJ Physical
profile NN Physical
, , Physical
endothelial JJ Physical
function NN Physical
, , Physical
cerebral JJ Physical
circulation NN Physical
, , Physical
and CC Physical
quality NN Physical
of IN Physical
life NN Physical
. . Physical
-DOCSTART- -X- N

residual JJ Physical
periodontal NN Physical
pathogens NNS Physical
. . Physical
residual JJ Other
retention NN Other
of IN Other
periodontal JJ Other
pathogens NNS Other
. . Other
mean JJ Other
counts NNS Other
Aa NNP Other
, , Other
Pg NNP Other
, , Other
or CC Other
NS NNP Other
experimental JJ Other
counts NNS Other
microbial NN Other
counts NNS Other
-DOCSTART- -X- N

morphological JJ Physical
lesions NNS Physical
or CC Physical
plaques NNS Physical
, , None
vascular JJ Physical
distensibility NN Physical
or CC None
arterial JJ Physical
compliance NN Physical
serum NN Physical
lipid JJ Physical
fractions NNS Physical
and CC None
arterial JJ Physical
compliance NN Physical
Arterial JJ Physical
compliance NN Physical
reduced VBD Physical
total JJ Physical
cholesterol NN Physical
( ( Physical
TC NNP Physical
) ) Physical
, , None
LDL-C NNP Physical
, , None
and CC None
triglyceride NN Physical
levels NNS Physical
increased VBD Physical
HDL-C NNP Physical
increase NN Physical
in IN Physical
HDL NNP Physical
decrease NN Physical
in IN Physical
serum NN Physical
TC NNP Physical
, , None
LDL-C NNP Physical
and CC None
triglyceride NN Physical
levels NNS Physical
distensibility NN Physical
coefficient NN Physical
( ( Physical
DC NNP Physical
) ) Physical
and CC None
compliance NN Physical
coefficient NN Physical
( ( Physical
CC NNP Physical
) ) Physical
increased VBD Physical
DC NNP Physical
and CC None
CC NNP Mental
increased VBD Physical
reduce VB Physical
blood NN Physical
lipid NN Physical
levels NNS Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
tolerability NN Other
efficacy NN Other
tolerability NN Other
serum JJ Physical
phosphorus NN Physical
levels NNS Physical
the DT Physical
profile NN Physical
of IN Physical
serum JJ Physical
phosphorus NN Physical
during IN Physical
titration NN Physical
and CC Physical
parathyroid NN Physical
hormone NN Physical
, , Physical
calcium NN Physical
, , Physical
and CC Physical
calcium NN Physical
x NN Physical
phosphorus NN Physical
( ( Physical
Ca NNP Physical
x NNP Physical
P NNP Physical
) ) Physical
product NN Physical
levels NNS Physical
. . Physical
safety NN Other
and CC Other
tolerability NN Other
of IN Other
lanthanum NN Other
carbonate NN Other
adverse JJ Adverse
events NNS Adverse
Mean NNP Physical
serum VBZ Physical
phosphorus JJ Physical
level NN Physical
phosphorus NN Physical
levels NNS Physical
serum JJ Physical
phosphorus NN Physical
levels NNS Physical
Ca NNP Physical
x JJ Physical
P NNP Physical
product NN Physical
levels NNS Physical
tolerated VBN Other
; : None
serious JJ Adverse
adverse JJ Adverse
event NN Adverse
effective JJ Other
well-tolerated JJ Other
serum JJ Physical
phosphorus NN Physical
levels NNS Physical
. . Physical
-DOCSTART- -X- N

decreased VBD None
DMI NNP None
in IN None
but CC None
DMI NNP None
increased VBD None
study NN None
, , None
ultrasonic JJ Physical
fat NN Physical
was VBD None
percentage NN None
of IN None
USDA NNP None
yield NN None
grade NN None
( ( None
YG NNP None
) ) None
percentage NN None
of IN None
USDA NNP None
YG NNP None
1 CD None
carcasses NNS None
( ( None
25.9 CD None
Marbling VBG None
scores NNS None
and CC None
the DT None
percentage NN None
of IN None
carcasses NNS None
grading VBG None
USDA NNP None
Choice NNP None
and CC None
Prime NNP None
were VBD None
marbling NN None
and CC None
quality NN None
grades NNS None
did VBD None
The DT None
amount NN None
of IN None
HCW NNP None
gain NN None
tended VBD None
-DOCSTART- -X- N

period NN None
. . None
Pulse NNP None
wave VBP None
velocity NN None
of IN None
the DT None
aorta NN None
( ( None
PWV NNP None
) ) None
, , None
brachial JJ None
artery NN None
flow NN None
mediated VBN None
dilatation NN None
( ( None
FMD NNP None
) ) None
, , None
nitroglycerin RB None
mediated VBN None
dilatation NN None
( ( None
NMD NNP None
) ) None
, , None
microvascular JJ None
endothelial JJ None
function NN None
( ( None
reactive JJ None
hyperemia NN None
index NN None
[ NNP None
RHI NNP None
] NNP None
) ) None
, , None
and CC None
circulating VBG None
biomarkers NNS None
of IN None
inflammation NN None
, , None
insulin NN None
resistance NN None
, , None
and CC None
atherosclerosis NN None
risk NN None
the DT None
28-Joint JJ None
Count NNP None
Disease NNP None
Activity NNP None
Score NNP None
( ( None
DAS-28 NNP None
) ) None
C-reactive JJ None
protein NN None
( ( None
CRP NNP None
) ) None
and CC None
the DT None
Short NNP None
Form NNP None
( ( None
36 CD None
) ) None
Health NNP None
Survey NNP None
quality NN None
of IN None
life NN None
questionnaire NN None
. . None
When WRB None
decreased VBD None
pulse JJ None
wave NN None
velocity NN None
( ( None
ie JJ None
, , None
reduced VBN None
RA NNP None
disease NN None
activity NN None
( ( None
P=0.02 NNP None
) ) None
and CC None
CRP NNP None
levels NNS None
( ( None
P=0.001 NNP None
tolerated VBN None
. . None
CONCLUSIONS NNP None
-DOCSTART- -X- N

local JJ Physical
relapse-free JJ Physical
rate NN Physical
regional JJ Physical
relapse-free JJ Physical
rate NN Physical
overall JJ Mortality
survival NN Mortality
surgical JJ None
resection NN None
following VBG None
radiotherapy JJ None
failure NN None
. . None
overall JJ Mortality
survival NN Mortality
was VBD None
surgical JJ Adverse
complication NN Adverse
rate NN Adverse
. . None
Serious JJ Adverse
late JJ Adverse
radiation NN Adverse
toxicity NN Adverse
-DOCSTART- -X- N

tolerated VBN Other
Nitrogen NNP Physical
balance NN Physical
nutritional JJ Physical
protein NN Physical
markers NNS Physical
( ( Physical
albumin NN Physical
, , Physical
transferrin NN Physical
, , Physical
and CC Physical
retinol VB Physical
binding VBG Physical
protein NN Physical
) ) Physical
Infections NNP Adverse
major JJ Physical
septic JJ Physical
morbidity NN Physical
-DOCSTART- -X- N

incidence NN Physical
of IN Physical
chronic JJ Physical
lung NN Physical
disease NN Physical
incidence NN Physical
of IN Physical
chronic JJ Physical
lung NN Physical
disease NN Physical
death NN Mortality
, , None
pneumothorax NN Physical
, , Physical
intraventricular JJ Physical
haemorrhage NN Physical
, , None
number NN Other
of IN Other
ventilator NN Other
days NNS Other
, , Other
or CC Other
length NN Other
of IN Other
oxygen NN Other
dependency NN Other
medium NN None
and CC None
longer JJR None
term NN None
outcome NN None
measures NNS None
-DOCSTART- -X- N

noncompliance NN Mental
, , None
irritability NN Mental
and CC None
adaptive JJ Mental
functioning NN Mental
tantrums NNS Mental
, , Mental
aggression NN Mental
and CC Mental
self-injury NN Mental
noncompliance NN Mental
and CC None
adaptive JJ Mental
functioning NN Mental
symptom JJ Other
functional JJ Other
-DOCSTART- -X- N

operating NN Other
time NN Other
, , None
blood NN Physical
loss NN Physical
, , None
complications NNS Adverse
, , None
febrile JJ Mortality
morbidity NN Mortality
, , None
analgesics NNS Other
administration NN Other
and CC None
hospital JJ Other
stay NN Other
Median JJ Physical
uterine JJ Physical
weight NN Physical
Median JJ Other
operating NN Other
time NN Other
analgesics JJ Physical
administration NN Physical
median JJ Other
hospital NN Other
stay NN Other
operating VBG Other
time NN Other
analgesics NNS Physical
administration NN Physical
hospital NN Other
stay NN Other
advantages NNS Other
operating NN Other
time NN Other
post-operative JJ Pain
pain NN Pain
recovery NN Physical
. . None
conversion NN Physical
to TO Physical
laparotomy VB Physical
. . None
-DOCSTART- -X- N

ineffective JJ Other
lack NN Other
of IN Other
success NN Other
Duration NN Physical
of IN Physical
whoops JJ Physical
post-treatment NN Physical
Mean JJ Physical
number NN Physical
of IN Physical
whoops NNS Physical
duration NN Physical
of IN Physical
whoops NNS Physical
differences NNS Physical
beneficial JJ Other
effect NN Other
-DOCSTART- -X- N

Neurophysiological JJ Mental
responses NNS Mental
to TO Mental
faces VBZ Mental
and CC Mental
gaze JJ Mental
direction NN Mental
face NN Mental
processing NN Mental
abnormalities NNS Mental
ERP NNP Mental
markers NNS Mental
of IN Mental
face NN Mental
and CC Mental
gaze NN Mental
processing NN Mental
response NN Mental
to TO Mental
gaze VB Mental
direction NN Mental
sensitivity NN Mental
to TO Mental
gaze VB Mental
direction NN Mental
face NN Mental
inversion NN Mental
effect NN Mental
abnormalities NNS Mental
in IN Mental
gaze NN Mental
processing NN Mental
and CC Mental
altered JJ Mental
neural JJ Mental
specialisation NN Mental
abnormalities NNS Mental
-DOCSTART- -X- N

pharmacokinetics NNS Physical
of IN Physical
paracetamol NN Physical
in IN Physical
saliva NN Physical
. . None
in IN Other
vitro JJ Other
reaction NN Other
paracetamol JJ Physical
absorption NN Physical
. . None
in IN Other
vivo JJ Other
interaction NN Other
of IN Other
paracetamol NN Other
and CC Other
ferrous JJ Other
ion NN Other
. . None
AUC8 NNP Physical
Cmax NNP Physical
paracetamol NN Other
pharmacokinetic JJ Other
parameter NN Other
oral JJ Other
clearance NN Other
( ( Other
C1/F NNP Other
) ) Other
volume NN Physical
of IN Physical
distribution NN Physical
decreased JJ Other
paracetamol NN Physical
absorption NN Physical
-DOCSTART- -X- N

heterozygous JJ Physical
or CC Physical
homozygous JJ Physical
M66I NNP Physical
and CC Physical
R492W NNP Physical
variant NN Physical
alleles NNS Physical
, , Physical
or CC Physical
homozygous JJ Physical
P153L NNP Physical
, , Physical
V257M NNP Physical
, , Physical
and CC Physical
E305X NNP Physical
variant JJ Physical
alleles NNS Physical
. . None
homozygous JJ Physical
for IN Physical
E158K NNP Physical
homozygous JJ Physical
for IN Physical
E308G NNP Physical
variant JJ Physical
alleles NNS Physical
. . None
homozygosity NN Physical
mucosal NN Physical
prostanoid NN Physical
levels NNS Physical
-DOCSTART- -X- N

surface NN Physical
perfusion NN Physical
increase NN None
of IN None
plasma JJ Physical
glucose JJ Physical
concentration NN Physical
Stress NNP Physical
mediated VBD Physical
hypokalaemia NN Physical
median JJ Physical
values NNS Physical
of IN Physical
the DT Physical
plasma NN Physical
potassium NN Physical
concentrations NNS Physical
moderate JJ Physical
compensated VBN Physical
acidosis NN Physical
marked JJ Physical
increase NN Physical
of IN Physical
paCO2 NN Physical
greater JJR Physical
fall NN Physical
of IN Physical
pH NN Physical
fall NN Physical
in IN Physical
oxygen NN Physical
uptake NN Physical
oxygen FW Physical
uptake NN Physical
oxygen NN Physical
uptake NN Physical
-DOCSTART- -X- N

irreversible JJ Physical
renal JJ Physical
failure NN Physical
serum NN Physical
myeloma NN Physical
protein IN Physical
value NN Physical
renal JJ Physical
function NN Physical
. . None
-DOCSTART- -X- N

acute JJ Physical
expansion NN Physical
property NN Physical
and CC None
long-term JJ Physical
neointimal JJ Physical
responses NNS Physical
stent JJ Physical
expansion NN Physical
neointimal JJ Physical
growth NN Physical
negative JJ Adverse
edge NN Adverse
effects NNS Adverse
, , Adverse
unhealed JJ Adverse
dissections NNS Adverse
, , Adverse
or CC Adverse
late RB Adverse
stent-vessel JJ Adverse
wall NN Adverse
malapposition NN Adverse
-DOCSTART- -X- N

the DT None
need NN Other
for IN Other
more RBR Other
effective JJ Other
treatments NNS Other
individual JJ None
differences NNS None
in IN None
the DT None
likelihood NN None
of IN None
returning VBG Mental
to TO Mental
smoking VBG Mental
following VBG Mental
treatment NN Mental
for IN None
-DOCSTART- -X- N

improvement NN None
in IN None
rectal JJ None
bleeding NN None
, , None
physician NN None
's POS None
disease NN None
activity NN None
rating NN None
, , None
stool JJ None
frequency NN None
, , None
the DT None
SDAI NNP None
at IN None
month NN None
6/end CD None
of IN None
treatment NN None
, , None
patients NNS None
-DOCSTART- -X- N

Long-term JJ None
outcome NN None
predict VB Other
the DT Other
efficacy NN Other
of IN Other
antimigraine JJ Other
therapy NN Other
. . None
maintained VBD Other
treatment NN Other
benefit NN Other
benefit NN None
early JJ Physical
onset NN Physical
migraine NN Physical
response NN Physical
. . Mental
-DOCSTART- -X- N

efficacy NN Other
beta2-adrenoceptor JJ Physical
tolerance NN Physical
. . None
S-potassium NN Other
, , None
heart NN Other
rate NN Other
corrected VBD Other
Q-T NNP Other
interval NN Other
( ( Other
Q-Tc NNP Other
) ) Other
, , None
and CC None
tremor NN Other
score NN Other
tremor NN Other
score NN Other
S-potassium NNP Physical
-DOCSTART- -X- N

Active JJ None
warming NN None
, , None
not RB None
passive JJ None
heat NN None
retention NN None
normothermia JJ Physical
Tympanic JJ Physical
temperature NN Physical
Duration NNP Physical
of IN Physical
anesthesia NN Physical
, , Physical
invasiveness NN Physical
of IN Physical
surgery NN Physical
, , Physical
and CC Physical
baseline NN Physical
core NN Physical
temperature NN Physical
Core NNP Physical
temperature NN Physical
reduction NN Physical
from IN Physical
baseline NN Physical
values NNS Physical
core JJ Physical
temperature NN Physical
maintaining VBG Physical
intraoperative JJ Physical
normothermia NN Physical
-DOCSTART- -X- N

deep RB Physical
venous JJ Physical
thrombosis NN Physical
risk NN Physical
of IN Physical
thrombosis NN Physical
cases NNS Physical
of IN Physical
deep JJ Physical
venous JJ Physical
thrombosis NN Physical
peroperative VB Physical
and CC Physical
postoperative JJ Physical
bleeding NN Physical
. . None
-DOCSTART- -X- N

Pain NNP Pain
intensity NN Pain
pain NN Pain
relief NN Pain
incidence NN Adverse
of IN Adverse
side JJ Adverse
effects NNS Adverse
visual JJ Physical
hallucinations NNS Physical
toxicity NN Adverse
safe JJ Other
, , Other
effective JJ Other
and CC Other
wall RB Other
tolerated JJ Other
-DOCSTART- -X- N

acute JJ Physical
prokinetic JJ Physical
efficacy NN Physical
gastric JJ Physical
emptying VBG Physical
Gamma NNP Physical
camera NN Physical
images NNS Physical
( ( None
CFB NNP Physical
) ) None
percent NN Physical
gastric JJ Physical
retention NN Physical
gastric JJ Physical
emptying NN Physical
-DOCSTART- -X- N

sex NN Physical
hormone NN Physical
metabolism NN Physical
sex NN Physical
hormone NN Physical
metabolism NN Physical
serum NN Physical
estrone NN Physical
, , Physical
estradiol NN Physical
, , Physical
sex NN Physical
hormone-binding JJ Physical
globulin NN Physical
, , Physical
dehydroepiandrosterone NN Physical
sulfate NN Physical
, , Physical
prolactin NN Physical
, , Physical
or CC Physical
progesterone NN Physical
concentrations NNS Physical
menstrual JJ Physical
cycle NN Physical
length NN Physical
or CC Physical
the DT Physical
urinary JJ Physical
estrogen NN Physical
metabolite NNS Physical
ratio NN Physical
of IN Physical
2-hydroxyestrone CD Physical
to TO Physical
16 CD Physical
alpha-hydroxyestrone NN Physical
urinary JJ Physical
estrogen NN Physical
metabolites NNS Physical
menstrual JJ Physical
cycle NN Physical
, , Physical
serum JJ Physical
sex NN Physical
hormones NNS Physical
, , Physical
or CC Physical
urinary JJ Physical
estrogen NN Physical
metabolite NN Physical
ratio NN Physical
-DOCSTART- -X- N

patients NNS None
died VBD Mortality
during IN None
experienced VBD None
graft NN Adverse
loss NN Adverse
( ( None
an DT None
acute JJ Adverse
rejection NN Adverse
episode NN None
of IN None
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
, , None
viral JJ Adverse
infections NNS None
and CC None
fungal JJ Adverse
infections NNS Adverse
cases NNS None
of IN None
posttransplant JJ Adverse
lymphoproliferative JJ None
disorder NN Adverse
( ( Adverse
PTLD NNP None
calculated VBD None
GFR NNP None
at IN None
-DOCSTART- -X- N

muscle VB Physical
metaboreflex JJ Physical
stimulation NN Physical
, , None
hypoxia NN None
( ( None
target VB None
hyperoxia NN None
( ( None
FiO2 NNP None
PECO NNP None
. . None
Ventilation NNP None
( ( None
Ve NNP None
) ) None
, , None
heart NN None
rate NN None
( ( None
HR NNP None
) ) None
, , None
blood NN None
pressure NN None
, , None
and CC None
muscle NN None
sympathetic JJ None
nervous JJ None
activity NN None
( ( None
MSNA NNP None
) ) None
data NNS None
were VBD None
lower JJR None
MSNA NNP None
( ( None
P NNP None
higher JJR None
HR NNP None
ventilatory NN None
and CC None
MSNA NNP None
responses NNS None
hypoxic VB None
PECO NNP None
were VBD None
CC NNP None
are VBP None
not RB None
sensitized VBN None
during IN None
that IN None
stimulation NN None
of IN None
the DT None
metaboreflex NN None
activates VBZ None
, , None
but CC None
CC NNP None
-DOCSTART- -X- N

overall JJ Mortality
survival NN Mortality
[ NNP Mortality
OS NNP Mortality
; : None
OS NNP Physical
survival NN Mortality
-DOCSTART- -X- N

serum JJ Physical
( ( Physical
TRUS NNP Physical
) ) Physical
serum NN Physical
PSA NNP Physical
sensitive JJ Physical
technique NN Physical
risk NN Physical
of IN Physical
having VBG Physical
prostate NN Physical
cancer NN Physical
serum JJ Physical
PSA NNP Physical
alone RB Physical
estimated JJ Other
cost NN Other
curable JJ Other
morbidity NN Mortality
and CC Mortality
mortality NN Mortality
from IN Mortality
prostate NN Mortality
cancer NN Mortality
-DOCSTART- -X- N

early JJ Pain
postoperative JJ Pain
pain NN Pain
operative JJ Other
time NN Other
, , Other
complication NN Adverse
rate NN Adverse
( ( Adverse
including VBG Adverse
conversions NNS Adverse
) ) Adverse
, , Adverse
and CC Other
recovery NN Other
time NN Other
( ( Other
days NNS Other
of IN Other
oral JJ Other
opiate JJ Other
usage NN Other
and CC Other
return NN Other
to TO Other
work VB Other
) ) Other
body NN Mental
image NN Mental
cosmetic JJ Mental
appearance NN Mental
higher JJR None
inpatient NN None
opiate NN None
usage NN None
( ( None
laparoscopy NN None
. . None
Operative JJ None
time NN None
for IN None
SILS NNP None
case NN None
differences NNS None
in IN None
length NN None
of IN None
stay NN None
, , None
complications NNS None
, , None
oral JJ None
pain NN None
medication NN None
usage NN None
after IN None
discharge NN None
, , None
or CC None
return VB None
to TO None
work VB None
. . None
physical JJ None
attractiveness NN None
( ( None
4.0 CD None
better JJR None
scars NNS None
( ( None
more RBR None
pain NN None
operative JJ None
times NNS None
without IN None
-DOCSTART- -X- N

response NN Other
response NN Other
rates NNS Other
or CC Other
rates NNS Other
of IN Other
return NN Other
. . Other
-DOCSTART- -X- N

Death NNP Mortality
or CC None
neurological JJ Physical
deterioration NN Physical
at IN Physical
day NN Physical
10 CD Physical
systolic JJ Physical
BP NNP Physical
mean JJ Physical
arterial JJ Physical
pressure NN Physical
pulse JJ Physical
pressure NN Physical
BP NNP Physical
variability NN Physical
deterioration NN Physical
alone RB Physical
, , None
and CC None
recurrent JJ Physical
stroke NN Physical
. . None
death NN Mortality
neurologic JJ Physical
deterioration NN Physical
, , None
deterioration NN Physical
recurrent JJ Physical
stroke NN Physical
-DOCSTART- -X- N

Myoclonic JJ Physical
movements NNS Physical
and CC Physical
sedation NN Physical
Pulse NNP Physical
oximetry NN Physical
, , Physical
noninvasive JJ Physical
arterial JJ Physical
blood NN Physical
pressure NN Physical
, , Physical
and CC Physical
heart NN Physical
rate NN Physical
myoclonic JJ Physical
movements NNS Physical
-DOCSTART- -X- N

Effective NNP Physical
Cardiac NNP Physical
Treatment NNP Physical
: : None
quality NN Other
of IN Other
care NN Other
adjusted VBN Mortality
mortality NN Mortality
length NN Other
of IN Other
in-hospital JJ Other
stay NN Other
, , None
physician JJ Other
visits NNS Other
after IN Other
discharge NN Other
, , None
waiting VBG Other
times NNS Other
for IN Other
invasive JJ Other
cardiac NN Other
procedures NNS Other
, , Other
and CC None
readmissions NNS Other
for IN Other
cardiac JJ Other
complications NNS Other
. . None
quality NN None
improvement NN None
effectiveness NN Other
-DOCSTART- -X- N

long-term JJ Physical
adaptation NN Physical
of IN Physical
blood NN Physical
lipids NNS Physical
long-term JJ Physical
adaptation NN Physical
of IN Physical
blood NN Physical
lipids NNS Physical
serum JJ Physical
short-chain JJ Physical
fatty JJ Physical
acids NNS Physical
( ( Physical
SCFAs NNP Physical
) ) Physical
relation NN Physical
between IN Physical
changes NNS Physical
in IN Physical
serum NN Physical
acetate NN Physical
and CC Physical
changes NNS Physical
in IN Physical
blood NN Physical
lipids NNS Physical
. . None
Carbohydrate NNP Physical
intakes NNS Physical
Fasting VBG Physical
serum JJ Physical
SCFAs NNP Physical
serum JJ Physical
acetate NN Physical
Serum NNP Physical
butyrate NN Physical
Changes NNS Physical
in IN Physical
serum NN Physical
acetate NN Physical
changes NNS Physical
in IN Physical
lipids NNS Physical
. . None
changes NNS Physical
in IN Physical
serum NN Physical
acetate NN Physical
changes NNS Physical
in IN Physical
the DT Physical
ratio NN Physical
of IN Physical
total JJ Physical
to TO Physical
HDL NNP Physical
cholesterol NN Physical
postprandial JJ Physical
( ( Physical
P NNP Physical
= NNP Physical
0.016 CD Physical
) ) Physical
triacylglycerols NNS Physical
. . None
serum NN Physical
SCFAs NNP Physical
carbohydrate NN Physical
and CC Physical
fiber NN Physical
intakes NNS Physical
serum NN Physical
acetate NN Physical
long-term JJ Physical
adaptive JJ Physical
changes NNS Physical
in IN Physical
blood NN Physical
lipids NNS Physical
. . None
-DOCSTART- -X- N

Clofibrate NNP Other
and CC None
diabetes VBZ Other
control NN Other
reduce VB Other
fasting VBG Physical
or CC Physical
post-prandial JJ Physical
blood NN Physical
glucose NN Physical
24 CD Physical
h NN Physical
glycosuria NN Physical
; : None
M-value NNP Physical
, , None
an DT None
index NN Physical
of IN Physical
diabetes NNS Physical
control NN Physical
. . None
diabetes NNS Physical
control NN Physical
24 CD Physical
h NN Physical
glycosuria NN Physical
M-value NNP Physical
. . None
plasma NN Physical
fibrinogen NN Physical
. . None
-DOCSTART- -X- N

earthquake-related JJ Mental
fears NNS Mental
Significant JJ Physical
treatment NN Physical
effects NNS Physical
improvement NN Other
rate NN Other
cost-effective JJ Other
-DOCSTART- -X- N

total JJ Pain
subjective JJ Pain
neck NN Pain
, , Pain
shoulder NN Pain
, , Pain
and CC Pain
head NN Pain
pain NN Pain
based VBN Pain
on IN Pain
visual JJ Pain
analog NN Pain
scales NNS Pain
; : None
objective JJ Physical
total JJ Physical
range NN Physical
of IN Physical
neck NN Physical
motion NN Physical
( ( Physical
ROM NNP Physical
) ) Physical
, , Physical
and CC None
the DT None
Vernon-Mior NNP Physical
subjective JJ Physical
function NN Physical
index NN Physical
. . None
trend NN None
toward IN None
improvement NN None
in IN None
ROM NNP Physical
and CC None
reduction NN None
in IN None
pain NN Pain
Vernon-Mior JJ Physical
scale NN Physical
improvement NN None
ROM NNP Physical
subjective JJ Pain
pain NN Pain
subjective JJ Physical
functioning NN Physical
. . None
-DOCSTART- -X- N

proportion NN None
of IN None
animals NNS None
lambing VBG None
to TO None
introduction NN None
to TO None
lambing NN None
and CC None
the DT None
mean JJ None
lambing NN None
day NN None
proportion NN None
of IN None
animals NNS None
lambing VBG None
to TO None
the DT None
first JJ None
service NN None
or CC None
overall JJ None
, , None
interval NN None
8-month JJ None
lambing NN None
interval NN None
was VBD None
-DOCSTART- -X- N

loss NN Physical
of IN Physical
consciousness NN Physical
loss NN Physical
of IN Physical
verbal JJ Physical
contact NN Physical
with IN Physical
the DT Physical
patient NN Physical
) ) None
duration NN Other
of IN Other
induction NN Other
total JJ Other
dose NN Other
systolic JJ Physical
and CC Physical
diastolic JJ Physical
arterial JJ Physical
pressure NN Physical
incidence NN Physical
of IN Physical
apnoea NN Physical
-DOCSTART- -X- N

therapeutic JJ Adverse
effect NN Adverse
intelligence NN Physical
, , Physical
daily JJ Physical
life NN Physical
and CC Physical
social JJ Physical
activity NN Physical
ability NN Physical
. . Physical
scores NNS Other
for IN Other
the DT Other
Mini-Mental JJ Other
State NNP Other
Examination NNP Other
( ( Other
MMSE NNP Other
) ) Other
, , None
Ability NNP Physical
of IN Physical
Daily NNP Physical
Life NNP Physical
( ( Physical
ADL NNP Physical
) ) Physical
and CC None
the DT Adverse
therapeutic JJ Adverse
effects NNS Adverse
MMSE NNP Physical
and CC Physical
ADL NNP Physical
total JJ Physical
effective JJ Physical
rate NN Physical
therapeutic JJ Physical
effect NN Physical
-DOCSTART- -X- N

effect NN Other
postoperative JJ Pain
pain NN Pain
relief NN Pain
Pain NNP Pain
pain NN Pain
levels NNS Pain
average JJ Physical
analgesic JJ Physical
requirement NN Physical
pain NN Pain
-DOCSTART- -X- N

adverse JJ Adverse
effects NNS Adverse
. . None
response NN Other
tolerated VBN Other
Apneic NNP Physical
episodes VBZ Physical
requiring VBG Physical
intubation NN Physical
retreatment NN Other
progressed VBD Physical
to TO Physical
stage VB Physical
5 CD Physical
retinal JJ Physical
detachment NN Physical
. . None
-DOCSTART- -X- N

response NN Physical
rate NN Physical
responses NNS Physical
difference NN Mortality
in IN Mortality
survival NN Mortality
Median JJ Mortality
survival NN Mortality
pancreatic JJ Mortality
carcinoma NN Mortality
median JJ Mortality
survival NN Mortality
Leukopenia NNP Physical
performance NN Physical
status NN Physical
survival NN Mortality
alter VB Physical
the DT Physical
dismal JJ Physical
prognosis NN Physical
-DOCSTART- -X- N

mental JJ Mental
health NN Mental
functioning NN Mental
. . Mental
hopelessness NN Mental
and CC Mental
depression NN Mental
levels NNS Mental
. . Mental
hopelessness NN Mental
and CC Mental
depression NN Mental
-DOCSTART- -X- N

pain NN Pain
intensity NN Pain
and CC None
pain NN Pain
relief NN Pain
analgesic JJ Other
effectiveness NN Other
of IN Pain
the DT Pain
combination NN Pain
on IN Pain
all DT Pain
measures NNS Pain
of IN Pain
efficacy NN Pain
( ( None
sum NN Pain
of IN Pain
pain NN Pain
intensity NN Pain
differences NNS Pain
, , None
largest JJS Pain
pain NN Pain
intensity NN Pain
difference NN Pain
, , None
total JJ Pain
pain NN Pain
relief NN Pain
, , None
largest JJS Pain
pain NN Pain
relief NN Pain
, , None
and CC None
time NN Pain
to TO Pain
remedication NN Pain
) ) None
. . None
incidence NN Adverse
of IN Adverse
adverse JJ Adverse
effects NNS Adverse
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
Serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
Increase NN Other
over IN Other
the DT Other
baseline NN Other
treadmill NN Other
exercise NN Other
test NN Other
total JJ Other
treadmill NN Other
exercise NN Other
test NN Other
duration NN Other
; : None
time NN Physical
to TO Physical
first JJ Physical
anginal JJ Physical
pain NN Physical
time NN Physical
to TO Physical
ST NNP Physical
segment NN Physical
depression NN Physical
mVolt NN None
safe JJ Other
tolerated VBN Other
. . None
-DOCSTART- -X- N

arch NN Other
dimensions NNS Other
-DOCSTART- -X- N

objective JJ Physical
sleep NN Physical
testing NN Physical
symptoms NNS Physical
of IN Physical
rhinitis NN Physical
, , Physical
sleep NN Physical
, , Physical
and CC Physical
daytime JJ Physical
somnolence NN Physical
disrupted VBN Physical
sleep NN Physical
sleep NN Physical
and CC Physical
daytime JJ Physical
somnolence NN Physical
. . None
improvement NN Physical
of IN Physical
congestion NN Physical
, , Physical
sleep NN Physical
, , Physical
and CC Physical
daytime JJ Physical
somnolence NN Physical
. . None
subjective JJ Physical
congestion NN Physical
and CC None
daytime JJ Physical
somnolence NN Physical
and CC None
improving VBG Physical
sleep NN Physical
overnight JJ Other
sleep NN Other
testing NN Other
( ( Physical
polysomnography NN Physical
) ) Physical
. . Physical
Questionnaires NNS Other
, , None
quality NN Other
of IN Other
life NN Other
instruments NNS Other
, , Other
daily JJ Other
diary NN Other
, , None
Epworth NNP Other
Sleepiness NNP Other
Scale NNP Other
, , Other
and CC Other
an DT Other
overnight JJ Other
sleep JJ Other
test NN Other
with IN Other
polysomnograms NNS Other
sleep NN Physical
tests NNS Physical
and CC Physical
subjective JJ Physical
tests NNS Physical
subjective JJ Physical
sleep NN Physical
apnea/hypopnea NN Physical
index NN Physical
Daytime NNP Physical
sleepiness NN Physical
and CC None
fatigue NN Physical
subjective JJ Physical
sleep NN Physical
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
Stool NNP Physical
cultures NNS Physical
for IN Physical
Shigella NNP Physical
, , None
Salmonella NNP Physical
, , None
Campylobacter NNP Physical
spp NN Physical
. . None
and CC None
diarrheagenic JJ Physical
Escherichia NNP Physical
coli NNS Physical
Clinical JJ Other
response NN Other
and CC Other
safety NN Other
Clinical JJ Other
cure NN Other
or CC Other
improvement NN Other
adverse JJ Adverse
events NNS Adverse
Joint JJ Physical
examination NN Physical
safe JJ Other
effective JJ Other
-DOCSTART- -X- N

Expression NN Physical
of IN Physical
VEGF NNP Physical
and CC Physical
VEGFR-2 NNP Physical
remission NN Physical
VEGFR-2 NNP Physical
staining NN Physical
levels NNS Physical
VEGF/VEGFR-2 NNP Physical
of IN Physical
leukemic JJ Physical
blasts NNS Physical
-DOCSTART- -X- N

Reduction NN Physical
of IN Physical
oral JJ Physical
mucositis NN Physical
Mucositis NNP Physical
reduction NN Physical
of IN Physical
mucositis NN Physical
. . Physical
Oral NNP Physical
mucositis NN Physical
symptom NN Physical
of IN Physical
oral JJ Physical
mucositis NN Physical
with IN Physical
or CC Physical
without IN Physical
oral JJ Physical
candidiasis NN Physical
. . Physical
Oral NNP Physical
mucositis NN Physical
time NN Physical
to TO Physical
first JJ Physical
episode NN Physical
of IN Physical
mucositis NN Physical
mucositis NN Physical
mucositis NN Physical
oral JJ Physical
mucositis NN Physical
-DOCSTART- -X- N

safety NN Other
and CC Other
efficacy NN Other
irritability NN Physical
symptoms NNS Physical
time NN None
to TO None
relapse VB None
between IN None
.097 NNP None
) ) None
. . None
Kaplan-Meier NNP None
relapse NN None
rates NNS None
at IN None
common JJ None
adverse JJ None
events NNS None
during IN None
were VBD None
weight JJ None
increase NN None
( ( None
25.2 CD None
% NN None
) ) None
, , None
somnolence NN None
( ( None
and CC None
vomiting VBG None
( ( None
were VBD None
upper JJ None
respiratory NN None
tract NN None
infection NN None
( ( None
2.3 CD None
% NN None
) ) None
, , None
constipation NN None
( ( None
and CC None
movement NN None
disorder NN None
( ( None
time NN None
to TO None
relapse VB None
during IN None
-DOCSTART- -X- N

non-Q-wave JJ Physical
MI NNP Physical
( ( Physical
NQMI NNP Physical
) ) Physical
rates NNS Physical
NQMI NNP Physical
rates NNS Physical
of IN Physical
in-hospital JJ Physical
NQMI NNP Physical
side JJ Physical
branch NN Physical
occlusion NN Physical
-DOCSTART- -X- N

teacher-rated JJ Mental
hyperactivity NN Mental
subscale NN Mental
of IN Mental
the DT Mental
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
. . None
much JJ Other
improved VBN Other
very RB Other
much JJ Other
improved VBN Other
Clinical NNP Mental
Global NNP Mental
Impressions NNP Mental
Improvement NNP Mental
item NN Mental
parent-rated JJ Mental
and/or JJ Mental
teacher-rated JJ Mental
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
hyperactivity NN Mental
subscale NN Mental
score NN Mental
. . None
effect NN Other
sizes NNS Other
Adverse JJ Adverse
effects NNS Adverse
-DOCSTART- -X- N

autistic JJ Physical
behaviour NN Physical
visual JJ Mental
analogue NN Mental
scale NN Mental
( ( Mental
VAS NNP Mental
) ) Mental
and CC Mental
the DT Mental
aberrant JJ Mental
behaviour NN Mental
checklist NN Mental
( ( Mental
ABC NNP Mental
) ) Mental
. . Mental
parental JJ Mental
ratings NNS Mental
only RB Mental
( ( Mental
VAS NNP Mental
scores VBZ Mental
) ) Mental
-DOCSTART- -X- N

in-hospital JJ Mortality
mortality NN Mortality
rates NNS Other
death NN Mortality
or CC Mortality
reinfarction NN Mortality
recurrent JJ Physical
myocardial JJ Physical
ischemia NN Physical
stroke VBD Physical
in-hospital JJ Mortality
mortality NN Mortality
recurrent NN Physical
myocardial JJ Physical
ischemia NN Physical
unscheduled JJ Adverse
catheterization NN Adverse
and CC None
revascularization NN Physical
procedures NNS Physical
hospital NN Other
stay NN Other
improved VBN Mortality
survival NN Mortality
rates NNS Adverse
of IN Adverse
stroke NN Physical
, , None
reinfarction NN Physical
, , None
and CC None
recurrent JJ Physical
myocardial JJ Physical
ischemia NN Physical
. . None
mortality NN Mortality
recurrent NN Physical
ischemia NN Physical
subsequent JJ Other
invasive NN Other
procedures NNS Other
discharge NN Other
. . None
-DOCSTART- -X- N

stereotypy NN Mental
effects NNS Other
stereotyped JJ Mental
behaviour NN Mental
frequency NN Mental
of IN Mental
stereotypic NN Mental
behaviour NN Mental
rates NNS Mental
of IN Mental
all DT Mental
types NNS Mental
of IN Mental
stereotypy NN Mental
; : Mental
stereotypy NNS Mental
easy JJ Other
-DOCSTART- -X- N

IJV NNP Physical
could MD None
be VB None
located VBN None
course NN None
of IN None
the DT None
IJV NNP Physical
number NN Other
of IN Other
punctures NNS Other
incidence NN Adverse
of IN Adverse
complications NNS Adverse
. . None
time NN Other
required VBN Other
to TO Other
locate VB Other
the DT Other
site NN Other
direction NN Other
of IN Other
puncture NN Other
total JJ Other
time NN Other
for IN Other
catheter NN Other
placement NN Other
hematoma NN Adverse
-DOCSTART- -X- N

GH NNP Physical
Significantly NNP Other
lower JJR Other
peak NN Other
and CC Other
area NN Other
under IN Other
the DT Other
curve NN Other
( ( Other
AUC NNP Other
) ) Other
GH NNP Other
concentrations NNS Other
rise NN Physical
in IN Physical
GH NNP Physical
output NN Physical
pituitary JJ Physical
sensitivity NN Physical
and CC Physical
reduced JJ Physical
responsiveness NN Physical
. . Physical
-DOCSTART- -X- N

clinical JJ Physical
, , None
biophysical JJ Physical
, , None
and CC None
echographic JJ Physical
evaluations NNS Physical
efficacy NN Other
, , Other
tolerability NN Other
, , Other
and CC Other
safety NN Other
Dover NNP Other
classification NN Other
scale NN Other
for IN Other
photoaging VBG Other
biophysical JJ Other
and CC Other
ecographic JJ Other
measurements NNS Other
. . None
tactile JJ Other
roughness NN Other
and CC Other
fine JJ Other
lines NNS Other
elasticity NN Other
sebum JJ Other
excretion NN Other
echographic JJ Other
parameters NNS Other
reshaping NN Other
of IN Other
dermal JJ Other
tissue NN Other
. . None
tolerated VBN Other
adverse JJ Adverse
effects NNS Adverse
. . None
-DOCSTART- -X- N

sensitive JJ Other
and CC Other
specific JJ Other
HPLC NNP Other
method NN Other
. . None
Rapid JJ Physical
absorption NN Physical
Cmax NNP Physical
values NNS Physical
significant JJ None
difference NN Physical
rate NN Other
and CC Other
extent NN Other
of IN Other
absorption NN Other
bioavailability NN Other
naproxen JJ Physical
concentration NN Physical
clinically RB Other
different JJ Other
-DOCSTART- -X- N

diphtheria NN Physical
antitoxin NN Physical
levels NNS Physical
diphtheria NN Physical
antitoxin NN Physical
level NN Physical
antitoxin JJ Physical
level NN Physical
diphtheria VBN Physical
antitoxin JJ Physical
level NN Physical
-DOCSTART- -X- N

secondary JJ None
basal NN Physical
and CC Physical
squamous JJ Physical
cell NN Physical
carcinomas NN Physical
of IN Physical
the DT Physical
skin NN Physical
. . None
time NN Physical
to TO Physical
first VB Physical
nonmelanoma JJ Physical
skin NN Physical
cancer NN Physical
diagnosis NN Physical
time NN Physical
to TO Physical
multiple VB Physical
skin JJ Physical
tumors NNS Physical
risk NN Physical
of IN Physical
basal NN Physical
cell NN Physical
carcinoma NN Physical
elevated VBN Physical
risk NN Physical
of IN Physical
squamous JJ Physical
cell NN Physical
carcinoma NN Physical
total JJ Physical
nonmelanoma JJ Physical
skin NN Physical
cancer NN Physical
preventing VBG Physical
basal NN Physical
cell NN Physical
carcinoma NN Physical
risk NN Physical
of IN Physical
squamous JJ Physical
cell NN Physical
carcinoma NN Physical
and CC Physical
total JJ Physical
nonmelanoma NN Physical
skin NN Physical
cancer NN Physical
. . Physical
-DOCSTART- -X- N

climacteric JJ Other
complaints NNS Other
. . Other
clinical JJ Physical
efficacy NN Physical
vasomotor NN Mental
symptoms NNS Mental
endometrium NN Other
biopsies NNS Mental
. . Mental
Irregular JJ Other
uterine JJ Other
bleeding NN Other
clinical JJ Physical
efficacy NN Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
toxicity NN Other
Proven NNP Physical
, , Physical
probable JJ Physical
, , Physical
or CC Physical
possible JJ Physical
fungal JJ Physical
infections NNS Physical
fungal JJ Physical
infection NN Physical
toxicity NN Physical
effective JJ None
toxic JJ Physical
fungal JJ Physical
infections NNS Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

metabolic JJ Physical
control NN Physical
in IN Physical
blood NN Physical
glucose NN Physical
control NN Physical
insulin NN Physical
requirements NNS Physical
Blood NNP Physical
glucose JJ Physical
concentrations NNS Physical
Plasma NNP Physical
C-peptide JJ Physical
and CC Physical
counter-regulatory JJ Physical
hormones NNS Physical
Glycaemia NNP Physical
median JJ Physical
amount NN Physical
of IN Physical
insulin NN Physical
administered VBN Physical
Plasma NNP Physical
catecholamine JJ Physical
concentrations NNS Physical
cortisol JJ Physical
concentrations NNS Physical
. . Physical
blood NN Physical
glucose VB Physical
control NN Physical
insulin NN None
requirements NNS None
-DOCSTART- -X- N

were VBD None
body JJ None
weight NN None
, , None
oestrus NN None
incidences NNS None
, , None
plasma JJ None
oestradiol IN None
17-? JJ None
, , None
plasma JJ None
progesterone NN None
, , None
conception NN None
rate NN None
, , None
gestation NN None
period NN None
, , None
lambing VBG None
rate NN None
, , None
and CC None
birth NN None
weight NN None
of IN None
lambs NN None
. . None
reduced VBN None
body NN Physical
weight NN Physical
, , Physical
oestrus JJ Physical
duration NN Physical
, , Physical
birth NN Physical
weight NN Physical
of IN Physical
lambs NN Physical
, , Physical
and CC Physical
oestradiol JJ Physical
17-? JJ None
whereas NNS None
significantly RB None
( ( None
p JJ None
< NNP None
0.05 CD None
) ) None
increased VBD None
oestrus JJ Other
cycle NN Other
length NN Other
and CC None
progesterone NN Physical
. . None
Furthermore RB None
terms NNS None
of IN None
growth NN None
and CC None
reproduction NN None
to TO None
body NN None
weight NN None
, , None
average JJ Other
daily JJ Other
gain NN Other
, , None
oestradiol JJ None
17-? JJ None
and CC None
progesterone JJ None
concentrations NNS None
. . None
This DT None
-DOCSTART- -X- N

platelet NN Physical
thromboxane NN Physical
formation NN Physical
Stimulated VBN Physical
platelet NN Physical
thromboxane NN Physical
formation NN Physical
plasma NN Physical
levels NNS Physical
of IN Physical
platelet NN Physical
factor NN Physical
4 CD Physical
and CC Physical
aggregation NN Physical
responses NNS Physical
to TO Physical
collagen VB Physical
and CC Physical
ADP NNP Physical
thromboxane NN Physical
formation NN Physical
Exercise NN Physical
induced JJ Physical
change NN Physical
of IN Physical
thromboxane NN Physical
synthesis NN Physical
PF4 NNP Physical
plasma NN Physical
levels NNS Physical
Whole JJ Physical
blood NN Physical
aggregation NN Physical
after IN Physical
collagen NN Physical
stimulation NN Physical
aggregation NN Physical
collagen NN Physical
dependent JJ Physical
platelet NN Physical
activation NN Physical
-DOCSTART- -X- N

mortality NN Mortality
outcome NN Mortality
significant JJ Mortality
mortality NN Mortality
benefit NN Mortality
mortality NN Mortality
; : None
fatal JJ Mortality
cases NNS Mortality
deaths NNS Mortality
mortality NN Mortality
benefit NN Mortality
-DOCSTART- -X- N

resting NN Physical
global JJ Physical
and CC Physical
regional JJ Physical
myocardial JJ Physical
function NN Physical
. . Physical
-DOCSTART- -X- N

p16 NN Physical
( ( Physical
INK4a NNP Physical
) ) Physical
Expression NN Physical
p16 NN Physical
( ( Physical
INK4a NNP Physical
) ) Physical
expression NN Physical
p16 NN Physical
( ( Physical
INK4a NNP Physical
) ) Physical
expression NN Physical
univariate JJ Mortality
survival NN Mortality
( ( Mortality
Cox NNP Mortality
) ) Mortality
analysis NN Mortality
p16 NN Physical
( ( Physical
INK4a NNP Physical
) ) Physical
expression NN Physical
diagnosis NN Physical
of IN Physical
CIN2 NNP Physical
. . None
CIN2 NNP Physical
. . None
-DOCSTART- -X- N

quality NN Mental
of IN Mental
life NN Mental
and CC Mental
back RB Mental
extensor JJ Mental
strength NN Mental
quality NN Mental
of IN Mental
life NN Mental
and CC Mental
back RB Mental
extensor JJ Mental
strength NN Mental
. . Mental
increasing VBG Mental
back RB Mental
extensor NN Mental
strength NN Mental
decreasing VBG Mental
risk NN Mental
of IN Mental
vertebral JJ Mental
fractures NNS Mental
. . Mental
enhance VB Mental
back RB Mental
extensor JJ Mental
strength NN Mental
and CC Mental
improve VB Mental
the DT Mental
quality NN Mental
of IN Mental
life NN Mental
spinal JJ Mental
range NN Mental
of IN Mental
motion NN Mental
Isometric NNP Mental
back RB Mental
extensor NN Mental
strength NN Mental
, , Mental
spinal JJ Mental
range NN Mental
of IN Mental
motion NN Mental
, , Mental
and CC Mental
scores NNS Mental
for IN Mental
quality NN Mental
of IN Mental
life NN Mental
Back NNP Physical
extensor NN Physical
strength NN Physical
significantly RB Physical
increased VBD Physical
Scores NNS Mental
for IN Mental
quality NN Mental
of IN Mental
life NN Mental
increased VBN Mental
quality NN Mental
of IN Mental
life NN Mental
score NN Mental
effective JJ Mental
in IN Mental
improving VBG Mental
the DT Mental
quality NN Mental
of IN Mental
life NN Mental
and CC Mental
back RB Mental
extensor JJ Mental
strength NN Mental
-DOCSTART- -X- N

five CD None
of IN None
seven CD None
primary JJ None
outcome JJ None
measures NNS None
( ( None
parent NN Mental
ratings NNS Mental
and CC None
direct JJ None
child NN None
measures NNS None
) ) None
staff NN Other
ratings NNS Other
parent NN Other
, , Other
child NN Other
and CC Other
staff NN Other
satisfaction NN Other
treatment NN Mental
fidelity NN Mental
. . Mental
-DOCSTART- -X- N

sexual JJ Physical
function NN Physical
sexual JJ Physical
function NN Physical
mean JJ Physical
change NN Physical
from IN Physical
baseline NN Physical
in IN Physical
erectile JJ Physical
function NN Physical
mean JJ Physical
change NN Physical
from IN Physical
baseline NN Physical
in IN Physical
ejaculatory JJ Physical
function NN Physical
erectile JJ Physical
function NN Physical
ejaculatory JJ Physical
function NN Physical
Dizziness NNP Adverse
erectile JJ Physical
function NN Physical
-DOCSTART- -X- N

gaze NN Mental
onto IN Mental
the DT Mental
eye NN Mental
and CC Mental
mouth JJ Mental
regions NNS Mental
of IN Mental
faces VBZ Mental
eye NN Mental
movements NNS Mental
fixation JJ Mental
specificity NN Mental
-DOCSTART- -X- N

efficacy NN Other
score NN Mental
of IN Mental
childhood NN Mental
autism NN Mental
rating NN Mental
scale NN Mental
( ( Mental
CARS NNP Mental
) ) Mental
clinical JJ Other
efficacy NN Other
CARS NNPS Mental
totally RB Other
effective JJ Other
rate NN Other
clinical JJ Other
efficacy NN Other
curative JJ Other
effect NN Other
-DOCSTART- -X- N

symptomatic JJ Other
improvement NN Other
in IN Other
symptomatic JJ Physical
response NN Physical
side NN Adverse
effects NNS Adverse
galactorrhea NN Physical
important JJ Adverse
side NN Adverse
effects NNS Adverse
. . None
symptomatic JJ Other
improvement NN Other
-DOCSTART- -X- N

quality NN Other
of IN Other
life NN Other
Quality NN Other
of IN Other
Life NNP Other
( ( Other
QOL NNP Other
) ) Other
QOL NNP Other
assessment NN Other
physical JJ Mental
and CC Mental
emotional JJ Mental
functioning NN Mental
and CC None
dyspnea NN Physical
appetite NN Physical
QOL NNP Other
QOL NNP Other
-DOCSTART- -X- N

Plasma NNP Physical
level NN Physical
of IN Physical
endotoxin NN Physical
and CC None
all PDT Physical
the DT Physical
cytokines NNS Physical
after IN Physical
CRRT NNP Physical
initiation NN Physical
serial JJ Physical
change NN Physical
of IN Physical
endotoxin NN Physical
, , Physical
IL-1 NNP Physical
beta NN Physical
, , Physical
IL-6 NNP Physical
and CC Physical
IL-8 NNP Physical
plasma JJ Physical
TNF-alpha JJ Physical
levels NNS Physical
-DOCSTART- -X- N

cutaneous JJ Physical
lesions NNS Physical
mean JJ Other
durations NNS Other
resolution NN Physical
of IN Physical
associated JJ Physical
local JJ Physical
and/or NN Physical
systemic NN Physical
symptoms NNS Physical
. . Physical
response NN Other
time NN Other
Lyme NNP Physical
borreliosis NN Physical
; : None
-DOCSTART- -X- N

Back NNP Pain
pain NN Pain
relieving VBG Pain
back RB Pain
pain NN Pain
chronic JJ Pain
low JJ Pain
back RB Pain
pain NN Pain
back-related JJ Physical
dysfunction NN Physical
and CC Physical
symptom NN Physical
bothersomeness NN Physical
. . Physical
physical JJ Physical
measurements NNS Physical
( ( None
e.g. NN None
flexion NN Physical
) ) None
relieve VB Pain
back RB Pain
pain NN Pain
and CC Pain
dysfunction NN Pain
. . Pain
-DOCSTART- -X- N

improve VB Mortality
survival NN Mortality
and CC Physical
reduce VB Physical
local JJ Physical
recurrences NNS Physical
and CC Physical
metastases NNS Physical
survival NN Mortality
rate NN Mortality
lengths NNS Physical
of IN Physical
disease-free JJ Physical
status NN Physical
and CC Physical
survival NN Physical
of IN Physical
patients NNS Physical
highly RB Other
advantageous JJ Other
no DT Other
advantage NN Other
occurrence NN Physical
of IN Physical
lung NN Physical
metastases NNS Physical
. . Physical
-DOCSTART- -X- N

bone NN Physical
flap NN Physical
infection NN Physical
overall JJ Physical
rate NN Physical
of IN Physical
post-operative JJ Physical
deep JJ Physical
wound NN Physical
infections NNS Physical
including VBG Physical
meningitis NN Physical
and CC Physical
abscesses NNS Physical
different JJ None
post-operative JJ Physical
deep JJ Physical
wound NN Physical
infection NN Physical
. . None
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
were VBD None
HIV-free JJ None
infant JJ None
survival NN None
at IN None
months NNS None
; : None
HIV-free NNP None
survival NN None
at IN None
breastfed VBN None
; : None
AIDS-free JJ None
survival NN None
in IN None
serious JJ None
adverse JJ None
events NNS None
in IN None
babies NNS None
. . None
Analysis NN None
cumulative JJ None
rate NN None
of IN None
HIV NNP None
transmission NN None
at IN None
cumulative JJ None
rate NN None
of IN None
HIV NNP None
transmission NN None
or CC None
death NN None
at IN None
12 CD None
the DT None
cumulative JJ None
rate NN None
of IN None
HIV NNP None
transmission NN None
at IN None
( ( None
p=0?02 NN None
) ) None
. . None
AIDS-free JJ None
survival NN None
The DT None
incidence NN None
of IN None
laboratory NN None
and CC None
clinical JJ None
serious JJ None
adverse JJ None
events NNS None
in IN None
both DT None
safe JJ None
and CC None
reduces VBZ None
the DT None
risk NN None
of IN None
HIV NNP None
transmission NN None
to TO None
infants NNS None
. . None
-DOCSTART- -X- N

Clinician JJ Other
and CC Other
patient JJ Other
acceptance NN Other
, , None
feasibility NN Other
, , None
and CC None
technology NN Other
issues NNS Other
feasible JJ Other
, , None
affordable JJ Other
, , None
and CC None
acceptable JJ Other
-DOCSTART- -X- N

the DT None
frequency NN None
of IN None
serious JJ None
adverse JJ None
events NNS None
. . None
Peripheral NNP None
blood NN None
counts NNS None
, , None
CD34 NNP None
( ( None
+ NNP None
) ) None
count NN None
, , None
and CC None
functional JJ None
outcome NN None
assessed VBD None
lesion NN None
volume NN None
, , None
atrophy NN None
, , None
and CC None
the DT None
presence NN None
of IN None
iron-labeled JJ None
CD34 NNP None
( ( None
+ NNP None
) ) None
cells NNS None
with IN None
serious JJ None
adverse JJ None
events NNS None
: : None
G-CSF JJ None
15 CD None
death NN None
or CC None
dependency NN None
( ( None
modified JJ None
the DT None
number NN None
of IN None
injections NNS None
received VBN None
. . None
G-CSF NNP None
increased VBD None
CD34 NNP None
( ( None
+ NNP None
) ) None
and CC None
total JJ None
white JJ None
cell NN None
counts NNS None
of IN None
9.5- CD None
reduction NN None
in IN None
MRI NNP None
ischemic JJ None
lesion NN None
volume NN None
with IN None
labeled VBD None
CD34 NNP None
( ( None
+ NNP None
) ) None
cells NNS None
had VBD None
-DOCSTART- -X- N

subjective JJ Other
workload NN Other
assessment NN Other
technique NN Other
sensitivity NN Other
sensitive JJ Other
conventional JJ Other
SWAT NNP Other
scale NN Other
pretask JJ Other
completion NN Other
time NN Other
-DOCSTART- -X- N

design NN None
. . None
Quantity NN None
of IN None
alcohol NN None
consumed VBN None
per IN None
week NN None
and CC None
heavy JJ Mental
episodic JJ Mental
drinking VBG Mental
one CD Mental
month NN Mental
later RBR Mental
were VBD None
baseline NN None
alcohol NN None
measures NNS None
, , None
hierarchical JJ None
less JJR None
alcohol NN None
use NN None
and CC None
fewer JJR Mental
heavy JJ Mental
drinking NN Mental
episodes NNS Mental
at IN None
about IN None
alcohol NN None
use NN None
and CC None
-DOCSTART- -X- N

plaque NN Physical
index NN Physical
, , Physical
gingival NN Physical
index NN Physical
, , Physical
bleeding VBG Physical
on IN Physical
probing VBG Physical
, , Physical
probing VBG Physical
depth NN Physical
, , Physical
probing VBG Physical
attachment JJ Physical
level NN Physical
and CC Physical
microscopic NN Physical
counts NNS Physical
probing VBG Physical
depth NN Physical
and CC Physical
density NN Physical
of IN Physical
micro-organisms NN Physical
rate NN Physical
of IN Physical
bleeding VBG Physical
on IN Physical
pocket NN Physical
probing NN Physical
probing NN Physical
attachment NN Physical
gain NN Physical
-DOCSTART- -X- N

cognitive-behavioral JJ Mental
therapy NN Mental
with IN None
children NNS Mental
's POS Mental
anxiety NN Mental
symptoms NNS Mental
higher JJR None
level NN None
of IN None
anxiety NN None
lower JJR None
anxiety NN None
-DOCSTART- -X- N

provide VB Mental
correct JJ Mental
justifications NNS Mental
of IN Mental
the DT Mental
speaker NN Mental
's POS Mental
behavior NN Mental
mistaken JJ Mental
belief NN Mental
and CC Mental
of IN Mental
the DT Mental
resulting JJ Mental
emotional JJ Mental
impact NN Mental
-DOCSTART- -X- N

Blood NNP Physical
and CC Physical
sputum NN Physical
eosinophils NNS Physical
and CC Physical
serum NN Physical
levels NNS Physical
of IN Physical
eosinophil NN Physical
cationic JJ Physical
protein NN Physical
( ( Physical
ECP NNP Physical
) ) Physical
and CC Physical
intercellular JJ Physical
adhesion NN Physical
molecule-1 NN Physical
( ( Physical
ICAM-1 NNP Physical
) ) Physical
FEV1 NNP Physical
and CC Physical
Mth-PD20 NNP Physical
Mth-DRS NNP Physical
. . None
number NN Physical
of IN Physical
patients NNS Physical
presenting VBG Physical
a DT Physical
level NN Physical
of IN Physical
plateau NN Physical
serum NN Physical
ECP NNP Physical
levels NNS Physical
Mth-DRS NNP Physical
values NNS Physical
, , Physical
sputum NN Physical
eosinophils NNS Physical
and CC Physical
serum VB Physical
ECP NNP Physical
levels NNS Physical
-DOCSTART- -X- N

effectiveness NN Other
, , None
side NN Adverse
effects NNS Adverse
and CC None
tolerance NN Physical
between IN Physical
calcium NN Physical
acetate NN Physical
( ( Physical
CA NNP Physical
) ) Physical
and CC Physical
calcium NN Physical
carbonate NN Physical
( ( Physical
CC NNP Physical
) ) Physical
calcium NN Physical
corrected VBD Physical
to TO Physical
total JJ Physical
protein NN Physical
, , Physical
P NNP Physical
, , Physical
PTH NNP Physical
( ( Physical
intact JJ Physical
molecule NN Physical
) ) Physical
and CC Physical
bicarbonate NN Physical
. . None
CA NNP Other
was VBD Other
poorly RB Other
tolerated VBN Other
changes NNS Physical
in IN Physical
serum NN Physical
P NNP Physical
levels NNS Physical
Serum NNP Physical
calcium NN Physical
-DOCSTART- -X- N

uterine JJ Physical
leiomyoma NN Physical
size NN Physical
and CC Physical
symptoms NNS Physical
Mean NNP Physical
uterine JJ Physical
volume NN Physical
shrank NN Physical
Leiomyoma-related JJ Physical
symptoms NNS Physical
Amenorrhea NNP Physical
Hemoglobin NNP Physical
levels NNS Physical
hot JJ Physical
flashes NNS Physical
Simple NNP Physical
endometrial JJ Physical
hyperplasia NN Physical
atypical JJ Physical
hyperplasia NN Physical
leiomyoma NN Physical
regression NN Physical
, , None
improvement NN Other
in IN Other
symptoms NNS Other
, , None
and CC None
few JJ Adverse
side NN Adverse
effects NNS Adverse
. . None
-DOCSTART- -X- N

heart NN Physical
rate NN Physical
, , Physical
respiration NN Physical
rate NN Physical
, , Physical
blood NN Physical
pressure NN Physical
, , Physical
and CC Physical
transcutaneous JJ Physical
oxygen NN Physical
saturation NN Physical
. . Physical
Subjective JJ Physical
assessment NN Physical
of IN Physical
the DT Physical
infant NN Physical
's POS Physical
cry NN Physical
intensity NN Physical
and CC Physical
corneal NN Physical
haze NN Physical
-DOCSTART- -X- N

parental JJ Mental
satisfaction NN Mental
and CC Mental
conflict NN Mental
about RB Mental
parenting VBG Mental
sleeper JJ Mental
effect NN Mental
for IN Mental
parental JJ Mental
efficacy NN Mental
. . None
-DOCSTART- -X- N

Roles NNS None
of IN None
adapalene NN None
irritation NN Adverse
efficacy NN Other
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

disability NN Physical
Distance NNP Physical
walked VBD Physical
in IN Physical
6 CD Physical
minutes NNS Physical
and CC Physical
sum NN Physical
of IN Physical
the DT Physical
function NN Physical
, , None
pain NN Pain
, , None
and CC None
stiffness JJ Physical
subscores NNS Physical
of IN Physical
the DT Physical
Western NNP Physical
Ontario NNP Physical
and CC Physical
McMaster NNP Physical
Universities NNP Physical
Osteoarthritis NNP Physical
Index NNP Physical
( ( Physical
WOMAC NNP Physical
) ) Physical
. . None
6-minute JJ Physical
walk NN Physical
distance NN Physical
and CC None
WOMAC NNP Physical
score NN Physical
6-minute JJ Physical
walk NN Physical
distances NNS Physical
WOMAC NNP Physical
scores NNS Physical
distance NN Physical
walked VBD Physical
in IN Physical
6 CD Physical
minutes NNS Physical
WOMAC JJ Physical
scores NNS Physical
baseline JJ Physical
WOMAC NNP Physical
scores NNS Physical
and CC None
walking VBG Physical
distance NN Physical
; : None
knee NN Physical
arthroplasty NN Physical
. . None
functional JJ Other
benefits NNS Other
surgical JJ Other
intervention NN Other
. . None
-DOCSTART- -X- N

cognitive JJ Physical
impairment NN Physical
significant JJ Physical
cognitive JJ Physical
impairment NN Physical
Computerized NNP Mental
Neuropsychological NNP Mental
Test NNP Mental
Battery NNP Mental
( ( Mental
CNTB NNP Mental
) ) Mental
decreased VBN Physical
salivation NN Physical
and CC Physical
heart NN Physical
rate NN Physical
. . None
effect NN Physical
on IN Physical
CNTB NNP Mental
scores NNS Mental
, , None
increased VBN Physical
salivation NN Physical
, , None
and CC None
increased VBD Physical
heart NN Physical
rate NN Physical
. . None
cholinomimetic JJ Physical
effects NNS Physical
changes NNS Mental
in IN Mental
CNTB NNP Mental
scores NNS Mental
, , None
heart NN Physical
rate NN Physical
, , None
and CC None
salivation NN Physical
cholinomimetic JJ Physical
activity NN Physical
muscarinic JJ Physical
effects NNS Physical
-DOCSTART- -X- N

American NNP Physical
Urological NNP Physical
Association NNP Physical
symptom VBD Physical
score RB Physical
, , None
peak JJ Physical
urine JJ Physical
flow NN Physical
rate NN Physical
prostate NN Physical
specific JJ Physical
antigen NN Physical
( ( Physical
PSA NNP Physical
) ) Physical
-DOCSTART- -X- N

satisfaction NN Other
rate NN Other
, , None
efficacy NN Other
complication NN Adverse
rate NN Adverse
Quality NN Other
of IN Other
the DT Other
visualization NN Other
of IN Other
the DT Other
uterine JJ Other
cavity NN Other
, , None
procedure NN Other
time NN Other
, , None
complications NNS Adverse
, , None
patient JJ Other
discomfort NN Other
, , None
and CC None
satisfaction NN Other
rate NN Other
. . None
abdominal NN Pain
and CC Pain
shoulder NN Pain
tip NN Pain
pain NN Pain
vasovagal JJ Physical
reactions NNS Physical
higher JJR Other
satisfaction NN Other
rate NN Other
and CC None
a DT None
lower JJR Other
operative JJ Other
time NN Other
-DOCSTART- -X- N

motor NN Physical
skills NNS Physical
. . Physical
effective JJ Other
intervention NN Other
-DOCSTART- -X- N

AIDS-defining JJ Physical
event NN Physical
, , None
death NN Mortality
, , None
or CC None
CD4 NNP Physical
cell VBP Physical
count NN Physical
decline NN Physical
change NN Physical
in IN Physical
CD4 NNP Physical
cell NN Physical
count NN Physical
hazard NN Other
ratios NNS Other
( ( None
HRs NNP None
) ) None
AIDS NNP Mortality
or CC Mortality
death NN Mortality
, , None
for IN None
death NN Mortality
, , None
and CC None
for IN None
virological JJ Physical
failure NN Physical
Mean JJ Physical
change NN Physical
in IN Physical
CD4 NNP Physical
cell NN Physical
count NN Physical
HRs NNP Other
AIDS NNP Mortality
or CC Mortality
death NN Mortality
and CC None
virological JJ Physical
failure NN Physical
HRs NNP Other
AIDS NNP Mortality
or CC Mortality
death NN Mortality
discontinue VB Other
treatment NN Other
toxic NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

clinical JJ Other
efficacy NN Other
pregnancy NN Physical
rate NN Physical
Chinese JJ Physical
medicine NN Physical
syndrome NN Physical
integrals NNS Physical
, , Physical
serum JJ Physical
endometrium NN Physical
antibody NN Physical
( ( Physical
EMAb NNP Physical
) ) Physical
and CC Physical
cancer NN Physical
antigen NN Physical
125 CD Physical
( ( Physical
CA125 NNP Physical
) ) Physical
levels NNS Physical
pregnancy NN Physical
rate NN Physical
Chinese JJ Physical
medicine NN Physical
syndrome JJ Physical
integral NN Physical
Chinese JJ Physical
medicine NN Physical
syndrome JJ Physical
integral JJ Physical
serum NN Physical
EMAb NNP Physical
serum NN Physical
CA125 NNP Physical
level NN Physical
blood NN Physical
stasis NN Physical
toxin NN Physical
accumulation NN Physical
syndrome NN Physical
negative JJ Physical
conversion NN Physical
of IN Physical
EMAb NNP Physical
serum NN Physical
CA125 NNP Physical
levels NNS Physical
clinical JJ Physical
pregnancy NN Physical
rate NN Physical
-DOCSTART- -X- N

Safety NN Other
, , Other
tolerability NN Other
, , Other
and CC Other
immunogenicity NN Other
immunity NN None
and CC None
safety NN None
profiles NNS None
was VBD None
VZV NNP None
interferon-gamma JJ None
( ( None
IFN-? NNP None
) ) None
enzyme-linked JJ None
immunospot NN None
( ( None
ELISPOT NNP None
) ) None
assay NN None
and CC None
VZV NNP None
glycoprotein VBD None
enzyme-linked JJ None
immunosorbent NN None
antibody NN None
( ( None
gpELISA NN None
) ) None
assay NN None
experiences NNS None
( ( None
AEs NNP None
) ) None
vaccine-related JJ None
AEs NNP None
VZV NNP None
ELISPOT NNP None
geometric JJ None
mean NN None
count NN None
( ( None
GMC NNP None
) ) None
of IN None
spot-forming JJ None
cells NNS None
per IN None
10 CD None
( ( None
6 CD None
) ) None
peripheral JJ None
blood NN None
mononuclear JJ None
cells NNS None
GMC NNP None
ELISPOT NNP None
response NN None
geometric JJ None
mean NN None
titers NNS None
( ( None
GMTs NNP None
) ) None
IFN-? NNP None
ELISPOT NNP None
and CC None
gpELISA NN None
assays NNS None
safe JJ None
immunity NN None
-DOCSTART- -X- N

efficacy NN Other
Z NNP Physical
scores NNS Physical
bone NN Physical
alkaline NN Physical
phosphatase NN Physical
( ( Physical
B-ALP NNP Physical
) ) Physical
and CC None
osteocalcin $ Physical
( ( Physical
OC NNP Physical
) ) Physical
. . None
imbalance NN Physical
in IN Physical
bone NN Physical
remodeling VBG Physical
high JJ Physical
bone NN Physical
resorption NN Physical
. . None
Bone NNP Physical
mineral JJ Physical
density NN Physical
( ( Physical
BMD NNP Physical
) ) Physical
changes NNS Physical
in IN Physical
BMD NNP Physical
lumbar NN Physical
spine NN Physical
and CC None
the DT None
femoral JJ Physical
neck NN Physical
Biochemical JJ Physical
markers NNS Physical
except IN None
urinary JJ Physical
calcium NN Physical
and CC Physical
hydroxyproline NN Physical
BMD NNP Physical
changes NNS Physical
at IN Physical
the DT Physical
lumbar NN Physical
spine NN Physical
. . None
positive JJ Physical
spine NN Physical
BMD NNP Physical
changes NNS Physical
bone RB Physical
biochemical JJ Physical
markers NNS Physical
association NN Physical
of IN Physical
B-ALP NNP Physical
and CC Physical
D-Pyr NNP Physical
BMD NNP Physical
variance NN Physical
association NN None
of IN Physical
B-ALP NNP Physical
, , None
PTH NNP Physical
, , None
and CC None
estradiol RB Physical
biochemical JJ Other
bone NN Other
markers NNS Other
bone NN Physical
effect NN Physical
increase NN None
-DOCSTART- -X- N

exercise NN Mental
capacity NN Mental
, , None
measuring VBG Mental
distance NN Mental
walked VBD Mental
on IN Mental
a DT Mental
6-min JJ Mental
walking NN Mental
test NN Mental
time NN Mental
taken VBN Mental
to TO Mental
climb VB Mental
two CD Mental
flights NNS Mental
of IN Mental
stairs NNS Mental
; : Physical
symptoms NNS Physical
activity NN Other
of IN Other
daily JJ Other
living NN Other
questionnaire NN Other
Mean JJ Mental
distance NN Mental
walked VBD Mental
No DT Other
significant JJ Other
difference NN Other
ability NN Physical
to TO Physical
climb VB Physical
stairs NNS Physical
marked JJ Other
improvement NN Other
symptomatic JJ Other
questionnaire NN Other
score NN Other
physiological JJ Physical
pacing VBG Physical
Physiological JJ Physical
pacing NN Physical
increase NN Other
exercise NN Mental
tolerance NN Mental
improves VBZ Physical
symptoms NNS Physical
; : None
-DOCSTART- -X- N

efficacies NNS Other
( ( Physical
13 CD Physical
) ) Physical
C NNP Physical
urea JJ Physical
breath NN Physical
adverse JJ Adverse
events NNS Adverse
eradication NN Other
rate NN Other
-DOCSTART- -X- N

postgraduate JJ Other
year NN Other
( ( Other
PGY NNP Other
) ) Other
according VBG None
to TO None
operative JJ Other
time NN Other
, , None
technical JJ Mental
skills NNS Mental
23-step JJ Other
objective NN Other
structured VBD Other
tool NN Other
, , Other
and CC Other
error NN Other
rate NN Other
. . Other
technical JJ Other
skills NNS Other
and CC Other
error NN Other
rate NN Other
. . Other
technical JJ Other
skills NNS Other
, , Other
with IN Other
no DT Other
difference NN Other
in IN Other
error NN Other
rate NN Other
. . Other
operative JJ Other
time NN Other
technical JJ Other
skills NNS Other
error NN Other
rate NN Other
relevant JJ Other
and CC Other
accurate JJ Other
objective JJ Other
assessment NN Other
operative JJ Other
skills NNS Other
and CC Other
improvement NN Other
-DOCSTART- -X- N

body NN Physical
mass NN Physical
index NN Physical
Lean JJ Physical
body NN Physical
mass NN Physical
( ( Physical
LBM NNP Physical
) ) Physical
and CC None
body NN Physical
fat NN Physical
( ( Physical
BF NNP Physical
) ) Physical
serum JJ Physical
IGF-I NNP Physical
, , None
LBM NNP Physical
, , None
and CC None
TBW NNP Physical
BF NNP Physical
serum JJ Physical
GHBP NNP Physical
BF NNP Physical
baseline JJ Physical
GHBP NNP Physical
level NN Physical
GH-induced JJ Physical
increment NN Physical
in IN Physical
IGF-I NNP Physical
and CC Physical
TBW NNP Physical
BF NNP Physical
-DOCSTART- -X- N

expressive JJ Mental
language NN Mental
, , None
behaviour NN Mental
and CC None
other JJ Mental
symptoms NNS Mental
Global NNP Other
Behaviour NNP Other
Rating NNP Other
Scales NNP Other
, , None
Additional NNP Physical
Rating NNP Physical
Scales NNP Physical
of IN Physical
other JJ Physical
symptoms NNS Physical
by IN Physical
parents NNS Physical
and CC Physical
therapists NNS Physical
monthly JJ Other
completion NN Other
of IN Other
the DT Other
Rescorla NNP Other
Language NNP Other
Development NNP Other
Survey NNP Other
. . None
significant JJ Physical
improvement NN Physical
in IN Physical
behaviour NN Physical
, , None
food NN Physical
variety NN Physical
, , None
gastrointestinal JJ Physical
symptoms NNS Physical
, , None
sleep JJ Physical
quality NN Physical
, , None
engagement NN Other
with IN Other
therapist NN Other
, , None
or CC None
the DT Other
Language NNP Other
Development NNP Other
Survey NNP Other
Vocabulary NNP Other
or CC Other
Sentence NNP Other
Complexity NNP Other
Scores NNP Other
. . None
significant JJ Other
improvement NN Other
autism NN Physical
symptoms NNS Physical
improvement NN Mental
in IN Mental
food NN Mental
variety NN Mental
-DOCSTART- -X- N

frequency NN Physical
and CC Physical
severity NN Physical
of IN Physical
variable JJ Physical
decelerations NNS Physical
in IN Physical
the DT Physical
first JJ Physical
stage NN Physical
of IN Physical
labor NN Physical
newborn JJ Physical
serum NN Physical
electrolyte NN Physical
levels NNS Physical
mean JJ Physical
umbilical JJ Physical
arterial NN Physical
and CC Physical
venous JJ Physical
pH NN Physical
significant JJ Other
decrease NN Other
cesarean JJ Physical
delivery NN Physical
for IN Physical
fetal JJ Physical
distress NN Physical
heart NN Physical
rate NN Physical
decelerations NNS Physical
-DOCSTART- -X- N

EEG NNP Physical
seizure NN Physical
morphology NN Physical
heart NN Physical
rate NN Physical
and CC Physical
blood NN Physical
pressure NN Physical
seizure NN Physical
morphology NN Physical
. . Physical
duration NN Physical
of IN Physical
motor NN Physical
convulsion NN Physical
, , Physical
duration NN Physical
of IN Physical
electroencephalogram NN Physical
( ( Physical
EEG NNP Physical
) ) Physical
seizure NN Physical
, , Physical
degree NN Physical
of IN Physical
seizure NN Physical
regularity NN Physical
, , Physical
and CC Physical
degree NN Physical
of IN Physical
postictal JJ Physical
EEG NNP Physical
suppression NN Physical
. . Physical
quality NN Physical
of IN Physical
the DT Physical
ictal JJ Physical
regularity NN Physical
. . Physical
ictal JJ None
regularity NN None
. . None
-DOCSTART- -X- N

Onset NNP Physical
time NN Physical
of IN Physical
anesthetic JJ Physical
action NN Physical
, , Physical
duration NN Physical
of IN Physical
anesthesia NN Physical
, , Physical
time NN Physical
until IN Physical
first JJ Physical
postoperative JJ Physical
requirement NN Physical
for IN Physical
pain NN Physical
medication NN Physical
, , Physical
and CC Physical
digital-brachial JJ Physical
artery NN Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
index NN Physical
Local JJ Adverse
vascular JJ Adverse
effects NNS Adverse
side JJ Adverse
effects NNS Adverse
onset NN Physical
of IN Physical
anesthesia NN Physical
mean JJ Physical
onset NN Physical
time NN Physical
mean JJ Other
duration NN Other
of IN Other
postoperative JJ Other
anesthesia NN Other
digital-brachial JJ Physical
artery NN Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
index NN Physical
effectively RB Other
-DOCSTART- -X- N

ST NNP Mental
segment NN Mental
depression NN Mental
Treadmill NNP Other
exercise NN Other
tests NNS Other
72-hour JJ Other
electrocardiographic JJ Other
recordings NNS Other
Episodes NNS Mental
of IN Mental
asymptomatic JJ Mental
ST NNP Mental
depression NN Mental
cumulative JJ Physical
duration NN Physical
circadian JJ Physical
variation NN Physical
ischemic JJ Physical
type NN Physical
ST NNP Physical
segment NN Physical
depression NN Physical
changes NNS Physical
in IN Physical
heart NN Physical
rate NN Physical
exercise NN Physical
test NN Physical
end NN Physical
points NNS Physical
Time NN Physical
to TO Physical
ST NNP Physical
segment NN Physical
depression NN Physical
exercise-induced JJ Physical
ST NNP Physical
depression NN Physical
ischemic JJ Mental
type NN Mental
ST NNP Mental
depression NN Mental
-DOCSTART- -X- N

Incidence NN Physical
of IN Physical
puberty NN Physical
puberty NN Other
. . None
weight NN Physical
heavier JJR Physical
puberty NN None
weight NN Physical
gains NNS Physical
Pubertal JJ Physical
BW NNP Physical
incidence NN Physical
of IN Physical
puberty NN Physical
puberty NN Physical
incidence NN Physical
of IN Physical
puberty NN Physical
-DOCSTART- -X- N

surgical JJ Physical
wound NN Physical
infection NN Physical
( ( Physical
SWI NNP Physical
) ) Physical
SWI NNP Physical
incidence NN Physical
of IN Physical
wound JJ Physical
infection NN Physical
incidence NN Physical
of IN Physical
enterococcal JJ Physical
infections NNS Physical
SWI NNP Physical
rate NN Physical
enterococcal JJ Physical
and CC Physical
Bacteroides NNP Physical
coverage NN Physical
. . Physical
-DOCSTART- -X- N

benefit/disadvantage NN Other
effectiveness NN Other
hematopoietic JJ Physical
recovery NN Physical
survived VBD Mortality
median JJ Physical
numbers NNS Physical
of IN Physical
transfused JJ Physical
mononuclear JJ Physical
cells NNS Physical
( ( Physical
MNC NNP Physical
) ) Physical
, , Physical
CD34 NNP Physical
( ( Physical
+ NNP Physical
) ) Physical
cells NNS Physical
, , Physical
and CC Physical
CFU-GM NNP Physical
time NN Other
to TO Other
achieve VB Other
an DT Other
absolute JJ Other
neutrophil NN Other
count NN Other
( ( Other
ANC NNP Other
) ) Other
of IN Other
> $ Other
0.5 CD Other
x $ Other
10 CD Other
( ( Other
9 CD Other
) ) Other
/L NN Other
duration NN Other
of IN Other
febrile JJ Other
days NNS Other
platelet JJ Other
recovery NN Other
to TO Other
> VB Other
20 CD Other
x JJ Other
10 CD Other
( ( Other
9 CD Other
) ) Other
/L NN Other
platelet JJ Other
transfusion-dependent JJ Other
days NNS Other
engraftment JJ Physical
kinetics NNS Physical
recovery NN Physical
of IN Physical
granulocytes NNS Physical
recovery NN Physical
of IN Physical
platelets NNS Physical
. . Physical
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
proportion NN Physical
of IN Physical
eyes NNS Physical
with IN Physical
complete JJ Physical
resolution NN Physical
of IN Physical
SRF NNP Physical
mean NN Physical
changes NNS Physical
in IN Physical
logarithm NN Physical
of IN Physical
the DT Physical
minimum JJ Physical
angle NN Physical
of IN Physical
resolution NN Physical
best-corrected JJ Physical
visual JJ Physical
acuity NN Physical
( ( Physical
BCVA NNP Physical
) ) Physical
, , Physical
central JJ Physical
retinal JJ Physical
thickness NN Physical
( ( Physical
CRT NNP Physical
) ) Physical
angiographic JJ Physical
findings NNS Physical
resolution NN Physical
of IN Physical
SRF NNP Physical
without IN Physical
rescue NN Physical
treatment NN Physical
mean JJ Physical
decrease NN Physical
in IN Physical
CRT NNP Physical
improvement NN Physical
in IN Physical
BCVA NNP Physical
choroidal JJ Physical
hyperpermeability NN Physical
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

improved JJ Mental
memory NN Mental
performance NN Mental
-DOCSTART- -X- N

overall JJ Mortality
survival NN Mortality
( ( Mortality
OS NNP Mortality
) ) Mortality
; : Mortality
time NN Mortality
from IN Mortality
first JJ Mortality
progression NN Mortality
to TO Mortality
death NN Mortality
( ( Mortality
TFPTD NNP Mortality
) ) Mortality
and CC None
tolerability NN Mortality
. . None
response NN Mortality
rate NN Mortality
, , None
median JJ Mortality
OS NNP Mortality
and CC None
median JJ Mortality
TFPTD NNP Mortality
TFPTD NNP Mortality
; : None
Toxicity NN Adverse
OS NNP Mortality
TFPTD NNP Mortality
. . None
-DOCSTART- -X- N

fever NN Physical
clearance NN Physical
times NNS Physical
treatment NN Other
failures NNS Other
acute NN Other
treatment NN Other
failure NN Other
-DOCSTART- -X- N

alone RB None
. . None
Probing VBG None
bone NN None
levels NNS None
( ( None
PBL NNP None
) ) None
from IN None
and CC None
probing VBG None
pocket NN None
depths NNS None
( ( None
PPD NNP None
) ) None
were VBD None
groups NNS None
. . None
Healing NNP None
was VBD None
mean JJ None
PPD NNP None
from IN None
in IN None
PBL NNP None
PPD NNP None
PBL NNP None
gain NN None
PPD NNP None
reduction NN None
and CC None
PBL NNP None
gain NN None
( ( None
p JJ None
-DOCSTART- -X- N

recurrence NN Physical
of IN Physical
colorectal JJ Physical
adenomas NN Physical
. . None
development NN Physical
of IN Physical
recurrent NN Physical
colorectal NN Physical
adenomas NN Physical
one CD Physical
recurrent NN Physical
adenoma NN Physical
; : None
unadjusted JJ Physical
risk NN Physical
ratio NN Physical
mean NN Physical
( ( Physical
+/-SE JJ Physical
) ) Physical
number NN Physical
of IN Physical
such JJ Physical
lesions NNS Physical
rate NN Physical
of IN Physical
recurrence NN Physical
of IN Physical
large JJ Physical
adenomas NNS Physical
advanced JJ Physical
adenomas NN Physical
risk NN Physical
of IN Physical
recurrence NN Physical
-DOCSTART- -X- N

Postoperative JJ Other
morphine NN Other
consumption NN Other
Visual JJ Pain
analogue NN Pain
pain NN Pain
scores NNS Pain
-DOCSTART- -X- N

chronic NN Physical
, , Physical
stroke-related JJ Physical
upper-extremity NN Physical
( ( Physical
UE NNP Physical
) ) Physical
UE NNP Physical
Fugl-Meyer NNP Physical
Assessment NNP Physical
( ( Physical
FMA NNP Physical
) ) Physical
mean VBP Physical
change NN Physical
modest JJ Other
gains NNS Other
in IN Other
the DT Other
FMA NNP Physical
response NN None
( ( None
CONCLUSIONS NNP None
Chronic NNP None
UE NNP None
deficits NNS None
are VBP None
responsive JJ None
was VBD None
not RB None
superior JJ None
to TO None
training VBG None
-DOCSTART- -X- N

Blood NNP Physical
pressure NN Physical
glucose JJ Physical
infusion NN Physical
rate NN Physical
( ( Physical
GIR NNP Physical
) ) Physical
, , None
muscle FW Physical
sympathetic JJ Physical
nerve NN Physical
activity NN Physical
( ( Physical
MSA NNP Physical
) ) Physical
and CC None
renal JJ Physical
and CC Physical
total JJ Physical
body NN Physical
norepinephrine NN Physical
( ( Physical
NE NNP Physical
) ) Physical
kinetics NNS Physical
( ( Physical
radioisotope VB Physical
dilution NN Physical
) ) Physical
Fasting VBG Physical
insulin NN Physical
Resting VBG Physical
MSA NNP Physical
, , None
total JJ Physical
body NN Physical
and CC Physical
right JJ Physical
renal NN Physical
NE NNP Physical
spillover NN Physical
Systolic NNP Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressures NNS Physical
blood NN Physical
pressure NN Physical
or CC None
sympathetic JJ Physical
activity NN Physical
-DOCSTART- -X- N

Pulsatile NNP Physical
insulin NN Physical
delivery NN Physical
plasma VB Physical
C-peptide NNP Physical
and CC None
glucagon NN Physical
levels NNS Physical
basal NN Physical
plasma NN Physical
glucagon NN Physical
and CC None
C-peptide JJ Physical
levels NNS Physical
arginine-induced JJ Physical
glucagon NN Physical
response NN Physical
. . None
basal NN Physical
or CC Physical
arginine-stimulated JJ Physical
glucagon NN Physical
response NN Physical
. . None
arginine-induced JJ Physical
glucagon NN Physical
release NN Physical
physiological JJ Physical
modulator NN Physical
of IN Physical
islet NN Physical
A- NNP Physical
and CC Physical
B-cell NNP Physical
function NN Physical
. . None
pulsatile NN Physical
physiological JJ Physical
release NN Physical
of IN Physical
insulin NN Physical
. . None
-DOCSTART- -X- N

haemato-immunological JJ Physical
responses NNS Physical
hemato-immunological JJ Physical
parameters NNS Physical
terms NNS None
of IN None
growth NN None
and CC None
improvement NN None
in IN None
weight JJ None
gain NN None
percentage NN None
was VBD None
observed VBN None
. . None
Erythrocyte NNP None
( ( None
RBC NNP None
) ) None
count NN None
, , None
leucocyte NN None
( ( None
WBC NNP None
) ) None
count NN None
, , None
haemoglobin NN None
content NN None
and CC None
respiratory JJ None
burst NN None
activity NN None
were VBD None
, , None
serum JJ Physical
albumin NN Physical
, , Physical
globulin NN Physical
and CC Physical
lysozyme JJ Physical
activity NN Physical
were VBD None
haemato-immunological JJ None
-DOCSTART- -X- N

perinatal NN Mortality
survival NN Mortality
. . Mortality
neonatal JJ Mortality
death NN Mortality
deaths NNS Mortality
management NN Other
of IN Other
intrapartum-related JJ Other
neonatal JJ Other
hypoxia NN Other
health NN Other
workers NNS Other
performance NN Other
intrapartum NN Mortality
outcome NN Mortality
and CC Mortality
early JJ Mortality
neonatal JJ Mortality
survival NN Mortality
. . Mortality
-DOCSTART- -X- N

20-item JJ Mental
Toronto NNP Mental
Alexithymia NNP Mental
Scale NNP Mental
, , Mental
the DT Mental
Coping NNP Mental
Inventory NNP Mental
for IN Mental
Stressful NNP Mental
Situations NNP Mental
, , Mental
the DT Mental
Motion NNP Mental
Picture NNP Mental
Mind-Reading NNP Mental
task NN Mental
, , Mental
and CC Mental
an DT Mental
ASD NNP Mental
questionnaire NN Mental
. . Mental
Center NNP Mental
for IN Mental
Epidemiological NNP Mental
Studies NNPS Mental
Depression NNP Mental
Scale NNP Mental
, , Mental
the DT Mental
World NNP Mental
Health NNP Mental
Organization NNP Mental
Quality NNP Mental
of IN Mental
Life NNP Mental
Scale NNP Mental
26-item JJ Mental
version NN Mental
, , Mental
the DT Mental
Global NNP Mental
Assessment NNP Mental
of IN Mental
Functioning NNP Mental
, , Mental
State-trait NNP Mental
Anxiety NNP Mental
Inventory NNP Mental
, , Mental
Social NNP Mental
Phobia NNP Mental
and CC Mental
Anxiety NNP Mental
Inventory NNP Mental
, , Mental
and CC Mental
Liebowitz NNP Mental
Social NNP Mental
Anxiety NNP Mental
Scale NNP Mental
. . Mental
-DOCSTART- -X- N

pain NN Pain
relief NN Pain
Maternal JJ Physical
vital JJ Physical
parameters NNS Physical
Analgesia NNP Pain
sedation NN Physical
maternal JJ Physical
vital JJ Physical
parameters NNS Physical
, , Physical
fetal JJ Physical
heart NN Physical
rate NN Physical
( ( Physical
FHR NNP Physical
) ) Physical
or CC Physical
Apgar NNP Physical
scores NNS Physical
Analgesia NNP None
Additional JJ Pain
analgesic JJ Pain
requirement NN Pain
satisfactory JJ Pain
analgesia NN Pain
duration NN Other
-DOCSTART- -X- N

home NN Physical
readiness NN Physical
PONV NNP Physical
postoperative JJ Physical
antiemetic JJ Physical
requirements NNS Physical
Postoperative JJ Physical
sedation NN Physical
, , Physical
analgesic JJ Physical
requirements NNS Physical
, , Physical
and CC Physical
psychomotor NN Physical
recovery NN Physical
propofol-like JJ Physical
recovery NN Physical
profile NN Physical
-DOCSTART- -X- N

clinical JJ Physical
and CC Physical
radiographic JJ Other
performance NN Other
Thereafter NNP None
, , None
clinical JJ None
and CC None
radiographic JJ None
data NNS None
were VBD None
RESULTS NNP None
None NN None
of IN None
were VBD None
found VBN None
loose RB None
during IN None
100 CD None
% NN None
) ) None
. . None
Few JJ None
clinical JJ None
problems NNS None
were VBD None
the DT None
overall JJ None
average JJ None
marginal JJ None
bone NN None
loss NN None
was VBD None
crowns NNS None
, , None
no DT None
significant JJ None
differences NNS None
were VBD None
more JJR None
bone JJ None
loss NN None
as IN None
obvious JJ None
clinical JJ None
or CC None
radiographic JJ None
differences NNS None
between IN None
loose JJ None
abutment JJ None
screws NNS None
and/or VBP None
fistulas NNS None
during IN None
-DOCSTART- -X- N

Multiple JJ Physical
sclerosis NN Physical
risk NN Physical
risk NN Physical
of IN Physical
developing VBG Physical
multiple JJ Physical
sclerosis NN Physical
( ( Physical
MS NNP Physical
) ) Physical
Development NNP Physical
of IN Physical
MS NNP Physical
and CC Mental
neurologic JJ Physical
disability NN Physical
assessment NN Physical
. . Mental
cumulative JJ Physical
probability NN Physical
of IN Physical
developing VBG Physical
MS NNP Physical
by IN Physical
15 CD Physical
years NNS Physical
after IN Physical
onset NN Physical
of IN Physical
optic JJ Physical
neuritis NN Physical
MS NNP Physical
risk NN Physical
of IN Physical
developing VBG Physical
MS NNP Physical
risk NN Physical
for IN Physical
MS NNP Physical
the DT Physical
15-year JJ Physical
risk NN Physical
of IN Physical
MS NNP Physical
. . None
developing VBG Physical
MS NNP Physical
. . None
MS NNP Physical
-DOCSTART- -X- N

repetitive JJ Mental
behaviors NNS Mental
and CC None
growth NN Physical
hormone NN Physical
response NN Physical
specific JJ Physical
neurobiological JJ Physical
markers NNS Physical
core VB Physical
symptomatology NN Physical
. . None
growth NN Physical
hormone NN Physical
response NN Physical
linked VBD Physical
this DT Physical
measure NN Physical
of IN Physical
serotonergic JJ Physical
function NN Physical
the DT Mental
severity NN Mental
of IN Mental
severity NN Mental
of IN Mental
repetitive JJ Mental
behaviors NNS Mental
at IN Mental
baseline NN Mental
measured VBN None
by IN None
YBOCS-compulsion NNP Mental
score NN Mental
, , None
significantly RB None
positively RB None
correlated VBN None
peak JJ Physical
delta NN Physical
growth NN Physical
hormone NN Physical
response NN Physical
and CC None
area NN Physical
under IN Physical
the DT Physical
curve NN Physical
growth NN Physical
hormone NN Physical
response NN Physical
severity NN Mental
of IN Mental
a DT Mental
specific JJ Mental
behavioral JJ Mental
dimension NN Mental
( ( Mental
repetitive JJ Mental
behaviors NNS Mental
) ) Mental
parallels VBP Mental
the DT Mental
sensitivity NN Mental
sumatriptan NN Physical
elicited VBN Physical
GH NNP Physical
response NN Physical
. . None
-DOCSTART- -X- N

nephrotoxicity NN Physical
Ototoxicity NNP Physical
Clinical JJ Physical
and CC Physical
bacteriological JJ Physical
responses NNS Physical
effective JJ Other
nephrotoxicity NN Physical
and CC None
ototoxicity NN Physical
-DOCSTART- -X- N

primary JJ None
outcome NN None
measure NN None
, , None
( ( None
unblinded JJ Mental
parent NN Mental
report NN Mental
) ) None
parent NN Mental
questionnaire NN Mental
. . None
level NN Other
of IN Other
satisfaction NN Other
-DOCSTART- -X- N

carotid JJ Physical
intima-media JJ Physical
thickening NN Physical
carotid NN Physical
far RB Physical
wall JJ Physical
intima-media JJ Physical
thickness NN Physical
HbA1c NNP Physical
HbA1c NNP Physical
carotid JJ Physical
intima-media JJ Physical
thickness NN Physical
triglyceride JJ Physical
, , Physical
highly-sensitive JJ Physical
C-reactive JJ Physical
protein NN Physical
, , Physical
and CC Physical
E-selectin NNP Physical
HbA1c NNP Physical
carotid JJ Physical
intima-media JJ Physical
thickness NN Physical
. . None
carotid JJ Physical
intima-media JJ Physical
thickness NN Physical
. . None
-DOCSTART- -X- N

Extensor NNP Physical
mechanism NN Physical
power NN Physical
output NN Physical
and CC None
physical JJ Physical
performance NN Physical
on IN Physical
a DT Physical
battery NN Physical
of IN Physical
timed JJ Physical
functional JJ Physical
activities NNS Physical
power NN Physical
output NN Physical
change NN None
in IN None
power NN Physical
output NN Physical
Posthoc NNP Physical
testing VBG Physical
all DT None
post-operative JJ Mental
assessments NNS Mental
. . None
power NN Physical
output NN Physical
of IN Physical
their PRP$ Physical
contralateral JJ Physical
limb NN Physical
extensor NN Physical
power NN Physical
-DOCSTART- -X- N

Skin NNP Physical
concentrations NNS Physical
controlled VBD Other
release NN Other
local JJ Physical
tissue NN Physical
concentrations NNS Physical
of IN Physical
TSI NNP Physical
-DOCSTART- -X- N

self-reported JJ Physical
and CC Physical
biometric JJ Physical
indicators NNS Physical
of IN Physical
cardiovascular JJ Physical
disease NN Physical
self-reported JJ Physical
attitudes NNS Physical
( ( Physical
on IN Physical
diet NN Physical
, , Physical
exercise NN Physical
, , Physical
and CC Physical
mental JJ Physical
health NN Physical
) ) Physical
biometric JJ Physical
measures NNS Physical
( ( Physical
eg NN Physical
, , Physical
body NN Physical
weight NN Physical
, , Physical
waist JJ Physical
circumference NN Physical
) ) Physical
. . Physical
dietary JJ Mental
attitudes NNS Mental
, , Mental
dietary JJ Mental
self-efficacy NN Mental
, , Mental
and CC Mental
exercise NN Mental
, , Mental
and CC Mental
reductions NNS Mental
in IN Mental
distress NN Mental
symptoms NNS Mental
. . None
waist NN Physical
circumference NN Physical
cardiovascular JJ Physical
disease NN Physical
risk NN Physical
factors NNS Physical
. . Physical
-DOCSTART- -X- N

morning NN Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
BP NNP Physical
) ) Physical
obstructive JJ Physical
sleep JJ Physical
apnea NN Physical
sympathetic JJ Physical
vasoconstrictor NN Physical
tone NN Physical
. . None
Daytime NNP Physical
muscle NN Physical
sympathetic JJ Physical
nerve NN Physical
activity NN Physical
( ( Physical
MSNA NNP Physical
) ) Physical
left JJ Physical
ventricular JJ Physical
ejection NN Physical
fraction NN Physical
( ( Physical
LVEF NNP Physical
) ) Physical
and CC None
morning NN Physical
systolic JJ Physical
BP NNP Physical
. . None
Muscle NNP Physical
sympathetic JJ Physical
nerve NN Physical
activity NN Physical
, , None
BP NNP Physical
, , None
and CC None
heart NN Physical
rate NN Physical
( ( Physical
HR NNP Physical
) ) Physical
OSA NNP Physical
, , None
MSNA NNP Physical
, , None
systolic JJ Physical
BP NNP Physical
, , Physical
or CC None
HR NNP Physical
. . None
OSA NNP Physical
daytime JJ Physical
MSNA NNP Physical
systolic JJ Physical
BP NNP Physical
HR NNP Physical
daytime JJ Physical
MSNA NNP Physical
, , None
systolic JJ Physical
BP NNP Physical
, , None
and CC None
HR NNP Physical
. . Physical
BP NNP Physical
-DOCSTART- -X- N

successful JJ Other
favorable JJ Other
outcome NN Other
favorable JJ Other
outcome NN Other
analysis NN Physical
( ( Physical
Manetl-Naenszel NNP Physical
test NN Physical
) ) None
no DT Other
difference NN Other
antibiotic JJ Physical
toxicity NN Physical
serious JJ Physical
superinfection NN Physical
-DOCSTART- -X- N

safety NN Other
and CC None
efficacy NN Other
2 CD Other
consecutive JJ Other
decreases NNS Other
in IN Other
iPTH NN Other
levels NNS Other
baseline NN None
. . None
decreases NNS Other
in IN Other
iPTH JJ Other
levels NNS Other
hypercalcemia NN Physical
, , None
hyperphosphatemia NN Physical
, , None
and CC None
elevated VBD Physical
calcium-phosphorus JJ Physical
product NN Physical
levels NNS Physical
urinary JJ Physical
calcium NN Physical
and CC Physical
phosphorus JJ Physical
excretion NN Physical
or CC None
deterioration NN Physical
in IN Physical
kidney NN Physical
function NN Physical
-DOCSTART- -X- N

depressive NN Mental
and CC Mental
anxiety NN Mental
symptoms NNS Mental
Higher JJR Mental
levels NNS Mental
of IN Mental
emotional JJ Mental
distress NN Mental
post-intervention NN Mental
sexual JJ Mental
and CC Mental
drug-taking JJ Mental
risk NN Mental
. . Mental
sexual JJ Mental
and CC Mental
drug-taking JJ Mental
risks NNS Mental
depressive JJ Mental
symptoms NNS Mental
sexual JJ Mental
risk NN Mental
behavior NN Mental
. . Mental
-DOCSTART- -X- N

proportion NN Physical
of IN Physical
patients NNS Physical
with IN Physical
residual JJ Physical
tumor NN Physical
healed VBD None
-DOCSTART- -X- N

child VB Pain
pain NN Pain
) ) Pain
self-report JJ Pain
scale NN Pain
named VBN Pain
visual JJ Pain
analog NN Pain
scale NN Pain
( ( Pain
VAS NNP Pain
) ) Pain
of IN Pain
pain NN Pain
. . Other
pain NN Pain
facial NN Pain
pain NN Pain
scale NN Pain
[ VBP Other
Children NNP Pain
's POS Pain
Hospital NNP Pain
of IN Pain
Eastern NNP Pain
Ontario NNP Pain
Pain NNP Pain
Scale NNP Pain
: : Other
parents NNS Pain
VAS NNP Pain
pain NN Pain
-DOCSTART- -X- N

pulmonary JJ Physical
function NN Physical
, , None
length NN Physical
of IN Physical
time NN Physical
mean JJ Physical
FEV1 NNP Physical
physicians NNS Physical
' POS Physical
assessments NNS Physical
of IN Physical
patients NNS Physical
' POS Physical
clinical JJ Physical
response NN Physical
patients NNS Other
' POS Other
subjective JJ Other
symptom NN Other
scores NNS Other
. . None
cardiovascular JJ Physical
effects NNS Physical
, , None
laboratory NN Physical
values NNS Physical
, , None
or CC None
adverse JJ Adverse
events NNS Adverse
. . None
preference NN Other
for IN Other
one CD Other
of IN Other
the DT Other
delivery NN Other
systems NNS Other
-DOCSTART- -X- N

time NN Physical
to TO Physical
definitive VB Physical
worsening NN Physical
Karnofsky NNP Physical
performance NN Physical
status NN Physical
time NN Physical
to TO Physical
5 CD Physical
% NN Physical
definitive JJ Physical
weight NN Physical
loss NN Physical
, , Physical
time NN Physical
to TO Physical
definitive JJ Physical
worsening NN Physical
of IN Physical
appetite NN Physical
by IN Physical
one CD Physical
grade NN Physical
, , Physical
pain-free JJ Mortality
survival NN Mortality
( ( Physical
defined VBN Physical
as IN Physical
time NN Pain
to TO Pain
first JJ Pain
appearance NN Pain
of IN Pain
pain NN Pain
) ) Physical
, , Physical
and CC Physical
time NN Physical
to TO Physical
first JJ Physical
cancer NN Physical
pain-related JJ Physical
opioid JJ Physical
intake NN Physical
. . Physical
time NN Physical
to TO Physical
definitive JJ Physical
worsening NN Physical
of IN Physical
KPS NNP Physical
time NN Physical
to TO Physical
definitive JJ Physical
weight NN Physical
loss NN Physical
and CC Physical
time NN Physical
to TO Physical
definitive JJ Physical
worsening NN Physical
of IN Physical
appetite NN Physical
Pain-free JJ Pain
survival NN Pain
and CC Pain
time NN Pain
to TO Pain
first JJ Pain
cancer NN Pain
pain-related JJ Pain
opioid JJ Pain
intake NN Pain
quality NN Other
of IN Other
life NN Other
, , Physical
time NN Physical
to TO Physical
progression NN Physical
, , Physical
and CC Physical
overall JJ Mortality
survival NN Mortality
-DOCSTART- -X- N

differences NNS None
in IN None
mortality NN Mortality
, , None
morbidity NN Other
or CC None
incapacity NN Physical
for IN Physical
work NN Physical
-DOCSTART- -X- N

Delavirdine NNP Other
exposure NN Other
maximum JJ Other
drug NN Other
concentration NN Other
in IN Other
serum NN Other
( ( Other
Cmax NNP Other
) ) Other
area NN Other
under IN Other
the DT Other
concentration-time JJ Other
curve NN Other
extent NN Other
of IN Other
N-dealkylation NNP Other
ratio NN Other
of IN Other
the DT Other
N-dealkylated JJ Other
delavirdine NN Other
AUC0 NNP Other
-- : Other
> JJ Other
infinity NN Other
delavirdine NN Other
AUC0 NNP Other
-- : Other
> JJ Other
infinity NN Other
didanosine NN Other
exposure NN Other
Cmax NNP Other
AUC0 NNP Other
-- : Other
> JJ Other
infinity NN Other
-DOCSTART- -X- N

Comparison NNP None
time NN Other
required VBN Other
administer VB None
quantify VB Other
and CC None
compare VB Other
the DT Other
time NN Other
needed VBN Other
to TO Other
treat VB Other
mean JJ Other
time NN Other
needed VBN Other
planning NN None
selection NN None
-DOCSTART- -X- N

costs NNS Other
of IN Other
care NN Other
resources NNS Other
costs NNS Other
incurred VBN Other
Costs NNS Other
costs NNS Other
annual JJ Other
cost NN Other
of IN Other
intensive JJ Other
therapy NN Other
cost NN Other
of IN Other
conventional JJ Other
therapy NN Other
( ( None
$ $ None
1,700/year CD None
cost NN Other
frequency NN Other
of IN Other
outpatient JJ Other
visits NNS Other
resources NNS Other
used VBN Other
in IN Other
self-care NN Other
. . None
-DOCSTART- -X- N

IL-6R JJ Physical
mRNA NN Physical
response NN Physical
IL-6R NNP Physical
mRNA NN Physical
levels NNS Physical
IL-6R NNP Physical
mRNA NN Physical
response NN Physical
mRNA JJ Physical
level NN Physical
of IN Physical
IL-6R NNP Physical
IL-6R NNP Physical
gene NN Physical
expression NN Physical
levels NNS Physical
training NN Physical
status NN Physical
intramuscular JJ Physical
glycogen NN Physical
levels NNS Physical
IL-6R JJ Physical
mRNA NN Physical
production NN Physical
-DOCSTART- -X- N

complete JJ Physical
protective JJ Physical
immunity NN Physical
clinical JJ Physical
signs NNS Physical
of IN Physical
pseudorabies NNS Physical
virus NN Physical
excretion NN Physical
. . None
fever NN Physical
period NN Physical
of IN Physical
growth NN Physical
arrest NN Physical
excreted VBD Physical
virus NN Physical
IgM NNP Physical
and CC Physical
IgA NNP Physical
responses NNS Physical
serum NN Physical
oropharyngeal JJ Physical
fluid NN Physical
primary JJ Physical
serum NN Physical
IgM NNP Physical
, , Physical
IgG1 NNP Physical
, , Physical
and CC Physical
IgG2 NNP Physical
responses NNS Physical
mucosal NN Physical
responses VBZ Physical
. . None
memory NN Physical
responses NNS Physical
in IN None
serum NN None
and CC None
in IN None
oropharyngeal JJ None
fluid NN None
. . None
-DOCSTART- -X- N

gastric NN Physical
emptying NN Physical
gastric JJ Physical
emptying NN Physical
upper JJ Physical
gastrointestinal NN Physical
symptoms NNS Physical
solid JJ Physical
gastric JJ Physical
emptying VBG Physical
blood NN Physical
glucose JJ Physical
concentration NN Physical
gastric JJ Physical
emptying VBG Physical
-DOCSTART- -X- N

showing JJ Mental
responsiveness NN Mental
to TO Mental
joint JJ Mental
attention NN Mental
structured VBN Mental
joint JJ Mental
attention NN Mental
assessment NN Mental
child-initiated JJ Physical
joint NN Physical
attention NN Physical
mother-child JJ Physical
interaction NN Physical
. . Physical
types NNS Physical
of IN Physical
symbolic JJ Physical
play NN Physical
play NN Physical
levels NNS Physical
play NN Physical
assessment NN Physical
interaction NN Physical
with IN Physical
their PRP$ Physical
mothers NNS Physical
. . Physical
specificity NN Physical
and CC Physical
generalizability NN Physical
of IN Physical
joint JJ Physical
attention NN Physical
and CC Physical
play NN Physical
interventions NNS Physical
-DOCSTART- -X- N

Allelic JJ Physical
imbalance NN Physical
allelic JJ Physical
loss NN Physical
allelic JJ Physical
loss NN Physical
overall JJ Physical
frequency NN Physical
of IN Physical
allelic JJ Physical
imbalance NN Physical
allelic JJ Physical
loss NN Physical
or CC Physical
retention NN Physical
allelic JJ Physical
loss NN Physical
allele NN Physical
allelic JJ Physical
loss NN Physical
allelic JJ Physical
loss NN Physical
loss NN Physical
of IN Physical
one CD Physical
allele NN Physical
at IN Physical
one CD Physical
frequency NN Physical
of IN Physical
allelic JJ Physical
imbalance NN Physical
allelic JJ Physical
deletion NN Physical
-DOCSTART- -X- N

efficacy NN Other
and CC None
safety NN Other
durability NN Other
safety NN Other
. . None
-DOCSTART- -X- N

incidence NN Physical
of IN Physical
loco-regional JJ Physical
recurrences NNS Physical
overall JJ Mortality
survival NN Mortality
. . Mortality
The DT Mortality
relapse-free JJ Mortality
survival NN Mortality
survival NN Mortality
number NN Mortality
of IN Mortality
deaths NNS Mortality
caused VBN Mortality
by IN Mortality
myocardial JJ Mortality
infarction NN Mortality
-DOCSTART- -X- N

combined JJ Physical
incidence NN Physical
of IN Physical
cardiovascular JJ Physical
disease NN Physical
and CC None
renal JJ Physical
failure NN Physical
total JJ Mortality
deaths NNS Mortality
and CC None
any DT None
safety NN Physical
problems NNS Physical
. . None
blood NN Physical
pressures NNS Physical
( ( Physical
systolic/diastolic JJ Physical
) ) Physical
deaths NNS Mortality
-DOCSTART- -X- N

smoking VBG Mental
cessation NN Mental
. . None
smoking NN Mental
abstinence NN Mental
expired JJ Other
air NN Other
carbon NN Other
monoxide NN Other
. . Other
abstinence NN Mental
withdrawal NN Adverse
symptoms NNS Adverse
Abstinence NN Mental
rates NNS Mental
abstinence JJ Mental
-DOCSTART- -X- N

well RB None
tolerated VBN None
drug-attributed JJ None
serious JJ None
adverse JJ None
events NNS None
. . None
were VBD None
upper JJ None
respiratory NN None
tract NN None
infection NN None
, , None
headache NN None
, , None
and CC None
back RB None
pain NN None
, , None
all DT None
mild VBP None
to TO None
moderate VB None
. . None
mild JJ None
hypersensitivity NN None
reaction NN None
. . None
demonstrated VBD None
slight JJ None
enlargement NN None
of IN None
a DT None
preexisting NN None
midbrain NN Adverse
lesion NN None
. . None
Electrocardiography NNP None
and CC None
laboratory NN None
values NNS None
( ( None
including VBG None
CSF NNP None
) ) None
new JJ None
microhemorrhage NN None
, , None
vasogenic JJ None
edema NN None
, , None
or CC None
meningoencephalitis NN Physical
the DT None
area NN None
under IN None
the DT None
plasma JJ None
concentration-time JJ None
profile NN None
Mean JJ None
terminal JJ None
half-life NN None
measurable JJ None
CSF NNP None
ponezumab NN None
concentrations NNS None
mean JJ None
CSF NNP None
A? NNP None
-DOCSTART- -X- N

survival VBP Mortality
event-free JJ Mortality
survival NN Mortality
( ( Mortality
EFS NNP Mortality
; : None
overall JJ Mortality
survival NN Mortality
( ( Mortality
OS NNP Mortality
) ) Mortality
. . Mortality
hazard NN Physical
ratios NNS Physical
hematologic JJ Physical
toxicities NNS Physical
EFS NNP Physical
and CC Physical
OS NNP Physical
hazard NN Physical
ratios NNS Physical
EFS NNP Physical
and CC Physical
OS NNP Physical
toxicity NN Physical
. . None
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
venous JJ Physical
thromboembolism NN Physical
up RB Physical
to TO Physical
day NN Physical
10 CD Physical
. . Physical
major JJ Physical
bleeding NN Physical
and CC None
all-cause JJ Mortality
mortality NN Mortality
. . None
venous JJ Physical
thromboembolism NN Physical
rate NN Physical
proximal JJ Physical
deep JJ Physical
vein NN Physical
thrombosis NN Physical
rate NN Physical
Major JJ Physical
bleeds NNS Physical
died VBN Mortality
. . None
venous JJ Physical
thromboembolism NN Physical
rate NN None
low JJ Physical
bleeding NN Physical
risk NN Physical
-DOCSTART- -X- N

platelet NN Physical
aggregation NN Physical
, , Physical
and CC Physical
platelet NN Physical
production NN Physical
of IN Physical
malondialdehyde NN Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
Blood NNP Physical
pressure NN Physical
Platelet NNP Physical
aggregation NN Physical
platelet NN Physical
aggregation NN Physical
Malondialdehyde NNP Physical
MDA-basal NNP Physical
; : None
MDA-activated NNP Physical
; : None
MDA-basal NNP Physical
MDA-activated NNP Physical
ratio NN Physical
MDA-basal JJ Physical
: : Physical
MDA-activated JJ Physical
blood NN Physical
pressure NN Physical
platelet JJ Physical
aggregation NN Physical
platelet NN Physical
production NN Physical
of IN Physical
malondialdehyde NN Physical
-DOCSTART- -X- N

Resource NNP None
utilization NN None
economic JJ None
costs NNS None
resource NN Other
utilization NN Other
direct JJ Other
economic JJ Other
costs NNS Other
Resource NNP Other
utilization NN Other
, , None
procedures NNS Other
, , None
and CC None
direct JJ Other
costs NNS Other
( ( Other
number NN Other
of IN Other
admissions NNS Other
or CC Other
length NN Other
of IN Other
stay NN Other
) ) Other
average JJ Other
number NN Other
of IN Other
dressing VBG Other
changes NNS Other
performed VBN Other
per IN Other
patient NN Other
outpatient NN Other
treatment NN Other
visits NNS Other
average JJ Other
direct JJ Other
cost NN Other
per IN Other
average JJ Other
total JJ Other
cost NN Other
to TO Other
achieve VB Other
healing NN Other
resource NN Other
utilization NN Other
proportion NN None
of IN None
patients NNS None
lower JJR Other
overall JJ Other
cost NN Other
of IN Other
care NN Other
-DOCSTART- -X- N

death NN Mortality
or CC None
dependency NN Mental
( ( None
modified JJ None
Rankin NNP None
Scale NNP None
[ NNP None
mRS NN None
] NNP None
Early JJ Mental
neurologic JJ Mental
deterioration NN Mental
( ( Mental
END NNP Mental
) ) Mental
infarct JJ Physical
volume NN Physical
mRS NN Physical
score NN Physical
infarct NN Physical
volume NN Physical
risk NN None
of IN None
death NN Mortality
or CC None
dependency NN Physical
END NNP Mental
mean JJ Physical
infarct JJ Physical
volume NN Physical
END NNP Mental
mean JJ Physical
infarct JJ Physical
volume NN Physical
-DOCSTART- -X- N

higher JJR Physical
levels NNS Physical
of IN Physical
biomarkers NNS Physical
of IN Physical
inflammation NN Physical
myocyte JJ Physical
injury NN Physical
B-type NNP Physical
natriuretic JJ Physical
peptide NN Physical
( ( Physical
BNP NNP Physical
) ) Physical
, , None
C-reactive JJ Physical
protein NN Physical
( ( Physical
CRP NNP Physical
) ) Physical
, , None
and CC None
tumor NN Physical
necrosis NN Physical
factor NN Physical
( ( Physical
TNF NNP Physical
) ) Physical
Endothelin-1 NNP Physical
BNP NNP Physical
CRP NNP Physical
apparent JJ None
temperature NN None
higher JJR None
BNP NNP None
. . None
apparent JJ None
temperature NN None
was VBD None
CRP NNP None
. . None
with IN None
TNF NNP Physical
or CC None
endothelin-1 JJ Physical
were VBD None
between IN None
temperature NN None
and CC None
both DT None
BNP NNP None
and CC None
CRP-predictors NNS None
of IN None
heart NN None
failure NN None
prognosis NN None
and CC None
severity NN None
. . None
-DOCSTART- -X- N

effectivity NN Other
safeness NN Other
values NNS Physical
of IN Physical
red JJ Physical
blood NN Physical
count NN Physical
serum NN Physical
values NNS Physical
of IN Physical
soluble JJ Physical
transferrin NN Physical
receptors NNS Physical
and CC Physical
ferritin NNS Physical
iron NN Physical
cell NN Physical
saturation NN Physical
body NN Physical
iron NN Physical
reserves NNS Physical
adverse JJ Adverse
events NNS Adverse
effective JJ Other
serious JJ Adverse
adverse JJ Adverse
event NN Adverse
-DOCSTART- -X- N

Relapse NNP Physical
mean JJ Physical
+/- JJ Physical
SD NNP Physical
followup NN Physical
cured VBN Physical
clinical JJ Physical
remission NN Physical
maintenance NN Other
regimen NN Other
of IN Other
low-dose JJ Other
corticosteroids NNS Other
. . None
died VBD Mortality
deaths NNS Mortality
treatment NN Adverse
side NN Adverse
effects NNS Adverse
death NN Mortality
5-year JJ Mortality
cumulative JJ Mortality
survival NN Mortality
rates NNS Mortality
-DOCSTART- -X- N

morphology NN Other
and CC Other
motility NN Other
of IN Other
sperm NN Other
changes NNS Other
of IN Other
density NN Other
, , Other
motility NN Other
and CC Other
morphology NN Other
of IN Other
sperm NN Other
semen NNS Other
analysis NN Other
system NN Other
density NN Other
, , Other
motility NN Other
and CC Other
morphology NN Other
of IN Other
sperm NN Other
sperm JJ Other
deformity NN Other
rate NN Other
density NN Other
and CC Other
motility NN Other
of IN Other
sperm NN Other
sperm JJ Other
deformity NN Other
rate NN Other
-DOCSTART- -X- N

pupillary JJ Physical
dilatation NN Physical
pupillary JJ Physical
dilatation NN Physical
mean JJ Physical
pupillary JJ Physical
decrease NN Physical
pupillary JJ Physical
size NN Physical
age NN Mental
of IN Mental
the DT Mental
patient NN Mental
, , None
lens VBZ Physical
status NN Physical
, , None
number NN Physical
of IN Physical
cryo NN Physical
applications NNS Physical
, , None
duration NN Other
of IN Other
surgery NN Other
, , None
and CC None
the DT None
size NN Other
and CC Other
extent NN Other
of IN Other
buckle NN Other
mean JJ Physical
pupillary JJ Physical
change NN Physical
intraoperative JJ Physical
miosis NN Physical
during IN Physical
-DOCSTART- -X- N

Safety NN Other
safety NN Other
and CC Other
tolerability NN Other
Serum NNP Physical
creatinine NN Physical
Serum NNP Physical
potassium NN Physical
blood NN Physical
pressure NN Physical
seated VBN Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
SDBP NNP Physical
) ) Physical
seated VBN Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
SSBP NNP Physical
) ) None
proteinuria NN Physical
. . None
total JJ None
number NN None
of IN None
patients NNS None
adverse JJ Adverse
experiences NNS Adverse
adverse JJ None
experiences NNS None
. . None
hyperkalaemia NN Physical
serum JJ Physical
creatinine NN Physical
, , None
acute JJ Physical
renal JJ Physical
failure NN Physical
or CC None
hospitalization NN Other
. . None
safe JJ Other
well RB Other
tolerated VBN Other
-DOCSTART- -X- N

preeclampsia NN Physical
preeclampsia NN Physical
. . None
occurrence NN Physical
of IN Physical
preeclampsia NN Physical
hypertension NN Physical
proteinuria NN Physical
mean JJ Physical
plasma NN Physical
concentration NN Physical
of IN Physical
TXB2 NNP Physical
, , None
a DT Physical
metabolite NN Physical
of IN Physical
TXA2 NNP Physical
6-keto JJ Physical
prostaglandin NN Physical
F1 NNP Physical
alpha NN Physical
, , None
a DT Physical
metabolite NN Physical
of IN Physical
PGI2 NNP Physical
maternal JJ Adverse
or CC Adverse
fetal JJ Adverse
side NN Adverse
effects NNS Adverse
observed VBN Adverse
. . None
prevention NN Physical
of IN Physical
-DOCSTART- -X- N

biomarkers NNS Physical
of IN Physical
dietary JJ Physical
intake NN Physical
Conditional NNP Physical
logistic JJ Physical
regression NN Physical
estimate VB Physical
adjusted VBN Physical
odds NNS Physical
ratios NNS Physical
( ( Physical
OR NNP Physical
) ) Physical
95 CD None
% NN None
CI NNP None
. . None
Isoflavone NNP Physical
concentrations NNS Physical
risk NN Physical
of IN Physical
fibroadenomas NN Physical
. . None
Adjusted VBN Physical
OR NNP Physical
( ( Physical
95 CD Physical
% NN Physical
CI NNP Physical
) ) Physical
inverse JJ Physical
associations NNS Physical
percentages NNS Physical
of IN Physical
the DT Physical
RBC NNP Physical
( ( Physical
n-3 JJ Physical
) ) Physical
fatty JJ Physical
acids NNS Physical
, , Physical
eicosapentaenoic JJ Physical
acid NN Physical
( ( Physical
EPA NNP Physical
) ) Physical
docosapentaenoic NN Physical
acid NN Physical
( ( Physical
DPA NNP Physical
) ) Physical
carotenoids NNS Physical
, , Physical
vitamin FW Physical
C NNP Physical
, , Physical
retinol NN Physical
, , Physical
and CC Physical
ferritin NNS Physical
inverse JJ Physical
associations NNS Physical
plasma NN Physical
isoflavone NN Physical
concentrations NNS Physical
RBC NNP Physical
EPA NNP Physical
and CC Physical
DPA NNP Physical
fibroadenoma NN Physical
risk NN Physical
risk NN Physical
of IN Physical
fibroadenomas NN Physical
. . Physical
-DOCSTART- -X- N

risk NN Mental
for IN Mental
confession NN Mental
. . Mental
admitted VBD Mental
to TO Mental
distal JJ Mental
consequence NN Mental
. . Mental
proximal NN Mental
and CC Mental
distal JJ Mental
consequences NNS Mental
admission NN Physical
rate NN Physical
. . None
-DOCSTART- -X- N

Evaluation NN Other
pharmacokinetic JJ Physical
interaction NN Physical
pharmacodynamic JJ Physical
interaction NN Physical
antiplatelet NN Physical
activity NN Physical
. . None
antiplatelet NN Physical
activity NN Physical
of IN Physical
ASA NNP Physical
, , Physical
as IN Physical
assessed VBN Physical
by IN Physical
ARU NNP Other
ratio NN Other
relative NN Other
to TO Other
baseline VB Other
in IN Other
the DT Other
VerifyNow NNP Other
ASA NNP Other
assay VBP Other
; : None
suppression NN Physical
of IN Physical
serum NN Physical
thromboxane NN Physical
B NNP Physical
( ( Physical
2 CD Physical
) ) Physical
( ( Physical
TXB NNP Physical
( ( Physical
2 CD Physical
) ) Physical
) ) Physical
achieved VBN None
ARU NNP None
< $ None
baseline NN None
) ) None
platelet NN None
aggregation NN None
was VBD None
platelet NN None
aggregation NN None
( ( None
reduced VBN None
serum NN None
TXB NNP None
( ( None
2 CD None
) ) None
by IN None
serum NN None
TXB NNP None
( ( None
2 CD None
) ) None
levels NNS None
( ( None
well RB None
tolerated VBN None
. . None
pharmacodynamic JJ None
interaction NN None
between IN None
platelet VB None
function NN None
. . None
-DOCSTART- -X- N

serial JJ Physical
change NN Physical
in IN Physical
perfusion NN Physical
Complete JJ Physical
loss NN Physical
of IN Physical
perfusion NN Physical
loss NN Physical
of IN Physical
perfusion NN Physical
alterations NNS Physical
in IN Physical
coronary JJ Physical
blood NN Physical
flow NN Physical
-DOCSTART- -X- N

morphine JJ Pain
consumption NN Pain
and CC Pain
visual JJ Pain
analog NN Pain
scale NN Pain
pain NN Pain
scores NNS Pain
. . Pain
pain NN None
scores NNS None
. . None
Patient-controlled JJ None
analgesia JJ None
morphine NN None
consumption NN None
hallucinations NNS None
nightmares NNS None
. . None
incidence NN None
of IN None
adverse JJ None
effects NNS None
morphine NN None
consumption NN None
patient-controlled JJ None
analgesia NN None
morphine NN None
requirement NN None
-DOCSTART- -X- N

low-density JJ Physical
lipoprotein-cholesterol NN Physical
( ( Physical
LDL-C NNP Physical
) ) Physical
-lowering VBG Physical
LDL-C JJ Physical
LDL-C NNP Physical
triglyceride NN Physical
and CC Mental
high-density NN Physical
lipoprotein NNS Physical
cholesterol NN Physical
levels NNS Physical
LDL-C NNP Physical
-DOCSTART- -X- N

that IN None
DAT1 NNP None
moderated VBD None
treatment NN None
response NN None
( ( None
.009 NNP None
) ) None
. . None
In IN None
children NNS None
with IN None
no DT None
or CC None
1 CD None
DAT1 NNP None
10-repeat JJ None
allele NN None
, , None
superior JJ None
treatment NN None
effects NNS None
of IN None
BPT NNP None
+ NNP None
RCC NNP None
compared VBN None
with IN None
RCC NNP None
alone RB None
were VBD None
present JJ None
( ( None
p JJ None
= NNP None
.005 NNP None
) ) None
, , None
which WDT None
was VBD None
not RB None
the DT None
case NN None
in IN None
children NNS None
with IN None
2 CD None
DAT1 NNP None
10-repeat JJ None
alleles NNS None
( ( None
p JJ None
= NNP None
.57 NNP None
) ) None
. . None
DAT1 NNP None
in IN None
behavioral JJ None
intervention NN None
directed VBD None
-DOCSTART- -X- N

subjective JJ Other
rating NN Other
scale NN Other
speech JJ Mental
intelligibility NN Mental
speech NN Mental
intelligibility NN Mental
Subjective JJ Other
rating NN Other
scores NNS Other
speech JJ Mental
intelligibility NN Mental
noise NN Mental
protection NN Mental
enhanced JJ Other
noise NN Other
protection NN Other
-DOCSTART- -X- N

pain NN Pain
, , None
function NN Physical
, , None
and CC None
quality NN Other
of IN Other
life NN Other
average JJ Pain
pain NN Pain
severity NN Pain
chemotherapy-induced JJ Pain
peripheral JJ Pain
neuropathic JJ Pain
pain NN Pain
Pain NNP Pain
severity NN Pain
Brief JJ Pain
Pain NNP Pain
Inventory-Short NNP Pain
Form NNP Pain
average NN Pain
pain NN Pain
item NN Pain
pain NN Pain
average JJ None
pain NN None
average JJ Pain
pain NN Pain
score NN Pain
pain NN Pain
pain NN Pain
-DOCSTART- -X- N

pain NN Pain
, , Pain
stiffness NN Pain
and CC Pain
function NN Pain
. . Pain
pain NN Pain
, , Pain
stiffness NN Pain
and CC Pain
function NN Pain
values NNS Pain
pain NN Pain
, , Pain
stiffness NN Pain
and CC Pain
function NN Pain
-DOCSTART- -X- N

overall JJ Mortality
median JJ Mortality
survival NN Mortality
complete JJ Other
response NN Other
( ( Other
CR NNP Other
) ) Other
partial JJ Other
response NN Other
( ( Other
PR NNP Other
) ) Other
stable JJ Other
disease NN Other
( ( Other
SD NNP Other
) ) Other
progressive JJ Other
disease NN Other
( ( Other
PD NNP Other
) ) Other
. . Physical
median JJ Mortality
survival NN Mortality
survival NN Mortality
median JJ Mortality
survival NN Mortality
survival NN Mortality
-DOCSTART- -X- N

maximum JJ Physical
lactate NN Physical
steady JJ Physical
state NN Physical
. . Physical
change NN Physical
in IN Physical
lactate NN Physical
. . Physical
lactate NN Physical
steady JJ Physical
state NN Physical
( ( Physical
LSS NNP Physical
) ) Physical
lactate NN Physical
MLSS NNP Physical
velocity NN Physical
. . Physical
-DOCSTART- -X- N

Addictive JJ Mental
'Internet CD None
addiction NN None
' '' None
addictive JJ Mental
Internet NNP Mental
use NN Mental
addictive JJ Mental
Internet NNP Mental
use NN None
Internet NNP Mental
use NN Mental
use VB Mental
Internet NNP Mental
addictively RB Mental
addictive JJ Mental
Internet NNP Mental
use NN None
addictive JJ Mental
Internet NNP Mental
use NN Mental
. . None
-DOCSTART- -X- N

severe JJ Physical
visual JJ Physical
loss NN Physical
Fluorescein NNP Physical
angiographic JJ Physical
growth NN Physical
of IN Physical
classic JJ Physical
and CC Physical
occult NN Physical
CNV NNP Physical
temporary JJ Physical
growth NN Physical
retardation NN Physical
severe JJ Physical
visual JJ Physical
loss NN Physical
-DOCSTART- -X- N

survival JJ Mortality
all-cause JJ Mortality
mortality NN Mortality
aneurysm-related JJ Mortality
mortality NN Mortality
, , None
health-related JJ Physical
quality NN Physical
of IN Physical
life NN Physical
( ( Physical
HRQL NNP Physical
) ) Physical
, , None
postoperative JJ Adverse
complications NNS Adverse
, , None
and CC None
hospital NN Other
costs NNS Other
. . Other
30-day JJ Mortality
operative JJ Mortality
mortality NN Mortality
in IN Mortality
the DT Mortality
EVAR NNP Mortality
group NN Mortality
died VBN Mortality
overall JJ Mortality
mortality NN Mortality
all-cause JJ Mortality
mortality NN Mortality
aneurysm-related JJ Mortality
mortality NN Mortality
. . None
mean JJ Other
hospital NN Other
costs NNS Other
per IN Other
patient NN Other
over IN Other
4 CD Other
years NNS Other
30-day JJ Mortality
operative JJ Mortality
mortality NN Mortality
-DOCSTART- -X- N

risk NN Physical
of IN Physical
functional JJ Physical
ovarian JJ Physical
cysts NNS Physical
. . Physical
follicular JJ Physical
development NN Physical
ovulation NN Physical
relative JJ Physical
risk NN Physical
( ( Physical
RR NNP Physical
) ) Physical
of IN Physical
developing VBG Physical
a DT Physical
follicular JJ Physical
structure NN Physical
greater JJR Physical
than IN Physical
30 CD Physical
mm NN Physical
in IN Physical
diameter NN Physical
risk NN Physical
with IN Physical
the DT Physical
lower-dose JJ Physical
monophasic NN Physical
pill NN Physical
maximum JJ Physical
ovulation NN Physical
rate NN Physical
suppression NN Physical
of IN Physical
follicular JJ Physical
development NN Physical
. . Physical
-DOCSTART- -X- N

mortality NN Mortality
. . Mortality
rate NN Mortality
of IN Mortality
mortality NN Mortality
-DOCSTART- -X- N

safety NN Other
immunogenicity NN Other
Safety NN Other
Varicella-zoster JJ Physical
virus NN Physical
( ( Physical
VZV NNP Physical
) ) Physical
antibody NN Physical
responses NNS Physical
VZV NNP Physical
antibody NN Physical
geometric JJ Physical
mean NN Physical
titer NN Physical
( ( Physical
GMT NNP Physical
VZV NNP Physical
antibody NN Physical
geometric JJ Physical
mean NN Physical
rise NN Physical
( ( Physical
GMR NNP Physical
incidence NN Adverse
of IN Adverse
vaccine-related JJ Adverse
serious JJ Adverse
adverse JJ Adverse
experiences NNS Adverse
( ( Adverse
AEs NNP Adverse
) ) Adverse
GMTs NNP Physical
GMT NNP Physical
GMRs NNPS Physical
vaccine-related JJ Adverse
serious JJ Adverse
AEs NNP Adverse
safety NN Other
injection-site JJ Adverse
AEs NNP Adverse
systemic JJ Adverse
AEs NNP Adverse
vaccine-related JJ Adverse
AEs NNP Adverse
safety NN Other
immunogenic JJ Other
-DOCSTART- -X- N

efficacy NN Other
basic JJ Mental
emotion NN Mental
recognition NN Mental
tasks NNS Mental
, , None
mindreading VBG Mental
and CC None
theory NN Mental
of IN Mental
mind NN Mental
( ( Mental
TOM NNP Mental
) ) Mental
tasks NNS Mental
recognition NN Mental
of IN Mental
anger NN Mental
TOM NNP Mental
social JJ Mental
skills NNS Mental
efficacy NN Other
-DOCSTART- -X- N

HIV NNP None
RNA NNP None
< VBD None
HIV NNP None
RNA NNP None
between IN None
patients NNS None
. . None
PI-associated JJ None
resistance NN None
mutations NNS None
were VBD None
-DOCSTART- -X- N

cutaneous JJ Physical
photodamage NN Physical
ultraviolet NN Physical
radiation NN Physical
( ( Physical
UVR NNP Physical
) ) Physical
-induced VBD Physical
erythema NN Physical
. . None
erythemal JJ Physical
sensitivity NN Physical
RESULTS VB None
Mean NNP None
? . None
SD NNP None
erythemal JJ None
D NNP None
( ( None
30 CD None
) ) None
was VBD None
in IN None
MMP-1 NNP None
( ( None
reduction NN None
in IN None
fibrillin-1 NN None
( ( None
P NNP None
= NNP None
UVR-induced JJ None
MMP-1 NNP None
was VBD None
in IN None
fibrillin-1 NN None
was VBD None
similarly RB None
. . None
mtDNA JJ None
3895-bp JJ None
provides VBZ None
protection NN None
against IN None
acute NN None
and CC None
potentially RB None
longer-term JJ None
aspects NNS None
of IN None
photodamage NN None
. . None
-DOCSTART- -X- N

lumbar JJ Pain
pain NN Pain
Pain NNP Pain
intensity NN Pain
functional JJ Physical
ability NN Physical
pain NN Pain
intensity NN Pain
functional JJ Physical
ability NN Physical
pain NN Pain
intensity NN Pain
functional JJ Physical
ability NN Physical
-DOCSTART- -X- N

efficacy NN Other
visual JJ Physical
acuity NN Physical
EOG NNP Physical
indices NNS Physical
( ( Physical
amplitude NN Physical
or CC Physical
frequency NN Physical
of IN Physical
nystagmus NN Physical
, , Physical
or CC Physical
both DT Physical
) ) Physical
symptomatic JJ Physical
pendular NN Physical
or CC Physical
gaze NN Physical
evoked VBN Physical
jerk NN Physical
nystagmus NN Physical
-DOCSTART- -X- N

analgesia NN None
side NN Adverse
effects NNS Adverse
. . Adverse
Pain NN Pain
scores NNS Pain
( ( Pain
rest NN Pain
, , Pain
cough NN Pain
, , Pain
and CC Pain
ambulation NN Pain
) ) Pain
, , Pain
side JJ Pain
effects NNS Pain
( ( Pain
nausea NN Pain
, , Pain
pruritus NN Pain
, , Pain
sedation NN Pain
, , Pain
motor NN Pain
block NN Pain
, , Pain
hypotension NN Pain
, , Pain
and CC Pain
orthostasis NN Pain
) ) Pain
, , Pain
and CC Pain
patient-controlled JJ Pain
epidural JJ Pain
analgesia NN Pain
consumption NN Pain
Motor NNP Physical
block NN Physical
severity NN Adverse
. . Adverse
ropivacaine-4 JJ Physical
microg NN Physical
fentanyl JJ Physical
solution NN Physical
ropivacaine NN None
and CC None
fentanyl NN None
. . None
analgesia NN None
motor NN Physical
block NN Physical
determinant NN Adverse
of IN Adverse
motor NN Adverse
block NN Adverse
-DOCSTART- -X- N

cardiac JJ Physical
muscle NN Physical
mass NN Physical
Left NNP Physical
ventricular JJ Physical
muscle NN Physical
mass NN Physical
( ( Physical
LVM NNP Physical
) ) Physical
ejection NN Physical
fraction NN Physical
( ( Physical
EF NNP Physical
) ) Physical
electrocardiography NN Other
( ( Other
ECG NNP Other
) ) Other
Median JJ Other
LVM NNP Other
EF NNP Physical
MWC NNP Physical
ST NNP Other
deviations NNS Other
Irregular JJ Physical
heart NN Physical
rhythm NN Physical
the DT Physical
left NN Physical
ventricular JJ Physical
mass NN Physical
B-Hb NNP Physical
, , None
blood NN Physical
pressure NN Physical
-DOCSTART- -X- N

pain NN Pain
, , Pain
unpleasantness NN Pain
of IN Pain
taste NN Pain
and CC Pain
overall JJ Pain
discomfort NN Pain
experienced VBD Pain
pain NN Pain
and CC Pain
discomfort NN Pain
pain NN Pain
or CC Pain
overall JJ Pain
discomfort NN Pain
sensation NN Physical
of IN Physical
bad JJ Physical
taste NN Physical
unpleasantness NN Other
pain VBN Pain
unpleasantness NN Mental
of IN Mental
taste NN Mental
-DOCSTART- -X- N

wound JJ Physical
sepsis NN Physical
. . Physical
Infection NN Physical
bacteria NNS Adverse
sepsis NN Physical
-DOCSTART- -X- N

outcomes NNS None
outcomes NNS None
hematoma/seroma NN Physical
orchitis NN Physical
neuralgia NN Physical
neuralgia JJ Physical
patient-reported JJ Pain
pain NN Pain
, , None
activity NN Physical
, , None
and CC None
satisfaction NN Other
Medical NNP Other
Outcomes NNP Other
Study NNP Other
Short NNP Other
Form NNP Other
3 CD Other
. . None
pain NN Pain
pain NN Pain
and CC None
less JJR Physical
activity NN Physical
recurrence NN Physical
and CC None
neuralgia NN Physical
. . None
-DOCSTART- -X- N

learning NN Mental
and CC Mental
behavior NN Mental
behavioral JJ Mental
symptoms NNS Mental
and CC Mental
learning VBG Mental
behavioral JJ Mental
symptoms NNS Mental
. . None
learned VBD Mental
the DT Mental
discrimination NN Mental
-DOCSTART- -X- N

motor NN Physical
function NN Physical
, , None
motor NN Physical
control NN Physical
, , None
ambulation NN Physical
, , None
and CC None
daily JJ Physical
functions NNS Physical
after IN Physical
stroke NN Physical
. . None
Fugl-Meyer NNP Physical
Assessment NNP Physical
( ( Physical
FMA NNP Physical
) ) Physical
and CC Physical
muscle NN Physical
tone NN Physical
measured VBN None
by IN None
Myoton-3 NNP Other
for IN Other
motor NN Other
impairment NN Other
Box NNP Physical
and CC Physical
Block NNP Physical
Test NNP Physical
( ( Physical
BBT NNP Physical
) ) Physical
10-Meter JJ Physical
Walk NNP Physical
Test NNP Physical
( ( Physical
10 CD Physical
MWT NNP Physical
) ) Physical
kinematic JJ Physical
parameters NNS Physical
for IN Physical
motor NN Physical
control NN Physical
Motor NNP Physical
Activity NNP Physical
Log NNP Physical
ABILHAND NNP Physical
Questionnaire NNP Physical
for IN Physical
daily JJ Physical
function NN Physical
. . None
FMA NNP Physical
total JJ Physical
scores NNS Physical
synergistic JJ Physical
shoulder NN Physical
abduction NN Physical
during IN Physical
reach NN Physical
BBT NNP Physical
10 CD Physical
MWT NNP Physical
manual JJ Physical
dexterity NN Physical
and CC Physical
ambulation NN Physical
. . None
motor NN Physical
impairment NN Physical
and CC Physical
synergistic JJ Physical
shoulder NN Physical
abduction NN Physical
-DOCSTART- -X- N

skin JJ Physical
wheal NN Physical
and CC Adverse
flare JJ Physical
reaction NN Physical
skin JJ Adverse
reaction NN Adverse
to TO Adverse
intradermal VB Adverse
histamine JJ Adverse
injection NN Adverse
AS-induced NNP Physical
wheal JJ Physical
reaction NN Physical
some DT None
reduction NN None
of IN None
AS-induced NNP None
wheal NN None
-DOCSTART- -X- N

measures NNS Mental
of IN Mental
behavior NN Mental
improvement NN Physical
in IN Physical
behavior NN Physical
. . Physical
-DOCSTART- -X- N

primary JJ None
and CC None
secondary JJ None
outcome NN None
primary JJ None
outcome NN None
measures NNS None
efficacious JJ Other
-DOCSTART- -X- N

Toxicity NN Other
and CC Other
efficacy NN Other
efficacy NN Other
and CC Other
toxicity NN Other
event-free JJ Mortality
and CC Mortality
overall JJ Mortality
survival NN Mortality
toxicity NN Adverse
event-free JJ Mortality
or CC Mortality
overall JJ Mortality
survival NN Mortality
CNS NNP Physical
relapse NN Physical
risk NN Mortality
of IN Mortality
death NN Mortality
veno-occlusive JJ Adverse
disease NN Adverse
of IN Adverse
the DT Adverse
liver NN Adverse
. . None
non-cirrhotic JJ Physical
portal JJ Physical
hypertension NN Physical
toxicity NN Adverse
overall JJ Other
benefit NN Other
. . None
-DOCSTART- -X- N

cessation NN Mental
quit NN Mental
rates NNS Mental
Infant NNP Physical
birth NN Physical
weight VBD Physical
Birth NNP Physical
weight VBD Physical
for IN Physical
infants NNS Physical
born VBN Physical
to TO Physical
women NNS Physical
who WP Physical
quit VBP Physical
smoking VBG Physical
Peer NNP Other
counseling NN Other
number NN Mental
of IN Mental
cigarettes NNS Mental
smoked VBN Mental
daily RB Mental
cigarette NN Mental
abstinence NN Mental
rates NNS Mental
. . None
Infant NNP Physical
birth NN Physical
weight NN Physical
newborn JJR Physical
health NN Physical
-DOCSTART- -X- N

effectiveness NN Other
internet NN Other
accessed VBD Other
training VBG Other
program NN Other
Content NNP Other
and CC Other
Delivery NNP Other
. . None
significantly RB Mental
more RBR Mental
effective JJ Mental
verbal JJ Mental
content NN Mental
skills NNS Mental
-DOCSTART- -X- N

final JJ Physical
height NN Physical
( ( Physical
FH NNP Physical
) ) Physical
duration NN Other
of IN Other
GH NNP Other
treatment NN Other
FH NNP Physical
FH NNP Physical
in IN Physical
centimeters NNS Physical
decrease NN Other
in IN Other
height JJ Other
velocity NN Other
( ( Other
HV NNP Other
) ) Other
changed VBD Other
significantly RB Other
to TO Other
a DT Other
stable JJ Other
HV NNP Other
bone NN Physical
maturation NN Physical
FH NNP Physical
SD NNP Physical
score NN Physical
: : None
GH NNP Physical
dose NN Physical
, , None
height VBD Physical
SD NNP Physical
score NN Physical
chronological JJ Physical
age NN Physical
at IN Physical
start NN Physical
of IN Physical
treatment NN Physical
HV NNP Physical
well RB Other
tolerated VBN Other
. . None
FH NNP Physical
-DOCSTART- -X- N

counts NNS Physical
of IN Physical
most JJS Physical
lymphocyte JJ Physical
subsets NNS Physical
CD4 NNP Physical
T NNP Physical
cells NNS Physical
CD45RA NNP Physical
( ( Physical
low/- JJ Physical
) ) Physical
CD4 NNP Physical
T NNP Physical
cells NNS Physical
; : None
phytohemagglutinin NN None
herpesvirus VB None
antigen-stimulated JJ None
proliferation NN None
, , None
T NNP Physical
cells NNS Physical
appeared VBD Other
equally RB Other
functional JJ Other
. . None
Median JJ Physical
serum NN Physical
IgG NNP Physical
levels NNS Physical
similar JJ None
rate NN Physical
of IN Physical
definite NN Physical
infections NNS Physical
after IN Physical
engraftment NN Physical
rate NN Physical
of IN Physical
severe JJ Physical
( ( Physical
inpatient JJ Physical
treatment NN Physical
required VBN Physical
) ) Physical
definite NN Physical
infections NNS Physical
after IN Physical
engraftment NN Physical
difference NN Physical
in IN Physical
the DT Physical
rates NNS Physical
of IN Physical
definite JJ Physical
infections NNS Physical
greatest JJS None
intermediate NN None
lowest JJS None
Death NNP Mortality
associated VBD None
with IN None
a DT None
fungal NN None
or CC None
bacterial JJ None
infection NN None
occurred VBD None
between IN None
day NN None
30 CD None
and CC None
day NN None
365 CD None
lymphocyte-subset JJ Physical
counts NNS Physical
infections NNS Physical
. . None
-DOCSTART- -X- N

average NN Physical
of IN Physical
anginal JJ Physical
attacks NNS Physical
, , Other
number NN Other
of IN Other
weekly JJ Other
sublingual JJ Other
nitrate NN Other
, , Other
heart NN Physical
rate NN Physical
, , Other
systolic JJ Physical
and CC Physical
diastolic JJ Physical
pressure NN Physical
at IN Physical
rest NN Physical
and CC Physical
at IN Physical
the DT Physical
end NN Physical
of IN Physical
diltiazem JJ Physical
period NN Physical
depression NN Physical
for IN Physical
ST-segment NNP Physical
Heart NNP Physical
rate NN Physical
and CC Other
systolic JJ Physical
plus CC Physical
diastolic JJ Physical
pressures NNS Physical
-DOCSTART- -X- N

eyes NNS Other
were VBD Other
rescued VBN Other
eyes NNS Other
were VBD Other
saved VBN Other
cure NN Other
rate NN Other
-DOCSTART- -X- N

three-year JJ Mortality
relapse-free JJ Mortality
survival NN Mortality
rate NN Mortality
adverse JJ Adverse
events NNS Adverse
relapsed VBN Other
died NN Mortality
of IN Mortality
toxicity NN Mortality
. . None
relapsed VBD Physical
. . None
relapsed VBN Physical
. . None
localized JJ Physical
lymphoblastic JJ Physical
disease NN Physical
-DOCSTART- -X- N

of IN Physical
flunarizine JJ Physical
area NN Physical
under IN Physical
the DT Physical
curve NN Physical
( ( Physical
AUC NNP Physical
) ) Physical
and CC Physical
maximum JJ Physical
plasma JJ Physical
concentration NN Physical
( ( Physical
Cmax NNP Physical
) ) Physical
. . Physical
estimate VB Physical
the DT Physical
area NN Physical
under IN Physical
the DT Physical
curve NN Physical
( ( Physical
AUC NNP Physical
) ) Physical
and CC Physical
maximum JJ Physical
plasma JJ Physical
concentration NN Physical
( ( Physical
Cmax NNP Physical
) ) Physical
. . Physical
estimates NNS Physical
for IN Physical
both DT Physical
AUC NNP Physical
and CC None
Cmax NNP Physical
. . None
mean NN Physical
predicted VBD Physical
AUC NNP Physical
of IN Physical
flunarizine NN Physical
observed JJ Physical
AUC NNP Physical
bias NN Other
of IN Other
the DT Other
prediction NN Other
predicted VBD Physical
Cmax NNP Physical
of IN Physical
flunarizine NN Physical
observed JJ Physical
mean NN Physical
Cmax NNP Physical
bias NN Other
and CC Other
precision NN Other
of IN Other
the DT Other
prediction NN Other
-DOCSTART- -X- N

function NN Physical
, , Physical
fatigue NN Physical
, , Physical
and CC Physical
sleep JJ Physical
quality NN Physical
mobility NN Physical
Ambulatory NNP None
Post NNP None
Acute NNP None
Care NNP None
Basic NNP None
Mobility NNP None
Short NNP None
Form NNP None
. . None
included VBD None
ratings NNS None
of IN None
pain NN None
and CC None
sleep JJ None
quality NN None
the DT None
ability NN None
to TO None
perform VB None
daily JJ None
activities NNS None
quality NN None
of IN None
life NN None
and CC None
fatigue NN None
improved JJ None
mobility NN None
fatigue NN None
and CC None
sleep JJ None
quality NN None
the DT None
mobility NN None
, , None
fatigue NN None
, , None
and CC None
sleep JJ None
quality NN None
-DOCSTART- -X- N

safety NN Other
in IN Other
safety NN Other
and CC Other
acceptability NN Other
severe RB Adverse
or CC Adverse
life-threatening JJ Adverse
adverse JJ Adverse
events NNS Adverse
( ( Adverse
AE NNP Adverse
) ) Adverse
. . None
urogenital JJ Adverse
AE NNP Adverse
mild JJ Adverse
events NNS Adverse
. . None
urogenital JJ Adverse
AE NNP Adverse
intermenstrual JJ Adverse
bleeding NN Adverse
AE NNP Adverse
abdominal/pelvic NN Adverse
pain NN Adverse
safe JJ Other
, , Other
well RB Other
tolerated VBN Other
and CC Other
acceptable JJ Other
HIV NNP Physical
transmission NN Physical
and CC Physical
acquisition NN Physical
. . None
-DOCSTART- -X- N

insulin NN Physical
requirements NNS Physical
glycaemic JJ Physical
control NN Physical
glycaemic JJ Physical
response NN Physical
rate NN Physical
daily JJ Physical
insulin NN Physical
dose NN Physical
postprandial JJ Physical
changes NNS Physical
in IN Physical
blood NN Physical
glucose NN Physical
, , Physical
serum JJ Physical
insulin NN Physical
and CC Physical
C-peptide NNP Physical
mean JJ Physical
daily JJ Physical
insulin NN Physical
dose NN Physical
Postprandial JJ Physical
increases NNS Physical
in IN Physical
blood NN Physical
glucose NN Physical
, , None
insulin NN Physical
and CC None
C-peptide NNP Physical
mean JJ Physical
increase NN Physical
in IN Physical
2-h JJ Physical
postprandial JJ Physical
serum NN Physical
insulin NN Physical
glycaemic JJ Physical
control NN Physical
insulin NN Physical
resistance NN Physical
and CC Physical
hyperinsulinaemia NN Physical
. . Physical
-DOCSTART- -X- N

cytotoxicity-effects NNS Adverse
survival NN Mortality
rates NNS Mortality
complete JJ Physical
response NN Physical
( ( Physical
CR NNP Physical
) ) Physical
partial JJ Physical
response NN Physical
( ( Physical
PR NNP Physical
) ) Physical
stable JJ Physical
disease NN Physical
( ( Physical
SD NNP Physical
) ) Physical
progressive JJ Physical
disease NN Physical
overall JJ Physical
response NN Physical
rate NN Physical
( ( Physical
RR NNP Physical
) ) Physical
RR NNP Physical
based VBN Physical
on IN Physical
an DT Physical
intent-to-treat JJ Physical
analysis NN Physical
Median JJ Mortality
survival NN Mortality
granulocytopenia NN Physical
grade NN Physical
IV NNP Physical
febrile JJ Physical
neutropenia NNS Physical
CR NNP Physical
PR NNP Physical
SD NNP Physical
PD NNP Physical
overall JJ Physical
RR NNP Physical
RR NNP None
based VBN None
on IN None
an DT None
intent-to-treat JJ None
analysis NN None
Median JJ None
survival NN None
RR NNP Physical
was VBD Physical
significantly RB Physical
higher JJR Physical
clinical JJ None
response NN None
making VBG None
additional JJ None
treatment NN None
feasible NN None
higher RBR None
proportion NN Other
of IN Other
patients NNS Other
with IN Other
a DT Other
performance NN Other
status NN Other
2+3 CD Other
achieving VBG Other
a DT Other
response NN Other
significantly RB None
longer RBR None
survival JJ Mortality
survival NN Mortality
at IN Mortality
12 CD Mortality
months NNS Mortality
Grade NNP Physical
IV NNP Physical
granulocytopenia NN Physical
and CC Physical
thrombocytopenia NN Physical
more RBR None
frequent JJ None
haematological JJ Adverse
side-effects NNS Adverse
cytotoxicity NN Adverse
-DOCSTART- -X- N

progression-free JJ Mortality
survival NN Mortality
( ( Mortality
PFS NNP Mortality
) ) Mortality
. . None
overall JJ Mortality
survival NN Mortality
, , None
tumor NN Physical
response NN Physical
rate NN Physical
( ( None
Response NNP Physical
Evaluation NNP Physical
Criteria NNP Physical
in IN Physical
Solid NNP Physical
Tumors NNP Physical
) ) None
, , None
and CC None
safety NN Other
. . None
PFS NNP Mortality
objective JJ Physical
response NN Physical
rate NN Physical
median JJ Physical
duration NN Physical
of IN Physical
response NN Physical
diarrhea RB Adverse
, , None
hypertension NN Adverse
, , None
hair NN Adverse
color NN Adverse
changes NNS Adverse
, , None
nausea NN Physical
, , None
anorexia NN Adverse
, , None
and CC None
vomiting VBG Adverse
. . None
-DOCSTART- -X- N

efficacy NN Other
tolerability NN Other
symptoms NNS Physical
score NN Physical
peak JJ Physical
expiratory NN Physical
flow NN Physical
( ( Physical
PEF NNP Physical
) ) Physical
-derived VBD Physical
parameters NNS Physical
bronchial JJ Physical
response NN Physical
bronchial JJ Physical
responsiveness NN Physical
immunologic JJ Physical
humoral JJ Physical
and CC Physical
cellular JJ Physical
parameters NNS Physical
in IN Physical
peripheral JJ Physical
blood NN Physical
local JJ Adverse
important JJ Adverse
adverse JJ Adverse
reactions NNS Adverse
systemic JJ Adverse
side NN Adverse
effects NNS Adverse
systemic JJ Adverse
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

time NN Physical
on IN Physical
mechanical JJ Physical
ventilation NN Physical
, , Other
duration NN Other
of IN Other
weaning VBG Other
and CC Other
length NN Other
of IN Other
stay NN Other
in IN Other
oxygenation NN Physical
and CC Other
ventilation NN Physical
age NN Other
, , Other
sex NN Other
, , Other
indication NN Other
for IN Other
MV NNP Other
, , Other
PRISM NNP Other
score NN Other
, , Other
Comfort NNP Other
scale NN Other
, , Other
use NN Other
of IN Other
sedatives NNS Other
or CC Other
ventilation NN Other
and CC Other
oxygenation NN Other
parameters NNS Other
. . Other
median JJ Other
time NN Other
on IN Other
MV NNP Other
duration NN Other
of IN Other
weaning VBG Other
length NN Other
of IN Other
hospital NN Other
stay NN Other
MV NNP Other
, , Other
duration NN Other
of IN Other
weaning VBG Other
or CC Other
time NN Other
spent VBN Other
in IN Other
the DT Other
PICU NNP Other
. . Other
-DOCSTART- -X- N

pain NN Pain
tolerance VB Other
postoperative JJ Pain
relief NN Pain
of IN Pain
pain NN Pain
degree NN Pain
of IN Pain
pain NN Pain
Nausea NN Adverse
and CC Adverse
vomiting NN Adverse
relief NN Pain
of IN Pain
postoperative JJ Pain
pain NN Pain
. . None
tolerance NN Other
-DOCSTART- -X- N

sickness JJ Physical
absence NN Physical
. . None
sickness JJ Physical
absence NN Physical
from IN Physical
work NN Physical
sickness JJ Physical
absence NN Physical
Sickness JJ Physical
absence NN Physical
( ( Physical
number NN Physical
of IN Physical
days NNS Physical
) ) Physical
compliance NN Mental
sickness JJ Physical
absence NN Physical
duration NN Other
of IN Other
absence NN Other
absence NN Other
sickness JJ Physical
absences NNS Physical
compliance NN Mental
sickness NN Physical
absence NN Physical
. . None
-DOCSTART- -X- N

coronal VB Physical
and CC Physical
root VB Physical
canal JJ Physical
dentin NN Physical
. . None
Bond NNP Other
strength NN Other
data NNS Other
were VBD None
analyzed VBN None
with IN None
two-way JJ Other
repeated JJ Other
measures NNS Other
ANOVA NNP Other
and CC Other
Tukey NNP Other
's POS Other
test NN Other
relationship NN Other
between IN Other
the DT Other
adhesives NNS Other
-DOCSTART- -X- N

difference NN None
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
half-life NN Physical
( ( Physical
T1/2 NNP Physical
) ) Physical
T1/2 NNP Physical
increased VBD Physical
accumulated VBD Physical
T1/2 NNP Physical
increases VBZ Physical
effect NN Other
more RBR None
prominent JJ None
in IN None
blacks NNS None
accumulate VBP Physical
more JJR Physical
Na NNP Physical
-DOCSTART- -X- N

Heartburn NNP Physical
local JJ Physical
antimicrobial JJ Physical
activity NN Physical
. . None
Relapse NNP Physical
local JJ Physical
and CC Physical
systemic JJ Physical
activity NN Physical
, , None
stability NN Physical
at IN Physical
low JJ Physical
pH NN Physical
, , None
and CC None
good JJ Physical
penetration NN Physical
into IN Physical
gastric JJ Physical
mucus NN Physical
. . None
-DOCSTART- -X- N

improvements NNS Physical
in IN Physical
severity NN Mental
and CC Mental
behavioral JJ Mental
features NNS Mental
of IN Mental
autistic JJ Mental
disorder NN Mental
( ( Mental
stereotypies NNS Mental
, , Mental
lethargy NN Mental
, , Mental
irritability NN Mental
, , Mental
hyperactivity NN Mental
, , Mental
emotional JJ Mental
reciprocity NN Mental
, , Mental
sharing VBG Mental
pleasures NNS Mental
) ) Mental
and CC None
improvements NNS Mental
in IN Mental
language NN Mental
and CC Mental
communication NN Mental
, , Mental
socialization NN Mental
, , Mental
and CC Mental
daily RB Mental
living VBG Mental
skills NNS Mental
Autism NNP Mental
Behavior NNP Mental
Checklist NNP Mental
, , Mental
the DT Mental
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
, , Mental
the DT Mental
Vineland NNP Mental
Adaptive NNP Mental
Behavior NNP Mental
scales NNS Mental
, , Mental
the DT Mental
PL-ADOS NNP Mental
, , Mental
or CC Mental
the DT Mental
CARS NNPS Mental
. . None
Parent NN Mental
rating NN Mental
scales NNS Mental
-DOCSTART- -X- N

ratings NNS Other
of IN Other
autism NN Other
and CC Other
anger NN Other
ratings NNS Mental
of IN Mental
repetitive JJ Mental
and CC Mental
compulsive JJ Mental
behaviors NNS Mental
. . None
ratings NNS Mental
of IN Mental
hyperactivity NN Mental
. . None
obsessive-compulsive JJ Mental
and CC None
core NN Physical
symptoms NNS Physical
-DOCSTART- -X- N

Circulating NNP Physical
tumour JJ Physical
cells NNS Physical
initial JJ None
rise NN None
in IN None
circulating VBG Physical
cells NNS Physical
after IN None
the DT None
first JJ None
cycle NN None
-DOCSTART- -X- N

pharmacokinetics NNS Physical
therapeutic JJ Other
efficacy NN Other
toxicity NN Physical
peak JJ Physical
plasma NN Physical
concentration NN Physical
time NN Physical
to TO Physical
reach VB Physical
peak JJ Physical
concentration NN Physical
lag NN Other
time NN Other
absorption NN Physical
rate NN Physical
bodyweight-corrected JJ Physical
area NN Physical
under IN Physical
the DT Physical
curve NN Physical
( ( Physical
AUC0-12 NNP Physical
) ) Physical
elimination NN Physical
half-life NN Physical
total JJ Other
clearance NN Other
circadian JJ Physical
rhythms NN Physical
-DOCSTART- -X- N

reflective JJ Physical
ocular JJ Physical
itching NN Physical
scores NNS Physical
Subject-reported JJ Adverse
adverse JJ Adverse
events NNS Adverse
( ( Adverse
AEs NNP Adverse
) ) Adverse
instantaneous JJ Other
and CC Other
reflective JJ Other
ocular JJ Other
itching NN Other
scores NNS Other
tolerated VBN Other
, , None
and CC None
AEs NNP Adverse
effectively RB Other
and CC None
safely RB Other
treated VBD None
ocular JJ Physical
itching NN Physical
-DOCSTART- -X- N

No NNP Other
significant JJ Other
differences NNS Other
accuracy NN Other
of IN Other
TCT NNP Other
registration NN Other
lower JJR Other
-DOCSTART- -X- N

Clinical NNP Mental
Global NNP Mental
Impressions NNP Mental
( ( Mental
CGI NNP Mental
) ) Mental
and CC None
the DT Mental
Children NNP Mental
's POS Mental
Psychiatric NNP Mental
Rating NNP Mental
Scale NNP Mental
( ( Mental
CPRS NNP Mental
) ) Mental
. . None
symptom VBN Mental
reduction NN Mental
. . None
CGI NNP Mental
CPRS NNP Mental
Autism NNP Mental
Factor NNP Mental
drowsiness NN Adverse
and CC Adverse
weight JJ Adverse
gain NN Adverse
. . None
treatment NN None
-DOCSTART- -X- N

appetite JJ Physical
improvement NN Physical
and CC Physical
weight VBD Physical
gain NN Physical
differences NNS Physical
in IN Physical
appetite NN Physical
or CC Physical
weight NN Physical
quality NN Other
of IN Other
life NN Other
( ( Other
QOL NNP Other
) ) Other
QOL NNP Other
Toxicity NN Adverse
impotence NN Physical
-DOCSTART- -X- N

Radiation NN Other
and CC Other
contrast NN Other
agent NN Other
doses NNS Other
Quantitative JJ Other
image NN Other
quality NN Other
parameters NNS Other
and CC Other
figure NN Other
of IN Other
merit NN Other
( ( Other
FOM NNP Other
) ) Other
image NN Other
quality NN Other
effective JJ Other
dose NN Other
and CC Other
amount NN Other
of IN Other
contrast NN Other
agent NN Other
respectively RB None
. . None
Image NNP None
noise NN None
was VBD None
0.0001 CD None
) ) None
. . None
Signal-to-noise JJ None
ratio NN None
( ( None
SNR NNP None
) ) None
and CC None
contrast-to-noise JJ Other
ratio NN Other
( ( Other
CNR NNP Other
) ) Other
in IN None
the DT None
proximal JJ None
right JJ None
coronary NN None
artery NN None
( ( None
RCA NNP None
) ) None
and CC None
left VBD None
main JJ None
coronary JJ None
artery NN None
( ( None
LMA NNP None
) ) None
FOM NNP None
were VBD None
all DT None
difference NN None
in IN None
image NN None
quality NN None
score NN None
between IN None
decreased VBN None
SNR NNP None
and CC None
CNR NNP None
of IN None
coronary JJ None
artery NN None
reduces VBZ None
radiation NN None
and CC None
contrast NN None
agent NN None
doses NNS None
in IN None
CCTA NNP None
-DOCSTART- -X- N

wound NN Physical
healing NN Physical
, , None
water NN Physical
loss NN Physical
, , None
inflammation NN Physical
, , None
and CC None
pain NN Pain
alleviation NN Pain
. . None
transepidermal JJ Physical
water NN Physical
loss NN Physical
secondary JJ Other
efficacy NN Other
burn NN Physical
injuries NNS Physical
-DOCSTART- -X- N

Range NNP Physical
of IN Physical
motion NN Physical
, , None
Constant NNP Physical
score NN Physical
, , None
Oxford NNP Physical
Shoulder NNP Physical
Score NNP Physical
, , None
Short NNP Physical
Form NNP Physical
36 CD Physical
, , None
and CC None
Hospital NNP Mental
Anxiety NNP Mental
and CC Physical
Disability NNP Physical
Scale NNP Physical
( ( Physical
HADS NNP Physical
) ) Physical
mean JJ Physical
Constant NNP Physical
score NN Physical
shoulder NN Physical
symptoms NNS Physical
on IN Physical
Oxford NNP Physical
and CC Physical
Constant NNP Physical
scores NNS Physical
individual JJ Other
physiotherapy NN Other
or CC Other
home NN Other
exercises NNS Other
alone RB Other
physiotherapy NN Physical
groups NNS Physical
over IN Physical
home NN Physical
exercises NNS Physical
HADS NNP Physical
scores VBZ Physical
HADS NNP Physical
anxiety NN Physical
score NN Physical
-DOCSTART- -X- N

incidence NN Physical
of IN Physical
inversion NN Physical
ankle NN Physical
sprains NNS Physical
risk NN Other
ratio NN Other
for IN Other
injured JJ Other
individuals NNS Other
Inversion NNP Physical
ankle NN Physical
sprains NNS Physical
-DOCSTART- -X- N

social JJ Mental
skills NNS Mental
efficacy NN Other
social JJ Mental
skills NNS Mental
their PRP$ None
social JJ None
skills NNS None
abilities NNS None
. . None
intervention NN None
: : None
emotion NN None
recognition NN None
and CC None
social JJ None
interactions NNS None
. . None
areas NNS None
: : None
facial JJ None
recognition NN None
, , None
emotion NN None
recognition NN None
, , None
and CC None
social JJ None
interactions NNS None
. . None
social JJ None
interactions NNS None
in IN None
-DOCSTART- -X- N

decreased VBD Mental
Arousal NNP Mental
, , Mental
Elation NNP Mental
, , Mental
Positive NNP Mental
Mood NNP Mental
and CC Mental
Vigor NNP Mental
increased VBD Mental
Anxiety NNP Mental
, , Mental
Depression NNP Mental
and CC Physical
Fatigue NNP Physical
increased VBD Mental
Arousal NNP Mental
and CC None
Vigor NNP Mental
likely JJ Other
to TO Other
be VB Other
sedative-like JJ Adverse
effects NNS Adverse
decreased VBD Mental
Anxiety NNP Mental
and CC Mental
increased VBD Mental
Friendliness NNP Mental
more RBR Other
frequent JJ Other
recreational JJ Other
use NN Other
of IN Other
marijuana NN Other
and CC Other
stimulants NNS Other
. . Other
demographic JJ Adverse
variables NNS Adverse
and CC Adverse
subjective JJ Adverse
drug NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

evolution NN Physical
of IN Physical
PAN NNP Physical
etiological JJ Physical
agent NN Physical
of IN Physical
the DT Physical
vasculitis NN Physical
. . Physical
prognosis NN Physical
control NN Physical
of IN Physical
the DT Physical
disease NN Physical
. . None
control NN Physical
of IN Physical
the DT Physical
disease NN Physical
infectious JJ Adverse
side NN Adverse
effects NNS Adverse
effective JJ Other
cured VBD None
length NN Physical
of IN Physical
HBV NNP Physical
infection NN Physical
seroconversion NN Physical
rate NN Physical
. . Physical
-DOCSTART- -X- N

relative JJ Physical
risk NN Physical
confidence NN Physical
intervals NNS Physical
RR NNP Physical
rectal JJ Physical
bleeding NN Physical
colorectal JJ Physical
cancer NN Physical
-DOCSTART- -X- N

segmental JJ Physical
sensitivity NN Physical
specificity NN Other
sensitivity NN Physical
Time NNP Other
since IN Other
MI NNP Other
and CC None
SPECT NNP Other
defect VBP Other
location NN Other
and CC Other
intensity NN Other
extent NN Adverse
of IN Adverse
defects NNS Adverse
on IN Adverse
MCE NNP Adverse
moderate JJ Adverse
or CC Adverse
severe JJ Adverse
perfusion NN Adverse
defects NNS Adverse
SPECT NNP Adverse
defects NNS Adverse
-DOCSTART- -X- N

nausea NN Physical
, , Physical
vomiting VBG Physical
and CC Physical
appetite JJ Physical
loss NN Physical
complete JJ Physical
inhibition NN Physical
rate NN Physical
of IN Physical
vomiting VBG Physical
grade NN Physical
of IN Physical
vomiting VBG Physical
Nausea NN Physical
Appetite NNP Physical
loss NN Physical
nausea NN Physical
on IN Physical
appetite JJ Physical
loss NN Physical
inhibitory NN Physical
effect NN Physical
on IN Physical
vomiting VBG Physical
nausea NN Physical
appetite JJ Physical
loss NN Physical
-DOCSTART- -X- N

risk NN Physical
of IN Physical
new JJ Physical
neoplasia NN Physical
risk NN Physical
of IN Physical
a DT Physical
patient NN Physical
having VBG Physical
new JJ Physical
adenomas NN Physical
significant JJ Physical
neoplasia NN Physical
( ( Physical
carcinoma NN Physical
or CC Physical
adenoma NN Physical
with IN Physical
villous JJ Physical
structure NN Physical
, , Physical
severe JJ Physical
dysplasia NN Physical
, , Physical
or CC Physical
diameter NN Physical
> VBP Physical
10 CD Physical
mm NN Physical
) ) None
higher JJR Physical
risk NN Physical
of IN Physical
new JJ Physical
adenomas NN Physical
. . None
adenomas NN Physical
. . None
risk NN Physical
of IN Physical
new JJ Physical
significant JJ Physical
neoplasia NN Physical
. . None
cancer NN Physical
risk NN Physical
of IN Physical
new JJ Physical
adenomas NNS Physical
neoplasia NN Physical
-DOCSTART- -X- N

postoperative JJ Pain
pain NN Pain
and CC Pain
local JJ Pain
inflammation NN Pain
efficacy NN Other
points NNS None
. . None
Efficacy NN None
was VBD None
total JJ None
amount NN None
of IN None
morphine NN None
consumed VBN None
, , None
pain VBP None
intensity NN None
, , None
range NN None
of IN None
motion NN None
( ( None
ROM NNP None
) ) None
, , None
the DT None
concentration NN None
change NN None
of IN None
PGE-2 NNP None
and CC None
IL-6 NNP None
of IN None
joint JJ None
fluid NN None
, , None
and CC None
postoperative JJ None
nausea NN None
and CC None
vomiting NN None
( ( None
PONV NNP None
) ) None
postoperatively RB None
less JJR None
morphine NN None
, , None
experienced VBD None
less JJR None
pain NN None
scores NNS None
, , None
and CC None
more RBR None
ROM NNP None
( ( None
P NNP None
postoperatively RB None
. . None
The DT None
concentration NN None
of IN None
PGE-2 NNP None
and CC None
IL-6 NNP None
of IN None
joint JJ None
fluid NN None
postoperatively RB None
. . None
The DT None
overall JJ None
incidence NN None
of IN None
PONV NNP None
postoperative JJ None
analgesic JJ None
management NN None
as IN None
defined VBN None
requirement NN None
, , None
lower JJR None
pain NN None
scores NNS None
and CC None
ROM NNP None
, , None
significantly RB None
lowered VBD None
local JJ None
inflammation NN None
factors NNS None
PGE2 NNP None
and CC None
IL-6 NNP None
-DOCSTART- -X- N

efficiency NN Other
overall JJ Other
length NN Other
of IN Other
stay NN Other
simplified JJ None
score NN None
was VBD None
the DT None
predictive JJ None
model NN None
was VBD None
the DT None
simplified VBN None
score NN None
was VBD None
hospitalization NN None
of IN None
32 CD None
days NNS None
or CC None
longer JJR None
; : None
having VBG None
-DOCSTART- -X- N

assess VB Other
and CC Other
compare VB Other
the DT Other
effectiveness NN Other
Modified NNP Physical
versions NNS Physical
of IN Physical
the DT Physical
Investigator NNP Physical
and CC Physical
Patient NNP Physical
Global NNP Physical
Improvement NNP Physical
Scores NNP Physical
average JJ Physical
number NN Physical
of IN Physical
lesions NNS Physical
in IN Other
the DT Other
diclofenac NN Other
sodium NN Other
group NN Other
before IN Other
and CC Other
after IN Other
treatment NN Other
number NN Other
of IN Other
lesions NNS Other
in IN Other
the DT Other
5-Fluorouracil JJ Other
group NN Other
therapeutic JJ Physical
response NN Physical
adverse JJ Adverse
effects NNS Adverse
Erythema NNP Adverse
, , Adverse
edema NN Adverse
, , Adverse
crusts NNS Adverse
and CC Adverse
itching VBG Adverse
-DOCSTART- -X- N

blocking VBG Physical
antibody NN Physical
activity NN Physical
rise NN Physical
in IN Physical
blocking VBG Physical
antibody NN Physical
activity NN Physical
blocking VBG Physical
antibody NN Physical
activity NN Physical
levels NNS Physical
postseasonal JJ Physical
specific JJ Physical
IgE NNP Physical
rise NN Physical
erythema JJ Physical
induration NN Physical
systemic JJ Adverse
reactions NNS Adverse
symptomatic JJ Other
improvement NN Other
-DOCSTART- -X- N

essential JJ Physical
headache NN Physical
Migraine NNP Other
Index NNP Other
general JJ Other
assessment NN Other
of IN Other
the DT Other
attacks NNS Other
, , None
i.e NN None
. . None
severity NN Physical
, , None
duration NN Physical
and CC None
frequency NN Other
. . None
mean JJ Other
score NN Other
values NNS Other
( ( None
Wilcoxon NNP Other
's POS Other
test NN Other
) ) None
-DOCSTART- -X- N

perioperative JJ Physical
myocardial JJ Physical
infarction NN Physical
and CC None
death NN Mortality
death NN Mortality
or CC None
nonfatal JJ Physical
myocardial JJ Physical
infarction NN Physical
primary-outcome JJ Physical
events NNS Physical
Myocardial JJ Physical
infarction NN Physical
hypotension NN Physical
nonfatal JJ Physical
cardiac JJ Physical
arrest NN Physical
death NN Mortality
nonfatal JJ Physical
myocardial JJ Physical
infarction NN Physical
; : None
clinically RB Physical
important JJ Physical
hypotension NN Physical
and CC None
nonfatal JJ Physical
cardiac JJ Physical
arrest NN Physical
. . None
-DOCSTART- -X- N

human JJ Physical
respiratory NN Physical
pattern NN Physical
Pattern NNP Physical
regulation NN Physical
dynamics NNS Physical
were VBD None
estimated VBN None
from IN None
the DT Physical
computed VBN Physical
impulse JJ Physical
responses NNS Physical
of IN Physical
tidal JJ Physical
volume NN Physical
and CC Physical
inspiratory NN Physical
and CC Physical
expiratory JJ Physical
durations NNS Physical
. . None
variability NN Physical
in IN Physical
response NN Physical
strategies NNS Physical
nonlinearity NN Physical
qualitative JJ Physical
variation NN Physical
-DOCSTART- -X- N

systolic JJ Physical
function NN Physical
of IN Physical
the DT Physical
left JJ Physical
ventricle NN Physical
, , None
arrhythmia NN Physical
and CC None
clinical JJ Physical
symptoms NNS Physical
Left NNP Physical
ventricular JJ Physical
systolic JJ Physical
function NN Physical
arrhythmia NN Physical
systolic NN Physical
and CC Physical
diastolic JJ Physical
volumes NNS Physical
left JJ Physical
ventricular JJ Physical
systolic JJ Physical
dysfunction NN Physical
-DOCSTART- -X- N

Ease NNP Other
of IN Other
insertion NN Other
, , Physical
quality NN Other
of IN Other
airway NN Other
seal NN Other
, , Physical
fibre-optic JJ Other
view NN Other
and CC Physical
postoperative JJ Physical
pharyngeal NN Physical
morbidity NN Physical
First-time JJ Other
and CC Other
second-time JJ Other
success NN Other
rates NNS Other
airway NN Physical
Time NNP Other
until IN Other
delivery NN Other
of IN Other
first JJ Other
tidal JJ Other
volume NN Other
Fixation NNP Other
and CC Physical
manipulation NN Other
time NN Physical
Airway NNP Physical
seal JJ Physical
pressure NN Physical
postoperative JJ Physical
pharyngeal NN Physical
morbidities NNS Physical
. . Adverse
hoarseness NN Adverse
airway RB Physical
seal NN Physical
-DOCSTART- -X- N

Gingival NNP Physical
overgrowth NN Physical
Gingival NNP Physical
overgrowth NN Physical
gingival JJ Physical
overgrowth NN Physical
) ) None
gingival JJ Physical
overgrowth NN Physical
gingival NN Physical
overgrowth NN Physical
-DOCSTART- -X- N

CEA NNP Physical
values NNS Physical
: : None
5-year JJ Mortality
overall JJ Mortality
survival NN Mortality
5-year JJ Mortality
disease-free JJ Mortality
survival NN Mortality
5-year JJ Mortality
overall JJ Mortality
survival NN Mortality
rate NN Mortality
-DOCSTART- -X- N

risk NN Other
of IN Other
an DT Other
adverse JJ Other
outcome-absence NN Other
of IN Other
documentation NN Other
of IN Other
discharge NN Other
planning NN Other
, , None
elevated JJ Physical
temperature NN Physical
, , None
abnormal JJ Physical
pulse NN Physical
, , None
and CC None
unaddressed JJ Physical
abnormal JJ Physical
test NN Physical
results NNS Physical
examined-abnormal JJ Physical
blood NN Physical
pressure NN Physical
, , None
IV NNP Physical
fluids NNS Physical
or CC Physical
drugs NNS Physical
, , None
and CC None
wound JJ Physical
drainage NN Physical
abnormal JJ Physical
pulse NN Physical
, , None
increased JJ Physical
temperature NN Physical
unaddressed JJ Physical
abnormal JJ Physical
tests NNS Physical
-DOCSTART- -X- N

number NN Mental
of IN Mental
male JJ Mental
partners NNS Mental
, , Mental
number NN Mental
of IN Mental
unprotected JJ Mental
anal JJ Mental
intercourse NN Mental
partners NNS Mental
, , Mental
proportion NN Mental
reporting NN Mental
unprotected JJ Mental
sex NN Mental
, , Mental
number NN Mental
of IN Mental
acts NNS Mental
protected VBN Mental
by IN Mental
condoms NNS Mental
, , Mental
self-efficacy NN Mental
, , Mental
condom NN Mental
attitudes NNS Mental
, , Mental
condom NN Mental
intentions NNS Mental
, , Mental
social JJ Mental
isolation NN Mental
and CC Mental
psychological JJ Mental
distress NN Mental
. . None
sexual JJ Mental
risk NN Mental
behaviors NNS Mental
, , Mental
social JJ Mental
isolation NN Mental
and CC Mental
psychological JJ Mental
distress NN Mental
self-efficacy NN Other
, , Other
condom NN Other
attitudes NNS Other
and CC Other
condom NN Other
-DOCSTART- -X- N

survival NN Mortality
median JJ Mortality
survival NN Mortality
time NN Mortality
( ( Mortality
FUDR NNP Mortality
, , Mortality
pump NN Mortality
) ) Mortality
-DOCSTART- -X- N

frontoparietal JJ Physical
white JJ Physical
matter NN Physical
integrity NN Physical
white JJ Physical
matter NN Physical
integrity NN Physical
( ( Physical
WMI NNP Physical
) ) Physical
diffusion NN Physical
tensor NN Physical
imaging NN Physical
( ( Physical
DTI NNP Physical
) ) Physical
WMI NNP Physical
DTI NNP None
scans NNS None
. . None
affected VBD None
WMI NNP None
in IN None
time NN None
interaction NN None
for IN None
WMI NNP None
in IN None
group NN None
by IN None
time NN None
by IN None
attendance NN None
interaction NN None
, , None
higher JJR None
attendance NN None
at IN None
with IN None
increased JJ None
WMI NNP None
. . None
Heart NNP None
rate NN None
and CC None
the DT None
total JJ None
dose NN None
of IN None
exercise NN None
correlated VBN None
with IN None
WMI NNP None
changes NNS None
in IN None
increased VBD None
WMI NNP None
was VBD None
with IN None
improved JJ None
scores NNS None
on IN None
a DT None
measure NN None
of IN None
attention NN None
and CC None
improved VBN None
teacher JJ None
ratings NNS None
of IN None
executive NN None
function NN None
. . None
intervention NN None
improves VBZ None
WMI NNP None
in IN None
-DOCSTART- -X- N

symptomatic JJ Physical
improvement NN Physical
bacterial JJ Physical
eradication NN Physical
active JJ Physical
had VBD None
active JJ None
disease NN Physical
clinical JJ Other
efficacy NN Other
risk NN Adverse
of IN Adverse
ototoxicity NN Adverse
. . None
-DOCSTART- -X- N

assessment NN Physical
MEG-X JJ Physical
formation NN Physical
rate NN Physical
side NN None
effects NNS None
Child-Pugh NNP Adverse
score NN Adverse
side NN Physical
effects NNS Physical
. . Physical
fewer JJR Physical
side NN Physical
effects NNS Physical
-DOCSTART- -X- N

general JJ Other
increase NN Other
in IN Other
the DT Other
number NN Other
of IN Other
microorganisms NNS Other
from IN Other
gastric JJ Other
mucosa NN Other
selection NN Other
of IN Other
resistant JJ Other
enterobacteria NN Other
increase NN Other
in IN Other
beta-lactamase JJ Other
production NN Other
Eradication NN Other
of IN Other
H. NNP Other
pylori NN Other
in IN Other
the DT Other
omeprazole-amoxycillin JJ Other
group NN Other
No DT Other
viable JJ Other
H. NNP Other
pylori NN Other
saliva NN Physical
, , None
dental JJ Physical
plaque NN Physical
or CC None
faecal JJ Physical
samples NNS Physical
. . None
intestinal JJ Physical
microflora NN Physical
. . Physical
-DOCSTART- -X- N

hemoglobin NN Physical
( ( Physical
Hb NNP Physical
) ) Physical
correction NN Physical
vitality NN Physical
and CC Physical
physical JJ Physical
function NN Physical
and CC Physical
experienced JJ Physical
greater JJR Physical
improvement NN Physical
in IN Physical
symptoms NNS Physical
of IN Physical
fatigue NN Physical
serious JJ Adverse
adverse JJ Adverse
drug NN Adverse
events NNS Adverse
. . None
correcting VBG Physical
anemia NN Physical
, , None
replenishing VBG Physical
iron NN Physical
stores NNS Physical
, , None
and CC None
improving VBG Other
quality NN Other
of IN Other
life NN Other
. . None
-DOCSTART- -X- N

Percentages NNS Physical
of IN Physical
the DT Physical
plasma JJ Physical
concentrations NNS Physical
of IN Physical
the DT Physical
principal JJ Physical
metabolites NNS Physical
desacetyldiltiazem NNS Physical
and CC Physical
N-desmethyldiltiazem NNP Physical
to TO Physical
diltiazem VB Physical
plasma NN Physical
diltiazem NN Physical
concentration NN Physical
and CC None
percent JJ Physical
heart NN Physical
rate NN Physical
reduction NN Physical
. . None
Mean JJ None
+/- JJ None
SD NNP None
Emax NNP None
EC50 NNP Physical
plasma NN Physical
diltiazem NN Physical
concentration NN Physical
heart NN Physical
rate NN Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
SBP NNP Physical
) ) Physical
or CC None
diastolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
DBP NNP Physical
) ) Physical
-DOCSTART- -X- N

the DT None
rate NN None
of IN None
H. NNP None
pylori FW None
eradication NN None
was VBD None
significantly RB None
higher JJR None
for IN None
triple JJ None
therapy NN None
20/23 CD None
cases NNS None
, , None
87.0 CD None
% NN None
; : None
95 CD None
% NN None
confidence NN None
interval NN None
( ( None
CI NNP None
) ) None
, , None
0.664-0.972 JJ None
) ) None
than IN None
for IN None
dual JJ None
therapy NN None
the DT None
difference NN None
between IN None
the DT None
groups NNS None
in IN None
the DT None
rate NN None
of IN None
H. NNP None
pylori FW None
eradication NN None
was VBD None
marginally RB None
significant JJ None
Side JJ None
effects NNS None
were VBD None
reported VBN None
by IN None
five CD None
patients NNS None
receiving VBG None
triple JJ None
therapy NN None
( ( None
skin JJ Adverse
rash NN Adverse
nausea NN Adverse
headache NN Adverse
abdominal JJ Adverse
pain NN Adverse
four CD None
patients NNS None
receiving VBG None
dual JJ None
therapy NN None
( ( None
skin JJ Physical
rash NN Physical
abdominal JJ Adverse
pain NN Adverse
diarrhoea NN Adverse
All DT None
side NN None
effects NNS None
resolved VBD None
spontaneously RB None
after IN None
termination NN None
of IN None
treatment NN None
. . None
There EX None
was VBD None
no DT None
significant JJ None
difference NN None
in IN None
safety NN Other
between IN None
the DT None
two CD None
regimens NNS None
. . None
Triple JJ None
therapy NN None
with IN None
metronidazole NN None
, , None
amoxycillin NN None
, , None
and CC None
omeprazole NN None
was VBD None
significantly RB None
more RBR None
effective JJ None
for IN None
the DT None
eradication NN None
of IN None
H. NNP None
pylori FW None
than IN None
dual JJ None
therapy NN None
with IN None
amoxycillin NN None
and CC None
omeprazole JJ None
alone RB None
. . None
-DOCSTART- -X- N

prostate NN Adverse
specific JJ Adverse
antigen NN Adverse
relapse-free JJ Adverse
survival NN Adverse
rates NNS Adverse
clinical JJ Physical
or CC Physical
pathological JJ Physical
parameters NNS Physical
prostate VB Physical
specific JJ Physical
antigen NN Physical
relapse NN Physical
rates NNS Physical
-DOCSTART- -X- N

antihypertensive JJ Physical
effects NNS Physical
supine JJ Physical
DBP NNP Physical
significantly RB None
reduced VBN None
DBP VBP Physical
DBP NNP Physical
No DT Adverse
adverse JJ Adverse
side NN Adverse
effects NNS Adverse
proteinuria NN Adverse
-DOCSTART- -X- N

improve VB Physical
the DT Physical
voice NN Physical
quality NN Physical
pneumatic JJ Physical
artificial JJ Physical
source NN Physical
of IN Physical
voice NN Physical
incorporated VBN Physical
in IN Physical
a DT Physical
regular JJ Physical
tracheoesophageal NN Physical
( ( Physical
TE NNP Physical
) ) Physical
shunt NN Physical
valve NN Physical
. . Physical
speech JJ Physical
rate NN Physical
, , Physical
maximal JJ Physical
phonation NN Physical
time NN Physical
, , Physical
perceptual JJ Physical
voice NN Physical
evaluation NN Physical
of IN Physical
read-aloud JJ Physical
prose NN Physical
by IN Physical
an DT Physical
expert NN Physical
listener NN Physical
, , Physical
, , Physical
and CC Physical
self-assessment JJ Physical
by IN Physical
the DT Physical
patients NNS Physical
. . Physical
extensive JJ Other
acoustical JJ Other
and CC Other
aerodynamic JJ Physical
in IN Physical
vivo JJ Physical
registrations NNS Physical
newly RB Other
developed VBN Other
data NNS Other
acquisition NN Other
system NN Other
. . Other
improves VBZ Physical
voice JJ Physical
quality NN Physical
and CC Physical
increases VBZ Physical
the DT Physical
average JJ Physical
pitch NN Physical
of IN Physical
voice NN Physical
, , Physical
without IN Physical
decreasing VBG Physical
intelligibility NN Physical
or CC Physical
necessitating VBG Physical
other JJ Physical
pressure NN Physical
and CC Physical
airflow NN Physical
rates NNS Physical
than IN Physical
regular JJ Physical
TE NNP Physical
shunt NN Physical
speech NN Physical
. . Physical
Pitch NNP Physical
regulation NN Physical
feasible JJ Other
-DOCSTART- -X- N

bleeding VBG Physical
events NNS Physical
related JJ Mortality
deaths NNS Mortality
bleeding VBG Physical
deaths NNS Mortality
variceal JJ Physical
hemorrhage NN Physical
. . None
bleeding NN Physical
, , Physical
bleeding VBG Physical
risk NN Physical
deaths NNS Mortality
-DOCSTART- -X- N

frequency NN None
occult NN Physical
testicular JJ Physical
leukemia NN Physical
( ( Physical
TL NNP Physical
) ) Physical
disease-free JJ Mortality
survival NN Mortality
( ( Mortality
DFS NNP Mortality
) ) Mortality
relapsed VBD Physical
died VBD Mortality
. . None
developed VBD Physical
isolated JJ Physical
overt JJ Physical
TL NNP Physical
. . None
DFS NNP Physical
after IN Physical
testicular JJ Physical
biopsy NN Physical
significantly RB None
better RBR None
subsequent JJ None
bone NN Physical
marrow NN Physical
( ( Physical
BM NNP Physical
) ) Physical
relapse NN Physical
and CC None
death NN Mortality
. . None
higher JJR Physical
salvage NN Physical
rate NN Physical
-DOCSTART- -X- N

Preinjection NN Physical
mean NN Physical
( ( Physical
+/- JJ Physical
SD NNP Physical
) ) Physical
IOP NNP Physical
Preoperative JJ Physical
intraocular JJ Physical
pressures NNS Physical
Pre- NNP Physical
and CC Physical
postinjection NN Physical
IOP NNP Physical
Pain NN Pain
scores NNS Pain
for IN Pain
delivery NN Pain
of IN Pain
the DT Pain
anesthetic JJ Pain
numerical JJ Other
rating NN Other
scale NN Other
Complete JJ Physical
akinesia NN Physical
incomplete JJ Physical
akinesia NN Physical
lateral JJ Physical
muscle NN Physical
function NN Physical
-DOCSTART- -X- N

vision NN Physical
loss NN Physical
Biosafety NNP Other
Treatment-emergent JJ None
adverse JJ None
events NNS None
including VBG None
blood NN None
chemistry NN None
metabolites NNS None
were VBD None
supplementation NN None
elevated VBD None
plasma NN None
and CC None
red JJ None
blood NN None
cell-DHA JJ None
4.4- JJ None
and CC None
for IN None
vitamin NN None
A NNP None
, , None
vitamin NN None
E NNP None
, , None
platelet NN None
aggregation NN None
, , None
antioxidant JJ None
activity NN None
, , None
lipoprotein NN None
cholesterol NN None
, , None
or CC None
oxidized VBN None
LDL NNP None
levels NNS None
( ( None
0.14 CD None
) ) None
. . None
Adverse JJ None
events NNS None
were VBD None
and CC None
not RB None
considered VBN None
severe JJ None
( ( None
gastrointestinal JJ None
[ NN None
GI NNP None
] NNP None
irritability NN None
, , None
blood NN None
chemistry NN None
alterations NNS None
) ) None
. . None
tolerate VB None
persistent JJ None
GI NNP None
discomfort NN None
. . None
with IN None
limited JJ None
safety NN None
risks NNS None
in IN None
Nevertheless NNP None
, , None
GI NNP None
symptoms NNS None
should MD None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
efficacy NN Other
and CC Other
safety NN Other
treatment NN Other
efficacy NN Other
and CC None
ulcer JJ Physical
healing VBG Physical
rate NN Physical
. . None
Vital NNP Physical
signs NNS Physical
and CC None
blood/ JJ Other
urine JJ Other
analysis NN Other
endoscopic NN Other
ulcer JJ Other
healing VBG Other
rate NN Other
Healing VBG Physical
rate NN Physical
development NN Physical
of IN Physical
symptoms NNS Physical
, , None
number NN Pain
of IN Pain
episodes NNS Pain
of IN Pain
ulcer-related JJ Pain
pain NN Pain
, , None
total JJ Physical
ulcerated JJ Physical
surface NN Physical
area NN Physical
or CC None
subjective JJ None
ratings NNS None
by IN None
the DT None
patients NNS None
and CC None
investigators NNS None
tolerance NN Other
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

abstinence NN Mental
. . Physical
abstinence NN Mental
outcomes NNS Mental
baseline JJ Physical
characteristics NNS Physical
and CC Physical
posttreatment NN Physical
and CC Physical
follow-up JJ Physical
cocaine NN Physical
outcomes NNS Physical
durations NNS Mental
of IN Mental
cocaine NN Mental
abstinence NN Mental
cocaine-negative JJ Mental
sample NN Mental
outcomes NNS None
cocaine NN Mental
abstinence NN Mental
-DOCSTART- -X- N

low JJ Pain
back RB Pain
pain NN Pain
intensity NN Pain
, , None
disability NN Physical
, , None
and CC None
complete JJ Other
remission NN Other
. . None
participants NNS Other
' POS Other
perception NN Other
of IN Other
improvement NN Other
in IN Other
low JJ Physical
back RB Physical
symptoms NNS Physical
. . None
pain NN Pain
and CC None
disability NN Physical
risk NN Physical
of IN Physical
complete JJ Physical
remission NN Physical
mean JJ Pain
changes NNS Pain
in IN Pain
pain NN Pain
and CC None
disability NN Physical
and CC None
risk NN Other
of IN Other
remission NN Other
pain-free JJ Pain
-DOCSTART- -X- N

safety NN Other
and CC Other
efficacy NN Other
motor NN Physical
symptoms NNS Physical
in IN Physical
Parkinson NNP Physical
disease NN Physical
( ( Physical
PD NNP Physical
) ) Physical
improving VBG Physical
gait NN Physical
disability NN Physical
safety NN Other
and CC Other
clinical JJ Other
efficacy NN Other
gait NN Physical
and CC Physical
bradykinesia NN Physical
, , None
Unified NNP Other
Parkinson NNP Other
's POS Other
Disease NNP Other
Rating NNP Other
Scale NNP Other
( ( Other
UPDRS NNP Other
) ) Other
, , Physical
and CC None
additional JJ Mental
clinical NN Mental
, , None
neuropsychological JJ Mental
, , None
and CC None
neurophysiologic JJ Mental
measures NNS Mental
. . None
mood NN Mental
gait NN Physical
, , None
bradykinesia NN Physical
, , None
UPDRS NNP Physical
, , None
and CC None
other JJ None
measures NNS None
. . None
EEG/EMG NNP Mental
increase NN Physical
of IN Physical
cortical JJ Physical
excitability NN Physical
or CC Physical
epileptic JJ Physical
activity NN Physical
. . None
discomfort NN Pain
or CC Pain
pain NN Pain
tinnitus NN Adverse
safe JJ Other
and CC None
improves VBZ Mental
mood NN Mental
motor NN Physical
performance NN Physical
and CC Physical
functional JJ Physical
status NN Physical
was VBD None
not RB None
effective JJ Other
gait NN Physical
, , None
upper JJ Physical
extremity NN Physical
bradykinesia NN Physical
, , None
or CC None
other JJ Physical
motor NN Physical
symptoms NNS Physical
in IN Physical
-DOCSTART- -X- N

endotoxemia NN Physical
endotoxemia NN Physical
Endotoxin NNP Physical
concentration NN Physical
, , None
liver JJ Physical
function NN Physical
tests NNS Physical
Endotoxin NNP Physical
concentration NN Physical
endotoxin NN Physical
concentrations NNS Physical
endotoxin NN Physical
concentration NN Physical
endotoxin NN Physical
concentration NN Physical
liver JJ Physical
function NN Physical
tests NNS Physical
-DOCSTART- -X- N

depressive JJ Mental
symptoms NNS Mental
and CC Mental
functioning VBG Mental
RESULTS NNP None
Baseline NNP None
HAM-D?? NNP None
scores NNS None
for IN None
desvenlafaxine NN None
20.4 CD None
. . None
Adjusted VBN None
mean JJ None
differences NNS None
between IN None
HAM-D?? JJ None
scores NNS None
were VBD None
SDS NNP None
baseline NN None
scores NNS None
the DT None
HAM-D?? NNP None
SDS NNP None
. . None
Adverse JJ None
events NNS None
and CC None
Arizona NNP None
Sexual NNP None
Experience NNP None
Scale NNP None
scores NNS None
were VBD None
-DOCSTART- -X- N

infectious JJ Physical
symptoms NNS Physical
higher JJR Physical
morbidity NN Physical
morbidity NN Physical
morbidity NN Physical
-DOCSTART- -X- N

Efficacy NN Other
safety NN Other
efficacy NN Other
safety NN Other
changes NNS Physical
in IN Physical
trough JJ Physical
supine NN Physical
systolic NN Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
sSBP NN Physical
, , Physical
sDBP NN Physical
) ) Physical
Equivalence NN Physical
assessed VBN None
decreased VBD Physical
sSBP NN Physical
confidence NN Physical
interval NN Physical
predefined JJ Physical
equivalence NN Physical
interval NN Physical
sDBP NN Physical
decreased VBN Physical
confidence NN Other
interval NN Other
equivalence NN Physical
interval NN Physical
antihypertensive JJ Other
efficacy NN Other
equivalent JJ Physical
sSBP NN Physical
tolerated VBN Other
. . None
-DOCSTART- -X- N

efficacy NN Other
Efficacy NN Other
was VBD None
assessed VBN None
as IN None
success/failure NN Other
, , Other
success NN Other
statistically RB Other
significant JJ Other
difference NN Other
other JJ None
criteria NNS None
( ( None
lung NN Physical
function NN Physical
, , Physical
rescue NN Physical
salbutamol NNS Physical
intake VBP Physical
during IN Physical
day NN Physical
and CC Physical
night NN Physical
) ) None
. . None
Side-effects NNS Adverse
Efficacy NN Other
and CC Other
tolerance NN Other
-DOCSTART- -X- N

duration NN Physical
of IN Physical
intoxication NN Physical
symptoms NNS Physical
and CC Physical
local JJ Physical
symptoms NNS Physical
duration NN Physical
of IN Physical
the DT Physical
relapse NN Physical
, , Physical
activated JJ Physical
expression NN Physical
of IN Physical
IFN-gamma NNP Physical
mRNA NN Physical
, , Physical
and CC Physical
improved VBD Physical
IFN-gamma-producing NNP Physical
capacity NN Physical
of IN Physical
blood NN Physical
leukocytes NNS Physical
. . Physical
-DOCSTART- -X- N

referral NN None
) ) None
. . None
Body NNP None
weight VBD None
, , None
physical JJ None
performance NN None
, , None
handgrip JJ None
strength NN None
, , None
energy NN None
intake NN None
, , None
protein JJ None
intake NN None
and CC None
fat-free JJ None
mass NN None
were VBD None
outcomes NNS None
body NN None
weight NN None
( ( None
-0.15-1.12 NN None
) ) None
, , None
physical JJ None
performance NN None
( ( None
? . None
handgrip JJ None
strength NN None
( ( None
? . None
effect NN None
on IN None
body NN None
weight NN None
in IN None
physically RB None
-DOCSTART- -X- N

The DT None
overall JJ None
survival NN None
significant JJ None
increase NN None
in IN None
the DT None
duration NN None
of IN None
first JJ None
remission NN None
first JJ None
relapse NN None
to TO None
death NN None
the DT None
incidence NN None
of IN None
first JJ None
or CC None
second JJ None
remissions NNS None
, , None
the DT None
time NN None
taken VBN None
to TO None
enter VB None
remission NN None
longer JJR None
remissions NNS None
. . None
developed VBD None
leukaemic JJ None
central-nervous-system NN None
( ( None
CSN NNP None
) ) None
involvement NN None
, , None
in IN None
remission NN None
length NN None
in IN None
survival NN None
after IN None
CNS NNP None
relapse NN None
may MD None
protect VB None
the DT None
CNS NNP None
against IN None
leukaemic JJ None
infiltration NN None
of IN None
CNS NNP None
prophylaxis NN None
. . None
-DOCSTART- -X- N

duration NN Other
of IN Other
artificial JJ Other
ventilation NN Other
and CC Physical
pulmonary JJ Physical
oxygenation NN Physical
ability NN Physical
mortality NN Mortality
and CC None
the DT None
concentrations NNS Mortality
of IN Mortality
PMN-E NNP Mortality
, , Mortality
SP-D NNP Mortality
, , Mortality
TNF-alpha NNP Mortality
and CC Mortality
IL-8 NNP Mortality
in IN Mortality
blood NN Mortality
. . None
duration NN Other
of IN Other
artificial JJ Other
ventilation NN Other
, , None
pulmonary JJ Physical
oxygenation NN Physical
ability NN Physical
, , Physical
and CC None
the DT None
blood NN Physical
PMN-E NNP Physical
, , Physical
SP-D NNP Physical
, , Physical
TNF-alpha NNP Physical
and CC Physical
IL-8 NNP Physical
concentrations NNS Physical
alveolar JJ Physical
dysfunction NN Physical
respiratory NN Physical
function NN Physical
-DOCSTART- -X- N

prolonged JJ Mortality
survival NN Mortality
Overall JJ Mortality
survival NN Mortality
( ( Mortality
OS NNP Mortality
) ) Mortality
vomiting VBG Adverse
rise NN Adverse
in IN Adverse
serum JJ Adverse
creatinine NN Adverse
abdominal JJ Adverse
pain NN Adverse
neurotoxicity NN Adverse
pattern NN Adverse
of IN Adverse
relapse NN Adverse
died VBN Mortality
; : None
-DOCSTART- -X- N

Tactile NNP Other
feedback NN Other
force VBP Other
feedback NN Other
and CC None
tactile JJ Other
sensation NN Other
( ( Other
haptics NNS Other
) ) Other
force NN Other
feedback NN Other
haptic JJ Physical
feedback NN Physical
texture NN Mental
, , None
shape NN Mental
, , None
and CC None
consistency NN Mental
of IN Mental
an DT Mental
object NN Mental
. . None
Inspection NN Other
by IN Other
direct JJ Other
palpation NN Other
, , None
conventional JJ Other
instruments NNS Other
, , None
and CC None
laparoscopic JJ Other
instruments NNS Other
Direct NNP Physical
palpation NN Physical
haptic JJ Other
feedback NN Other
. . None
-DOCSTART- -X- N

combined VBN Mortality
incidence NN Mortality
of IN Mortality
death NN Mortality
, , None
reinfarction NN Physical
, , None
stroke VBD Physical
or CC None
new JJ Physical
myocardial JJ Physical
ischaemia NN Physical
. . None
-DOCSTART- -X- N

full-scale JJ Mental
IQ NNP Mental
-DOCSTART- -X- N

haemoglobin JJ Physical
A1c NNP Physical
and CC Physical
urine JJ Physical
albumin NN Physical
: : Physical
creatinine NN Physical
ratio NN Physical
( ( Physical
DCA NNP Physical
2000 CD Physical
) ) Physical
, , Physical
lipids NNS Physical
( ( Physical
Cholestech NNP Physical
LDX NNP Physical
) ) Physical
and CC Physical
international JJ Physical
normalized VBN Physical
ratio NN Physical
( ( Physical
CoaguChek NNP Physical
S NNP Physical
) ) Physical
. . Physical
Median JJ Other
within-practice JJ Other
imprecision NN Other
high-density NN Physical
lipoprotein-cholesterol NN Physical
( ( Physical
HDL-C NNP Physical
) ) Physical
imprecision NN None
HDL-C NNP Physical
. . None
-DOCSTART- -X- N

CT NNP Physical
and CC Physical
MRI NNP Physical
measurements NNS Physical
of IN Physical
tibial JJ Physical
tubercle-trochlear JJ Physical
groove NN Physical
distances NNS Physical
Tibial NNP Physical
tubercle-trochlear JJ Physical
groove NN Physical
distance NN Physical
( ( Physical
TT-TG NNP Physical
) ) Physical
TT-TG NNP Physical
distance NN Physical
measurements NNS Physical
TT-TG NNP Physical
distances NNS Physical
Interobserver NNP Physical
reliability NN Physical
intermethod JJ Physical
reliability NN Physical
TT-TG JJ Physical
distance NN Physical
Interobserver NNP Physical
reliability NN Physical
ICC NNP Physical
TT-TG JJ Physical
distance NN Physical
underwent JJ None
distal JJ None
realignment NN None
by IN None
the DT None
mean JJ None
TT-TG NNP None
distance NN None
was VBD None
The DT None
TT-TG JJ None
distance NN None
can MD None
excellent JJ None
interrater NN None
reliability NN None
on IN None
the DT None
TT-TG NNP None
distance NN None
when WRB None
-DOCSTART- -X- N

delayed JJ Physical
MRP NNP Physical
onset NN Physical
and CC None
peak NN Other
times NNS Other
-DOCSTART- -X- N

blood NN Physical
staining NN Physical
Insertion NN Other
frequently RB Other
successful JJ Other
faster RBR None
failed VBD Other
insertions NNS Other
aetiology NN Other
of IN Other
failed JJ Other
insertion NN Other
blood NN Other
staining VBG Other
blood VBD Physical
staining NN Physical
success NN None
rate NN None
trauma JJ None
-DOCSTART- -X- N

, , None
overall JJ None
survival NN None
was VBD None
identical JJ None
five-year JJ None
survival JJ None
17 CD None
% NN None
in IN None
The DT None
incidence NN None
of IN None
late JJ None
grade NN None
3-5 JJ None
toxicities NNS None
was VBD None
16 CD None
regarding VBG None
overall JJ None
survival NN None
, , None
disease-free JJ None
survival NN None
or CC None
long-term JJ None
toxicity NN None
. . None
CONCLUSION VB None
compromise VB None
survival NN None
. . None
As IN None
done VBN None
term NN None
toxicity NN None
is VBZ None
needed VBN None
-DOCSTART- -X- N

Cost-effectiveness NN Other
Anxiety NNP Mental
and CC None
fear NN Mental
cost-effectiveness JJ Other
analysis NN Other
cost-effectiveness JJ Other
analysis NN Other
means NNPS None
, , None
95 CD None
% NN None
confidence NN None
intervals NNS None
[ VBP None
95 CD None
% NN None
CI NNP None
] NNP None
, , None
incremental JJ Other
cost-effectiveness JJ Other
graphic NN Other
and CC Other
acceptability NN Other
curve NN Other
estimated JJ None
means VBZ None
of IN None
direct JJ Other
costs NNS Other
and CC None
reduction NN Mental
of IN Mental
fear NN Mental
of IN Mental
progression NN Mental
incremental JJ Other
cost-effectiveness JJ Other
ratio NN Other
acceptability NN Other
curve NN Other
cost-effective JJ Other
cost-effectiveness NN Other
-DOCSTART- -X- N

maximal JJ Physical
voluntary JJ Physical
cycling VBG Physical
power NN Physical
Perceived NNP Physical
exertion NN Physical
time NN Physical
to TO Physical
exhaustion NN Physical
-DOCSTART- -X- N

Acid NNP Physical
resistance NN Physical
acid JJ Physical
resistance NN Physical
challenged VBD Other
with IN Other
acid NN Other
in IN Physical
vitro NN Physical
level NN Physical
of IN Physical
remineralization NN Physical
microradiography NN Other
. . None
level NN Physical
of IN Physical
remineralization NN Physical
lesions NNS Physical
remineralized VBN Physical
demineralization NN Physical
superior JJ Other
more RBR Physical
resistant JJ Physical
-DOCSTART- -X- N

Efficacy NN Other
safety NN Other
efficacy NN Other
safety NN Other
flea NN None
comb NN None
counts NNS None
clinical JJ None
evaluations NNS None
of IN None
FAD NNP None
mean JJ Physical
flea NN Physical
counts NNS Physical
mean JJ Physical
flea NN Physical
counts NNS Physical
mean JJ Physical
flea NN Physical
counts NNS Physical
mean JJ Physical
flea NN Physical
counts NNS Physical
heartworm JJ Physical
prevention NN Physical
rate NN Physical
adverse JJ Adverse
events NNS Adverse
effective JJ Other
signs NNS None
associated VBN None
with IN None
FAD NNP None
heartworms NNS None
safe JJ Other
-DOCSTART- -X- N

cluster NN Adverse
of IN Adverse
seizures NNS Adverse
status NN Adverse
epilepticus NN Adverse
symptoms NNS Adverse
of IN Adverse
systemic JJ Adverse
lupus NN Adverse
erythematodes NNS Adverse
. . None
stillbirth NN Mortality
. . None
blood-brain JJ None
barrier NN None
cluster NN Adverse
of IN Adverse
seizures NNS Adverse
. . None
risk NN Physical
for IN Physical
epileptic JJ Physical
seizures NNS Physical
. . None
-DOCSTART- -X- N

clinical JJ Physical
proteinuria NN Physical
progression NN Physical
of IN Physical
albuminuria NNS Physical
microalbuminuria NNS Physical
clinical JJ Physical
proteinuria NN Physical
progression NN Physical
albuminuria NN Physical
progression NN Physical
of IN Physical
albuminuria NN Physical
-DOCSTART- -X- N

uterine JJ Physical
and CC Physical
follicular JJ Physical
Doppler NNP Physical
flow NN Physical
ovarian JJ Physical
response NN Physical
to TO Physical
gonadotrophin VB Physical
lower JJR Other
cancellation NN Other
rate NN Other
, , Physical
an DT Physical
increased JJ Physical
number NN Physical
of IN Physical
oocytes NNS Physical
collected VBN Physical
, , None
and CC None
embryos RB Other
transferred VBN Other
increased VBD Physical
plasma NN Physical
and CC Physical
follicular JJ Physical
fluid NN Physical
concentrations NNS Physical
of IN Physical
arginine NN Physical
, , Physical
citrulline NN Physical
, , Physical
NO2-/NO3- NNP Physical
, , Physical
and CC Physical
IGF-1 NNP Physical
Significant JJ Physical
Doppler NNP Physical
flow NN Physical
improvement NN Physical
pregnancies NNS Physical
pregnancies NNS Physical
ovarian JJ Physical
response NN Physical
, , None
endometrial JJ Physical
receptivity NN Physical
and CC Physical
pregnancy NN Physical
rate NN Physical
. . None
-DOCSTART- -X- N

cancer-specific JJ Mortality
mortality NN Mortality
. . None
mortality NN Mortality
rates NNS Mortality
( ( None
radical JJ Other
prostatectomy NN Other
, , None
percutaneous JJ Other
radiotherapy NN Other
and CC None
permanent JJ Other
seed NN Other
implantation NN Other
and CC None
active JJ Other
surveillance NN Other
) ) None
-DOCSTART- -X- N

Gastrointestinal NNP Physical
safety NN Physical
antiplatelet NN Physical
activity NN Physical
. . None
platelet NN Physical
functions NNS Physical
gastroduodenal JJ Physical
lesions NNS Physical
predefined VBN Physical
scoring NN Physical
system NN Physical
. . None
Basal NNP Physical
and CC Physical
posttreatment JJ Physical
platelet NN Physical
aggregation NN Physical
Mucosal NNP Physical
endoscopic JJ Physical
injury NN Physical
score NN Physical
gastric JJ Adverse
and CC Adverse
duodenal JJ Adverse
toxicity NN Adverse
total JJ Physical
gastric NN Physical
and CC Physical
duodenal JJ Physical
endoscopic NN Physical
score NN Physical
AA-induced JJ Physical
platelet NN Physical
aggregation NN Physical
serum NN Physical
TXB NNP Physical
( ( Physical
2 CD Physical
) ) Physical
platelet NN Physical
TXB NNP Physical
( ( Physical
2 CD Physical
) ) Physical
generation NN Physical
gastrointestinal JJ Physical
damage NN Physical
. . None
-DOCSTART- -X- N

complications NNS Adverse
postoperative JJ Adverse
complications NNS Adverse
postoperative JJ Adverse
complications NNS Adverse
retinal JJ Physical
detachment NN Physical
corneal NN Physical
decompensation NN Physical
. . None
Cystoid NNP Adverse
macular JJ Adverse
edema NN Adverse
postoperative JJ Adverse
vitreous JJ Adverse
prolaps NNS Adverse
into IN Adverse
the DT Adverse
anterior JJ Adverse
chamber NN Adverse
spontaneous JJ Pain
complaints NNS Pain
of IN Pain
pain NN Pain
capsular JJ Physical
fibrosis NN Physical
visual JJ Physical
acuity NN Physical
frequent JJ Physical
capsular JJ Physical
fibrosis NN Physical
. . None
-DOCSTART- -X- N

equivalence NN Other
equivalent JJ Other
95 CD Physical
% NN Physical
confidence NN Physical
interval NN Physical
( ( Physical
CI NNP Physical
) ) Physical
proportions NNS Physical
of IN Physical
patients NNS Physical
achieving VBG Physical
an DT Physical
HIV-1 JJ Other
RNA NNP Other
level NN Other
of IN Other
< $ Other
400 CD Other
copies/mL NN Other
failure NN Other
Median JJ Physical
increase NN Physical
above IN Physical
baseline NN Physical
in IN Physical
CD4 NNP Physical
( ( Physical
+ NNP Physical
) ) Physical
cell NN Physical
count NN Physical
incidences NNS Adverse
of IN Adverse
adverse JJ Adverse
events NNS Adverse
, , Adverse
disease NN Adverse
progression NN Adverse
, , Adverse
and CC Adverse
HIV-associated JJ Adverse
conditions NNS Adverse
-DOCSTART- -X- N

uptake NN Physical
uptake NN Other
of IN Other
irfluenza JJ Other
immunisation NN Other
numbers NNS Mental
of IN Mental
individuals NNS Mental
in IN Mental
each DT Mental
group NN Mental
receiving VBG Mental
immunisation NN Mental
, , Physical
and CC Physical
practice NN Other
costs NNS Other
of IN Other
a DT Other
telephone-appointing JJ Other
programme NN Other
. . Physical
immunisation NN Mental
rate NN Mental
immunisation NN Mental
income NN Other
generated VBD Other
'number NNP Other
needed VBD Other
to TO Other
telephone NN Other
' '' None
immunisation NN Physical
Immunisation NN Mental
rates NNS Mental
immunisation NN Mental
rates NNS Mental
-DOCSTART- -X- N

rate NN Adverse
of IN Adverse
complications NNS Adverse
. . None
mortality NN Mortality
Major JJ Adverse
complications NNS Adverse
Minor JJ Adverse
complications NNS Adverse
achievement NN Physical
of IN Physical
pneumoperitoneum NN Physical
-DOCSTART- -X- N

knowledge NN Mental
of IN Mental
benefits NNS Mental
and CC Mental
harms NNS Mental
of IN Mental
screening NN Mental
, , Mental
and CC None
secondary JJ None
outcomes NNS None
, , None
informed VBN Mental
choice NN Mental
( ( None
composite JJ Mental
of IN Mental
knowledge NN Mental
, , None
values NNS Mental
and CC Mental
intention NN Mental
) ) None
, , None
anxiety NN Mental
and CC Mental
acceptability NN Mental
of IN Mental
the DT Mental
DA NNP Mental
knowledgeable JJ Mental
made VBN Physical
a DT Physical
decision NN Physical
start VB Physical
screening VBG Physical
now RB Physical
proportion NN Mental
of IN Mental
women NNS Mental
who WP Mental
made VBD Mental
an DT Mental
informed JJ Mental
choice NN Mental
anxious JJ Mental
. . None
knowledge NN Mental
indecision NN Mental
feelings NNS Mental
of IN Mental
anxiety NN Mental
. . None
-DOCSTART- -X- N

heterotopic JJ Physical
ossification NN Physical
heterotopic NN Physical
ossification NN Physical
( ( Physical
HO NNP Physical
) ) Physical
effectiveness NN Other
of IN Other
preoperative JJ Other
irradiation NN Other
Heterotopic NNP Physical
ossification NN Physical
was VBD None
scored VBN None
according VBG None
to TO None
the DT None
Brooker NNP Other
Grading NNP Other
system NN Other
. . Other
heterotopic NN Physical
ossification NN Physical
( ( None
Brooker NNP Other
Score NNP Other
I PRP None
: : None
( ( None
Brooker NNP Other
Score NNP Other
I PRP None
: : None
heterotopic NN Physical
ossification NN Physical
heterotopic NN Physical
ossification NN Physical
( ( Physical
Brooker NNP Other
Score NNP Other
III NNP Other
and CC Other
IV NNP Other
) ) Physical
heterotopic NN Physical
ossification NN Physical
( ( None
Brooker NNP Other
Score NNP Other
heterotopic NN Physical
ossification NN Physical
HO NNP Physical
heterotopic NN Physical
ossification NN Physical
-DOCSTART- -X- N

Forty-three JJ Physical
variables NNS Physical
( ( Physical
history NN Physical
of IN Physical
hypertension NN Physical
, , Physical
hypercholesterolemia NN Physical
, , Physical
congestive JJ Physical
heart NN Physical
failure NN Physical
[ NNP Physical
CHF NNP Physical
] NNP Physical
, , Physical
ventricular JJ Physical
tachycardia NN Physical
, , Physical
and CC Physical
age NN Physical
) ) Physical
; : Physical
( ( Physical
CHF NNP Physical
after IN Physical
discharge NN Physical
, , Physical
New NNP Physical
York NNP Physical
Heart NNP Physical
Association NNP Physical
functional JJ Physical
class NN Physical
, , Physical
heart NN Physical
rate NN Physical
, , Physical
pulmonary JJ Physical
rates NNS Physical
, , Physical
and CC Physical
smoking NN Physical
) ) Physical
Mortality NNP Mortality
risk NN Mortality
range NN Mortality
of IN Mortality
mortality NN Mortality
-DOCSTART- -X- N

depression NN Mental
and CC Mental
anxiety NN Mental
self-esteem NNS Mental
: : None
psychological JJ Mental
aspect NN Mental
depression NN Mental
, , Mental
anxiety NN Mental
, , None
and CC None
self-esteem JJ Mental
. . None
RBDI NNP Mental
questionnaire NN Mental
( ( Mental
Raitasalo NNP Mental
's POS Mental
modification NN Mental
of IN Mental
the DT Mental
short JJ Mental
form NN Mental
of IN Mental
the DT Mental
Beck NNP Mental
Depression NNP Mental
Inventory NNP Mental
) ) Mental
. . None
depression NN Mental
better JJR Mental
self-esteem NN Mental
proportions NNS None
depressed JJ Mental
anxious JJ Mental
depression NN Mental
and CC Mental
anxiety NN Mental
self-esteem NN Mental
-DOCSTART- -X- N

surface NN Physical
proteins NNS Physical
Serum NNP Physical
and CC Physical
fecal JJ Physical
antibodies NNS Physical
against IN Physical
SsWC NNP Physical
, , Physical
LPS NNP Physical
, , Physical
and CC Physical
IpaC NNP Physical
tolerated VBN Other
. . None
fever NN Adverse
or CC Adverse
severe JJ Adverse
gastrointestinal JJ Adverse
symptoms NNS Adverse
Antibody NN Physical
responses NNS Physical
Serum NNP Physical
IgG NNP Physical
or CC Physical
IgA NNP Physical
responses NNS Physical
Fecal JJ Physical
IgA NNP Physical
responses NNS Physical
serum JJ Physical
IgA NNP Physical
levels NNS Physical
IgG NNP Physical
increases VBZ Physical
immunogenic JJ None
protective JJ Other
tolerated VBN Other
immunogenic JJ None
-DOCSTART- -X- N

liver RB Physical
blood NN Physical
tests NNS Physical
nor CC Physical
histological JJ Physical
appearances NNS Physical
of IN Physical
the DT Physical
liver NN Physical
serum NN Physical
titres NNS Physical
of IN Physical
hepatitis NN Physical
B NNP Physical
surface NN Physical
antigen NN Physical
. . Physical
-DOCSTART- -X- N

antinociceptive JJ Physical
effects NNS Physical
antinociceptive JJ Pain
role NN Pain
antinociceptive JJ None
effect NN None
O'Leary-Sant NNP Physical
validated VBD Physical
IC NNP Physical
questionnaire NN Physical
or CC Physical
with IN Physical
voiding JJ Physical
charts NNS Physical
and CC None
a DT None
visual JJ None
analog NN None
pain VBP None
scale JJ None
urodynamic JJ Physical
evaluations NNS Physical
. . Physical
subjective JJ Other
improvement NN Other
Interstitial NNP Physical
Cystitis NNP Physical
Symptom NNP Physical
Index NNP Physical
and CC Physical
Interstitial NNP Physical
Cystitis NNP Physical
Problem NNP Physical
Index NNP Physical
mean NN Physical
scores NNS Physical
Daytime NNP Pain
frequency NN Pain
, , Pain
nocturia NN Pain
, , Pain
and CC Pain
pain NN Pain
by IN Pain
visual JJ Pain
analog NN Pain
scale NN Pain
first JJ Physical
desire NN Physical
to TO Physical
void VB Physical
and CC Physical
maximal VB Physical
cystometric JJ Physical
capacity NN Physical
antinociceptive JJ Pain
effect NN Pain
-DOCSTART- -X- N

UTC NNP Other
procedure NN Other
. . None
ultrasonographic JJ Other
three-dimensional JJ Other
stability NN Other
of IN Other
echo NN Other
patterns NNS Other
, , None
qua JJ Other
intensity NN Other
and CC None
distribution NN Other
over IN Other
contiguous JJ Other
transverse JJ Other
images NNS Other
. . None
echotypes NNS Physical
highly RB Other
stable JJ Other
; : None
medium NN Other
stable JJ Other
; : None
highly RB Other
variable JJ Other
constantly RB Other
low JJ Other
echo-types NNS Other
tendon NN Other
thickness NN Other
echo JJ Other
pattern NN Other
. . None
tendon NN Other
thickness NN Other
Intraclass NNP Other
Correlation NNP Other
Coefficient NNP Other
tendon NN Other
thickness NN Other
-DOCSTART- -X- N

free JJ Physical
radical JJ Physical
generation NN Physical
Free JJ Physical
radicals NNS Physical
Global NNP Physical
and CC Physical
right JJ Physical
heart NN Physical
functions NNS Physical
free JJ Physical
radicals NNS Physical
generation NN Physical
in IN Physical
coronary JJ Physical
sinus NN Physical
blood NN Physical
free JJ Physical
radicals NNS Physical
in IN Physical
arterial JJ Physical
samples NNS Physical
Cardiac NNP Physical
index NN Physical
( ( Physical
CI NNP Physical
) ) Physical
and CC None
right JJ Physical
ventricular NN Physical
ejection NN Physical
fraction NN Physical
( ( Physical
RVEF NNP Physical
) ) Physical
free JJ Physical
radicals NNS Physical
generation NN Physical
. . None
free JJ Physical
radicals NNS Physical
generation NN Physical
-DOCSTART- -X- N

refractory JJ Physical
angina NN Physical
pectoris NN Physical
, , None
acute JJ Physical
myocardial JJ Physical
infarction NN Physical
, , None
death NN Mortality
, , None
emergency NN Physical
PTCA NNP Physical
and CC None
CABG NNP Physical
. . None
symptom NN Physical
and CC Physical
electrocardiogram NN Physical
lowered VBD Physical
heart NN Physical
rate NN Physical
and CC None
myocardial JJ Other
oxygen NN Other
consumption NN Other
index NN Other
onsets NNS Physical
of IN Physical
refractory JJ Physical
angina NNS Physical
pectoris NN Physical
reduced VBN Other
more RBR Other
significantly RB Other
heart NN Physical
rate NN Physical
reduced VBN Other
significantly RB Other
heart NN Physical
rate NN Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
was VBD None
AM NNP None
pre-dose JJ None
FEV NNP None
( ( None
1 CD None
) ) None
and CC None
other JJ None
measures NNS None
of IN None
lung NN None
function NN None
, , None
rescue NN None
albuterol NN None
use NN None
, , None
health NN None
status NN None
and CC None
exacerbations NNS None
. . None
RESULTS VB None
The DT None
significantly RB None
improved VBD None
lung JJ None
function NN None
indices NNS None
including VBG None
AM NNP None
pre-dose JJ None
FEV NNP None
( ( None
1 CD None
) ) None
, , None
2 CD None
h NN None
post-dose JJ None
FEV NNP None
( ( None
1 CD None
) ) None
, , None
AM NNP None
pre-dose JJ None
FVC NNP None
, , None
2 CD None
h NN None
post-dose JJ None
FVC NNP None
and CC None
AM NNP None
pre-dose JJ None
IC NNP None
reducing VBG None
rescue NN Other
albuterol NN Other
use NN Other
. . None
However RB None
groups NNS None
in IN None
health NN None
status NN None
or CC None
COPD NNP None
exacerbations NNS None
. . None
The DT None
incidence NN None
adverse JJ None
events NNS None
was VBD None
similar JJ None
improves VBZ None
lung JJ None
function NN None
without IN None
the DT None
risk NN None
of IN None
adverse JJ None
events NNS None
-DOCSTART- -X- N

cardiovascular JJ Physical
response NN Physical
blood NN Physical
pressure NN Physical
rate NN Physical
pressure NN Physical
product NN Physical
heart NN Physical
rate NN Physical
. . Physical
pressor NN Physical
response NN Physical
the DT Physical
cold NN Physical
. . Physical
cardiovascular JJ Physical
variables NNS Physical
rate NN Physical
pressure NN Physical
product NN Physical
pain NN Other
threshold JJ Other
cardiovascular JJ Physical
variables NNS Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
change NN Physical
in IN Physical
A1C NNP Physical
at IN Physical
study JJ Physical
end NN Physical
. . None
changes NNS Physical
in IN Physical
fasting VBG Physical
glucose NN Physical
, , None
lipids NNS Physical
, , None
weight NN Physical
, , None
adverse JJ Adverse
events NNS Adverse
, , None
and CC None
safety NN Other
. . None
A1C NNP None
fasting VBG Physical
plasma NN Physical
glucose NN Physical
homeostasis NN Physical
model NN Physical
assessment-insulin JJ Physical
resistance NN Physical
Total JJ Physical
cholesterol NN Physical
, , None
LDL NNP Physical
cholesterol NN Physical
, , None
and CC None
triglycerides NNS Physical
Body NNP Physical
weight VBD Physical
adrenocorticotrophic JJ Physical
hormone NN Physical
Basal NNP Physical
cortisol JJ Physical
homeostasis NN Physical
, , None
testosterone NN Physical
in IN Physical
men NNS Physical
, , None
and CC None
free JJ Physical
androgen NN Physical
index NN Physical
in IN Physical
women NNS Physical
efficacious JJ Other
tolerated VBN Other
glucose JJ Physical
and CC Physical
cardiovascular JJ Physical
risk NN Physical
factors NNS Physical
-DOCSTART- -X- N

efficacy NN Other
of IN None
mitomycin NN None
C NNP None
plus CC None
doxorubicin JJ None
response NN Other
rates NNS Other
total JJ Other
response NN Other
rate NN Other
disease JJ Adverse
progression NN Adverse
. . None
progression NN Physical
rates NNS Physical
efficacy NN Other
to TO Other
BCG NNP Other
-DOCSTART- -X- N

productive JJ Mental
performance NN Mental
and CC Mental
egg NN Mental
quality NN Mental
productive JJ Mental
performance NN Mental
and CC Mental
egg NN Mental
quality NN Mental
. . None
feed NN Mental
intake NN Mental
, , Mental
egg NN Mental
weight NN Mental
, , Mental
and CC Mental
egg NN Mental
mass NN Mental
egg NN Mental
production NN Mental
feed JJ Mental
conversion NN Mental
ratio NN Mental
( ( Mental
FCR NNP Mental
) ) Mental
BW NNP Mental
shell NN Mental
thickness NN Mental
and CC Mental
shell NN Mental
strength NN Mental
albumen NNS Mental
height VBD Mental
and CC Mental
Haugh NNP Mental
units NNS Mental
yolk JJ Mental
color NN Mental
egg NN Mental
quality NN Mental
-DOCSTART- -X- N

area NN Physical
under IN Physical
the DT Physical
plasma JJ Physical
concentration-time JJ Physical
curve NN Physical
( ( Physical
AUC NNP Physical
) ) Physical
, , Physical
the DT Physical
maximum JJ Physical
plasma JJ Physical
concentration NN Physical
( ( Physical
Cmax NNP Physical
) ) Physical
the DT Physical
time NN Physical
to TO Physical
reach VB Physical
peak JJ Physical
concentration NN Physical
( ( Other
Tmax NNP Other
) ) Other
. . None
AUC NNP Other
AUC NNP Other
AUC NNP Other
Cmax NNP Other
or CC None
Tmax NNP Other
Cmax NNP Other
Tmax NNP Other
plateau NN Physical
concentration NN Physical
AUC NNP Other
, , None
Tmax NNP Other
, , None
and CC None
Cmax NNP Other
5h CD Other
AUC NNP Other
AUCinf NNP Other
. . None
confidence NN None
intervals NNS None
, , None
probability NN None
values NNS None
, , None
and CC None
nonparametric JJ None
tests NNS None
. . None
single-point JJ Other
short-term JJ Other
AUC NNP Other
AUC NNP Other
, , None
Cmax NNP Other
, , None
and CC None
Tmax NNP Other
-DOCSTART- -X- N

control NN Physical
of IN Physical
blood NN Physical
pressure NN Physical
and CC None
total JJ Physical
cholesterol NN Physical
blood NN Physical
pressure NN Physical
( ( Physical
BP NNP Physical
) ) Physical
, , None
total JJ Physical
cholesterol NN Physical
( ( Physical
TC NNP Physical
) ) Physical
both DT Physical
BP NNP Physical
and CC None
TC NNP Physical
( ( Physical
BP/TC NNP Physical
) ) Physical
proportions NNS Physical
of IN Physical
patients NNS Physical
achieving VBG Physical
BP NNP Physical
, , None
TC NNP Physical
, , None
and CC None
BP/TC NNP Physical
therapeutic JJ Physical
goals NNS Physical
mean JJ Physical
BP NNP Physical
and CC None
TC NNP Physical
values NNS Physical
. . None
BP NNP Physical
was VBD None
assessed VBN None
manually RB None
TC NNP Physical
enzymatic JJ None
dry JJ None
method NN None
. . None
goals NNS None
for IN None
BP NNP Physical
, , None
TC NNP Physical
, , None
and CC None
BP/TC NNP Physical
. . None
goals NNS None
for IN None
BP NNP Physical
TC NNP Physical
BP/TC NNP Physical
BP NNP Physical
, , None
TC NNP Physical
, , None
and CC None
BP/TC NNP Physical
-DOCSTART- -X- N

maximal JJ Physical
exercise NN Physical
tolerance NN Physical
effects NNS Other
maximal JJ Physical
exercise NN Physical
tolerance NN Physical
cardiovascular JJ None
parameters NNS None
The DT None
maximal JJ None
time NN None
of IN None
tolerance NN None
( ( None
Tlim NNP None
) ) None
, , None
metabolic JJ None
equivalents NNS None
( ( None
METs NNP None
) ) None
and CC None
Bruce NNP None
stage NN None
reached VBD None
Furthermore UH None
, , None
the DT None
HR NNP None
, , None
double JJ None
product NN None
and CC None
Borg NNP None
score NN None
at IN None
isotime NN None
the DT None
time NN None
of IN None
recovery NN None
showed VBD None
differences NNS None
between IN None
before IN None
and CC None
after IN None
training NN None
( ( None
delta JJ None
values NNS None
) ) None
the DT None
Tlim NNP None
, , None
METs NNP None
and CC None
HR NNP None
at IN None
training NN None
can MD None
improve VB None
maximal JJ None
performance NN None
and CC None
post-exercise JJ None
-DOCSTART- -X- N

drop NN Physical
in IN Physical
high-energy JJ Physical
phosphates NNS Physical
hemodynamic JJ Physical
evaluation NN Physical
stroke-work NN Physical
index NN Physical
needing VBG Physical
inotropic JJ Physical
support NN Physical
myocardial JJ Physical
content NN Physical
of IN Physical
ATP NNP Physical
and CC Physical
creatine NN Physical
phosphate NN Physical
myocardial JJ Physical
ATP NNP Physical
and CC Physical
creatine VB Physical
phosphate JJ Physical
-DOCSTART- -X- N

Histopathologic NNP Physical
changes NNS Physical
of IN Physical
the DT Physical
superficial JJ Physical
peels NNS Physical
with IN Physical
necrosis NN Physical
applied VBD Other
strength NN Other
increased VBD Other
deepest JJS Physical
peel NN Physical
-DOCSTART- -X- N

heart NN Physical
rate NN Physical
or CC Physical
blood NN Physical
pressure NN Physical
responses VBZ Physical
tolerance NN Other
indices NNS Other
heart NN Physical
rate NN Physical
or CC Physical
blood NN Physical
pressure NN Physical
cumulative JJ Other
stress NN Other
index NN Other
and CC Physical
the DT Physical
duration NN Physical
of IN Physical
negative JJ Physical
pressure NN Physical
exposure NN Physical
-DOCSTART- -X- N

EEG NNP Physical
discharges NNS Physical
attention-deficit/hyperactivity NN Physical
disorder NN Physical
( ( Physical
ADHD NNP Physical
) ) Physical
symptoms NNS Physical
. . Physical
abnormal JJ Physical
clinical JJ Adverse
seizures NNS Adverse
. . Adverse
sex NN Mental
, , Mental
age NN Mental
, , Mental
intellectual JJ Mental
disability NN Mental
, , Mental
language NN Mental
level NN Mental
, , Mental
or CC Mental
baseline VB Mental
ADHD NNP Mental
symptoms NNS Mental
, , Mental
autistic JJ Mental
symptoms NNS Mental
Autism NNP Mental
Diagnostic NNP Mental
Observation NNP Mental
Schedule-2 NNP Mental
criteria NNS Mental
) ) Mental
ADHD NNP Mental
symptom NN Mental
severity NN Mental
. . Mental
-DOCSTART- -X- N

Blood NNP Physical
flow NN Physical
and CC Physical
plasma JJ Physical
fibrinolytic JJ Physical
factors NNS Physical
increases NNS Physical
in IN Physical
the DT Physical
blood NN Physical
flow NN Physical
plasma JJ Physical
t-PA JJ Physical
concentrations NNS Physical
release NN Physical
of IN Physical
active JJ Physical
t-PA NN Physical
substance NN Physical
P NNP Physical
response NN Physical
was VBD Physical
unaffected JJ Physical
. . None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
rates NNS Physical
of IN Physical
retinitis NN Physical
progression NN Physical
rates NNS Physical
of IN Physical
increase NN Physical
in IN Physical
retinal JJ Physical
area NN Physical
involved VBN Physical
by IN Physical
CMV NNP Physical
, , Physical
visual JJ Physical
field NN Physical
loss NN Physical
, , Physical
or CC Physical
visual JJ Physical
acuity NN Physical
outcomes NNS Physical
. . None
mortality NN Mortality
rate NN Mortality
mortality NN Mortality
mortality NN Mortality
rates NNS Mortality
mortality NN Mortality
rate NN Mortality
mortality NN Mortality
rate NN Mortality
ineffective JJ Other
mortality NN Mortality
rate NN Mortality
-DOCSTART- -X- N

pain NN Pain
relief NN Pain
scores NNS Pain
, , None
number NN Other
of IN Other
daily JJ Other
doses NNS Other
of IN Other
study NN Other
medication NN Other
, , None
number NN Other
of IN Other
daily JJ Other
doses NNS Other
of IN Other
supplemental JJ Other
analgesics NNS Other
, , None
number NN Other
of IN Other
patients NNS Other
who WP Other
discontinued VBD Other
therapy NN Other
due JJ Other
to TO Other
an DT Other
unsatisfactory JJ Other
analgesic JJ Other
response NN Other
overall JJ Pain
mean JJ Pain
daily JJ Pain
pain NN Pain
relief NN Pain
score NN Pain
overall JJ Other
mean JJ Other
number NN Other
of IN Other
daily JJ Other
doses NNS Other
of IN Other
study NN Other
medication NN Other
overall JJ Other
mean JJ Other
number NN Other
of IN Other
daily JJ Other
doses NNS Other
of IN Other
supplemental JJ Other
analgesics NNS Other
number NN Other
of IN Other
patients NNS Other
who WP Other
discontinued VBD Other
treatment NN Other
due JJ Other
to TO Other
an DT Other
unsatisfactory JJ Other
analgesic JJ Other
response NN Other
pain NN Pain
relief NN Pain
scores NNS Pain
daily JJ Other
doses NNS Other
of IN Other
study NN Other
medication NN Other
daily JJ Other
doses NNS Other
of IN Other
supplemental JJ Other
analgesics NNS Other
global JJ Other
assessment NN Other
scores NNS Other
efficacy NN Other
number NN Adverse
of IN Adverse
patients NNS Adverse
experiencing VBG Adverse
adverse JJ Adverse
events NNS Adverse
mean JJ Other
number NN Other
of IN Other
patients NNS Other
who WP Other
discontinued VBD Other
treatment NN Other
due JJ Other
to TO Other
adverse JJ Other
events NNS Other
-DOCSTART- -X- N

resting VBG Physical
motor NN Physical
threshold NN Physical
( ( Physical
RMT NNP Physical
) ) Physical
, , None
short-interval JJ Physical
intra-cortical JJ Physical
inhibition NN Physical
( ( Physical
SICI NNP Physical
) ) Physical
, , None
intracortical JJ Physical
facilitation NN Physical
( ( Physical
ICF NNP Physical
) ) Physical
, , None
and CC None
cortical JJ Physical
silent JJ Physical
period NN Physical
( ( Physical
CSP NNP Physical
) ) Physical
. . None
RMT NNP Physical
was VBD Physical
decreased VBN Physical
SICI NNP Physical
decrease NN Physical
of IN Physical
SICI NNP Physical
Minor NNP Physical
RMT NNP Physical
changes NNS Physical
-DOCSTART- -X- N

cardiovascular JJ Physical
effects NNS Physical
of IN Physical
FOB NNP Physical
. . Physical
heart NN Physical
rate NN Physical
( ( Physical
HR NNP Physical
) ) Physical
and CC Physical
systolic/diastolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
SBP/DBP NNP Physical
) ) Physical
HR NNP Physical
, , None
SBP NNP Physical
, , Physical
DBP NNP Physical
or CC None
RPP NNP Physical
Adverse JJ Adverse
events NNS Adverse
during IN Adverse
bronchoscopy NN Adverse
SBP NNP Physical
-DOCSTART- -X- N

mortality NN Mortality
median JJ Mortality
long-term JJ Mortality
survival NN Mortality
recurrence NN Physical
of IN Physical
ascites NNS Physical
median JJ Other
duration NN Other
of IN Other
hospitalization NN Other
incidence NN Adverse
of IN Adverse
infections NNS Adverse
, , Adverse
gastrointestinal JJ Adverse
bleeding NN Adverse
, , Adverse
and CC Adverse
encephalopathy NN Adverse
disabling VBG Physical
ascites NNS Physical
survival NN Mortality
-DOCSTART- -X- N

functional JJ Mental
multiple JJ Mental
times NNS Mental
per IN Mental
hour NN Mental
acquired VBN Mental
language NN Mental
skills NNS Mental
, , Mental
and CC Mental
-DOCSTART- -X- N

a DT None
Visual JJ None
Analog NNP None
Scale NNP None
, , None
during IN None
for IN None
VAS NNP None
1 CD None
( ( None
0.1 CD None
0.0001 CD None
) ) None
and CC None
VAS $ None
3 CD None
( ( None
0.8 CD None
demonstrated VBN None
for IN None
VAS NNP None
2 CD None
( ( None
1.8 CD None
No DT None
major JJ None
complication NN None
was VBD None
-DOCSTART- -X- N

incidence NN Physical
of IN Physical
any DT Physical
target NN Physical
vessel NN Physical
revascularization NN Physical
( ( Physical
TVR NNP Physical
) ) None
higher JJR Mortality
1-year JJ Mortality
mortality NN Mortality
incidence NN Mortality
of IN Mortality
death NN Mortality
, , None
myocardial JJ Physical
infarction NN Physical
( ( Physical
MI NNP Physical
) ) Physical
, , Physical
or CC None
urgent JJ Physical
TVR NNP Physical
death NN Mortality
, , None
MI NNP None
, , None
or CC None
any DT None
TVR NNP Physical
TVR NNP Physical
1-year JJ Mortality
mortality NN Mortality
-DOCSTART- -X- N

evaluate VB None
the DT None
cost NN Physical
development NN Other
and CC Other
sustainability NN Other
cost-effectiveness JJ Other
analysis NN None
Resource NNP Physical
use NN Physical
data NNS None
length NN Other
of IN Other
stay NN Other
, , None
investigations NNS Other
performed VBD Other
, , None
multiprofessional JJ Other
input NN Other
nursing NN Other
input NN Other
. . Other
Clinical JJ Physical
outcome NN Physical
Barthel NNP Physical
Index NNP Physical
Cost NNP Other
per IN Other
day NN Other
cost NN Other
per IN Other
hospital NN Other
stay NN Other
Postdischarge NNP Other
community NN Other
care NN Other
costs NNS Other
incremental JJ None
cost-effectiveness JJ Other
ratio NN Physical
-DOCSTART- -X- N

Predictive NNP Other
accuracy NN Other
of IN Other
each DT Other
Cox NNP Other
proportional JJ Other
hazards NNS Other
model NN Other
the DT Other
c-statistic JJ Other
and CC Other
calibration JJ Other
chi-square NN Other
. . None
Baseline NNP Physical
IOP NNP Physical
CCT NNP Physical
-DOCSTART- -X- N

relief NN Other
. . None
opened VBD Mental
the DT Mental
envelope NN Mental
effective JJ Other
drug NN Other
drowsiness NN Mental
-DOCSTART- -X- N

percentage NN Physical
of IN Physical
patients NNS Physical
with IN Physical
endoscopically-verified JJ Physical
healing NN Physical
Heartburn NNP Physical
, , Physical
retrosternal JJ Physical
pain NN Physical
and CC Physical
belching NN Physical
Relief NN Physical
of IN Physical
heartburn NN Physical
number NN Adverse
of IN Adverse
patients NNS Adverse
with IN Adverse
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

red JJ Other
lesions NNS Other
vasculature NN Other
and CC Other
red JJ Other
lesions NNS Other
red JJ Physical
lesions NNS Physical
sensitivity NN Other
Performance NNP Other
-DOCSTART- -X- N

ongoing JJ Physical
pregnancy NN Physical
rate NN Physical
per IN Physical
transfer NN Physical
cycle NN Physical
-DOCSTART- -X- N

central JJ Physical
effects NNS Physical
drowsiness NN Physical
, , None
ataxia NN Physical
and CC None
incoordination NN Physical
. . None
cognitive NN Mental
, , None
psychomotor NN Mental
and CC None
subjective JJ Mental
function NN Mental
psychometric JJ Mental
tests NNS Mental
sedative JJ Mental
action NN Mental
behavioural JJ Mental
effects NNS Mental
-DOCSTART- -X- N

bone NN Physical
marrow NN Physical
relapses NNS Physical
death NN Mortality
Survival NN Mortality
-DOCSTART- -X- N

effects NNS Adverse
population NN Other
selection NN Other
and CC Physical
pregnancy NN Physical
outcome NN Physical
incidence NN Physical
of IN Physical
preeclampsia NN Physical
differences NNS Other
diabetes NNS Physical
mellitus NNS Physical
-DOCSTART- -X- N

quality NN Other
of IN Other
analgesia NN Other
and CC None
side-effects NNS Adverse
onset NN None
of IN None
analgesia NN None
was VBD None
faster RBR None
consumption NN None
of IN None
bupivacaine NN None
was VBD None
lower JJR None
less JJR Physical
unilateral JJ Physical
analgesia NN Physical
higher JJR None
incidence NN Adverse
of IN Adverse
posterior JJ Adverse
presentation NN Adverse
pruritus NN Adverse
hypotension NN Adverse
somnolence NN Adverse
nausea NN Adverse
meningitis NN Adverse
. . None
-DOCSTART- -X- N

Utero-ovarian JJ Physical
ultrasound JJ Physical
analysis NN Physical
and CC Physical
color NN Physical
Doppler NNP Physical
evaluation NN Physical
of IN Physical
uterine JJ Physical
and CC Physical
stromal JJ Physical
ovarian JJ Physical
arteries NNS Physical
. . Physical
analysis NN Physical
of IN Physical
brachial JJ Physical
artery NN Physical
flow-mediated JJ Physical
vasodilatation NN Physical
and CC Physical
24-hour JJ Physical
ambulatory NN Physical
blood NN Physical
pressure NN Physical
monitoring NN Physical
Fasting VBG Physical
blood NN Physical
samples NNS Physical
hirsutism NN Physical
, , Physical
hyperandrogenemia NN Physical
, , Physical
and CC Physical
ultrasound NN Physical
and CC Physical
color NN Physical
Doppler NNP Physical
ovarian JJ Physical
parameters NNS Physical
. . Physical
diurnal JJ Physical
and CC Physical
24-hour JJ Physical
blood NN Physical
pressure NN Physical
. . Physical
lipid JJ Physical
profile NN Physical
circulating VBG Physical
triglycerides NNS Physical
. . Physical
area NN Physical
under IN Physical
the DT Physical
curve NN Physical
for IN Physical
glucose NN Physical
, , Physical
insulin NN Physical
, , Physical
and CC Physical
C-peptide NNP Physical
insulinogenic JJ Physical
index NN Physical
homeostatic JJ Physical
model NN Physical
assessment NN Physical
estimate NN Physical
for IN Physical
insulin NN Physical
resistance NN Physical
values NNS Physical
. . Physical
-DOCSTART- -X- N

Lymphocele NNP Physical
development NN Physical
of IN Physical
lymphocele NN Physical
incidence NN Physical
of IN Physical
lymphoceles NNS Physical
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
compliance NN Mental
non-inferiority NN Mental
safety NN Other
of IN Other
artesunate JJ Other
plus CC Other
amodiaquine JJ Other
adequate JJ Physical
response NN Physical
to TO Physical
treatment NN Physical
on IN Physical
D14 NNP Physical
safety NN Physical
incidence NN Adverse
of IN Adverse
adverse JJ Adverse
events NNS Adverse
. . None
adequate JJ Other
responses NNS Other
to TO Other
treatment NN Other
non-inferiority NN Mental
well RB Other
tolerated VBN Other
. . Other
gastrointestinal JJ Adverse
disorders NNS Adverse
pruritus NN Adverse
safety NN Other
profiles NNS Other
efficacy NN None
good JJ None
tolerability NN None
-DOCSTART- -X- N

anxiety NN Mental
and CC None
depression NN Mental
symptoms NNS Mental
depression NN Mental
, , None
anxiety NN Mental
and CC None
rumination NN Mental
positive JJ Mental
affect NN Mental
-DOCSTART- -X- N

hypoxemia NN Physical
hypoxemia NN Physical
and CC Physical
hemodynamic JJ Physical
instability NN Physical
duration NN Physical
of IN Physical
hypoxemia NN Physical
( ( Physical
transcutaneous JJ Physical
partial JJ Physical
pressure NN Physical
of IN Physical
O2 NNP Physical
arterial JJ Physical
blood NN Physical
oxygen NN Physical
saturation NN Physical
arterial JJ Physical
blood NN Physical
pressure NN Physical
, , Physical
heart NN Physical
rate NN Physical
, , Physical
or CC Physical
plasma VB Physical
beta-endorphin JJ Physical
, , Physical
cortisol NN Physical
, , Physical
and CC Physical
glucose JJ Physical
concentration NN Physical
duration NN Physical
of IN Physical
hypoxemia NN Physical
distress NN Physical
-DOCSTART- -X- N

mood NN Mental
fatigue NN Mental
confusion NN Mental
tension NN Mental
and CC Mental
fatigue NN Mental
tension NN Mental
fatigue NN Mental
confusion NN Mental
-DOCSTART- -X- N

colorectal JJ Physical
adenoma JJ Physical
recurrence NN Physical
: : None
adenoma NN Adverse
adjusted JJ Physical
odds NNS Physical
ratio NN Physical
for IN Physical
recurrence NN Physical
odds NNS Physical
ratio NN Physical
associated VBN Physical
with IN Physical
the DT Physical
fibre NN Physical
treatment NN Physical
adverse JJ Adverse
effects NNS Adverse
on IN Adverse
colorectal JJ Adverse
adenoma NN Adverse
recurrence NN Adverse
adenoma JJ Physical
recurrence NN Physical
. . None
-DOCSTART- -X- N

infections NNS Physical
infection NN Physical
pointers NNS Physical
incidence NN Physical
and CC Physical
magnitude NN Physical
of IN Physical
febrile JJ Physical
temperatures NNS Physical
-DOCSTART- -X- N

rate NN Other
of IN Other
continuation NN Other
rate NN Other
of IN Other
on-time JJ Other
injections NNS Other
prolonged VBN Physical
bleeding NN Physical
-DOCSTART- -X- N

nurse JJ Other
outcomes NNS Other
Attitudes NNP Other
, , Other
knowledge NN Other
, , Other
and CC Other
application NN Other
skills NNS Other
cancer NN Other
pain NN Other
knowledge NN Other
and CC Other
changing VBG Other
attitudes NNS Other
. . None
-DOCSTART- -X- N

asthmatic JJ Physical
attacks NNS Physical
Respiratory NNP Physical
variables NNS Physical
asthma NN Physical
symptoms NNS Physical
declined VBD Mental
cardiovascular JJ Physical
condition NN Physical
exercise-induced JJ Physical
asthma NN Physical
exercise-induced VBN Physical
asthma NNS Physical
effects NNS Other
-DOCSTART- -X- N

Objective JJ Physical
response NN Physical
rates NNS Physical
, , None
time NN Physical
to TO Physical
progression NN Physical
, , None
survival NN Mortality
and CC None
safety NN Other
time NN Physical
to TO Physical
progression NN Physical
, , None
objective JJ Physical
response NN Physical
rates NNS Physical
, , None
duration NN Physical
of IN Physical
response NN Physical
, , None
and CC None
survival NN Mortality
adverse JJ Adverse
experiences NNS Adverse
weight NN Adverse
gain NN Adverse
, , None
fluid JJ Adverse
retention NN Adverse
, , None
and CC None
dyspnea NN Adverse
nausea NN Adverse
and CC Adverse
vomiting NN Adverse
efficacious JJ Physical
weight NN Adverse
gain NN Adverse
, , Adverse
fluid JJ Adverse
retention NN Adverse
and CC Adverse
dyspnea NN Adverse
nausea NN Adverse
and CC Adverse
vomiting NN Adverse
. . None
-DOCSTART- -X- N

assess VB Physical
protocol-related JJ Physical
logistical JJ Physical
issues NNS Physical
, , None
randomization NN Physical
, , None
HSD NNP Other
safety NN Other
, , Other
and CC None
follow VB Mental
up RP Mental
rates NNS Mental
survival JJ Mortality
and CC None
neurocognitive JJ Physical
end NN Physical
point NN Physical
estimates NNS Physical
. . None
Mean NNP Physical
injury NN Physical
severity NN Physical
score NN Physical
length NN Other
of IN Other
stay NN Other
, , None
Sequential NNP Physical
Organ NNP Physical
Failure NNP Physical
Assessment NNP Physical
maximum NN Physical
, , Physical
Multiple NNP Physical
Organ NNP Physical
Dysfunction NNP Physical
Score NNP Physical
maximum NN Physical
, , Physical
delta JJ Physical
Multiple NNP Physical
Organ NNP Physical
Dysfunction NNP Physical
Score NNP Physical
, , Physical
or CC Physical
Apache NNP Physical
scores NNS Physical
. . None
Initial JJ Other
head NN Other
scans NNS Other
adverse JJ Adverse
events NNS Adverse
Alive JJ Mortality
at IN Mortality
30 CD Mortality
days NNS Mortality
Disability NN Physical
rating NN Physical
scale NN Physical
Glasgow NNP Physical
Outcome NNP Physical
Scale NNP Physical
Evaluation NNP Physical
Functional JJ Physical
Independence NNP Physical
Measure NNP Physical
-DOCSTART- -X- N

value NN Physical
of IN Physical
transbronchial JJ Physical
lung NN Physical
biopsy NN Physical
parenchymal JJ Physical
specimen NNS Physical
Diagnostic JJ Other
yield NN Other
tissue NN Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
graded VBD Physical
ocular JJ Physical
itching NN Physical
hyperemia NN Physical
in IN Physical
conjunctival NN Physical
, , Physical
ciliary JJ Physical
, , Physical
and CC Physical
episcleral JJ Physical
vessel NN Physical
beds NNS Physical
. . Physical
ocular JJ Physical
itching NN Physical
and CC None
hyperemia NN Physical
itching NN Physical
hyperemia NN None
effective JJ Other
hyperemia NN Physical
and CC None
ocular JJ Physical
itching NN Physical
comfortable JJ Other
ocular JJ Physical
itching NN Physical
and CC None
hyperemia NN Physical
-DOCSTART- -X- N

average JJ Other
time NN Other
spent VBN Other
in IN Other
the DT Other
operating NN Other
room NN Other
or CC None
in IN None
the DT Other
total JJ Other
irrigation NN Other
fluid NN Other
room NN Physical
temperature NN Physical
irrigation NN Physical
fluid NN Physical
body NN Physical
temperature NN Physical
. . None
temperature NN Physical
irrigation NN Other
fluid NN Other
. . None
elevation NN None
core NN Physical
body NN Physical
temperature NN Physical
. . None
body NN Physical
temperature NN Physical
-DOCSTART- -X- N

decrease NN Mental
in IN Mental
the DT Mental
number NN Mental
of IN Mental
episodes NNS Mental
severity NN Mental
episodes NNS Mental
knowledge NN Mental
and CC Mental
skills NNS Mental
-DOCSTART- -X- N

postoperative JJ Physical
nausea NN Physical
and CC Physical
vomiting NN Physical
postoperative JJ Physical
nausea NN Physical
and CC Physical
vomiting NN Physical
( ( Physical
PONV NNP Physical
) ) Physical
PONV NNP Physical
PONV NNP None
efficacy NN Other
PONV NNP None
PONV NNP None
extrapyramidal NN Physical
symptoms NNS Physical
PONV NNP None
PONV NNP None
PONV NNP None
Extrapyramidal NNP None
symptoms NNS None
PONV NNP None
PONV NNP None
-DOCSTART- -X- N

central JJ Physical
arterial JJ Physical
compliance NN Physical
central JJ Physical
arterial JJ Physical
compliance NN Physical
. . None
maximal JJ Physical
muscle NN Physical
strength NN Physical
and CC Physical
increased VBD Physical
total JJ Physical
lean JJ Physical
body NN Physical
mass NN Physical
carotid NN Other
artery NN Other
compliance NN Other
or CC None
carotid-femoral JJ Physical
pulse JJ Physical
wave NN Physical
velocity NN Physical
following VBG None
ST NNP Other
or CC Other
ST+aerobic NNP Other
exercise NN Other
. . None
Carotid NNP Physical
artery JJ Physical
compliance NN Physical
plasma JJ Physical
vasoconstrictor NN Physical
hormones NNS Physical
or CC Physical
carotid VB Physical
artery JJ Physical
vasoreactivity NN Physical
central JJ Physical
arterial JJ Physical
compliance NN Physical
-DOCSTART- -X- N

no DT Other
improvement NN Other
frequency NN Physical
of IN Physical
induction NN Physical
resistance NN Physical
rate NN Physical
of IN Physical
complete JJ Physical
remission NN Physical
or CC None
restored VBN Physical
chronic JJ Physical
phase NN Physical
survival NN Mortality
Blast NNP Physical
expression NN Physical
of IN Physical
Pgp NNP Physical
LRP NNP Physical
rate NN Physical
of IN Physical
CR/CP NNP Physical
-DOCSTART- -X- N

quality NN Other
of IN Other
life NN Other
: : None
quality NN Other
of IN Other
life NN Other
scores NNS None
: : None
Menopausal NNP None
Quality NNP None
of IN None
Life NNP None
Questionnaire NNP None
( ( None
MENQOL NNP None
) ) None
total NN None
and CC None
domain NN None
( ( None
vasomotor NN None
symptoms NNS None
, , None
psychosocial JJ None
, , None
physical JJ None
and CC None
sexual JJ None
) ) None
. . None
Mean NNP None
baseline NN None
vasomotor NN None
symptoms JJ None
frequency NN None
the DT None
mean JJ None
baseline NN None
total JJ None
MENQOL NNP None
score NN None
for IN None
MENQOL NNP None
vasomotor NN None
symptom NN None
domain NN None
and CC None
sexuality NN None
domain NN None
total JJ None
MENQOL NNP None
scores NNS None
the DT None
MENQOL NNP None
physical JJ None
domain NN None
score NN None
improve VB None
quality NN None
of IN None
life NN None
; : None
improve VB None
menopausal NN None
quality NN None
of IN None
life NN None
; : None
-DOCSTART- -X- N

Rates NNS Mental
of IN Mental
drug NN Mental
use IN Mental
self-report NN Mental
overall JJ Other
prevalence NN Other
rates NNS Other
urinalysis NN Other
positives NNS Other
self-report JJ Mental
positives NNS Mental
. . None
drug NN Other
use NN Other
assessment NN Other
-DOCSTART- -X- N

Placental JJ Physical
growth NN Physical
factor NN Physical
( ( Physical
PlGF NNP Physical
) ) Physical
PlGF NNP Mental
death NN Mortality
, , Physical
myocardial JJ Physical
infarction NN Physical
( ( Physical
MI NNP Physical
) ) Physical
, , Physical
unstable JJ Physical
angina NN Physical
, , Physical
revascularization NN Physical
or CC Physical
stroke NN Physical
risk NN Other
of IN Other
death NN Mortality
or CC Other
MI NNP Physical
risk NN Mortality
of IN Mortality
death NN Mortality
or CC Other
MI NNP Physical
PlGF NNP Physical
-DOCSTART- -X- N

fever NN Physical
successful JJ Other
( ( None
apyrexia NN None
( ( None
infectious JJ Mortality
death NN Mortality
or CC Mortality
delay NN Mortality
in IN Mortality
treatment NN Mortality
of IN Mortality
underlying JJ Mortality
disease NN Mortality
due JJ Mortality
to TO Mortality
infection NN Mortality
) ) None
glycopeptide JJ Physical
addition NN Physical
efficacy NN Other
empiric JJ Other
glycopeptide NN Other
antibiotic JJ Other
administration NN Other
-DOCSTART- -X- N

development NN Physical
of IN Physical
new JJ Physical
dysplasia NN Physical
incidence NN Physical
of IN Physical
dysplasia NN Physical
-DOCSTART- -X- N

As IN None
compared VBN None
with IN None
the DT None
placebo NN None
group NN None
, , None
after IN None
only RB None
14 CD None
days NNS None
, , None
the DT None
patients NNS None
treated VBN None
with IN None
trimetazidine NN None
showed VBN None
statistically RB None
significant JJ None
increases NNS None
in IN None
the DT None
maximum JJ None
workload NN None
level NN None
attained VBD None
before IN None
ST NNP None
depression NN None
occurred VBD None
( ( None
31 CD None
% NN None
versus NN None
- : None
6 CD None
% NN None
; : None
P NNP None
= NNP None
0.009 CD None
) ) None
, , None
the DT None
total JJ None
work NN None
performed VBD None
( ( None
31 CD None
% NN None
versus IN None
2 CD None
% NN None
; : None
P NNP None
= NNP None
0.024 CD None
) ) None
and CC None
a DT None
significant JJ None
decrease NN None
in IN None
the DT None
systolic JJ None
tension NN None
time NN None
( ( None
double JJ None
product NN None
) ) None
/workload NN None
ratio NN None
( ( None
-5 CD None
% NN None
versus IN None
+11 CD None
% NN None
; : None
P NNP None
= NNP None
0.005 CD None
) ) None
. . None
-DOCSTART- -X- N

The DT None
clinical JJ None
improvement NN None
was VBD None
the DT None
number NN None
of IN None
patients NNS None
still RB None
incapacitated VBN None
was VBD None
) ) None
. . None
Peak-to-peak JJ None
and CC None
mean JJ None
systolic JJ None
pressure NN None
differences NNS None
across IN None
the DT None
valves NNS None
were VBD None
compared VBN None
. . None
Left NNP None
ventricular JJ None
end-diastolic JJ None
pressure NN None
( ( None
LVEDP NNP None
) ) None
, , None
group NN None
, , None
LVEDP NNP None
did VBD None
-DOCSTART- -X- N

efficacy NN Other
, , Other
safety NN Other
, , Other
and CC Other
patient JJ Other
tolerability NN Other
brucellosis NN Physical
: : None
average JJ Other
number NN Other
of IN Other
days NNS Other
without IN Other
fever NN Other
and CC Other
symptoms NNS Other
relapses NNS Adverse
; : None
brucellosis NN Physical
-DOCSTART- -X- N

blood VBD Physical
pressure NN Physical
. . Physical
hypertension NN Physical
clinical JJ Physical
endpoints NNS Physical
-DOCSTART- -X- N

less JJR Pain
pain NN Pain
-DOCSTART- -X- N

debonded VBD Physical
fractured VBD Physical
restorations NNS Other
replaced VBN Other
. . None
functional JJ Other
alfa JJ Physical
ratings NNS Physical
over IN Physical
time NN Physical
with IN Other
respect NN Other
to TO Other
criteria VB Other
marginal JJ Other
adaptation NN Other
and CC Other
marginal JJ Other
discoloration NN Other
. . None
-DOCSTART- -X- N

recurrent JJ Physical
caries NNS Physical
rate NN Physical
of IN Physical
new JJ Physical
or CC Physical
recurrent JJ Physical
carious JJ Physical
lesions NNS Physical
in IN Physical
the DT Physical
group NN Physical
odds NNS Physical
ratio NN Physical
of IN Physical
the DT Physical
occurrence NN Physical
of IN Physical
any DT Physical
new JJ Physical
or CC Physical
recurrent JJ Physical
caries NNS Physical
well-tolerated JJ Other
and CC Other
safe JJ Other
complications NNS Adverse
efficacy NN Other
to TO Other
a DT Other
SnF NNP Other
( ( Other
2 CD Other
) ) Other
gel NN Other
rates NNS Physical
of IN Physical
control NN Physical
-DOCSTART- -X- N

recurrences NNS Physical
toxic JJ Adverse
effects NNS Adverse
. . None
-DOCSTART- -X- N

Deliberate NNP Physical
hypotension NN Physical
cardiac JJ Physical
output NN Physical
systemic JJ Physical
vascular JJ Physical
resistance NN Physical
arterial JJ Physical
pressure NN Physical
. . None
Systemic NNP Physical
vascular JJ Physical
resistance NN Physical
plasma JJ Physical
renin NN Physical
activity NN Physical
. . None
mean JJ Physical
arterial JJ Physical
pressure NN Physical
systemic JJ Physical
vascular JJ Physical
resistance NN Physical
cardiac JJ Physical
output NN Physical
. . None
Plasma NNP Physical
renin NN Physical
activity NN Physical
levels NNS Physical
Heart NNP Physical
rate NN Physical
marked JJ Physical
myocardial JJ Physical
depression NN Physical
-DOCSTART- -X- N

seasonal JJ Physical
allergic JJ Physical
rhinitis NN Physical
symptoms NNS Physical
improvements NNS Physical
rhinitis NN Physical
symptoms NNS Physical
improvement NN Physical
in IN Physical
the DT Physical
nasal JJ Physical
index NN Physical
occurred VBD Physical
greater JJR None
overall JJ None
improvement NN None
in IN None
symptoms NNS None
adverse JJ Adverse
events NNS Adverse
. . Adverse
reduces NNS Physical
effectively RB Physical
the DT Physical
severity NN Physical
of IN Physical
symptoms NNS Physical
of IN Physical
-DOCSTART- -X- N

Children NNP Other
's POS Other
Hospital NNP Other
of IN Other
Eastern NNP Other
Ontario NNP Other
Pain NNP Other
Scale NNP Other
( ( Other
CHEOPS NNP Other
) ) Other
-DOCSTART- -X- N

episodes NNS Mental
of IN Mental
anger NN Mental
confidence NN Mental
managing VBG Mental
anger NN Mental
in IN Mental
their PRP$ Mental
child NN Mental
. . None
-DOCSTART- -X- N

median JJ Other
duration NN Other
of IN Other
response NN Other
Overall JJ Mortality
median JJ Mortality
survival NN Mortality
Toxicity NN Adverse
both DT None
treatments NNS None
were VBD None
well RB Other
tolerated VBN Other
. . Other
-DOCSTART- -X- N

complete JJ Physical
response NN Physical
( ( Physical
CR NNP Physical
) ) Physical
rates NNS Physical
objective JJ Physical
response NN Physical
rates NNS Physical
partial JJ Physical
response NN Physical
survival NN Mortality
rates NNS Mortality
toxicities NNS Adverse
-DOCSTART- -X- N

incidence NN Adverse
of IN Adverse
side NN Adverse
effects NNS Adverse
was VBD Adverse
lowest JJS Adverse
drowsiness NN Adverse
-DOCSTART- -X- N

early JJ Adverse
postoperative JJ Adverse
complications NNS Adverse
cerebrovascular JJ Physical
accidents NNS Physical
graft NN Physical
occlusion NN Physical
angina JJ Physical
recurrence NN Physical
graft NN Physical
occlusion NN Physical
and CC None
angina JJ Physical
recurrence NN Physical
. . None
-DOCSTART- -X- N

improvement NN Mental
of IN Mental
social JJ Mental
skills NNS Mental
eliciting VBG Other
, , Other
generalizing VBG Other
and CC Other
maintaining VBG Mental
the DT Mental
targeted VBN Mental
social JJ Mental
skills NNS Mental
Verbal NNP Mental
Comprehension NNP Mental
Index NNP Mental
( ( Mental
VCI NNP Mental
) ) Mental
scores VBZ Mental
from IN Mental
the DT Mental
WISC-IV JJ Mental
intelligence NN Mental
test NN Mental
-DOCSTART- -X- N

side NN Adverse
effects NNS Adverse
gynaecomastia NN Physical
Toxicity NN Adverse
and CC None
early JJ Mortality
death NN Mortality
-DOCSTART- -X- N

respiratory JJ Physical
distress JJ Physical
syndrome NN Physical
respiratory NN Physical
distress NN Physical
syndrome NN Physical
respiratory NN Physical
distress NN Physical
syndrome NN Physical
endometritis NN Physical
neonatal JJ Physical
infections NNS Physical
and CC Physical
cesarean JJ Physical
section NN Physical
rates NNS Physical
-DOCSTART- -X- N

the DT Mental
behavioral JJ Mental
performance NN Mental
brain NN Mental
activity NN Mental
behavior NN Mental
and CC Mental
event-related JJ Mental
brain NN Mental
potentials NNS Mental
( ( Mental
ERPs NNP Mental
) ) None
interviews NNS Mental
behavioral JJ Mental
criteria NNS Mental
Scores NNS Mental
on IN Mental
standardized JJ Mental
measures NNS Mental
face NN Mental
inversion NN Mental
effect NN Mental
behaviorally RB Mental
and CC Mental
electrophysiological JJ Mental
changes NNS Mental
to TO Mental
faces VBZ Mental
face NN Mental
processing NN Mental
-DOCSTART- -X- N

Outcome NN Other
outcome NN Other
clinical JJ Other
and CC Other
biologic JJ Other
features NNS Other
progression-free JJ Mortality
survival NN Mortality
( ( Mortality
PFS NNP Mortality
) ) Mortality
rate NN Mortality
overall JJ Mortality
survival NN Mortality
( ( Mortality
OS NNP Mortality
) ) Mortality
rate NN Mortality
PFS NNP Mortality
rate NN Mortality
OS NNP Mortality
rate NN Mortality
5-year JJ Mortality
PFS NNP Mortality
PFS NNP Mortality
OS NNP Mortality
survival JJ Mortality
advantage NN Mortality
-DOCSTART- -X- N

( ( None
operative JJ Other
time NN Other
, , None
fluid JJ Physical
absorption NN Physical
, , None
complications NNS Adverse
, , None
need VBP Physical
for IN Physical
second JJ Physical
intervention NN Physical
) ) None
( ( None
pregnancy NN Physical
, , None
abortion NN Physical
, , None
term NN Physical
and CC Physical
preterm JJ Physical
delivery NN Physical
, , Physical
modality NN Physical
of IN Physical
delivery NN Physical
, , Physical
cervical JJ Physical
cerclage NN Physical
) ) None
Operative JJ Other
time NN Other
and CC None
fluid JJ Physical
absorption NN Physical
cumulative JJ Adverse
complication NN Adverse
rate NN Adverse
reproductive JJ Other
parameters NNS Other
pregnancy NN Physical
and CC Physical
delivery NN Physical
rates NNS Physical
spontaneous JJ Physical
abortions NNS Physical
. . None
cesarean JJ Physical
section NN Physical
without IN Physical
differences NNS Physical
operating NN Other
time NN Other
complication NN Adverse
rate NN Adverse
. . None
-DOCSTART- -X- N

repetitive JJ Mental
behavior NN Mental
aggression NN Mental
anxiety NN Mental
or CC Mental
nervousness NN Mental
( ( Mental
P NNP Mental
< NNP Mental
.02 NNP Mental
) ) Mental
, , Mental
depression NN Mental
( ( Mental
P NNP Mental
< NNP Mental
.03 NNP Mental
) ) Mental
, , Mental
irritability NN Mental
( ( Mental
P NNP Mental
< NNP Mental
.01 NNP Mental
) ) Mental
overall JJ None
behavioral JJ Mental
symptoms NNS Mental
of IN Mental
autism NN Mental
social JJ Mental
behavior NN Mental
and CC Mental
language NN Mental
mild JJ Adverse
, , Adverse
transient JJ Adverse
sedation NN Adverse
tolerated VBN Other
extrapyramidal JJ Adverse
effects NNS Adverse
, , Physical
cardiac JJ Adverse
events NNS Adverse
, , Physical
or CC Physical
seizures NNS Adverse
. . Physical
-DOCSTART- -X- N

was VBD None
patient-reported JJ None
changes NNS None
in IN None
hay NN None
fever NN None
symptoms NNS None
assessed VBN None
by IN None
a DT None
visual JJ None
analog NN None
scale NN None
. . None
were VBD None
weekly JJ None
visual JJ None
analog NN None
scale JJ None
symptom NN None
scores NNS None
during IN None
pollen NN None
season NN None
, , None
use NN None
of IN None
rescue NN None
medication NN None
, , None
changes NNS None
in IN None
conjunctival NN None
and CC None
skin NN None
reactivity NN None
, , None
as RB None
well RB None
as IN None
safety NN None
. . None
RESULTS NNP None
Hay NNP None
fever NN None
symptoms NNS None
during IN None
the DT None
pollen NN None
season NN None
with IN None
drug-related JJ None
adverse JJ None
events NNS None
( ( None
AEs NNP None
) ) None
, , None
by IN None
pruritus NN None
, , None
erythema NN None
, , None
wheal NN None
, , None
or CC None
eczema NN None
. . None
systemic JJ None
AEs NNP None
The DT None
dropout NN None
rate NN None
to TO None
AEs NNP None
serious JJ None
AE NNP None
-DOCSTART- -X- N

tooth JJ Physical
widths NNS Physical
vestibulo-oral JJ Physical
dimension NN Physical
. . None
Overall JJ Other
tooth JJ Other
width NN Other
crown JJ Physical
diameters NNS Physical
tooth-size NN Physical
dental-arch JJ Physical
space NN Physical
-DOCSTART- -X- N

Brief NNP Pain
Pain NNP Pain
Inventory NNP Pain
, , Pain
the DT Pain
% NN Pain
pain NN Pain
relief NN Pain
pain NN Pain
relief NN Pain
achieved VBN Pain
statistically RB Other
significant JJ Other
t-test NN Other
and CC Other
the DT Other
Wilcoxon NNP Other
Rank NNP Other
Sum NNP Other
test NN Other
. . Other
pain NN Pain
pain NN Physical
relief NN Physical
-DOCSTART- -X- N

Effect NN Physical
ventricular JJ Physical
arrhythmias NN Physical
Clinical NNP Physical
, , None
biochemical JJ Physical
, , None
and CC None
48-hour JJ Physical
ambulatory NN Physical
electrocardiographic JJ Physical
data NN Physical
Signal-averaged JJ Physical
electrocardiograms NNS Physical
Average JJ Physical
LV NNP Physical
posterior NN Physical
wall NN Physical
thickness NN Physical
Systolic NNP Physical
blood NN Physical
pressure NN Physical
( ( Physical
BP NNP Physical
) ) Physical
Serum NNP Physical
potassium NN Physical
ventricular JJ Physical
premature NN Physical
contractions NNS Physical
ventricular JJ Physical
tachycardia NN Physical
signal-averaged JJ Physical
electrocardiography NN Physical
ventricular JJ Physical
arrhythmias NNS Physical
signal-averaged JJ Physical
electrocardiographic JJ Physical
variables NNS Physical
. . None
-DOCSTART- -X- N

survival JJ Mortality
time NN Mortality
Three CD Mortality
long-term JJ Mortality
survivors NNS Mortality
were VBD None
seen VBN None
in IN None
the DT None
latter JJ None
group NN None
. . None
-DOCSTART- -X- N

T NNP Physical
lymphocytes NNS Physical
, , None
NK NNP Physical
cell NN Physical
number NN Physical
and CC None
cytotoxic JJ Other
activity NN Other
absolute NN Physical
lymphocyte NN Physical
number NN Physical
and CC None
percentage NN Physical
of IN Physical
CD3 NNP Physical
cells NNS Physical
. . None
CD16 NNP Physical
cells NNS Physical
NK NNP Physical
cell VBP Physical
cytotoxic JJ Physical
activity NN Physical
hematocrit NN Physical
level NN Physical
anemia NN Physical
CD3 NNP Physical
, , Physical
CD4 NNP Physical
, , Physical
CD8 NNP Physical
and CC Physical
CD16 NNP Physical
cell NN Physical
numbers NNS Physical
CD4/CD8 NNP Physical
ratio NN Physical
. . None
Cytotoxic NNP Physical
activity NN Physical
of IN Physical
NK NNP Physical
cells NNS Physical
lymphocyte JJ Physical
number NN Physical
. . None
CD8 NNP Physical
and CC Physical
CD16 NNP Physical
cell NN Physical
percentage NN Physical
CD4/CD8 NNP Physical
ratio NN Physical
. . None
-DOCSTART- -X- N

efficacy NN Other
Effects NNS Mental
on IN Mental
behaviour NNS Mental
Autism NNP Mental
Treatment NNP Mental
Evaluation NNP Mental
Checklist NNP Mental
score NN Mental
( ( Mental
ATEC NNP Mental
) ) Mental
clinical JJ Mental
improvement NN Mental
Clinical NNP Mental
Global NNP Mental
Impression NNP Mental
( ( Mental
CGI NNP Mental
) ) Mental
system NN Mental
; : Other
clinical JJ Mental
change NN Mental
( ( Mental
CGIC NNP Mental
) ) Mental
and CC Mental
severity NN Mental
( ( Mental
CGIS NNP Mental
) ) Mental
sub-scores NNS Mental
. . Mental
mean JJ Mental
total JJ Mental
ATEC NNP Mental
scores NNS Mental
total JJ Mental
ATEC NNP Mental
score NN Mental
CGI NNP Mental
scores NNS Mental
severity NN Mental
scores NNS Mental
( ( Mental
CGIS NNP Mental
) ) Mental
change NN Mental
scores NNS Mental
( ( Mental
CGIC NNP Mental
) ) Mental
overall JJ Mental
behaviour NN Mental
CGI NNP Mental
sub-scores NNS Mental
safe JJ Other
and CC Other
well RB Other
tolerated VBN Other
minimal JJ Adverse
side NN Adverse
effect NN Adverse
-DOCSTART- -X- N

active JJ Mental
lifestyle NN Mental
and CC None
improved JJ Other
quality NN Other
of IN Other
life NN Other
active JJ Mental
lifestyle NN Mental
and CC None
improved JJ None
quality NN Physical
of IN Physical
life NN Physical
( ( Physical
QoL NNP Physical
) ) Physical
everyday JJ Mental
physical JJ Mental
activity NN Mental
( ( Mental
PA NNP Mental
, , Mental
novel JJ Mental
accelerometry-based JJ Mental
activity NN Mental
monitor NN Mental
) ) Mental
and CC None
QoL NNP Physical
several JJ Other
related JJ Other
parameters NNS Other
. . None
active JJ Mental
lifestyle NN Mental
or CC None
improved VBN None
QoL NNP Physical
peak NN Physical
power NN Physical
6-min JJ Physical
walk NN Physical
distance NN Physical
muscle NN Physical
strength NN Physical
depression NN Mental
peak NN Physical
Vo NNP Physical
( ( Physical
2 CD Physical
) ) Physical
knee $ Physical
extension NN Physical
strength NN Physical
active JJ Mental
lifestyle NN Mental
or CC None
improved VBN None
QoL NNP Physical
. . None
everyday JJ None
PA NNP None
-DOCSTART- -X- N

mean NN Physical
hemoglobin NN Physical
concentration NN Physical
hematocrit NN Physical
cerebral JJ Adverse
infarctions NNS Adverse
intracerebral JJ Adverse
hematoma NN Adverse
infarction NN Adverse
risk NN Physical
of IN Physical
a DT Physical
first JJ Physical
stroke NN Physical
-DOCSTART- -X- N

report VBP Other
individual JJ Mental
and CC Mental
family-level JJ Mental
factors NNS Mental
frequently RB None
refusal NN Other
participation NN None
higher JJR Mental
educational JJ Mental
attainment NN Mental
. . Mental
enroll VB None
female JJ None
enroll VB None
diagnosed VBN Physical
more RBR Physical
recently RB Physical
parent NN Other
was VBD Other
partnered VBN Other
parent NN Mental
lived VBD Mental
in IN Mental
the DT Mental
same JJ Mental
city NN Mental
as IN Mental
the DT Mental
case NN Mental
-DOCSTART- -X- N

Serum NNP Physical
magnesium NN Physical
levels NNS Physical
were VBD Physical
measured VBN Physical
survive VB Mortality
survival NN Mortality
functional JJ Physical
and CC Physical
renal JJ Physical
impairment NN Physical
. . None
survival NN Mortality
ventricular JJ Physical
tachycardia NN Physical
, , None
length NN Physical
of IN Physical
longest JJS Physical
run NN Physical
or CC Physical
frequency NN Physical
of IN Physical
ventricular JJ Physical
premature NN Physical
beats NNS Physical
baseline NN Other
Holter NNP Other
monitoring NN Other
sudden JJ Mortality
death NN Mortality
or CC Mortality
death NN Mortality
ventricular JJ Physical
ectopic NN Physical
activity NN Physical
-DOCSTART- -X- N

rates NNS Mortality
of IN Mortality
remission NN Mortality
and CC Mortality
survival JJ Mortality
time NN Mortality
survival JJ Mortality
time NN Mortality
-DOCSTART- -X- N

lymphocyst JJ Physical
formation NN Physical
lymphocysts NNS Physical
Lymphocysts NNS Physical
postoperative JJ Physical
fever NN Physical
pelvic JJ Physical
lymphocysts NNS Physical
-DOCSTART- -X- N

Prognostic JJ Physical
significance NN Physical
beneficial JJ Other
effect NN Other
Reinfarction NNP Physical
death NN Mortality
ST-T JJ Physical
reinfarction NN Physical
extensive JJ Physical
damage NN Physical
peak JJ Physical
MB-creatine JJ Physical
kinase NN Physical
levels NNS Physical
higher JJR Mortality
mortality NN Mortality
rate NN Mortality
Angina NNP Physical
transient JJ Physical
ST-T JJ Physical
changes NNS Physical
cumulative JJ Physical
life-table JJ Physical
incidence NN Physical
risk NN Mortality
of IN Mortality
reinfarction NN Physical
and CC None
death NN Mortality
angina RB Physical
associated VBN Physical
with IN Physical
transient JJ Physical
electrocardiographic JJ Physical
changes NNS Physical
viable JJ Physical
jeopardized JJ Physical
myocardium NN Physical
-DOCSTART- -X- N

Efficacy NN Other
and CC Other
safety NN Other
scores NNS None
International NNP Physical
Index NNP Physical
of IN Physical
Erectile NNP Physical
Function NNP Physical
( ( Physical
IIEF NNP Physical
) ) Physical
questions NNS Physical
3 CD Physical
and CC Physical
4 CD Physical
satisfied JJ None
intercourse JJ Physical
success NN Physical
rate NN Physical
. . None
severity NN None
; : None
dizziness NN Adverse
tinnitus NN Adverse
-DOCSTART- -X- N

disease NN Physical
activity NN Physical
remission NN Physical
assessment NN Physical
Simplified NNP None
Disease NNP None
Activity NNP None
Index NNP None
( ( None
SDAI NNP None
) ) None
scores VBZ None
, , None
Clinical JJ None
Disease NNP None
Activity NNP None
Index NNP None
( ( None
CDAI NNP None
) ) None
scores VBZ None
, , None
and CC None
the DT None
Disease NNP None
Activity NNP None
Score NNP None
in IN None
Disease NNP Physical
activity NN Physical
states NNS Physical
, , Physical
including VBG Physical
remission NN Physical
Changes NNS Physical
in IN Physical
the DT Physical
DAS28 NNP Physical
, , None
the DT Physical
SDAI NNP Physical
score NN Physical
, , None
and CC None
the DT None
CDAI NNP Physical
score NN Physical
SDAI NNP Physical
CDAI NNP Physical
. . None
improvement NN Physical
in IN Physical
disease NN Physical
activity NN Physical
However RB None
, , None
DAS28 NNP None
remission NN None
rates NNS None
were VBD None
the DT None
SDAI NNP None
and CC None
CDAI NNP None
remission NN None
rates NNS None
. . None
with IN None
DAS28 NNP None
remission NN None
also RB None
had VBD None
disease NN None
remission NN None
according VBG None
treatment NN None
, , None
SDAI NNP None
and CC None
CDAI NNP None
remission NN None
rates NNS None
were VBD None
DAS28 NNP None
remission NN None
rates NNS None
were VBD None
DAS28 NNP None
remission NN None
but CC None
without IN None
CDAI NNP None
remission NN None
had VBD None
higher JJR None
swollen JJ None
joint JJ None
counts NNS None
but CC None
lower JJR None
erythrocyte NN None
sedimentation NN None
rates NNS None
( ( None
ESRs NNP None
) ) None
compared VBN None
CONCLUSION NNP None
Disease NNP None
activity NN None
in IN None
activity NN None
. . None
Remission NN None
rates NNS None
were VBD None
-DOCSTART- -X- N

H-reflex JJ Physical
measurements NNS Physical
maximum JJ Physical
H-reflex NNP Physical
maximum JJ Physical
M-wave JJ Physical
measurements NNS Physical
soleus NN Physical
H/M NNP Physical
ratio NN Physical
soleus NN Physical
H/M NNP Physical
ratios NNS Physical
. . None
fibularis JJ Physical
longus NN Physical
soleus NN Physical
H/M NNP Physical
ratios NNS Physical
. . None
soleus JJ Physical
muscle NN Physical
activation NN Physical
. . None
-DOCSTART- -X- N

repetitive JJ Mental
behaviors NNS Mental
Repetitive JJ Mental
behaviors NNS Mental
safety NN Other
efficacy NN Other
measures NNS Mental
of IN Mental
repetitive JJ Mental
behaviors NNS Mental
and CC None
global JJ Mental
improvement NN Mental
. . None
CY-BOCS NNP Mental
compulsion NN Mental
scale NN Mental
. . None
effect NN Other
size NN Other
CGI NNP Mental
autism NN Mental
score NN Mental
phase NN None
order NN None
effect NN None
. . None
composite JJ Mental
measure NN Mental
of IN Mental
global JJ Mental
effectiveness NN Mental
. . None
treatment NN Adverse
emergent JJ Adverse
side NN Adverse
effects NNS Adverse
. . None
repetitive JJ Mental
behaviors NNS Mental
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
hyperactivity NN Adverse
discrimination NN Mental
learning NN Mental
self-injurious JJ Mental
behavior NN Mental
. . None
Untoward JJ Adverse
effects NNS Adverse
serious JJ Adverse
untoward JJ Adverse
effects NNS Adverse
-DOCSTART- -X- N

propensity NN Mental
Matsumoto NNP Physical
Adolphs NNP Physical
] NNP None
tit-for-tat NN Physical
Izuma NNP Physical
not RB None
donate VB None
more JJR None
to TO None
charity NN None
when WRB None
they PRP None
engage VBP None
in IN None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
the DT None
difference NN None
in IN None
DMVF NNP None
at IN None
12 CD None
were VBD None
differences NNS None
in IN None
daily JJ None
mean NN None
: : None
( ( None
i NN None
) ) None
voiding NN None
frequency NN None
at IN None
4 CD None
and CC None
8 CD None
weeks NNS None
; : None
( ( None
ii NN None
) ) None
urgency NN None
frequency NN None
; : None
( ( None
iii NN None
) ) None
urgency NN None
incontinence NN None
frequency NN None
; : None
( ( None
iv NN None
) ) None
incontinence NN None
frequency NN None
; : None
( ( None
v NN None
) ) None
nocturia NN None
frequency NN None
; : None
and CC None
( ( None
vi NN None
) ) None
quality NN None
of IN None
life NN None
score NN None
. . None
for IN None
safety NN None
analysis NN None
were VBD None
adverse JJ None
events NNS None
, , None
vital JJ None
signs NNS None
, , None
residual JJ None
urine NN None
volume NN None
and CC None
clinical JJ Other
laboratory NN Other
tests NNS Other
. . None
An DT None
efficacy NN None
analysis NN None
DMVF NNP None
at IN None
12 CD None
-DOCSTART- -X- N

raised VBN Physical
serum NN Physical
prolactin NN Physical
levels NNS Physical
. . None
prolactin JJ Physical
secretion NN Physical
. . None
serum JJ Physical
prolactin NN Physical
levels NNS Physical
serum NN Physical
prolactin NN Physical
levels NNS Physical
-DOCSTART- -X- N

efficacy NN Other
, , Other
safety NN Other
quality NN Physical
of IN Physical
sleep NN Physical
number NN Physical
of IN Physical
nocturnal JJ Physical
voids NNS Physical
mean JJ Physical
number NN Physical
of IN Physical
nocturnal JJ Physical
voids NNS Physical
duration NN Physical
of IN Physical
the DT Physical
first JJ Physical
sleep JJ Physical
period NN Physical
Quality NN Physical
of IN Physical
sleep NN Physical
Adverse JJ Adverse
events NNS Adverse
treatment NN None
nocturnal JJ Physical
voiding NN Physical
frequency NN Physical
sleep JJ Physical
quality NN Physical
-DOCSTART- -X- N

disability NN Physical
and CC Physical
falls VBZ Physical
in IN Physical
disability NN Physical
and CC Physical
falls VBZ Physical
in IN Physical
incidence NN Physical
of IN Physical
declining VBG Physical
functional JJ Physical
status NN Physical
incidence NN Physical
of IN Physical
falls NNS Physical
short-term JJ Other
health NN Other
benefits NNS Other
benefits NNS Other
diminished VBN Other
-DOCSTART- -X- N

associations NNS Other
of IN Other
creatinine JJ Other
clearance NN Other
( ( Other
CrCl NNP Other
) ) Other
outcomes NNS None
CrCl NNP Physical
the DT Other
Cockcroft NNP Other
and CC Other
Gault NNP Other
formula NN Other
CrCl NNP Physical
logistic JJ Other
regression NN Other
models NNS Other
. . None
bleeding VBG Adverse
risk NN Adverse
-DOCSTART- -X- N

CRP NNP Physical
and CC None
prothrombin VB Physical
fragment JJ Physical
1 CD Physical
and CC Physical
2 CD Physical
( ( Physical
F1+2 NNP Physical
) ) Physical
CRP NNP Physical
CRP NNP Physical
F1+2 NNP Physical
response NN Physical
to TO Physical
the DT Physical
influenza JJ Physical
vaccination NN Physical
CRP-levels NNP Physical
-DOCSTART- -X- N

effect NN Physical
on IN Physical
blood NN Physical
lipids NNS Physical
increased VBD Other
DHA NNP Physical
concentration NN Physical
in IN Physical
plasma NN Physical
proportion NN Physical
in IN Physical
erythrocyte JJ Physical
lipids NNS Physical
serum NN Physical
total JJ Physical
cholesterol NN Physical
, , Physical
LDL NNP Physical
cholesterol NN Physical
, , Physical
and CC Physical
plasma NN Physical
apolipoprotein NN Physical
B NNP Physical
concentrations NNS Physical
LDL NNP Physical
cholesterol NN Physical
: : Physical
apolipoprotein NN Physical
B NNP Physical
ratio NN Physical
increase NN Physical
in IN Physical
LDL NNP Physical
size NN Physical
. . None
Plasma NNP Physical
lathosterol NN Physical
and CC Physical
plant NN Physical
sterol NN Physical
concentrations NNS Physical
increases VBZ Physical
LDL NNP Physical
cholesterol NN Physical
-DOCSTART- -X- N

safety NN Other
, , Other
tolerability NN Other
, , Other
and CC Other
antiviral JJ Other
activity NN Other
frequency NN Other
of IN Other
infection NN Other
and CC Other
viral JJ Other
shedding NN Other
; : Physical
infected JJ Physical
viral JJ Other
titer NN Other
area NN Other
under IN Other
the DT Other
curve NN Other
median NN Other
( ( Other
IQR NNP Other
) ) Other
duration NN Other
of IN Other
viral JJ Other
shedding VBG Other
symptom JJ Physical
scores NNS Physical
nasal JJ Physical
proinflammatory JJ Physical
cytokine NN Physical
levels NNS Physical
. . Physical
mild NN Adverse
to TO Adverse
moderate VB Adverse
nausea NN Adverse
-DOCSTART- -X- N

calcium JJ Physical
intake NN Physical
, , None
osteoporosis NN Mental
knowledge NN Mental
, , None
and CC None
self-efficacy NN Mental
effectiveness NN Other
calcium NN Physical
intake NN Physical
, , None
knowledge NN Mental
, , None
and CC None
self-efficacy NN Mental
Dietary NNP Physical
calcium NN Physical
intake NN Physical
, , None
osteoporosis NN Other
knowledge NN Other
, , None
health NN Other
beliefs NNS Other
, , None
and CC None
self-efficacy NN Mental
. . None
calcium NN Physical
intake NN Physical
, , None
knowledge NN Mental
, , None
and CC None
self-efficacy NN Mental
health NN Physical
belief NN Physical
subscales NNS Physical
. . None
calcium NN Physical
intake NN Physical
. . None
-DOCSTART- -X- N

urogenital JJ Physical
and CC Physical
sexual JJ Physical
health NN Physical
urogenital JJ Physical
and CC Physical
sexuality NN Physical
score NN Physical
vaginal JJ Physical
health NN Physical
index NN Physical
and CC Physical
the DT Physical
vaginal JJ Physical
maturation NN Physical
index NN Physical
( ( Physical
VMI NNP Physical
) ) Physical
Changes NNP Physical
in IN Physical
the DT Physical
urogenital JJ Physical
and CC Physical
sexuality NN Physical
score NN Physical
along IN Physical
with IN Physical
vaginal JJ Physical
health NN Physical
index NN Physical
and CC Physical
VMI NNP Physical
. . Physical
sexuality NN None
score NN None
adverse JJ Adverse
effects NNS Adverse
urogenital JJ Physical
atrophy NN Physical
improving VBG Physical
sexual JJ Physical
function NN Physical
-DOCSTART- -X- N

neuromuscular JJ Physical
blockade NN Physical
Mechanomyographic NNP Physical
and CC Physical
clinical JJ Physical
evaluation NN Physical
by IN Physical
single JJ Physical
twitch NN Physical
and CC None
TOF NNP Physical
stimulation NN Physical
of IN Physical
the DT Physical
ulnar JJ Physical
nerve NN Physical
at IN Physical
the DT Physical
wrist NN Physical
concomitant JJ Physical
abductor NN Physical
pollicis NN Physical
muscle NN Physical
onset JJ Other
time NN Other
duration NN Other
of IN Other
action NN Other
single JJ Physical
twitch NN Physical
recovery NN Physical
single JJ Physical
twitch NN Physical
recovery NN Physical
recovery NN Physical
rate NN Physical
of IN Physical
vecuronium NN Physical
-DOCSTART- -X- N

healthcare NN Other
cost NN Other
data NNS Other
Cost NN Other
differences NNS Other
Healthcare NNP Other
cost NN Other
differences NNS Other
healthcare NN Other
costs NNS Other
cost VBD Other
cost NN Other
short-term JJ Other
healthcare NN Other
costs NNS Other
. . None
-DOCSTART- -X- N

Intracapillary JJ Physical
glomerular NN Physical
metastases NNS Physical
-DOCSTART- -X- N

Airway NNP Other
management NN Other
LMA NNP Other
successfully RB Other
successful JJ Mental
Skill NNP Mental
performance NN Mental
and CC Mental
retention NN Mental
performance NN Mental
effective JJ Other
-DOCSTART- -X- N

control NN Physical
of IN Physical
Total JJ Mortality
mortality NN Mortality
relative JJ Mortality
risk NN Mortality
of IN Mortality
death NN Mortality
Mortality NN Mortality
Complication NN Physical
rates NNS Physical
interval NN Physical
of IN Physical
five CD Physical
days NNS Physical
without IN Physical
bleeding NN Physical
bleeding VBG Physical
controlled VBN Physical
as RB None
safe JJ Other
as IN Other
sclerotherapy NN Other
emergency NN Physical
treatment NN Physical
of IN Physical
bleeding VBG Physical
-DOCSTART- -X- N

severity NN Physical
of IN Physical
RLS NNP Physical
severe JJ Adverse
vomiting NN Adverse
sleep JJ Physical
time NN Physical
CGI NNP Physical
scale NN Physical
carryover NN Other
or CC Other
period NN Other
effect NN Other
RLS NNP Physical
symptoms NNS Physical
-DOCSTART- -X- N

Observations NNS Other
and CC Other
tests NNS Other
development NN Other
-DOCSTART- -X- N

Cure NN Other
rates NNS Other
post-treatment JJ Physical
reappearance NN Physical
of IN Physical
parasitemia NN Physical
negative JJ Physical
parasitemias NN Physical
parasitemia NN Physical
ineffectiveness NN Other
safe JJ Other
and CC Other
effective JJ Other
-DOCSTART- -X- N

pain NN Pain
analgesic JJ Other
consumption NN Other
pain NN Pain
pain NN Pain
analgesic JJ Other
intake NN Other
bone NN Physical
density NN Physical
distal JJ Physical
radius NN Physical
bone NN Physical
mass NN Physical
-DOCSTART- -X- N

hemoglobin JJ Physical
concentration NN Physical
need NN Physical
for IN Physical
blood NN Physical
transfusions NNS Physical
; : None
duration NN Other
of IN Other
ICU NNP Other
stay NN Other
; : Other
time NN Other
in IN Other
the DT Other
study NN Other
; : Other
volume NN Other
of IN Other
all DT Other
blood NN Other
drawn NN Other
, , Other
discarded VBD Other
, , Other
or CC Other
lost VBN Other
due JJ Other
to TO Other
leakage VB Other
; : Other
hemoglobin JJ Physical
concentrations NNS Physical
; : None
blood NN Physical
transfusions NNS Physical
; : None
and CC None
accidental JJ Mental
needle JJ Mental
injuries NNS Mental
. . None
Arterial JJ Physical
pressure NN Physical
waveforms NNS Physical
Mean NNP Physical
hemoglobin JJ Physical
concentrations NNS Physical
volume NN Other
of IN Other
blood NN Other
drawn NN Other
and CC Other
discarded VBD Other
from IN Other
arterial JJ Other
catheters NNS Other
total JJ Other
volume NN Other
of IN Other
blood NN Other
discarded VBN Other
Mean NNP Physical
hemoglobin JJ Physical
concentration NN Physical
mean JJ Physical
hemoglobin NN Physical
concentration NN Physical
mean JJ Physical
hemoglobin NN Physical
concentration NN Physical
mean JJ Physical
change NN Physical
in IN Physical
hemoglobin JJ Physical
concentration NN Physical
Hemoglobin NNP Physical
concentration NN Physical
Univariate NNP Physical
and CC Physical
multiple JJ Physical
regression NN Physical
analysis NN Physical
blood NN Physical
volume NN Physical
Transfusion NN Physical
requirements NNS Physical
pressure NN Physical
waveforms NNS Physical
. . None
accidental JJ Mental
needle JJ Mental
injuries NNS Mental
hemoglobin JJ Physical
concentration NN Physical
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

pain NN Pain
relief NN Pain
hand NN Pain
pain NN Pain
. . Pain
pain NN Pain
stimulus JJ None
temperature NN None
on IN None
pain NN None
ratings NNS None
, , None
but CC None
main JJ None
effect NN None
of IN None
condition NN None
( ( None
p JJ None
a DT None
condition NN None
x JJ None
temperature NN None
interaction NN None
( ( None
p JJ None
determine VB None
heat NN None
and CC None
cold JJ None
pain NN None
thresholds NNS None
during IN None
involved VBN None
heat NN None
and CC None
cold JJ None
detection NN None
thresholds NNS None
and CC None
paradoxical JJ None
heat NN None
sensations NNS None
. . None
Again NNP None
main JJ None
effect NN None
of IN None
condition NN None
on IN None
heat NN None
pain NN None
threshold NN None
( ( None
p JJ None
cold JJ None
pain NN None
threshold NN None
( ( None
p JJ None
secondary JJ None
measures NNS None
( ( None
p VB None
induce VB None
analgesia NN None
. . None
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
overall JJ Mortality
progression-free JJ Mortality
survival NN Mortality
rates NNS Mortality
overall JJ Other
response NN Other
rates NNS Other
Median JJ Mortality
overall JJ Mortality
survival NN Mortality
times NNS Mortality
overall JJ Mortality
survival NN Mortality
Severe JJ Adverse
hematologic JJ Adverse
toxicity NN Adverse
efficacy NN Other
safety NN Other
-DOCSTART- -X- N

[ JJ None
No DT Other
effect NN Other
binging VBG Mental
number NN Mental
of IN Mental
binges NNS Mental
bulimia NN Mental
scale NN Mental
of IN Mental
the DT Mental
Eating NNP Mental
Disorder NNP Mental
Inventory NNP Mental
. . None
number NN Mental
of IN Mental
binges NNS Mental
and CC Mental
the DT Mental
scores NNS Mental
on IN Mental
the DT Mental
bulimia NN Mental
scale NN Mental
significant JJ Other
statistical JJ Other
differences NNS Other
Symptom-Check-List NNP Mental
( ( Mental
SCL-90R NNP Mental
) ) Mental
no DT Other
effect NN Other
-DOCSTART- -X- N

distant JJ Physical
metastasis NN Physical
and CC None
mortality NN Mortality
tumor NN Physical
nuclei NN Physical
staining VBG Physical
positive JJ Physical
per-sample JJ Other
mean JJ Other
intensity NN Other
score NN Other
( ( Physical
MIS NNP Physical
) ) Physical
overall JJ Mortality
mortality NN Mortality
( ( None
OM NNP None
) ) None
distant JJ Physical
metastasis NN Physical
( ( Physical
DM NNP Physical
) ) Physical
and CC None
cause-specific JJ Mortality
mortality NN Mortality
( ( Mortality
CSM NNP Mortality
) ) Mortality
. . None
MDM2 NNP Physical
overexpression NN Physical
DM NNP Physical
Ki-67 NNP None
overexpression NN None
DM NNP Physical
CSM NNP Mortality
OM NNP Mortality
P53 NNP Physical
overexpression NN Physical
OM NNP Mortality
overexpression NN Physical
of IN Physical
both DT Physical
Ki-67 NNP Physical
and CC Physical
MDM2 NNP Physical
significantly RB Other
increased VBN Other
failure NN Other
rates NNS Other
MDM2 NNP Physical
and CC None
Ki-67 NNP Physical
expression NN Physical
levels NNS Physical
distant JJ Physical
metastasis NN Physical
and CC None
mortality NN Mortality
-DOCSTART- -X- N

on IN None
lung NN None
function NN None
and CC None
the DT None
inflammatory JJ None
response NN None
to TO None
one-lung JJ None
ventilation NN None
. . None
The DT None
concentrations NNS None
of IN None
serum NN None
and CC None
bronchoalveolar JJ None
lavage NN None
fluid NN None
cytokines NNS None
reduced VBD None
both DT None
peak NN None
and CC None
plateau NN None
both DT None
) ) None
ventilatory NN None
pressures NNS None
. . None
lung NN None
compliance NN None
the DT None
concentrations NNS None
of IN None
tumour JJ None
necrosis NN None
factor-? NN None
, , None
interleukin-1? JJ None
, , None
interleukin-6 JJ None
and CC None
interleukin-8 JJ None
in IN None
bronchoalveolar JJ None
lavage NN None
fluid NN None
, , None
but CC None
increased VBD None
interleukin-10 JJ None
30 CD None
improving VBG None
ventilatory NN None
mechanics NNS None
and CC None
reducing VBG None
the DT None
inflammatory JJ None
response NN None
to TO None
-DOCSTART- -X- N

intraoperative JJ Physical
blood NN Physical
loss NN Physical
and CC Physical
a DT Physical
lower JJR Physical
rate NN Physical
of IN Physical
wound NN Physical
complications NNS Physical
femoral JJ Physical
shaft NN Physical
fracture NN Physical
-DOCSTART- -X- N

Western JJ Physical
Ontario NNP Physical
and CC Physical
McMaster NNP Physical
University NNP Physical
Osteoarthritis NNP Physical
Index NNP Physical
( ( Physical
WOMAC NNP Physical
) ) Physical
scores VBZ Physical
, , None
20 CD Physical
meters NNS Physical
ambulatory JJ Physical
time NN Physical
knee VB Physical
range NN Physical
of IN Physical
motion NN Physical
( ( Physical
ROM NNP Physical
) ) Physical
WOMAC NNP Physical
scores NNS Physical
ambulatory JJ Physical
time NN Physical
and CC None
knee NN Physical
range NN Physical
of IN Physical
motion NN Physical
-DOCSTART- -X- N

long-term JJ Other
radiologic JJ Other
outcome NN Other
development NN Physical
of IN Physical
joint JJ Physical
damage NN Physical
evaluate VB Other
the DT Other
radiologic JJ Other
progression NN Other
radiographs NN Other
analyzed VBN Physical
by IN Physical
using VBG Physical
the DT Physical
Larsen NNP Physical
score NN Physical
Larsen NNP Physical
score NN Physical
erosive JJ Physical
changes NNS Physical
radiologic JJ Other
progression NN Other
long-term JJ Other
radiologic NN Other
damage NN Other
-DOCSTART- -X- N

degree NN Physical
of IN Physical
anesthesia NN Physical
degree NN Physical
of IN Physical
anesthesia NN Physical
-DOCSTART- -X- N

Goal NNP Mental
attainment NN Mental
scaling NN Mental
Goal NNP Mental
attainment JJ Mental
scaling NN Mental
( ( Mental
GAS NNP Mental
) ) Mental
-DOCSTART- -X- N

Pain NNP Pain
intensity NN Pain
( ( Pain
rest NN Pain
and CC Pain
passive JJ Pain
mobilisation NN Pain
) ) Pain
use NN None
of IN None
rescue NN Other
medication NN Other
( ( None
piritramide JJ Other
by IN None
patient NN Other
controlled VBN Other
analgesia NN Other
) ) None
pain NN Pain
reduction NN Pain
Piritramide NNP Other
consumption NN Other
analgesic JJ Other
effect NN Other
. . Other
-DOCSTART- -X- N

-DOCSTART- -X- N

median JJ Physical
neutrophil NN Physical
count NN Physical
duration NN Physical
of IN Physical
hospital NN Physical
stay NN Physical
, , Physical
the DT Physical
number NN Physical
of IN Physical
antibiotic JJ Physical
days NNS Physical
, , Physical
and CC Physical
the DT Mental
number NN Mental
of IN Mental
fever JJ Mental
days NNS Mental
lymphocyte NN Physical
count NN Physical
haemoglobin NN Physical
concentrations NNS Physical
and CC Physical
platelets NNS Physical
counts NNS Physical
, , Physical
and CC Physical
higher JJR Physical
plasma NN Physical
urea JJ Physical
creatinine NN Physical
and CC Physical
bilirubin NN Physical
leukaemic JJ Physical
relapse NN Physical
. . Physical
-DOCSTART- -X- N

pulses NNS Physical
of IN Physical
PRD NNP Physical
and CC Physical
VCR NNP Physical
CCR NNP Physical
rates NNS Physical
CNS NNP Physical
and CC Physical
testicular JJ Physical
relapses NNS Physical
incidence NN Physical
of IN Physical
infections NNS Physical
duration NN Physical
of IN Physical
CCR NNP Physical
. . None
-DOCSTART- -X- N

body NN Mental
dissatisfaction NN Mental
: : None
body NN Mental
dissatisfaction NN Mental
body NN Mental
dissatisfaction NN Mental
diet VB Mental
-DOCSTART- -X- N

self-reported JJ Mental
sleep NN Mental
and CC None
quality NN Other
of IN Other
life NN Other
efficacy NN Other
improve VB Mental
sleep NN Mental
, , Mental
mood NN Mental
and CC None
quality NN Physical
of IN Physical
life NN Physical
Outcomes NNS None
included VBD None
sleep JJ None
quality NN None
, , None
mood NN None
and CC None
quality NN None
of IN None
life NN None
questionnaires NNS None
( ( None
PSQI NNP None
, , None
Epworth NNP None
Sleepiness NNP None
Scale NNP None
[ NNP None
ESS NNP None
] NNP None
, , None
Short-form NNP None
36 CD None
[ NNP None
SF-36 NNP None
] NNP None
, , None
Center NNP None
for IN None
Epidemiological NNP None
Studies NNPS None
Depression NNP None
Scale NNP None
[ NNP None
CES-D NNP None
] NNP None
) ) None
. . None
in IN None
sleep JJ None
quality NN None
on IN None
the DT None
global JJ None
PSQI NNP None
sleep JJ None
latency NN None
sleep JJ None
duration NN None
daytime JJ None
dysfunction NN None
and CC None
sleep JJ None
efficiency NN None
in IN None
depressive JJ None
symptoms NNS None
daytime JJ None
sleepiness NN None
and CC None
improvements NNS None
in IN None
vitality NN None
improve VB None
sleep JJ None
quality NN None
, , None
mood NN None
and CC None
quality NN None
of IN None
life NN None
-DOCSTART- -X- N

spinal JJ Physical
bupivacaine NN Physical
ropivacaine NN Physical
Pinprick NNP Other
anesthesia NN Other
, , Physical
motor NN Physical
strength NN Physical
, , Physical
tolerance NN Physical
to TO Physical
electrical JJ Physical
stimulation NN Physical
and CC Physical
thigh JJ Physical
tourniquet NN Physical
, , Physical
and CC Physical
time NN Other
to TO Other
ambulation NN Other
Peak NNP Other
block NN Other
height NN Other
Sensory JJ Other
anesthesia NN Other
complete JJ Other
block NN Other
regression NN Other
Lower JJR Other
extremity NN Other
motor NN Other
blockade NN Other
gastrocnemius JJ Physical
strength NN Physical
: : Physical
tourniquet JJ Other
tolerance NN Other
time NN Other
to TO Other
ambulation NN Other
, , Other
spontaneous JJ Other
voiding NN Other
, , Other
and CC Other
discharge NN Other
hemodynamic JJ Physical
measurements NNS Physical
transient JJ Physical
neurologic NN Physical
symptoms NNS Physical
. . Adverse
quality NN Other
of IN Other
2-CP JJ Other
spinal JJ Other
anesthesia NN Other
systemic JJ Adverse
side NN Adverse
effects NNS Adverse
. . None
-DOCSTART- -X- N

effects NNS Physical
of IN Physical
DPP-4 NNP Physical
inhibition NN Physical
on IN Physical
fasting VBG Physical
islet NN Physical
function NN Physical
. . None
insulin JJ Physical
secretion NN Physical
in IN Physical
response NN Physical
to TO Physical
iv VB Physical
glucose JJ Physical
and CC Physical
arginine JJ Physical
glycosylated JJ Physical
hemoglobin NN Physical
GLP-1 NNP Physical
acute JJ Physical
insulin NN Physical
and CC Physical
C-peptide JJ Physical
responses NNS Physical
C-peptide NNP Physical
response NN Physical
-DOCSTART- -X- N

clinical JJ Physical
and CC Physical
psychosocial JJ Physical
outcomes NNS Physical
patients NNS Mental
' POS Mental
independence NN Mental
self-efficacy NN Mental
psychosocial JJ Mental
problems NNS Mental
altered VBD Mental
body NN Mental
perception NN Mental
, , Mental
sexual JJ Mental
activity NN Mental
avoidance NN Mental
, , Mental
and CC Mental
feeling VBG Mental
stigmatized VBN Mental
. . Mental
perceived VBN Mental
self-control NN Mental
and CC Mental
independence NN Mental
sexual JJ Mental
activity NN Mental
and CC Mental
socialization NN Mental
. . Mental
-DOCSTART- -X- N

disease NN Physical
risk NN Physical
colonize VB Physical
the DT Physical
and CC Physical
modify VB Physical
its PRP$ Physical
microbial JJ Physical
ecology NN Physical
quantitative JJ Physical
aerobic NN Physical
and CC Physical
anaerobic JJ Physical
cultures NNS Physical
. . Physical
Colonization NNP Physical
with IN Physical
LGG NNP Physical
occurred VBD Physical
Colonization NN Physical
bacterial JJ Physical
species NNS Physical
mean NN Physical
log NN Physical
colony NN Physical
forming VBG Physical
units NNS Physical
( ( Physical
CFU NNP Physical
) ) Physical
increase NN Physical
in IN Physical
species NNS Physical
number NN Physical
by IN Physical
day NN Physical
7 CD Physical
, , Physical
with IN Physical
further JJ Physical
increases NNS Physical
by IN Physical
day NN Physical
21 CD Physical
. . Physical
increased VBN Physical
Gram NNP Physical
( ( Physical
+ NNP Physical
) ) Physical
and CC Physical
anaerobic JJ Physical
species NNS Physical
. . None
species NNS Physical
number NN Physical
Mean NNP Physical
log NN Physical
CFU NNP Physical
of IN Physical
Gram NNP Physical
( ( Physical
- : Physical
) ) Physical
bacteria NNS Physical
Gram NNP Physical
( ( Physical
+ NNP Physical
) ) Physical
mean VBP Physical
log NN Physical
CFU NNP Physical
species NNS Physical
number NN Physical
or CC Physical
quantitative JJ Physical
counts NNS Physical
LGG NNP Other
was VBD Other
well RB Other
tolerated VBN Other
neonatal JJ Physical
response NN Physical
to TO Physical
a DT Physical
probiotic JJ Physical
preparation NN Physical
neonatal JJ Physical
intestinal JJ Physical
colonization NN Physical
patterns NNS Physical
. . None
-DOCSTART- -X- N

iron NN Physical
stores NNS Physical
infant NN Physical
's POS Physical
hemoglobin NN Physical
and CC Physical
serum NN Physical
ferritin VBP Physical
3 CD Physical
months NNS Physical
after IN Physical
delivery NN Physical
. . None
mean JJ Physical
infant NN Physical
ferritin NN Physical
and CC Physical
Hb NNP Physical
at IN Physical
3 CD Physical
months NNS Physical
Hb NNP Physical
anemia NN Physical
Iron NNP Physical
stores NNS Physical
and CC None
Hb NNP Physical
-DOCSTART- -X- N

gaze NN Mental
and CC Mental
smile JJ Mental
behaviors NNS Mental
stronger JJR Mental
temporal JJ Mental
contingencies NNS Mental
. . Mental
verbal JJ Mental
initiatives NNS Mental
. . Mental
-DOCSTART- -X- N

Pain NN Pain
pain NN Pain
side-effect JJ Adverse
profiles NNS Adverse
and CC None
patient JJ Mental
satisfaction NN Mental
. . None
median JJ Other
time NN Other
from IN Other
ED NNP Other
mean JJ Pain
NRS NNP Pain
pain NN Pain
score NN Pain
mean JJ Pain
decrease NN Pain
in IN Pain
pain NN Pain
scores NNS Pain
pain NN Pain
No UH None
differences NNS None
side JJ Adverse
effects NNS Adverse
or CC None
patient JJ Mental
satisfaction NN Mental
. . None
decreased VBD None
NRS NNP Pain
pain NN Pain
scores NNS Pain
superior JJ Other
pain NN Pain
relief NN Pain
-DOCSTART- -X- N

instrument NN Mental
rating NN Mental
six CD Mental
repetitive JJ Mental
behaviours NNS Mental
: : Mental
need NN Mental
to TO Mental
know VB Mental
, , Mental
repeating VBG Mental
, , Mental
ordering VBG Mental
, , Mental
need NN Mental
to TO Mental
tell/ask VB Mental
, , Mental
self-injury NN Mental
, , Mental
and CC Mental
touching VBG Mental
. . None
repetitive JJ Mental
behaviours NNS Mental
oral JJ Physical
m-CPP NNS Physical
prolactin NN Physical
response NN Physical
to TO Physical
m-CPP NN Physical
-DOCSTART- -X- N

Asymptomatic JJ Physical
days NNS Physical
daily JJ Mental
drug NN Mental
consumption NN Mental
flow-rate JJ Other
values NNS Other
residual JJ Physical
volume NN Physical
and CC Physical
functional JJ Physical
residual JJ Physical
capacity NN Physical
. . Physical
decrease NN None
clinical JJ Physical
scores NNS Physical
. . Physical
significantly RB Physical
better JJR Physical
run-in JJ Physical
values NNS Physical
non-trial JJ Other
drug NN Other
consumption NN Other
. . None
flow NN Physical
rate NN Physical
RV/TLC NNP Physical
ratio NN Physical
adverse JJ Physical
reactions NNS Physical
-DOCSTART- -X- N

Clinical JJ Physical
pharmacology NN Physical
pharmacokinetics NNS Physical
and CC None
effects NNS Physical
behaviour NN Mental
plasma JJ Physical
concentrations NNS Physical
of IN Physical
cortisol NN Physical
and CC Physical
vasopressin NN Physical
Drug NNP Physical
and CC Physical
hormone NN Physical
analyses NNS Physical
in IN Physical
plasma NN Physical
Behavioural NNP Mental
data NNS Mental
plasma JJ Physical
concentration NN Physical
of IN Physical
methadone NN Physical
terminal JJ None
half-life NN None
volume NN None
of IN None
distribution NN None
plasma JJ None
clearance NN None
time NN None
to TO None
maximal VB None
plasma JJ None
concentration NN None
maximal JJ Physical
plasma NN Physical
concentration NN Physical
of IN Physical
methadone NN Physical
terminal JJ None
half-life NN None
bioavailability NN Physical
Concentrations NNS Physical
of IN Physical
both DT Physical
cortisol NNS Physical
and CC Physical
vasopressin NN Physical
observed JJ None
behavioural JJ None
effects NNS None
licking NN Mental
and CC Mental
swallowing NN Mental
whining VBG Mental
pain NN Pain
half-life NN None
variation NN Physical
in IN Physical
plasma JJ Physical
concentrations NNS Physical
frequency NN Mental
of IN Mental
whining VBG Mental
Cortisol NNP Mental
and CC Mental
vasopressin JJ Mental
concentrations NNS Mental
in IN Mental
plasma NN Mental
analgesia NN Pain
-DOCSTART- -X- N

outcome NN None
. . None
failure NN Other
to TO Other
respond VB Other
, , Other
delayed JJ Other
responses NNS Other
, , Other
partial JJ Other
responses NNS Other
, , Other
relapses NNS Other
early JJ Mortality
deaths NNS Mortality
reduce VB Adverse
these DT Adverse
complications NNS Adverse
. . Adverse
response NN Other
early JJ Mortality
deaths NNS Mortality
, , Mortality
blood NN Physical
counts NNS Physical
survival NN Mortality
. . Mortality
responses NNS Other
absent NN Other
, , Other
partial JJ Other
complete JJ Other
died VBD Mortality
peripheral JJ Physical
blood NN Physical
counts NNS Physical
Neutrophil NNP Physical
counts VBZ Physical
platelet NN Physical
counts NNS Physical
actuarial JJ Mortality
survival NN Mortality
reduce VB Mortality
early JJ Mortality
deaths NNS Mortality
peripheral JJ Physical
blood NN Physical
counts NNS Physical
survival NN Mortality
response NN Other
rate NN Other
-DOCSTART- -X- N

thymus NN Physical
and CC Physical
activation-regulated JJ Physical
chemokine NN Physical
( ( Physical
TARC NNP Physical
) ) Physical
serum NN Physical
levels NNS Physical
rating NN Mental
scale NN Mental
( ( Mental
CARS NNP Mental
) ) Mental
score NN Mental
CARS NNP None
score NN None
and CC None
blood NN Physical
samples NNS Physical
for IN Physical
TARC NNP Physical
serum NN Physical
level NN Physical
The DT None
serum NN Physical
levels NNS Physical
of IN Physical
TARC NNP Physical
decreased VBD None
CARS NNP None
score NN None
( ( None
the DT None
serum NN None
of IN None
TARC NNP Physical
level NN Physical
and CC None
the DT None
CARS NNP None
score NN None
, , None
age NN None
, , None
or CC None
gender VB None
for IN None
decreased VBD None
serum JJR None
level NN None
of IN None
TARC NNP None
in IN None
-DOCSTART- -X- N

immune JJ Physical
response NN Physical
to TO Physical
the DT Physical
HBV NNP Physical
vaccine NN Physical
antibody NN Physical
response NN Physical
peripheral JJ Physical
blood NN Physical
mononuclear NN Physical
cells NNS Physical
-DOCSTART- -X- N

improved JJ Mental
adherence RB Mental
relative JJ Mental
to TO Mental
controls VB Mental
doses NNS Other
taken VBN Other
in IN Other
total JJ Other
correct VBP Other
dose NN Other
was VBD Other
taken VBN Other
doses VBZ Other
taken VBN Other
on IN Other
schedule NN Other
-DOCSTART- -X- N

effects NNS Physical
of IN Physical
a DT Physical
physical JJ Physical
activity NN Physical
program NN Physical
for IN Physical
pain JJ Pain
severity NN Pain
, , Pain
level NN Pain
of IN Pain
disability NN Pain
and CC Pain
fear NN Pain
of IN Pain
movement/ NN Pain
( ( Pain
re NN Pain
) ) Pain
injury NN Pain
response NN Other
effects NNS Physical
of IN Physical
advice NN Physical
and CC Physical
individualized JJ Physical
sub-maximal JJ Physical
exercise NN Physical
programs NNS Physical
-DOCSTART- -X- N

sum NN Pain
of IN Pain
pain NN Pain
intensity NN Pain
difference NN Pain
( ( Pain
SPID NNP Pain
) ) Pain
over IN Physical
30 CD Physical
min JJ Physical
post-administration NN Physical
. . None
pain NN Pain
intensity NN Pain
difference NN Pain
( ( Pain
PID NNP Pain
) ) Pain
and CC None
pain NN Pain
relief NN Pain
( ( Pain
PR NNP Pain
) ) Pain
long-term JJ Other
safety NN Other
phase NN Other
of IN Other
up IN Other
to TO Other
12 CD Other
months NNS Other
. . None
Adverse JJ Adverse
events NNS Adverse
SPID NNP Pain
PID NNP Pain
and CC None
PR NNP Pain
well-tolerated JJ Other
both DT Other
systemically RB Other
and CC Other
sublingually RB Other
drug-related JJ Adverse
adverse JJ Adverse
event NN Adverse
nausea NN Adverse
vomiting VBG Adverse
somnolence NN Adverse
serious JJ Adverse
AE NNP Adverse
( ( Adverse
mild JJ Adverse
affect VBP Adverse
lability NN Adverse
) ) Adverse
-DOCSTART- -X- N

placental JJ Physical
expulsion NN Physical
duration NN Physical
of IN Physical
the DT Physical
placental JJ Physical
expulsion NN Physical
after IN Physical
prostaglandin NN Physical
F2 NNP Physical
alpha NN Physical
injection NN Physical
placental JJ Physical
expulsions NNS Physical
incidence NN Physical
of IN Physical
manual JJ Physical
lysis NN Physical
of IN Physical
the DT Physical
placenta NN Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
duration NN Other
of IN Other
therapy NN Other
Gram-positive JJ Physical
bacteria NNS Physical
cured VBN Physical
. . None
safe JJ Other
, , Other
effective JJ Other
-DOCSTART- -X- N

day NN Physical
# # Physical
1 CD Physical
, , Physical
2 CD Physical
and CC Physical
3 CD Physical
hemoglobin NN Physical
patient JJ Other
mobilization NN Other
-DOCSTART- -X- N

atrial JJ Physical
electromechanical JJ Physical
coupling NN Physical
atrial JJ Physical
fibrillation NN Physical
( ( Physical
AF NNP Physical
) ) Physical
. . Physical
AF NNP Physical
development NN Physical
atrial JJ None
electromechanical JJ None
coupling NN None
. . None
RESULTS NNP None
Baseline NNP None
blood NN None
pressures NNS None
, , None
electrocardiographic JJ None
and CC None
echocardiographic JJ None
findings NNS None
, , None
and CC None
atrial JJ None
electromechanical JJ None
coupling NN None
were VBD None
reduced VBD None
blood NN None
pressure NN None
after IN None
> NNP None
0.05 CD None
) ) None
. . None
Atrial JJ None
electromechanical JJ None
coupling NN None
time NN None
intervals NNS None
showed VBD None
CONCLUSION NNP None
Prolonged VBD None
interatrial JJ None
electromechanical JJ None
time NN None
intervals NNS None
in IN None
-DOCSTART- -X- N

Hemodynamics NNS Physical
, , None
rate NN Other
of IN Other
cesarean JJ Other
delivery NN Other
, , None
sensory JJ Other
block NN Other
level NN Other
, , Other
Bromage NNP Physical
motor NN Physical
scale NN Physical
scores NNS Physical
, , None
instrument-assisted JJ Other
delivery NN Other
, , None
oxytocin NN Other
use NN Other
, , None
visual JJ Pain
analog NN Pain
scale NN Pain
( ( Pain
VAS NNP Pain
) ) Pain
scores VBZ Pain
, , None
Apgar NNP Physical
scores VBZ Physical
, , None
umbilical JJ Physical
cord NN Physical
artery NN Physical
analysis NN None
, , None
and CC None
maternal JJ Adverse
side-effects NNS Adverse
including VBG Adverse
nausea NN Adverse
, , Adverse
vomiting VBG Adverse
, , Adverse
pruritus NN Adverse
, , Adverse
urinary JJ Adverse
retention NN Adverse
, , Adverse
shivering VBG Adverse
, , Adverse
hypotension NN Adverse
, , Adverse
and CC Adverse
respiratory JJ Adverse
depression NN Adverse
maternal JJ Physical
hemodynamics NNS Physical
, , None
neonatal JJ Physical
heart NN Physical
rate NN Physical
, , None
VAS NNP Pain
scores VBZ Pain
, , None
rate NN Other
of IN Other
cesarean JJ Other
delivery NN Other
, , None
sensory JJ Physical
block NN Physical
level NN Physical
, , None
Bromage NNP Physical
motor NN Physical
scale NN Physical
scores NNS Physical
, , None
instrument-assisted JJ Other
delivery NN Other
, , None
oxytocin NN Other
use NN Other
, , None
hypotension NN Adverse
, , None
nausea NN Adverse
, , None
vomiting NN Adverse
, , None
and CC None
respiratory JJ Adverse
depression NN Adverse
pruritus NN Adverse
, , Adverse
shivering NN Adverse
, , Adverse
and CC Adverse
urinary JJ Adverse
retention NN Adverse
Umbilical JJ Physical
artery NN Physical
pH NN Physical
Birth-weight NNP Physical
, , None
umbilical JJ Physical
artery NN Physical
PO NNP Physical
( ( Physical
2 CD Physical
) ) Physical
and CC Physical
base NN Physical
deficit NN Physical
, , None
and CC None
Apgar NNP Physical
scores NNS Physical
-DOCSTART- -X- N

attitude JJ Mental
clarity NN Mental
attitude NN Mental
correctness NN Mental
attitude VBP Mental
clarity NN Mental
and CC None
attitude NN Mental
correctness NN Mental
can MD None
have VB None
distinct JJ None
antecedents NNS None
( ( None
repeated VBN None
expression NN None
and CC None
consensus NN None
feedback NN None
, , None
respectively RB None
) ) None
. . None
play VBP Mental
an DT Mental
independent JJ Mental
role NN Mental
in IN Mental
persuasion NN Mental
and CC Mental
resistance NN Mental
situations NNS Mental
. . None
clarity NN None
and CC None
correctness JJ None
increase NN None
, , None
attitudes VBZ Mental
become VBP Mental
more RBR Mental
resistant JJ Mental
-DOCSTART- -X- N

A1C NNP Physical
reduction NN Physical
A1C NNP Physical
A1C NNP Physical
or CC None
FPG NNP Physical
A1C NNP None
or CC None
FPG NNP None
A1C NNP Physical
and CC None
FPG NNP Physical
serious JJ Adverse
hypoglycemic JJ Adverse
events NNS Adverse
concurrent JJ None
antidiabetic JJ None
therapy NN None
history NN None
of IN None
angina NN None
. . None
FPG NNP Physical
and CC None
A1C NNP Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

Outcomes NNS None
effectiveness NN Other
. . None
differences NNS Other
in IN Other
the DT Other
discharge NN Other
rate NN Other
or CC None
in IN Other
the DT Other
median JJ Other
length NN Other
of IN Other
stay NN Other
-DOCSTART- -X- N

HIF-1alpha NNP Physical
genotypes NNS Physical
HIF-1alpha NNP Physical
genotypes NNS Physical
C1772T NNP Physical
polymorphism NN Physical
-DOCSTART- -X- N

Efficacy NN Other
and CC Other
safety NN Other
efficacy NN Other
and CC Other
safety NN Other
change NN Physical
in IN Physical
neuropathy JJ Physical
between IN Physical
baseline NN Physical
and CC Physical
week NN Physical
48 CD Physical
, , Physical
demonstrated VBN Physical
by IN Physical
the DT Physical
Neuropathy NNP Physical
Impairment NNP Physical
Score NNP Physical
quantitative JJ Physical
sensory NN Physical
tests NNS Physical
using VBG Physical
the DT Physical
CASE NNP Physical
IV NNP Physical
System NNP Physical
, , Physical
the DT Physical
Neuropathy NNP Physical
Symptom NNP Physical
and CC Physical
Change NNP Physical
questionnaire NN Physical
, , Physical
the DT Physical
Patient NNP Physical
Benefit NNP Physical
Questionnaire NNP Physical
( ( Physical
PBQ NNP Physical
) ) Physical
, , Physical
and CC Physical
a DT Physical
global JJ Physical
symptom NN Physical
assessment NN Physical
, , Physical
as RB Physical
well RB Physical
as IN Physical
nerve NN Physical
conduction NN Physical
studies NNS Physical
and CC Physical
occurrence NN Physical
of IN Physical
new JJ Physical
plantar JJ Physical
foot NN Physical
ulcers NNS Physical
. . None
adverse JJ Adverse
events NNS Adverse
. . Adverse
adverse JJ Adverse
events NNS Adverse
site NN Pain
pain/hyperalgesia NN Pain
and CC Pain
other JJ Pain
pain NN Pain
syndromes NNS Pain
. . None
global JJ Physical
symptom NN Physical
assessment NN Physical
-DOCSTART- -X- N

performance NN Mental
on IN Mental
theory NN Mental
of IN Mental
mind NN Mental
tasks NNS Mental
no DT Other
improvement NN Other
. . None
executive NN Mental
function NN Mental
tasks NNS Mental
-DOCSTART- -X- N

noninvasive JJ Other
haemoglobin NN Other
measurement NN Other
haemoglobin NN Physical
haemoglobin NN Physical
pulse JJ None
oximetry NN None
haemoglobin NN None
concentration NN None
decreased VBD None
pulse JJ None
oximetry NN None
haemoglobin NN None
concentration NN None
less JJR None
pulse JJ None
oximetry NN Physical
haemoglobin NN Physical
concentration NN None
and CC None
true JJ None
haemoglobin NN None
concentrations NNS None
( ( None
the DT None
bias NN None
-DOCSTART- -X- N

effectiveness NN Other
and CC Other
safety NN Other
fatigue JJ Physical
( ( None
measured VBN None
by IN None
Chalder NNP Other
fatigue NN Other
questionnaire NN Other
score NN Other
) ) None
and CC None
physical JJ Physical
function NN Physical
( ( None
measured VBN None
by IN None
short JJ Other
form-36 JJ Other
subscale NN Other
score NN Other
) ) None
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
serious JJ Adverse
adverse JJ Adverse
reactions NNS Adverse
mean JJ Physical
fatigue NN Physical
scores NNS Physical
physical JJ None
function NN None
scores NNS None
less JJR None
fatigue NN None
( ( None
CBT NNP None
better JJR None
physical JJ None
function NN None
adverse JJ None
reactions NNS None
fatigue NN None
syndrome NN None
-DOCSTART- -X- N

duration NN Other
of IN Other
labour NN Other
need NN Pain
for IN Pain
analgesia NN Pain
incidence NN Physical
of IN Physical
fetal JJ Physical
heart NN Physical
abnormalities NNS Physical
Apgar NNP Physical
scores VBZ Physical
augmentations NNS Other
with IN Other
oxytocic JJ Other
drugs NNS Other
. . Other
third JJ Other
stage NN Other
loss NN Other
-DOCSTART- -X- N

musculoskeletal-related JJ Adverse
side NN Adverse
effects NNS Adverse
cardiovascular JJ Physical
and CC Physical
diabetes VBZ Physical
risk NN Physical
factors NNS Physical
bone NN Physical
mineral JJ Physical
density NN Physical
; : Physical
2 CD Physical
) ) Physical
cardiorespiratory NN Physical
function NN Physical
and CC Physical
maximal JJ Physical
oxygen NN Physical
capacity NN Physical
; : Physical
3 CD Physical
) ) Physical
body NN Physical
composition NN Physical
( ( Physical
lean JJ Physical
mass NN Physical
and CC Physical
fat JJ Physical
mass NN Physical
) ) Physical
; : Physical
4 CD Physical
) ) Physical
blood NN Physical
pressure NN Physical
and CC Physical
cardiovascular JJ Physical
function NN Physical
; : Physical
5 CD Physical
) ) Physical
lipids NNS Physical
and CC Physical
glycemic JJ Physical
control NN Physical
; : Physical
and CC Physical
6 CD None
) ) None
quality NN Other
of IN Other
life NN Other
and CC Other
psychological JJ Other
distress NN Other
. . None
determination NN None
of IN None
the DT None
strength NN None
of IN None
effect NN None
of IN None
exercise NN None
on IN None
the DT None
well NN None
established VBN None
musculoskeletal NN None
, , None
cardiovascular JJ None
and CC None
insulin JJ None
metabolism NN None
side NN Adverse
effects NNS Adverse
of IN None
androgen NN None
deprivation NN None
in IN None
prostate JJ None
cancer NN None
patients NNS None
. . None
bone NN Physical
density NN Physical
, , Physical
cardiovascular JJ Physical
function NN Physical
, , Physical
lean JJ Physical
and CC Physical
fat JJ Physical
mass NN Physical
, , Physical
physical JJ Physical
function NN Physical
and CC Physical
falls VBZ Physical
risk NN Physical
fracture NN Physical
risk NN Physical
, , Physical
improve VB Physical
physical JJ Physical
and CC Physical
functional JJ Physical
ability NN Physical
, , None
quality NN Other
of IN Other
life NN Other
and CC None
ultimately RB Mortality
survival JJ Mortality
rate NN Mortality
-DOCSTART- -X- N

significant JJ None
inhibition NN None
of IN None
adenosine JJ None
diphosphate NN None
( ( None
ADP NNP None
) ) None
and CC None
arachidonic JJ None
acid NN None
( ( None
AA NNP None
) ) None
-induced VBD None
PA NNP None
( ( None
reduced VBN None
AA NNP None
induced JJ None
PA NNP None
values NNS None
of IN None
PA NNP None
after IN None
AA NNP None
stimulus NN None
( ( None
p JJ None
stronger JJR None
inhibition NN None
after IN None
ADP NNP None
stimulus NN None
inhibiting VBG None
aggregation NN None
, , None
triggered VBD None
-DOCSTART- -X- N

Serum NNP Physical
concentrations NNS Physical
of IN Physical
D-cycloserine NNP Physical
, , Physical
relevant JJ Physical
amino NN Physical
acids NNS Physical
, , Physical
and CC Physical
homovanillic JJ Physical
acid NN Physical
cognitive JJ Mental
battery NN Mental
mean JJ Mental
reduction NN Mental
in IN Mental
negative JJ Mental
symptoms NNS Mental
performance NN Mortality
on IN Mortality
any DT Mortality
cognitive JJ Mortality
test NN Mortality
-DOCSTART- -X- N

primary JJ None
end NN None
point NN None
114-day JJ Mortality
grades NNS Mortality
2-4 JJ Mortality
acute JJ Mortality
GVHD-free NNP Mortality
survival NN Mortality
Grades NNP Mortality
2-4 JJ Mortality
GVHD NNP Mortality
Neutrophil NNP Physical
and CC Physical
platelet VB Physical
engraftment NN Physical
Oropharyngeal NNP Physical
mucositis NN Physical
Oral NNP Physical
Mucositis NNP Physical
Assessment NNP Physical
Scale NNP Physical
score VBD Physical
toxicity NN Adverse
Chronic NNP Mortality
GVHD NNP Mortality
, , Mortality
relapse-free JJ Mortality
survival NN Mortality
, , Mortality
and CC Mortality
overall JJ Mortality
survival NN Mortality
at IN Mortality
2 CD Mortality
years NNS Mortality
-DOCSTART- -X- N

Interleukin-1 JJ Physical
beta NN Physical
( ( Physical
IL-1 NNP Physical
beta NN Physical
) ) Physical
interleukin-1 JJ Physical
( ( Physical
IL-1 NNP Physical
) ) Physical
. . Physical
IL-1 NNP Physical
beta NN Physical
biochemical JJ Physical
measures NNS Physical
or CC Physical
liver VB Physical
histological JJ Physical
stage NN Physical
. . Physical
serum JJ Physical
bilirubin NN Physical
and CC Physical
histologic JJ Physical
stage NN Physical
alkaline JJ Physical
phosphatase NN Physical
synthesis NN Physical
of IN Physical
IL-1 NNP Physical
beta NN Physical
IL-2-induced NNP Physical
IL-1 NNP Physical
beta NN Physical
synthesis NN Physical
S NNP Physical
epidermidis-induced JJ Physical
IL-1 NNP Physical
beta NN Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
for IN Other
management NN Other
of IN Other
lower JJR Other
urinary JJ Other
tract NN Other
symptoms NNS Other
The DT Other
efficacy NN Other
and CC Other
safety NN Other
of IN Other
tamsulone-FS NN Other
was VBD Other
comparable JJ Other
to TO Other
those DT Other
of IN Other
omnik FW Other
. . Other
prostatic JJ Physical
adenoma NN Physical
. . Physical
-DOCSTART- -X- N

endurance NN Physical
time NN Physical
ratio NN Physical
of IN Physical
high- JJ Physical
to TO Physical
low-frequency JJ Physical
power NN Physical
of IN Physical
the DT Physical
diaphragmatic JJ Physical
electromyogram NN Physical
( ( Physical
EMGdi NNP Physical
) ) Physical
EMGdi NNP Physical
PI NNP Physical
, , Physical
mmax NN Physical
and CC Physical
maximal JJ Physical
transdiaphragmatic JJ Physical
pressure NN Physical
( ( Physical
Pdi NNP Physical
) ) Physical
intensity NN Physical
of IN Physical
the DT Physical
IES NNP Physical
rose VBD Physical
with IN Physical
time NN Physical
ratio NN Physical
of IN Physical
Pdi NNP Physical
superimposed VBN Physical
Pdi NNP Physical
twitch NN Physical
and CC Physical
Pdi NNP Physical
twitch NN Physical
of IN Physical
relaxed JJ Physical
diaphragm NN Physical
value NN Physical
of IN Physical
( ( Physical
1-superimposed JJ Physical
Pdi NNP Physical
twitch/Pdi NN Physical
twitch NN Physical
of IN Physical
relaxed JJ Physical
diaphragm NN Physical
) ) Physical
. . Physical
-DOCSTART- -X- N

high-sensitivity JJ Other
C-reactive JJ Other
protein NN Other
( ( Other
hsCRP NN Other
) ) Other
and CC Other
interleukin JJ Other
( ( Other
IL NNP Other
) ) Other
-6 NN Other
, , Other
decreased VBN Other
inflammatory JJ Physical
biomarkers NNS Physical
favored VBD Physical
change NN Physical
in IN Physical
hsCRP NN Physical
apnea-hypopnea JJ Physical
index NN Physical
improving VBG Physical
night-time JJ Physical
oxygen NN Physical
saturation NN Physical
Weight NNP Physical
loss NN Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
Skeletal-related JJ Physical
events NNS Physical
( ( Physical
SREs NNP Physical
) ) Physical
pain NN Pain
, , None
analgesic JJ Other
use NN Other
, , None
and CC None
quality NN Physical
of IN Physical
life NN Physical
. . None
SRE NNP Physical
SRE NNP Physical
. . None
SRE NNP Physical
Mean NNP Pain
pain NN Pain
and CC None
analgesic JJ Other
scores NNS Other
declined VBD Pain
quality-of-life JJ Physical
scores NNS Physical
remained VBD Physical
stable JJ Physical
pyrexia VBN Adverse
bone NN Adverse
pain NN Adverse
Serum NNP Physical
creatinine NN Physical
levels NNS Physical
did VBD None
not RB None
significantly RB None
increase VB None
SREs NNP Physical
-DOCSTART- -X- N

Complete NNP Physical
ophthalmologic JJ Physical
examinations NNS Physical
logarithm NN Physical
of IN Physical
minimum JJ Physical
angle NN Physical
of IN Physical
resolution NN Physical
( ( Physical
logMAR JJ Physical
) ) Physical
best-corrected JJ Physical
visual JJ Physical
acuity NN Physical
( ( Physical
BCVA NNP Physical
) ) Physical
, , Physical
central JJ Physical
macular JJ Physical
thickness NN Physical
( ( Physical
CMT NNP Physical
) ) Physical
shown VBN Physical
by IN Physical
optical JJ Physical
coherence NN Physical
tomography-3 NN Physical
Baseline NNP Physical
BCVA NNP Physical
( ( Physical
logMAR NN Physical
) ) Physical
and CC Physical
CMT NNP Physical
BCVA NNP Physical
CMT NNP Physical
BCVA NNP Physical
logMAR NN Physical
CMT NNP Physical
BCVA NNP Physical
CMT NNP Physical
BCVA NNP Physical
CMT NNP Physical
-DOCSTART- -X- N

efficacy NN Other
efficacy NN Other
safety NN Other
improvements NNS Other
; : None
17-item JJ Mental
HAMD NNP Mental
total NN Mental
score NN Mental
clinical JJ Mental
global JJ Mental
impression NN Mental
severity NN Mental
of IN Mental
illness NN Mental
global JJ Mental
improvement NN Mental
items NNS Mental
or CC Mental
the DT Mental
Montgomery-Asberg JJ Mental
depression NN Mental
rating NN Mental
scale NN Mental
17-item JJ Mental
HAMD NNP Mental
total NN Mental
score NN Mental
) ) Mental
tolerated VBN Other
adverse JJ Adverse
events NNS Adverse
. . None
discontinued VBN Other
prematurely RB Other
adverse JJ Adverse
events NNS Adverse
safety NN Other
tolerability NN Other
-DOCSTART- -X- N

disruptive NN Mental
and CC Mental
repetitive JJ Mental
behaviors NNS Mental
side NN Adverse
effects NNS Adverse
. . None
Clinical JJ Mental
Global NNP Mental
Impressions- NNP Mental
Improvement NNP Mental
( ( Mental
CGI-I NNP Mental
) ) Mental
significant JJ Physical
weight JJ Physical
gain NN Physical
global JJ Mental
functioning NN Mental
of IN Mental
PDDs NNP Mental
weight JJ Physical
gain NN Physical
-DOCSTART- -X- N

Bone NNP Physical
mineral JJ Physical
density NN Physical
( ( Physical
BMD NNP Physical
) ) Physical
of IN Physical
lumbar NN Physical
spine NN Physical
( ( Physical
L1-L4 NNP Physical
) ) Physical
and CC Physical
proximal JJ Physical
femur NN Physical
Venous NNP Physical
blood NN Physical
samples NNS None
serum JJ Physical
cytokines NNS Physical
including VBG Physical
interleukin-1beta JJ Physical
( ( Physical
IL-1beta NNP Physical
) ) Physical
, , Physical
tumor JJ Physical
necrosis NN Physical
factor-alpha NN Physical
( ( Physical
TNF-alpha NNP Physical
) ) Physical
, , Physical
RANKL NNP Physical
, , Physical
osteoprotegerin NN Physical
, , Physical
and CC Physical
markers NNS Physical
of IN Physical
bone NN Physical
formation NN Physical
and CC Physical
resorption NN Physical
. . None
Levels NNP None
of IN None
serum NN Physical
cytokines NNS Physical
Markers NNS Physical
of IN Physical
bone NN Physical
metabolism NN Physical
serum JJ Physical
levels NNS Physical
of IN Physical
RANKL NNP Physical
and CC Physical
IL-1beta NNP Physical
significantly RB None
decreased VBD None
level NN Physical
of IN Physical
osteoprotegerin JJ Physical
significantly RB None
increased VBN None
significant JJ None
difference NN None
was VBD None
found VBN None
in IN None
TNF-alpha NNP Physical
level NN Physical
. . None
level NN None
of IN None
serum JJ Physical
cytokines NNS Physical
bone NN Physical
turnover NN Physical
, , None
both DT None
markers NNS Physical
of IN Physical
bone NN Physical
resorption NN Physical
and CC Physical
formation NN Physical
significantly RB None
decreased VBN None
-DOCSTART- -X- N

sun JJ Mental
protective JJ Mental
behaviors NNS Mental
. . None
-DOCSTART- -X- N

tolerance NN Other
to TO Other
the DT Other
antianginal JJ Other
effect NN Other
. . None
Exercise NN Physical
performance NN Physical
Exercise NN Physical
time NN Physical
to TO Physical
onset VB Physical
of IN Physical
angina NN Physical
, , Physical
total JJ Physical
exercise NN Physical
duration NN Physical
and CC Physical
time NN Physical
to TO Physical
1 CD Physical
mm NNS Physical
ST NNP Physical
segment NN Physical
depression NN Physical
tolerance NN Other
to TO Other
antianginal JJ Other
effect NN Other
-DOCSTART- -X- N

Clinical JJ Other
performance NN Other
level NN Other
of IN Other
accuracy NN Other
measurements NNS Other
IOP NNP Other
-DOCSTART- -X- N

sedentary JJ Mental
behavior NN Mental
sedentary JJ Mental
behavior NN Mental
and CC None
high JJ Mental
energy NN Mental
density NN Mental
foods NNS Mental
physical JJ Mental
activity NN Mental
and CC None
fruits NNS Mental
and CC Mental
vegetables NNS Mental
body NN Physical
mass NN Physical
index NN Physical
( ( Physical
z-BMI NN Physical
) ) Physical
sedentary JJ Mental
behaviors NNS Mental
z-BMI JJ Physical
changes NNS Physical
sedentary JJ Mental
behaviors NNS Mental
changes NNS None
in IN None
activity NN Mental
level NN Mental
z-BMI NN Physical
changes NNS Physical
. . None
sedentary JJ Mental
behaviors NNS Mental
sedentary JJ Mental
behaviors NNS Mental
behavioral JJ Mental
economic JJ Mental
relationships NNS Mental
in IN Mental
eating NN Mental
and CC Mental
activity NN Mental
-DOCSTART- -X- N

anticholinergic NN Physical
and CC Physical
antiarrhythmic JJ Physical
properties NNS Physical
maximal JJ Other
tolerable JJ Other
dose NN Other
tear JJ Physical
and CC Physical
saliva JJ Physical
quantitation NN Physical
, , Physical
24 CD Physical
hour NN Physical
electrocardiogram NN Physical
( ( Physical
ECG NNP Physical
) ) Physical
, , Physical
exercise VBP Physical
testing VBG Physical
and CC Physical
programmed VBD Physical
ventricular JJ Physical
stimulation NN Physical
. . Physical
maximal NN Other
tolerable JJ Other
dose NN Other
Maximal JJ Adverse
side NN Adverse
effects NNS Adverse
questionnaire NN Adverse
scores NNS Adverse
anticholinergic JJ Physical
activity NN Physical
-DOCSTART- -X- N

measures NNS Physical
of IN Physical
dystonic JJ Physical
impairment NN Physical
. . Physical
significant JJ Other
improvement NN Other
-DOCSTART- -X- N

tobacco NN Mental
using VBG Mental
habits NNS Mental
dietary JJ Mental
intake NN Mental
. . None
relationship NN Physical
between IN Physical
tobacco NN Mental
smoking NN Mental
and CC Physical
intake NN Mental
of IN Mental
macro NN Mental
and CC Mental
micronutrients NNS Mental
. . None
associations NNS None
between IN None
smoking NN None
and CC None
macronutrient NN Physical
consumption NN Physical
, , None
hemoglobin NN Physical
A1c NNP Physical
( ( Physical
HbA1c NNP Physical
) ) Physical
, , None
body JJ Physical
mass NN Physical
index NN Physical
( ( Physical
BMI NNP Physical
) ) Physical
, , None
and CC None
serum VB Physical
lipid JJ Physical
levels NNS Physical
Statistically NNP None
significant JJ None
correlations NNS None
between IN None
smoking NN None
and CC None
nutrient JJ Other
intake NN Other
, , None
HbA1c NNP Physical
, , None
and CC None
serum VB Physical
lipid JJ Physical
levels NNS Physical
. . None
Cigarette NNP Mental
, , Mental
cigar NN Mental
, , Mental
or CC Mental
pipe NN Mental
use NN Mental
caloric JJ Physical
intake NN Physical
consumed VBD Physical
more RBR Physical
fat JJ Mental
, , Mental
cholesterol NN Mental
, , Mental
and CC Mental
alcohol NN Mental
. . None
serum JJ None
low-density NN None
lipoprotein NN None
( ( None
LDL NNP None
) ) None
/high-density NN None
lipoprotein NN None
( ( None
HDL NNP None
) ) None
ratios NNS None
and CC None
triglycerides NNS None
. . None
Serum NNP Physical
cholesterols NNS Physical
, , None
LDL/HDL NNP Physical
ratios NNS Physical
, , None
LDL NNP Physical
cholesterols VBZ Physical
, , None
and CC None
triglyceride JJ Physical
determinations NNS Physical
HDL NNP Physical
cholesterols NNS Physical
Nutrient NNP Mental
intake NN Mental
diet JJ Physical
with IN Physical
higher JJR Physical
risks NNS Physical
of IN Physical
atherosclerosis NN Physical
, , Physical
cancer NN Physical
, , Physical
and CC Physical
other JJ Physical
degenerative JJ Physical
diseases NNS Physical
. . None
fat JJ None
diet JJ Mental
and CC None
tobacco NN Mental
use NN Mental
-DOCSTART- -X- N

endurance NN Mental
, , Physical
resistance NN Mental
, , Physical
strength NN Mental
and CC Physical
coordination NN Physical
physical JJ Mental
performance NN Mental
characteristic JJ Mental
nor CC Mental
in IN Mental
coordination NN Mental
. . None
-DOCSTART- -X- N

reductions NNS Physical
in IN Physical
blood NN Physical
pressure NN Physical
Fasting VBG Physical
and CC Physical
post-prandial JJ Physical
plasma NN Physical
glucose NN Physical
, , None
glycosylated VBN Physical
haemoglobin NN Physical
and CC None
plasma JJ Physical
lipids NNS Physical
albumin JJ Physical
excretion NN Physical
rate NN Physical
( ( Physical
AER NNP Physical
) ) Physical
. . None
reduction NN Physical
in IN Physical
AER NNP Physical
tolerated VBN Other
AER NNP Physical
antihypertensive JJ Physical
effect NN Physical
AER NNP Physical
-DOCSTART- -X- N

[ JJ None
Hepatoprotective NNP Physical
activity NN Physical
efficiency NN Other
functional JJ Physical
activity NN Physical
hepatoprotective JJ Physical
, , Physical
antioxidative JJ Physical
, , Physical
and CC Physical
anticholestatic JJ Physical
activities NNS Physical
-DOCSTART- -X- N

changes NNS Physical
in IN Physical
transcutaneous JJ Physical
PCO2 NNP Physical
( ( Physical
tcPCO2 NN Physical
) ) Physical
, , None
subjective JJ Mental
anxiety NN Mental
, , None
heart NN Physical
rate NN Physical
and CC None
blood NN Physical
pressure NN Physical
fall NN Physical
in IN Physical
tcPCO2 NN Physical
and CC None
the DT Physical
cardiovascular JJ Physical
response NN Physical
tcPCO2 NN Physical
acute JJ Physical
hyperventilation NN Physical
fall NN Physical
in IN Physical
tcPCO2 NN Physical
occurrence NN Mental
of IN Mental
anxiety-related JJ Mental
somatic NN Mental
symptoms NNS Mental
-DOCSTART- -X- N

effectiveness NN Other
of IN Other
a DT Other
tailored JJ Other
decision NN Other
aid NN Other
questionnaire NN Other
follow-up JJ Other
questionnaire NN Other
. . Other
decisional JJ Other
conflict NN Other
( ( Other
ie JJ Other
, , Other
uncertainty NN Other
) ) Other
genetic JJ Physical
testing NN Physical
informed JJ Other
choice NN Other
higher JJR Other
knowledge NN Other
levels NNS Other
-DOCSTART- -X- N

plasma NN Physical
potassium NN Physical
and CC Physical
blood NN Physical
glucose JJ Physical
concentrations NNS Physical
potassium NN Physical
and CC Physical
glucose JJ Physical
concentrations NNS Physical
plasma NN Physical
potassium NN Physical
concentration NN Physical
10 CD Physical
min NN Physical
after IN Physical
injection NN Physical
blood NN Physical
glucose JJ Physical
concentration NN Physical
plasma JJ Physical
potassium NN Physical
blood NN Physical
glucose NN Physical
30 CD Physical
min NN Physical
potassium NN Physical
glucose NN Physical
-DOCSTART- -X- N

accuracy NN Other
clinical JJ Physical
neurosensory NN Physical
testing VBG Physical
statistical JJ Other
efficacy NN Other
of IN Other
the DT Other
clinical JJ Other
neurosensory JJ Other
test NN Other
positive JJ Mental
predictive NN Mental
and CC Mental
negative JJ Mental
predictive NN Mental
values NNS Mental
statistically RB Physical
significant JJ Physical
positive JJ Physical
relationship NN Physical
found VBD Physical
between IN Physical
the DT Physical
sensory JJ Physical
impairment NN Physical
score NN Physical
and CC Physical
the DT Physical
degree NN Physical
of IN Physical
nerve NN Physical
injury NN Physical
. . None
less RBR Other
efficient JJ Other
high JJ Physical
incidence NN Physical
of IN Physical
false-positive JJ Physical
false-negative JJ Other
statistical JJ Other
efficiency NN Other
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
effective JJ Other
blood NN Physical
pressure NN Physical
control NN Physical
. . Physical
pressure NN None
-DOCSTART- -X- N

arterial JJ Physical
blood NN Physical
pressure NN Physical
and CC None
sodium NN Physical
metabolism NN Physical
arterial JJ Physical
blood NN Physical
pressure NN Physical
and CC None
sodium NN Physical
metabolism NN Physical
Night NNP Physical
urinary JJ Physical
sodium NN Physical
and CC None
potassium JJ Physical
excretion NN Physical
blood NN Physical
pressure NN Physical
lowered VBN None
form NN None
hypertension NN Physical
urinary JJ Physical
sodium NN Physical
excretion NN Physical
and CC None
reduction NN Physical
of IN Physical
arterial JJ Physical
blood NN Physical
pressure NN Physical
-DOCSTART- -X- N

eradication NN Physical
therapies NNS Physical
. . None
eradication NN Physical
sensitivity NN Other
of IN Other
H. NNP Other
pylori FW None
to TO None
metronidazole VB None
Tetracycline-containing JJ None
quadruple NN None
rescue NN None
therapy NN None
-DOCSTART- -X- N

homocysteine NN Physical
levels NNS Physical
. . Other
Clinical JJ Physical
outcomes NNS Physical
endpoint NN Other
death NN Mortality
, , None
nonfatal JJ Physical
acute NN Physical
coronary JJ Physical
syndrome NN Physical
, , None
and CC None
serious JJ Other
re-hospitalization NN Other
Advanced NNP Physical
age NN Physical
and CC Physical
diabetes NNS Physical
not RB None
beneficial JJ None
and CC None
may MD None
even RB None
be VB None
harmful JJ None
prevention NN Physical
of IN Physical
cardiovascular JJ Physical
events NNS Physical
-DOCSTART- -X- N

weight JJ Physical
gain NN Physical
: : None
mean NN None
of IN None
CON NNP None
gained VBD None
a DT None
significant JJ None
weight NN None
loss NN None
compared VBN None
facilitate VB None
weight NN None
loss NN None
in IN None
-DOCSTART- -X- N

endurance NN Physical
performance NN Physical
aerobic JJ Physical
endurance NN Physical
. . None
aerobic JJ Physical
endurance NN Physical
performance NN Physical
. . Physical
time NN Physical
to TO Physical
exhaustion NN Physical
Blood NNP Physical
glucose NN Physical
and CC Physical
plasma JJ Physical
insulin NN Physical
levels NNS Physical
aerobic JJ Physical
endurance NN Physical
performance NN Physical
-DOCSTART- -X- N

activated JJ Physical
CECs NNP Physical
disease NN Physical
progressive JJ Physical
cases NNS Physical
expression NN Physical
of IN Physical
survivin JJ Physical
mRNA NN Physical
disease NN Physical
progressive JJ Physical
cases NNS Physical
activated VBN Physical
CECs NNP Physical
activated VBN Physical
CECs NNP Physical
time NN Physical
to TO Physical
progression NN Physical
( ( Physical
TTP NNP Physical
) ) Physical
amount NN Physical
of IN Physical
survivin NN Physical
mRNA NN Physical
in IN Physical
serum JJ Physical
post-therapy NN Physical
and CC Physical
TTP NNP Physical
-DOCSTART- -X- N

motor NN Physical
response NN Physical
to TO Physical
acute VB Physical
treatment NN Physical
with IN Physical
levodopa NN Physical
bioavailability NN Other
duration NN Physical
of IN Physical
the DT Physical
motor NN Physical
response NN Physical
to TO Physical
levodopa NN Physical
Plasma NNP Other
levodopa JJ Other
concentrations NNS Other
latency NN Physical
to TO Physical
onset VB Physical
of IN Physical
motor NN Physical
response NN Physical
prolonging VBG Other
the DT Other
duration NN Other
of IN Other
the DT Other
benefit NN Other
-DOCSTART- -X- N

efficacy NN Other
and CC Other
tolerability NN Other
overall JJ Physical
response NN Physical
rate NN Physical
( ( Physical
ORR NNP Physical
; : Physical
partial JJ Physical
or CC Physical
complete JJ Physical
response NN Physical
) ) Physical
. . Physical
ORR NNP Physical
prolonged JJ Adverse
progression-free JJ Adverse
survival NN Adverse
( ( Adverse
PFS NNP Adverse
; : Adverse
PFS NNP Mortality
neutropenia NN Physical
and CC Physical
leukopenia NN Physical
plasma JJ Physical
concentration NN Physical
of IN Physical
doxorubicin NN Physical
. . Physical
-DOCSTART- -X- N

develop VB Other
, , Other
implement NN Other
, , Other
and CC Other
evaluate VB Other
a DT Other
-DOCSTART- -X- N

plasma JJ Physical
androgen NN Physical
levels NNS Physical
female JJ Mental
sexual JJ Mental
function NN Mental
among IN Mental
Sexual JJ Mental
function NN Mental
Hormone NNP Physical
assays NNS Physical
total JJ Physical
testosterone NN Physical
and CC Physical
free JJ Physical
androgen NN Physical
index NN Physical
FSFI NNP Mental
desire NN Mental
score NN Mental
-DOCSTART- -X- N

Scores NNP None
on IN None
the DT None
FACES NNP None
Pain NNP None
Rating NNP None
Scale NNP None
measured VBD None
at IN None
10-minute JJ None
intervals NNS None
and CC None
all DT None
use NN None
of IN None
analgesic JJ None
medications NNS None
in IN None
the DT None
PACU NNP None
. . None
RESULTS NNP None
Median JJ None
FACES NNP None
scores NNS None
doses NNS None
of IN None
opioid NN None
and CC None
nonopioid JJ None
medications NNS None
were VBD None
given VBN None
-DOCSTART- -X- N

Hamilton NNP Physical
depression NN Physical
scale NN Physical
scores NNS Physical
adverse JJ Adverse
events NNS Adverse
or CC Adverse
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

Plasma NNP Physical
HIV NNP Physical
RNA NNP Physical
levels NNS Physical
, , None
neuropsychologic RB Physical
functioning NN Physical
, , Mental
and CC None
self-reported JJ Adverse
adverse JJ Adverse
events NNS Adverse
Efficacy NN Other
adverse JJ Adverse
clinical NN Adverse
, , Adverse
virologic NN Adverse
, , Adverse
or CC Adverse
neuropsychologic JJ Adverse
events NNS Adverse
mean JJ Physical
natural JJ Physical
killer NN Physical
cell NN Physical
cytotoxicity NN Physical
-DOCSTART- -X- N

Cost-effectiveness NN Other
cost-effectiveness NN Other
Economic JJ Other
outcomes NNS Other
costs NNS Other
and CC Other
health NN Other
benefits NNS Other
Telephone NNP Other
Counselling NNP Other
cost-effective JJ Other
cost-effective JJ Other
cost-effective JJ Other
cost-effective JJ Other
. . None
-DOCSTART- -X- N

overall JJ Physical
frequency NN Physical
of IN Physical
paraesthesia NN Physical
frequency NN Physical
of IN Physical
paraesthesia NN Physical
frequency NN Other
of IN Other
paraesthesia NN Other
-DOCSTART- -X- N

glaucomatous JJ Physical
damage NN Physical
pattern-reversal JJ Other
electroretinograms NNS Other
( ( Other
PERGs NNP Other
) ) Other
and CC None
visual JJ Other
evoked VBN Other
potentials NNS Other
( ( Other
VEPs NNP Other
) ) Other
glaucomatous JJ Physical
alterations NNS Physical
occurring VBG Physical
in IN Physical
ganglion NN Physical
cells NNS Physical
: : Physical
functional JJ Physical
( ( Physical
reversible JJ Physical
) ) Physical
and CC Physical
anatomical JJ Physical
( ( Physical
irreversible JJ Physical
) ) Physical
. . Physical
glaucomatous JJ Physical
damage NN Physical
-DOCSTART- -X- N

sleep JJ Mental
disturbance NN Mental
. . None
self-assessed JJ Mental
sleepiness NN Mental
self-assessment NN Mental
of IN Mental
night NN Mental
sleep NN Mental
for IN Mental
day-shift JJ Mental
days NNS Mental
and CC Mental
for IN Mental
fatigue NN Mental
. . None
Mean NNP Physical
response NN Physical
time NN Physical
frequency NN Adverse
of IN Adverse
perceived JJ Adverse
adverse JJ Adverse
events NNS Adverse
and CC Adverse
near JJ Adverse
misses NNS Adverse
-DOCSTART- -X- N

detailed JJ None
scoring NN None
system NN None
that WDT None
included VBD None
the DT None
ability NN Physical
to TO Physical
eradicate VB Physical
infection NN Physical
, , None
the DT None
functional JJ Physical
status NN Physical
of IN Physical
the DT Physical
limb NN Physical
, , None
and CC None
the DT None
radiographic JJ Physical
appearance NN Physical
of IN Physical
the DT Physical
bone NN Physical
and CC Physical
joint NN Physical
. . None
-DOCSTART- -X- N

gastric JJ Physical
emptying VBG Physical
. . None
abomasal NN Physical
emptying VBG Physical
. . None
Abomasal NNP Physical
emptying VBG Physical
acetaminophen NN Physical
and CC Physical
glucose JJ Physical
absorption NN Physical
. . None
plasma NN Physical
acetaminophen NN Physical
concentration NN Physical
time NN Physical
of IN Physical
actual JJ Physical
C NNP Physical
( ( Physical
max NN Physical
) ) Physical
( ( Physical
actual JJ Physical
T NNP Physical
( ( Physical
max NN Physical
) ) Physical
) ) Physical
abomasal JJ Physical
emptying VBG Physical
rate NN Physical
Abomasal NNP Physical
emptying VBG Physical
rate NN Physical
time NN None
to TO None
actual JJ None
T NNP None
( ( None
max NN None
) ) None
model NN Physical
T NNP Physical
( ( Physical
max NN Physical
) ) Physical
abomasal JJ Physical
emptying VBG Physical
rate NN Physical
rate NN Physical
of IN Physical
abomasal NN Physical
emptying VBG Physical
-DOCSTART- -X- N

Saccade VB Physical
metrics NNS Physical
( ( Physical
e.g. NN Physical
velocity NN Physical
, , None
amplitude NN Physical
, , None
accuracy NN Physical
) ) None
saccade JJ Physical
endpoint NN Physical
accuracy NN Physical
initial JJ Physical
saccade NN Physical
endpoint NN Physical
corrective JJ Physical
saccades NNS Physical
accuracy NN Physical
response NN Physical
inhibition NN Physical
errors NNS Physical
. . None
-DOCSTART- -X- N

ischemic JJ Physical
episodes NNS Physical
Efficacy NN Other
exercise NN Other
test NN Other
parameters NNS Other
. . None
ambulatory JJ Physical
ischemia NN Physical
; : None
ischemic JJ Physical
episodes NNS Physical
. . None
-DOCSTART- -X- N

psychosocial JJ Mental
and CC Mental
health-promoting JJ Mental
behavioral JJ Mental
outcomes NNS Mental
behavioral JJ Mental
factors NNS Mental
cognitive JJ Other
and CC Other
psychological JJ Other
resources NNS Other
peer-mentored JJ Other
, , Other
a DT Other
nurse JJ Other
case-managed JJ Other
, , Other
or CC Other
a DT Other
standard JJ Other
care NN Other
HIV NNP Other
risk-reduction NN Other
behavioral JJ Mental
factors NNS Mental
and CC Mental
cognitive JJ Mental
and CC Mental
psychological JJ Mental
resources NNS Mental
self-esteem NN Mental
. . Mental
self-esteem NN Mental
, , Mental
life NN Mental
satisfaction NN Mental
, , Mental
psychological JJ Mental
well-being NN Mental
, , Mental
use NN Mental
of IN Mental
noninjection NN Mental
drugs NNS Mental
, , Mental
sex NN Mental
with IN Mental
multiple JJ Mental
partners NNS Mental
, , Mental
and CC Mental
unprotected JJ Mental
sex NN Mental
modify VB Mental
HIV NNP Mental
risk NN Mental
behaviors NNS Mental
-DOCSTART- -X- N

transthoracic JJ Other
echocardiographic JJ Other
detection NN Other
patent NN Physical
foramen NNS Physical
ovale VBP Physical
. . None
precordial JJ Other
echocardiographic JJ Other
detection NN Other
atrial JJ Physical
defects NNS Physical
Catheterization NN Other
and CC Physical
echocardiographic JJ Other
assessment NN Other
of IN Physical
patent NN Physical
foramen NNS Physical
ovale VBP Physical
Patent NNP None
foramen NNS None
ovale NN None
intensity NN Other
of IN Other
left JJ Other
ventricular JJ Other
opacification NN Other
sensitive JJ Physical
assessment NN Physical
of IN Physical
patent NN Physical
foramen NNS Physical
ovale VBP Physical
ability NN Other
of IN Other
precordial JJ Other
contrast NN Other
echocardiography NN Other
to TO Other
diagnose VB Other
patent JJ Other
foramen NNS Other
ovale VBP Other
. . Other
-DOCSTART- -X- N

Peak NNP Adverse
E NNP Adverse
( ( Adverse
2 CD Adverse
) ) Adverse
levels NNS Adverse
, , Adverse
days NNS Adverse
of IN Adverse
stimulation NN Adverse
with IN Adverse
rFSH NN Adverse
, , Adverse
total JJ Adverse
rFSH NN Adverse
dosage NN Adverse
, , Adverse
total JJ Adverse
number NN Adverse
of IN Adverse
oocytes NNS Adverse
retrieved VBN Adverse
, , Adverse
M2 NNP Adverse
oocytes VBZ Adverse
retrieved VBN Adverse
, , Adverse
total JJ Adverse
number NN Adverse
of IN Adverse
embryos NN Adverse
, , Adverse
number NN Adverse
of IN Adverse
embryos NN Adverse
transferred VBN Adverse
, , Adverse
number NN Adverse
of IN Adverse
Grade-1 NNP Adverse
embryos NN Adverse
transferred VBD Adverse
, , Adverse
clinical JJ Adverse
pregnancy NN Adverse
rate NN Adverse
( ( Adverse
positive JJ Adverse
fetal JJ Adverse
cardiac JJ Adverse
activity NN Adverse
) ) Adverse
, , Adverse
and CC Adverse
cancellation NN Adverse
rates NNS Adverse
of IN Adverse
stimulation NN Adverse
and CC Adverse
embryo NN Adverse
transfer NN Adverse
. . Adverse
Clinical NNP Physical
pregnancy NN Physical
rates NNS Physical
peak JJ Physical
serum NN Physical
E NNP Physical
( ( Physical
2 CD Physical
) ) Physical
concentration NN Physical
, , Physical
days NNS Physical
of IN Physical
stimulation NN Physical
with IN Physical
rFSH NN Physical
, , Physical
total JJ Physical
number NN Physical
of IN Physical
M2 NNP Physical
oocytes VBZ Physical
retrieved VBN Physical
, , Physical
number NN Physical
of IN Physical
embryos NN Physical
transferred VBN Physical
, , Physical
clinical JJ Physical
pregnancy NN Physical
rates NNS Physical
, , Physical
and CC Physical
cancellation NN Physical
rates NNS Physical
-DOCSTART- -X- N

plasma NNS Physical
glucose JJ Physical
levels NNS Physical
blood NN Physical
glucose NN Physical
levels NNS Physical
fasting VBG Physical
plasma NN Physical
glucose NN Physical
2-hour JJ Physical
postprandial JJ Physical
blood NN Physical
sugar NN Physical
levels NNS Physical
care NN Other
satisfaction NN Other
score NN Other
. . None
-DOCSTART- -X- N

pressure-flow JJ Other
parameters NNS Other
pressure-flow JJ Other
parameters NNS Other
PFS NNP Other
parameters NNS Other
. . None
Detrusor NNP Other
pressure NN Other
( ( None
PdetQmax NNP Physical
) ) None
Abrams-Griffiths NNP Other
classification NN Other
-DOCSTART- -X- N

stool NN Physical
fat JJ Physical
excretion NN Physical
and CC None
coefficient NN Physical
of IN Physical
fat JJ Physical
absorption NN Physical
( ( Physical
CFA NNP Physical
) ) Physical
statistically RB None
significant JJ None
preference NN None
Stool NNP Physical
fat NN Physical
( ( Physical
g/day NN Physical
) ) Physical
and CC None
CFA NNP Physical
( ( None
% NN None
) ) None
fat JJ Physical
absorption NN Physical
-DOCSTART- -X- N

Movement JJ Physical
trajectories NNS Physical
accurate JJ Other
when WRB Other
binocular JJ Other
information NN Other
was VBD Other
present JJ Other
. . None
proportional JJ None
rate NN None
control NN None
strategy NN None
rather RB None
than IN None
a DT None
constant JJ None
? . None
strategy NN None
. . None
the DT None
walk-to-reach NN None
task NN None
, , None
used VBD None
monocular JJ None
and/or NN None
binocular NN None
? . None
information NN None
to TO None
guide VB None
the DT None
head NN None
and CC None
using VBG None
relative JJ None
disparity NN None
? . None
to TO None
guide VB None
the DT None
hand NN None
to TO None
final JJ None
target NN None
acquisition NN None
, , None
switching VBG None
perform VB None
simulations NNS None
that WDT None
proportional JJ None
rate NN None
control NN None
is VBZ None
used VBN None
head NN None
centric NN None
, , None
then RB None
hand-centric JJ None
?-based JJ None
information NN None
, , None
using VBG None
the DT None
? . None
-DOCSTART- -X- N

event-free JJ Mortality
survival NN Mortality
( ( Mortality
EFS NNP Mortality
) ) Mortality
overall JJ Mortality
survival NN Mortality
hepatic JJ Physical
veno-occlusive JJ Physical
disease NN Physical
( ( Physical
VOD NNP Physical
) ) Physical
. . None
VOD NNP Physical
disproportionate VB Physical
thrombocytopenia NN Physical
portal JJ Physical
hypertension NN Physical
-DOCSTART- -X- N

visual JJ Mental
working JJ Mental
memory NN Mental
task NN Mental
. . None
Absolute NNP Mental
timing VBG Mental
error NN Mental
-DOCSTART- -X- N

significant JJ Other
improvements NNS Other
in IN Other
any DT Other
of IN Other
the DT Other
outcome NN Other
measures NNS Other
. . None
mean JJ Mental
total NN Mental
score NN Mental
on IN Mental
the DT Mental
Autism NNP Mental
Behavior NNP Mental
Checklist NNP Mental
mean JJ Other
decreases NNS Other
in IN Other
scores NNS Mental
treatment-limiting JJ Adverse
adverse JJ Adverse
effects NNS Adverse
. . None
not RB Other
an DT Other
effective JJ Other
treatment NN Other
-DOCSTART- -X- N

calcium NN Physical
bioavailability NN Physical
calcium NN Physical
availability NN Physical
fasting VBG Physical
blood NN Physical
samples NNS Physical
Calcium NNP Physical
solubility NN Physical
and CC None
absorption NN Physical
across IN Physical
Caco-2 NNP Physical
cells NNS Physical
solubility NN Physical
calcium NN Physical
bioavailability NN Physical
Serum NNP Physical
and CC Physical
urine JJ Physical
biochemical JJ Physical
parameters NNS Physical
related VBN Physical
to TO Physical
calcium NN Physical
status NN Physical
and CC Physical
bone NN Physical
metabolism NN Physical
deoxypyridinoline JJ Physical
bone NN Other
turnover NN Other
-DOCSTART- -X- N

standard JJ Mental
psychiatric NN Mental
rating NN Mental
scales NNS Mental
17-item JJ Mental
Hamilton NNP Mental
Rating NNP Mental
Scale NNP Mental
for IN Mental
Depression NNP Mental
Clinical JJ Other
Global NNP Other
Impressions-Improvement NN Other
score NN Other
HAM-D-17 JJ Mental
scores NNS Mental
HAM-D-17 NNP Mental
score NN Mental
Montgomery-Asberg NNP Mental
Depression NNP Mental
Rating NNP Mental
Scale NNP Mental
; : Mental
the DT Mental
HAM-D NNP Mental
retardation NN Mental
, , Mental
anxiety NN Mental
, , Mental
and CC Mental
sleep JJ Mental
disturbance NN Mental
factors NNS Mental
; : Mental
and CC Mental
HAM-D NNP Mental
item NN Mental
1 CD Mental
mean JJ None
nefazodone NN Other
dose NN None
well RB Other
tolerated VBN Other
adverse JJ Adverse
events NNS Adverse
efficacy NN Other
. . None
-DOCSTART- -X- N

patient NN Mental
ability NN Mental
and CC None
preference NN Mental
to TO Mental
speak VB Mental
to TO Mental
receptionists NNS Mental
and CC Mental
disclose VB Mental
confidential JJ Mental
information NN Mental
without IN Mental
being VBG Mental
overhead JJ Mental
and CC Mental
concern NN Mental
about IN Mental
disclosure NN Mental
of IN Mental
items NNS Mental
of IN Mental
confidential JJ Mental
personal JJ Mental
information NN Mental
. . None
tell VB Mental
receptionists NNS Mental
things NNS Mental
they PRP Mental
did VBD Mental
not RB Mental
want VB Mental
others NNS Mental
to TO Mental
hear VB Mental
. . Mental
others NNS None
heard VBP None
their PRP$ None
name NN None
, , None
address NN None
, , None
date NN None
of IN None
birth NN None
, , None
reason NN None
for IN None
emergency NN None
department NN None
attendance NN None
, , None
and CC None
telephone NN None
number NN None
, , None
but CC None
not RB None
their PRP$ None
marital JJ None
status NN None
. . None
disclosure NN None
of IN None
information NN None
-DOCSTART- -X- N

nighttime JJ Physical
heartburn NN Physical
, , None
GERD-related JJ Physical
sleep NN Physical
disturbances NNS Physical
, , None
sleep JJ Physical
quality NN Physical
, , None
work NN Physical
productivity NN Physical
, , None
and CC None
regular JJ Mental
activities NNS Mental
. . None
nighttime JJ Physical
heartburn NN Physical
. . None
resolution NN Other
of IN Other
sleep JJ Physical
disturbances NNS Physical
, , None
sleep VBP Physical
quality NN Physical
measured VBN None
by IN None
the DT Other
Pittsburgh NNP Physical
Sleep NNP Physical
Quality NNP Physical
Index NNP Physical
( ( Physical
PSQI NNP Physical
) ) Physical
questionnaire NN Physical
, , None
and CC None
work NN Mental
productivity NN Mental
measured VBN None
by IN None
the DT Other
Work NNP Mental
Productivity NNP Mental
and CC Mental
Activity NNP Mental
Impairment NNP Mental
Questionnaire NNP Mental
. . None
Nighttime NNP Physical
heartburn NN Physical
GERD-related JJ Physical
sleep JJ Physical
disturbances NNS Physical
PSQI NNP Physical
global JJ Physical
score NN Physical
-DOCSTART- -X- N

pacing-induced JJ Other
termination NN Other
of IN Other
atrial JJ Other
flutter NN Other
sinus VB Physical
rhythm NN Physical
. . Physical
incidence NN Physical
of IN Physical
pacing-induced JJ Physical
atrial JJ Physical
fibrillation NN Physical
. . Physical
The DT Physical
atrial JJ Physical
flutter NN Physical
cycle NN Physical
length NN Physical
atrial JJ Physical
monophasic JJ Physical
action NN Physical
potential JJ Physical
duration NN Physical
tachycardia JJ Physical
cycle NN Physical
length NN Physical
nor CC Physical
action NN Physical
potential JJ Physical
duration NN Physical
termination NN Physical
of IN Physical
atrial JJ Physical
flutter NN Physical
by IN Physical
atrial JJ Physical
overdrive JJ Physical
pacing NN Physical
. . Physical
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
Efficacy NNP Other
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
Irritability NNP Mental
subscale NN Mental
( ( Mental
primary JJ Mental
efficacy NN Mental
measure NN Mental
) ) Mental
and CC None
the DT None
clinician-rated JJ Mental
Clinical JJ Mental
Global NNP Mental
Impressions-Improvement NNP Mental
score NN Mental
. . None
Safety NNP Other
and CC Other
tolerability NN Other
improvement NN Other
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
Irritability NNP Mental
subscale NN Mental
scores NNS Mental
improvements NNS Mental
in IN Mental
mean JJ Mental
Clinical JJ Mental
Global NNP Mental
Impressions-Improvement NNP Mental
score NN Mental
adverse JJ Adverse
events NNS Adverse
adverse JJ Adverse
event NN Adverse
sedation NN None
. . None
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
: : None
presyncope NN Adverse
aggression NN Adverse
weight NN Physical
change NN Physical
efficacious JJ Other
safe JJ Other
well RB Other
tolerated VBN Other
-DOCSTART- -X- N

Recovery NNP Physical
was VBD Physical
rapid JJ Physical
complete JJ Physical
recovery NN Physical
degree NN Physical
of IN Physical
flexion NN Physical
remaining VBG Physical
in IN Physical
the DT Physical
great JJ Physical
toe NN Physical
Full NNP Physical
motor NN Physical
recovery NN Physical
subjective JJ Adverse
signs NNS Adverse
of IN Adverse
central JJ Adverse
nervous JJ Adverse
system NN Adverse
side NN Adverse
effects NNS Adverse
mean JJ Physical
plasma JJ Physical
level NN Physical
no DT Physical
leak NN Physical
of IN Physical
contrast NN Physical
medium NN Physical
under IN Physical
the DT Physical
tourniquet NN Physical
cuff NN Physical
( ( Physical
300 CD Physical
mmHg NN Physical
) ) Physical
fastest JJS Other
large JJ Adverse
number NN Adverse
of IN Adverse
central JJ Adverse
side NN Adverse
effects NNS Adverse
less RBR Physical
suitable JJ Physical
for IN Physical
clinical JJ Physical
work NN Physical
. . Physical
-DOCSTART- -X- N

Speilberger NNP Physical
's POS Physical
State NNP Physical
Trait NNP Physical
Inventory NNP Physical
, , None
the DT Adverse
Side NNP Adverse
Effects NNP Adverse
Profile NNP Adverse
, , None
and CC None
the DT None
Coping NNP Mental
Strategies NNP Mental
Profile NNP Mental
anxiety NN Mental
, , None
severity NN Adverse
of IN Adverse
side NN Adverse
effects NNS Adverse
, , None
helpfulness NN Other
of IN Other
self-care JJ Other
strategies NNS Other
, , None
and CC None
coping VBG Mental
strategies NNS Mental
. . None
clinically RB Physical
significant JJ Physical
-DOCSTART- -X- N

number NN Physical
of IN Physical
facial JJ Physical
inflammatory JJ Physical
lesions NNS Physical
number NN Physical
of IN Physical
lesions NNS Physical
efficacy NN Other
and CC Other
safety NN Other
-DOCSTART- -X- N

pocket NN Physical
probing VBG Physical
depth NN Physical
( ( Physical
PPD NNP Physical
) ) Physical
and CC Physical
bleeding VBG Physical
index NN Physical
( ( Physical
BI NNP Physical
) ) Physical
mean JJ Physical
PPD NNP Physical
mean JJ Physical
BI NNP Physical
mean JJ Physical
PPD NNP Physical
mean JJ Physical
PPD NNP Physical
mean JJ Physical
BI NNP Physical
mean JJ Physical
PPD NNP Physical
mean JJ Physical
BI NNP Physical
mean JJ Physical
PPD NNP Physical
mean JJ Physical
PPD NNP Physical
mean JJ Physical
PPD NNP Physical
-DOCSTART- -X- N

peripheral JJ Physical
vasodilator NN Physical
profile NN Physical
short- JJ Physical
and CC Physical
long-term JJ Physical
effects NNS Physical
Venous JJ Physical
volume NN Physical
diameter NN Physical
of IN Physical
the DT Physical
radial NN Physical
and CC Physical
temporal JJ Physical
arteries NNS Physical
, , Physical
calf NN Physical
blood NN Physical
flow NN Physical
subcutaneous JJ Physical
blood NN Physical
flow NN Physical
acute JJ Physical
venodilator NN Physical
effect NN Physical
changes NNS Physical
in IN Physical
venous JJ Physical
volume NN Physical
development NN Mental
of IN Mental
tolerance NN Mental
nitroglycerin-induced JJ Physical
changes NNS Physical
in IN Physical
arterial JJ Physical
diameters NNS Physical
microcirculatory JJ Other
subcutaneous JJ Other
blood NN Other
flow NN Other
after IN Other
1 CD Other
h NN Other
nitroglycerin-induced JJ Physical
venodilation NN Physical
effect NN Physical
of IN Physical
nitroglycerin NN Physical
on IN Physical
small JJ Physical
resistance NN Physical
vessels NNS Physical
( ( Other
regulating VBG Physical
subcutaneous JJ Physical
blood NN Physical
flow NN Physical
) ) Other
without IN Other
affecting VBG Other
the DT Other
response NN Other
to TO Other
nitroglycerin VB Other
in IN Other
middle-sized JJ Other
arteries NNS Other
. . Other
nitrate JJ Physical
tolerance NN Physical
vasodilator NN Physical
profile NN Physical
-DOCSTART- -X- N

efficacy NN Other
, , Other
tolerability NN Other
and CC Other
first-dose JJ Other
blood-pressure JJ Other
response NN Other
Efficacy NN Other
assessed VBN Other
six-minute JJ Other
walking NN Other
test NN Other
, , Other
the DT Other
New NNP Other
York NNP Other
Heart NNP Other
Association NNP Other
( ( Other
NYHA NNP Other
) ) Other
class NN Other
, , Other
a DT Other
functional JJ Other
lifescale NN Other
( ( Other
FLS NNP Other
) ) Other
questionnaire NN Other
and CC Other
the DT Other
cardiothoracic NN Other
ratio NN Other
( ( Other
CTR NNP Other
) ) Other
-at NN Other
study NN Other
entry NN Other
and CC Other
at IN Other
the DT Other
end NN Other
of IN Other
the DT Other
maintenance NN Other
phase NN Other
. . Other
Blood NNP Physical
pressure NN Physical
distance NN Physical
walked VBD Physical
during IN Physical
the DT Physical
six-minute JJ Physical
walking NN Physical
test NN Physical
improved VBN Physical
statistically RB Other
significant JJ Other
. . Other
significant JJ None
changes NNS None
FLS NNP Physical
or CC Physical
CTR NNP Physical
. . None
statistically RB Other
significant JJ Other
difference NN Other
hypotension NN Physical
first-dose JJ Physical
blood-pressure JJ Physical
response NN Physical
. . Other
-DOCSTART- -X- N

change VBN Physical
in IN Physical
blood NN Physical
pressure NN Physical
and CC Physical
change NN Other
in IN Other
the DT Other
percentage NN Other
of IN Other
patients NNS Other
in IN Other
each DT Other
group NN Other
with IN Other
controlled VBN Other
blood NN Other
pressure NN Other
. . Physical
blood NN Physical
pressure NN Physical
control NN Physical
-DOCSTART- -X- N

parent-reported JJ Mental
child NN Mental
behavior NN Mental
, , None
parenting VBG Mental
styles NNS Mental
, , None
parental JJ Other
satisfaction NN Other
, , None
and CC None
conflict NN Mental
about IN Mental
parenting VBG Mental
. . None
-DOCSTART- -X- N

larger JJR Physical
cyst NN Physical
reduction NN Physical
albendazole JJ Physical
sulfoxide NN Physical
levels NNS Physical
in IN Physical
plasma NN Physical
. . None
safe JJ Other
and CC Other
more RBR Other
effective JJ Other
insufficient JJ Other
-DOCSTART- -X- N

EPA NNP Mental
and CC Mental
DHA NNP Mental
intake VBP Mental
. . Physical
EPA NNP Physical
and CC Physical
DHA NNP Physical
relative JJ Physical
concentrations NNS Physical
in IN Physical
red JJ Physical
blood NN Physical
cells NNS Physical
( ( Physical
RBC NNP Physical
) ) Physical
. . Physical
between IN None
intake NN None
of IN None
EPA NNP None
, , None
DHA NNP None
and CC None
EPA NNP None
+ NNP None
DHA NNP None
and CC None
corresponding JJ None
concentration NN None
in IN None
RBC NNP None
was VBD None
EPA+DHA NNP None
intake NN None
and CC None
RBC NNP None
EPA NNP None
+ NNP None
DHA NNP None
concentration NN None
indicated VBD None
predicted VBD None
RBC NNP None
EPA NNP None
+ NNP None
DHA NNP None
concentration NN None
. . None
EPA NNP None
and CC None
DHA NNP None
intakes NNS None
that WDT None
their PRP$ None
RBC NNP None
concentrations NNS None
. . None
between IN None
EPA NNP None
+ NNP None
DHA NNP None
intakes NNS None
from IN None
with IN None
RBC NNP None
EPA NNP None
+ NNP None
DHA NNP None
concentrations NNS None
. . None
-DOCSTART- -X- N

The DT None
overall JJ None
success NN None
rate NN None
The DT None
duration NN None
of IN None
follow JJ None
up IN None
until IN None
negative JJ None
?-hCG NN None
was VBD None
?-hCG NN None
and CC None
gestational JJ None
mass NN None
diameter NN None
were VBD None
with IN None
successful JJ None
outcome NN None
in IN None
success NN None
rate NN None
was VBD None
groups NNS None
in IN None
adverse JJ None
effects NNS None
. . None
CONCLUSION NNP None
-DOCSTART- -X- N

response NN Physical
rate NN Physical
to TO Physical
alpha VB Physical
interferon NN Physical
( ( Physical
IFN NNP Physical
) ) Physical
normal JJ Physical
ALT NNP Physical
and CC None
serum VB Physical
HBV-DNA NNP Physical
levels NNS Physical
normal JJ Physical
ALT NNP Physical
undetectable JJ Physical
HBV-DNA NN Physical
response NN None
. . None
remission NN Other
rate NN Physical
of IN Physical
long JJ Physical
term NN Physical
response NN Physical
-DOCSTART- -X- N

myocardial JJ Physical
ischaemia NN Physical
ischaemia NN Physical
Myocardial NNP Physical
ischaemia NN Physical
intracoronary JJ Physical
( ( Physical
i.c JJ Physical
. . Physical
) ) Physical
ECG NNP Physical
ST NNP Physical
shift NN Physical
Collateral NNP Physical
flow JJ Physical
index NN Physical
( ( Physical
CFI NNP Physical
) ) Physical
without IN Physical
iCSO NN Physical
, , Physical
that WDT None
ECG NNP Physical
ST NNP Physical
segment NN Physical
shift NN Physical
i.c NN None
. . None
ECG NNP None
ST NNP None
shift NN None
reduction NN None
during IN None
( ( None
2 CD None
) ) None
=0.61 NN None
) ) None
. . None
Ischaemia NNP None
reduction NN None
with IN None
iCSO NN None
was VBD None
greatest VBN None
collateral NN None
function NN None
is VBZ None
-DOCSTART- -X- N

measure VB Pain
menstrual JJ Pain
pain NN Pain
, , Pain
daily RB Pain
pain NN Pain
, , Pain
and CC Pain
pain NN Pain
on IN Pain
intercourse NN Pain
and CC Pain
bowel NN Pain
movement NN Pain
; : Pain
Endometriosis NNP Other
Health NNP Other
Profile-30 NNP Other
( ( Other
EHP-30 NNP Other
) ) Other
endometriosis-specific JJ Other
quality-of-life JJ Other
questionnaire NN Other
Measure NN Physical
Yourself NNP Physical
Medical NNP Physical
Outcomes NNP Physical
Profile NNP Physical
( ( Physical
MYMOP NNP Physical
) ) Physical
a DT Physical
patient-centered JJ Physical
health NN Physical
questionnaire NN Physical
Liver NNP Physical
and CC Physical
renal JJ Physical
function NN Physical
EHP-30 NNP Physical
and CC Physical
MYMOP NNP Physical
scores NNS Physical
. . None
VAS NNP Physical
scores VBZ Physical
-DOCSTART- -X- N

fracture NN Physical
resistance NN Physical
fracture NN Physical
resistances NNS Physical
Fracture NN Physical
resistance NN Physical
Mean JJ Physical
fracture NN Physical
threshold NN Physical
no DT Physical
posts NNS Physical
fracture NN Physical
and CC Physical
polycarbonate NN Physical
resin NN Physical
crowns NNS Physical
fragmentation NN Physical
. . None
fracture NN Physical
resistance NN Physical
-DOCSTART- -X- N

cytomegalovirus NN None
anterior JJ Adverse
chamber NN Adverse
inflammation NN Adverse
and CC None
increased VBD Adverse
intraocular JJ Adverse
pressure NN Adverse
. . None
proportion NN Other
of IN Other
patients NNS Other
with IN Other
events NNS Other
number NN Other
of IN Other
injections NNS Other
increased VBN Other
. . Other
well RB Other
tolerated VBN Other
with IN Other
an DT Other
acceptable JJ Other
safety NN Other
profile NN Other
. . Other
Adverse JJ Adverse
ocular JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

improvement NN None
of IN None
vertigo NN Physical
and CC None
provoked VBD Physical
nystagmus NNS Physical
VR NNP Physical
-DOCSTART- -X- N

Endoscopic NNP Physical
, , Physical
clinical JJ Physical
, , Physical
and CC Physical
histologic JJ Physical
improvement NN Physical
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
and CC None
neural JJ Physical
tone NN Physical
blood NN Physical
pressure NN Physical
neural JJ Physical
tonicity NN Physical
efficacy NN Other
ischemic JJ Physical
episodes NNS Physical
; : None
Ischemic NNP Physical
episodes VBZ Physical
heart NN Physical
rate NN Physical
plasma JJ Physical
norepinephrine JJ Physical
level NN Physical
. . None
norepinephrine NN Physical
blood NN Physical
pressure NN Physical
24-h JJ Physical
ambulatory NN Physical
blood NN Physical
pressure NN Physical
. . None
Ischemic NNP Physical
episodes NNS Physical
neural JJ Physical
tone NN Physical
control NN Physical
of IN Physical
ischemia NN Physical
blood NN Physical
pressure NN Physical
-DOCSTART- -X- N

Influence NN None
Periotest/Osstell NNP Physical
measurements NNS Physical
peri-apical JJ Physical
bone NN Physical
lesion NN Physical
Periotest NNP Physical
Osstell NNP Physical
-DOCSTART- -X- N

Blood NNP Adverse
loss NN Adverse
operating VBG Other
time NN Other
hospital VB Other
stay NN Other
Complication NN Adverse
rates NNS Adverse
, , Adverse
and CC Adverse
involvement NN Adverse
of IN Adverse
circumferential JJ Adverse
and CC Adverse
radial JJ Adverse
margins NNS Adverse
local JJ Mortality
recurrence NN Mortality
, , Mortality
disease-free JJ Mortality
or CC Mortality
overall JJ Mortality
survival NN Mortality
. . Mortality
blood NN Adverse
loss NN Adverse
intestinal JJ Adverse
recovery NN Adverse
hospital NN Other
stay NN Other
oncological JJ Physical
outcomes NNS Physical
. . Physical
-DOCSTART- -X- N

Infarct NNP Physical
size NN Physical
, , Physical
occurrence NN Physical
of IN Physical
major JJ Physical
arrhythmias NNS Physical
, , Physical
heart NN Physical
failure NN Physical
, , Physical
left VBD Physical
ventricular JJ Physical
ejection NN Physical
fraction NN Physical
( ( Physical
LVEF NNP Physical
) ) Physical
, , Physical
TLT-related JJ Adverse
complications NNS Adverse
, , Physical
in-hospital JJ Mortality
and CC Mortality
6-month JJ Mortality
mortality NN Mortality
rates NNS Mortality
demographics NNS Physical
, , Physical
myocardial JJ Physical
enzyme NN Physical
release NN Physical
, , Physical
occurrence NN Physical
of IN Physical
major JJ Physical
arrhythmias NNS Physical
heart NN Physical
failure NN Physical
LVEF NNP Physical
at IN Physical
first JJ Physical
day NN Physical
discharge NN None
[ $ None
in-hospital JJ None
[ NN None
4 CD None
] NN None
or CC None
6-month JJ Mortality
mortality NN Mortality
rates NNS Mortality
[ VBP None
9 CD None
infarct JJ None
size NN None
or CC None
-DOCSTART- -X- N

cytomegalovirus NN Physical
disease NN Physical
cytomegalovirus NN Physical
efficacy NN Other
, , None
costs NNS Other
, , None
and CC None
safety NN Other
CMV-seropositive JJ Physical
. . Physical
CMV NNP Physical
incidence NN Physical
of IN Physical
CMV NNP Physical
viremia NN Physical
Treatment JJ Other
failure NN Other
( ( None
death NN Mortality
, , None
graft NN Adverse
loss NN Adverse
, , None
CMV NNP Physical
disease NN Physical
, , None
or CC None
withdrawal NN Other
from IN Other
study NN Other
) ) None
average JJ Other
CMV-associated JJ Other
costs NNS Other
per IN Other
patient NN Other
well RB Other
tolerated VBN Other
equally RB Other
safe JJ Other
and CC Other
effective JJ Other
cost-effective JJ Other
CMV-associated JJ Other
costs NNS Other
-DOCSTART- -X- N

Antiinflammatory JJ Physical
effects NNS Physical
lung JJ Physical
function NN Physical
antiinflammatory JJ Physical
effects NNS Physical
Induced NNP Physical
sputum JJ Physical
differential NN Physical
cell NN Physical
counts NNS Physical
Interleukin-8 NNP Physical
and CC Physical
neutrophil JJ Physical
elastase NN Physical
neutrophils NNS Physical
, , Physical
CD8+ NNP Physical
and CC Physical
CD4+ NNP Physical
T-lymphocyte NNP Physical
subsets NNS Physical
, , Physical
and CC Physical
CD68+ NNP Physical
macrophages NNS Physical
. . None
genes NNS Physical
for IN Physical
interleukin-8 NN Physical
and CC Physical
tumor NN Physical
necrosis NN Physical
factor-alpha NN Physical
sputum JJ Physical
endpoint NN Physical
or CC Physical
FEV1 NNP Physical
. . None
reductions NNS Physical
in IN Physical
CD8+ NNP Physical
CD68+ NNP Physical
cells NNS Physical
reductions NNS Physical
of IN Physical
CD8+ NNP Physical
CD68+ NNP Physical
airway JJ Physical
tissue NN Physical
inflammatory NN Physical
cells NNS Physical
-DOCSTART- -X- N

blood NN Physical
glutathione NN Physical
levels NNS Physical
plasma NN Physical
reduced VBN Physical
glutathione NN Physical
, , Physical
oxidized VBD Physical
glutathione NN Physical
, , Physical
cysteine NN Physical
, , Physical
taurine NN Physical
, , Physical
free JJ Physical
and CC Physical
total JJ Physical
sulfate NN Physical
, , Physical
and CC Physical
whole-blood JJ Physical
glutathione NN Physical
levels NNS Physical
. . Physical
plasma NN Physical
reduced VBD Physical
glutathione NN Physical
, , None
but CC None
not RB None
whole-blood JJ Physical
glutathione NN Physical
levels NNS None
plasma NN Physical
sulfate NN Physical
, , None
cysteine NN Physical
, , None
and CC None
taurine NN Physical
-DOCSTART- -X- N

primary JJ Physical
rupture NN Physical
of IN Physical
the DT Physical
membranes NNS Physical
preterm VB Physical
labour NN Physical
frequency NN Physical
of IN Physical
preterm JJ Physical
labour NN Physical
-DOCSTART- -X- N

Brain VB Physical
5-HT4R JJ Physical
binding NN Physical
positron NN Other
emission NN Other
tomography NN Other
( ( None
PET NNP None
) ) None
. . None
brain NN Physical
5-HT4R JJ Physical
binding NN Physical
5-HT4R JJ Physical
density NN Physical
-DOCSTART- -X- N

Clinical JJ Mental
Global NNP Mental
Impressions NNP Mental
( ( Mental
CGI NNP Mental
) ) Mental
Naltrexone NNP Adverse
Side NNP Adverse
Effects NNP Adverse
Rating NNP Adverse
Scale NNP Adverse
( ( Adverse
SE NNP Adverse
) ) Adverse
, , Adverse
Conners NNPS Mental
Parent NNP Mental
Impulsivity/Hyperactivity NNP Mental
Factor NNP Mental
, , None
Teacher NNP Mental
Hyperactivity NNP Mental
Factor NNP Mental
Early JJ Mental
Intervention NNP Mental
Developmental NNP Mental
Profile-Language NNP Mental
paired-associate JJ Other
learning NN Other
. . None
Side JJ Adverse
effects NNS Adverse
parent NN Mental
measures NNS Mental
Teacher NNP Mental
CGI NNP Mental
SE-Restlessness NNP Mental
learning VBG Mental
measures NNS Mental
behavior NN Mental
learning VBG Mental
-DOCSTART- -X- N

effects NNS Other
Arginine-vasopressin NNP Physical
( ( Physical
AVP NNP Physical
) ) Physical
, , Physical
atrial JJ Physical
natriuretic JJ Physical
peptide NN Physical
( ( Physical
alpha-hANP JJ Physical
) ) Physical
, , None
endothelin FW Physical
( ( Physical
ET-1 NNP Physical
) ) Physical
and CC None
cAMP NN Physical
Cmax NNP Physical
values NNS Physical
of IN Physical
asimadoline NN Physical
in IN Physical
plasma NN Physical
blood NN Physical
pressure NN Physical
, , None
heart NN Physical
rate NN Physical
, , None
GFR NNP Physical
or CC None
urine JJ Physical
electrolyte JJ Physical
excretion NN Physical
, , None
urine JJ Physical
volume NN Physical
CH2O NNP Physical
Urinary JJ Physical
excretion NN Physical
Plasma NNP Physical
AVP NNP Physical
-DOCSTART- -X- N

of IN Physical
pyridoxal NN Physical
5'-phosphate JJ Physical
( ( Physical
PLP NNP Physical
) ) Physical
degree NN Physical
of IN Physical
coenzyme NN Physical
saturation NN Physical
( ( Physical
activation JJ Physical
factor NN Physical
) ) Physical
of IN Physical
aspartate NN Physical
aminotransferase NN Physical
and CC None
alanine JJ Physical
aminotransferase NN Physical
( ( Physical
alphaEGOT JJ Physical
and CC Physical
alphaEGPT NN Physical
) ) Physical
in IN Physical
maternal JJ Physical
erythrocytes NNS Physical
. . None
maternal JJ Physical
plasma NN Physical
PLP NNP Physical
levels NNS Physical
plasma NN Physical
PLP NNP Physical
concentrations NNS Physical
in IN Physical
maternal JJ Physical
and CC Physical
cord JJ Physical
blood NN Physical
Measurements NNS Physical
of IN Physical
alphaEGOT NN Physical
and CC Physical
alphaEGPT NN Physical
plasma JJ Physical
PLP NNP Physical
assays NNS Physical
changes NNS Physical
in IN Physical
alphaEGOT NN Physical
and CC Physical
alphaEGPT NN Physical
plasma NN Physical
PLP NNP Physical
. . None
alphaEGOT NN Physical
plasma NN Physical
PLP NNP Physical
alphaEGPT NN Physical
and CC None
log NN Physical
plasma NN Physical
PLP NNP Physical
-DOCSTART- -X- N

The DT None
results NNS None
indicate VBP None
that IN None
, , None
like IN None
controls NNS None
, , None
experience NN Mental
interference NN Mental
from IN None
facial JJ None
features NNS None
that IN None
they PRP None
are VBP None
told VBN None
to TO None
ignore VB None
. . None
However RB None
, , None
while IN None
such JJ None
interference NN None
is VBZ None
released VBN None
for IN None
controls NNS None
if IN None
parts NNS None
of IN None
face NN None
composites NNS None
are VBP None
misaligned VBN None
, , None
show VBP None
comparable JJ Mental
interference NN Mental
from IN None
irrelevant JJ None
parts NNS None
regardless RB None
of IN None
alignment NN None
. . None
Two CD None
different JJ None
interpretations NNS None
are VBP None
discussed VBN None
, , None
both DT None
compatible JJ None
with IN None
the DT None
idea NN None
that WDT None
perceptual JJ None
and CC None
or CC None
attentional JJ None
abnormalities NNS None
in IN None
result NN None
in IN None
a DT None
diminished JJ None
level NN None
of IN None
expertise NN None
for IN None
faces VBZ None
. . None
-DOCSTART- -X- N

safety NN Other
, , Other
efficacy NN Other
and CC Other
tolerability NN Other
Behavioral NNP Mental
Rating VBG Mental
Scales NNS Mental
Safety NNP Mental
assessment NN Mental
vital JJ Adverse
signs NNS Adverse
, , Adverse
electrocardiogram NN Adverse
, , Adverse
electroencephalogram NN Adverse
, , Adverse
adverse JJ Adverse
events NNS Adverse
, , Adverse
laboratory NN Adverse
tests NNS Adverse
, , Adverse
extrapyramidal NN Adverse
symptoms NNS Adverse
and CC Adverse
the DT Adverse
side NN Adverse
effects NNS Adverse
. . None
Ritvo-Freeman NNP Mental
Real NNP Mental
Life NNP Mental
Rating NNP Mental
Scale NNP Mental
( ( Mental
RF-RLRS NNP Mental
) ) Mental
, , None
sensory JJ None
motor NN None
( ( None
subscale JJ None
I PRP None
) ) None
and CC None
language NN None
( ( None
subscale JJ None
V NNP None
) ) None
scores NNS None
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
( ( Mental
ABC NNP Mental
) ) Mental
and CC Mental
Turgay NNP Mental
DSM-IV NNP Mental
Pervasive NNP Mental
Developmental NNP Mental
Disorder NNP Mental
( ( Mental
PDD NNP Mental
) ) Mental
scale NN Mental
scores NNS Mental
prolactin NN Physical
alanine JJ Other
amino NN Other
transferase NN Other
( ( Other
ALT NNP Other
) ) Physical
Sensory NNP Mental
motor NN Mental
behaviors NNS Mental
( ( Mental
subscale JJ Mental
I PRP Mental
) ) Mental
language NN Mental
RF-RLRS NNP None
sensory NN None
motor NN None
and CC None
language NN None
subscale JJ None
scores NNS None
behavioral JJ Mental
symptoms NNS Mental
, , Mental
impulsivity NN Mental
, , Mental
language NN Mental
skills NNS Mental
impaired JJ Mental
social JJ Mental
relations NNS Mental
-DOCSTART- -X- N

repetitive JJ Mental
behaviors NNS Mental
repetitive JJ Mental
behaviors NNS Mental
repetitive JJ Mental
behaviors NNS Mental
six CD Mental
repetitive JJ Mental
behaviors NNS Mental
: : Mental
need NN Mental
to TO Mental
know VB Mental
, , Mental
repeating VBG Mental
, , Mental
ordering VBG Mental
, , Mental
need NN Mental
to TO Mental
tell/ask VB Mental
, , Mental
self-injury NN Mental
, , Mental
and CC Mental
touching VBG Mental
. . Mental
repetitive JJ Mental
behaviors NNS Mental
Repetitive JJ Mental
behavior NN Mental
-DOCSTART- -X- N

HFLCS NNP None
did VBD None
not RB None
cause VB None
a DT None
statistically RB None
significant JJ None
change NN None
in IN None
the DT None
shear JJ Other
bond NN Other
values NNS Other
of IN Other
either DT Other
metal NN Other
or CC Other
ceramic JJ Other
brackets NNS Other
Shear JJ Other
bond NN Other
values NNS Other
of IN Other
the DT Other
ceramic JJ Other
brackets NNS Other
bond NN Other
failure NN Other
modes VBZ Other
bond NN Other
strength NN Other
values NNS Other
bond NN Other
failure NN Other
modes NNS Other
shear JJ Other
bond NN Other
values NNS Other
of IN Other
either DT Other
metal NN Other
or CC Other
ceramic JJ Other
brackets NNS Other
Shear JJ Other
bond NN Other
values NNS Other
of IN Other
the DT Other
ceramic JJ Other
brackets NNS Other
-DOCSTART- -X- N

Exposure NNP Other
Prevention NNP Other
ratings NNS Other
exposures NNS None
inter-rater JJ Other
reliability NN Other
. . Other
reliability NN Other
of IN Other
the DT Other
overall JJ Other
exposure NN Other
prevention NN Other
ratings NNS Other
-DOCSTART- -X- N

root JJ Physical
canal JJ Physical
filling NN Physical
materials NNS Physical
-DOCSTART- -X- N

visual JJ Physical
analog NN Physical
scale NN Physical
( ( Physical
VAS NNP Physical
) ) Physical
, , Physical
the DT Physical
Oswestry NNP Physical
and CC Physical
the DT Physical
Million NNP Physical
disability NN Physical
indexes NNS Physical
, , Physical
isometric JJ Physical
and CC Physical
dynamic JJ Physical
trunk NN Physical
muscle NN Physical
strength NN Physical
, , Physical
mobility NN Physical
in IN Physical
the DT Physical
lumbar NN Physical
spine NN Physical
, , Physical
and CC Physical
straight-leg JJ Physical
raising NN Physical
mean JJ Physical
strength NN Physical
training NN Physical
frequency NN Physical
mean JJ Physical
stretching NN Physical
frequency NN Physical
Median JJ Pain
back RB Pain
and CC Pain
leg NN Pain
pain NN Pain
Million NNP Physical
and CC Physical
Oswestry NNP Physical
indices NNS Physical
isometric JJ Physical
trunk NN Physical
extension NN Physical
dynamic JJ Physical
and CC Physical
isometric JJ Physical
back NN Physical
extension NN Physical
and CC Physical
flexion NN Physical
strength NN Physical
mobility NN Physical
of IN Physical
the DT Physical
spine NN Physical
and CC Physical
repetitive JJ Physical
squat-test JJ Physical
results NNS Physical
physical JJ Physical
function NN Physical
parameters NNS Physical
physical JJ Physical
function NN Physical
, , Pain
pain NN Pain
, , Physical
or CC Physical
disability NN Physical
measures NNS Physical
-DOCSTART- -X- N

clinically RB Other
effective JJ Other
levels NNS Physical
of IN Physical
illicit JJ Physical
drug NN Physical
use NN Physical
reduction NN Mental
in IN Mental
heroin NN Mental
use NN Mental
cocaine NN Physical
urinalyses NNS Physical
heroin NNS Mental
use VBP Mental
-DOCSTART- -X- N

Efficiency NN Other
disease NN Physical
relapse NN Physical
. . None
survival NN Mortality
of IN Mortality
10-year JJ Mortality
survival NN Mortality
10-year JJ Mortality
survival NN Mortality
survival NN Mortality
of IN Mortality
survival NN Mortality
survival JJ Mortality
benefit NN Mortality
-DOCSTART- -X- N

The DT Other
number NN Other
of IN Other
repetitions NNS Other
in IN Other
each DT Other
test NN Other
was VBD None
recorded VBN None
as IN None
an DT None
outcome NN None
. . None
-DOCSTART- -X- N

efficacy NN Other
effectiveness NN Other
completed VBD Pain
a DT Pain
medication NN Other
log NN Other
, , Pain
and CC Pain
recorded VBD Pain
the DT Pain
presence NN Pain
and CC Pain
severity NN Pain
of IN Pain
opioid-related JJ Pain
adverse JJ Pain
effects NNS Pain
and CC Pain
children NNS Pain
's POS Pain
reports NNS Pain
of IN Pain
pain NN Pain
intensity NN Pain
using VBG Pain
a DT Pain
0 CD Pain
to TO Pain
10 CD Pain
numeric JJ Pain
rating NN Pain
scale NN Pain
. . Pain
pain JJ Pain
intensity NN Pain
scores NNS Pain
analgesic JJ Other
pain NN Pain
intensity NN Pain
scores NNS Pain
Pain NNP Pain
intensity NN Pain
scores NNS Pain
constipation NN Adverse
frequency NN Adverse
or CC Adverse
severity NN Adverse
of IN Adverse
opioid-related JJ Adverse
adverse JJ Adverse
effects NNS Adverse
. . Physical
-DOCSTART- -X- N

Total JJ Physical
calcium NN Physical
and CC Physical
PTH NNP Physical
levels NNS Physical
development NN Physical
of IN Physical
postoperative JJ Physical
hypoparathyroidism NN Physical
-DOCSTART- -X- N

language NN Mental
or CC Mental
autistic JJ Mental
behaviour NN Mental
measures NNS Mental
> NN Mental
or CC Mental
= $ Mental
6 CD Mental
points NNS Mental
on IN Mental
the DT Mental
language NN Mental
measure NN Mental
-DOCSTART- -X- N

immune JJ Physical
response NN Physical
Antitoxin NNP Physical
response NN Physical
Circulating VBG Physical
antibodies NNS Physical
were VBD Physical
measured VBN Physical
by IN Physical
enzyme-linked JJ Physical
immunosorbent NN Physical
assay NN Physical
( ( Physical
ELISA NNP Physical
) ) Physical
. . Physical
antibody NN Physical
titers NNS Physical
circulating NN Physical
T NNP Physical
and CC Physical
D NNP Physical
antitoxin NN Physical
levels NNS Physical
T NNP Physical
antitoxin NN Physical
levels NNS Physical
D NNP Physical
antitoxin NN Physical
levels NNS Physical
-DOCSTART- -X- N

effects NNS Other
cardiovascular NN Physical
and CC Physical
respiratory JJ Physical
functions NNS Physical
cardiovascular JJ Physical
and CC Physical
respiratory JJ Physical
functions NNS Physical
Intraocular JJ Physical
pressure NN Physical
, , Physical
blood NN Physical
pressure NN Physical
, , Physical
heart NN Physical
rate NN Physical
, , Physical
and CC Physical
respiratory JJ Physical
functions NNS Physical
, , Physical
including VBG Physical
percent NN Physical
forced VBD Physical
expiratory JJ Physical
volume NN Physical
in IN Physical
1 CD Physical
second JJ Physical
and CC Physical
peak JJ Physical
expiratory NN Physical
flow NN Physical
rate NN Physical
intraocular JJ Physical
pressure NN Physical
and CC Physical
cardiovascular JJ Physical
function NN Physical
respiratory NN Physical
function NN Physical
percent NN Physical
forced VBD Physical
expiratory JJ Physical
volume NN Physical
in IN Physical
1 CD Physical
second JJ Physical
, , Physical
peak JJ Physical
expiratory NN Physical
flow NN Physical
rate NN Physical
, , Physical
and CC Physical
expiratory JJ Physical
flow NN Physical
rate NN Physical
at IN Physical
75 CD Physical
% NN Physical
vital JJ Physical
capacity NN Physical
cardiovascular JJ Physical
and CC Physical
respiratory JJ Physical
functions NNS Physical
bronchial JJ Physical
sensitivity NN Physical
-DOCSTART- -X- N

effect NN Other
pharmacodynamic JJ Physical
effects NNS Physical
acceptability NN Other
pharmacokinetics NNS Other
time NN Physical
course NN Physical
of IN Physical
angiotensin NN Physical
converting VBG Physical
enzyme JJ Physical
inhibition NN Physical
blood NN Physical
pressure NN Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
plasma JJ Physical
renin NN Physical
activity NN Physical
perindoprilat NN Physical
ACE NNP Physical
inhibition NN Physical
well RB Other
tolerated VBN Other
clinically RB Physical
significant JJ Physical
change NN Physical
in IN Physical
routine JJ Physical
haematology NN Physical
or CC Physical
serum JJ Physical
biochemistry NN Physical
. . None
-DOCSTART- -X- N

adequate JJ Pain
analgesia NN Pain
. . None
pain NN Pain
scores NNS Pain
-DOCSTART- -X- N

Differential JJ Other
effects NNS Other
Total JJ Physical
peripheral JJ Physical
resistance NN Physical
( ( Physical
TPR NNP Physical
) ) Physical
, , None
heart NN Physical
rate-corrected JJ Physical
electromechanical JJ Physical
systole NN Physical
( ( Physical
QS2c NNP Physical
) ) Physical
preejection NN Physical
period NN Physical
( ( Physical
PEPc NNP Physical
) ) Physical
TRP NNP Physical
heart NN Physical
rate NN Physical
cardiac JJ Physical
output NN Physical
QS2c NNP Physical
prolongation NN Physical
of IN Physical
QS2c NNP Physical
negative JJ Physical
inotropic NN Physical
effect NN Physical
. . None
vasodilatory JJ Physical
effects NNS Physical
negative JJ Other
inotropic NN Other
effects NNS Other
-DOCSTART- -X- N

early JJ Physical
callus NN Physical
formation NN Physical
as IN None
rich JJ None
as IN None
intermediate NN None
as IN None
poor JJ None
improve VB None
early JJ None
callus NN None
formation NN None
-DOCSTART- -X- N

efficacy NN Other
number NN Physical
, , Physical
duration NN Physical
, , Physical
and CC Physical
anatomic JJ Physical
localization NN Physical
of IN Physical
relapses NNS Physical
number NN Other
average JJ Other
duration NN Other
recurrences NNS Other
number NN Other
average JJ Other
duration NN Other
relapses NNS Other
significant JJ Adverse
vaccine-induced JJ Adverse
side NN Adverse
effects NNS Adverse
. . None
number NN Other
and CC Other
duration NN Other
of IN Other
relapses NNS Other
-DOCSTART- -X- N

immediate JJ Other
efficacy NN Other
immediate JJ Other
clinical JJ Other
and CC Other
microbiological JJ Other
efficacy NN Other
gingival NN Physical
fluid NN Physical
flow NN Physical
, , Physical
probing VBG Physical
depths NNS Physical
, , Physical
bleeding VBG Physical
on IN Physical
probing VBG Physical
and CC Physical
suppuration NN Physical
Subgingival JJ Physical
bacterial JJ Physical
samples NNS Physical
Spirochaetes NNS None
dark-field JJ None
microscopy NN None
short-term JJ Other
clinical JJ Other
nor CC Other
microbiological JJ Other
efficacy NN Other
-DOCSTART- -X- N

patient JJ Other
satisfaction NN Other
ECG NNP Other
, , Physical
blood NN Physical
pressure NN Physical
, , Physical
respiratory NN Physical
rate NN Physical
, , Physical
oxygen NN Physical
saturation NN Physical
and CC Physical
sedation NN Other
score NN Other
. . Physical
haemodynamic JJ Physical
variables NNS Physical
Complications NNS Adverse
and CC Adverse
recovery NN Adverse
characteristics NNS Adverse
-DOCSTART- -X- N

Systemic NNP Physical
hemodynamic NN Physical
, , Physical
neurohormonal JJ Physical
, , Physical
and CC Physical
renal JJ Physical
effects NNS Physical
systemic JJ Physical
hemodynamic NN Physical
, , None
neurohormonal JJ Physical
, , None
and CC None
renal JJ Physical
effects NNS Physical
adverse JJ Adverse
events NNS Adverse
right JJ Physical
atrial JJ Physical
pressure NN Physical
and CC Physical
pulmonary JJ Physical
capillary JJ Physical
wedge NN Physical
pressure NN Physical
systemic JJ Physical
vascular JJ Physical
resistance NN Physical
cardiac JJ Physical
index NN Physical
heart NN Physical
rate NN Physical
plasma JJ Physical
norepinephrine NN Physical
and CC Physical
aldosterone NN Physical
Renal JJ Physical
hemodynamics NNS Physical
natriuretic JJ Physical
effect NN Physical
hemodynamic JJ Physical
effects NNS Physical
cardiac JJ Physical
preload NN Physical
and CC Physical
systemic JJ Physical
vascular JJ Physical
resistance NN Physical
cardiac JJ Physical
output NN Physical
heart NN Physical
rate NN Physical
Plasma NNP Physical
norepinephrine NN Physical
and CC Physical
aldosterone NN Physical
levels NNS Physical
-DOCSTART- -X- N

Delta NNP Mental
stage-of-change NN Mental
and CC Mental
rate NN Mental
of IN Mental
maintained VBN Mental
cessation NN Mental
rate NN Mental
of IN Mental
maintained VBN Mental
cessation NN Mental
mean JJ Physical
delta NN Physical
stage-of-change NN Physical
Maintained VBN Other
cessation NN Other
Mean JJ Other
delta JJ Other
stage-of-change NN Other
-DOCSTART- -X- N

rate NN Physical
of IN Physical
premature NN Physical
deliveries NNS Physical
perinatal JJ Mortality
death NN Mortality
or CC None
fetal JJ Adverse
malformations NNS Adverse
mean JJ Physical
birth NN Physical
weight NN Physical
-DOCSTART- -X- N

index NN Physical
and CC Physical
the DT Physical
risk NN Physical
of IN Physical
collapse NN Physical
extent NN Physical
of IN Physical
the DT Physical
necrotic JJ Physical
portion NN Physical
necrotic JJ Physical
portion NN Physical
-DOCSTART- -X- N

promote VB Other
cerebral JJ Other
lactate JJ Other
uptake NN Other
. . None
trial NN None
, , None
pH NN None
decreased VBD None
. . None
Arterial JJ None
lactate NN None
increased VBD None
the DT None
arterial-jugular JJ None
venous JJ None
lactate NN None
difference NN None
Accordingly RB None
, , None
the DT None
cerebral JJ Physical
metabolic NN Physical
ratio NN Physical
decreased VBD None
The DT None
enlarged JJ None
blood-buffering NN None
capacity NN None
after IN None
eliminated VBD None
metabolic JJ None
acidosis NN None
during IN None
the DT None
cerebral JJ None
lactate NN None
uptake NN None
and CC None
, , None
the DT None
cerebral JJ None
metabolic NN None
ratio NN None
. . None
-DOCSTART- -X- N

abnormal JJ Physical
muscle NN Physical
tone NN Physical
. . Physical
hypertonus NN Physical
. . Physical
no DT Other
significant JJ Other
differences NNS Other
-DOCSTART- -X- N

Anthropometry NNP None
, , None
blood NN None
pressure NN None
( ( None
BP NNP None
) ) None
, , None
blood NN None
lipids NNS None
, , None
pulse RB None
wave VBP None
velocity NN None
( ( None
PWV NNP None
) ) None
, , None
and CC None
NOx NNP None
( ( None
surrogate JJ None
marker NN None
for IN None
nitric JJ None
oxide NN None
) ) None
for IN None
anthropometry NN None
, , None
BP NNP None
, , None
or CC None
lipids NNS None
. . None
in IN None
PWV NNP None
in IN None
NOx NNP None
between IN None
PWV NNP None
and CC None
NOx NNP None
-DOCSTART- -X- N

cardiovascular NN Physical
( ( Physical
CV NNP Physical
) ) Physical
function NN Physical
Maximal NNP Physical
aerobic JJ Physical
power NN Physical
( ( Physical
VO2max NNP Physical
) ) Physical
, , None
with IN None
simultaneous JJ Physical
measurement NN Physical
of IN Physical
stroke NN Physical
volume NN Physical
( ( Physical
SV NNP Physical
) ) Physical
and CC None
cardiac JJ Physical
output NN Physical
( ( Physical
CO NNP Physical
) ) Physical
, , None
by IN None
impedance NN Other
cardiography NN Other
VO2max NNP Physical
( ( Physical
ml.kg-1 JJ Physical
min-1 NN Physical
) ) Physical
HCTmax NNP Physical
groups NNS Physical
VO2max NNP Physical
VO2max NNP Physical
SVmax NNP Physical
and CC None
COmax NNP Physical
cardiovascular JJ Physical
fitness NN Physical
. . None
-DOCSTART- -X- N

HAM-D JJ Physical
17 CD Physical
reduction NN Physical
YMR NNP Physical
score NN Physical
of IN Physical
> NN Physical
or CC Physical
=8 VB Physical
hypomania NN Physical
rapid JJ Mental
mood NN Mental
swing VBG Mental
into IN Mental
depression NN Mental
. . None
-DOCSTART- -X- N

platelet NN Physical
function NN Physical
profiles NNS Physical
platelet NN Physical
function NN Physical
profiles NNS Physical
platelet NN Physical
inhibition NN Physical
platelet NN Physical
function NN Physical
profiles NNS Physical
vasodilator-stimulated JJ Other
phosphoprotein NN Other
phosphorylation NN Other
assay NN Other
, , None
light JJ Other
transmittance NN Other
aggregometry NN Other
, , None
VerifyNow NNP Physical
P2Y12 NNP Physical
assay NN Physical
( ( None
Accumetric NNP None
, , None
Inc. NNP None
San NNP None
Diego NNP None
, , None
California NNP None
) ) None
, , None
and CC None
multiple JJ Other
electrode NN Other
aggregometry NN Other
high JJ Physical
on-treatment JJ Physical
platelet NN Physical
reactivity NN Physical
status NN Physical
. . None
P2Y NNP Physical
( ( Physical
12 CD Physical
) ) Physical
reactivity NN Physical
index NN Physical
vasodilator-stimulated JJ None
phosphoprotein NN None
phosphorylation NN None
14-day JJ Physical
P2Y NNP Physical
( ( Physical
12 CD Physical
) ) Physical
reactivity NN Physical
index NN Physical
assessment NN Physical
PD NNP Physical
measures NNS Physical
. . None
platelet NN Physical
inhibitory NN Physical
effects NNS Physical
-DOCSTART- -X- N

effectiveness NN Other
of IN Other
fennel NN Other
and CC Other
mefenamic JJ Other
acid NN Other
effectiveness NN Other
of IN Other
fennel NN Other
and CC Other
mefenamic JJ Other
acid NN Other
pain NN Pain
relief NN Pain
or CC Pain
pain NN Pain
decrease NN Pain
level NN Pain
of IN Pain
pain NN Pain
relief NN Pain
. . None
-DOCSTART- -X- N

efficacy NN Other
Response NNP Physical
, , Mortality
progression-free JJ Mortality
survival NN Mortality
( ( Mortality
PFS NNP Mortality
) ) Mortality
, , Mortality
and CC Mortality
overall JJ Mortality
survival NN Mortality
response NN Physical
rate NN Physical
disease-control JJ Physical
rate NN Physical
( ( Physical
response NN Physical
plus CC Physical
stable JJ Physical
disease NN Physical
) ) Physical
median JJ Mortality
PFS NNP Mortality
median JJ Mortality
overall JJ Mortality
survival NN Mortality
clinical JJ Physical
benefit NN Physical
-DOCSTART- -X- N

postoperative JJ Pain
pain NN Pain
scores NNS Pain
pain NN Pain
scores NNS Pain
pain NN Pain
scores NNS Pain
requirements NNS Pain
for IN Pain
supplemental JJ Pain
pain NN Pain
medications NNS Pain
incidence NN Adverse
of IN Adverse
postoperative JJ Adverse
vomiting NN Adverse
, , None
or CC None
length NN Other
of IN Other
time NN Other
spent VBN Other
in IN Other
the DT Other
recovery NN Other
room NN Other
. . None
-DOCSTART- -X- N

sputum NN Physical
cell NN Physical
differentials NNS Physical
airway RP Physical
eosinophilia NNS Physical
cell NN Physical
differentials NNS Physical
airway JJ Physical
response NN Physical
maximal JJ Physical
percent NN Physical
fall NN Physical
in IN Physical
FEV1 NNP Physical
from IN Physical
baseline NN Physical
percentage NN Physical
of IN Physical
sputum NN Physical
eosinophils NNS Physical
percentage NN Physical
of IN Physical
sputum NN Physical
eosinophils NNS Physical
between IN None
LTD4 NNP None
and CC None
methacholine NN None
eosinophilia VBP Physical
in IN Physical
sputum NN Physical
eosinophils NNS Physical
vigourous JJ Physical
airway NN Physical
narrowing VBG Physical
-DOCSTART- -X- N

pain NN Physical
behavioural JJ None
and CC None
physiological JJ None
observations NNS None
. . None
physiological JJ Physical
( ( Physical
heart NN Physical
rate NN Physical
and CC Physical
oxygen NN Physical
saturation NN Physical
) ) Physical
and CC Physical
behavioural JJ Physical
parameters NNS Physical
[ POS Physical
duration NN Physical
of IN Physical
crying VBG Physical
and CC Physical
modified VBN Physical
Neonatal NNP Physical
Facial NNP Physical
Coding NNP Physical
Scores NNP Physical
( ( Physical
NFCS NNP Physical
) ) Physical
] NN Physical
duration NN None
of IN None
crying NN None
mean JJ Physical
duration NN Physical
of IN Physical
crying VBG Physical
modified JJ None
NFCS NNP None
change NN Physical
in IN Physical
heart NN Physical
rate NN Physical
and CC Physical
oxygen NN Physical
saturation NN Physical
symptoms NNS Physical
-DOCSTART- -X- N

oxygen NN Physical
consumption NN Physical
( ( Physical
VO2 NNP Physical
) ) Physical
, , Physical
carbon NN Physical
dioxide NN Physical
production NN Physical
( ( Physical
VCO2 NNP Physical
) ) Physical
, , Physical
minute JJ Physical
ventilation NN Physical
( ( Physical
VE NNP Physical
) ) Physical
, , Physical
tidal JJ Physical
volume NN Physical
( ( Physical
VT NNP Physical
) ) Physical
, , None
respiratory JJ Physical
frequency NN Physical
( ( Physical
fR NN Physical
) ) Physical
, , Physical
inspiratory JJ Other
and CC Other
expiratory JJ Other
time NN Other
( ( Other
TI NNP Other
, , Other
TE NNP Other
) ) Other
and CC None
mean JJ Other
inspiratory NN Other
flow NN Other
( ( Other
VT/TI NNP Other
) ) Other
VE NNP Physical
, , None
VT NNP Physical
, , None
TI NNP Other
, , None
inspiratory JJ Physical
duty NN Physical
cycle NN Physical
( ( Other
TI/TTOT NNP Other
) ) Other
, , None
VCO2 NNP Physical
and CC None
VO2 NNP Physical
, , None
and CC None
a DT None
lower JJR Physical
fR NN Physical
VO2 NNP Physical
, , None
VCO2 NNP Physical
, , None
VE NNP Physical
, , None
VT NNP Physical
and CC None
VT/TI NNP Other
VO2 NNP Physical
ventilatory NN Physical
parameters NNS Physical
fR NN Physical
pedalling VBG Physical
rate NN Physical
on IN Physical
ventilatory NN Physical
and CC Physical
metabolic JJ Physical
parameters NNS Physical
pedalling VBG Other
rate NN Other
higher JJR Physical
breathing NN Physical
frequency NN Physical
, , None
( ( None
b NN None
) ) None
a DT Other
greater JJR Other
mechanical JJ Other
efficiency NN Other
, , None
and CC None
( ( None
c NN None
) ) None
lower JJR Other
ventilatory NN Other
equivalents NNS Other
of IN Other
O2 NNP Other
and CC Other
CO2 NNP Other
( ( Other
VE/VO2 NNP Other
and CC Other
VE/VCO2 NNP Other
) ) Other
-DOCSTART- -X- N

language NN Mental
abilities NNS Mental
caregivers NNS Other
' POS Other
knowledge NN Other
about IN Other
autism NN Other
perception NN Other
of IN Other
control NN Other
on IN Other
the DT Other
part NN Other
of IN Other
mothers NNS Other
parent NN Other
satisfaction NN Other
. . Other
-DOCSTART- -X- N

haemodynamic JJ Physical
state NN Physical
and CC Physical
cerebral JJ Physical
oxygen NN Physical
saturation NN Physical
hypotension NN Physical
, , Physical
risk NN Physical
of IN Physical
cerebral JJ Physical
hypoperfusion NN Physical
, , Physical
and CC Physical
cerebral JJ Physical
injury NN Physical
. . Physical
cerebral JJ Physical
perfusion NN Physical
postoperative JJ Physical
recovery NN Physical
mean JJ Physical
arterial JJ Physical
pressure NN Physical
, , Physical
cerebral JJ Physical
oxygen NN Physical
saturation NN Physical
, , Physical
middle JJ Physical
cerebral JJ Physical
artery NN Physical
velocity NN Physical
, , Physical
and CC Physical
cardiac JJ Physical
function NN Physical
using VBG Physical
transthoracic JJ Physical
echocardiography NN Physical
neurocognitive JJ Mental
function NN Mental
mean NN Physical
( ( Physical
SD NNP Physical
) ) Physical
cerebral JJ Physical
oxygen NN Physical
saturation NN Physical
level NN Physical
of IN Physical
cerebral JJ Physical
saturation NN Physical
upright NN Physical
Middle NNP Physical
cerebral JJ Physical
artery RB Physical
blood NN Physical
velocity NN Physical
hypotension NN Physical
systemic JJ Physical
vascular NN Physical
resistance NN Physical
cardiac JJ Physical
output NN Physical
. . Physical
postoperative JJ Mental
neurocognitive JJ Mental
dysfunction NN Mental
cerebral JJ Physical
desaturation NN Physical
Cerebral NNP Physical
oxygen IN Physical
saturation NN Physical
-DOCSTART- -X- N

Levels NNS Physical
of IN Physical
serum NN Physical
iron NN Physical
( ( Physical
Fe NNP Physical
) ) Physical
, , Physical
total JJ Physical
iron NN Physical
binding NN Physical
capacity NN Physical
( ( Physical
TIBC NNP Physical
) ) Physical
, , Physical
transferrin JJ Physical
saturation NN Physical
( ( Physical
TS NNP Physical
) ) Physical
, , Physical
serum JJ Physical
ferritin NN Physical
( ( Physical
SF NNP Physical
) ) Physical
, , Physical
transferrin NN Physical
( ( Physical
Tf NNP Physical
) ) Physical
, , Physical
soluble JJ Physical
transferrin NN Physical
receptor NN Physical
( ( Physical
sTfR NN Physical
) ) Physical
and CC Physical
blood NN Physical
routine JJ Physical
test NN Physical
, , Physical
as RB Physical
well RB Physical
as IN Physical
scoring NN Physical
of IN Physical
TCM NNP Physical
qi-blood JJ Physical
deficiency NN Physical
Syndrome NNP Physical
iron NN Physical
metabolism NN Physical
, , Physical
increase NN Physical
levels NNS Physical
of IN Physical
Fe NNP Physical
, , Physical
TS NNP Physical
, , Physical
SF NNP Physical
and CC Physical
reduce VB Physical
levels NNS Physical
of IN Physical
TIBC NNP Physical
, , Physical
Tf NNP Physical
, , Physical
sTfR NN Physical
total JJ Other
effective JJ Other
rate NN Other
-DOCSTART- -X- N

memory NN Mental
functioning NN Mental
, , Mental
psychomotor NN Mental
performance NN Mental
mood NN Mental
. . None
sedation NN Physical
memory NN Mental
and CC Mental
psychomotor NN Mental
performance NN Mental
tracking VBG Mental
performance NN Mental
divided VBN Physical
attention NN Physical
memory NN Physical
scanning NN Physical
: : None
word-learning JJ Mental
tests NNS Mental
and CC None
Sternberg NNP Mental
Memory NNP Mental
Scanning VBG Mental
Tests NNS Mental
laboratory JJ Other
test NN Other
performance NN Other
. . None
memory NN Mental
, , None
attention NN Mental
, , None
and CC None
tracking VBG Mental
performance NN Mental
divided JJ Mental
attention NN Mental
tracking NN Mental
-DOCSTART- -X- N

oxidized JJ Physical
regenerated VBN Physical
cellulose NN Physical
( ( Physical
ORC NNP Physical
) ) Physical
infection NN Physical
rate NN Physical
surgical JJ Physical
wound NN Physical
Microbial JJ Physical
contamination NN Physical
no DT None
cases NNS None
of IN None
wound NN Physical
dehiscence NN Physical
no DT Physical
clinically RB Physical
evident JJ Physical
superficial NN Physical
or CC Physical
deep JJ Physical
surgical JJ Physical
site NN Physical
infections NNS Physical
no DT Physical
or CC Physical
reduced VBN Physical
bacterial JJ Physical
contamination NN Physical
-DOCSTART- -X- N

oscillatory NN Physical
parameters NNS Physical
and CC Other
Raw NNP Physical
tc-PO2 NN Physical
and CC Other
Raw NNP Physical
greatest JJS None
change NN None
reactance NN None
Raw NNP Physical
and CC Other
FEV1 NNP Physical
. . Other
highest JJS None
values NNS None
reactance NN None
Raw NNP Physical
FEV1 NNP Physical
. . Other
variability NN None
reactance NN None
oscillatory JJ Physical
resistance NN Physical
and CC Other
Raw NNP Physical
. . Other
reactance NN None
-DOCSTART- -X- N

effectiveness NN Other
improved VBN None
in IN None
their PRP$ None
conceptual JJ None
ToM NNP None
skills NNS None
, , None
but CC None
their PRP$ None
elementary JJ None
understanding NN None
, , None
self PRP None
reported VBD None
empathic JJ None
skills NNS None
or CC None
parent NN None
reported VBN None
social JJ None
behaviour NN None
did VBD None
life NN None
mindreading VBG None
skills NNS None
-DOCSTART- -X- N

Efficacy NN Other
and CC Other
safety NN Other
disease NN Physical
response NN Physical
response NN Physical
rates NNS Physical
the DT None
overall JJ None
response NN None
rate NN None
[ NNP None
complete JJ None
clinical JJ None
response NN None
( ( None
CCR NNP None
) ) None
plus CC None
partial JJ None
response NN None
( ( None
PR NNP None
) ) None
] NN None
. . None
Total JJ None
UVA NNP None
doses NNS None
The DT None
safety NN None
profile NN None
was VBD None
acceptable JJ None
few JJ None
grade JJ None
3-4 JJ None
toxicities NNS None
observed VBN None
drop-outs NNS None
due JJ None
to TO None
toxicity NN None
were VBD None
best JJS None
overall JJ None
response NN None
( ( None
CCR NNP None
+ NNP None
PR NNP None
) ) None
rate NN None
The DT None
median JJ None
duration NN None
of IN None
response NN None
was VBD None
9?7 CD None
CCR NNP None
was VBD None
( ( None
CCR NNP None
22 CD None
% NN None
) ) None
combination NN None
therapy NN None
( ( None
CCR NNP None
31 CD None
% NN None
) ) None
. . None
CCR NNP None
was VBD None
sustained VBN None
sessions NNS None
needed VBD None
to TO None
achieve VB None
CCR NNP None
in IN None
the DT None
dose NN None
required VBN None
to TO None
achieve VB None
CCR NNP None
difference NN None
in IN None
response NN None
rate NN None
or CC None
response NN None
duration NN None
was VBD None
observed VBN None
fewer JJR None
PUVA NNP None
sessions NNS None
and CC None
lower JJR None
UVA NNP None
dose NN None
required VBN None
to TO None
achieve VB None
CCR NNP None
-DOCSTART- -X- N

hip NN Physical
or CC Physical
knee NN Physical
osteoarthritis NN Physical
. . None
daily JJ Physical
functioning VBG Physical
during IN Physical
the DT Physical
first JJ Physical
year NN Physical
after IN Physical
the DT Physical
treatment NN Physical
, , Physical
assessed VBN Physical
on IN Physical
the DT Physical
Health NNP Physical
Assessment NNP Physical
Questionnaire NNP Physical
. . None
health NN Other
related JJ Other
quality NN Other
of IN Other
life NN Other
, , Other
specific JJ Other
complaints NNS Other
, , None
fatigue NN Physical
, , None
and CC None
costs NNS Other
. . None
Illness NNP Mental
cognitions NNS Mental
, , None
global JJ Mental
perceived VBN Mental
effect NN Mental
and CC Mental
self-efficacy NN Mental
costs NNS Other
and CC None
effectiveness NN Other
-DOCSTART- -X- N

anaesthetic JJ Physical
consumption NN Physical
analgesic JJ Physical
requirements NNS Physical
. . Physical
duration NN Physical
of IN Physical
block NN Physical
, , Physical
sedation NN Physical
and CC Physical
analgesic JJ Physical
consumption NN Physical
Time NNP Pain
to TO Pain
first VB Pain
pain NN Pain
, , Pain
analgesic JJ Pain
request NN Pain
, , None
return NN Physical
of IN Physical
motor NN Physical
function NN Physical
, , None
visual JJ Pain
analogue NN Pain
pain NN Pain
and CC None
sedation NN Physical
scores NNS Physical
Vital JJ Physical
signs NNS Physical
time NN Pain
to TO Pain
analgesic VB Pain
need NN Pain
total JJ Pain
analgesic JJ Pain
consumption NN Pain
analgesic JJ Pain
consumption NN Pain
-DOCSTART- -X- N

lumbar NN Physical
spine NN Physical
bone NN Physical
mineral JJ Physical
density NN Physical
lumbar NN Physical
spine NN Physical
( ( Physical
LS NNP Physical
) ) Physical
bone NN Physical
mineral JJ Physical
density NN Physical
( ( Physical
BMD NNP Physical
) ) Physical
BMD NNP Physical
LS NNP Physical
BMD NNP Physical
increased VBD None
LS NNP None
BMD NNP None
versus NN None
increased VBD None
LS NNP None
BMD NNP None
increased VBD None
total JJ None
hip NN None
BMD NNP None
LS NNP None
BMD NNP None
significant JJ None
LS NNP None
BMD NNP None
increasing VBG None
LS NNP None
BMD NNP None
-DOCSTART- -X- N

24h CD Physical
substrate JJ Physical
oxidation NN Physical
. . None
24 CD Physical
h NN Physical
substrate JJ Physical
oxidation NN Physical
Substrate NNP Physical
oxidation NN Physical
24 CD Physical
h NN Physical
carbohydrate NN Physical
( ( Physical
CHO NNP Physical
) ) Physical
balances NNS Physical
fat JJ Physical
balances NNS Physical
shortage NN Physical
of IN Physical
70 CD Physical
g NN Physical
of IN Physical
CHO NNP Physical
fat JJ Physical
balance NN Physical
CHO NNP Physical
oxidation NN Physical
24h CD Physical
CHO NNP Physical
balance NN Physical
24 CD Physical
h NN Physical
substrate JJ Physical
utilization NN Physical
carbohydrate NN Physical
oxidation NN Physical
24 CD Physical
fat JJ Physical
oxidation NN Physical
. . None
-DOCSTART- -X- N

mortality NN Mortality
2-year JJ Mortality
mortality NN Mortality
-DOCSTART- -X- N

social JJ Mental
interaction NN Mental
skills NNS Mental
gains NNS Mental
in IN Mental
social JJ Mental
interaction NN Mental
skills NNS Mental
standard JJ Mental
language NN Mental
assessments NNS Mental
. . None
Initiation NN Mental
of IN Mental
joint JJ Mental
attention NN Mental
, , Mental
involvement NN Mental
, , Mental
and CC Mental
severity NN Mental
of IN Mental
language NN Mental
delay NN Mental
language NN Mental
skills NNS Mental
interaction NN Mental
skills NNS Mental
. . None
-DOCSTART- -X- N

problem NN Mental
behavior NN Mental
completed VBD Mental
more JJR Mental
academic JJ Mental
tasks NNS Mental
concept NN Pain
of IN Pain
illness NN Pain
and CC Pain
pain NN Pain
-DOCSTART- -X- N

inflammatory JJ Physical
changes NNS Physical
histopathology NN Physical
score NN Physical
gastric JJ Physical
lesions NNS Physical
. . Physical
histopathology NN Physical
scores NNS Physical
free JJ Physical
of IN Physical
infection NN Physical
. . Physical
regression NN Physical
in IN Physical
histopathology NN Physical
score NN Physical
H NNP Physical
pylori FW Physical
negative JJ Physical
time NN Physical
. . Physical
H NNP Physical
pylori JJ Physical
regression NN Physical
progression NN Physical
rate NN Physical
of IN Physical
healing NN Physical
of IN Physical
gastric JJ Physical
lesions NNS Physical
years NNS Adverse
free JJ Adverse
of IN Adverse
infection NN Adverse
Preneoplastic NNP Physical
gastric JJ Physical
lesions NNS Physical
H NNP None
pylori NN None
infection NN None
. . None
-DOCSTART- -X- N

number NN Other
of IN Other
intubations NNS Other
required VBN Other
to TO Other
achieve VB Other
an DT Other
appropriately RB Other
sized JJ Other
tube NN Other
need NN Other
to TO Other
use VB Other
more JJR Other
than IN Other
21.min-1 JJ Other
fresh JJ Other
gas NN Other
flow NN Other
concentration NN Physical
of IN Physical
nitrous JJ Physical
oxide NN Physical
in IN Physical
the DT Physical
operating NN Physical
room NN Physical
incidence NN Physical
of IN Physical
croup NN Physical
appropriate JJ None
appropriate JJ None
lungs NNS Physical
of IN None
patients NNS None
adequately RB Other
ventilated VBN Other
Ambient NNP Other
nitrous JJ Other
oxide IN Other
concentration NN Other
croup NN Physical
symptoms NNS Physical
appropriate JJ None
Advantages NNS Other
avoidance NN Other
of IN Other
repeated VBN Other
laryngoscopy NN Other
, , None
use NN Other
of IN Other
low JJ Other
fresh JJ Other
gas NN Other
flow NN Other
reduction NN Other
of IN Other
the DT Other
concentration NN Other
of IN Other
anesthetics NNS Other
detectable JJ Other
in IN Other
the DT Other
operating NN Other
room NN Other
. . None
-DOCSTART- -X- N

climacteric NN Physical
symptoms NNS Physical
, , None
gonadotrophin JJ Physical
release NN Physical
bone NN Physical
resorption NN Physical
reduction NN Physical
in IN Physical
symptoms NNS Physical
, , None
plasma JJ Physical
follicle NN Physical
stimulating VBG Physical
hormone NN Physical
concentration NN Physical
, , None
and CC None
urinary JJ Physical
calcium NN Physical
and CC Physical
hydroxyproline JJ Physical
excretion NN Physical
. . None
relation NN Physical
of IN Physical
the DT Physical
response NN Physical
to TO Physical
plasma VB Physical
oestradiol JJ Physical
values NNS Physical
side NN Adverse
effects NNS Adverse
additional JJ Other
benefit NN Other
. . None
-DOCSTART- -X- N

CTTH NNP Physical
score NN Physical
( ( Physical
including VBG Physical
the DT Physical
score NN Physical
of IN Physical
headache NN Physical
attack NN Physical
frequency NN Physical
and CC Physical
the DT Physical
score NN Physical
of IN Physical
headache NN Physical
severity NN Physical
) ) Physical
efficacy NN None
CTTH NNP Physical
score NN Physical
score NN Physical
in IN Physical
the DT Physical
sticking VBG Physical
needling VBG Physical
group NN Physical
effective JJ None
rate NN None
reducing VBG Pain
the DT Pain
pain NN Pain
attack NN Pain
frequency NN Pain
and CC Physical
severity NN Physical
of IN Physical
-DOCSTART- -X- N

controlling VBG Physical
intraocular JJ Physical
pressure NN Physical
drop NN Physical
in IN Physical
intraocular JJ Physical
pressure NN Physical
intraocular JJ Physical
pressure NN Physical
-DOCSTART- -X- N

3-fold JJ Physical
median JJ Physical
M-CSF NNP Physical
2-fold JJ Physical
CRP NNP Physical
11-dehydro-TXB JJ Physical
M-CSF NNP Physical
, , None
CRP NNP Physical
, , None
11-dehydro-TXB JJ Physical
2 CD Physical
, , None
and CC None
prothrombin NN Physical
fragments NNS Physical
1+2 CD Physical
remained VBD Physical
higher JJR Physical
-DOCSTART- -X- N

effectiveness NN Other
Effectiveness NNP Other
quality NN Other
of IN Other
care NN Other
clinical JJ Other
effectiveness NN Other
panic NN Mental
, , None
anxiety NN Mental
sensitivity NN Mental
, , None
depression NN Mental
, , None
and CC None
disability NN Mental
variables NNS Mental
Adequacy NNP Other
of IN Other
pharmacotherapy NN Other
algorithm NN Other
adequate NN Other
( ( Other
type NN Other
, , Other
dose NN Other
, , Other
duration NN Other
) ) Other
medication NN Other
adhere VB Physical
to TO Physical
this DT Physical
medication NN Physical
improved VBD Mental
anxiety NN Mental
, , None
depression NN Mental
, , None
and CC None
disability NN Mental
measures NNS Mental
effects NNS None
quality NN Other
of IN Other
care NN Other
and CC None
clinical JJ Other
and CC Other
functional JJ Other
outcomes NNS Other
quality NN Other
of IN Other
care NN Other
intensity NN Mental
-DOCSTART- -X- N

endothelial JJ Physical
function NN Physical
endothelial JJ Physical
function NN Physical
, , None
cardiovascular JJ Physical
biomarkers NNS Physical
, , None
and CC None
anthropometric JJ Physical
measures NNS Physical
change NN Physical
in IN Physical
FMD NNP Physical
changes NNS Physical
in IN Physical
plasma NN Physical
lipids NNS Physical
, , Physical
A1C NNP Physical
, , None
fasting VBG Physical
glucose NN Physical
, , None
insulin NN Physical
sensitivity NN Physical
, , None
and CC None
anthropometric JJ Physical
measures NNS Physical
. . None
Endothelial NNP Physical
function NN Physical
fasting VBG Physical
serum NN Physical
glucose NN Physical
and CC None
lowered VBD None
serum NN Physical
total JJ Physical
cholesterol NN Physical
and CC Physical
LDL NNP Physical
cholesterol NN Physical
anthropometric JJ Physical
measures NNS Physical
, , None
plasma NN Physical
A1C NNP Physical
, , None
and CC None
insulin JJ Physical
sensitivity NN Physical
. . None
cardiac JJ Physical
risk NN Physical
. . None
-DOCSTART- -X- N

5-year JJ Mortality
cause NN Mortality
specific JJ Mortality
survivals NNS Mortality
5-year JJ Mortality
survival NN Mortality
rates NNS Mortality
Five-year JJ Physical
local JJ Physical
failure NN Physical
rates NNS Physical
Moderate-to-severe JJ Physical
complications NNS Physical
bladder NN Physical
and CC Physical
rectal JJ Physical
complications NNS Physical
Severe JJ Physical
complications NNS Physical
dead JJ Mortality
statistically RB Mortality
significant JJ Mortality
differences NNS Mortality
between IN Mortality
2 CD Mortality
treatment NN Mortality
schedules NNS Mortality
in IN Mortality
survival NN Mortality
rates NNS Mortality
, , None
failure NN Other
patterns NNS Other
and CC None
complications NNS Physical
rates NNS Physical
. . None
-DOCSTART- -X- N

pulmonary JJ Other
function NN Other
tests NNS Other
rapid JJ Physical
bronchodilation NN Physical
duration NN Other
incidence NN Physical
of IN Physical
tremor NN Physical
Tachycardia NNP Physical
and CC Physical
palpitations NNS Physical
duration NN Other
of IN Other
action NN Other
-DOCSTART- -X- N

cytomegalovirus NN Physical
viremia NN Physical
number NN Physical
of IN Physical
samples NNS Physical
PCR NNP Physical
viremia NN Physical
and CC Physical
PCR NNP Physical
viruria NNS Physical
CMV NNP Physical
PCR NNP Physical
viremia NNP Physical
-DOCSTART- -X- N

analgesic JJ Pain
effects NNS Pain
analgesic JJ Pain
efficacy NN Pain
efficacy NN Other
reductions NNS Pain
in IN Pain
pain NN Pain
analgesic JJ Pain
efficacy NN Pain
efficacy NN None
well RB Other
tolerated VBN Other
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

severity NN Physical
duration NN Physical
of IN Physical
their PRP$ Physical
rhinorrhea JJ Physical
decline NN Other
in IN Other
severity NN Other
decline NN Physical
in IN Physical
duration NN Physical
of IN Physical
the DT Physical
rhinorrhea NN Physical
relief NN None
in IN None
both DT None
severity NN Physical
and CC Physical
duration NN Physical
of IN Physical
rhinorrhea NN Physical
Wilcoxon NNP Other
signed-rank JJ Other
test NN Other
highly RB None
significant JJ None
severity NN Physical
and CC Physical
duration NN Physical
of IN Physical
rhinorrhea NN Physical
quality NN Other
of IN Other
life NN Other
. . None
-DOCSTART- -X- N

chorea NN Physical
measures NNS Physical
of IN Physical
chorea NN Physical
( ( Physical
UHDRS NNP Physical
chorea NN Physical
score NN Physical
, , Physical
video JJ Physical
ratings NNS Physical
) ) Physical
chorea NN Physical
Voluntary JJ Physical
motor NN Physical
performance NN Physical
functional JJ Physical
disability NN Physical
drowsiness NN Adverse
, , Adverse
fatigue NN Adverse
, , Adverse
anticholinergic NN Adverse
symptoms NNS Adverse
, , Adverse
and CC Adverse
walking VBG Adverse
difficulties NNS Adverse
. . None
-DOCSTART- -X- N

increased VBD Physical
the DT Physical
occipital JJ Physical
P3 NNP Physical
component NN Physical
of IN Physical
the DT Physical
ERP NNP Physical
to TO Physical
visual JJ Physical
targets NNS Physical
, , None
( ( Physical
b NN Physical
) ) Physical
decreased VBD Physical
the DT Physical
occipital JJ Physical
P3 NNP Physical
component NN Physical
of IN Physical
the DT Physical
ERP NNP Physical
to TO Physical
auditory JJ Physical
targets NNS Physical
, , None
( ( Physical
c NN Physical
) ) Physical
did VBD Physical
not RB Physical
affect VB Physical
visual JJ Physical
and CC Physical
auditory JJ Physical
parietal JJ Physical
target NN Physical
P3 NNP Physical
components NNS Physical
, , None
and CC None
( ( None
d NN None
) ) None
also RB None
did VBD None
not RB None
affect VB None
the DT None
A/Pcz/300 NNP None
to TO None
auditory VB None
novel JJ None
stimuli NNS None
. . None
increased VBD Physical
the DT Physical
N1 NNP Physical
component NN Physical
of IN Physical
the DT Physical
ERP NNP Physical
to TO Physical
task-irrelevant JJ Physical
auditory NN Physical
stimuli NNS Physical
. . None
-DOCSTART- -X- N

Blood NNP Physical
plasma NN Physical
levels NNS Physical
roxithromycin JJ Physical
concentrations NNS Physical
blood NN Physical
plasma NN Physical
pharmacokinetics NNS Physical
roxithromycin NN Physical
concentrations NNS Physical
in IN Physical
gastric JJ Physical
juice NN Physical
gastric JJ Physical
tissue NN Physical
concentration NN Physical
of IN Physical
roxithromycin NN Physical
-DOCSTART- -X- N

positive JJ Other
proximal JJ Other
outcomes NNS Other
. . Other
Perceived NNP Other
responsibility NN Other
struggle NN Other
cooperation NN Mental
responsibility NN Mental
struggle NN Mental
cooperation NN Mental
responsibility NN Mental
, , Mental
struggle NN Mental
, , Mental
and CC Mental
cooperation NN Mental
-DOCSTART- -X- N

lexical JJ Mental
decision NN Mental
performance NN Mental
selective JJ Mental
performance NN Mental
deficits NNS Mental
classify VB Mental
words NNS Mental
as IN Mental
unpleasant JJ Mental
. . Mental
correctly VB Mental
classify VB Mental
neutral JJ Mental
words NNS Mental
explicit JJ Mental
misattribution NN Mental
of IN Mental
salience NN Mental
to TO Mental
neutral JJ Mental
stimuli NNS Mental
. . None
-DOCSTART- -X- N

renal JJ Physical
function NN Physical
, , Physical
hematuria NN Physical
, , Physical
proteinuria NN Physical
, , Physical
blood NN Physical
IgA NNP Physical
general JJ Other
effective JJ Other
rate NN Other
decreasing VBG Physical
hematuria NN Physical
, , Physical
proteinuria NN Physical
, , Physical
blood NN Physical
IgA NNP Physical
and CC Physical
improving VBG Physical
renal JJ Physical
function NN Physical
( ( Physical
P NNP Physical
-DOCSTART- -X- N

proportion NN Physical
of IN Physical
patients NNS Physical
with IN Physical
GI-2 NNP Physical
recovery NN Physical
and CC Physical
DCO NNP Physical
written VBN Physical
by IN Physical
each DT Physical
POD NNP Physical
GI-2 JJ Physical
recovery NN Physical
on IN Physical
or CC Physical
before IN Physical
POD NNP Physical
5 CD Physical
GI-2 NNP Physical
recovery NN Physical
-DOCSTART- -X- N

reduction NN Other
duration NN Physical
of IN Physical
clinical JJ Physical
symptoms NNS Physical
and CC Physical
duration NN Physical
of IN Physical
treatment NN Physical
-DOCSTART- -X- N

pulp NN None
vitality NN None
, , None
Adjusted VBN None
survival JJ None
rates NNS None
were VBD None
for IN None
pulp NN None
vitality NN None
to TO None
-DOCSTART- -X- N

dopamine JJ Other
type-2 JJ Other
receptor NN Other
( ( Other
DRD2 NNP Other
) ) Other
polymorphisms NNS Other
were VBD Other
genotyped VBN Other
. . Other
Baseline NNP Physical
prolactin NN Physical
levels NNS Physical
prolactin NN Physical
Prolactin NN Physical
levels NNS Physical
Prolactin NN Physical
levels NNS Physical
-DOCSTART- -X- N

LDL-cholesterol NNP Physical
plasma NN Physical
triacylglycerol NN Physical
. . None
triacylglycerol NN Physical
levels NNS Physical
. . None
plasma JJ Physical
LDL-cholesterol NNP Physical
, , None
triacylglycerol NN Physical
and CC None
total JJ Physical
ApoB NNP Physical
. . None
ApoB NNP None
pool NN None
sizes NNS None
of IN None
larger JJR None
triacylglycerol-rich JJ None
VLDL NNP None
particles NNS None
smaller JJR Physical
VLDL NNP Physical
particles NNS Physical
intermediate JJ Physical
density NN Physical
lipoprotein NN Physical
total JJ Physical
fractional JJ Physical
catabolic NN Physical
rate NN Physical
of IN Physical
VLDL1-ApoB NNP Physical
production NN Physical
rates NNS Physical
of IN Physical
VLDL2- NNP Physical
, , Physical
IDL- NNP Physical
or CC Physical
LDL- NNP Physical
VLDL1-ApoB NNP Physical
production NN Physical
rate NN Physical
side NN Adverse
effects NNS Adverse
LDL-ApoB JJ Physical
catabolism NN Physical
catabolism NN Physical
of IN Physical
triacylglycerol-rich JJ Physical
lipoproteins NNS Physical
catabolism NN Physical
of IN Physical
VLDL1-ApoB NNP Physical
VLDL2-ApoB NNP Physical
IDL-ApoB NNP Physical
VLDL1-ApoB NNP Physical
-DOCSTART- -X- N

disseminated JJ Physical
tumour NN Physical
cells NNS Physical
( ( Physical
DTCs NNP Physical
) ) Physical
detectable JJ Physical
DTCs NNP Physical
osteonecrosis NN Physical
-DOCSTART- -X- N

Detection NN None
sensitivity NN Other
, , Other
specificity NN Other
, , Other
and CC Other
accuracy NN Other
of IN Other
CT NNP Other
recurrent NN Physical
sensitivity NN Other
, , Other
specificity NN Other
, , Other
and CC Other
accuracy NN Other
of IN Other
Tc-MIBI NNP Other
SPECT NNP Other
sensitivity NN Other
, , Other
specificity NN Other
, , Other
and CC Other
accuracy NN Other
of IN Other
FDG-PET NNP Other
sensitivity NN Other
, , Other
specificity NN Other
, , Other
and CC Other
accuracy NN Other
recurrent NN Physical
or CC Physical
residual JJ Physical
NPC NNP Physical
accuracy NN Other
-DOCSTART- -X- N

onset NN Physical
of IN Physical
mean NN Physical
( ( Physical
+/- JJ Physical
SD NNP Physical
) ) Physical
time NN Physical
to TO Physical
90 CD Physical
% NN Physical
block NN Physical
and CC None
the DT None
onset JJ None
time NN None
succinylcholine NN Other
onset JJ Other
time NN Other
of IN Other
succinylcholine NN Other
at IN Other
the DT Other
adductor NN Other
pollicis NN Other
Clinical JJ Other
duration NN Other
at IN Other
the DT Other
adductor NN Other
pollicis NN Other
( ( Other
AMG NNP Other
) ) Other
onset NN Physical
of IN Physical
the DT Physical
-DOCSTART- -X- N

Symptom JJ Physical
relief NN Physical
urine JJ Physical
retention NN Physical
first RB Physical
stool JJ Physical
time NN Physical
, , Physical
wound IN Physical
healing VBG Physical
time NN Physical
, , None
mean JJ Other
hospital NN Other
stay NN Other
score NN Physical
of IN Physical
symptom NN Physical
symptom NN Physical
grade NN Physical
Decrements NNS Physical
of IN Physical
symptom NN Physical
grade NN Physical
urine JJ Physical
retention NN Physical
rate NN Physical
and CC None
mean JJ Other
hospital NN Other
stay NN Other
relieve VB Other
-DOCSTART- -X- N

impact NN None
Blood NNP Other
gas NN Other
analysis NN Other
and CC Other
spirometry NN Other
data NNS Other
Pao NNP Physical
( ( Physical
2 CD Physical
) ) Physical
values NNS Physical
Lung NNP Physical
compliance NN Physical
-DOCSTART- -X- N

efficacy NN Other
Aberrant NNP Other
Behavior NNP Other
Checklist-Community NNP Other
( ( Other
ABC-C NNP Other
) ) Other
Rating VBG Other
Scale NNP Other
( ( Physical
total JJ Physical
score NN Physical
) ) Physical
. . None
ABC-C JJ Other
Rating NNP Other
Scale NNP Other
scores VBZ Other
scores NNS Other
in IN Other
the DT Other
ABC-C NNP Other
Rating NNP Other
Scale NNP Other
-DOCSTART- -X- N

Remission NN Physical
in IN Physical
association NN Physical
of IN Physical
time NN Physical
to TO Physical
remission NN Physical
baseline JJ None
disease NN None
activity NN None
disease NN Physical
activity NN Physical
CDAI NNP Physical
remission NN Physical
and CC None
sustained VBN None
remission NN None
( ( None
similar JJ None
CDAI NNP None
remission NN None
rates NNS None
( ( None
39 CD None
methotrexate NN None
, , None
remission NN None
rates NNS None
were VBD None
respectively RB None
. . None
Remission NN None
occurred VBD None
differences NNS None
in IN None
compliance NN None
, , None
patient JJ None
populations NNS None
, , None
or CC None
sequence NN None
of IN None
combination NN None
therapy NN None
initiation NN None
. . None
Generally RB None
remission NN None
than IN None
scores NNS None
. . None
Continued VBN None
remission NN None
appeared VBD None
CONCLUSIONS NNP None
Remission NNP None
by IN None
remission NN None
. . None
Continued VBN None
remission NN None
may MD None
be VB None
-DOCSTART- -X- N

heart NN Physical
rate NN Physical
and CC None
forearm NN Physical
blood NN Physical
flow NN Physical
heart NN Physical
rate NN Physical
and CC None
forearm NN Physical
blood NN Physical
flow NN Physical
forearm NN Physical
blood NN Physical
flow NN Physical
heart NN Physical
rate NN Physical
response NN Physical
forearm NN Physical
blood NN Physical
flow NN Physical
. . None
heart NN Physical
rate NN Physical
responses NNS Physical
forearm NN Physical
blood NN Physical
flow NN Physical
responses NNS Physical
. . None
heart NN Physical
rate NN Physical
and CC Mental
forearm NN Physical
blood NN Physical
flow NN Physical
responses NNS Physical
. . None
forearm NN Physical
blood NN Physical
flow NN Physical
heart NN Physical
rate NN Physical
. . None
heart NN Physical
rate NN Physical
responses NNS Physical
forearm NN Physical
blood NN Physical
flow NN Physical
responses NNS Physical
. . None
forearm NN Physical
blood NN Physical
flow NN Physical
heart NN Physical
rate NN Physical
forearm JJ Physical
blood NN Physical
flow NN Physical
. . None
-DOCSTART- -X- N

deep JJ Physical
cervical JJ Physical
flexor NN Physical
endurance NN Physical
: : Physical
cervicogenic JJ Physical
headache NN Physical
mechanical JJ Physical
neck NN Physical
pain NN Physical
. . None
deep JJ Physical
cervical JJ Physical
muscle NN Physical
endurance NN Physical
. . None
deep JJ Physical
cervical JJ Physical
flexor NN Physical
muscle NN Physical
endurance NN Physical
Flexor NNP Physical
Endurance NNP Physical
Test NNP Physical
endurance NN Physical
of IN Physical
the DT Physical
deep JJ Physical
cervical JJ Physical
flexors NNS Physical
. . None
cervicogenic JJ Physical
headache NN Physical
and CC None
mechanical JJ Physical
neck NN Physical
pain NN Physical
. . None
-DOCSTART- -X- N

Skin NNP Physical
manifestations NNS Physical
of IN Physical
inhaled JJ Physical
corticosteroids NNS Physical
skin NN Adverse
bruising NN Adverse
( ( Physical
as RB Physical
well RB Physical
as IN Physical
other JJ Physical
cutaneous JJ Adverse
manifestations NNS Adverse
) ) Physical
easy JJ Physical
skin NN Physical
bruising NN Physical
and CC None
other JJ None
systemic JJ Physical
effects NNS Physical
of IN Physical
ICS NNP Physical
therapy NN Physical
adrenal JJ Adverse
suppression NN Adverse
and CC Physical
loss NN Adverse
of IN Adverse
bone JJ Adverse
mineral JJ Adverse
density NN Adverse
( ( Adverse
BMD NNP Adverse
) ) Physical
. . None
bruising NN Adverse
and/or NN Adverse
skin NN Adverse
rashes NNS Adverse
, , Adverse
slow JJ Adverse
healing NN Adverse
of IN Adverse
cuts NNS Adverse
or CC Adverse
sores NNS Adverse
, , Physical
or CC Physical
other JJ Physical
skin JJ Adverse
changes NNS Adverse
. . Physical
easy JJ Adverse
bruising NN Adverse
slow JJ Adverse
healing NN Adverse
of IN Adverse
skin NN Adverse
cuts NNS Adverse
or CC Adverse
sores NNS Adverse
risk NN Adverse
of IN Adverse
bruising VBG Adverse
. . Physical
skin JJ Adverse
bruising NN Adverse
suppression NN Adverse
of IN Adverse
adrenal JJ Adverse
function NN Adverse
or CC None
the DT None
loss NN Adverse
of IN Adverse
BMD NNP Adverse
easy JJ Adverse
bruising NN Adverse
and CC None
impairment NN Adverse
in IN Adverse
skin NN Adverse
healing NN Adverse
skin JJ Adverse
bruising NN Adverse
systemic JJ Adverse
toxicity NN Adverse
-DOCSTART- -X- N

HBeAg NNP Physical
in IN Physical
the DT Physical
serum NN Physical
. . Physical
effective JJ Other
HBV NNP Physical
replication NN Physical
indicators NNS Physical
of IN Physical
liver JJ Physical
disease NN Physical
-DOCSTART- -X- N

triglyceride/high-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
ratio NN Physical
Coronary NNP Physical
atheroma NN Physical
progression NN Physical
changes NNS Physical
in IN Physical
biochemical JJ Physical
parameters NNS Physical
, , None
percent JJ Physical
atheroma NN Physical
volume NN Physical
, , None
and CC None
total JJ Physical
atheroma NN Physical
volume NN Physical
high-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
( ( Physical
HDL-C NNP Physical
) ) Physical
glycated JJ Physical
hemoglobin NN Physical
, , Physical
triglycerides NNS Physical
, , Physical
and CC Physical
C-reactive JJ Physical
protein NN Physical
percent NN Physical
atheroma NN Physical
volume NN Physical
and CC Physical
triglycerides NNS Physical
triglyceride/HDL-C JJ Physical
ratio NN Physical
glycated VBD Physical
hemoglobin NN Physical
low-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
apolipoprotein RB Physical
B NNP Physical
apolipoprotein RB Physical
A-I NNP Physical
HDL-C NNP Physical
triglycerides NNS Physical
triglyceride/HDL-C JJ Physical
ratio NN Physical
glycated JJ Physical
hemoglobin NN Physical
triglyceride/HDL-C NN Physical
percent NN Physical
atheroma NN Physical
volume NN Physical
total JJ Physical
atheroma NN Physical
volume NN Physical
triglyceride/HDL-C JJ Physical
ratio NN Physical
atheroma NN Physical
progression NN Physical
-DOCSTART- -X- N

tolerance NN Other
and CC Other
effectiveness NN Other
daily JJ Physical
pain NN Physical
response NN Physical
was VBD Physical
assessed VBN Physical
using VBG Physical
a DT Physical
visual JJ Physical
analogue NN Physical
scale NN Physical
card NN Physical
mean JJ Pain
daily JJ Pain
pain NN Pain
scores NNS Pain
mean JJ Pain
individual JJ Pain
daily RB Pain
pain NN Pain
scores NNS Pain
pain RB Physical
pain RB None
Crossover NNP Other
and CC Other
multivariate NN Other
analyses NNS Other
Dose-limiting JJ Adverse
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

toxicity NN Physical
and CC None
survival NN Mortality
3 CD Mental
cycles NNS Mental
of IN Mental
adjuvant JJ Mental
therapy NN Mental
renal JJ Physical
toxicity NN Physical
, , None
leucopenia NN Physical
, , None
and CC None
anaemia NN Physical
thrombocytopenia NN Physical
3 CD Mortality
year NN Mortality
disease NN Mortality
free JJ Mortality
survival NN Mortality
rates NNS Mortality
3 CD Mortality
year NN Mortality
overall JJ Mortality
survival NN Mortality
rates NNS Mortality
tolerability NN Other
of IN Other
carboplatin NN Other
based VBN Other
regimen NNS Other
-DOCSTART- -X- N

misoprostol NN Physical
misoprostol NN Physical
peripheral JJ Physical
vascular JJ Physical
resistance NN Physical
leg NN Physical
blood NN Physical
flow NN Physical
volume NN Physical
and CC None
a DT None
corresponding JJ Physical
increase NN Physical
in IN Physical
leg JJ Physical
peripheral JJ Physical
vascular JJ Physical
resistance NN Physical
heart NN Physical
rate NN Physical
adverse JJ Physical
experiences NNS Physical
vasoconstrictive JJ Physical
or CC Physical
vasodilative JJ Physical
-DOCSTART- -X- N

effect NN Other
sizes NNS Other
Yale-Brown JJ Other
Obsessive NNP Other
Compulsive NNP Other
Scale NNP Other
) ) None
effectively RB Other
-DOCSTART- -X- N

blood NN Physical
count NN Physical
and CC Physical
differential JJ Physical
. . Physical
increase NN Physical
in IN Physical
the DT Physical
hematocrit NN Physical
hemoglobin NN Physical
levels NNS Physical
increased VBD Physical
platelet NN Physical
count NN Physical
increased VBD None
DE NNP Other
effect NN Other
WBC NNP Physical
, , Physical
neutrophils RB Physical
, , Physical
lymphocytes VBZ Physical
erythrocytes VBZ Physical
. . Physical
increases NNS Physical
in IN Physical
matrix JJ Physical
metalloproteinase-9 NN Physical
, , Physical
interleukins NNS Physical
( ( Physical
IL NNP Physical
) ) Physical
-1 NNP Physical
beta NN Physical
, , Physical
6 CD Physical
and CC Physical
10 CD Physical
E-selectin NNP Physical
, , Physical
intercellular JJ Physical
adhesion NN Physical
molecule-1 NN Physical
vascular JJ Physical
cell NN Physical
adhesion NN Physical
molecule NN Physical
-1 NNP Physical
myeloperoxidase VB Physical
22 CD Physical
hemoconcentration NN Physical
and CC Physical
thrombocytosis NN Physical
-DOCSTART- -X- N

the DT None
erythrocyte JJ None
proportion NN None
of IN None
EPA NNP None
( ( None
the DT None
omega-3 JJ None
index NN None
( ( None
increased VBD None
erythrocyte JJ None
DHA NNP None
( ( None
and CC None
EPA NNP None
( ( None
The DT None
omega-3 JJ None
index NN None
increased VBD None
increase VB None
erythrocyte NN None
EPA NNP None
or CC None
the DT None
omega-3 JJ None
index NN None
. . None
plasma NN None
uric JJ None
acid NN None
or CC None
antioxidant JJ None
capacity NN None
in IN None
groups NNS None
. . None
Plasma NNP None
malondialdehyde NN None
( ( None
MDA NNP None
) ) None
increased VBD None
decreased VBD None
erythrocyte JJ None
linoleic NN None
acid NN None
hydroperoxides NNS None
but CC None
their PRP$ None
MDA NNP None
concentrations NNS None
. . None
enhanced JJ None
incorporation NN None
of IN None
EPA NNP None
and CC None
DHA NNP None
into IN None
-DOCSTART- -X- N

heart NN Physical
rate NN Physical
and CC Physical
mean VB Physical
arterial JJ Physical
pressure NN Physical
, , None
oxygen NN Physical
saturation NN Physical
, , None
visual JJ Physical
analogue NN Physical
score NN Physical
( ( Physical
VAS NNP Physical
) ) Physical
, , Physical
verbal JJ Physical
rating NN Physical
scale NN Physical
( ( Physical
VRS NNP Physical
) ) Physical
, , None
rescue NN Other
analgesic JJ Other
requirements NNS Other
, , None
total JJ Other
opioid JJ Other
consumption NN Other
demographic JJ Physical
data NNS Physical
, , Physical
mean JJ Physical
arterial JJ Physical
pressure NN Physical
, , Physical
heart NN Physical
rate NN Physical
or CC Physical
oxygen NN Physical
saturation NN Physical
area NN Physical
under IN Physical
the DT Physical
curve NN Physical
VAS NNP Physical
and CC Physical
VRS NNP Physical
scores NNS Physical
rescue NN Physical
analgesic JJ Physical
requirement NN Physical
and CC Physical
the DT Physical
total JJ Physical
opioid JJ Physical
consumption NN Physical
time NN Other
to TO Other
first JJ Other
mobilisation NN Other
and CC None
the DT None
Likert NNP None
score NN None
block NN Other
onset VBD Other
time NN Other
-DOCSTART- -X- N

Effectiveness NN Other
active JJ Physical
androgen NN Physical
level NN Physical
efficacy NN Other
Efficacy NN Other
facial JJ Physical
acne JJ Physical
lesion NN Physical
counts NNS Physical
global JJ Physical
assessment NN Physical
subject NN Other
's POS Other
self-assessment NN Other
within-cycle JJ Physical
variation NN Physical
( ( Physical
cycle NN Physical
6 CD Physical
) ) Physical
in IN Physical
lesion NN Physical
counts NNS Physical
. . Physical
improvement NN Physical
mean JJ Physical
decrease NN Physical
in IN Physical
inflammatory JJ Physical
lesion NN Physical
count NN Physical
mean JJ Physical
decrease NN Physical
in IN Physical
total JJ Physical
lesion NN Physical
count NN Physical
investigator NN Physical
's POS Physical
global JJ Physical
assessment NN Physical
secondary JJ Physical
efficacy NN Physical
measures NNS Physical
( ( Physical
total JJ Physical
comedones NNS Physical
, , Physical
open JJ Physical
comedones NNS Physical
, , Physical
closed VBD Physical
comedones NNS Physical
, , Physical
papules NNS Physical
, , Physical
pustules NNS Physical
, , Physical
and CC Physical
the DT Physical
subject NN Physical
's POS Physical
self-assessment NN Physical
of IN Physical
study NN Physical
treatment NN Physical
) ) Physical
safe JJ Other
and CC Other
effective JJ Other
treatment NN Other
of IN Other
moderate JJ Other
acne NNS Other
vulgaris VBP Other
-DOCSTART- -X- N

brain NN Physical
regions NNS Physical
sensitive VBP Physical
to TO Physical
musical JJ Physical
structure NN Physical
scrambling NN Other
of IN Other
both DT Other
pitch NN Other
and CC Other
rhythmic JJ Other
structure NN Other
high-level JJ Other
linguistic JJ Other
structure NN Other
. . None
representations NNS Other
of IN Other
musical JJ Other
structure NN Other
-DOCSTART- -X- N

Progression-free NNP None
survival NN None
, , None
the DT None
primary JJ None
including VBG None
overall JJ None
survival NN None
, , None
response NN None
rate NN None
, , None
and CC None
safety/toxicity NN None
, , None
were VBD None
assessed VBN None
) ) None
. . None
Median JJ None
overall JJ None
survival NN None
time NN None
was VBD None
9.1 CD None
achieved VBN None
tumor NN None
regression NN None
, , None
with IN None
-DOCSTART- -X- N

Quality NN Other
of IN Other
life NN Other
standardized JJ Other
rhinoconjunctivitis NN Other
quality NN Other
of IN Other
life NN Other
questionnaire NN Other
( ( Other
RQLQ NNP Other
( ( Other
S NNP Other
) ) Other
) ) Other
; : Other
RQLQ NNP Other
( ( Other
S NNP Other
) ) Other
score NN Other
RQLQ NNP Other
( ( Other
S NNP Other
) ) Other
domains VBZ Other
. . None
RQLQ NNP Other
( ( Other
S NNP Other
) ) Other
rhinoconjunctivitis NN Physical
quality NN Physical
of IN Physical
life NN Physical
increased VBD None
-DOCSTART- -X- N

cognitive JJ Mental
function NN Mental
postprocedure NN Mental
cognitive JJ Mental
function NN Mental
Telephone NNP Mental
Interview NNP Mental
of IN Mental
Cognitive NNP Mental
Status NNP Mental
( ( Mental
TICS NNP Mental
) ) Mental
. . None
mean JJ Mental
TICS NNP Mental
score NN Mental
mean JJ Mental
TICS NNP Mental
score NN Mental
mean JJ Mental
TICS NNP Mental
score NN Mental
postprocedure NN Mental
cognitive JJ Mental
function NN Mental
. . None
number NN Other
of IN Other
jaw JJ Other
lift NN Other
interventions NNS Other
-DOCSTART- -X- N

cost-effectiveness NN Other
of IN Other
realtime NN Other
teledermatology NN Other
clinical JJ Physical
outcomes NNS Physical
consultation NN Other
similar JJ None
-- : None
almost RB None
observed JJ Other
marginal JJ Other
cost NN Other
per IN Other
patient NN Other
observed JJ Other
marginal JJ Other
cost NN Other
total JJ Other
observed JJ Other
costs NNS Other
teledermatology NN None
average JJ Other
costs NNS Other
-DOCSTART- -X- N

clinical JJ Physical
condition NN Physical
oxidative JJ Physical
stress NN Physical
NO NNP Physical
metabolites NNS Physical
, , None
NADPH NNP Physical
-- : Physical
diaphorase NN Physical
( ( Physical
eNOS NN Physical
) ) Physical
nitrite JJ Physical
reductase NN Physical
( ( Physical
iNOS NN Physical
) ) Physical
and CC None
peroxinitrite JJ Physical
( ( Physical
ONOO NNP Physical
) ) Physical
brain NN Physical
natriuretic JJ Physical
peptide NN Physical
in IN Physical
blood NN Physical
plazma NN Physical
. . None
oxidative JJ Physical
stress NN Physical
level NN Physical
of IN Physical
NT-pro NNP Physical
BNP NNP Physical
-DOCSTART- -X- N

Tumors NNPS Adverse
cleared VBD Adverse
or CC Adverse
the DT Adverse
target NN Adverse
tumor NN Adverse
area NN Adverse
Confocal JJ None
microscopy NN None
assessments NNS None
excision NN Physical
results NNS Physical
-DOCSTART- -X- N

body NN Physical
weight NN Physical
, , Physical
menstrual JJ Physical
function NN Physical
, , Physical
and CC Physical
ratings NNS Physical
on IN Physical
the DT Physical
Morgan NNP Physical
and CC Physical
Russell NNP Physical
scales NNS Physical
. . Physical
Family NNP Physical
therapy NN Physical
was VBD Physical
found VBN Physical
to TO Physical
be VB Physical
more RBR Physical
effective JJ Physical
than IN Physical
individual JJ Physical
therapy NN Physical
-DOCSTART- -X- N

. . None
duration NN Other
and CC Other
intensity NN Other
of IN Other
attacks NNS Other
, , None
working VBG Physical
ability NN Physical
, , Physical
vigilance NN Physical
, , None
and CC None
overall JJ Other
evaluation NN Other
of IN Other
the DT Other
drugs NNS Other
-DOCSTART- -X- N

severe JJ Adverse
adverse JJ Adverse
effects NNS Adverse
mean JJ Physical
pupillary JJ Physical
diameter NN Physical
mydriasis NN Physical
mydriasis NN Physical
mean JJ Physical
heart NN Physical
rate NN Physical
or CC None
systolic NN Physical
and CC None
diastolic JJ Physical
blood NN Physical
pressure NN Physical
-DOCSTART- -X- N

Samples NNS None
of IN None
vastus NN None
lateralis NNS None
muscle NN None
PGC-1alpha NNP Physical
and CC Physical
COX5B NNP Physical
PGC-1alpha NNP Physical
and CC Physical
MT-CO2 NNP Physical
-DOCSTART- -X- N

Cosmesis NN Physical
infection NN Adverse
, , None
dehiscence NN Adverse
, , None
pain NN Pain
, , None
closure NN Physical
time NN Physical
, , Physical
and CC None
other JJ Adverse
adverse JJ Adverse
events NNS Adverse
. . None
Cosmesis NNP Physical
scores NNS Physical
Rates NNS Adverse
of IN Adverse
infection NN Adverse
, , Physical
dehiscence NN Physical
, , None
and CC None
other JJ None
adverse JJ Adverse
events NNS Adverse
Closure NN Pain
time NN Pain
and CC Pain
pain NN Pain
scores NNS Pain
cosmesis NN Other
and CC Other
safety NN Other
profile NN Other
-DOCSTART- -X- N

effect NN Other
ANC NNP Physical
total JJ Physical
white JJ Physical
blood NN Physical
cell NN Physical
( ( Physical
WBC NNP Physical
) ) Physical
count NN Physical
. . None
Neutrophils NNP Physical
and CC Physical
eosinophils NNS Physical
increase NN Physical
in IN Physical
WBC NNP Physical
WBC NNP Physical
Viral JJ Physical
replication NN Physical
human JJ Physical
immunodeficiency NN Physical
virus NN Physical
( ( Physical
HIV NNP Physical
) ) Physical
p24 NN Physical
antigen NN Physical
( ( Physical
Ag NNP Physical
) ) Physical
ability NN Other
to TO Other
culture NN Other
virus NN Other
-DOCSTART- -X- N

heart NN Physical
rate NN Physical
heart NN Physical
rates NNS Physical
higher JJR None
ECG NNP Physical
signs NNS Physical
of IN Physical
ischaemia NN Physical
severe JJ Physical
hypotension NN Physical
associated VBN Physical
with IN Physical
tachycardia NN Physical
. . None
SVR NNP Physical
MAP NNP Physical
well RB Other
tolerated VBN Other
; : None
severe JJ Physical
hypotension NN Physical
. . None
MAP NNP Physical
overall JJ Physical
haemodynamic JJ Physical
course NN Physical
stable JJ Physical
haemodynamics NNS Physical
tachycardic JJ Physical
elevations NNS Physical
in IN Physical
diastolic JJ Physical
and CC Physical
mean JJ Physical
arterial NN Physical
pressures NNS Physical
PCWP NNP Physical
; : None
mean JJ Physical
PA NNP Physical
pressures NNS Physical
and CC None
CVP NNP Physical
increased VBN Other
. . None
-DOCSTART- -X- N

blood NN Physical
loss NN Physical
and CC None
range NN Physical
of IN Physical
motion NN Physical
blood NN Physical
loss NN Physical
and CC None
range NN Physical
of IN Physical
motion NN Physical
fully RB None
. . None
Perioperative JJ None
blood NN None
loss NN None
, , None
hidden JJ None
blood NN None
loss NN None
, , None
knee NN None
swelling NN None
, , None
ecchymosis NN None
, , None
analgesia NN None
requirements NNS None
, , None
range NN None
of IN None
motion NN None
( ( None
ROM NNP None
) ) None
, , None
fixed VBN None
flexion NN None
deformity NN None
( ( None
FFD NNP None
) ) None
, , None
straight-leg JJ None
raising VBG None
action NN None
, , None
and CC None
postoperative JJ None
complications NNS None
within IN None
6 CD None
weeks NNS None
of IN None
surgery NN None
were VBD None
The DT None
postoperative JJ None
hidden JJ None
blood NN None
loss NN None
, , None
knee NN None
swelling NN None
, , None
and CC None
scope NN None
of IN None
ecchymosis NN None
were VBD None
and CC None
ROM NNP None
and CC None
straight-leg JJ None
raising VBG None
action NN None
were VBD None
perioperative JJ None
blood NN None
loss NN None
, , None
the DT None
amount NN None
of IN None
morphine NN None
used VBN None
, , None
or CC None
FFD NNP None
in IN None
ROM NNP None
and CC None
FFD NNP None
at IN None
6 CD None
weeks NNS None
postoperatively RB None
mitigate VB None
knee NN None
swelling VBG None
and CC None
other JJ None
beneficial JJ None
results NNS None
during IN None
-DOCSTART- -X- N

design NN None
. . None
Fridericia NNP None
's POS None
formula NN None
( ( None
QTcF NNP None
= NNP None
QT/RR NNP None
( ( None
0.33 CD None
) ) None
) ) None
was VBD None
used VBN None
for IN None
QT-interval JJ None
correction NN None
. . None
The DT None
mean JJ None
QTcF NNP None
was VBD None
mean JJ None
QTcF NNP None
-DOCSTART- -X- N

QT NNP Physical
interval NN Physical
corrected VBD Physical
for IN Physical
heart NN Physical
rate NN Physical
( ( Physical
QTc NNP Physical
) ) Physical
QTcI NNP Physical
duration NN Physical
cardiac JJ Physical
repolarization NN Physical
. . Physical
heart NN Physical
rate NN Physical
, , None
PR NNP Physical
, , None
or CC None
QRS NNP Physical
interval JJ Physical
duration NN Physical
. . Physical
QTcI NNP Physical
QTc NNP Physical
at IN Physical
Cmax NNP Physical
adverse JJ Adverse
events NNS Adverse
( ( Adverse
AEs NNP Adverse
) ) Adverse
AEs NNP Adverse
cardiac JJ Physical
repolarization NN Physical
, , None
heart NN Physical
rate NN Physical
, , None
PR NNP Physical
or CC None
QRS NNP Physical
interval JJ Physical
duration NN Physical
, , None
or CC None
ECG NNP Physical
morphology NN Physical
-DOCSTART- -X- N

caloric JJ Physical
intake NN Physical
weight JJ Physical
gain NN Physical
caloric JJ Physical
intake NN Physical
and CC None
weight JJ Physical
gain NN Physical
. . None
percentage NN Physical
of IN Physical
the DT Physical
estimated VBN Physical
energy NN Physical
requirement NN Physical
and CC Physical
body NN Physical
mass NN Physical
index NN Physical
z VBD Physical
score NN Physical
. . None
caloric JJ Physical
intake NN Physical
percentage NN Physical
of IN Physical
the DT Physical
estimated VBN Physical
energy NN Physical
requirement NN Physical
weight JJ Physical
gain NN Physical
body NN Physical
mass NN Physical
index NN Physical
z NN Physical
score NN Physical
energy NN Physical
requirement NN Physical
-DOCSTART- -X- N

self-esteem NN Mental
alcoholics NNS Mental
' POS Mental
self-esteem NN Mental
. . None
Tennessee NNP Mental
Self-Concept NNP Mental
Scale NNP Mental
( ( Mental
TSCS NNP Mental
) ) Mental
TSCS NNP Mental
scales NNS Mental
Moral-Ethical JJ Mental
scale NN Mental
altruistic JJ Mental
( ( Mental
moral JJ Mental
) ) Mental
behavior NN Mental
-DOCSTART- -X- N

Aberrant NNP Mental
Behaviour NNP Mental
Checklist-Community NNP Mental
( ( Mental
ABC-C NNP Mental
) ) None
Childhood NNP Mental
Autism NNP Mental
Rating NNP Mental
Scale NNP Mental
( ( Mental
relating VBG Mental
to TO Mental
people NNS Mental
and CC Mental
verbal JJ Mental
communication NN Mental
) ) None
ABC-C NNP Mental
and CC Mental
the DT Mental
Childhood NNP Mental
Autism NNP Mental
Rating NNP Mental
Scale NNP Mental
scores VBZ Mental
behaviour NN None
extrapyramidal NN Physical
symptoms NNS Physical
frequency NN Adverse
of IN Adverse
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

glucose JJ Physical
counterregulation NN Physical
counterregulatory NN Physical
defects NNS Physical
counterregulatory NN Physical
and CC Physical
cardiovascular JJ Physical
responses NNS Physical
. . None
growth NN Physical
hormone NN Physical
, , Physical
symptoms NNS Physical
, , Physical
heart NN Physical
rate NN Physical
, , Physical
and CC Physical
pulse JJ Physical
pressure NN Physical
induced VBD Physical
sweating VBG Physical
at IN Physical
higher JJR Physical
plasma NN Physical
glucose NN Physical
levels NNS Physical
reduced VBD Physical
exogenous JJ Physical
glucose NN Physical
requirements NNS Physical
cardiovascular NN Physical
, , Physical
metabolic NN Physical
, , Physical
and CC Physical
symptom JJ Physical
responses NNS Physical
-DOCSTART- -X- N

pancreatitis NN Physical
Post-ERCP NNP Physical
pancreatitis NN Physical
severity NN Adverse
of IN Adverse
immediate JJ Adverse
bleeding NN Adverse
, , Adverse
as IN None
graded VBN None
by IN None
a DT None
3-point JJ None
scale NN None
from IN None
1 CD None
( ( None
no DT None
bleeding NN None
) ) None
to TO None
3 CD None
( ( None
injection NN None
or CC None
balloon NN Other
tamponade JJ None
therapy NN None
required VBN None
to TO None
stop VB None
bleeding NN None
) ) None
and CC None
evidence NN Adverse
of IN Adverse
delayed JJ Adverse
bleeding VBG Adverse
24 CD None
hours NNS None
after IN None
ERCP NNP None
. . None
post-ERCP JJ Physical
pancreatitis NN Physical
pancreatitis NN Physical
delayed VBN Physical
bleeding NN Physical
minor JJ Adverse
bleeding NN Adverse
episodes NNS Adverse
Delayed NNP Adverse
episodes IN Adverse
of IN Adverse
bleeding VBG Adverse
-DOCSTART- -X- N

airway RB None
leak JJ None
pressure NN None
, , None
ease NN None
and CC None
time NN None
for IN None
insertion NN None
, , None
fibreoptic JJ None
examination NN None
, , None
incidence NN None
of IN None
gastric JJ None
insufflation NN None
and CC None
complications NNS None
. . None
Median JJ None
range NN None
] NNP None
) ) None
time NN None
to TO None
successful JJ None
device NN None
placement NN None
was VBD None
initial JJ None
airway NN None
leak NN None
pressures NNS None
( ( None
16 CD None
airway NN None
leak NN None
pressures NNS None
at IN None
p=0.81 NN None
) ) None
; : None
fibreoptic JJ None
position NN None
, , None
incidence NN None
of IN None
gastric JJ None
insufflation NN None
, , None
or CC None
complications NNS None
. . None
Both DT None
provided VBD None
effective JJ None
ventilation NN None
without IN None
the DT None
need NN None
for IN None
airway JJ None
manipulation NN None
. . None
The DT None
-DOCSTART- -X- N

serum NN Physical
lipids NNS Physical
systolic JJ Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressures NNS Physical
. . Physical
serum NN Physical
lipids NNS Physical
, , Physical
apolipoproteins NNS Physical
, , Physical
lipoproteins VBZ Physical
or CC Physical
atherosclerotic JJ Physical
indices NNS Physical
no DT Other
significant JJ Other
inter-group JJ Other
differences NNS Other
. . Other
serious JJ Adverse
side NN Adverse
effects NNS Adverse
or CC Adverse
abnormal JJ Adverse
laboratory NN Adverse
tests NNS Adverse
adverse JJ Adverse
effect NN Adverse
-DOCSTART- -X- N

Physical JJ Physical
findings NNS Physical
and CC Physical
symptoms NNS Physical
lumbar JJS Physical
spine NN Physical
bone NN Physical
mineral JJ Physical
density NN Physical
Symptom NNP Physical
and CC Physical
pelvic JJ Physical
examination NN Physical
scores NNS Physical
endometriosis NN Physical
scores NNS Physical
Mean NNP Physical
bone JJ Physical
mineral NN Physical
density NN Physical
values NNS Physical
loss NN Physical
in IN Physical
bone NN Physical
density NN Physical
pain NN Pain
relief NN Pain
bone JJ Physical
mineral JJ Physical
density NN Physical
-DOCSTART- -X- N

concreteness JJ Mental
effects NNS Mental
in IN Mental
concreteness NN Mental
effects NNS Mental
in IN Mental
memory NN Mental
for IN Mental
text JJ Mental
concreteness NN Mental
effects NNS Mental
-DOCSTART- -X- N

systemic JJ Physical
hypertension NN Physical
. . None
likelihood NN Physical
of IN Physical
hypertension NN Physical
reported VBD Other
readings NNS Other
and CC Other
lower JJR Other
accuracy NN Other
. . None
-DOCSTART- -X- N

Mini-Mental JJ Mental
State NNP Mental
Examination NNP Mental
Geriatric NNP Mental
Depression NNP Mental
Scale NNP Mental
cognitive JJ Mental
performance NN Mental
. . None
reliability NN Other
. . None
cognitive JJ Mental
functions NNS Mental
-DOCSTART- -X- N

safety NN Physical
, , None
immunogenicity NN Physical
, , None
and CC None
pharmacokinetic JJ Physical
profile NN Physical
safety NN Other
and CC None
pharmacokinetics NNS Other
( ( None
serum JJ Other
concentrations NNS Other
of IN Other
rabies NNS Other
antibodies NNS Other
) ) None
pharmacokinetic JJ Physical
parameters NNS Physical
relative JJ Other
bioavailability NN Other
absorption NN Physical
rates NNS Physical
antibody NN Physical
level NN Physical
geometric JJ Physical
mean NN Physical
titer NN Physical
( ( Physical
GMT NNP Physical
) ) Physical
values NNS Physical
evolution NN Physical
of IN Physical
GMT NNP Physical
values NNS Physical
safety NN Physical
evaluation NN Physical
serum NN Other
samples NNS Other
for IN Other
anti-rabies NNS Other
antibody JJ Other
titration NN Other
serious JJ Adverse
reactions NNS Adverse
immediate JJ Adverse
( ( Adverse
anaphylactic JJ Adverse
type NN Adverse
) ) Adverse
or CC Adverse
delayed VBN Adverse
( ( Adverse
serum JJ Adverse
sickness NN Adverse
) ) Adverse
allergic NN Adverse
reactions NNS Adverse
GMT NNP Physical
profiles NNS Physical
protective JJ Physical
antibody NN Physical
titers NNS Physical
GMT NNP Physical
values NNS Physical
antibody NN Other
responses NNS Other
-DOCSTART- -X- N

-DOCSTART- -X- N

cardiac JJ Physical
output NN Physical
( ( Physical
CO NNP Physical
) ) Physical
CO NNP Physical
Mean NNP Physical
cardiac JJ Physical
output NN Physical
hypoxemia NN Physical
heart NN Physical
rate NN Physical
. . None
cardiac JJ Physical
output NN Physical
-DOCSTART- -X- N

total JJ Physical
triiodothyronine NN Physical
( ( Physical
TT3 NNP Physical
) ) Physical
, , Physical
total JJ Physical
thyroxine NN Physical
( ( Physical
TT4 NNP Physical
) ) Physical
, , Physical
free JJ Physical
T3 NNP Physical
( ( Physical
FT3 NNP Physical
) ) Physical
, , Physical
free JJ Physical
T4 NNP Physical
( ( Physical
FT4 NNP Physical
) ) Physical
, , Physical
thyroxine JJ Physical
receptor NN Physical
antibody NN Physical
( ( Physical
TRAb NNP Physical
) ) Physical
, , Physical
supersensitive JJ Physical
thyrotropin NN Physical
( ( Physical
S-TSH NNP Physical
) ) Physical
serum NN Physical
TT3 NNP Physical
, , Physical
TT4 NNP Physical
, , Physical
FT3 NNP Physical
, , Physical
FT4 NNP Physical
and CC Physical
S-TSH NNP Physical
contents NNS Physical
TT3 NNP Physical
, , Physical
FT3 NNP Physical
, , Physical
TRAb NNP Physical
TT4 NNP Physical
, , Physical
FT4 NNP Physical
and CC Physical
increase NN Physical
of IN Physical
S-TSH NNP Physical
-DOCSTART- -X- N

Pain NNP Pain
relief NN Pain
peak JJ Physical
expiratory NN Physical
flow NN Physical
rate NN Physical
-- : Physical
a DT Physical
Total JJ Physical
intramuscular JJ Physical
analgesic NN Physical
requirements NNS Physical
in IN Physical
the DT Physical
first JJ Physical
24 CD Physical
hours NNS Physical
, , Physical
time NN Physical
to TO Physical
satisfactory VB Physical
transfer NN Physical
to TO Physical
oral JJ Physical
analgesia NN Physical
, , Physical
antiemetic JJ Physical
requirements NNS Physical
and CC None
length NN Other
of IN Other
stay NN Other
in IN Other
hospital NN Other
postoperatively RB Other
Peak NNP Physical
expiratory JJ Physical
flow NN Physical
rate NN Physical
was VBD Physical
compared VBN Physical
pre- JJ Physical
and CC Physical
postoperatively RB Physical
postoperative JJ Adverse
nausea NN Adverse
and CC Adverse
vomiting NN Adverse
peak NN Physical
expiratory NN Physical
flow NN Physical
rate NN Physical
. . None
-DOCSTART- -X- N

self-initiated JJ Mental
questions NNS Mental
self-initiated JJ Mental
questions NNS Mental
-DOCSTART- -X- N

toxicity NN Adverse
and CC Other
tolerance NN Other
dose JJ Other
level NN Other
tolerable JJ Other
grade JJ Adverse
3/4 CD Adverse
toxicity NN Adverse
. . Adverse
tolerated VBN Other
mild-to-moderate JJ Adverse
constitutional JJ Adverse
symptoms NNS Adverse
. . None
Grade VB Adverse
3/4 CD Adverse
toxicity NN Adverse
Interleukin-2 NNP Adverse
dose JJ Adverse
reductions NNS Adverse
toxicity NN Adverse
. . Adverse
relapse NN Adverse
died VBN Mortality
Median JJ Mortality
survival NN Mortality
3-year JJ Mortality
disease-free JJ Mortality
survival NN Mortality
rate NN Mortality
Median JJ Mortality
overall JJ Mortality
survival NN Mortality
3-year JJ Mortality
survival NN Mortality
rate NN Mortality
disease-free JJ Mortality
survival NN Mortality
or CC Mortality
3-year JJ Mortality
survival NN Mortality
tolerated VBN Other
clinical JJ Other
efficacy NN Other
and CC Other
favorable JJ Other
toxicity NN Other
-DOCSTART- -X- N

Mold NNP Other
was VBD Other
visible JJ Other
water NN Other
damage NN Other
damp JJ Other
conditions NNS Other
Dust-trapping JJ Other
reservoirs NNS Other
Cockroach NNP Other
infestation NN Other
in IN Other
the DT Other
past JJ Other
3 CD Other
months NNS Other
association NN Other
of IN Other
roaches NNS Other
and CC Other
asthma NN Other
. . None
allergy-control JJ Other
mattress NN Other
covers NNS Other
. . Other
-DOCSTART- -X- N

antibiotic JJ Other
administration NN Other
Wound NNP Physical
infection NN Physical
Wound NNP Physical
infection NN Physical
-DOCSTART- -X- N

proctocolectomy NN Physical
functional JJ Physical
score NN Physical
or CC Physical
bowel NN Physical
frequency NN Physical
functional JJ Physical
score NN Physical
or CC Physical
bowel NN Physical
frequency NN Physical
U.C NNP Physical
. . Physical
-DOCSTART- -X- N

Transient NNP Physical
ischaemic JJ Physical
attacks NNS Physical
with IN Physical
ST NNP Physical
segment NN Physical
elevation NN Physical
or CC Physical
depression NN Physical
, , Physical
with IN Physical
or CC Physical
without IN Physical
pain NN Physical
continuous JJ Other
electrocardiographic JJ Other
monitoring NN Other
. . None
number NN Physical
of IN Physical
attacks NNS Physical
-DOCSTART- -X- N

Serum NNP Physical
specimens VBZ Physical
( ( Physical
or CC Physical
plasma NN Physical
from IN Physical
patients NNS Physical
on IN Physical
hemodialysis NN Physical
) ) None
absolute JJ Physical
bioavailability NN Physical
GCV NNP Physical
levels NNS Physical
GCV NNP Physical
concentrations NNS Physical
Absolute NNP Physical
bioavailability NN Physical
GCV NNP Physical
concentrations NNS Physical
-DOCSTART- -X- N

Total JJ Physical
albumin JJ Physical
supplementation NN Physical
and CC None
hepatic JJ Physical
transaminases NNS Physical
Constitutive JJ Physical
proteins NNS Physical
such JJ Physical
as IN Physical
albumin NN Physical
, , Physical
prealbumin NN Physical
, , Physical
and CC Physical
retinol-binding JJ Physical
protein NN Physical
levels NNS Physical
acute JJ Physical
phase NN Physical
proteins NNS Physical
such JJ Physical
as IN Physical
alpha JJ Physical
1-acid JJ Physical
glycoprotein NN Physical
, , Physical
C3 NNP Physical
complement NN Physical
, , Physical
alpha JJ Physical
2-macroglobulin JJ Physical
, , Physical
and CC Physical
fibrinogen NN Physical
levels NNS Physical
Albumin NNP Physical
supplementation NN Physical
during IN Physical
the DT Physical
acute JJ Physical
hospitalization NN Physical
Hepatic JJ Physical
transaminases NNS Physical
normal JJ None
levels NNS None
. . None
constitutive JJ Physical
protein NN Physical
acute JJ Physical
phase NN Physical
protein NN Physical
levels NNS Physical
. . None
-DOCSTART- -X- N

morbidity NN Mortality
and CC Mortality
mortality NN Mortality
morbidity NN Mortality
and CC Mortality
mortality NN Mortality
clinical JJ Other
response NN Other
on IN Other
day NN Other
7 CD Other
parasitological JJ Mortality
response NN Mortality
by IN Mortality
day NN Mortality
10 CD Mortality
and CC None
mortality NN Mortality
at IN Mortality
day NN Mortality
8 CD Mortality
. . None
diarrhoea NN Physical
C NNP Physical
parvum NN Physical
eradicated VBN None
died VBN Mortality
adverse JJ Adverse
events NNS Adverse
resolution NN Mortality
of IN Mortality
diarrhoea NN Mortality
, , Adverse
parasitological JJ Adverse
eradication NN Adverse
, , Adverse
and CC Adverse
mortality NN Adverse
-DOCSTART- -X- N

repetitive JJ Mental
behaviours NNS Mental
repetitive JJ Physical
, , Physical
repetitive JJ Mental
behaviours NNS Mental
Children NNP Mental
's POS Mental
Yale-Brown JJ Mental
Obsessive NNP Mental
Compulsive NNP Mental
Scale NNP Mental
( ( Mental
C-YBOCS NNP Mental
) ) Mental
repetitive JJ Mental
behaviours NNS Mental
-DOCSTART- -X- N

locoregional JJ Physical
control NN Physical
disease NN Physical
specific JJ Physical
survival NN Physical
influence NN None
of IN None
EGFr NNP None
histopathological JJ Physical
differentiation NN Physical
overall JJ Physical
treatment NN Physical
time NN Physical
of IN Physical
radiotherapy NN Physical
responded VBD None
tumor NN Physical
differentiation NN Physical
. . None
prominent JJ Other
separation NN Other
of IN Other
response NN Other
: : None
differentiation NN None
disease NN Mortality
specific JJ Mortality
survival NN Mortality
superior JJ None
to TO None
conventional JJ None
treatment NN None
response NN None
expression NN Physical
of IN Physical
EGFr NNP Physical
tumor NN Physical
differentiation NN Physical
. . Physical
-DOCSTART- -X- N

safety NN Other
and CC Other
efficacy NN Other
number NN Physical
of IN Physical
painful JJ Physical
joints NNS Physical
and CC Physical
swollen JJ Physical
joints NNS Physical
, , Physical
joint JJ Physical
pain NN Physical
and CC Physical
joint JJ Physical
swelling NN Physical
indices NNS Physical
, , Physical
left VBD Physical
and CC Physical
right JJ Physical
grip NN Physical
strength NN Physical
, , Physical
investigator NN Physical
global JJ Physical
assessment NN Physical
, , Physical
and CC Physical
patient JJ Physical
global JJ Physical
assessment NN Physical
overall JJ Other
therapeutic JJ Other
response NN Other
analgesic JJ Other
medication NN Other
morning NN Physical
stiffness NN Physical
, , Physical
walking VBG Physical
time NN Physical
, , Physical
erythrocyte JJ Physical
sedimentation NN Physical
rate NN Physical
, , Physical
C-reactive JJ Physical
protein NN Physical
, , Physical
or CC Physical
rheumatoid VB Physical
factor NN Physical
adverse JJ Adverse
experiences NNS Adverse
thrombocytopenia NN Adverse
adverse JJ None
effects NNS None
anti-inflammatory JJ Other
activity NN Other
favorable JJ Other
safety NN Other
profile NN Other
-DOCSTART- -X- N

Analgesic JJ Other
efficacy NN Other
analgesic JJ Other
efficacy NN Other
and CC Other
safety NN Other
pain JJ Pain
intensity NN Pain
and CC Pain
pain NN Pain
relief NN Pain
efficacious JJ Other
sum NN Pain
of IN Pain
the DT Pain
pain NN Pain
intensity NN Pain
differences NNS Pain
( ( Pain
SPID NNP Pain
) ) Pain
, , Pain
total JJ Pain
pain NN Pain
relief NN Pain
( ( Pain
TOTAL NNP Pain
) ) Pain
, , None
percent JJ Pain
SPID NNP Pain
, , None
duration NN Other
of IN Other
effect NN Other
, , None
and CC None
time NN Other
to TO Other
remedication NN Other
. . None
percent NN Pain
SPID NNP Pain
percent NN Pain
SPID NNP Pain
efficacy NN Other
pain NN Pain
intensity NN Pain
and CC Pain
relief NN Pain
effective JJ Other
pain NN Pain
intensity NN Pain
difference NN Pain
( ( Pain
PID NNP Pain
) ) Pain
and CC Pain
relief NN Pain
scores NNS Pain
, , None
as RB None
well RB None
as IN None
for IN None
SPID NNP Pain
and CC None
TOTAL NNP Pain
. . None
effective JJ Other
relief NN Pain
PID NNP Pain
as RB None
well RB None
as IN None
SPID NNP Pain
and CC None
TOTAL NNP Pain
. . None
effective JJ Other
SPID NNP Pain
, , None
TOTAL NNP Pain
, , None
and CC None
hourly RB Other
measures NNS Other
PID NNP Pain
. . None
longer JJR Other
duration NN Other
longer JJR Other
time NN Other
to TO Other
remedication VB Other
duration NN Other
of IN Other
analgesic JJ Other
efficacy NN Other
-DOCSTART- -X- N

group NN Mental
difference NN Mental
in IN Mental
patient NN Mental
related JJ Mental
barriers NNS Pain
to TO Pain
management NN Pain
of IN Pain
cancer NN Pain
pain NN Pain
pain NN Pain
intensity NN Pain
& CC None
interference NN Pain
, , None
adherence NN Pain
, , None
coping VBG Pain
and CC None
HRQoL NNP Pain
. . None
cancer NN Pain
pain NN Pain
. . Pain
-DOCSTART- -X- N

Plasma NNP Physical
antioxidant JJ Physical
status NN Physical
Plasma NNP Physical
glutathione NN Physical
( ( Physical
GSH NNP Physical
) ) Physical
and CC None
alpha- JJ Physical
and CC Physical
gamma-tocopherol JJ Physical
concentrations NNS Physical
GSH NNP Physical
redox NN Physical
state NN Physical
Plasma NNP Physical
cysteine JJ Physical
concentrations NNS Physical
Plasma NNP Physical
vitamin JJ Physical
C NNP Physical
and CC Physical
zinc NNP Physical
concentrations NNS Physical
and CC None
GSH NNP Physical
peroxidase NN Physical
activity NN Physical
Plasma VB Physical
alpha-tocopherol JJ Physical
concentrations NNS Physical
plasma JJ Physical
antioxidants NNS Physical
GSH-glutathione NNP Physical
disulfide NN Physical
, , None
cysteine-cystine NN Physical
, , None
and CC None
vitamin FW Physical
E NNP Physical
status NN Physical
-DOCSTART- -X- N

bladder NN Physical
sensation NN Physical
volumes NNS Physical
and CC Physical
the DT Physical
number NN Physical
of IN Physical
detrusor NN Physical
contractions NNS Physical
Bladder NNP None
sensation NN None
volumes NNS None
were VBD None
number NN None
of IN None
detrusor JJ None
contractions NNS None
or CC None
the DT None
bladder NN None
volume NN None
at IN None
which WDT None
the DT None
first JJ None
detrusor NN None
contraction NN None
had VBD None
occurred VBN None
with IN None
and CC None
lowered VBD None
bladder JJR None
sensation NN None
volumes NNS None
( ( None
normal JJ None
-DOCSTART- -X- N

Pain NNP Physical
Rating NNP Physical
Index NNP Physical
, , Physical
Roland-Morris NNP Physical
Disability NNP Physical
Questionnaire NNP Physical
( ( Physical
RMDQ NNP Physical
) ) Physical
, , Physical
and CC Physical
EuroQol NNP Physical
reduction NN Physical
in IN Physical
functional JJ Physical
disability NN Physical
( ( Physical
RMDQ NNP Physical
) ) Physical
-DOCSTART- -X- N

outpatient JJ Physical
hysteroscopy NN Physical
. . Physical
hysteroscopy NN Physical
mean JJ Physical
+/- JJ Physical
SD NNP Physical
pain NN Physical
score NN Physical
hysteroscopy NN None
outpatient NN Physical
hysteroscopy NN Physical
-DOCSTART- -X- N

facial JJ Mental
emotion NN Mental
recognition NN Mental
and CC None
amygdala JJ Mental
reactivity NN Mental
eye NN Mental
gaze NN Mental
and CC Physical
emotion NN Mental
recognition NN Mental
emotion NN Mental
recognition NN Mental
modulate JJ Physical
regional JJ Mental
activity NN Mental
in IN Mental
brain NN Mental
areas NNS Mental
associated VBN Mental
with IN Mental
face NN Mental
perception NN Mental
performance NN Other
in IN Other
a DT Other
facial JJ Mental
emotion NN Mental
recognition NN Mental
task NN Other
increased VBN Other
left JJ Other
amygdala NN Mental
reactivity NN Mental
increased JJ Mental
activity NN Mental
neural JJ Mental
network NN Mental
social JJ Mental
cognitive JJ Mental
functioning NN Mental
-DOCSTART- -X- N

loss NN Physical
of IN Physical
tooth JJ Physical
substance NN Physical
weight JJ Physical
loss NN Physical
of IN Physical
root JJ Physical
substance NN Physical
weight JJ Physical
loss NN Physical
remove VB Physical
more RBR Physical
tooth JJ Physical
substance NN Physical
-DOCSTART- -X- N

Efficacy NN Other
and CC Other
safety NN Other
Biochemical NNP Physical
[ NNP Physical
peak-stimulated JJ Physical
LH NNP Physical
, , Physical
estradiol NN Physical
( ( Physical
girls NNS Physical
) ) Physical
, , Physical
and CC Physical
testosterone NN Physical
( ( Physical
boys NNS Physical
) ) Physical
] NN Physical
and CC Physical
anthropometric JJ Physical
( ( Physical
growth NN Physical
rate NN Physical
, , Physical
bone NN Physical
age NN Physical
acceleration NN Physical
, , Physical
pubertal JJ Physical
progression NN Physical
) ) Physical
parameters NNS Physical
safety NN None
Peak-stimulated JJ None
LH NNP None
Basal NNP Physical
sex NN Physical
steroid NN Physical
suppression NN Physical
, , None
growth NN Physical
rates NNS Physical
, , None
pubertal JJ Physical
progression NN Physical
, , None
bone NN Physical
age NN Physical
advancement NN Physical
, , None
and CC None
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

graft NN Physical
liver NN Physical
, , Physical
signs NNS Physical
of IN Physical
hyperfibrinolysis NN Physical
Tissue-type JJ Physical
plasminogen NN Physical
activator NN Physical
( ( Physical
t-PA JJ Physical
) ) Physical
activity NN Physical
Blood NNP Physical
product NN Physical
requirements NNS Physical
packed JJ Physical
red JJ Physical
blood NN Physical
cells NNS Physical
plasma NN Other
requirements NNS Other
survived VBN Mortality
retransplantation NN Physical
host-versus-graft JJ Physical
reactions NNS Physical
. . Physical
t-PA JJ Physical
release NN Physical
-DOCSTART- -X- N

serum NN Physical
lipoproteins NNS Physical
metabolites NNS Physical
of IN Physical
arachidonic JJ Physical
acid NN Physical
biochemical JJ Physical
risk NN Physical
factors NNS Physical
for IN Physical
ischaemic JJ Physical
heart NN Physical
disease NN Physical
serum NN Physical
cholesterol NN Physical
concentrations NNS Physical
high JJ Physical
density NN Physical
lipoprotein VBP Physical
subfraction NN Physical
two CD Physical
( ( Physical
HDL2 NNP Physical
) ) Physical
subfraction NN Physical
three CD Physical
( ( Physical
HDL3 NNP Physical
) ) Physical
low JJ Physical
density NN Physical
lipoprotein NN Physical
fraction NN Physical
plasma JJ Physical
6-keto-prostaglandin JJ Physical
F1 NNP Physical
alpha NN Physical
concentration NN Physical
serum NN Physical
thromboxane NN Physical
B2 NNP Physical
concentration NN Physical
prostaglandin VBP Physical
E2 NNP Physical
concentrations NNS Physical
plasma JJ Physical
6-keto-prostaglandin JJ Physical
F1 NNP Physical
alpha NN Physical
concentration NN Physical
serum JJ Physical
HDL2 NNP Physical
cholesterol NN Physical
concentration NN Physical
serum NN Physical
lipoproteins NNS Physical
circulating VBG Physical
metabolites NNS Physical
of IN Physical
arachidonic JJ Physical
acid NN Physical
-DOCSTART- -X- N

questionnaire NN Other
and CC None
a DT None
hypnotic JJ Other
susceptibility NN Other
scale NN Other
. . None
cigarette NN Mental
consumption NN Mental
hypnotic JJ Mental
susceptibility NN Mental
. . None
-DOCSTART- -X- N

plasma NN Physical
levels NNS Physical
circulating NN Physical
levels NNS Physical
of IN Physical
A-beta NNP Physical
protein NN Physical
1-40 JJ Physical
( ( Physical
A NNP Physical
beta RB Physical
40 CD Physical
) ) Physical
. . None
mean NN Physical
( ( Physical
S.E NNP Physical
. . Physical
) ) Physical
increase NN Physical
of IN Physical
A NNP Physical
beta NN Physical
40 CD Physical
the DT Physical
plasma JJ Physical
level NN Physical
of IN Physical
A NNP Physical
beta NN Physical
40 CD Physical
-DOCSTART- -X- N

contrast NN Other
sensitivity NN Other
contrast NN Physical
sensitivity NN Physical
statistically RB Other
significantly RB Other
better RBR Other
contrast NN Other
sensitivity NN Other
contrast NN Other
sensitivity NN Other
-DOCSTART- -X- N

effect NN Other
blood NN None
samples NNS None
for IN None
the DT None
treatment NN None
B NNP None
. . None
Safety NNP None
was VBD None
assessed VBN None
by IN None
recording VBG None
of IN None
vital JJ None
signs NNS None
and CC None
electrocardiogram NN None
, , None
clinical JJ None
laboratory NN None
tests NNS None
and CC None
adverse JJ None
event NN None
reporting NN None
. . None
respectively RB None
. . None
The DT None
median JJ None
time NN None
to TO None
Cmax NNP None
( ( None
tmax NN None
) ) None
for IN None
apparent JJ None
terminal JJ None
half-life NN None
( ( None
t? NN None
) ) None
was VBD None
unaffected VBN None
the DT None
geometric JJ None
mean NN None
ratio NN None
( ( None
for IN None
Cmax NNP None
and CC None
reported VBD None
an DT None
adverse JJ None
event NN None
with IN None
headache NN None
-DOCSTART- -X- N

on IN None
serum JJ None
concentrations NNS None
of IN None
FSH NNP None
immunoreactivity NN None
the DT None
number NN None
and CC None
size NN None
of IN None
growing VBG None
follicles NNS None
, , None
and CC None
inhibin NN None
B NNP None
and CC None
oestradiol JJ None
concentrations NNS None
The DT None
rate NN None
of IN None
follicular JJ None
development NN None
The DT None
number NN None
of IN None
follicles NNS None
?11mm NNP None
was VBD None
rise NN None
of IN None
inhibin NN None
B NNP None
and CC None
oestradiol JJ None
concentrations NNS None
was VBD None
stimulation NN None
. . None
Serum NNP None
levels NNS None
of IN None
FSH NNP None
immunoreactivity NN None
were VBD None
number NN None
and CC None
size NN None
of IN None
growing VBG None
follicles NNS None
and CC None
serum NN None
inhibin NN None
B NNP None
and CC None
oestradiol JJ None
concentrations NNS None
as IN None
analysis NN None
) ) None
. . None
Serum NNP None
FSH NNP None
immunoreactivity NN None
levels NNS None
were VBD None
similar JJ None
growth NN None
rate NN None
of IN None
follicles NNS None
though IN None
slightly RB None
higher JJR None
number NN None
of IN None
follicles NNS None
were VBD None
induced JJ None
pharmacodynamic JJ None
effects NNS None
at IN None
-DOCSTART- -X- N

serum VB Physical
cholesterol NN Physical
levels NNS Physical
pharmacokinetic JJ Other
profile NN Other
, , Other
tolerability NN Other
and CC Other
effect NN Other
of IN Other
the DT Other
drug NN Other
on IN Other
serum NN Other
cholesterol NN Other
. . Other
Plasma NNP Physical
concentrations NNS Physical
plasma NN Physical
concentrations NNS Physical
plasma JJ Physical
concentrations NNS Physical
AUC NNP Other
and CC Other
Cmax NNP Other
plasma JJ Physical
concentrations NNS Physical
plasma JJ Physical
concentrations NNS Physical
significant JJ Physical
signs NNS Physical
, , Physical
symptoms NNS Physical
or CC Physical
changes NNS Physical
in IN Physical
serum NN Physical
cholesterol NN Physical
levels NNS Physical
serum NN Physical
cholesterol NN Physical
diarrhoea NN Adverse
. . None
-DOCSTART- -X- N

outcomes RB None
probing VBG Physical
depth NN Physical
reduction NN Physical
( ( Physical
PD NNP Physical
) ) Physical
, , None
horizontal JJ Physical
clinical JJ Physical
attachment NN Physical
level NN Physical
( ( Physical
CAL-h NNP Physical
) ) Physical
gain NN Physical
, , None
and CC None
increase VB Physical
in IN Physical
gingival JJ Physical
recession NN Physical
( ( Physical
GR NNP Physical
) ) Physical
. . None
vertical JJ Physical
clinical JJ Physical
attachment NN Physical
level NN Physical
( ( Physical
CAL-v NNP Physical
) ) Physical
gain NN Physical
PD NNP Physical
reduction NN Physical
CAL-v JJ Physical
gain NN Physical
GR NNP Physical
increase NN Physical
closure NN Physical
of IN Physical
the DT Physical
furcation NN Physical
defect NN Physical
superior JJ Physical
horizontal JJ Physical
clinical JJ Physical
attachment NN Physical
level NN Physical
gain NN Physical
-DOCSTART- -X- N

median JJ Other
time NN Other
delay NN Other
non-significant JJ None
decrease NN None
in IN None
30-day JJ Mortality
mortality NN Mortality
was VBD None
observed VBN None
in IN None
favour NN None
of IN None
the DT None
pre-hospital JJ None
group NN None
the DT None
decrease NN Mortality
in IN Mortality
cardiac JJ Physical
death NN Physical
observed VBD None
some DT Adverse
complications NNS Adverse
occurred VBD None
more RBR None
frequently RB None
in IN None
the DT None
pre-hospital JJ None
group NN None
overall JJ None
incidence NN None
for IN None
serious JJ Adverse
complications NNS Adverse
was VBD None
similar JJ None
for IN None
both DT None
groups NNS None
. . None
the DT None
pre-hospital JJ Other
thrombolytic JJ Other
strategy NN Other
in IN None
is VBZ None
both DT None
effective JJ Other
and CC Other
safe JJ Other
when WRB None
performed VBN None
by IN None
well-equipped JJ Other
well-staffed JJ Other
mobile JJ Other
emergency NN Other
units NNS Other
. . None
-DOCSTART- -X- N

embolization NN Physical
platelet POS Physical
aggregation NN Physical
and CC Physical
adhesion NN Physical
antiplatelet NN Other
efficacy NN Other
number NN Physical
of IN Physical
Doppler NNP Physical
embolic JJ Physical
signals NNS Physical
in IN Physical
the DT Physical
L-arginine NNP Physical
and CC Physical
GSNO NNP Physical
number NN Physical
of IN Physical
embolic JJ Physical
signals NNS Physical
The DT None
reduction NN Other
in IN Other
the DT Other
signals NNS Other
attenuate VBP Physical
Doppler NNP Physical
embolic JJ Physical
signals NNS Physical
-DOCSTART- -X- N

improve VB Other
quality NN Other
of IN Other
care NN Other
. . Other
recommend VB Mental
guideline-consistent JJ Mental
care NN Mental
order NN Mental
an DT Mental
eye NN Mental
exam NN Mental
for IN Mental
diabetes NNS Mental
patients NNS Mental
improve VB Other
-DOCSTART- -X- N

intensity NN Other
scores NNS Other
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
clinical JJ Other
cure NN Other
rate NN Other
bacteriological JJ Other
success NN Other
rate NN Other
Eradication NN Other
or CC Other
presumed VBN Other
eradication NN Other
drug-related JJ Adverse
event NN Adverse
diarrhoea NNS Adverse
nausea/vomiting VBG Adverse
abdominal JJ Adverse
pain NN Adverse
skin JJ Physical
reactions NNS Physical
clinically NN Other
and CC Other
bacteriologically RB Other
tolerated VBN Other
. . None
-DOCSTART- -X- N

lower JJR Physical
oesophageal JJ Physical
sphincter NN Physical
pressure NN Physical
( ( Physical
LOSP NNP Physical
) ) Physical
LOSP NNP Physical
LOSP NNP Physical
-DOCSTART- -X- N

overall JJ Mortality
and CC Mortality
progression-free JJ Mortality
survival NN Mortality
Survival NNP Mortality
analysis NN Mortality
tumor NN Physical
relapse NN Physical
5-year JJ Mortality
overall JJ Mortality
survival NN Mortality
rates NNS Mortality
5-year JJ Mortality
progression-free JJ Mortality
survival NN Mortality
rates NNS Mortality
toxicity NN Physical
leukopenia NN Physical
emesis NN Physical
treatment-related JJ Mortality
deaths NNS Mortality
-DOCSTART- -X- N

tolerated VBD Other
main JJ None
toxic NN Adverse
effects NNS Adverse
were VBD None
fever RB Adverse
and CC None
general JJ Adverse
fatigue NN Adverse
. . None
toxicity NN Adverse
hepatic JJ Physical
and CC Physical
renal JJ Physical
functions NNS Physical
eosinophilia NN Physical
( ( Physical
12/18 CD Physical
) ) Physical
and CC None
thrombocythemia NN Adverse
Peripheral JJ Physical
natural JJ Physical
killer NN Physical
( ( Physical
NK NNP Physical
) ) Physical
and CC Physical
LAK NNP Physical
activities NNS Physical
total JJ Physical
white JJ Physical
blood NN Physical
cell NN Physical
counts NNS Physical
IL-2 NNP Physical
receptor NN Physical
expression NN Physical
of IN Physical
peripheral JJ Physical
blood NN Physical
mononuclear NN Physical
cells NNS Physical
and CC Physical
significant JJ Physical
rises NNS Physical
in IN Physical
numbers NNS Physical
of IN Physical
Leu11 NNP Physical
( ( Physical
CD16 NNP Physical
) ) Physical
+ NN Physical
, , Physical
OKM1 NNP Physical
( ( Physical
CD11 NNP Physical
) ) Physical
+ NN Physical
and CC Physical
OKIa1 NNP Physical
( ( Physical
HLA-DR NNP Physical
) ) Physical
+ NN Physical
unresectable JJ Physical
hepatoma NN Physical
no DT Physical
change NN Physical
( ( Physical
NC NNP Physical
) ) Physical
or CC Physical
progressive JJ Physical
disease NN Physical
( ( Physical
PD NNP Physical
) ) Physical
. . None
-DOCSTART- -X- N

irritable JJ Physical
bowel NN Physical
syndrome NN Physical
All DT Physical
central JJ Physical
IBS NNP Physical
symptoms NNS Physical
Rectal JJ Pain
pain NN Pain
thresholds NNS Pain
, , None
rectal JJ Physical
smooth JJ Physical
muscle NN Physical
tone NN Physical
, , Physical
and CC Physical
autonomic JJ Physical
functioning NN Physical
( ( Physical
except IN Physical
sweat NN Physical
gland VBP Physical
reactivity NN Physical
) ) Physical
somatization NN Mental
and CC Mental
psychological JJ Mental
distress NN Mental
IBS NNP None
symptoms NNS None
psychological JJ Mental
distress NN Mental
and CC Mental
somatization NN Mental
. . Physical
-DOCSTART- -X- N

expression NN Physical
of IN Physical
Yes-associated JJ Physical
protein NN Physical
Yes-associated JJ Physical
protein NN Physical
( ( Physical
YAP1 NNP Physical
) ) Physical
YAP1 NNP Physical
YAP1 NNP Physical
protein NN Physical
intensity NN Physical
Recurrence-free JJ Mortality
survival NN Mortality
cell NN Physical
viability NN Physical
luciferase NN Physical
ERE NNP Physical
YAP1 NNP None
expression NN None
expression NN None
correlated VBD None
low JJ None
YAP1 NNP None
mRNA NN None
was VBD None
decreased JJ None
recurrence-free JJ None
survival NN None
in IN None
that IN None
YAP1 NNP None
may MD None
absent JJ None
YAP1 NNP None
protein NN None
expression NN None
was VBD None
impaired JJ None
tamoxifen NN None
response NN None
which WDT None
increased JJ None
progesterone NN None
receptor NN None
( ( None
PgR NNP None
) ) None
expression NN None
and CC None
Decreased VBD None
YAP1 NNP None
expression NN None
is VBZ None
-DOCSTART- -X- N

compare VB None
Complications NNP Adverse
Disabilities NNS Physical
of IN Physical
the DT Physical
Arm NNP Physical
, , None
Shoulder NNP Physical
and CC Physical
Hand NNP Physical
( ( Physical
DASH NNP Physical
) ) Physical
score NN Physical
Constant JJ Physical
Shoulder NNP Physical
Score NNP Physical
outcome JJ None
measurement NN None
clavicular JJ Physical
shortening NN Physical
. . None
Fracture NNP Physical
union NN Physical
nonunion NN Physical
symptomatic JJ Other
malunions NNS Other
Medial NNP Other
nail JJ Other
protrusion NN Other
Implant JJ Other
failure NN Other
with IN Other
revision NN Other
surgery NN Other
DASH NNP Physical
scores NNS Physical
Constant JJ Physical
scores NNS Physical
posttraumatic JJ Physical
clavicular JJ Physical
shortening NN Physical
; : None
satisfied JJ Other
overall JJ Mental
outcome NN Mental
. . None
nonunion NN Other
delayed VBN Other
union NN Other
return NN Other
to TO Other
daily JJ Other
activities NNS Other
functional JJ Other
outcome NN Other
. . None
Clavicular JJ Physical
shortening NN Physical
overall JJ Other
satisfaction NN Other
-DOCSTART- -X- N

12-hour JJ Physical
postoperative JJ Physical
levels NNS Physical
of IN Physical
serum NN Physical
hemoglobin NNS Physical
serum NN Physical
levels NNS Physical
of IN Physical
total JJ Physical
protein NN Physical
and CC Physical
albumin NN Physical
serum NN Physical
fibrinogen NN Physical
and CC None
platelet NN Physical
counts NNS Physical
allogeneic JJ Physical
product NN Physical
transfusion NN Physical
index NN Physical
and CC None
the DT None
chest-tube JJ Physical
blood NN Physical
drainage NN Physical
indices NNS Physical
lower JJR None
enhanced VBN Physical
biochemical JJ Physical
and CC Physical
clinical JJ Other
patient NN Other
outcomes VBZ Other
-DOCSTART- -X- N

knee NN Physical
scores NNS Physical
, , None
patient JJ Physical
self-assessment NN Physical
, , None
and CC None
radiographic JJ Physical
outcomes NNS Physical
. . None
-DOCSTART- -X- N

length NN Other
of IN Other
stay NN Other
length NN Other
of IN Other
stay NN Other
. . Other
-DOCSTART- -X- N

6-minute JJ Other
walk NN Other
test NN Other
functional JJ Physical
class NN Physical
weight JJ Physical
loss NN Physical
total JJ Physical
cholesterol NN Physical
low-density JJ Physical
lipoprotein NN Physical
cholesterol NN Physical
triglycerides NNS Physical
weight JJ Physical
loss NN Physical
and CC None
symptoms NNS Physical
of IN Physical
relief NN Physical
-DOCSTART- -X- N

Behavioral JJ Mental
changes NNS Mental
Behavior NNP Mental
, , Mental
attention NN Mental
, , Mental
and CC Mental
orientation NN Mental
behavior JJ Mental
problems NNS Mental
-DOCSTART- -X- N

C-reactive NNP Physical
protein NN Physical
, , Physical
homocysteine NN Physical
, , Physical
and CC Physical
plasma VB Physical
lipid JJ Physical
levels NNS Physical
Sudden NNP Physical
cardiac JJ Physical
death NN Physical
( ( Physical
SCD NNP Physical
) ) Physical
C-reactive JJ Physical
protein NN Physical
( ( Physical
CRP NNP Physical
) ) Physical
, , Physical
homocysteine NN Physical
, , Physical
and CC Physical
lipids NNS Physical
CRP NNP Physical
levels NNS Physical
CRP NNP Physical
levels NNS Physical
SCD NNP Physical
lipid JJ Physical
parameters NNS Physical
, , Physical
homocysteine NN Physical
, , Physical
and CC Physical
multiple JJ Physical
cardiac JJ Physical
risk NN Physical
factors NNS Physical
SCD NNP Physical
. . None
-DOCSTART- -X- N

saturated JJ Mental
fat JJ Mental
intake NN Mental
( ( Mental
g NN Mental
) ) Mental
intake NN Mental
of IN Mental
fruit NN Mental
( ( Mental
serves NNS Mental
) ) Mental
, , Mental
vegetables NNS Mental
( ( Mental
serves NNS Mental
) ) Mental
, , Mental
grain NN Mental
and CC Mental
cereals NNS Mental
total JJ Mental
and CC Mental
wholegrain NN Mental
( ( Mental
serves NNS Mental
) ) Mental
fruit JJ Mental
intake NN Mental
total JJ Mental
saturated JJ Mental
fat JJ Mental
intake NN Mental
. . None
mean JJ Mental
vegetable JJ Mental
intake NN Mental
-DOCSTART- -X- N

Changes NNP Physical
in IN Physical
FIM NNP Physical
and CC Physical
Tinetti NNP Physical
scale NN Physical
scores NNS Physical
, , Physical
and CC Physical
dependence NN Physical
on IN Physical
walking VBG Physical
aids NNS Physical
. . Physical
clinical JJ Other
and CC Other
functional JJ Other
scale NN Other
scores NNS Other
. . Other
( ( Other
FIM NNP Physical
total NN Physical
score NN Physical
FIM NNP Physical
motor NN Physical
subscore NN Physical
Tinetti NNP Physical
scale NN Physical
score NN Physical
frequently RB Other
to TO Other
1 CD Other
crutch NN Other
-DOCSTART- -X- N

weight NN Physical
gained VBN Physical
interdialysis NN Physical
, , None
mean JJ Physical
blood NN Physical
pressure NN Physical
predialysis NN Physical
and CC Physical
postdialysis NN Physical
, , None
and CC None
hemoconcentration NN Physical
. . None
Serum NNP Physical
Na+ NNP Physical
levels NNS Physical
Hypotensive NNP Physical
episodes NNS Physical
and CC Physical
cramps NNS Physical
amount NN Physical
of IN Physical
hypertonic JJ Physical
and CC Physical
normal JJ Physical
saline NN Physical
-DOCSTART- -X- N

Efficacy NN Other
efficacy NN Other
efficacy NN Other
tolerability NN Other
frequency NN Physical
of IN Physical
severe JJ Physical
exacerbations NNS Physical
respiratory NN Physical
symptoms NNS Physical
, , Physical
forced VBD Physical
expiratory JJ Physical
volume NN Physical
in IN Physical
1 CD Physical
s NN Physical
( ( Physical
FEV NNP Physical
( ( Physical
1 CD Physical
) ) Physical
) ) Physical
, , Physical
shuttle JJ Physical
walking VBG Physical
test NN Physical
distance NN Physical
and CC Physical
St. NNP Physical
George NNP Physical
's POS Physical
Respiratory NNP Physical
Questionnaire NNP Physical
scores NNS Physical
total JJ Physical
number NN Physical
of IN Physical
exacerbations NNS Physical
number NN Physical
of IN Physical
patients NNS Physical
experiencing VBG Physical
at IN Physical
least JJS Physical
one CD Physical
exacerbation NN Physical
during IN Physical
the DT Physical
study NN Physical
type JJ Physical
3 CD Physical
Anthonisens NNP Physical
's POS Physical
exacerbations NNS Physical
dyspnea NN Adverse
, , Adverse
cough NN Adverse
, , Adverse
sputum NN Adverse
amount NN Adverse
and CC Adverse
purulence NN Adverse
. . None
FEV NNP Physical
( ( Physical
1 CD Physical
) ) Physical
area NN Physical
under IN Physical
the DT Physical
FEV NNP Physical
( ( Physical
1 CD Physical
) ) Physical
-time NN Physical
curve NN Physical
during IN Physical
the DT Physical
6-month JJ Physical
period NN Physical
shuttle JJ Physical
walking VBG Physical
test NN Physical
distance NN Physical
and CC Physical
scores NNS Physical
of IN Physical
the DT Physical
St. NNP Physical
George NNP Physical
's POS Physical
Respiratory NNP Physical
Questionnaire NNP Physical
-DOCSTART- -X- N

Antimigraine NNP Other
efficacy NN Other
antimigraine NN Other
efficacy NN Other
2-hour JJ None
pain NN None
relief NN None
rates NNS None
The DT None
2-hour JJ None
pain NN None
relief NN None
rates NNS None
had VBD None
2-hour JJ None
pain NN None
relief NN None
-DOCSTART- -X- N

Helicobacter NNP None
pylori NN None
and CC None
the DT None
recurrence NN None
of IN None
duodenal JJ None
ulcer NN None
. . None
H. NNP None
pylori NN None
pylori NN Physical
H. NNP None
pylori NN None
eradicated VBN Other
ulcers NNS Physical
healed VBN Other
diarrhea NN Adverse
duodenal JJ Physical
ulcers NNS Physical
recurred VBD Physical
Ulcers NNS Physical
recurred VBD Physical
H. NNP None
pylori NN None
eradication NN Other
of IN Physical
H. NNP Physical
pylori NN None
-DOCSTART- -X- N

safety NN Other
and CC Other
tolerability NN Other
safety NN Other
and CC Other
tolerability NN Other
Safety NN Other
changes NNS Physical
in IN Physical
injected JJ Physical
joint NN Physical
tenderness NN Physical
and CC Physical
swelling VBG Physical
scores NNS Physical
Synovial JJ Physical
fluid NN Physical
TNFR NNP Physical
: : Physical
Fc NNP Physical
protein NN Physical
decrease NN Physical
in IN Physical
swelling VBG Physical
safety NN Other
and CC Other
efficacy NN Other
-DOCSTART- -X- N

AP-1 NNP Physical
inhibition NN Physical
Vascular JJ None
function NN None
human JJ None
atherosclerosis NN None
minimal JJ None
AP-1 NNP None
activation NN None
of IN None
AP-1 NNP None
activation NN None
and CC None
vulnerable JJ None
The DT None
expression NN None
of IN None
phospho-c-Jun JJ None
of IN None
circulating VBG None
hs-CRP JJ None
levels NNS None
other JJ None
markers NNS None
of IN None
systemic JJ None
inflammation NN None
and CC None
vascular JJ None
function NN None
. . None
-DOCSTART- -X- N

immunogenicity NN Physical
Serum NNP Physical
antibody NN Physical
responses NNS Physical
Anti-Hib JJ Physical
concentrations NNS Physical
were VBD None
determined VBN None
by IN None
the DT None
Farr-type NNP None
radioimmunoassay NN None
. . None
prevaccination NN Physical
anti-Hib JJ Physical
geometric JJ Physical
mean NN Physical
concentration NN Physical
( ( Physical
GMC NNP Physical
) ) Physical
GMC NNP Physical
GMC NNP Physical
immunogenic JJ Physical
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
clinical JJ Physical
management NN Physical
clinic JJ Physical
blood NN Physical
pressure NN Physical
readings NNS Physical
. . None
blood NN Physical
pressure NN Physical
blood NN Physical
pressure NN Physical
blood NN Physical
pressure NN Physical
response NN Physical
'white-coat NNP Physical
' POS Physical
hypertension NN Physical
. . Physical
blood NN Physical
pressures NNS Physical
coronary JJ Physical
heart NN Physical
disease NN Physical
: : None
clinic NN Physical
readings NNS Physical
blood NN Physical
pressure NN Physical
high-density NN Physical
lipoprotein NN Physical
insulin NN Physical
, , None
cholesterol NN Physical
and CC None
triglycerides NNS Physical
-DOCSTART- -X- N

epithelial JJ Physical
healing NN Physical
abnormal JJ Physical
proliferation NN Physical
of IN Physical
pterygium-like JJ Physical
tissue NN Physical
-DOCSTART- -X- N

error NN Mental
rates NNS Mental
for IN Mental
facial JJ Mental
emotion NN Mental
labeling NN Mental
( ( Mental
DANVA2 NNP Mental
) ) Mental
ability NN Mental
to TO Mental
recognize VB Mental
anger NN Mental
QoL NNP Physical
efficacy NN Other
-DOCSTART- -X- N

knowledge NN Other
, , Other
attitudes NNS Other
, , Other
planned VBD Other
and CC Other
actual JJ Other
behaviour NN Other
towards NNS Other
breastfeeding VBG Other
. . Other
-DOCSTART- -X- N

Efficacy NNP Other
safety NN Other
change NN None
in IN None
Aberrant NNP None
Behavior NNP None
Checklist-Irritability NNP None
( ( None
primary JJ None
endpoint NN None
Clinical JJ None
Global NNP None
Impressions-Severity NN None
and CC None
Children NNP None
's POS None
Yale-Brown JJ None
Obsessive NNP None
Compulsive NNP None
Scale NNP None
scores VBZ None
improved VBN None
Somnolence NNP None
, , None
sedation NN None
and CC None
increased VBD None
appetite RB None
occurred VBN None
, , None
increased VBD None
appetite RB None
occurred VBD None
-DOCSTART- -X- N

30-day JJ None
mortality NN None
. . None
30-day JJ None
mortality NN None
did VBD None
not RB None
The DT None
median JJ None
hospital NN None
stay NN None
was VBD None
The DT None
median JJ None
ventilation NN None
time NN None
( ( None
14 CD None
median JJ None
catecholamine NN None
dose NN None
, , None
frequency NN None
of IN None
dialysis-dependent JJ None
acute JJ Physical
renal JJ Physical
failure NN Physical
( ( None
28 CD None
cardiac JJ None
indices NNS None
, , None
and CC None
frequency NN None
of IN None
a DT None
low JJ None
cardiac JJ None
output NN None
syndrome NN None
( ( None
26 CD None
-DOCSTART- -X- N

quality NN Mortality
of IN Mortality
survival NN Mortality
. . None
survival JJ Mortality
time NN Mortality
and CC None
quality NN Mortality
of IN Mortality
survival NN Mortality
. . None
median JJ Mortality
survival NN Mortality
time NN Mortality
median JJ Other
total JJ Other
sum NN Other
of IN Other
vitagram NN Other
points NNS Other
median JJ Other
sum NN Other
of IN Other
vitagram NN Other
points NNS Other
survival NN Mortality
. . None
-DOCSTART- -X- N

Hypocalcemic NNP Physical
symptoms NNS Physical
, , Physical
serum JJ Physical
calcium NN Physical
, , Physical
and CC Physical
parathyroid VB Physical
hormone NN Physical
( ( Physical
PTH NNP Physical
) ) Physical
levels NNS Physical
hypocalcemia NN Physical
symptomatic JJ Physical
and CC Physical
laboratory JJ Physical
hypocalcemia NN Physical
Serum NNP Physical
calcium NN Physical
levels NNS Physical
postoperative JJ Physical
hypocalcemia NN Physical
-DOCSTART- -X- N

painful JJ Pain
LMA NNP Other
insertion NN Other
-DOCSTART- -X- N

survival NN Mortality
overall JJ Mortality
survival NN Mortality
disease VB Physical
progression NN Physical
quality NN Mental
of IN Mental
life NN Mental
. . None
survival JJ Mortality
benefit NN Mortality
median JJ Mortality
survival NN Mortality
significant JJ Mortality
survival JJ Mortality
benefit NN Mortality
2-year JJ Mortality
survival NN Mortality
Progression-free JJ Mortality
survival NN Mortality
musculoskeletal JJ Pain
pain NN Pain
and CC Pain
inflammation NN Pain
. . None
Events NNS Physical
of IN Physical
anaemia NN Physical
, , Physical
abdominal JJ Physical
pain NN Physical
, , Physical
jaundice NN Physical
and CC Physical
weight JJ Physical
loss NN Physical
-DOCSTART- -X- N

myocardial JJ Physical
oxygen NN Physical
consumption NN Physical
. . Physical
left JJ Physical
ventricular NN Physical
( ( Physical
LV NNP Physical
) ) Physical
function NN Physical
. . Physical
myocardial JJ Physical
oxygen NN Physical
consumption NN Physical
( ( Physical
MVO NNP Physical
( ( Physical
2 CD Physical
) ) Physical
) ) Physical
MVO NNP Physical
( ( Physical
2 CD Physical
) ) Physical
LV NNP Physical
ejection NN Physical
fraction NN Physical
MVO NNP Physical
( ( Physical
2 CD Physical
) ) Physical
LV NNP Physical
peak NN Physical
+dP/dt NN Physical
LV NNP Physical
function NN Physical
MVO NNP Physical
( ( Physical
2 CD Physical
) ) Physical
LV NNP Physical
function NN Physical
MVO NNP None
( ( None
2 CD None
) ) None
. . None
-DOCSTART- -X- N

stress NN Mental
immune JJ Physical
response NN Physical
Stress NNP Physical
response NN Physical
plasma NN Physical
cortisol NN Physical
and CC None
blood NN Physical
glucose NN Physical
levels NNS Physical
. . None
Immune NNP Physical
function NN Physical
immunoglobulin NN Physical
A NNP Physical
( ( Physical
IgA NNP Physical
) ) Physical
levels NNS Physical
. . None
Patients NNS Pain
' POS Pain
postoperative JJ Pain
pain NN Pain
, , None
anxiety NN Mental
, , None
blood NN Physical
pressure NN Physical
( ( Physical
BP NNP Physical
) ) Physical
, , Physical
heart NN Physical
rate NN Physical
( ( Physical
HR NNP Physical
) ) Physical
and CC Physical
oxygen JJ Physical
saturation NN Physical
were VBD None
also RB None
studied VBN None
as IN None
stress NN Physical
markers NNS Physical
. . None
level NN Physical
of IN Physical
cortisol NN Physical
anxiety NN Mental
and CC None
pain NN Pain
morphine NN Other
morphine NN Physical
pain NN Pain
IgA NNP Physical
, , Physical
blood NN Physical
glucose NN Physical
, , Physical
BP NNP Physical
, , Physical
HR NNP Physical
and CC Physical
oxygen NN Physical
saturation NN Physical
anxiety NN Mental
, , None
pain NN Pain
morphine NN Other
consumption NN Other
. . None
-DOCSTART- -X- N

tensile JJ Other
bond NN Other
strength NN Other
tensile NN Other
bond NN Other
strength NN Other
-DOCSTART- -X- N

Breathing VBG Physical
pattern NN Physical
and CC Physical
thoracoabdominal JJ Physical
motion NN Physical
Breathing NNP Physical
frequency NN Physical
and CC Physical
minute JJ Physical
ventilation NN Physical
inspiratory JJ Physical
time NN Physical
and CC Physical
prolongation NN Physical
of IN Physical
duty NN Physical
ratio NN Physical
Contribution NN Physical
of IN Physical
rib JJ Physical
cage NN Physical
movement NN Physical
on IN Physical
tidal JJ Physical
volume NN Physical
-DOCSTART- -X- N

Mechanical JJ Physical
efficiency NN Physical
and CC None
propulsion NN Physical
technique NN Physical
mechanical JJ Physical
efficiency NN Physical
Mechanical JJ Physical
efficiency NN Physical
, , None
oxygen NN Physical
uptake NN Physical
, , None
heart NN Physical
rate NN Physical
, , None
timing VBG Other
parameters NNS Other
and CC None
stroke NN Physical
angles NNS Physical
stroke NN Physical
pattern NN Physical
. . None
Mechanical NNP Physical
efficiency NN Physical
increased VBD None
and CC None
metabolic JJ Physical
cost NN Physical
decreased VBN None
Push NNP Other
time NN Other
cycle NN Other
frequency NN Other
stroke NN Physical
angle NN Physical
single-looping NN Other
over IN Other
propulsion NN Other
mechanical JJ Physical
efficiency NN Physical
and CC None
metabolic JJ Physical
cost NN Physical
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
intraocular JJ Physical
pressure NN Physical
, , None
visual JJ Physical
acuity NN Physical
, , None
and CC None
visual JJ Physical
fields NNS Physical
intraocular JJ Physical
pressure NN Physical
intraocular JJ Physical
pressure NN Physical
high JJ Physical
intraocular JJ Physical
pressure NN Physical
visual JJ Physical
acuity NN Physical
. . None
late-onset JJ Physical
bleb NN Physical
leaks NNS Physical
-DOCSTART- -X- N

effect NN Other
of IN Other
hand NN Other
excavation NN Other
, , None
bur JJ Other
excavation NN Other
, , None
air-abrasion NN Other
, , None
laser JJR Other
ablation NN Other
, , None
chemomechanical JJ Other
methods NNS Other
and CC None
sono-abrasion NN Other
. . None
residual JJ Other
smear NN Other
layer NN Other
patent NN Physical
orifices NNS Physical
of IN Physical
dentinal JJ Physical
tubules NNS Physical
-DOCSTART- -X- N

delayed JJ Physical
graft NN Physical
function NN Physical
( ( Other
DGF NNP Other
) ) None
and CC None
impaired JJ Physical
wound NN Physical
healing VBG Physical
( ( None
biopsy-proven JJ None
acute NN None
rejection NN None
, , None
BPAR NNP None
; : None
graft NN None
loss NN None
, , None
death NN None
, , None
DGF NNP None
, , None
wound VBD None
healing VBG None
complications NNS None
related VBN None
to TO None
transplant VB None
surgery NN None
or CC None
loss NN None
to TO None
follow-up NN None
) ) None
was VBD None
64.6 CD None
estimated VBD None
glomerular JJ None
filtration NN None
rate NN None
was VBD None
48 CD None
month NN None
12 CD None
. . None
DGF NNP None
and CC None
wound VBD None
healing VBG None
complications NNS None
were VBD None
groups NNS None
. . None
Adverse JJ None
events NNS None
led VBD None
good JJ None
efficacy NN None
, , None
renal JJ None
function NN None
and CC None
safety NN None
profile NN None
. . None
There EX None
-DOCSTART- -X- N

speed NN Mental
and CC Mental
power NN Mental
. . Physical
physical JJ Physical
test NN Physical
performance NN Physical
vertical JJ Other
jump NN Other
and CC Other
Agility-15m JJ Other
variables NNS Other
( ( Physical
p JJ Physical
soccer-specific JJ Mental
sprint NN Mental
performance NN Mental
( ( Physical
15 CD Physical
m NN Physical
) ) Physical
-DOCSTART- -X- N

pneumonia NN Physical
ventilator-free JJ Other
days NNS Other
intensive JJ Other
care NN Other
unit-free JJ Other
days NNS Other
rates NNS Physical
of IN Physical
acute JJ Physical
kidney NN Physical
injury NN Physical
, , Physical
gastrointestinal JJ Physical
hemorrhage NN Physical
, , Physical
and CC Physical
fracture NN Physical
nonunion NN Physical
pneumonia NN Physical
-DOCSTART- -X- N

wound IN Physical
healing VBG Physical
efficacy NN Other
tolerability NN Other
nasal-breathing-resistance NN Physical
according VBG Other
to TO Other
scores NNS Other
efficacy NN Other
tolerability NN Other
compliance NN Other
improvement NN Physical
efficacy NN Other
tolerability NN Other
-DOCSTART- -X- N

plasma JJ Physical
norepinephrine NN Physical
levels NNS Physical
intraarterial JJ Physical
blood NN Physical
pressure NN Physical
, , Physical
EKG NNP Physical
and CC Physical
muscle NN Physical
sympathetic JJ Physical
nerve NN Physical
activity NN Physical
( ( Physical
MSNA NNP Physical
) ) Physical
Reduction NN Physical
in IN Physical
sympathetic JJ Physical
tone NN Physical
tolerance NN Physical
to TO Physical
tilt VB Physical
basal NN Physical
plasma NN Physical
NorEpi NNP Physical
levels NNS Physical
and CC None
MSNA NNP Physical
syncope NN Physical
sympathetic JJ Physical
activity NN Physical
-DOCSTART- -X- N

intrauterine JJ Physical
pressure NN Physical
intrauterine JJ Physical
pressure NN Physical
active JJ Physical
and CC Physical
cumulative JJ Physical
active JJ Physical
pressures NNS Physical
individual JJ Physical
active JJ Physical
pressure NN Physical
Cumulative JJ Physical
active JJ Physical
pressure NN Physical
uterine JJ Physical
activity NN Physical
individual JJ Physical
active JJ Physical
pressures NNS Physical
. . None
-DOCSTART- -X- N

duration NN Other
task NN Other
difficulty NN Other
presence NN Other
or CC Other
absence NN Other
of IN Other
feedback NN Other
on IN Other
performance NN Other
accuracy NN Other
. . Other
proportion NN Other
of IN Other
identifications NNS Other
of IN Other
the DT Other
standard NN Other
individual JJ Other
presentations NNS Other
of IN Other
the DT Other
standard NN Other
were VBD Other
stored VBN Other
and CC Other
used VBN Other
. . Other
-DOCSTART- -X- N

evaluate VB Physical
the DT Physical
local JJ Physical
penetration NN Physical
of IN Physical
the DT Physical
drug NN Physical
. . None
determine VB Other
whether IN Other
ketoprofen NN Other
entered VBD Other
the DT Other
systemic JJ Other
circulation NN Other
. . None
concentration NN Physical
of IN Physical
ketoprofen NN Physical
concentration NN Physical
of IN Physical
ketoprofen NN Physical
concentration NN Physical
of IN Physical
ketoprofen NN Physical
concentration NN Physical
of IN Physical
ketoprofen NN Physical
in IN Physical
fat JJ Physical
tissue NN Physical
and CC Physical
synovial JJ Physical
tissue NN Physical
-DOCSTART- -X- N

lifestyle JJ Mental
behaviors NNS Mental
knowledge NN Mental
related VBN Mental
to TO Mental
anatomy VB Mental
and CC Mental
physiology VB Mental
, , Mental
diet JJ Mental
, , Mental
and CC Mental
lifestyle JJ Mental
risk NN Mental
factors NNS Mental
associated VBN Mental
with IN Mental
the DT Mental
development NN Mental
of IN Mental
heart NN Mental
disease NN Mental
and CC Mental
cancer NN Mental
. . Mental
-DOCSTART- -X- N

dopaminergic NN Physical
( ( Physical
DA NNP Physical
) ) Physical
function NN Physical
clinical JJ Other
efficacy NN Other
motor NN Physical
hyperactivity NN Physical
and CC Physical
attention NN Physical
symptoms NNS Physical
. . None
sedative JJ Physical
effect NN Physical
stimulant JJ Physical
effect NN Physical
-DOCSTART- -X- N

predialysis JJ Physical
anti-Xa JJ Physical
levels NNS Physical
20 CD Physical
to TO Physical
24 CD Physical
hours NNS Physical
after IN Physical
the DT Physical
third JJ Physical
LMWH NNP Physical
dose NN Physical
thromboembolic JJ Physical
events NNS Physical
and CC Physical
major JJ Physical
bleeding NN Physical
. . None
Mean JJ Physical
predialysis NN Physical
anti-Xa JJ Physical
level NN Physical
20-24 JJ Physical
hours NNS Physical
invasive JJ None
procedures NNS None
were VBD None
experienced VBD None
serious JJ None
adverse JJ None
events NNS None
( ( None
-DOCSTART- -X- N

procedural JJ Mental
and CC Mental
declarative JJ Mental
knowledge NN Mental
of IN Mental
DTT NNP Mental
. . None
declarative NN Mental
and CC Mental
procedural JJ Mental
knowledge NN Mental
-DOCSTART- -X- N

Weight NNP Physical
loss NN Physical
HOMA NNP Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
body NN Physical
mass NN Physical
index NN Physical
fat JJ Physical
mass NN Physical
HOMA NNP Physical
weight NN Physical
, , None
fat JJ Physical
mass NN Physical
and CC None
HOMA NNP Physical
-DOCSTART- -X- N

rapid JJ Physical
muscle NN Physical
fatigue NN Physical
muscle NN Physical
fatigue NN Physical
isometric JJ Physical
force NN Physical
force-time JJ Physical
integral JJ Physical
( ( Physical
FTI NNP Physical
) ) Physical
fatigue NN Physical
time NN Physical
measurements NNS Physical
FTI NNP Physical
measurements NNS Physical
. . None
muscle NN Physical
fatigue NN Physical
. . None
fatigue JJ Physical
time NN Physical
or CC None
FTI NNP Physical
measurements NNS Physical
. . None
recovery NN Physical
of IN Physical
muscle NN Physical
strength NN Physical
. . None
-DOCSTART- -X- N

VAS NNP Pain
scores NNS Pain
areas NNS Physical
of IN Physical
allodynia NN Physical
and CC Physical
pin-prick JJ Physical
hyperalgesia NN Physical
pain NN Pain
threshold NN Pain
and CC None
the DT None
summation NN Other
threshold NN Other
to TO Other
electrical JJ Other
stimuli NNS Other
and CC Physical
the DT Physical
summation NN Other
threshold NN Other
to TO Other
heat VB Other
stimuli NNS Other
degree NN Physical
of IN Physical
the DT Physical
temporal JJ Physical
summation NN Physical
to TO Physical
electrical JJ Physical
and CC Physical
heat NN Physical
stimuli NNS Physical
-DOCSTART- -X- N

clinically RB Other
computed JJ Other
tomography NN Other
of IN Other
the DT Other
brain NN Other
. . None
response NN Other
rate NN Other
response NN Other
rate NN Other
Time NN Physical
to TO Physical
progression NN Physical
in IN Other
the DT Other
brain NN Other
longer RBR Other
Clinical JJ Other
response NN Other
response NN None
median JJ Mortality
survival NN Mortality
time NN Mortality
Overall JJ None
survival NN None
response NN Other
rate NN Other
Survival NNP Mortality
-DOCSTART- -X- N

lower JJR Physical
extremity NN Physical
joint NN Physical
mechanics NNS Physical
and CC None
muscle NN Physical
Electromyographic NNP Physical
( ( Physical
EMG NNP Physical
) ) Physical
patterns VBZ Physical
maintaining VBG Physical
control NN Physical
of IN Physical
the DT Physical
trunk NN Physical
and CC None
preventing VBG Physical
collapse NN Physical
Distinct NNP Physical
lower JJR Physical
extremity NN Physical
joint JJ Physical
moment NN Physical
and CC None
power NN Physical
patterns NNS Physical
moment NN Physical
of IN Physical
support NN Physical
( ( None
M NNP None
( ( None
s PRP None
) ) None
) ) None
reactive JJ Physical
balance NN Physical
control NN Physical
-DOCSTART- -X- N

independent JJ Physical
ratings NNS Physical
of IN Physical
child NN Physical
goal NN Physical
attainment NN Physical
and CC Physical
several JJ Physical
process NN Physical
measures NNS Physical
( ( Physical
e.g. NN Physical
consultant NN None
and CC None
teacher NN None
fidelity NN None
) ) None
-DOCSTART- -X- N

median JJ Other
duration NN Other
median JJ Mortality
survival NN Mortality
time NN Mortality
response NN Physical
rate NN Physical
, , None
time NN Other
to TO Other
treatment NN Other
failure NN Other
( ( Other
TTF NNP Other
) ) Other
, , None
and CC None
median JJ Mortality
survival NN Mortality
time NN Mortality
TTF NNP Other
survival NN Mortality
longer RBR Mortality
median JJ Mortality
survival NN Mortality
time NN Mortality
-DOCSTART- -X- N

determination NN Physical
of IN Physical
the DT Physical
duration NN Other
of IN Other
the DT Other
relapse-free JJ Mortality
interval NN Mortality
. . None
relapse-free JJ Mortality
interval NN Mortality
or CC Physical
overall JJ Mortality
survival NN Mortality
. . None
number NN Physical
of IN Physical
invaded JJ Physical
lymph NN Physical
nodes NNS Physical
. . None
estimated VBN Other
relapse NN Physical
rate NN Physical
overall JJ Mortality
survival NN Mortality
duration NN Mortality
of IN Mortality
disease-free JJ Mortality
survival NN Mortality
or CC None
overall JJ Mortality
survival NN Mortality
-DOCSTART- -X- N

Killip NNP Physical
class NN Physical
, , None
lower JJR Physical
baseline NN Physical
systolic JJ Physical
pressure NN Physical
, , None
intravenous JJ Other
preenrollment NN Other
lidocaine NN Other
use NN Other
thrombolysis VB Physical
baseline NN Physical
systolic JJ Physical
pressure NN Physical
, , None
intravenous JJ Physical
lidocaine NN Physical
baseline JJ Physical
heart NN Physical
rate NN Physical
30-day JJ Mortality
mortality NN Mortality
rate NN Mortality
1-year JJ Mortality
mortality NN Mortality
rates NNS Mortality
30-day JJ Mortality
and CC Mortality
1-year JJ Mortality
mortality NN Mortality
rates NNS Mortality
mortality NN Mortality
rates NNS Mortality
-DOCSTART- -X- N

incidence NN Physical
and CC Physical
frequency NN Physical
of IN Physical
hypotension NN Physical
and CC Physical
vasopressor NN Physical
therapy NN Physical
Hypotension NNP Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
absolute JJ Physical
systolic JJ Physical
BP NNP Physical
readings NNS Physical
incidence NN Physical
of IN Physical
hypotension NN Physical
incidence NN Adverse
of IN Adverse
ephedrine NN Adverse
use NN Adverse
, , Adverse
incidence NN Adverse
of IN Adverse
nausea/vomiting NN Adverse
median JJ Other
total NN Other
dose NN Other
of IN Other
ephedrine NN Other
hypotension NN Physical
need NN Other
for IN Other
vasopressor NN Other
therapy NN Other
-DOCSTART- -X- N

activated JJ Physical
clotting NN Physical
time NN Physical
plethysmographic JJ Physical
evaluation NN Physical
for IN Physical
RAO NNP Physical
Early JJ Mental
RAO NNP Mental
Chronic NNP Mental
RAO NNP Mental
activated JJ Physical
clotting NN Physical
time NN Physical
-DOCSTART- -X- N

Pharmacokinetic JJ Other
and CC Physical
safety NN Other
assessments NNS Physical
bioavailability NN Other
systemic JJ Other
exposure NN Other
safe JJ Other
and CC Other
well RB Other
tolerated VBN Other
-DOCSTART- -X- N

Adherence NNP Mental
3-day JJ Other
food NN Other
records NNS Other
and CC Other
urine JJ Other
collections NNS Other
in IN Other
children NNS Other
and CC Other
adults NNS Other
. . None
sodium NN Mental
intakes NNS Mental
and CC None
blood NN Physical
pressures NNS Physical
Sodium NNP Mental
intake NN Mental
height NN Physical
, , None
weight NN Physical
, , None
or CC None
blood NN Physical
pressure NN Physical
. . None
-DOCSTART- -X- N

Childhood NNP Mental
Autism NNP Mental
Rating NNP Mental
Scale NNP Mental
( ( Mental
CARS NNP Mental
) ) Mental
, , None
hand NN Physical
muscle NN Physical
testing NN Physical
, , None
and CC None
modified VBD Mental
clinical JJ Mental
global JJ Mental
impression NN Mental
( ( Mental
CGI NNP Mental
) ) Mental
forms VBZ Mental
; : None
parent NN Mental
completed VBD Mental
Autism NNP Mental
Treatment NNP Mental
Evaluation NNP Mental
Checklist NNP Mental
( ( Mental
ATEC NNP Mental
) ) Mental
, , None
treatment NN Mental
adherence NN Mental
measurement NN Mental
( ( Mental
TAM NNP Mental
) ) Mental
, , None
frequency NN Adverse
and CC Adverse
intensity NN Adverse
of IN Adverse
side JJ Adverse
effect NN Adverse
rating NN Adverse
( ( Adverse
FISER NNP Adverse
) ) Adverse
/global VBD Adverse
rating NN Adverse
of IN Adverse
side JJ Adverse
effect NN Adverse
burden NN Adverse
( ( Adverse
GRSEB NNP Adverse
) ) Adverse
/patient VBD Adverse
report NN Adverse
of IN Adverse
incidence NN Adverse
of IN Adverse
side NN Adverse
effects NNS Adverse
( ( Adverse
PRISE NNP Adverse
) ) Adverse
forms NNS Adverse
; : None
and CC None
lab VB None
testing VBG None
. . None
CARS NNP Mental
CGI NNP Mental
ATEC NNP Mental
scores NNS Mental
. . None
hand NN Physical
muscle NN Physical
strength NN Physical
cognitive JJ Mental
scores NNS Mental
CARS NNP Mental
scores NNS Mental
-DOCSTART- -X- N

Efficiency NN Other
survival VB Mortality
rate NN Mortality
meiotic JJ Physical
spindle NN Physical
competence NN Physical
. . None
efficiency NN Other
survival NN Mortality
rate NN Mortality
maintenance NN Physical
of IN Physical
meiotic JJ Physical
spindle NN Physical
. . None
Survival NNP Mortality
rates NNS Mortality
and CC None
maintenance NN Other
of IN Other
meiotic JJ Other
spindle NN Other
observed VBD Other
immediately RB Other
after IN Other
warming VBG Other
and CC Other
3 CD Other
hours NNS Other
after IN Other
incubation NN Other
. . None
survival NN Mortality
rate NN Mortality
detectable JJ Physical
spindle NN Physical
survival JJ Mortality
rates NNS Mortality
meiotic JJ Physical
spindle NN Physical
competence NN Physical
. . None
-DOCSTART- -X- N

mood NN Mental
disturbance NN Mental
less JJR Mental
loneliness NN Mental
higher-quality NN Mental
relationship NN Mental
with IN Mental
a DT Mental
significant JJ Mental
other JJ Mental
cancer-related JJ Physical
worry NN Physical
or CC Physical
well-being NN Physical
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

sputum JJ Physical
interleukin-8 NN Physical
induced JJ Physical
sputum NN Physical
interleukin-8 JJ Physical
( ( Physical
IL-8 NNP Physical
) ) Physical
lung NN Physical
function NN Physical
Total JJ Physical
cell NN Physical
count NN Physical
( ( Physical
TCC NNP Physical
) ) Physical
, , Physical
differential JJ Physical
cell NN Physical
counts NNS Physical
( ( Physical
DCCs NNP Physical
) ) Physical
and CC Physical
IL-8 NNP Physical
in IN Physical
induced JJ Physical
sputum NN Physical
indices NNS Physical
of IN Physical
lung NN Physical
function NN Physical
TCC NNP Physical
and CC Physical
absolute JJ Physical
neutrophil NN Physical
count NN Physical
Sputum NNP Physical
IL-8 NNP Physical
concentration NN Physical
parameters NNS Physical
lung NN Physical
function NN Physical
sputum NN Physical
TCC NNP Physical
, , Physical
absolute JJ Physical
neutrophil NN Physical
count NN Physical
and CC Physical
IL-8 NNP Physical
concentration NN Physical
airway NN Physical
inflammation NN Physical
-DOCSTART- -X- N

clinical JJ Physical
and CC Physical
biochemical JJ Physical
response NN Physical
no DT Physical
change NN Physical
in IN Physical
serum JJ Physical
adrenaline NN Physical
no DT None
measurable JJ Physical
clinical JJ Physical
response NN Physical
. . None
-DOCSTART- -X- N

signal-averaged JJ Physical
electrocardiograms NNS Physical
. . Physical
prolongation NN Physical
of IN Physical
P-wave NNP Physical
and CC Physical
QRS NNP Physical
complex JJ Physical
durations NNS Physical
on IN Physical
signal-averaged JJ Physical
electrocardiograms NNS Physical
. . Physical
signal-averaged JJ Physical
P-wave NNP Physical
and CC Physical
QRS NNP Physical
complexes NNS Physical
. . None
Signal-averaged JJ None
electrocardiograms NNS None
Signal-averaged JJ Physical
P-wave NNP Physical
and CC Physical
QRS NNP Physical
complex JJ Physical
durations NNS Physical
QRS NNP Physical
duration NN Physical
P-wave NNP Physical
duration NN Physical
or CC Physical
heart NN Physical
rate NN Physical
Average JJ Physical
caffeine JJ Physical
level NN Physical
in IN Physical
saliva JJ Physical
signal-averaged JJ Physical
QRS NNP Physical
complexes NNS Physical
. . None
-DOCSTART- -X- N

heart NN Physical
diameters NNS Physical
, , Physical
systolic JJ Physical
and CC Physical
diastolic JJ Physical
left VBD Physical
ventricle NN Physical
function NN Physical
and CC Physical
mean JJ Physical
values NNS Physical
of IN Physical
pulmonary JJ Physical
artery NN Physical
pressure NN Physical
heart NN Physical
diameters NNS Physical
and CC None
left VBD Physical
ventricle NN Physical
systolic JJ Physical
function NN Physical
parameters NNS Physical
left JJ Physical
ventricle NN Physical
diastolic JJ Physical
function NN Physical
MVA NNP Physical
signs NNS None
pulmonary JJ Physical
hypertension NN Physical
-DOCSTART- -X- N

Efficacy NN Other
, , Other
safety NN Other
, , Other
and CC Other
steady-state JJ Other
pharmacokinetics NNS Other
efficacy NN Other
, , Other
safety NN Other
, , Other
and CC Other
pharmacokinetics NNS Other
overall JJ Pain
pain NN Pain
intensity NN Pain
, , None
analgesic JJ Other
efficacy NN Other
, , None
or CC None
adverse JJ Adverse
events NNS Adverse
. . None
pain NN Pain
scores NNS Pain
pain JJ Pain
management NN Pain
AUC NNP Other
ratio NN Other
Fluctuation NN Other
indices NNS Other
analgesia RB None
fluctuation NN Physical
in IN Physical
plasma JJ Physical
morphine NN Physical
concentration NN Physical
pain NN Pain
control NN Pain
. . None
-DOCSTART- -X- N

aroma NN Other
on IN Other
galvanic JJ Other
skin NN Other
response NN Other
relaxation NN Mental
patterns NNS Mental
: : None
relaxed VBD Mental
relaxed VBD Mental
self-reported JJ Mental
relaxation NN Mental
attitudes NNS Mental
-DOCSTART- -X- N

senile JJ Physical
dementia NN Physical
Efficacy NN Other
psychometric JJ Mental
tests NNS Mental
. . None
safe JJ Other
adverse JJ Adverse
reactions NNS Adverse
. . None
-DOCSTART- -X- N

high JJ Other
standard NN Other
of IN Other
care NN Other
Post-Discharge NNP Other
Network NNP Other
Coordination NNP Other
Program NNP Other
frequency NN Other
and CC Other
duration NN Other
of IN Other
patient JJ Other
re-hospitalization NN Other
. . None
Post-Discharge NNP Other
Network NNP Other
Coordination NNP Other
Program NNP Other
. . None
social JJ Mental
support NN Mental
, , None
change NN Mental
in IN Mental
psychiatric JJ Mental
symptoms NNS Mental
, , None
quality NN Physical
of IN Physical
life NN Physical
, , None
and CC None
independence NN Mental
in IN Mental
daily JJ Mental
functioning NN Mental
. . None
post-discharge NN Other
network NN Other
coordination NN Other
program NN Other
integration NN Other
of IN Other
the DT Other
patients NNS Other
into IN Other
their PRP$ Other
social JJ Other
networks NNS Other
coordinating VBG Other
outpatient JJ Other
care NN Other
addressing VBG Physical
concerns NNS Physical
of IN Physical
daily JJ Physical
life NN Physical
. . None
-DOCSTART- -X- N

ASI NNP Other
recurrence-free JJ Physical
period NN Physical
risk NN Other
reduction NN Other
for IN Other
recurrences NNS Other
. . None
Recurrence-free JJ Mortality
survival NN Mortality
overall JJ Mortality
survival NN Mortality
. . None
-DOCSTART- -X- N

postoperative JJ Physical
adhesion NN Physical
reformation NN Physical
effectiveness NN Physical
of IN Physical
Interceed NNP Physical
( ( Physical
TC7 NNP Physical
) ) Physical
adhesions NNS Physical
Interceed NNP Other
( ( Other
TC7 NNP Other
) ) Other
-treated VBD Other
area NN Physical
involved VBN Physical
with IN Physical
adhesions NNS Physical
adhesions NNS Physical
postoperative JJ Physical
adhesions NNS Physical
-DOCSTART- -X- N

pathological JJ Other
complete JJ Other
response NN Other
( ( Other
pCR NN Other
) ) Other
safety NN Other
and CC Other
efficacy NN Other
. . None
TMN NNP Physical
grade VBD Adverse
1/2 CD Adverse
acneiform NN Adverse
skin NN Adverse
rash NN Adverse
grade VBD Adverse
3 CD Adverse
radiodermatitis NN Adverse
diarrhea NN Adverse
hypersensitivity NN Adverse
pCR NN Other
T- JJ Other
and CC Other
N-downstaging JJ Other
rates NNS Other
Total JJ Other
sphincter JJ Other
preservation NN Other
rate NN Other
Non-fatal JJ Adverse
perioperative JJ Adverse
complications NNS Adverse
delayed VBN Adverse
wound NN Adverse
healing VBG Adverse
-DOCSTART- -X- N

platelet NN Physical
aggregation NN Physical
. . Physical
bioavailability NN Other
of IN Other
cyclosporin NN Other
A NNP Other
Urinary JJ Physical
excretion NN Physical
of IN Physical
6-beta-hydroxycortisol NNP Physical
cyclosporin JJ Physical
bioavailability NN Physical
cyclosporin NN Physical
blood NN Physical
levels NNS Physical
Cyclosporin NNP None
bioavailability NN None
-DOCSTART- -X- N

Cost-effectiveness NN Other
Problem NNP Physical
Solving NNP Physical
Treatment NNP Physical
treatment NN Mental
severity NN Mental
of IN Mental
depressive JJ Mental
symptoms NNS Mental
, , None
according VBG None
to TO None
the DT None
PHQ9 NNP Physical
. . None
remission NN Physical
as IN Physical
measured VBN Physical
with IN Physical
the DT Physical
PHQ9 NNP Physical
and CC Physical
the DT Physical
IDS-SR NNP Physical
, , Physical
and CC None
cost-effectiveness NN Other
measured VBN None
with IN None
the DT Other
TiC-P NNP Other
, , None
the DT Other
EQ-5D NNP Other
and CC None
the DT Other
SF-36 NNP Other
. . None
-DOCSTART- -X- N

hepatic JJ Physical
venous JJ Physical
oxygen NN Physical
saturation NN Physical
( ( Physical
ShvO2 NNP Physical
) ) Physical
and CC Physical
splanchnic JJ Physical
oxygen NN Physical
( ( Physical
O2 NNP Physical
) ) Physical
extraction NN Physical
. . Physical
hemodynamic JJ Physical
parameters NNS Physical
, , None
arterial JJ Physical
( ( Physical
SaO2 NNP Physical
) ) Physical
, , Physical
mixed JJ Physical
venous JJ Physical
( ( Physical
SvO2 NNP Physical
) ) Physical
, , None
and CC None
hepatic JJ Physical
venous JJ Physical
oxygen NN Physical
saturations NNS Physical
, , None
systemic JJ Physical
and CC Physical
splanchnic JJ Physical
O2 NNP Physical
extraction NN Physical
, , Physical
arterial JJ Physical
, , Physical
mixed JJ Physical
venous JJ Physical
, , Physical
and CC Physical
hepatic JJ Physical
venous JJ Physical
lactate NN Physical
concentrations NNS Physical
. . None
Cardiac NNP Physical
output NN Physical
( ( Physical
CO NNP Physical
) ) Physical
and CC Physical
mean JJ Physical
arterial JJ Physical
pressure NN Physical
( ( Physical
MAP NNP Physical
) ) Physical
SaO2 NNP Physical
, , None
SvO2 NNP Physical
, , None
and CC None
systemic JJ Physical
O2 NNP Physical
extraction NN Physical
ShvO2 NNP Physical
ShvO2 NNP Physical
splanchnic JJ Physical
O2 NNP Physical
extraction NN Physical
ShvO2 NNP Physical
splanchnic JJ Physical
perfusion NN Physical
CO NNP Physical
and CC None
MAP NNP Physical
splanchnic JJ Physical
perfusion NN Physical
-DOCSTART- -X- N

cognitive NN Mental
and CC Mental
behavioral JJ Mental
attitudes NNS Mental
cognitive JJ Mental
and CC Mental
behavioral JJ Mental
attitudes NNS Mental
more RBR None
persuasive JJ Mental
effects NNS Mental
on IN Mental
behavioral JJ Mental
attitudes NNS Mental
attitudes NNS None
towards IN None
autism NN Mental
. . None
-DOCSTART- -X- N

cell NN Physical
proliferation NN Physical
survival NN Mortality
. . None
efficacy NN Other
safety NN Other
median JJ Mortality
progression-free JJ Mortality
survival NN Mortality
overall JJ Mortality
survival NN Mortality
Median JJ Mortality
progression-free JJ Mortality
survival NN Mortality
overall JJ None
survival NN None
higher JJR None
adverse JJ None
event NN None
was VBD None
neutropenia-reported JJ None
Hyperglycaemia NNP None
was VBD None
reported VBN None
Serious JJ None
adverse JJ None
events NNS None
were VBD None
reported VBN None
improve VB None
outcomes RB None
. . None
Our PRP$ None
-DOCSTART- -X- N

infection NN Physical
Incidence NNP Mortality
of IN Mortality
major JJ Mortality
infection NN Mortality
, , Mortality
death NN Mortality
related VBN Mortality
to TO Mortality
infection NN Mortality
, , Mortality
and CC Mortality
death NN Mortality
. . Mortality
Infection NN Mortality
rates NNS Mortality
deaths NNS Mortality
infection NN Physical
deaths NNS Mortality
early JJ Mortality
deaths NNS Mortality
death NN Mortality
infection-related JJ None
-DOCSTART- -X- N

Four-year JJ Mortality
survival NN Mortality
survival NN Mortality
and CC None
RFS NNP Mortality
experience NN Mortality
shows VBZ Mortality
-DOCSTART- -X- N

total JJ Physical
Childhood NNP Mental
Autism NNP Mental
Rating NNP Mental
Scale NNP Mental
score NN Physical
Children NNP Mental
's POS Mental
Global NNP Mental
Assessment NNP Mental
Scale NNP Mental
score NN Mental
Childhood NNP Mental
Autism NNP Mental
Rating NNP Mental
Scale NNP Mental
score NN Mental
Children NNP Mental
's POS Mental
Global NNP Mental
Assessment NNP Mental
Scale NNP Mental
score NN Mental
social JJ Mental
responsiveness NN Mental
and CC Other
nonverbal JJ Mental
communication NN Mental
symptoms NNS Physical
of IN Physical
hyperactivity NN Mental
and CC Physical
aggression NN Mental
. . Physical
appetite NN Physical
and CC None
a DT None
mild JJ None
weight NN Physical
gain NN Physical
, , None
mild JJ Physical
sedation NN Physical
in IN None
20 CD None
% NN None
, , None
and CC None
transient NN Physical
dyskinesias NN Physical
global JJ Mental
functioning NN Mental
and CC Physical
social JJ Mental
responsiveness NN Mental
reducing VBG Physical
hyperactivity NN Mental
and CC Physical
aggression NN Mental
-DOCSTART- -X- N

urinary JJ Physical
albumin NN Physical
excretion NN Physical
kidney NN Physical
function NN Physical
Renal JJ Physical
function NN Physical
glomerular JJ Physical
filtration NN Physical
rate NN Physical
urinary JJ Physical
albumin JJ Physical
excretion NN Physical
rate NN Physical
( ( Physical
radioimmunoassay NN Physical
) ) Physical
. . Physical
arterial JJ Physical
blood NN Physical
pressure NN Physical
urinary JJ Physical
albumin JJ Physical
excretion NN Physical
rate NN Physical
fractional JJ Physical
clearance NN Physical
of IN Physical
albumin NN Physical
Glomerular JJ Physical
filtration NN Physical
rate NN Physical
blood NN Physical
glucose JJ Physical
concentration NN Physical
glomerular JJ Physical
filtration NN Physical
rate NN Physical
-DOCSTART- -X- N

Information NN Mental
on IN Mental
eating NN Mental
patterns NNS Mental
, , None
dietary JJ Mental
intake NN Mental
, , None
weight NN Physical
and CC None
metabolic JJ Physical
variables NNS Physical
number NN Mental
of IN Mental
snacks NNS Mental
energy NN Mental
intake NN Mental
E NNP None
% NN None
( ( None
energy NN None
percent NN None
) ) None
fat NN None
E NNP Physical
% NN Physical
protein NN Physical
and CC Physical
fiber VB Physical
intake NN Physical
lost VBD Other
weight NN Other
weight JJ Other
loss NN Other
metabolic JJ Physical
variables NNS Physical
high-density NN Physical
lipoprotein NN Physical
1-year JJ Other
weight NN Other
loss NN Other
. . None
-DOCSTART- -X- N

symptoms NNS Mental
and CC Mental
signs NNS Mental
of IN Mental
adverse JJ Adverse
clinical JJ Adverse
effects NNS Adverse
-DOCSTART- -X- N

Bednet NNP Other
use NN Other
Coverage NNP Other
efficiency NN Other
-DOCSTART- -X- N

mean JJ Other
time NN Other
analgesic JJ Other
drugs NNS Other
recurrence NN Physical
of IN Physical
the DT Physical
disease NN Physical
air NN Physical
leak NN Physical
complication NN Adverse
Cost NN Other
of IN Other
ICT NNP Other
and CC Other
VATS NNP Other
hospitalization NN Other
time NN Other
recurrence NN Physical
of IN Physical
the DT Physical
disease NN Physical
and CC None
the DT None
cost NN Other
of IN Other
the DT Other
treatment NN Other
. . None
-DOCSTART- -X- N

Plasma NNP Physical
total JJ Physical
cholesterol NN Physical
, , None
HDL-cholesterol NNP Physical
, , None
LDL-cholesterol NNP Physical
and CC Physical
triglycerides NNS Physical
, , None
urinary JJ Physical
protein NN Physical
excretion NN Physical
and CC None
the DT None
number NN Physical
of IN Physical
podocytes NNS Physical
total JJ Physical
cholesterol NN Physical
LDL-cholesterol NNP Physical
triglycerides NNS Physical
increase NN Physical
in IN Physical
HDL-cholesterol NNP Physical
Urinary JJ Physical
protein NN Physical
excretion NN Physical
urinary JJ Physical
podocyte NN Physical
excretion NN Physical
lipid JJ Physical
levels NNS Physical
, , None
urinary JJ Physical
protein NN Physical
excretion NN Physical
and CC None
urinary JJ Physical
podocyte NN Physical
excretion NN Physical
. . None
LDL-cholesterol NNP Physical
triglycerides NNS Physical
HDL-cholesterol NNP Physical
urinary JJ Physical
protein NN Physical
urinary JJ Physical
podocytes NNS Physical
-DOCSTART- -X- N

markers NNS Physical
of IN Physical
inflammation NN Physical
and CC Physical
oxidative JJ Physical
stress NN Physical
markers NNS Physical
of IN Physical
inflammation NN Physical
and CC Physical
oxidative JJ Physical
stress NN Physical
. . None
plasma JJ None
inflammatory JJ None
markers NNS None
IL-6 NNP None
, , None
C-reactive NNP None
protein NN None
, , None
tumor NN None
necrosis NN None
factor NN None
receptors NNS None
I PRP None
and CC None
II NNP None
( ( None
TNF-RI NNP None
and CC None
-RII NNP None
) ) None
, , None
monocyte JJ None
chemotactic JJ None
protein-1 NN None
and CC None
E-selectin NNP None
, , None
and CC None
urinary JJ None
8-iso-PGF NN None
( ( None
2? CD None
) ) None
, , None
a DT None
marker NN None
of IN None
lipid JJ None
peroxidation NN None
. . None
lower JJR None
TNF-RI NNP None
concentrations NNS None
higher JJR None
E-selectin JJ None
concentrations NNS None
other JJ None
inflammatory JJ None
markers NNS None
. . None
affect JJ None
inflammatory NN None
markers NNS None
. . None
The DT None
urine JJ None
concentration NN None
of IN None
8-iso-PGF JJ None
( ( None
2? CD None
) ) None
[ NN None
affect JJ None
plasma NN None
concentrations NNS None
of IN None
inflammatory JJ None
markers NNS None
, , None
the DT None
urine JJ None
8-iso-PGF JJ None
( ( None
2? CD None
) ) None
concentration NN None
. . None
However RB None
-DOCSTART- -X- N

incidence NN Adverse
of IN Adverse
grade NN Physical
2+ CD Physical
sensory NN Physical
neuropathy NN Physical
( ( Adverse
SN NNP Adverse
) ) Adverse
toxicity NN Adverse
( ( Adverse
CTCAE NNP Adverse
v RB Adverse
3.0 CD Adverse
) ) Adverse
grade NN Physical
2+ CD Physical
SN NNP Physical
toxicity NN Physical
grade NN Physical
2+ CD Physical
SN NNP Physical
time NN None
to TO None
onset VB None
of IN None
neuropathy JJ None
( ( None
P NNP None
was VBD None
well RB None
tolerated VBN None
overall JJ None
sensory JJ None
neuropathy NN None
-DOCSTART- -X- N

urinary JJ Adverse
leakage NN Adverse
haemorrhagic JJ Adverse
episode NN Adverse
. . None
mild JJ Adverse
residue NNS Adverse
collective JJ Adverse
fluid NN Adverse
dilatation NN Adverse
without IN Adverse
obstruction NN Adverse
-DOCSTART- -X- N

15-year JJ Physical
actuarial JJ Physical
locoregional JJ Physical
recurrence NN Physical
rate NN Physical
rates NNS Adverse
of IN Adverse
severe JJ Adverse
acute JJ Adverse
toxicity NN Adverse
15-year JJ Adverse
actuarial JJ Adverse
rate NN Adverse
of IN Adverse
severe JJ Adverse
late JJ Adverse
RT NNP Adverse
complications NNS Adverse
-DOCSTART- -X- N

acute NN Physical
and CC Physical
chronic JJ Physical
gastritis NN Physical
activity NN Physical
of IN Physical
IM NNP Physical
acute NN Physical
gastritis NN Physical
acute NN Physical
and CC Physical
chronic JJ Physical
gastritis NN Physical
GA NNP Physical
acute NN Physical
and CC Physical
chronic JJ Physical
gastritis NN Physical
IM NNP Physical
GA NNP Physical
pathologic JJ Physical
changes NNS Physical
-DOCSTART- -X- N

infectious JJ Adverse
or CC Adverse
hemorrhagic JJ Adverse
complications NNS Adverse
infectious JJ Adverse
or CC Adverse
hemorrhagic JJ Adverse
complications NNS Adverse
amount NN Physical
of IN Physical
rectal NN Physical
and CC Physical
urethral JJ Physical
bleeding NN Physical
infection NN Adverse
after IN Adverse
biopsy NN Adverse
. . Physical
amount NN Physical
of IN Physical
urethral JJ Physical
bleeding NN Physical
Rectal JJ Physical
bleeding NN Physical
High JJ Physical
fever NN Physical
Bacteriuria NNP Physical
in IN Physical
post-biopsy JJ Physical
urine JJ Physical
cultures NNS Physical
urethral JJ Physical
bleeding NN Physical
. . None
rectal JJ Physical
bleeding NN Physical
bacteriuria NN Physical
High NNP Adverse
fever NN Adverse
and CC Adverse
hospitalization NN Adverse
-DOCSTART- -X- N

delay VB Other
recurrence NN Other
recurrence NN Other
rate NN Other
. . None
Survival NN Mortality
-DOCSTART- -X- N

signs NNS Physical
of IN Physical
irritation NN Physical
subjective JJ Physical
complaints NNS Physical
such JJ None
as IN None
itching NN Physical
or CC Physical
burning NN Physical
erythema NN Physical
with IN Physical
or CC Physical
without IN Physical
infiltration NN Physical
Nonallergic NNP Physical
skin JJ Physical
irritation NN Physical
systemic JJ Physical
reactions NNS Physical
. . None
tolerated VBN Other
-DOCSTART- -X- N

ratings NNS Mental
of IN Mental
attention-deficit/hyperactivity NN Mental
disorder NN Mental
( ( Mental
ADHD NNP Mental
) ) Mental
and CC None
associated VBN Mental
behavior NN Mental
behavioral JJ Mental
effects NNS Mental
parent NN Other
and CC Other
teacher RB Other
behavioral JJ Other
ratings NNS Other
hyperactive JJ Mental
and CC Mental
impulsive JJ Mental
behavior NN Mental
at IN Mental
both DT Mental
home NN Mental
and CC Mental
school NN Mental
. . None
inattentive JJ Mental
and CC Mental
oppositional JJ Mental
behavior NN Mental
social JJ Mental
skills NNS Mental
. . None
exacerbation NN Mental
of IN Mental
stereotypies NNS Mental
side JJ Adverse
effects NNS Adverse
efficacious JJ Other
and CC Other
well-tolerated JJ Other
-DOCSTART- -X- N

actuarial JJ Mortality
disease-free JJ Mortality
survival NN Mortality
overall JJ Mortality
actuarial JJ Mortality
survivals NNS Mortality
Local JJ Other
control NN Other
actuarial JJ Mortality
disease-free NN Mortality
and CC Mortality
overall JJ Mortality
survivals NNS Mortality
disease-free JJ Mortality
survival NN Mortality
overall JJ Mortality
actuarial JJ Mortality
survival NN Mortality
disease-free JJ Mortality
survival NN Mortality
toxicity NN Physical
doxorubicin-induced JJ Adverse
cardiomyopathy NN Adverse
congestive JJ Physical
heart NN Physical
failure NN Physical
disease-free JJ Mortality
survival NN Mortality
overall JJ Mortality
survival NN Mortality
-DOCSTART- -X- N

compare VB Physical
nitrogen NN Physical
, , Physical
mineral NN Physical
, , Physical
and CC Physical
zinc NN Physical
balance NN Physical
Nitrogen NNP Physical
and CC Physical
magnesium NN Physical
balances NNS Physical
calcium NN Physical
, , Physical
phosphorus NN Physical
, , Physical
and CC Physical
zinc NN Physical
retention NN Physical
of IN Physical
calcium NN Physical
, , Physical
phosphorus NN Physical
( ( Physical
both DT Physical
formulas NN Physical
) ) Physical
, , Physical
and CC Physical
zinc NN Physical
-DOCSTART- -X- N

quality NN Physical
of IN Physical
life NN Physical
QoL NNP Physical
longitudinal JJ Physical
quality NN Physical
of IN Physical
life NN Physical
( ( Physical
QoL NNP Physical
) ) Physical
QLQ-C30 JJ Physical
scores NNS Physical
frequencies NNS Physical
of IN Physical
QLQ-C30 NNP Physical
score NN Physical
improvement NN Physical
survival NN Mortality
until IN Mortality
definitive JJ Mortality
global JJ Mortality
health NN Mortality
score NN Mortality
( ( Mortality
GHS NNP Mortality
) ) Mortality
deterioration NN Mortality
global JJ Physical
health NN Physical
QoL NNP Physical
. . None
time NN Physical
until IN Physical
definitive JJ Physical
GHS NNP Physical
deterioration NN Physical
QoL NNP Physical
assessment NN Physical
-DOCSTART- -X- N

histology NN Other
Diagnostic JJ Other
accuracy NN Other
no DT Physical
added JJ Physical
complications NNS Physical
, , Other
no DT Other
increase NN Other
in IN Other
hospital JJ Other
stay NN Other
reduction NN Other
in IN Other
hospital NN Other
stay NN Other
-DOCSTART- -X- N

sensitivity NN Other
and CC Other
specificity NN Other
sensitivity NN Other
and CC Other
specificity NN Other
LC NNP Physical
coronary JJ Physical
artery NN Physical
lesions NNS Physical
. . None
-DOCSTART- -X- N

a DT None
projected JJ None
median JJ Mortality
overall JJ Mortality
survival NN Mortality
( ( Mortality
OS NNP Mortality
) ) Mortality
months NNS None
. . None
Marrow NNP None
and CC None
blood NN None
( ( None
T NNP None
cell NN None
) ) None
chimerism NN None
median NN None
of IN None
100 CD None
% NN None
donor NN None
( ( None
T NNP None
cell NN None
) ) None
-derived VBD None
DNA NNP None
. . None
has VBZ None
been VBN None
no DT None
secondary JJ Adverse
graft NN Adverse
failure NN Adverse
. . None
In IN None
patient NN None
died VBD None
of IN None
pneumonia NN None
, , None
and CC None
liver NN None
GVHD NNP None
pretransplant JJ None
conditioning NN None
is VBZ None
safe JJ None
is VBZ None
sufficiently RB None
immunosuppressive JJ None
to TO None
support VB None
evaluate VB None
the DT None
antileukemic JJ None
efficacy NN None
of IN None
Clo NNP None
pretransplant JJ None
conditioning NN None
therapy NN None
are VBP None
warranted VBN None
. . None
-DOCSTART- -X- N

bone NN Physical
metabolism NN Physical
bone NN Physical
bone NN Physical
properties NNS Physical
orthotopic RB Physical
endochondral JJ Physical
bone NN Physical
formation NN Physical
. . Physical
femoral JJ Physical
torsional JJ Physical
strength NN Physical
trabecular JJ Physical
femoral JJ Physical
metaphyseal JJ Physical
mineral JJ Physical
apposition NN Physical
rates NNS Physical
callus NN Physical
and CC Physical
bone NN Physical
union NN Physical
. . Physical
bone NN Physical
properties NNS Physical
. . None
-DOCSTART- -X- N

anxiety NN None
Spence NNP Mental
Child NNP Mental
Anxiety NNP Mental
Scale NNP Mental
-- : Mental
Child NNP Mental
( ( Mental
SCAS-C NNP Mental
) ) Mental
Clinical JJ Mental
Global NNP Mental
Impression-Severity NNP Mental
scale NN Mental
( ( Mental
CGI NNP Mental
-- : Mental
S NNP Mental
) ) Mental
generalized VBN Mental
anxiety NN Mental
and CC Mental
total JJ Mental
anxiety NN Mental
symptoms NNS Mental
CGI-S NNP Mental
-DOCSTART- -X- N

behavioral JJ Mental
symptoms NNS Mental
learning VBG Mental
Clinical JJ Mental
Global NNP Mental
Consensus NNP Mental
Ratings NNP Mental
fidgety NN Mental
and CC Mental
hyperactive JJ Mental
behavior NN Mental
overall JJ Mental
symptomatology NN Mental
discrimination NN Mental
learning VBG Mental
. . None
-DOCSTART- -X- N

vaccines NNS Other
Immunogenicity NNP Physical
local JJ Adverse
and CC Adverse
systemic JJ Adverse
reactions NNS Adverse
. . Adverse
Local JJ Physical
reactions NNS Physical
swelling VBG Adverse
and CC Adverse
redness NN Adverse
Fever NNP Adverse
Geometric NNP Physical
mean JJ Physical
titres NNS Physical
( ( Physical
GMTs NNP Physical
) ) Physical
ELISA NNP Other
pertussis VB Physical
toxin NN Physical
( ( Physical
PT NNP Physical
) ) Physical
and CC Physical
filamentous JJ Physical
haemagglutinin NN Physical
( ( Physical
FHA NNP Physical
) ) Physical
GMTs NNP Physical
of IN Physical
tetanus NN Physical
and CC Physical
diphtheria NN Physical
antitoxins NNS Physical
GMTs NNP Physical
to TO Physical
PT NNP Physical
GMTs NNP Physical
to TO Physical
FHA NNP Physical
immunogenic JJ Physical
less JJR Physical
local JJ Physical
and CC Physical
systemic JJ Physical
reactions NNS Physical
antibody NN Physical
titres NNS Physical
anti-PT JJ Physical
and CC Physical
anti-FHA JJ Physical
antibodies NNS Physical
-DOCSTART- -X- N

the DT None
pain NN None
relief NN None
using VBG None
pain NN None
relief NN None
and CC None
patient JJ None
satisfaction NN None
scores NNS None
( ( None
0.05 CD None
) ) None
. . None
Pain VB None
relief NN None
during IN None
the DT None
pain NN None
relief NN None
scoring VBG None
pain VB None
relief NN None
and CC None
side NN None
effects NNS None
. . None
-DOCSTART- -X- N

tachycardia NN Physical
heart NN Physical
rate NN Physical
heart NN Physical
rate NN Physical
and CC None
blood NN Physical
pressure NN Physical
increase NN None
in IN None
heart NN Physical
rate NN Physical
and CC None
blood NN Physical
pressure NN Physical
heart NN Physical
rate NN Physical
blood NN Physical
pressure NN Physical
heart NN Physical
rate NN Physical
-DOCSTART- -X- N

effectiveness NN Other
effectiveness NN Other
effective JJ Other
sleeping VBG Mental
behavior NN Mental
significantly RB Other
more RBR Other
effective JJ Other
movement NN Mental
and CC Mental
crying NN Mental
behaviors NNS Mental
significantly RB Other
more RBR Other
effective JJ Other
remainder NN None
of IN None
treatment NN None
no DT None
statistically RB None
significant JJ None
difference NN None
successful JJ Other
behavior NN Mental
evaluation NN Mental
effective JJ Other
-DOCSTART- -X- N

knee NN Physical
osteoarthritis NN Physical
Lysholm NNP Physical
knee NN Physical
score NN Physical
( ( Physical
LKSS NNP Physical
) ) Physical
. . Physical
LKSS NNP Physical
therapeutic JJ Other
efficacy NN Other
LKSS NNP Physical
: : None
LKSS NNP Physical
LKSS NNP Physical
LKSS NNP Physical
LKSS NNP Physical
clinical JJ Other
efficacy NN Other
-DOCSTART- -X- N

limb NN Physical
motor NN Physical
function NN Physical
Fugl-Meyer NNP Physical
Assessment NNP Physical
( ( Physical
FMA NNP Physical
) ) Physical
scale NN Physical
FMA NNP Physical
score NN Physical
improvement NN Physical
of IN Physical
FMA NNP Physical
score NN Physical
-DOCSTART- -X- N

mammographic JJ Physical
density NN Physical
and CC None
parenchymal JJ Physical
pattern NN Physical
. . None
Mammographic NNP Physical
densities NNS Physical
lower JJR Physical
to TO Physical
greater JJR Physical
parenchymal JJ Physical
density NN Physical
tissue NN Physical
density NN Physical
percentage NN Physical
increase NN Physical
in IN Physical
density NN Physical
percentage NN Physical
mammographic JJ Physical
density NN Physical
-DOCSTART- -X- N

S. NNP None
mutans NNS None
in IN None
saliva NN None
S. NNP None
mutans NNS None
caries NNS Physical
progression NN Physical
S. NNP None
mutans NN Physical
levels NNS Physical
. . None
new JJ Physical
or CC Physical
progressive JJ Physical
caries NNS Physical
-DOCSTART- -X- N

delta/theta JJ Physical
activity NN Physical
alpha NN Physical
and CC Physical
beta NN Physical
activity NN Physical
total JJ Physical
power NN Physical
centroid NN Physical
improvement NN Other
in IN Other
both DT Other
SDAT NNP Other
and CC Other
MID NNP Other
CGI NNP None
, , None
MMS NNP None
, , None
SCAG NNP None
, , None
and CC None
DSST NNP None
. . None
-DOCSTART- -X- N

agoraphobia NN Mental
early JJ Mental
onset NN Mental
of IN Mental
panic JJ Mental
disorder NN Mental
agoraphobia NNS Mental
. . None
treatment NN Other
response NN Other
similar JJ Other
early JJ Mental
, , Mental
medium NN Mental
or CC Mental
late JJ Mental
onset NN Mental
of IN Mental
panic JJ Mental
disorder NN Mental
. . None
panic JJ Mental
disorder NN Mental
and CC Mental
avoidance NN Mental
behavior NN Mental
age NN Mental
of IN Mental
onset NN Mental
of IN Mental
panic JJ Mental
disorder NN Mental
-DOCSTART- -X- N

The DT None
Autism NNP Mental
Behavior NNP Mental
Checklist NNP Mental
of IN None
non-adaptable JJ None
characteristics NNS None
areas NNS None
: : None
sensory NN Mental
, , Mental
use NN Mental
of IN Mental
the DT Mental
body NN Mental
and CC Mental
object NN Mental
, , Mental
Language NNP Mental
, , Mental
Psycho-social NNP Mental
and CC Mental
Relational NNP Mental
. . None
the DT None
total JJ None
scores NNS None
and CC None
in IN None
the DT None
areas NNS Mental
of IN Mental
language NN Mental
, , Mental
psycho-social JJ Mental
and CC Mental
relational JJ Mental
for IN None
the DT None
TG NNP None
. . None
observed VBD None
behavioral JJ None
changes NNS None
. . None
-DOCSTART- -X- N

persistent JJ Physical
epithelial JJ Physical
defects NNS Physical
. . None
Rate NN Physical
of IN Physical
healing NN Physical
of IN Physical
the DT Physical
epithelial JJ Physical
defects NNS Physical
decrease NN Physical
in IN Physical
the DT Physical
size NN Physical
of IN Physical
the DT Physical
epithelial JJ Physical
defect NN Physical
complete JJ Physical
re-epithelialisation NN Physical
faster RBR Physical
healing NN Physical
of IN Physical
the DT Physical
persistent JJ Physical
corneal NN Physical
epithelial JJ Physical
defects NNS Physical
-DOCSTART- -X- N

change NN Physical
in IN Physical
tests NNS Physical
of IN Physical
cardiovascular JJ Physical
autonomic JJ Physical
function NN Physical
. . Physical
Autonomic NNP Physical
function NN Physical
change NN Physical
in IN Physical
biochemical JJ Physical
parameters NNS Physical
[ VBP Physical
e.g NN Physical
. . Physical
plasma JJ Physical
renin NN Physical
activity NN Physical
, , Physical
leptin NN Physical
and CC Physical
interleukin-6 JJ Physical
] NN Physical
. . Physical
Change NN Physical
in IN Physical
cardiovascular JJ Physical
autonomic JJ Physical
function NN Physical
and CC Physical
blood NN Physical
analytes NNS Physical
blood NN Physical
pressure NN Physical
-DOCSTART- -X- N

rates NNS None
successful JJ Other
first-time JJ Other
intubation NN Other
unsuccessful JJ Other
first-time JJ Other
intubations NNS Other
successful JJ Other
intubations NNS Other
presence NN Other
of IN Other
a DT Other
laryngoscope NN Other
rate NN Other
of IN Other
successful JJ Other
first-time JJ Other
intubations NNS Other
. . None
successful JJ Other
-DOCSTART- -X- N

number NN Physical
of IN Physical
cigarettes NNS Physical
, , None
number NN Physical
of IN Physical
puffs NNS Physical
per IN Physical
cigarette NN Physical
, , None
and CC None
expired VBD Physical
air NN Physical
carbon NN Physical
monoxide NN Physical
level NN Physical
. . None
blood NN Physical
pressure NN Physical
standing VBG Physical
heart NN Physical
rate NN Physical
. . Physical
-DOCSTART- -X- N

macrovascular JJ Physical
events NNS Physical
myocardial JJ Physical
infarction NN Physical
stroke NN Physical
. . None
macrovascular JJ Physical
complications NNS Physical
. . None
macrovascular JJ Physical
morbidity NN Physical
mortality NN Mortality
composite NN Mortality
of IN Mortality
all-cause JJ Mortality
mortality NN Mortality
, , None
non JJ Physical
fatal JJ Physical
myocardial JJ Physical
infarction NN Physical
( ( None
including VBG None
silent JJ Physical
myocardial JJ Physical
infarction NN Physical
) ) None
, , None
stroke VBD Physical
, , None
acute JJ Physical
coronary JJ Physical
syndrome NN Physical
, , None
endovascular JJ Physical
or CC Physical
surgical JJ Physical
intervention NN Physical
in IN Physical
the DT Physical
coronary NN Physical
or CC Physical
leg NN Physical
arteries NNS Physical
, , None
and CC None
amputation NN Physical
above IN Physical
the DT Physical
ankle NN Physical
. . None
primary JJ Physical
composite JJ Physical
endpoint NN Physical
composite NN Mortality
of IN Mortality
all-cause JJ Mortality
mortality NN Mortality
, , Physical
non-fatal JJ Physical
myocardial JJ Physical
infarction NN Physical
, , Physical
and CC Physical
stroke VBD Physical
. . None
endpoint NN Physical
Overall JJ Other
safety NN Other
and CC None
tolerability NN Other
safety NN Other
profile NN Other
heart NN Physical
failure NN Physical
; : None
mortality NN Mortality
rates NNS Mortality
from IN Mortality
heart NN Mortality
failure NN Mortality
mortality NN Mortality
, , None
non-fatal JJ Physical
myocardial JJ Physical
infarction NN Physical
stroke VBD Physical
-DOCSTART- -X- N

contrast-induced JJ Adverse
nephropathy JJ Adverse
( ( Adverse
CIN NNP Adverse
) ) Adverse
. . Adverse
Contrast-induced JJ Adverse
nephropathy NN Adverse
increase NN Adverse
in IN Adverse
serum JJ Adverse
creatinine NN Adverse
level NN Adverse
> VBD Adverse
25 CD Adverse
% NN Adverse
demographic JJ None
properties NNS None
nephropathy JJ None
risk NN None
factors NNS None
. . None
change NN Adverse
in IN Adverse
creatinine JJ Adverse
clearance NN Adverse
incidence NN Adverse
of IN Adverse
CIN NNP Adverse
Mehran NNP Adverse
nephropathy NN Adverse
risk NN Adverse
score NN Adverse
risk NN Adverse
of IN Adverse
CIN NNP Adverse
protection NN None
CIN NNP Adverse
-DOCSTART- -X- N

Anti-angiogenic JJ Physical
effects NNS Physical
antioxidant JJ Physical
, , None
immunomodulatory JJ Physical
, , None
photoprotective JJ Physical
, , None
anti-angiogenic JJ Physical
, , None
and CC None
anti-inflammatory JJ Physical
properties NNS Physical
. . None
biopsies NNS Other
Immunohistochemistry NN Other
VEGF NNP None
and CC None
HIF-1 NNP None
?. NNP None
HIF-1 NNP None
? . None
expression NN None
was VBD None
showed VBD None
positive JJ None
staining NN None
in IN None
VEGF NNP None
expression NN None
was VBD None
influence VB None
HIF-1 NNP None
? . None
induction NN None
and CC None
VEGF NNP None
expression NN None
and CC None
prevention NN None
of IN None
-DOCSTART- -X- N

side NN Adverse
effects NNS Adverse
the DT None
mean JJ None
Yale-Brown JJ Mental
Obsessive-Compulsive JJ Mental
Scale NNP Mental
score NN Mental
. . None
lower JJR None
scores NNS None
for IN None
obsessive-compulsive JJ None
disorder NN None
, , None
improved JJ None
outcomes NNS None
. . None
-DOCSTART- -X- N

length NN Other
of IN Other
hospitalization NN Other
pain NN Pain
, , None
need VBP Physical
to TO Physical
stop VB Physical
feeding NN Physical
, , Pain
post-refeeding JJ Physical
LOH NNP Physical
re-admission NN Other
rates NNS Other
. . None
number NN Physical
of IN Physical
patients NNS Physical
requiring VBG Physical
cessation NN Physical
of IN Physical
feeding VBG Physical
because IN Pain
of IN Pain
pain NN Pain
or CC Pain
nausea NN Physical
median JJ Physical
LOH NNP Physical
after IN Physical
refeeding VBG Physical
calories NNS Physical
and CC Physical
grams NNS Physical
of IN Physical
fat NN Physical
28-day JJ Other
re-admission NN Other
rates NNS Other
mild JJ Physical
acute JJ Physical
pancreatitis NN Physical
LFSD NNP Physical
LOH NNP Other
. . None
-DOCSTART- -X- N

effect NN Other
on IN Other
survival NN Other
survival VBN Mortality
survival NN Mortality
median JJ Mortality
survival NN Mortality
survival NN Mortality
median JJ Mortality
survival NN Mortality
median JJ Mortality
survival NN Mortality
tolerated VBN Other
survival NN Mortality
survival JJ Mortality
-DOCSTART- -X- N

cephalad JJ Physical
dermatome JJ Physical
level NN Physical
of IN Physical
the DT Physical
block NN Physical
and CC None
degree NN Physical
of IN Physical
motor NN Physical
block NN Physical
Times NNS Physical
to TO Physical
two-segment JJ Physical
T-10 JJ Physical
regression NN Physical
Time NN Physical
to TO Physical
L-1 NNP Physical
regression NN Physical
hypotension NN Physical
and CC Adverse
emesis NN Physical
bradycardia NN Physical
and CC None
urinary JJ Physical
retention NN Physical
transient JJ Physical
neurological JJ Physical
symptoms NNS Physical
Sensory NNP Physical
and CC Physical
motor NN Physical
regression NN Physical
Side JJ Adverse
effects NNS Adverse
transient JJ Physical
neurological JJ Physical
symptoms NNS Physical
-DOCSTART- -X- N

elasticity NN Physical
Large NNP Physical
( ( Physical
C1 NNP Physical
) ) Physical
and CC Physical
small JJ Physical
artery NN Physical
elasticity NN Physical
( ( Physical
C2 NNP Physical
) ) Physical
reduced VBD None
body NN Physical
weight NN Physical
waist JJ None
circumference NN None
systolic JJ None
diastolic JJ None
blood NN None
pressures NNS None
, , None
cardiac JJ None
output NN None
( ( None
-4 CD None
% NN None
) ) None
, , None
plasma JJ None
TG NNP None
concentration NN None
homeostasis NN None
model NN None
assessment NN None
( ( None
HOMA NNP None
) ) None
score NN None
increased VBD Physical
plasma NN Physical
HDL NNP Physical
cholesterol NN Physical
adiponectin NN None
concentrations NNS None
. . None
significantly RB None
reduced VBN None
body NN None
weight NN None
waist JJ None
circumference NN None
systolic JJ Physical
diastolic JJ Physical
blood NN None
pressures NNS None
, , None
pulse JJ Physical
pressure NN Physical
heart NN None
rate NN None
plasma JJ Physical
TG NNP Physical
concentration NN Physical
HOMA NNP None
score NN None
increased JJ Physical
stroke NN Physical
volume NN Physical
plasma JJ None
HDL NNP None
cholesterol NN None
adiponectin JJ None
concentrations NNS None
C1 NNP None
C2 NNP None
artery NN None
elasticity NN None
. . None
systolic JJ Physical
blood NN Physical
pressure NN Physical
, , None
heart NN Physical
rate NN Physical
, , None
plasma NN Physical
TGs NNP Physical
, , None
C1 NNP Physical
, , None
and CC None
C2 NNP Physical
significantly RB None
greater JJR None
C1 NNP Physical
and CC None
C2 NNP Physical
weight JJ Physical
loss NN Physical
-DOCSTART- -X- N

severe JJ Physical
rotavirus NN Physical
gastroenteritis NN Physical
. . None
efficacy NN Other
protection NN Physical
against IN Physical
severe JJ Physical
rotavirus NN Physical
gastroenteritis NN Physical
efficacy NN Other
severe JJ Physical
rotavirus NN Physical
gastroenteritis NN Physical
severe JJ Physical
gastroenteritis NN Physical
-DOCSTART- -X- N

pain NN Pain
relief NN Pain
change NN Pain
in IN Pain
self-reported JJ Pain
pain NN Pain
visual JJ Other
analogue NN Other
scale NN Other
VAS NNP Other
change NN Other
scores NNS Other
at IN Other
10 CD Other
, , Other
60 CD Other
, , Other
90 CD Other
and CC Other
120 CD Other
min NN Other
, , Physical
analgesia NN Other
use NN Other
, , Physical
mode NN Other
of IN Other
birth NN Other
and CC Physical
maternal JJ Mental
satisfaction NN Mental
. . Physical
the DT None
VAS NNP None
, , None
primary JJ None
( ( None
VAS NNP None
pain RB None
score RB None
) ) None
and CC None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
International NNP Physical
Prostate NNP Physical
Symptom NNP Physical
Score NNP Physical
peak NN Physical
urinary JJ Physical
flow NN Physical
rate NN Physical
Differences NNS Other
in IN Other
treatment NN Other
efficacy NN Other
total JJ Physical
International NNP Physical
Prostate NNP Physical
Symptom NNP Physical
Score NNP Physical
irritative JJ Physical
obstructive JJ Physical
International NNP Physical
Prostate NNP Physical
Symptom NNP Physical
Score NNP Physical
International NNP Physical
Prostate NNP Physical
Symptom NNP Physical
Score NNP Physical
peak JJ Physical
urinary JJ Physical
flow NN Physical
rate NN Physical
adverse JJ Adverse
event NN Adverse
retrograde NN Adverse
ejaculation NN Adverse
retrograde JJ Adverse
ejaculation NN Adverse
. . None
orthostatic JJ Physical
hypotension NN Physical
urinary JJ Physical
symptoms NNS Physical
orthostatic JJ Physical
hypotension NN Physical
. . None
-DOCSTART- -X- N

Effectiveness NN Other
Vineland NNP Mental
Maladaptive NNP Mental
Behavior NNP Mental
Domain NNP Mental
and CC None
the DT None
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
. . Mental
Standardized NNP Other
neurologic JJ Other
examinations NNS Other
before IN None
and CC None
after IN None
treatment NN None
all DT None
behavioral JJ Mental
measures NNS Mental
-DOCSTART- -X- N

functional JJ Physical
ability NN Physical
physical JJ Physical
activity NN Physical
level NN Physical
anxiety NN Mental
, , Mental
depression NN Mental
functional JJ Mental
ability NN Mental
Sociodemographic NNP None
data NNS None
and CC None
clinical JJ None
features NNS None
Physical JJ None
activity NN None
level NN None
and CC None
energy NN None
expenditure NN None
Anxiety NN None
by IN None
The DT None
Screen NNP None
for IN None
Child NNP None
Anxiety NNP None
Related NNP None
Emotional NNP None
Disorders NNP None
( ( None
SCARED NNP None
) ) None
Depressive JJ None
symptoms NNS None
Pain NN None
and CC None
overall JJ None
well-being NN None
less JJR None
time NN None
in IN None
physical JJ None
activity NN None
( ( None
p JJ None
decrease NN None
in IN None
energy NN None
expenditure NN None
( ( None
p JJ None
= NNP None
higher JJR None
CHAQ NNP None
scores NNS None
( ( None
between IN None
the DT None
number NN None
of IN None
active JJ None
joint NN None
and CC None
disease NN None
duration NN None
( ( None
r JJ None
VAS NNP None
pain NN None
( ( None
r NN None
found VBN None
between IN None
VAS NNP None
overall JJ None
well-being NN None
and CC None
CDI NNP None
( ( None
r VB None
CHAQ NNP None
( ( None
r VB None
and CC None
VAS NNP None
pain NN None
between IN None
CHAQ NNP None
and CC None
CDI NNP None
that IN None
only JJ None
depression NN None
was VBD None
related VBN None
to TO None
anxiety NN None
, , None
functional JJ None
ability NN None
, , None
and CC None
well-being NN None
-DOCSTART- -X- N

itraconazole JJ Other
absorption NN Other
serum JJ Physical
versus NN Physical
time NN Physical
data NNS Physical
Peak NNP Other
serum JJ Other
concentration NN Other
and CC None
time NN Other
to TO Other
peak VB Other
mean JJ Other
+/- JJ Other
SD NNP Other
peak NN Other
serum NN Other
itraconazole JJ Other
concentration NN Other
absorption NN Other
of IN Other
itraconazole NN Other
. . None
-DOCSTART- -X- N

'controlled-release NNP Other
' POS Other
tablet NN Other
formulation NN Other
of IN Other
200 CD Other
mg NNS Other
100 CD None
mg NN None
indomethacin NN Other
suppository NN Other
pain VB Pain
at IN Pain
awakening NN Pain
and CC Pain
morning NN Pain
stiffness NN Pain
. . None
gastro-intestinal JJ Adverse
and CC Adverse
CNS NNP Adverse
disturbances NNS Adverse
side-effects NNS Adverse
ketoprofen NN Other
than IN None
with IN None
indomethacin NN Other
. . None
-DOCSTART- -X- N

Hb NNP Physical
, , Physical
Hct NNP Physical
, , Physical
FEP NNP Physical
, , Physical
and CC Physical
ferritin NNS Physical
hemoglobin NN Physical
-DOCSTART- -X- N

total JJ Physical
scores NNS Physical
sensory JJ Physical
motor NN Physical
scores NNS Physical
symptom JJ Physical
severity NN Physical
-DOCSTART- -X- N

sustained VBN Other
concentrations NNS Other
of IN Other
the DT Other
drug NN Other
lung JJ Physical
area NN Physical
under IN Physical
the DT Physical
curve NN Physical
ratio NN Physical
of IN Physical
AUC NNP Physical
( ( Physical
bronchial JJ Physical
washing NN Physical
) ) Physical
versus NN Physical
AUC NNP Physical
( ( Physical
plasma NN Physical
) ) Physical
AUC NNP Physical
( ( Physical
lung NN Physical
) ) Physical
versus NN Physical
AUC NNP Physical
( ( Physical
plasma NN Physical
) ) Physical
pharmacokinetic JJ Other
profile NN Other
-DOCSTART- -X- N

MET NNP None
expression NN None
did VBD None
terms NNS None
of IN None
objective JJ None
response NN None
rate NN None
, , None
progression-free JJ None
survival NN None
, , None
or CC None
overall JJ None
survival NN None
. . None
CONCLUSIONS NNP None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
toxicity NN Other
Complete JJ Other
response NN Other
( ( Other
CR NNP Other
) ) Other
rates NNS Other
confidence NN Other
interval NN Other
( ( Other
CI NNP Other
) ) Other
: : Other
failure-free JJ Mortality
survival NN Mortality
( ( Mortality
FFS NNP Mortality
) ) Mortality
and CC Mortality
overall JJ Mortality
survival NN Mortality
( ( Mortality
OS NNP Mortality
) ) Mortality
had VBD Mortality
statistical JJ Mortality
differences NNS Mortality
. . Mortality
actuarial JJ Mortality
FFS NNP Mortality
OS CC Mortality
rates NNS Mortality
Toxicity NN Adverse
therapy-related JJ Mortality
deaths NNS Mortality
neoplasia NN Physical
or CC Physical
acute NN Physical
leukemia NN Physical
The DT Physical
international JJ Physical
prognostic JJ Physical
index NN Physical
pleural JJ Physical
and CC Physical
pericardial JJ Physical
effusion NN Physical
and CC Physical
chemotherapy NN Physical
regimen NNS Physical
FFS NNP Mortality
and CC Mortality
OS NNP Mortality
. . Mortality
-DOCSTART- -X- N

practice NN Other
of IN Other
evidence-based JJ Other
care NN Other
intervention NN Other
effects NNS Other
effect NN Other
magnitudes NNS Other
frequently RB Other
efficacy NN Other
just-in-time JJ Other
evidence-based JJ Other
reminders NNS Other
-DOCSTART- -X- N

quality NN Other
of IN Other
life NN Other
, , None
work NN Other
productivity NN Other
medical JJ Other
resource NN Other
utilization NN Other
quality NN Other
of IN Other
life NN Other
( ( Other
QOL NNP Other
) ) Other
, , None
work NN Other
productivity NN Other
, , None
and CC None
medical JJ Other
resource NN Other
utilization NN Other
health-related JJ Physical
QOL NNP Physical
, , None
work NN Other
productivity NN Other
and CC None
resource NN Other
utilization NN Other
. . None
SF-36 NNP Physical
Health NNP Physical
Survey NNP Physical
Questionnaire NNP Physical
and CC Physical
additional JJ Physical
generic NN Physical
and CC Physical
specific JJ Physical
scales NNS Physical
. . None
Hepatitis NNP Other
Quality NNP Other
of IN Other
Life NNP Other
Questionnaire NNP Other
( ( Other
HQLQ NNP Other
) ) Other
-specific NN Other
scales NNS Other
impairment JJ None
health-related JJ Other
QOL NNP Other
. . None
work NN Other
productivity NN Other
, , None
less JJR Other
activity NN Other
impairment NN Other
, , None
decreased VBD Other
need NN Other
for IN Other
prescription NN Other
drugs NNS Other
to TO Other
treat VB Other
adverse JJ Adverse
effects NNS Adverse
, , None
and CC None
better JJR Mental
adherence NN Mental
to TO Mental
therapy NN Mental
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

patient NN Other
and CC Other
surgeon JJ Other
satisfaction NN Other
scores NNS Other
verbal JJ Pain
pain NN Pain
scale NN Pain
scores NNS Pain
postoperative JJ Other
analgesia NN Other
. . None
Ramsay NNP Other
sedation NN Other
scale NN Other
scores NNS Other
Intraocular JJ Physical
pressure NN Physical
alterations NNS Physical
Recovery JJ Other
time NN Other
patient JJ Other
satisfaction NN Other
scores NNS Other
pain NN Pain
scores NNS Pain
recovery NN Other
time NN Other
. . None
-DOCSTART- -X- N

results NNS Physical
quality NN Other
-DOCSTART- -X- N

RDN NNP Physical
levels NNS Physical
FMS NNP None
. . None
The DT None
digestibility NN None
coefficients NNS None
of IN None
all DT None
nutrients NNS None
and CC None
MPS NNP None
increased VBD None
( ( None
P NNP None
< NNP None
increasing VBG None
level NN None
of IN None
RDN NNP None
supplementation NN None
. . None
NCE NNP None
decreased VBD None
linearly RB None
of IN None
RDN NNP None
increased VBD None
. . None
CONCLUSION NNP None
-DOCSTART- -X- N

March-September NNP None
) ) None
. . None
Blood NN None
samples NNS None
were VBD None
Baseline NNP None
serum NN None
25 CD None
( ( None
OH NNP None
) ) None
D NNP None
was VBD None
mean VBP None
serum JJ None
25 CD None
( ( None
OH NNP None
) ) None
D NNP None
increased VBD None
0.001 CD None
) ) None
. . None
Serum NNP None
PTH NNP None
decreased VBD None
-DOCSTART- -X- N

satisfaction NN Other
rate NN Other
and CC None
the DT None
effectiveness NN Other
Satisfaction NN Other
rate NN Other
, , None
operative JJ Other
time NN Other
, , None
discharge NN Other
time NN Other
, , None
complication NN Adverse
rate NN Adverse
, , None
reintervention NN Other
rate NN Other
, , None
and CC None
resumption NN Other
of IN Other
normal JJ Other
activity NN Other
satisfaction NN Other
rate NN Other
Operative JJ Other
time NN Other
Intraoperative JJ Adverse
blood NN Adverse
loss NN Adverse
Reintervention NN Other
rates NNS Other
Discharge NNP Other
time NN Other
, , None
complication NN Adverse
rate NN Adverse
, , None
and CC None
resumption NN Other
of IN Other
normal JJ Other
activity NN Other
acceptability NN Other
shorter RB Other
operative JJ Other
time NN Other
, , None
and CC None
lower JJR Other
blood NN Other
loss NN Other
. . None
-DOCSTART- -X- N

blood NN Physical
loss NN Physical
cumulative JJ Other
rate NN Other
of IN Other
union NN Other
range NN Physical
of IN Physical
motion NN Physical
of IN Physical
the DT Physical
knee NN Physical
overall JJ Physical
results NNS Physical
complications NNS Adverse
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
disease JJ Physical
progression NN Physical
intolerable JJ Adverse
toxicity NN Adverse
. . None
tumor JJ Physical
response NN Physical
, , None
time NN Physical
to TO Physical
progression NN Physical
, , None
survival NN Physical
and CC Physical
toxicity NN Physical
. . None
improved VBN Physical
response NN Physical
rate NN Physical
time NN Physical
to TO Physical
progression NN Physical
survival JJ Mortality
time NN Mortality
toxicity NN Physical
Cumulative JJ Physical
5-FU JJ Physical
dose NN Physical
disease NN Physical
progression NN Physical
. . None
Fever NNP Physical
toxicity NN Adverse
. . None
grade NN Adverse
IV NNP Adverse
toxicity NN Adverse
-DOCSTART- -X- N

neurocognitive JJ Mental
functioning NN Mental
mean JJ Mental
Processing NNP Mental
Speed NNP Mental
Index NNP Mental
Processing NNP Mental
Speed NNP Mental
Index NNP Mental
score NN Mental
tests NNS Mental
of IN Mental
full-scale JJ Mental
intelligence NN Mental
quotient NN Mental
, , None
academic JJ Mental
achievement NN Mental
, , None
attention/concentration NN Mental
, , None
memory NN Mental
, , None
and CC None
visual JJ Mental
motor NN Mental
integration NN Mental
. . None
measures NNS Mental
of IN Mental
cognitive JJ Mental
functioning NN Mental
special JJ Mental
education NN Mental
services NNS Mental
, , None
neurologic JJ Mental
events NNS Mental
, , None
or CC None
use NN Mental
of IN Mental
psychotropic NN Mental
medications NNS Mental
. . None
neurocognitive JJ Mental
functioning NN Mental
processing VBG Mental
speed NN Mental
-DOCSTART- -X- N

Improved VBN Other
intraoperative JJ Other
management NN Other
effectiveness NN Other
immediate JJ Other
sealing NN Other
immediate JJ Other
sealing NN Other
ultimate JJ Physical
sealing NN Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

pin-prick JJ Pain
method NN Pain
Bromage NNP Physical
scale NN Physical
. . Physical
Heart NNP Physical
rate NN Physical
and CC Physical
blood NN Physical
pressure NN Physical
latency NN Pain
of IN Pain
analgesia NN Pain
duration NN Physical
of IN Physical
sensory JJ Physical
anesthesia NN Physical
two-segment JJ Pain
regression NN Pain
time NN Pain
total JJ Pain
duration NN Pain
of IN Pain
sensory JJ Pain
block NN Pain
inadequate JJ Pain
analgesia NN Pain
-DOCSTART- -X- N

Comparative JJ Physical
bioavailability NN Physical
comparative JJ Physical
bioavailability NN Physical
Plasma NNP Physical
samples NNS Physical
Terbinafine NN Physical
levels NNS Physical
were VBD None
determined VBN None
by IN None
high JJ Physical
pressure NN Physical
liquid NN Physical
chromatography NN Physical
with IN None
tandem JJ None
mass NN None
detection NN None
( ( None
HPLC-MS/MS NNP None
) ) None
pharmacokinetic JJ Other
parameters NNS Other
bioequivalence NN Mental
assessment NN Mental
( ( Mental
AUClast NNP Mental
, , Mental
AUCinf NNP Mental
and CC Mental
Cmax NNP Mental
) ) Mental
Classical JJ Other
90 CD Other
% NN Other
confidence NN Other
intervals NNS Other
( ( Other
90CI CD Other
) ) Other
classical JJ Other
90CI CD Other
AUClast NNP Other
Cmax NNP Other
results NNS None
gender NN Other
effects NNS Other
-DOCSTART- -X- N

survival NN Mortality
severe JJ Physical
bone NN Physical
marrow NN Physical
depression NN Physical
expired VBD Physical
from IN Physical
leukemia NN Physical
. . None
surgical JJ Physical
reexploration NN Physical
for IN Physical
intestinal JJ Physical
obstruction NN Physical
or CC Physical
bowel NN Physical
injury NN Physical
. . None
died VBD Mortality
Survival NNP Mortality
5-year JJ Mortality
actuarial JJ Mortality
survival NN Mortality
-DOCSTART- -X- N

Bronchodilatory JJ Physical
responses NNS Physical
spirometric JJ Physical
indices NNS Physical
and CC Physical
vital JJ Physical
signs NNS Physical
Mean NNP Physical
peak JJ Physical
FEV1 NNP Physical
change NN Physical
Safety NN Other
and CC Other
tolerability NN Other
-DOCSTART- -X- N

adaptive JJ Mental
behaviour NN Mental
, , None
autism NN Physical
symptoms NNS Physical
and CC None
cognitive/language NN Mental
skills NNS Mental
adaptive JJ Mental
behaviour NN Mental
and CC None
autism NN Physical
symptoms NNS Physical
adaptive JJ Mental
behaviour NN Mental
. . None
child JJ Mental
adaptive JJ Mental
behaviour NN Mental
and CC None
symptoms NNS Mental
of IN Mental
autism NN Mental
-DOCSTART- -X- N

identify VB Physical
the DT Physical
risk NN Physical
of IN Physical
progressive JJ Physical
stenoses NNS Physical
. . Physical
minimal JJ Physical
diameter NN Physical
number NN Physical
of IN Physical
conventional JJ Physical
stenosis NN Physical
parameters NNS Physical
correlation NN Other
changes NNS Physical
in IN Physical
minimal JJ Physical
diameter NN Physical
baseline NN Physical
% NN Physical
diameter NN Physical
stenosis NN Physical
minimal JJ Physical
diameter NN Physical
reference NN Physical
diameter NN Physical
of IN Physical
stenoses NNS Physical
changes NNS Other
were VBD Other
not RB Other
correlated VBN Other
stenosis NN Physical
length NN Physical
and CC Physical
plaque JJ Physical
area NN Physical
. . Physical
progressing VBG Physical
to TO Physical
occlusions NNS Physical
remaining VBG Physical
patent NN Physical
% NN Physical
diameter NN Physical
stenosis NN Physical
progression NN Physical
of IN Physical
coronary JJ Physical
disease NN Physical
stenoses NNS Physical
occlusions NNS Physical
progression NN Physical
of IN Physical
atherosclerosis NN Physical
predominantly RB Physical
occurred VBD Physical
-DOCSTART- -X- N

intelligence NN Mental
, , Mental
visual-spatial JJ Mental
skills NNS Mental
, , Mental
language NN Mental
, , Mental
and CC Mental
academics NNS Mental
adaptive JJ Mental
functioning NN Mental
behavior NN Mental
problems NNS Mental
-DOCSTART- -X- N

safety NN Other
and CC Other
efficacy NN Other
Safety NN Other
analyses NNS Other
minor JJ Adverse
skin NN Adverse
irritation NN Adverse
at IN Adverse
the DT Adverse
application NN Adverse
site NN Adverse
-- : Adverse
mostly RB Adverse
total JJ Adverse
and CC Adverse
severe JJ Adverse
gastrointestinal NN Adverse
( ( Adverse
GI NNP Adverse
) ) Adverse
adverse JJ Adverse
events NNS Adverse
, , None
including VBG None
dyspepsia NN Adverse
, , None
abdominal JJ Physical
pain NN Physical
, , None
diarrhea NN Adverse
, , None
and CC None
nausea NN Adverse
. . None
relief NN Physical
of IN Physical
symptoms NNS Physical
incidence NN Physical
of IN Physical
diclofenac-related JJ Physical
GI NNP Physical
complaints NNS Physical
and CC None
abnormal JJ Physical
laboratory NN Physical
values NNS Physical
. . None
-DOCSTART- -X- N

folate JJ Physical
polyglutamate NN Physical
. . None
-DOCSTART- -X- N

Onset/offset NNP Physical
characteristics NNS Physical
and CC Physical
intubating VBG Physical
conditions NNS Physical
onset PRP Physical
and CC Physical
offset VB Physical
of IN Physical
action NN Physical
and CC Physical
Neuromuscular JJ Other
monitoring NN Other
lag NN Other
times NNS Other
maximum JJ Other
block NN Other
intubating JJ Physical
conditions NNS Physical
at IN Physical
60 CD Physical
s NN Physical
onset JJ Other
time NN Other
degree NN Physical
of IN Physical
block NN Physical
at IN Physical
60 CD Physical
s NN Physical
recovery NN Physical
onset NN None
intubating NN Physical
conditions NNS Physical
recovery NN None
times NNS None
-DOCSTART- -X- N

failure NN Physical
of IN Physical
frequency NN Physical
of IN Physical
infusion NN Physical
failure NN Physical
Headaches NNS Physical
-DOCSTART- -X- N

variations NNS None
in IN None
reserve NN None
albumin-binding JJ None
capacity NN None
, , None
bilirubin NN None
, , None
albumin NN None
, , None
or CC None
red JJ None
cell NN None
bilirubin NN None
at IN None
pre NN None
and CC None
one-hour JJ None
post NN None
albumin NN None
infusion NN None
amount NN Physical
of IN Physical
bilirubin NN Physical
removed VBN Physical
per IN Physical
kilogram NN Physical
plasma VB Physical
bilirubin JJ Physical
concentration NN Physical
efficiency NN Physical
on IN Physical
bilirubin NN Physical
removal NN Physical
-DOCSTART- -X- N

Pain NN Pain
from IN Pain
the DT Pain
iliac JJ Pain
crest NN Pain
significantly RB Other
reduced VBN Other
pain NN Pain
from IN Pain
the DT Pain
primary JJ Pain
surgical JJ Pain
site NN Pain
was VBD Pain
increased VBN Pain
no DT Other
difference NN Other
no DT Other
significant JJ Other
pharmacokinetic JJ Physical
and CC Physical
pharmacodynamic JJ Physical
difference NN Other
maximal JJ Physical
plasma NN Physical
concentration NN Physical
( ( Physical
Cmax NNP Physical
) ) Physical
morphine NN Mental
consumption NN Mental
significant JJ Physical
peak NN Physical
of IN Physical
plasma JJ Physical
level NN Physical
-DOCSTART- -X- N

social JJ Mental
interactions NNS Mental
benefit VB Other
impact NN Other
social JJ Mental
behavior NN Mental
gains NNS Other
interactions NNS Mental
with IN Mental
an DT Mental
unfamiliar JJ Mental
nonhandicapped JJ Mental
peer NN Mental
interactions NNS Mental
with IN Mental
another DT Mental
child NN Mental
with IN Mental
PDD NNP Mental
, , Mental
and CC None
to TO None
the DT None
large JJ Mental
school NN Mental
setting VBG Mental
. . None
positive JJ Other
changes NNS Other
peer JJ Mental
relations NNS Mental
-DOCSTART- -X- N

visual JJ Physical
analog NN Physical
scale NN Physical
mean JJ Physical
index NN Physical
score NN Physical
of IN Physical
EQ-5D NNP Physical
and CC None
VAS NNP Physical
VARS NNP Physical
of IN Physical
EQ-5D NNP Physical
efficacy NN Other
local JJ Physical
tenderness NN Physical
subcutaneous JJ Physical
hemorrhage NN Physical
conjunctivitis NN Physical
severe JJ Adverse
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

characteristics NNS Mortality
, , None
complications NNS Adverse
, , None
and CC None
survival NN Mortality
racial JJ Other
differences NNS Other
demographic JJ Physical
features NNS Physical
, , Physical
atherosclerosis NN Physical
risk NN Physical
factors NNS Physical
, , Physical
and CC Physical
treatment NN Other
strategies NNS Other
; : Physical
mortality NN Mortality
rate NN Mortality
-DOCSTART- -X- N

social JJ Mental
skills NNS Mental
social JJ Mental
anxiety NN Mental
friendship JJ Mental
quality NN Mental
social JJ Mental
skills NNS Mental
knowledge NN Mental
of IN Mental
PEERS NNP Mental
concepts NNS Mental
and CC Mental
friendship NN Mental
skills NNS Mental
amount NN Mental
of IN Mental
get-togethers NNS Mental
levels NNS Mental
of IN Mental
social JJ Mental
anxiety NN Mental
, , None
core NN Mental
autistic NN Mental
symptoms NNS Mental
, , None
and CC None
problem NN Mental
behaviors NNS Mental
from IN Mental
pre-to JJ Mental
post-PEERS NNS Mental
. . None
social JJ Mental
skills NNS Mental
-DOCSTART- -X- N

Arterial JJ Physical
blood NN Physical
gases NNS Physical
, , None
spirometric JJ Other
tests NNS Other
, , None
bacteriologic JJ Physical
evaluation NN Physical
of IN Physical
sputum NN Physical
, , None
and CC None
patient NN Other
and CC Other
physician JJ Other
evaluation NN Other
of IN Other
the DT Other
severity NN Physical
of IN Physical
illness NN Physical
-DOCSTART- -X- N

influenced VBN Mental
by IN Mental
the DT Mental
information NN Mental
recorded VBN Mental
in IN Mental
their PRP$ Mental
memory NN Mental
aids NNS Mental
became VBD Mental
more RBR Mental
aware JJ Mental
of IN Mental
their PRP$ Mental
health NN Mental
. . None
more RBR Mental
worried JJ Mental
or CC Mental
depressed JJ Mental
perceptions NNS Mental
of IN Mental
health NN Mental
status NN Mental
. . None
-DOCSTART- -X- N

Graphical JJ None
plots NNS None
Escort NN Physical
values NNS Physical
peak JJ Physical
expiratory JJ Physical
flow NN Physical
rate NN Physical
and CC Physical
forced VBD Physical
expiratory JJ Physical
volume NN Physical
in IN Physical
one CD Physical
second NN Physical
. . Physical
peak JJ Physical
expiratory JJ Physical
flow NN Physical
rate NN Physical
measures NNS Physical
of IN Physical
lung NN Physical
function NN Physical
-DOCSTART- -X- N

nutrient JJ Physical
specifications NNS Physical
-DOCSTART- -X- N

identify VB Mental
and CC Mental
label VB Mental
basic JJ Mental
and CC Mental
complex JJ Mental
facial JJ Mental
expressions NNS Mental
emotion NN Mental
recognition NN Mental
social JJ Mental
behaviour NN Mental
social JJ Mental
behaviour NN Mental
social JJ Mental
behaviour NN Mental
-DOCSTART- -X- N

Communication NNP Mental
and CC Mental
Symbolic NNP Mental
Behavior NNP Mental
Scale NNP Mental
( ( Mental
CSBS NNP Mental
) ) Mental
, , None
Ritvo NNP Mental
Real-life NNP Mental
Rating NNP Mental
Scale NNP Mental
, , None
weekly JJ Mental
Global NNP Mental
Rating NNP Mental
Scale NNP Mental
( ( Mental
GBRS NNP Mental
) ) Mental
GBRS NNP Mental
CSBS NNP Mental
standard JJ Mental
scores NNS Mental
gastrointestinal NN Physical
symptoms NNS Physical
-DOCSTART- -X- N

glucose JJ Physical
appearance NN Physical
rate NN Physical
circulating NN Physical
glucose JJ Physical
concentration NN Physical
circulating VBG Physical
insulin NN Physical
, , Physical
C-peptide NNP Physical
, , Physical
glucagon NN Physical
, , Physical
alpha NN Physical
amino NN Physical
and CC Physical
urea JJ Physical
nitrogen NN Physical
, , Physical
and CC Physical
triglycerides NNS Physical
; : Physical
a DT Physical
decrease NN Physical
in IN Physical
nonesterified JJ Physical
fatty JJ Physical
acids NNS Physical
; : Physical
and CC Physical
a DT Physical
modest JJ Physical
increase NN Physical
in IN Physical
respiratory JJ Physical
quotient NN Physical
. . Physical
protein NN Physical
deaminated VBN Physical
and CC Physical
the DT Physical
amino NN Physical
groups NNS Physical
incorporated VBD Physical
into IN Physical
urea NN Physical
glucose NN Physical
quantity NN Physical
of IN Physical
amino JJ Physical
acids NNS Physical
deaminated VBD Physical
amount NN Physical
of IN Physical
glucose JJ Physical
appearing VBG Physical
in IN Physical
the DT Physical
circulation NN Physical
peripheral JJ Physical
plasma NN Physical
glucose JJ Physical
concentration NN Physical
glucose JJ Physical
concentration NN Physical
rate NN Physical
of IN Physical
glucose JJ Physical
disappearance NN Physical
. . Physical
-DOCSTART- -X- N

Contour NNP Other
detectability NN Other
spacing VBG Physical
saliency NN Physical
detectability NN Other
Contour NNP Other
detectability NN Other
average JJ None
density NN None
contour JJ Mental
detection NN Mental
critical JJ Physical
spacing NN Physical
global JJ Other
contour NN Other
integration NN Other
-DOCSTART- -X- N

disinfectant NN Physical
standard JJ Physical
disinfection NN Physical
significant JJ Other
quantitative JJ Other
diminished VBN Other
growth NN Other
toxic NN Adverse
or CC Adverse
allergic JJ Adverse
reaction NN Adverse
post-operatively RB Adverse
effective JJ Other
pre-operative JJ Physical
antimicrobial JJ Physical
treatment NN Physical
-DOCSTART- -X- N

reaction NN Other
time NN Other
error NN Other
rate NN Other
-DOCSTART- -X- N

total JJ Other
operating NN Other
time NN Other
. . Other
bladder JJ Physical
injury NN Physical
, , None
incision-to-delivery JJ Physical
time NN Physical
, , None
incision-to-fascial JJ Physical
closure NN Physical
time NN Physical
, , None
estimated VBN Physical
blood NN Physical
loss NN Physical
, , None
postoperative JJ Physical
microhematuria NN Physical
, , None
postoperative JJ Adverse
pain NN Adverse
, , None
hospital NN Physical
days NNS Physical
, , None
endometritis NN Adverse
, , None
and CC None
urinary JJ Adverse
tract NN Adverse
infection NN Adverse
. . None
median JJ Other
skin NN Other
incision NN Other
to TO Other
delivery NN Other
interval NN Other
total JJ Other
operating NN Other
time NN Other
bladder NN Physical
injuries NNS Physical
estimated VBN Physical
blood NN Physical
loss NN Physical
, , None
change NN Physical
in IN Physical
hemoglobin JJ Physical
level NN Physical
, , None
postoperative JJ Physical
microhematuria NN Physical
, , None
postoperative JJ Adverse
pain NN Adverse
, , None
hospital NN Physical
days NNS Physical
, , None
endometritis NN Adverse
, , None
or CC None
urinary JJ Adverse
tract NN Adverse
infection NN Adverse
. . None
-DOCSTART- -X- N

bile NN Physical
lipid JJ Physical
composition NN Physical
Bile NNP Physical
lipid JJ Physical
composition NN Physical
bile NN Physical
salts NNS Physical
and CC Physical
phospholipids NNS Physical
biliary VBP Physical
cholesterol NN Physical
concentration NN Physical
lithogenic JJ Physical
index NN Physical
gallstone NN Physical
formation NN Physical
-DOCSTART- -X- N

QOL NNP Physical
, , None
functional JJ Other
outcomes NNS Other
, , None
toxicity NN Adverse
profiles NNS Adverse
, , None
and CC None
survival NN Mortality
is VBZ None
QOL NNP None
score NN None
M.D NNP None
. . None
Anderson NNP None
Dysphagia NNP None
Inventory NNP None
( ( None
MDADI NNP None
) ) None
, , None
with IN None
secondary JJ None
endpoints NNS None
including VBG None
survival NN None
, , None
toxicity NN None
, , None
other JJ None
QOL NNP None
outcomes NNS None
, , None
and CC None
swallowing VBG None
function NN None
. . None
QOL NNP None
comparison NN None
survival JJ None
outcomes NNS None
. . None
-DOCSTART- -X- N

Safety NNP Other
overall JJ Other
feed NN Other
consumption NN Other
, , None
weight NN Physical
gain NN Physical
, , None
feed VBN Other
conversion NN Other
rates NNS Other
, , None
clinical JJ Other
pathology NN Other
measurements NNS Other
, , None
or CC None
tissue NN Physical
gross JJ Physical
and CC Physical
histopathologic JJ Physical
evaluations NNS Physical
safe JJ Other
-DOCSTART- -X- N

efficacy NN Other
Seizure NN Other
control NN Other
Seizures NNPS Physical
seizure NN Other
control NN Other
severity NN Physical
of IN Physical
the DT Physical
seizures NNS Physical
mild JJ Physical
seizures NNS Physical
seizures NNS Physical
severity NN None
seizures NNS Physical
end VBP None
anticonvulsants NNS Other
seizures NNS Physical
controlled VBN Other
-DOCSTART- -X- N

response NN Physical
rate NN Physical
or CC Physical
the DT Physical
clinical JJ Physical
benefit NN Physical
rate NN Physical
( ( Physical
CBR NNP Physical
) ) Physical
. . None
Pharmacokinetics NNPS Physical
and CC None
toxicities NNS Physical
Tumor NNP Physical
response NN Physical
Toxicities NNS Adverse
Pharmacokinetic JJ Physical
data NNS Physical
Response JJ Physical
rates NNS Physical
CBR NNP Physical
drug-related JJ Mortality
deaths NNS Mortality
. . Mortality
steady-state JJ Physical
plasma JJ Physical
concentrations NNS Physical
efficacy NN Other
safety NN Other
-DOCSTART- -X- N

risk NN None
death NN None
death NN None
survival NN Mortality
-DOCSTART- -X- N

Arm NNP Pain
pain NN Pain
10 CD Pain
point NN Pain
pain NN Pain
scale NN Pain
. . None
Secondary JJ Physical
outcomes NNS Physical
were VBD Physical
symptoms NNS Physical
measured VBN Physical
by IN Physical
the DT Physical
Levine NNP Physical
symptom NN Physical
severity NN Physical
scale NN Physical
, , None
function NN None
measured VBN None
by IN None
Pransky NNP None
's POS None
upper JJ None
extremity NN None
function NN None
scale NN None
, , None
and CC None
grip JJ None
strength NN None
. . None
Pain NNP Pain
severity NN Physical
scores NNS Physical
for IN Physical
arm NN Physical
symptoms NNS Physical
and CC Physical
grip JJ Physical
strength NN Physical
10 CD Pain
point NN Pain
arm NN Pain
pain NN Pain
scale NN Pain
-DOCSTART- -X- N

peak JJ Physical
flow NN Physical
rate NN Physical
after IN Physical
concentration NN Physical
of IN Physical
total JJ Physical
, , Physical
free JJ Physical
and CC Physical
complex JJ Physical
PSA NNP Physical
, , None
testosterone NN Physical
( ( Physical
total JJ Physical
and CC Physical
free JJ Physical
) ) Physical
, , Physical
dihydrotestosterone NN Physical
, , None
and CC None
prolactin NN Physical
in IN Physical
the DT Physical
blood NN Physical
. . Physical
Absence NN Adverse
of IN Adverse
adverse JJ Adverse
effects NNS Adverse
, , Adverse
biochemical JJ Adverse
abnormalities NNS Adverse
, , Adverse
changes NNS Adverse
in IN Adverse
clinical JJ Adverse
blood NN Adverse
and CC Adverse
urine NN Adverse
-DOCSTART- -X- N

Mean NNP Physical
VPA NNP Physical
trough IN Physical
blood NN Physical
levels NNS Physical
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
-- : Mental
Community NNP Mental
Scale NNP Mental
( ( Mental
ABC-C NNP Mental
) ) Mental
Irritability NNP Mental
subscale NN Mental
CGI NNP Mental
-- : Mental
Improvement NNP Mental
OAS NNP Mental
Increased VBN Adverse
appetite NN Adverse
and CC Adverse
skin NN Adverse
rash NN Adverse
spreading NN Adverse
skin NN Adverse
rash NN Adverse
serum NN Adverse
ammonia NN Adverse
levels NNS Adverse
slurred JJ Mental
speech NN Mental
and CC Mental
mild JJ Mental
cognitive JJ Mental
slowing NN Mental
. . None
sustained JJ Physical
response NN Physical
relapse NN Mental
of IN Mental
aggression NN Mental
. . None
-DOCSTART- -X- N

antibiotic JJ Physical
concentration NN Physical
concentrations NNS Physical
of IN Physical
ofloxacin NN Physical
greater JJR Physical
ofloxacin NN Physical
levels NNS Physical
ciprofloxacin NN Physical
-DOCSTART- -X- N

Acute NNP Physical
glucose JJ Physical
infusion NN Physical
resulted VBD None
in IN None
maternal JJ Adverse
hyperglycemia NN Adverse
, , None
hyperinsulinemia NN Physical
, , None
and CC None
an DT None
increase NN Physical
in IN Physical
the DT Physical
blood NN Physical
lactate NN Physical
level NN Physical
. . None
Cord NNP None
blood NN None
glucose NN None
, , None
insulin NN None
, , None
and CC None
lactate NN None
levels NNS None
were VBD None
also RB None
increased VBN None
in IN None
this DT None
group NN None
. . None
The DT None
key JJ None
finding NN None
of IN None
this DT None
study NN None
was VBD None
the DT None
significant JJ Physical
lowering NN Physical
of IN Physical
pH NN Physical
in IN Physical
the DT Physical
umbilical JJ Physical
cord NN Physical
vein NN Physical
( ( None
7.31 CD None
+/- JJ None
0.04 CD None
) ) None
and CC None
artery NN Physical
( ( None
7.21 CD None
+/- JJ None
0.06 CD None
) ) None
in IN None
the DT None
glucose-infused JJ None
group NN None
when WRB None
compared VBN None
with IN None
the DT None
non-glucose JJ Physical
infusion NN Physical
groups NNS None
( ( None
p NN None
less JJR None
than IN None
0.05 CD None
) ) None
. . None
Confounding VBG None
perinatal JJ None
factors NNS None
such JJ None
as IN None
maternal JJ Physical
position NN Physical
, , None
maternal JJ Physical
hypotension NN Physical
, , None
and CC None
prolonged VBD Physical
time NN Physical
of IN Physical
surgery NN Physical
did VBD None
not RB None
influence VB None
the DT None
fetal JJ None
acid-base JJ None
status NN None
. . None
Thus RB None
acute JJ None
maternal JJ Physical
glucose NN Physical
infusion NN Physical
in IN None
normal JJ None
patients NNS None
can MD None
cause VB None
fetal JJ Physical
hyperglycemia NN Physical
, , None
metabolic JJ Physical
acidosis NN Physical
, , None
and CC None
neonatal JJ Physical
hypoglycemia NN Physical
. . None
These DT None
findings NNS None
may MD None
be VB None
of IN None
particular JJ None
clinical JJ None
importance NN None
when WRB None
fetal JJ Physical
distress NN Physical
or CC None
fetal JJ Physical
hypoxemia NN Physical
is VBZ None
due JJ None
to TO None
other JJ None
perinatal JJ None
events NNS None
. . None
Under IN None
these DT None
circumstances NNS None
, , None
acute JJ Physical
maternal JJ Physical
glucose JJ Physical
infusion NN Physical
may MD None
further RB None
contribute VB None
to TO None
fetal JJ Physical
metabolic JJ Physical
acidosis NN Physical
. . None
-DOCSTART- -X- N

in IN None
parental JJ None
synchronous JJ None
response NN None
within IN None
parent-child JJ None
interaction NN None
. . None
showed VBD None
partial JJ None
mediation NN None
, , None
in IN None
synchrony NN None
accounting NN None
Improved VBN None
parental JJ None
synchronous JJ None
response NN None
-DOCSTART- -X- N

postoperative JJ Physical
intraocular JJ Physical
pressure NN Physical
intraocular JJ Physical
pressure NN Physical
Corneal NNP Physical
epithelial JJ Physical
defects NNS Physical
-DOCSTART- -X- N

effectiveness NN Other
of IN Other
a DT Other
pharmacy NN Other
discharge NN Other
plan NN Other
re-admission NN Other
to TO Other
hospital VB Other
within IN Other
6 CD Other
months NNS Other
. . None
number NN Mortality
of IN Mortality
deaths NNS Mortality
, , None
attendance NN Other
at IN Other
hospital JJ Other
outpatient NN Other
clinics NNS Other
and CC Other
general JJ Other
practice NN Other
and CC None
proportion NN Other
of IN Other
days NNS Other
in IN Other
hospital NN Other
over IN Other
the DT Other
follow-up JJ Other
period NN Other
, , None
together RB None
with IN None
patients NNS None
' POS None
general JJ Other
well-being NN Other
, , None
satisfaction NN Other
with IN Other
the DT Other
service NN Other
and CC None
knowledge NN Other
of IN None
and CC None
adherence NN Other
to TO Other
prescribed VB Other
medication NN Other
. . None
proportion NN Other
of IN Other
patients NNS Other
re-admitted JJ Other
to TO Other
hospital VB Other
-DOCSTART- -X- N

genetic JJ Mortality
interaction NN Mortality
profile NN Mortality
for IN Mortality
progression-free JJ Mortality
survival NN Mortality
( ( Mortality
PFS NNP Mortality
) ) Mortality
. . None
PFS NNP Mortality
genetic JJ Physical
interaction NN Physical
profile NN Physical
Median JJ Mortality
PFS NNP Mortality
genetic JJ Physical
profiles NNS Physical
PFS NNP Mortality
genetic JJ Physical
interaction NN Physical
-DOCSTART- -X- N

five-year JJ Physical
actuarial JJ Physical
rates NNS Physical
of IN Physical
cancer NN Physical
recurrence NN Physical
Overall JJ Mortality
survival NN Mortality
five-year JJ Physical
crude NN Physical
rates NNS Physical
of IN Physical
first JJ Physical
recurrence NN Physical
pattern NN Physical
of IN Physical
recurrence NN Physical
-DOCSTART- -X- N

dyads NNS Mental
involving VBG Mental
parents NNS Mental
' POS Mental
responsivity NN Mental
and CC Mental
children NNS Mental
's POS Mental
communication NN Mental
and CC Mental
productive JJ Mental
language NN Mental
development NN Mental
. . Mental
Communication NNP Mental
and CC Mental
language NN Mental
parental JJ Mental
responsivity NN Mental
growth NN Mental
rate NN Mental
of IN Mental
child-initiated JJ Mental
comments NNS Mental
growth NN Mental
rate NN Mental
of IN Mental
child-initiated JJ Mental
requests NNS Mental
growth NN Mental
of IN Mental
productive JJ Mental
language NN Mental
-DOCSTART- -X- N

cost-benefit JJ Other
cost-benefits NNS Other
metabolic JJ Physical
data NN Physical
glycemic JJ Physical
control NN Physical
reduced VBN Physical
glycemic JJ Physical
fluctuations NNS Physical
mild JJ Physical
hypoglycemic JJ Physical
events NNS Physical
Quality NN Other
of IN Other
life NN Other
, , None
judged VBN None
by IN None
Diabetes NNP Other
Control NNP Other
and CC Other
Complications NNP Other
Trial NNP Other
questionnaires NNS Other
Direct JJ Other
costs NNS Other
, , Other
including VBG Other
pump JJ Other
acquisition NN Other
, , Other
implantation NN Other
, , Other
and CC Other
follow-up NN Other
more RBR None
effective JJ Other
accepted VBN Other
costly JJ Other
glycemic JJ Physical
control NN Physical
-DOCSTART- -X- N

Actinic NNP Physical
keratoses NNS Physical
( ( Physical
AKs NNP Physical
) ) Physical
AK NNP Physical
. . None
AK NNP Physical
lesions NNS Physical
number NN Physical
and CC Physical
appearance NN Physical
of IN Physical
lesions NNS Physical
adverse JJ Adverse
effects NNS Adverse
clinically RB Physical
cleared VBN Physical
partially RB Physical
cleared VBN Physical
Clearance NN Physical
reduction NN Physical
in IN Physical
the DT Physical
size NN Physical
or CC Physical
number NN Physical
of IN Physical
AK NNP Physical
lesions NNS Physical
erythema NN Adverse
, , None
edema NN Adverse
, , None
induration NN Adverse
, , None
vesicles NNS Adverse
, , None
erosion NN Adverse
, , None
ulceration NN Adverse
, , None
excoriation NN Adverse
, , None
and CC None
scabbing VBG Adverse
. . None
tolerated VBN Other
AK NNP Physical
. . None
-DOCSTART- -X- N

water NN Physical
immersion NN Physical
calorimetry NN Physical
. . None
Body NNP Physical
mass NN Physical
index NN Physical
mean VBP Physical
thermogenic JJ Physical
response NN Physical
thermogenesis NN Physical
weight JJ Physical
loss NN Physical
. . None
resting VBG Physical
metabolism NN Physical
heat NN None
transfer NN None
from IN None
the DT None
body NN None
. . None
-DOCSTART- -X- N

lactoferrin NN Other
( ( Physical
LF NNP Physical
) ) Physical
tumour JJ Other
necrosis NN Other
factor-alpha NN Other
( ( Other
TNF-alpha NNP Other
) ) Other
duration NN Physical
of IN Physical
the DT Physical
main JJ Physical
symptoms NNS Physical
ulcer JJ Physical
scarring NN Physical
serum NN Physical
LF NNP Physical
and CC Physical
TNF-alpha NNP Physical
levels NNS Physical
-DOCSTART- -X- N

markers NNS Physical
blood NN Physical
pressure NN Physical
fibrinolytic JJ Physical
parameters NNS Physical
Tissue NNP Physical
plasminogen NN Physical
activator NN Physical
( ( Physical
t-PA JJ Physical
) ) Physical
antigen NN Physical
, , None
t-PA JJ Physical
activity NN Physical
, , None
plasminogen NN Physical
activator NN Physical
inhibitor-1 JJ Physical
( ( Physical
PAI-1 NNP Physical
) ) Physical
activity NN Physical
and CC None
plasma NN Physical
renin NN Physical
activity NN Physical
( ( Physical
PRA NNP Physical
) ) Physical
t-PA JJ Physical
antigen NN Physical
levels NNS Physical
t-PA NN Physical
or CC Physical
PAI-1 JJ Physical
activities NNS Physical
. . None
blood NN Physical
pressure NN Physical
. . None
t-PA JJ Physical
antigen NN Physical
levels NNS Physical
markers NNS Physical
of IN Physical
fibrinolysis NN Physical
-DOCSTART- -X- N

relevant JJ None
parameters NNS None
for IN None
rate NN None
( ( None
Cmax NNP Physical
ss NN Physical
, , Physical
Cmin NNP Physical
ss NN Physical
, , Physical
Cav NNP Physical
ss NN Physical
, , Physical
plateau NN Physical
time NN Physical
, , Physical
peak-trough JJ Physical
fluctuation NN Physical
, , Physical
nocturnal JJ Physical
excess NN Physical
, , Physical
tmax VB Physical
ss NN Physical
) ) None
extent NN Physical
of IN Physical
absorption NN Physical
( ( None
AUCss NNP None
) ) None
plateau NN Physical
times NNS Physical
small JJ Other
peak-trough JJ Other
fluctuations NNS Other
symmetrical JJ Physical
peaks NNS Physical
concentration/time NN Physical
profiles NNS Physical
-DOCSTART- -X- N

risk NN Physical
of IN Physical
major JJ Physical
( ( Physical
above- JJ Physical
or CC Physical
below-knee NN Physical
) ) Physical
lower JJR Physical
extremity NN Physical
amputation NN Physical
rate NN Physical
of IN Physical
limb-preserving JJ Physical
vascular JJ Physical
surgery NN Physical
rates NNS Physical
of IN Physical
primary JJ Physical
and CC Physical
repeat JJ Physical
amputation NN Physical
. . Physical
primary JJ Physical
and CC Physical
repeat JJ Physical
amputation NN Physical
amputation NN Physical
rates NNS Physical
-DOCSTART- -X- N

efficacy NN None
results NNS None
from IN None
the DT None
EEC NNP None
, , None
IgG NNP None
responses VBZ None
, , None
and CC None
tolerability NN None
. . None
total JJ None
symptom NN None
score NN None
significantly RB None
IgG1 NNP Physical
increased VBD None
tolerated VBN None
, , None
no DT None
serious JJ None
adverse JJ None
event NN None
occurred VBD None
two CD None
Grade NNP Adverse
II NNP Adverse
reactions NNS Adverse
, , None
according VBG None
-DOCSTART- -X- N

cardiovascular JJ None
risk NN None
factors NNS None
red JJ Physical
blood NN Physical
cell NN Physical
( ( Physical
RBC NNP Physical
) ) Physical
eicosapentaenoic JJ Physical
acid NN Physical
( ( Physical
EPA NNP Physical
) ) Physical
and CC Physical
docosahexaenoic JJ Physical
acid NN Physical
( ( Physical
DHA NNP Physical
) ) Physical
Systolic NNP Physical
blood NN Physical
pressure NN Physical
( ( Physical
SBP NNP Physical
) ) Physical
Plasma NNP Physical
triacylglycerol NN Physical
( ( Physical
TAG NNP Physical
) ) Physical
concentration NN Physical
insulin JJ Physical
sensitivity NN Physical
Plasma NNP Physical
high-density NN Physical
lipoprotein NN Physical
( ( Physical
HDL NNP Physical
) ) Physical
and CC Physical
non-HDL JJ Physical
cholesterol NN Physical
changes NNS Physical
in IN Physical
RBC NNP Physical
EPA NNP Physical
content NN Physical
changes NNS Physical
in IN Physical
SBP NNP Physical
and CC Physical
DBP NNP Physical
HDL NNP Physical
cholesterol NN Physical
and CC Physical
non-HDL JJ Physical
cholesterol NN Physical
concentrations NNS Physical
. . Physical
RBC NNP Physical
EPA NNP Physical
and CC Physical
plasma VB Physical
TAG NNP Physical
concentration NN Physical
or CC Physical
insulin JJ Physical
sensitivity NN Physical
. . Physical
BP NNP Physical
-DOCSTART- -X- N

plasma NN Physical
levels NNS Physical
of IN Physical
epinephrine NN Physical
, , Physical
norepinephrine NN Physical
, , Physical
glucose NN Physical
, , Physical
lactate NN Physical
Plasma NNP Physical
catecholamine JJ Physical
concentrations NNS Physical
Plasma NNP Physical
catecholamines NNS Physical
( ( Physical
epinephrine NN Physical
and CC Physical
norepinephrine NN Physical
) ) Physical
MAP NNP Physical
HR NNP Physical
plasma NN Physical
levels NNS Physical
of IN Physical
epinephrine NN Physical
and CC Physical
norepinephrine JJ Physical
glucose NN Physical
, , Physical
lactate NN Physical
and CC Physical
free JJ Physical
glycerol NN Physical
-DOCSTART- -X- N

time NN Physical
to TO Physical
first JJ Physical
recurrence NN Physical
of IN Physical
VT NNP Physical
or CC Physical
ventricular JJ Physical
fibrillation NN Physical
( ( Physical
VF NNP Physical
) ) Physical
. . Physical
Time NN Physical
to TO Physical
recurrence NN Physical
of IN Physical
VT NNP Physical
or CC Physical
VF NNP Physical
survival JJ Mortality
VT NNP Physical
or CC Physical
VF NNP Physical
no DT Mortality
deaths NNS Mortality
-DOCSTART- -X- N

resting VBG Physical
blood NN Physical
pressure NN Physical
Exercise NNP Physical
systolic JJ Physical
pressure NN Physical
incidence NN Adverse
of IN Adverse
side-effects NNS Adverse
-DOCSTART- -X- N

cognitive JJ Physical
deficits NNS Physical
cognitive JJ Physical
dysfunction NN Physical
dysfunction NN Physical
clinical JJ Physical
symptomatology NN Physical
. . Physical
severity NN Physical
of IN Physical
negative JJ Physical
symptoms NNS Physical
deficits NNS Mental
in IN Mental
memory NN Mental
, , None
verbal JJ Mental
fluency NN Mental
, , None
psychomotor NN Mental
speed NN Mental
and CC None
executive NN Physical
function NN Physical
. . None
Positive JJ Physical
symptoms NNS Physical
cognitive JJ Physical
deficits NNS Physical
. . None
duration NN Physical
of IN Physical
untreated JJ Physical
illness NN Physical
( ( Physical
DUI NNP Physical
) ) Physical
cognitive JJ Physical
impairment NN Physical
. . None
relationship NN None
exists VBZ None
between IN None
negative JJ Physical
symptoms NNS Physical
and CC None
cognitive JJ Mental
dysfunction NN Mental
. . None
severity NN Mental
of IN Mental
cognitive JJ Mental
dysfunction NN Mental
symptomatology NN Other
cognitive JJ Physical
dysfunction NN Physical
-DOCSTART- -X- N

effect NN Other
improvements NNS Physical
in IN Physical
oral JJ Physical
health NN Physical
status NN Physical
and CC Physical
oral JJ Physical
health NN Physical
behaviour NN Physical
statistically RB None
significant JJ None
improvements NNS None
in IN None
gingival JJ Physical
health NN Physical
as IN Physical
measured VBN Physical
by IN Physical
gingival NN Physical
bleeding NN Physical
and CC Physical
plaque NN Physical
indices NNS Physical
( ( Physical
GBI NNP Physical
and CC Physical
PI NNP Physical
) ) Physical
sustained VBN Other
use NN Other
of IN Other
toothbrushes NNS Other
and CC Other
dentifrice NN Other
beneficial JJ Physical
effect NN Physical
on IN Physical
oral JJ Physical
hygiene NN Physical
-DOCSTART- -X- N

STARS NNP Physical
and CC Physical
SRF NNP Physical
mRNA NN Physical
and CC Physical
decreases NNS Physical
in IN Physical
MRTF-A NNP Physical
mRNA NN Physical
with IN Physical
both DT Physical
ECC NNP Physical
and CC Physical
CONC NNP Physical
exercise NN Physical
STARS NNP Physical
protein NN Physical
pSRF JJ Physical
MRTF-A NNP Physical
protein NN Physical
total JJ Physical
SRF NNP Physical
protein NN Physical
. . None
whey NN Physical
protein NN Physical
supplementation NN Physical
. . Physical
acute JJ Physical
stimulation NN Physical
of IN Physical
the DT Physical
STARS NNP Physical
pathway NN Physical
-DOCSTART- -X- N

inflammatory JJ Physical
activity NN Physical
functional JJ Physical
capacity NN Physical
osteocalcin NN Other
levels NNS Other
inflammatory JJ Physical
activity NN Physical
erythrocyte JJ Physical
sedimentation NN Physical
rate NN Physical
( ( Physical
ESR NNP Physical
) ) Physical
C-reactive JJ Physical
protein NN Physical
( ( Physical
CRP NNP Physical
) ) Physical
CRP- NNP Physical
ESR NNP Physical
differences NNS Other
functional JJ Physical
capacity NN Physical
osteocalcin NN Physical
levels NNS Physical
alkaline JJ Other
phosphatase NN Other
bone NN Physical
turnover NN Physical
inflammatory JJ Physical
activity NN Physical
and CC None
functional JJ Physical
capacity NN Physical
. . None
alkaline VB Other
phosphatase NN Other
functional JJ Physical
capacity NN Physical
-DOCSTART- -X- N

healthy JJ Physical
eating VBG Physical
index NN Physical
Dietary JJ None
intake NN None
Overall JJ None
diet JJ None
quality NN None
The DT None
prevalence NN None
of IN None
poor JJ None
diet NNS None
the DT None
75th CD None
percentile NN None
for IN None
the DT None
vegetable JJ None
and CC None
fruit JJ None
component NN None
score NN None
the DT None
overall JJ None
dietary JJ None
quality NN None
-DOCSTART- -X- N

mood NN Mental
symptoms NNS Mental
mood NN Mental
effects NNS Mental
mood NN Mental
and CC Mental
physical JJ Mental
symptoms NNS Mental
noted VBD Mental
on IN Mental
a DT Mental
daily JJ Mental
rating NN Mental
scale NN Mental
. . None
physical JJ Mental
symptoms NNS Mental
mood NN Mental
symptoms NNS Mental
positive JJ Mental
mood NN Mental
symptoms NNS Mental
. . None
mood NN Mental
and CC Mental
physical JJ Mental
symptoms NNS Mental
-DOCSTART- -X- N

sleep NN Mental
daytime JJ Mental
behavior NN Mental
family NN Physical
functioning NN Physical
. . None
outcomes NNS None
. . None
Sleep NNP None
latency NN None
, , None
insomnia NN Physical
subscales NNS Physical
on IN Physical
the DT Physical
Children NNP Physical
's POS Physical
Sleep NNP Physical
Habits NNP Physical
Questionnaire NNP Physical
, , None
other JJ None
outcomes NNS None
related VBN None
to TO None
child VB None
and CC None
family NN Mental
functioning VBG Mental
improved VBN None
improved JJ None
sleep JJ None
onset NN None
delay NN None
in IN None
-DOCSTART- -X- N

closure JJ Other
time NN Other
, , None
patient JJ Other
comfort NN Other
, , None
and CC None
scar NN Other
quality NN Other
Operative JJ Other
time NN Other
faster RBR None
Comfort NNP None
scores NNS None
Complication NN Adverse
rates NNS Adverse
Patients NNS Other
' POS Other
visual JJ Other
assessment NN Other
of IN Other
linear JJ Other
scars NNS Other
rating NN Other
of IN Other
breasts NNS Other
wound IN Physical
closure NN Physical
comfort NN Other
and CC Other
scar NN Other
quality NN Other
efficiency NN Other
quality NN Other
-DOCSTART- -X- N

infant JJ Mental
mental JJ Mental
health NN Mental
incidence NN Mental
of IN Mental
infant JJ Mental
mental JJ Mental
health NN Mental
problems NNS Mental
-DOCSTART- -X- N

Visual NNP Mental
Analogue NNP Mental
Scale NNP Mental
( ( Mental
VAS NNP Mental
) ) Mental
, , None
satisfaction NN Other
scores NNS Other
, , None
morphine NN Physical
consumption NN Physical
and CC None
side NN Adverse
effects NNS Adverse
group?s NN None
VAS NNP Mental
scores VBZ Mental
to TO None
hours NNS None
. . None
VAS NNP None
scores NNS None
of IN None
longer RBR None
, , None
morphine JJ Physical
consumption NN Physical
values NNS Physical
were VBD None
satisfaction NN None
scores NNS None
were VBD None
-DOCSTART- -X- N

Mean JJ Physical
change NN Physical
in IN Physical
A1C NNP Physical
level NN Physical
A1C NNP Physical
incidence NN Physical
rate NN Physical
of IN Physical
severe JJ Physical
hypoglycemia NN Physical
Time NNP Physical
per IN Physical
day NN Physical
with IN Physical
glucose JJ Physical
levels NNS Physical
-DOCSTART- -X- N

behavioral JJ Mental
, , Mental
neuroendocrine JJ Mental
, , Mental
immune JJ Mental
, , Mental
and CC Mental
acute-phase JJ Mental
responses NNS Mental
) ) Physical
Behavioral JJ Physical
response NN Physical
variables NNS Physical
, , Physical
salivary JJ Physical
cortisol NN Physical
concentration NN Physical
, , Physical
WBC NNP Physical
count NN Physical
, , Physical
and CC Physical
serum JJ Physical
concentrations NNS Physical
of IN Physical
glucose NN Physical
, , Physical
prolactin NN Physical
, , Physical
haptoglobin NN Physical
, , Physical
and CC Physical
C-reactive JJ Physical
protein NN Physical
Behavioral NNP Mental
response NN Mental
variables NNS Mental
and CC Physical
serum NN Physical
prolactin NN Physical
concentration NN Physical
alertness NN Mental
and CC Mental
visual JJ Mental
exploration NN Mental
behaviors NNS Mental
serum NN Physical
prolactin NN Physical
concentrations NNS Physical
behavioral JJ Mental
and CC Mental
neuroendocrine JJ Mental
perioperative JJ Mental
stress NN Mental
responses NNS Mental
recovery NN Other
-DOCSTART- -X- N

Plasma NNP Physical
total JJ Physical
factor NN Physical
VII NNP Physical
mean NN Physical
fasting NN Physical
and CC Physical
postprandial JJ Physical
plasma NN Physical
levels NNS Physical
of IN Physical
total JJ Physical
factor NN Physical
VII NNP Physical
fasting NN Physical
and/or JJ Physical
postprandial JJ Physical
plasma NN Physical
levels NNS Physical
of IN Physical
active JJ Physical
factor NN Physical
VII NNP Physical
change NN Physical
in IN Physical
the DT Physical
fasting JJ Physical
level NN Physical
of IN Physical
total JJ Physical
factor NN Physical
VII NNP Physical
change NN Physical
in IN Physical
the DT Physical
fasting JJ Physical
level NN Physical
of IN Physical
active JJ Physical
factor NN Physical
VII NNP Physical
levels NNS Physical
of IN Physical
total JJ Physical
factor NN Physical
VII NNP Physical
risk NN Physical
of IN Physical
arterial JJ Physical
thromboembolism NN Physical
-DOCSTART- -X- N

rates NNS Mental
of IN Mental
limitation NN Mental
from IN Mental
secondary JJ Mental
conditions NNS Mental
lower JJR Mental
rates NNS Mental
of IN Mental
limitation NN Mental
pre- JJ None
to TO None
postdifferences NNS None
helpful JJ None
overcoming VBG Other
barriers NNS Other
to TO Other
employment NN Other
. . None
-DOCSTART- -X- N

basal JJ Physical
femoral JJ Physical
blood NN Physical
flow NN Physical
maximal JJ Physical
strength NN Physical
Whole JJ Physical
body NN Physical
lean JJ Physical
body NN Physical
mass NN Physical
leg VBZ Physical
fat-free JJ Physical
mass NN Physical
Basal NNP Physical
femoral JJ Physical
blood NN Physical
flow NN Physical
and CC Physical
vascular JJ Physical
conductance NN Physical
brachial JJ Physical
blood NN Physical
pressure NN Physical
, , None
plasma JJ Physical
endothelin-1 NN Physical
and CC Physical
angiotensin NN Physical
II NNP Physical
concentrations NNS Physical
, , None
femoral JJ Physical
artery NN Physical
wall NN Physical
thickness NN Physical
, , None
cardiac JJ Physical
output NN Physical
, , None
and CC None
systemic JJ Physical
vascular JJ Physical
resistance NN Physical
. . None
-DOCSTART- -X- N

parent-reported JJ Mental
anxiety NN Mental
symptoms NNS Mental
-DOCSTART- -X- N

Sinus NNP Physical
rhythm NN Physical
discomfort NN Pain
score NN Pain
complication NN Adverse
safely RB Other
and CC Other
effectively RB Other
-DOCSTART- -X- N

electrocardiographic JJ Physical
effects NNS Physical
. . None
cardiac JJ Other
safety NN Other
profile NN Other
prolongation NN Physical
of IN Physical
the DT Physical
QTc NNP Physical
interval NN Physical
frequency NN Physical
of IN Physical
overall JJ Physical
electrocardiographic JJ Physical
abnormalities NNS Physical
. . None
ventricular NN Physical
or CC Physical
supraventricular JJ Physical
tachycardia NN Physical
electrocardiographic JJ Physical
results NNS Physical
plasma NN Physical
concentrations NNS Physical
electrocardiographic JJ Physical
effects NNS Physical
cardiac JJ Physical
function NN Physical
. . None
-DOCSTART- -X- N

duration NN Physical
of IN Physical
neutropenia NN Physical
number NN Physical
of IN Physical
remissions NNS Physical
, , None
relapse-free JJ Mortality
survival NN Mortality
and CC None
survival NN Mortality
similar JJ None
clinical JJ Other
efficacy NN Other
-DOCSTART- -X- N

opioid JJ None
agonist JJ None
effects NNS None
physiological JJ Physical
and CC Physical
subjective JJ Physical
measures NNS Physical
. . None
the DT Physical
opioid JJ Physical
agonist JJ Physical
effects NNS Physical
abuse NN Other
liability NN Other
-DOCSTART- -X- N

area NN Other
under IN Other
the DT Other
ROC NNP Other
curve NN Other
PSA NNP Physical
value NN Physical
-DOCSTART- -X- N

Symptom NNP Physical
and CC Physical
medication NN Physical
scores NNS Physical
, , None
skin JJ Physical
test NN Physical
results NNS Physical
and CC None
( ( Physical
in IN Physical
asthmatic JJ Physical
patients NNS Physical
) ) Physical
FEV1 NNP Physical
values NNS Physical
Adverse JJ Adverse
effects NNS Adverse
significant JJ Physical
improvement NN Physical
in IN Physical
symptom NN Physical
and CC Physical
medication NN Physical
usage NN Physical
skin JJ Physical
test NN Physical
scores NNS Physical
decreased VBN Physical
FEV1 NNP Physical
improved VBD Physical
symptom NN Physical
and CC Physical
skin JJ Physical
test NN Physical
scores NNS Physical
did VBD Physical
not RB Physical
change VBP Other
No DT None
adverse JJ Adverse
effects NNS Adverse
-DOCSTART- -X- N

CFVR NNP Physical
major JJ Adverse
adverse JJ Adverse
cardiac NN Adverse
events NNS Adverse
risk NN Adverse
of IN Adverse
major JJ Adverse
adverse JJ Adverse
events NNS Adverse
adverse JJ Adverse
events NNS Adverse
risk NN Adverse
risk NN Adverse
of IN Adverse
major JJ Adverse
adverse JJ Adverse
cardiac NN Adverse
events NNS Adverse
. . None
-DOCSTART- -X- N

median JJ Pain
pain NN Pain
score NN Pain
, , None
ulcer JJ Physical
size NN Physical
, , None
number NN Physical
of IN Physical
ulcers NNS Physical
, , None
or CC None
total JJ Physical
number NN Physical
of IN Physical
ulcer JJ Physical
episodes NNS Physical
. . None
less JJR Pain
pain NN Pain
smaller JJR Physical
and CC Physical
fewer JJR Physical
ulcers NNS Physical
no DT Physical
improvement NN Physical
more RBR Physical
ulcer-free JJ Physical
days NNS Physical
differences NNS Physical
were VBD Physical
small JJ Physical
exception NN None
of IN None
median JJ None
ulcer NN None
size NN None
did VBD Physical
not RB Physical
reach VB Physical
statistical JJ Physical
significance NN Physical
. . Physical
Adverse JJ Adverse
effects NNS Adverse
not RB Other
significantly RB Other
different JJ Other
-DOCSTART- -X- N

length NN Mortality
of IN Mortality
survival NN Mortality
host NN Physical
immune JJ Physical
response NN Physical
and CC None
the DT None
incidence NN Adverse
of IN Adverse
side NN Adverse
effects NNS Adverse
. . None
survival NN Mortality
. . Mortality
white JJ Physical
cell NN Physical
and CC Physical
lymphocyte NN Physical
counts NNS Physical
T NNP Physical
cells NNS Physical
dramatic JJ Physical
skin NN Physical
reaction NN Physical
fever NN Physical
local JJ Physical
abscess NN Physical
formation NN Physical
fever RB Physical
abscess JJ Physical
formation NN Physical
-DOCSTART- -X- N

Cumulative JJ Other
amount NN Other
of IN Other
i.v NN Other
. . Other
morphine NN Other
used VBN Other
in IN Other
the DT Other
first JJ Other
24 CD Other
hours NNS Other
amount NN Other
of IN Other
the DT Other
drug NN Other
used VBN Other
during IN Other
each DT Other
2-h JJ Other
period NN Other
mean JJ Other
cumulative JJ Other
24-h JJ Other
i.v NN Other
. . Other
PCA NNP Other
morphine JJ Other
requirement NN Other
less JJR Other
morphine NN Other
maximum JJ Other
i.v NN Other
. . Other
PCA NNP Other
morphine NN Other
use NN Other
Analgesic NNP Other
efficacy NN Other
-DOCSTART- -X- N

TSAb NNP Physical
TSAb NNP Physical
remission NN Physical
. . Physical
initial JJ Physical
TSAb NNP Physical
levels NNS Physical
End-treatment JJ Physical
TSAb NNP Physical
values NNS Physical
relapse NN Physical
rate NN Physical
end-treatment JJ Physical
TSAb NNP Physical
Relapses NNS Physical
TSAb NN Physical
levels NNS Physical
. . None
-DOCSTART- -X- N

pregnancy NN Physical
occurrence NN Physical
. . Physical
stimulation NN Physical
cycle NN Physical
responses NNS Physical
, , None
pregnancy NN Physical
outcomes NNS Physical
, , None
incidence NN Physical
of IN Physical
OHSS NNP Physical
and CC None
types NNS Physical
of IN Physical
OHSS NNP Physical
chemical NN Physical
and CC Physical
clinical JJ Physical
pregnancy NN Physical
rates NNS Physical
number NN Physical
of IN Physical
retrieved JJ Physical
oocytes NNS Physical
Follicle NNP Physical
stimulating VBG Physical
hormone NN Physical
( ( Physical
FSH NNP Physical
) ) Physical
, , Physical
luteinizing VBG Physical
hormone NN Physical
( ( Physical
LH NNP Physical
) ) Physical
levels NNS Physical
, , Physical
number NN Physical
of IN Physical
follicles NNS Physical
, , Physical
number NN Physical
of IN Physical
follicles NNS Physical
> VBP Physical
18 CD Physical
mm NN Physical
, , Physical
relative JJ Physical
frequency NN Physical
of IN Physical
mature NN Physical
oocytes NNS Physical
, , Physical
number NN Physical
and CC Physical
days NNS Physical
of IN Physical
gonadotropin JJ Physical
injections NNS Physical
, , Physical
day NN Physical
of IN Physical
human JJ Physical
chorionic JJ Physical
gonadotropin NN Physical
( ( Physical
HCG NNP Physical
) ) Physical
administration NN Physical
, , Physical
estradiol JJ Physical
level NN Physical
and CC Physical
abortion NN Physical
-DOCSTART- -X- N

safety NN Other
and CC Other
efficacy NN Other
of IN Physical
LX4211 NNP Physical
glycated JJ Physical
hemoglobin NN Physical
A1c NNP Physical
proportion NN Physical
of IN Physical
subjects NNS Physical
achieving VBG Physical
a DT Physical
glycated JJ Physical
hemoglobin NN Physical
A1c NNP Physical
value NN Physical
of IN Physical
< $ Physical
7 CD Physical
% NN Physical
, , Physical
change NN Physical
from IN Physical
baseline NN Physical
in IN Physical
fasting VBG Physical
plasma NN Physical
glucose NN Physical
and CC Physical
postprandial JJ Physical
glucose NN Physical
( ( Physical
as IN Physical
part NN Physical
of IN Physical
an DT Physical
oral JJ Physical
glucose NN Physical
tolerance NN Physical
test NN Physical
) ) Physical
, , Physical
body NN Physical
weight NN Physical
, , Physical
and CC Physical
blood NN Physical
pressure NN Physical
. . Physical
Safety NN Other
hypoglycemia NN Physical
, , Physical
GI NNP Physical
symptoms NNS Physical
, , Physical
and CC Physical
incidence NN Physical
of IN Physical
genitourinary JJ Physical
tract NN Physical
infections NNS Physical
. . None
-DOCSTART- -X- N

Healing VBG Physical
rates NNS Physical
A DT None
highly RB None
significant JJ Physical
degree NN Physical
of IN Physical
discolouration NN Physical
of IN Physical
all DT Physical
parts NNS Physical
of IN Physical
the DT Physical
oral JJ Physical
cavity NN Physical
slight JJ Physical
staining NN Physical
of IN Physical
the DT Physical
tongue NN Physical
. . None
Blood NNP Physical
bismuth JJ Physical
concentrations NNS Physical
excellent JJ Other
patient NN Other
compliance NN Other
-DOCSTART- -X- N

and CC None
life NN Other
satisfaction NN Other
lower JJR None
depression NN Mental
( ( None
anxiety NN Mental
( ( None
ES NNP None
effects NNS None
for IN None
positive JJ None
affect NN None
, , None
depression NN Mental
, , None
and CC None
anxiety NN Mental
were VBD None
-DOCSTART- -X- N

anxiety NN Mental
level NN Mental
and CC None
self-reported JJ Physical
quality NN Physical
of IN Physical
life NN Physical
( ( Physical
QoL NNP Physical
) ) Physical
Chinese JJ Mental
State-Trait NNP Mental
Anxiety NNP Mental
Inventory NNP Mental
( ( Mental
C-STAI NNP Mental
) ) Mental
, , None
the DT Other
Quality NN Physical
of IN Physical
Life NNP Physical
Index NNP Physical
for IN Physical
Colostomy NNP Physical
( ( Physical
QoL-Colostomy NNP Physical
) ) Physical
and CC None
the DT None
Hong NNP Physical
Kong NNP Physical
Chinese JJ Physical
version NN Physical
of IN Physical
the DT Physical
World NNP Physical
Health NNP Physical
Organisation NNP Physical
Quality NNP Physical
of IN Physical
Life NNP Physical
Scale NNP Physical
( ( Other
WHOQoL NNP Other
) ) Other
C-STAI NNP Physical
score NN Physical
WHOQoL NNP Physical
score NN Physical
WHOQoL NNP Other
QoL NNP Other
QoL-Colostomy NNP Physical
quality NN Physical
of IN Physical
life NN Physical
anxiety NN Mental
-DOCSTART- -X- N

attitudes NNS Mental
, , Mental
self-efficacy NN Mental
, , Mental
and CC Mental
behavioral JJ Mental
intentions NNS Mental
-DOCSTART- -X- N

significant JJ Physical
and CC Physical
rapid JJ Physical
decline NN Physical
and/or NN Physical
disappearance NN Physical
of IN Physical
spirochetes NNS Physical
from IN Physical
the DT Physical
plaque NN Physical
significantly RB Other
greater JJR Other
benefit NN Other
from IN Other
the DT Other
metronidazole NN Other
reduction NN Other
of IN Other
surgical JJ Other
needs NNS Other
-DOCSTART- -X- N

subjective NN Physical
and CC Physical
objective JJ Physical
symptoms NNS Physical
and CC Physical
signs NNS Physical
improved VBN None
Histologically NNP None
demonstrable JJ None
signs NNS None
of IN None
inflammation NN Physical
No DT None
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

Hair NNP Physical
density NN Physical
and CC Physical
thicknesses NNS Physical
statistically RB Physical
significantly RB Physical
decreased VBN Physical
erythema NN Physical
index NN Physical
hair NN Physical
amount NN Physical
-DOCSTART- -X- N

MRI-monitored JJ Physical
disease NN Physical
activity NN Physical
active JJ Physical
lesions NNS Physical
. . None
MRI-monitored JJ Physical
disease NN Physical
Brain NNP Physical
MRI NNP Physical
scans NNS Physical
and CC Physical
clinical JJ Physical
assessments NNS Physical
cumulative JJ Physical
number NN Physical
of IN Physical
GdE NNP Physical
lesions NNS Physical
cumulative JJ Physical
number NN Physical
of IN Physical
GdE NNP Physical
lesions NNS Physical
per IN Physical
scan NN Physical
liver NN Physical
enzymes NNS Physical
. . None
Budd-Chiari NNP Adverse
syndrome-ie NN Adverse
thrombotic JJ Physical
venous JJ Physical
outflow JJ Physical
obstruction NN Adverse
of IN Adverse
the DT Adverse
liver-occurred JJ Adverse
liver NN Physical
enzymes NNS Physical
hepatic JJ Physical
decompensation NN Physical
. . None
MRI-measured JJ Physical
disease NN Physical
activity NN Physical
-DOCSTART- -X- N

mortality NN Mortality
overall JJ Mortality
mortality NN Mortality
survival NN Mortality
data NNS Mortality
-DOCSTART- -X- N

in IN None
H1N1 NNP None
A/California/07/2009 NNP None
hemagglutination NN None
inhibition NN None
( ( None
HI NNP None
) ) None
and CC None
neutralizing VBG None
( ( None
MN NNP None
) ) None
antibody NN None
titers NNS None
induced JJ None
seroprotection NN None
rates NNS None
of IN None
induced JJ None
seroprotection NN None
rates NNS None
in IN None
Both DT None
HI NNP None
and CC None
MN NNP None
antibodies NNS None
persisted VBD None
subjects NNS None
had VBD None
seroprotective JJ None
levels NNS None
of IN None
H1N1 NNP None
A/California/07/2009 NNP None
antibodies NNS None
at IN None
baseline NN None
. . None
Higher JJR None
baseline NN None
HI NNP None
titers NNS None
were VBD None
baseline NN None
A/California/07/2009 NNP None
neutralizing VBG None
antibody NN None
titers NNS None
were VBD None
reduced VBD None
A/H1N1/California/07/2009 NNP None
baseline NN None
titers NNS None
in IN None
55 CD None
tolerated VBN None
with IN None
-DOCSTART- -X- N

Heart NNP Physical
rate NN Physical
variability NN Physical
QT NNP Physical
dispersion NN Physical
QT NNP Physical
dispersion NN Physical
lower JJR Physical
HRV NNP Physical
measures NNS Physical
standard JJ Physical
deviation NN Physical
of IN Physical
N-Ns NNP Physical
( ( Physical
SDNN NNP Physical
) ) Physical
low JJ Physical
frequency NN Physical
( ( Physical
LF NNP Physical
) ) Physical
/high VBP Physical
frequency NN Physical
( ( Physical
HF NNP Physical
) ) Physical
ratio NN Physical
QT NNP Physical
dispersion NN Physical
and CC None
QTc NNP Physical
dispersion NN Physical
QT NNP Physical
dispersion NN Physical
HRV NNP Physical
parameters NNS Physical
. . None
heart NN Physical
rate NN Physical
-DOCSTART- -X- N

effect NN None
effect NN None
cell JJ Physical
cycle NN Physical
apoptosis NN Physical
rate NN Physical
Level NNP Physical
of IN Physical
NF-kappa NNP Physical
B NNP Physical
percentage NN Physical
of IN Physical
G0/G1 NNP Physical
stage NN Physical
cells NNS Physical
S NNP Physical
stage NN Physical
cell NN Physical
apoptosis NN Physical
apoptosis NN Physical
rate NN None
apoptosis NN Physical
-DOCSTART- -X- N

survival NN Mortality
benefits NNS Mortality
Complete NNP Other
resection NN Other
toxicity NN Adverse
, , Adverse
mainly RB Adverse
haematological JJ Adverse
, , Adverse
nausea/vomiting JJ Adverse
and CC Adverse
neutropenic JJ Adverse
fever NN Adverse
death NN Mortality
. . None
benefit NN Mortality
in IN Mortality
overall JJ Mortality
survival NN Mortality
survival JJ Mortality
benefit NN Mortality
-DOCSTART- -X- N

cognitive NN Mental
and CC Mental
language NN Mental
outcomes NNS Mental
functional JJ Mental
use NN Mental
of IN Mental
spoken JJ Mental
language NN Mental
joint JJ Mental
attention NN Mental
skill NN Mental
, , Mental
play VB Mental
level NN Mental
long-term JJ Mental
spoken JJ Mental
language NN Mental
outcomes NNS Mental
. . None
-DOCSTART- -X- N

child JJ Physical
physical JJ Physical
activity NN Physical
levels NNS Physical
during IN Mental
attendance NN Mental
at IN Mental
long RB Mental
day NN Mental
care NN Mental
. . None
acceptability NN Other
and CC Other
extent NN Other
of IN Other
implementation NN Other
of IN Other
the DT Other
intervention NN Other
by IN Other
services NNS Other
-DOCSTART- -X- N

effects NNS Other
on IN Other
performance NN Other
effects NNS Other
performance NN Other
times NNS Other
in IN Other
training NN Other
and CC Other
competition NN Other
Performance NN Other
time NN Other
performed VBD Other
substantially RB Other
better RBR Other
performance NN Other
in IN Other
training NN Other
and CC Other
competition NN Other
-DOCSTART- -X- N

promoting VBG Mental
psychological JJ Mental
well-being NN Mental
information NN Mental
recall NN Mental
psychological JJ Mental
distress NN Mental
. . None
positive JJ Mental
attitudes NNS Mental
recall VB Mental
significantly RB Mental
more JJR Mental
information NN Mental
about IN Mental
their PRP$ Mental
illness NN Mental
psychological JJ Mental
distress NN Mental
30-item JJ Mental
General NNP Mental
Health NNP Mental
Questionnaire NNP Mental
and CC Mental
the DT Mental
Hospital NNP Mental
Anxiety NNP Mental
and CC Mental
Depression NNP Mental
Scale NNP Mental
psychological JJ Mental
distress NN Mental
factual JJ Mental
retention NN Mental
psychological JJ Mental
distress NN Mental
-DOCSTART- -X- N

therapeutic JJ Other
efficacy NN Other
maximum JJ Physical
exercise NN Physical
time NN Physical
was VBD None
evaluated VBN None
using VBG None
an DT None
exercise NN Other
tolerance NN Other
test NN Other
left JJ Physical
ventricular JJ Physical
ejection NN Physical
fraction NN Physical
bidimensional JJ Other
echocardiography NN Other
. . None
values NNS Other
of IN Other
both DT Other
tests NNS Other
maximum JJ Physical
exercise NN Physical
time NN Physical
ventricular JJ Physical
ejection NN Physical
fraction NN Physical
efficaciously RB Other
-DOCSTART- -X- N

Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
( ( Mental
ABC NNP Mental
) ) Mental
hyperactivity NN Physical
and CC Physical
stereotypy NN Physical
hyperactivity NN Physical
. . Physical
adverse JJ Adverse
effects NNS Adverse
-DOCSTART- -X- N

learning VBG Mental
verbal JJ Mental
and CC Mental
nonverbal JJ Mental
tasks NNS Mental
learning VBG Mental
a DT Mental
novel JJ Mental
juice-making NN Mental
task NN Mental
producing VBG Mental
two CD Mental
novel JJ Mental
words NNS Mental
about IN Mental
the DT Mental
event NN Mental
. . None
novel JJ Mental
words NNS Mental
juice-making NN Mental
task NN Mental
four CD Mental
verbal NNS Mental
and CC Mental
two CD Mental
nonverbal JJ Mental
measures NNS Mental
advantage NN None
of IN None
enhanced JJ None
participatory JJ None
experience NN None
. . None
-DOCSTART- -X- N

size NN Physical
of IN Physical
the DT Physical
polyps NNS Physical
that WDT Physical
recurred VBD Physical
significant JJ None
difference NN Other
-DOCSTART- -X- N

abnormal JJ Physical
TSH NNP Physical
response NN Physical
to TO Physical
TRH NNP Physical
blunted JJ Physical
TSH NNP Physical
response NN Physical
thyrotropin-releasing JJ Physical
hormone NN Physical
( ( Physical
TRH NNP Physical
) ) Physical
hypothalamic NN Physical
somatostatinergic NN Physical
tone NN Physical
involvement NN Physical
of IN Physical
endogenous JJ Physical
opioids NNS Physical
in IN Physical
the DT Physical
mechanism NN Physical
underlying VBG Physical
the DT Physical
abnormal JJ Physical
TSH NNP Physical
response NN Physical
to TO Physical
TRH NNP Physical
TSH NNP Physical
response NN Physical
to TO Physical
TRH NNP Physical
( ( Physical
25 CD Physical
micrograms NNS Physical
in IN Physical
an DT Physical
intravenous JJ Physical
bolus NN Physical
) ) Physical
, , None
serum JJ Physical
total NN Physical
and CC Physical
free JJ Physical
T4 NNP Physical
and CC Physical
T3 NNP Physical
levels NNS Physical
, , None
and CC None
24-hour JJ Physical
urinary-free JJ Physical
cortisol NN Physical
levels NNS Physical
TRH NNP Other
tests NNS Other
after IN Other
prolonged JJ Other
starvation NN Other
TRH-induced NNP Physical
TSH NNP Physical
rise NN Physical
basal NN Physical
levels NNS Physical
of IN Physical
TSH NNP Physical
TSH NNP Physical
response NN Physical
to TO Physical
TRH NNP Physical
after IN Physical
prolonged JJ Physical
starvation NN Physical
. . None
cholinergic JJ Other
stimulatory NN Other
control NN Other
of IN Other
TSH NNP Other
secretion NN Other
-DOCSTART- -X- N

aerobic JJ Physical
fitness NN Physical
. . Physical
aerobic JJ Physical
fitness NN Physical
and CC None
body NN Physical
composition NN Physical
VO NNP Physical
( ( Physical
2max CD Physical
) ) Physical
Body NNP Physical
mass NN Physical
index NN Physical
( ( Physical
BMI NNP Physical
) ) Physical
VO NNP Physical
( ( Physical
2max CD Physical
) ) Physical
net JJ Physical
change NN Physical
in IN Physical
body NN Physical
mass NN Physical
net JJ Physical
fat NN Physical
% NN Physical
change NN Physical
-DOCSTART- -X- N

median JJ Physical
number NN Physical
of IN Physical
aflibercept JJ Physical
cycles NNS Physical
were VBD None
neutropenia RB None
( ( None
37 CD None
% NN None
) ) None
, , None
fatigue NN None
( ( None
and CC None
hypertension NN None
( ( None
patients NNS None
. . None
Plasma NNP None
levels NNS None
of IN None
free JJ None
over IN None
vascular JJ None
endothelial JJ None
growth NN None
factor-bound JJ None
aflibercept NN None
were VBD None
-DOCSTART- -X- N

systolic JJ Physical
blood NN Physical
pressure NN Physical
volatile JJ Physical
agent NN Physical
concentration NN Physical
in IN Physical
the DT Physical
blood NN Physical
hypotension NN Physical
speed NN Mental
of IN Mental
recovery NN Mental
. . None
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
renal JJ Physical
function NN Physical
systolic JJ Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
antihypertensive JJ Physical
activity NN Physical
plasma JJ Physical
renin NN Physical
activity NN Physical
( ( Physical
PRA NNP Physical
) ) Physical
and CC None
urinary JJ Physical
prostaglandin NN Physical
excretion NN Physical
( ( Physical
PGE2 NNP Physical
) ) Physical
-DOCSTART- -X- N

cortisol NN Physical
and CC Physical
glucose JJ Physical
response NN Physical
cortisol NN Mental
and CC Mental
glucose JJ Mental
response NN Mental
cortisol NN Mental
glucose JJ Physical
levels NNS Physical
mean JJ Physical
cortisol NN Physical
and CC Physical
glucose NN Physical
levels NNS Physical
blood NN Physical
glucose NN Physical
and CC None
cortisol NN Physical
-DOCSTART- -X- N

Plasma NNP Physical
levels NNS Physical
of IN Physical
lysozyme NN Physical
and CC Physical
beta-glucuronidase NN Physical
PMN NNP Physical
count NN Physical
blood NN Physical
cardioplegic JJ Physical
solution NN Physical
administration NN None
, , None
PMN NNP None
count NN None
in IN None
filtered JJ None
blood NN None
cardioplegic JJ None
solution NN None
was VBD None
) ) None
plasma VB None
beta-glucuronidase JJ None
levels NNS None
were VBD None
Beta-glucuronidase JJ None
levels NNS None
in IN None
coronary JJ None
sinus NN None
blood NN None
samples NNS None
collected VBN None
plasma FW None
lysozyme NN None
levels NNS None
in IN None
, , None
plasma VBP None
lysozyme JJ None
level NN None
in IN None
coronary JJ None
-DOCSTART- -X- N

well RB Other
tolerated VBN Other
notable JJ Physical
differences NNS Physical
incidence NN Physical
of IN Physical
tremor NN Physical
and CC Physical
taste NN Physical
of IN Physical
treatment NN Physical
clinically RB Physical
significant JJ Physical
abnormal JJ Physical
laboratory NN Physical
values NNS Physical
overall JJ Physical
differences NNS Physical
no DT Physical
clinically RB Physical
significant JJ Physical
differences NNS Physical
cardiac JJ Physical
variables NNS Physical
, , Physical
or CC Physical
in IN Physical
vital JJ Physical
signs NNS Physical
. . Physical
secondary JJ None
variables NNS None
no DT Physical
notable JJ Physical
differences NNS Physical
lung NN Physical
function NN Physical
, , Physical
exacerbations NNS Physical
or CC Physical
health-related JJ Physical
quality NN Physical
of IN Physical
life NN Physical
. . Physical
reduced VBD Other
rescue JJ Other
medication NN Other
usage NN Other
at IN Other
all DT Other
timepoints NNS Other
. . None
well RB Other
tolerated VBN Other
lack NN Other
of IN Other
sustained JJ Other
benefit NN Other
large-scale JJ Other
clinical JJ Other
efficacy NN Other
studies NNS Other
-DOCSTART- -X- N

baseline NN Other
Pap NNP Other
smear JJ Other
screening-coverage NN Other
rate NN Other
screening-coverage NN Other
rate NN Other
-DOCSTART- -X- N

intraocular JJ Physical
pressure NN Physical
( ( Physical
IOP NNP Physical
) ) Physical
prolonged JJ Other
therapeutic JJ Other
effect NN Other
efficacity NN Other
adverse JJ Adverse
side NN Adverse
effects NNS Adverse
Visual JJ Physical
disturbances NNS Physical
-DOCSTART- -X- N

presumed VBN Physical
therapy RB Physical
related VBN Physical
encephalopathy NN Physical
. . Physical
adverse JJ Physical
events NNS Physical
: : Physical
deaths NNS Physical
during IN Physical
continuous JJ Physical
complete JJ Physical
remission NN Physical
( ( Physical
CCR NNP Physical
) ) Physical
relapses NNS Physical
relapses NNS Physical
time NN Physical
from IN Physical
ALL NNP Physical
diagnosis NN Physical
to TO Physical
first JJ Physical
episode NN Physical
of IN Physical
CNS NNP Physical
leukemia NN Physical
, , Physical
systemic JJ Physical
therapy NN Physical
both DT Physical
before IN Physical
and CC Physical
after IN Physical
CNS NNP Physical
relapse NN Physical
, , Physical
and CC Physical
number NN Physical
of IN Physical
blasts NNS Physical
in IN Physical
the DT Physical
spinal JJ Physical
fluid NN Physical
at IN Physical
diagnosis NN Physical
of IN Physical
CNS NNP Physical
leukemia NN Physical
. . Physical
prolonged JJ Physical
survival NN Physical
with IN Physical
aggressive JJ Physical
therapy NN Physical
CSpRT NNP Physical
is VBZ Physical
possibly RB Physical
less RBR Physical
toxic JJ Physical
subsequent JJ Physical
BM NNP Physical
and CC Physical
testicular JJ Physical
relapse NN Physical
CNS NNP Physical
relapse NN Physical
spinal JJ Physical
irradiation NN Physical
superiority NN Physical
of IN Physical
CSpRT NNP Physical
. . Physical
-DOCSTART- -X- N

failure-free JJ Mortality
survival NN Mortality
( ( Mortality
FFS NNP Mortality
) ) Mortality
Response NN None
Response JJ Other
rate NN Other
complete JJ Other
response NN Other
[ NNP Other
CR NNP Other
] NNP Other
partial JJ Other
response NN Other
[ NNP Other
PR NNP Other
] NNP Other
FFS NNP Mortality
Response NNP Other
rate NN Other
CI NNP None
CR NNP Other
PR NNP Other
did VBD Mortality
not RB Mortality
influence VB Mortality
FFS NNP Mortality
Response JJ Other
rate NN Other
CI NNP None
CR NNP Other
PR NNP Other
FFS NNP Mortality
no DT Physical
effect NN Physical
FFS NNP Mortality
. . None
response NN Other
rate NN Other
FFS NNP Mortality
-DOCSTART- -X- N

symptomatic JJ Physical
anemia NN Physical
hematocrit JJ Physical
level NN Physical
hematocrit NN Physical
changes NNS Physical
in IN Physical
hematocrit NN Physical
level NN Physical
, , None
transfusion NN Other
requirements NNS Other
, , None
and CC None
quality NN Other
of IN Other
life NN Other
. . None
Quality-of-life JJ Other
increase NN None
in IN None
hematocrit NN Physical
hematocrit NN Physical
hematocrit JJ Physical
hematocrit NN Physical
level NN Physical
mean JJ Other
units NNS Other
of IN Other
blood NN Other
transfused VBN Other
per IN Other
patient NN Other
energy NN Other
level NN Other
and CC None
ability NN Other
to TO Other
perform VB Other
daily JJ Other
activities NNS Other
toxic JJ Adverse
effects NNS Adverse
diaphoresis NN Adverse
diarrhea NN Adverse
anemia RB Physical
-DOCSTART- -X- N

Delayed-onset NNP Physical
muscle NN Physical
soreness NN Physical
DOMS NNP Physical
DOMS NNP Physical
Baseline JJ Physical
measurements NNS Physical
DOMS NNP Physical
. . None
overall JJ Physical
arm NN Physical
discomfort NN Physical
elbow JJ Physical
extension NN Physical
isometric JJ Physical
strength NN Physical
both DT Physical
conditions NNS Physical
No DT Physical
significant JJ Physical
main JJ Physical
effect NN Physical
of IN Physical
treatment NN Physical
, , None
or CC None
time-by-treatment JJ Other
interaction NN Other
DOMS NNP Physical
. . None
-DOCSTART- -X- N

colon NN Other
cancer NN Other
screening VBG Other
knowledge NN Other
CRC NNP Other
knowledge NNP Other
and CC Other
health NN Other
belief NN Other
scores NNS Other
CRC NNP Other
knowledge NN Other
scores NNS Other
( ( Other
P NNP Other
< NNP Other
0.001 CD Other
) ) Other
, , None
perceived VBD Other
CRC NNP Other
risk NN Other
scores NNS Other
( ( Other
P NNP Other
= NNP Other
0.005 CD Other
) ) Other
, , None
FOBT NNP Other
barriers NNS Other
scores NNS Other
( ( Other
P NNP Other
= NNP Other
0.034 CD Other
) ) Other
and CC None
colonoscopy JJ Other
benefit NN Other
scores NNS Other
( ( Other
P NNP Other
< NNP Other
0.001 CD Other
) ) Other
. . None
knowledge NN Other
and CC Other
health NN Other
beliefs NNS Other
about IN Other
CRC NNP Other
screening NN Other
-DOCSTART- -X- N

QT NNP Physical
interval NN Physical
by IN Physical
central JJ Physical
reading NN Physical
and CC Physical
analysis NN Physical
, , None
and CC None
cardiovascular JJ Adverse
adverse JJ Adverse
events NNS Adverse
. . None
cardiovascular JJ Physical
events NNS Physical
Markedly RB Physical
abnormal JJ Physical
Fridericia NNP Physical
's POS Physical
correction NN Physical
of IN Physical
QT NNP Physical
values NNS Physical
Supraventricular JJ Physical
arrhythmias NN Physical
Other JJ Physical
arrhythmias JJ Physical
ischemic JJ Physical
heart NN Physical
disease NN Physical
-DOCSTART- -X- N

Validity NNP Other
and CC Other
reliability NN Other
validity NN Other
reliability NN Other
scores NNS Physical
from IN Physical
5-items JJ Physical
questionnaires NNS Physical
and CC Physical
6-items JJ Physical
clinical JJ Physical
score NN Physical
Median JJ Physical
scores NNS Physical
( ( Physical
min NN Physical
, , Physical
max NN Physical
) ) Physical
Internal NNP Other
consistency NN Other
reliability NN Other
5-items JJ Other
questionnaire NN Other
consistent JJ Other
6-items JJ Physical
clinical JJ Physical
score NN Physical
. . Physical
sensitivity NN Other
specificity NN Other
cutoff NN Other
point NN Other
sensitivity NN Other
specificity NN Other
validity NN Other
and CC Other
reliability NN Other
-DOCSTART- -X- N

overall JJ Mortality
( ( Mortality
OAS NNP Mortality
) ) Mortality
and CC Mortality
tumour $ Mortality
related VBN Mortality
survival NN Mortality
( ( Mortality
TRS NNP Mortality
) ) Mortality
TCM NNP None
, , None
histological JJ None
grading NN None
of IN None
myeloma NN None
cells NNS None
, , None
degree NN None
of IN None
bone NN None
marrow NN None
infiltration NN None
, , None
haemoglobin NN None
, , None
platelet NN None
counts NNS None
, , None
calcium NN None
, , None
creatinine NN None
, , None
albumin NN None
, , None
beta NN None
2M CD None
, , None
and CC None
Bence NNP None
Jones NNP None
proteinuria NNS None
histological JJ Physical
grading NN Physical
, , Physical
TCM NNP Physical
and CC Physical
platelets NNS Physical
survival JJ Mortality
times NNS Mortality
-DOCSTART- -X- N

Total JJ Other
control NN Other
( ( None
no DT Physical
vomiting NN Physical
, , None
no DT Physical
retching NN Physical
, , Physical
no DT Physical
nausea NN Physical
, , Physical
and CC Physical
no DT Physical
use NN Physical
of IN Physical
antiemetic JJ Physical
rescue NN Physical
medication NN Physical
) ) None
after IN None
the DT None
first JJ None
24 CD None
hr NN None
dose JJ Physical
levels NNS Physical
of IN Physical
granisetron NN Physical
tolerated VBN None
. . None
nausea NN Physical
and CC Physical
vomiting VBG Physical
-DOCSTART- -X- N

probability NN Physical
of IN Physical
pregnancy NN Physical
6-month JJ Physical
Kaplan-Meier NNP Physical
cumulative NN Physical
adjusted JJ Physical
risk NN Physical
of IN Physical
pregnancy NN Physical
Clinical JJ Physical
equivalence NN Physical
( ( Physical
noninferiority NN Physical
) ) Physical
true JJ Physical
risk NN Physical
of IN Physical
pregnancy NN Physical
pregnancy NN Physical
risk NN Physical
probability NN Physical
of IN Physical
pregnancy NN Physical
among IN Physical
FemCap NNP Physical
clinical JJ Physical
equivalence NN Physical
safe JJ Physical
urinary JJ Physical
tract NN Physical
infections NNS Physical
. . Physical
insertion NN Physical
, , Physical
dislodgement NN Physical
, , Physical
and CC Physical
especially RB Physical
removal JJ Physical
safety NN Mental
and CC Mental
acceptability NN Mental
6-month JJ Physical
pregnancy NN Physical
probabilities NNS Physical
-DOCSTART- -X- N

therapeutic JJ Other
efficacy NN Other
sites NNS Physical
improved VBN Physical
and/or RB Physical
cleared VBN Physical
Complete JJ Other
clearance NN Other
cleared VBN Other
Remission NNP Physical
periods NNS Physical
Tonsillar NNP Physical
focal JJ Physical
infection NN Physical
( ( Physical
TFI NNP Physical
) ) Physical
and CC None
dental JJ Physical
focal JJ Physical
infection NN Physical
( ( Physical
DFI NNP Physical
) ) Physical
focal JJ Physical
infection NN Physical
( ( Physical
FI NNP Physical
) ) Physical
, , None
TFI NNP Physical
and/or VBZ None
DFI NNP Physical
complete JJ Physical
clearance NN Physical
rates NNS Physical
and CC None
remission NN Physical
periods NNS Physical
-DOCSTART- -X- N

plasma NN Physical
fibrinogen NN Physical
, , Physical
haematocrit NN Physical
, , Physical
lipid JJ Physical
profile NN Physical
, , Physical
and CC Physical
walking VBG Physical
ability NN Physical
pain-free JJ Physical
walking NN Physical
time NN Physical
( ( Physical
PFWT NNP Physical
) ) Physical
and CC None
maximal JJ Physical
walking NN Physical
time NN Physical
( ( Physical
MWT NNP Physical
) ) Physical
and CC None
had VBD None
blood NN Physical
analyses NNS Physical
[ VBP Physical
for IN Physical
haematocrit NN Physical
, , Physical
fibrinogen NN Physical
, , Physical
triglycerides NNS Physical
, , Physical
and CC Physical
cholesterol NN Physical
: : Physical
total JJ Physical
, , Physical
high-density JJ Physical
lipoprotein NN Physical
( ( Physical
HDL NNP Physical
) ) Physical
and CC Physical
low-density JJ Physical
lipoprotein NN Physical
( ( Physical
LDL NNP Physical
) ) Physical
] VBD Physical
Total NNP Physical
and CC Physical
LDL NNP Physical
cholesterol NN Physical
levels NNS Physical
in IN None
the DT None
training NN None
group NN None
decreased VBD None
0.05 CD None
) ) None
HDL NNP Physical
cholesterol NN Physical
increased VBD None
( ( None
14.6 CD None
% NN None
) ) None
and CC None
triglycerides NNS Physical
decreased VBN None
( ( None
19 CD None
% NN None
) ) None
in IN None
Haematocrit NNP None
and CC None
fibrinogen NN Physical
changes NNS None
PFWT NNP Physical
was VBD None
MWT NNP Physical
-DOCSTART- -X- N

Montgomery NNP Mental
Asberg NNP Mental
Depression NNP Mental
Rating NNP Mental
Scale NNP Mental
. . Mental
remission NN Physical
response NN Physical
or CC Physical
remission NN Physical
-DOCSTART- -X- N

relapse NN Physical
of IN Physical
objective JJ Physical
response NN Physical
stabilisation NN None
. . None
objective JJ None
response NN None
stabilisation NN None
. . None
progression NN Mortality
free JJ Mortality
survival NN Mortality
-DOCSTART- -X- N

feasibility NN Other
and CC None
outcome NN Other
Safety NNP Other
, , None
clinical JJ Other
efficacy NN Other
, , None
survival NN Other
on IN Other
treatment NN Other
, , None
and CC None
radiographic JJ Physical
progression NN Physical
adverse JJ Adverse
events NNS Adverse
. . None
efficacy NN Other
) ) None
survival NN Mortality
adverse JJ Adverse
events NNS Adverse
. . None
damage NN Physical
score NN Physical
and CC None
number NN Physical
of IN Physical
eroded JJ Physical
joints NNS Physical
radiographic JJ Physical
progression NN Physical
-DOCSTART- -X- N

operative JJ Other
time NN Other
, , None
pain NN Pain
scores NNS Pain
, , None
complications NNS Adverse
, , None
day NN Other
of IN Other
discharge NN Other
, , None
return NN Other
to TO Other
work VB Other
, , None
and CC None
level NN Other
of IN Other
satisfaction NN Other
. . None
mean JJ Other
operative JJ Other
time NN Other
blood NN Physical
loss NN Physical
, , None
pain NN Pain
scores NNS Pain
and CC None
requirement NN Other
of IN Other
analgesics NNS Other
Mean NNP Other
hospital NN Other
stay NN Other
returned VBD Other
to TO Other
work VB Other
or CC Other
routine VB Other
activities NNS Other
satisfied VBN Other
safe JJ Other
and CC Other
effective JJ Other
postoperative JJ Pain
pain NN Pain
, , None
early JJ Other
discharge NN Other
, , None
less JJR Other
time NN Other
off IN Other
work NN Other
, , None
complications NNS Adverse
satisfied JJ Other
patient NN Other
-DOCSTART- -X- N

effectiveness NN Other
and CC Other
safety NN Other
change NN Mental
in IN Mental
intelligence NN Mental
quotient NN Mental
scores NNS Mental
on IN Mental
Stanford-Binet NNP Mental
Intelligence NNP Mental
Scale NNP Mental
( ( Mental
Hindi NNP Mental
adaptation NN Mental
by IN Mental
Kulshrestha NNP Mental
) ) Mental
, , Mental
change NN Mental
in IN Mental
behavioral JJ Mental
scores NNS Mental
by IN Mental
Conners NNS Mental
3 CD Mental
Parent NN Mental
Rating VBG Mental
Scale NNP Mental
( ( Mental
Short NNP Mental
) ) Mental
and CC None
Childhood NNP Mental
Autism NNP Mental
Rating NNP Mental
Scale NNP Mental
, , None
safety NN Other
, , Other
and CC Other
tolerability NN Other
of IN None
donepezil NN None
. . None
intelligence NN Mental
quotient NN Mental
behavioral JJ Mental
scales NNS Mental
-DOCSTART- -X- N

comparison NN None
accuracy NN Other
of IN Other
correspondences NNS Other
between IN Other
taught JJ Other
picture NN Other
and CC Other
object JJ Other
pairs NNS Other
and CC Other
accuracy NN Other
of IN Other
delayed JJ Other
correspondences NNS Other
in IN Other
learning VBG Other
outcome JJ Other
tests NNS Other
with IN None
all DT None
combinations NNS None
of IN None
object NN None
and CC None
picture NN None
pairs NNS None
presented VBN None
errors NNS Other
-DOCSTART- -X- N

cuffs NNS Physical
-- : Physical
efficacy NN Other
performance NN Other
cuff NN Physical
pressure NN Physical
cuff NN Physical
pressure NN Physical
cuff JJ Physical
pressure NN Physical
cuff NN Physical
pressure NN Physical
cuff NN Physical
pressure NN Physical
reliable JJ Physical
cuff NN Physical
pressure NN Physical
release NN Physical
cuff JJ Physical
pressure NN Physical
-DOCSTART- -X- N

degree NN Physical
of IN Physical
early JJ Physical
revascularization NN Physical
Miller NNP Physical
angiographic JJ Physical
index NN Physical
significant JJ Physical
degree NN Physical
of IN Physical
resolution NN Physical
Minor NNP Adverse
and CC Adverse
major JJ Adverse
bleeding NN Adverse
problems NNS Adverse
-DOCSTART- -X- N

safety NN Other
efficacy NN Other
safety NN Other
tolerability NN Other
dose JJ Adverse
limiting NN Adverse
toxicities NNS Adverse
safety NN Other
and CC Other
efficacy NN Other
toxicity NN Adverse
toxicity NN Adverse
response NN Other
rate NN Other
Median JJ Mortality
overall JJ Mortality
survival NN Mortality
Dose NNP Adverse
limiting VBG Adverse
toxicity NN Adverse
dose JJ Adverse
limiting VBG Adverse
toxicity NN Adverse
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
clinical JJ Physical
responses NNS Physical
Eradication NN Physical
of IN Physical
the DT Physical
original JJ Physical
serotype NN Physical
of IN Physical
group NN Physical
A NNP Physical
streptococci NN Physical
symptomatic JJ Physical
Staphylococcus NNP Physical
aureus NN Physical
was VBD Physical
isolated VBN Physical
from IN Physical
the DT Physical
throat NN Physical
flora NN Physical
incidence NN Adverse
of IN Adverse
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

Transthoracic NNP Other
impedance NN Other
( ( Other
TTI NNP Other
) ) Other
paddle JJ Other
force NN Other
. . Other
TTI NNP Physical
TTI NNP None
TTI NNP None
TTI NNP None
-DOCSTART- -X- N

development NN Physical
BNP NNP Physical
levels NNS Physical
CI-AKI NNP Physical
administration NN None
. . None
Logistic JJ None
regression NN None
analysis NN None
was VBD None
CI-AKI NNP None
. . None
CI-AKI NNP None
correlate NN None
of IN None
CI-AKI NNP None
( ( None
odds NNS None
variables NNS None
, , None
BNP NNP None
current JJ None
clinical JJ None
risk NN None
prediction NN None
model NN None
( ( None
net JJ None
Mehran NNP None
Risk NNP None
Score NNP None
( ( None
net JJ None
Measurement NNP None
of IN None
serum NN None
BNP NNP None
-DOCSTART- -X- N

safety NN Other
and CC Other
tolerability NN Other
frequency NN None
and CC None
severity NN None
of IN None
ocular JJ None
and CC None
systemic JJ None
adverse JJ None
events NNS None
. . None
Secondary JJ None
changes NNS None
in IN None
BCVA NNP None
and CC None
retinal JJ None
thickness NN None
. . None
RESULTS NNP None
No NNP None
dose-limiting JJ None
toxicities NNS None
were VBD None
ocular JJ None
adverse JJ None
events NNS None
were VBD None
transient NN None
. . None
Conjunctival NNP None
hyperemia NN None
, , None
hemorrhage NN None
, , None
and CC None
edema NN None
were VBD None
conjunctival JJ Physical
hemorrhage NN Physical
was VBD None
experienced VBD None
ocular JJ None
adverse JJ None
events NNS None
considered VBN None
: : None
Conjunctival NNP None
edema NN None
and CC None
reduced JJ None
visual JJ None
acuity NN None
were VBD None
serious JJ None
ocular JJ None
adverse JJ None
events NNS None
were VBD None
reported VBN None
. . None
No DT None
nonocular JJ None
adverse JJ None
events NNS None
were VBD None
. . None
Systemic JJ None
exposure NN None
to TO None
sirolimus VB None
was VBD None
blood NN None
concentrations NNS None
below IN None
a DT None
median JJ None
increase NN None
in IN None
BCVA NNP None
started VBD None
median JJ None
decrease NN None
in IN None
retinal JJ None
thickness NN None
was VBD None
median JJ None
increase NN None
in IN None
BCVA NNP None
letters NNS None
) ) None
; : None
the DT None
median JJ None
decrease NN None
in IN None
retinal JJ None
thickness NN None
was VBD None
-DOCSTART- -X- N

Nephrotoxicity NNP Physical
Ototoxicity NN Physical
No DT None
significant JJ None
difference NN None
was VBD None
found VBN None
between IN None
the DT None
two CD None
groups NNS None
for IN None
favourable JJ Other
clinical JJ Other
response NN Other
: : None
only JJ Other
effective JJ Other
antibiotic JJ Other
. . None
favourable JJ Other
bacteriological JJ Other
response NN Other
. . None
no DT None
significant JJ None
differences NNS None
all DT Adverse
adverse JJ Adverse
events NNS Adverse
. . None
Nephrotoxicity NNP Adverse
developed VBD None
Hearing NNP Adverse
loss NN Adverse
Phlebitis NN Adverse
Red JJ Physical
man NN Physical
syndrome NN Physical
efficacy NN Other
and CC Other
safety NN Other
profile NN Other
of IN None
similar JJ None
-DOCSTART- -X- N

overall JJ Mortality
local JJ Mortality
recurrence-free JJ Mortality
survival NN Mortality
rates NNS Mortality
at IN Mortality
higher JJR None
rate NN None
of IN None
recurrence NN None
was VBD None
) ) None
. . None
A DT None
postablation NN None
syndrome NN None
was VBD None
Tumour JJ None
necrosis NN None
factor-? NN None
was VBD None
significantly RB None
-DOCSTART- -X- N

reduces NNS Physical
and CC None
improves VBZ Physical
feedlot NN Physical
and CC Other
carcass NN Physical
performance NN Physical
parasite JJ Physical
burden NN Physical
, , None
feedlot NN Physical
performance NN Physical
carcass NN Other
merit NN Other
of IN Other
feedlot NN Other
cattle NNS Other
. . None
fewer JJR None
( ( None
P NNP None
= NNP None
0.02 CD None
) ) None
cattle NNS Other
retreated VBD Other
for IN Other
disease NN Other
fewer JJR Other
( ( Other
P NNP Other
= NNP Other
0.06 CD Other
) ) Other
worm NN Other
eggs NNS Other
per IN Other
fecal JJ Other
sample NN Other
more RBR None
DM NNP None
greater JJR None
ADG NNP None
heavier JJR Other
at IN Other
slaughter NN Other
heavier JJR Other
carcasses NNS Other
more RBR Physical
( ( Physical
P NNP Physical
= NNP Physical
0.07 CD Physical
) ) Physical
carcasses NNS Physical
USDA NNP None
Prime NNP None
or CC None
Choice NNP None
fewer JJR Other
( ( Other
P NNP Other
< NNP Other
0.01 CD Other
) ) Other
worm NN Other
eggs NNS Other
per IN Other
fecal JJ Other
sample NN Other
numbers NNS Other
of IN Other
adult NN Other
and CC Other
larval JJ Other
Cooperia NNP Other
and CC Other
Trichostrongylus NNP Other
spp NN Other
. . Other
in IN Physical
the DT Physical
small JJ Physical
intestine NN Physical
DM NNP Physical
greater JJR Mental
ADG NNP Mental
parasite JJ Physical
burden NN Physical
increased VBD Physical
feed NN Other
intake NN Other
, , None
ADG NNP None
carcass NN Physical
weight NN Physical
-DOCSTART- -X- N

MEG NNP Physical
premotor NN Physical
abnormalities NNS Physical
social JJ Mental
behavior NN Mental
social JJ Mental
functioning VBG Mental
social JJ Physical
cognition NN Physical
. . None
electrophysiological JJ Physical
modulation NN Physical
of IN Physical
the DT Physical
Mu-rhythm NNP Physical
magnetoencephalographic JJ Physical
Mu-modulations NNS Physical
grasping VBG Physical
movements NNS Physical
. . None
Mu-power NN Physical
Source NNP None
localization NN None
Activity NN Other
in IN Other
premotor NN Other
regions NNS Other
, , Other
IPL NNP Other
and CC Other
MOTG NNP Other
social JJ Mental
competence NN Mental
social JJ Mental
competence NN Mental
. . None
correlation NN None
with IN None
intellectual JJ Mental
ability NN Mental
abnormal JJ Physical
Mu-activity NNP Physical
social-function NN Mental
deficits NNS Mental
. . None
-DOCSTART- -X- N

postoperative JJ None
hip NN None
precautions NNS None
time-points NNS Other
at IN Other
which WDT Other
the DT Other
patient NN Other
first RB Other
drove VBD Other
and CC Other
ambulated VBD Other
dislocation NN Physical
ambulate VB Physical
with IN Physical
only RB Physical
a DT Physical
cane NN Physical
without IN Other
a DT Other
cane NN Other
without IN Other
a DT Other
limp NN Other
drove VBD Other
Pace NN Physical
of IN Physical
recovery NN Physical
pace NN None
of IN None
recovery NN None
increasing VBG None
complications NNS Adverse
. . None
-DOCSTART- -X- N

severe JJ Mental
disruptive JJ Mental
behavior NN Mental
relapse NN Mental
: : Mental
Weight NNP Physical
gain NN Physical
, , Physical
increased VBD Physical
appetite RB Physical
, , None
anxiety NN Physical
, , None
and CC None
fatigue NN Physical
disruptive JJ Mental
behavior NN Mental
weight JJ Physical
gain NN Physical
-DOCSTART- -X- N

Local JJ Mental
contextual JJ Mental
processing NN Mental
local JJ Mental
contextual JJ Mental
processing NN Mental
significant JJ Physical
reaction NN Mental
time NN Mental
( ( Mental
RT NNP Mental
) ) Mental
and CC None
P3b NNP Mental
latency NN Mental
differences NNS Physical
specific JJ Physical
prolongation NN Mental
attenuation NN Physical
of IN Physical
P3b NNP Mental
amplitudes NNS Mental
N1 NNP Mental
amplitudes NNS Mental
were VBD Physical
attenuated VBN Physical
utilize VB Mental
predictive JJ Mental
context NN Mental
ability NN Physical
was VBD Adverse
limited VBN Adverse
altered VBN Mental
processing NN Mental
of IN Mental
local JJ Mental
contextual JJ Mental
processing NN Mental
. . None
-DOCSTART- -X- N

the DT None
effect NN None
of IN None
rosiglitazone NN None
, , None
including VBG None
the DT None
Digit NNP None
Span NNP None
subtest JJS None
from IN None
the DT None
Wechsler NNP None
Adult NNP None
Intelligence NNP None
Scale-III NNP None
( ( None
WAIS-III NNP None
) ) None
, , None
the DT None
verbal JJ None
fluency NN None
test NN None
, , None
the DT None
Hopkins NNP None
Verbal NNP None
Learning NNP None
Test NNP None
( ( None
HVLT NNP None
) ) None
, , None
the DT None
Trail-Making JJ None
Test NNP None
( ( None
TMT NNP None
) ) None
and CC None
the DT None
Wisconsin NNP None
Card NNP None
Sorting NNP None
Test NNP None
( ( None
WCST NNP None
) ) None
was VBD None
demographic JJ None
or CC None
general JJ None
clinical JJ None
variables NNS None
between IN None
cognitive JJ Mental
performance NN Mental
over IN None
cognitive JJ Mental
benefit NN Mental
in IN None
-DOCSTART- -X- N

microvascular JJ Physical
obstruction NN Physical
microvascular JJ Physical
obstruction NN Physical
( ( Physical
MO NNP Physical
) ) Physical
microembolization NN Physical
Regional NNP Physical
wall NN Physical
motion NN Physical
score NN Physical
index NN Physical
( ( Physical
WMSI NNP Physical
) ) Physical
, , Physical
contrast RB Physical
score NN Physical
index NN Physical
( ( Physical
CSI NNP Physical
) ) Physical
, , Physical
endocardial JJ Physical
length NN Physical
of IN Physical
wall NN Physical
motion NN Physical
abnormality NN Physical
( ( Physical
WML NNP Physical
) ) Physical
and CC Physical
contrast NN Physical
defect NN Physical
( ( Physical
CDL NNP Physical
) ) Physical
, , None
end-diastolic JJ Physical
and CC Physical
end-systolic JJ Physical
left NN Physical
ventricular NN Physical
( ( Physical
LV NNP Physical
) ) Physical
volumes NNS Physical
, , None
and CC None
ejection NN Physical
fraction NN Physical
WMSI NNP Physical
, , Physical
CSI NNP Physical
, , Physical
WML NNP Physical
, , Physical
and CC Physical
CDL NNP Physical
ejection NN Physical
fraction NN Physical
LV NNP Physical
volumes NNS Physical
extent NN Physical
of IN Physical
MO NNP Physical
LV NNP Physical
volumes NNS Physical
. . None
extent NN Physical
of IN Physical
MO NNP Physical
myocardial JJ Physical
dysfunction NN Physical
LV NNP Physical
remodeling VBG Physical
. . None
MO NNP Physical
LV NNP Physical
remodeling NN Physical
. . None
-DOCSTART- -X- N

physiology NN Mental
and CC Mental
mood NN Mental
state NN Mental
mood NN Mental
, , None
and CC None
temperature NN Physical
and CC Physical
heart NN Physical
rate NN Physical
physiological JJ Physical
changes NNS Physical
in IN Physical
temperature NN Physical
and CC Physical
heart NN Physical
rate NN Physical
mood VBD Mental
ratings NNS Mental
tension-anxiety NN Mental
and CC Mental
confusion-bewilderment JJ Mental
mean JJ Mental
vigor-activity NN Mental
ratings NNS Mental
mean NN Mental
ratings NNS Mental
on IN Mental
the DT Mental
fatigue-inertia JJ Mental
subscale NN Mental
-DOCSTART- -X- N

psychological JJ Mental
well-being NN Mental
. . Physical
leisure NN Mental
activity NN Mental
. . Other
household/occupational JJ Mental
activity NN Mental
leisure NN Mental
activity NN Mental
-DOCSTART- -X- N

average JJ Other
duration NN Other
of IN Other
treatment NN Other
superiority NN Other
Galphimia NNP Physical
D6 NNP Physical
Galphimia NNP None
dilution NN None
10 CD None
( ( None
-6 NN None
) ) None
-DOCSTART- -X- N

Weakness NNP Adverse
moderate JJ None
to TO None
severe VB None
signs NNS None
and CC None
symptoms NNS None
of IN None
neuropathy JJ Physical
and CC Physical
myopathy JJ Physical
. . None
development NN Physical
of IN Physical
neuropathic JJ Physical
symptoms NNS Physical
. . None
fine-motor JJ Physical
coordination NN Physical
development NN Physical
of IN Physical
proximal JJ Physical
muscle NN Physical
weakness NN Physical
. . None
symptomatic JJ Physical
weakness NN Physical
-DOCSTART- -X- N

pain NN Pain
and CC None
walking NN Physical
time NN Physical
pain NN Pain
estimation NN Pain
on IN Pain
the DT Pain
visual JJ Pain
analogue NN Pain
scale NN Pain
( ( Pain
VAS NNP Pain
) ) Pain
for IN Pain
activities NNS Pain
of IN Pain
daily JJ Pain
living NN Pain
comfortable JJ Physical
walking NN Physical
time NN Physical
pain NN Pain
during IN Pain
activities NNS Pain
of IN Pain
daily JJ Pain
living NN Pain
comfortable JJ Physical
walking NN Physical
time NN Physical
-DOCSTART- -X- N

safety NN Other
and CC None
diagnostic JJ Other
accuracy NN Other
Diagnostic NNP Other
accuracy NN Other
side NN Adverse
effects NNS Adverse
frequencies NNS Physical
of IN Physical
ST NNP Physical
depression NN Physical
and CC None
chest NN Physical
pain NN Physical
frequency NN None
of IN None
severe JJ Adverse
side NN Adverse
effects NNS Adverse
such JJ None
as IN None
heart NN Adverse
block NN Adverse
and CC Adverse
hypotension NN Adverse
-DOCSTART- -X- N

flow-mediated JJ Physical
dilation NN Physical
( ( Physical
FMD NNP Physical
) ) Physical
isosorbide JJ Physical
dinitrate NN Physical
( ( Physical
ISDN NNP Physical
) ) Physical
-mediated VBD Physical
dilation NN Physical
clinical JJ Other
characteristics NNS Other
, , Physical
endothelial JJ Physical
function NN Physical
inflammatory JJ Physical
markers NNS Physical
. . None
FMD NNP Physical
ISDN-mediated JJ Physical
dilation NN Physical
reduced VBN Physical
malondialdehyde NN Physical
. . None
myeloperoxidase NN Physical
levels NNS Physical
CRP NNP Physical
nor CC Physical
fibrinogen NN Physical
levels NNS Physical
oxidative JJ Physical
stress NN Physical
, , Physical
improves VBZ Physical
endothelial JJ Physical
function NN Physical
, , Physical
ameliorates VBZ Physical
myeloperoxidase NN Physical
levels NNS Physical
-DOCSTART- -X- N

gastric JJ Physical
ulcers NNS Physical
incidences NNS Physical
of IN Physical
gastric JJ Physical
ulcers NNS Physical
incidence NN Physical
of IN Physical
gastric JJ Physical
ulcers NNS Physical
Mean NNP Other
gastric JJ Other
endoscopy NN Other
scores NNS Other
Mean JJ Other
esophageal NN Other
and CC Other
duodenal JJ Other
endoscopy NN Other
scores NNS Other
gastric JJ Other
endoscopy NN Other
scores NNS Other
Upper NNP Adverse
GI NNP Adverse
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

Pain NNP Physical
visual JJ Adverse
analogue NN Adverse
pain NN Adverse
scores NNS Adverse
reduced VBD Mental
pain NN Mental
scores NNS Mental
postoperative JJ Other
analgesia NN Other
. . Other
-DOCSTART- -X- N

gastric JJ Physical
cancer NN Physical
gastric JJ Physical
cancer NN Physical
, , None
precancerous JJ Physical
lesions NNS Physical
( ( Physical
dysplasia NN Physical
, , Physical
adenoma NN Physical
) ) Physical
, , Physical
other JJ Physical
cancers NNS Physical
, , None
and CC None
death NN Mortality
. . None
cured VBN Other
gastric JJ Physical
cancer NN Physical
or CC None
any DT Physical
precancerous JJ Physical
lesion NN Physical
. . None
study NN Physical
endpoints NNS Physical
other JJ None
than IN None
gastric JJ Physical
cancer NN Physical
. . None
-DOCSTART- -X- N

No DT None
significant JJ None
decrease NN None
in IN None
total JJ Physical
respiratory NN Physical
resistance NN Physical
at IN Physical
8 CD Physical
Hz NNP Physical
( ( Physical
Rrs NNP Physical
[ VBZ Physical
8 CD Physical
] NN Physical
) ) Physical
was VBD None
observed VBN None
after IN None
ipratropium NN None
, , None
whereas JJ None
Rrs NNP None
( ( None
8 CD None
) ) None
decreased VBD None
significantly RB None
20 CD None
min NNS None
after IN None
fenoterol NN None
and CC None
40 CD None
min NN None
after IN None
the DT None
combination NN None
regimen NNS None
( ( None
p NN None
less JJR None
than IN None
0.05 CD None
) ) None
. . None
All DT None
three CD None
studied VBD None
drugs NNS None
resulted VBD None
in IN None
a DT None
significant JJ None
increase NN None
in IN None
the DT None
reactance NN Physical
( ( Physical
p NN Physical
less JJR Physical
than IN Physical
0.01 CD Physical
) ) Physical
and CC None
decrease NN None
in IN None
resonant JJ Physical
frequency NN Physical
. . None
Both DT None
fenoterol NN None
( ( None
delta JJ None
FEV1 NNP None
34 CD None
percent NN None
, , None
p NN None
less JJR None
than IN None
0.0001 CD None
) ) None
and CC None
the DT None
combination NN None
regimen NNS None
( ( None
delta JJ None
FEV1 NNP None
38 CD None
percent NN None
, , None
p NN None
less JJR None
than IN None
0.0001 CD None
) ) None
resulted VBD None
in IN None
a DT None
significantly RB None
larger JJR None
increase NN None
in IN None
FEV1 NNP Physical
than IN None
ipratropium NN None
alone RB None
( ( None
delta JJ None
FEV1 NNP None
17 CD None
percent NN None
, , None
p NN None
less JJR None
than IN None
0.0001 CD None
) ) None
. . None
A DT None
second JJ Other
dose NN Other
of IN None
fenoterol NN None
and CC None
of IN None
the DT None
combination NN None
regimen NNS None
resulted VBD None
in IN None
a DT None
further JJ None
significant JJ None
increase NN None
in IN None
FEV1 NNP None
after IN None
120 CD None
min NN None
( ( None
p NN None
less JJR None
than IN None
0.05 CD None
) ) None
. . None
A DT None
second JJ None
dose NN None
of IN None
ipratropium NN None
did VBD None
not RB None
result VB None
in IN None
a DT None
further JJ None
significant JJ None
increase NN None
in IN None
FEV1 NNP None
. . None
changes NNS None
in IN None
respiratory NN None
impedance NN None
were VBD None
qualitatively RB None
similar JJ None
for IN None
all DT None
three CD None
drug NN None
regimens NNS None
, , None
but CC None
larger JJR None
in IN None
absolute NN None
terms NNS None
after IN None
fenoterol NN None
and CC None
the DT None
combination NN None
regimen NNS None
than IN None
after IN None
ipratropium NN None
. . None
The DT None
similar JJ None
effect NN None
of IN None
these DT None
drugs NNS None
on IN None
the DT None
reactance NN None
can MD None
be VB None
explained VBN None
by IN None
an DT None
increase NN None
in IN None
the DT None
capacitance NN Physical
of IN Physical
the DT Physical
respiratory NN Physical
system NN Physical
, , None
and CC None
in IN None
combination NN None
with IN None
a DT None
decrease NN None
in IN None
frequency NN None
dependence NN None
of IN None
resistance NN None
, , None
by IN None
assuming VBG None
a DT None
decrease NN None
in IN None
peripheral JJ None
airway NN None
resistance NN None
. . None
-DOCSTART- -X- N

child NN Mental
's POS Mental
focus NN Mental
of IN Mental
attention NN Mental
; : None
child JJ Mental
communication NN Mental
acts NNS Mental
; : None
child JJ Mental
communication NN Mental
. . None
children NNS Mental
's POS Mental
prompted VBN Mental
and CC Mental
spontaneous JJ Mental
communication NN Mental
. . None
verbal JJ Mental
responsiveness NN Mental
language NN Mental
development NN Mental
and CC Mental
communication NN Mental
-DOCSTART- -X- N

odds NNS Mental
of IN Mental
parents NNS Mental
reporting VBG Mental
care NN Mental
consistent JJ Mental
with IN Mental
that DT Mental
in IN Mental
a DT Mental
medical JJ Mental
home NN Mental
less RBR Physical
likely JJ Physical
for IN Physical
children NNS Physical
with IN Physical
autism NN Physical
primary JJ Other
care NN Other
consistent JJ Other
with IN Other
that DT Other
in IN Other
a DT Other
medical JJ Other
home NN Other
. . None
-DOCSTART- -X- N

self-recorded JJ Physical
blood NN Physical
pressure NN Physical
'Finapres NNS Physical
' POS Physical
finger NN Physical
blood NN Physical
pressure NN Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
blood NN Physical
pressure NN Physical
pressure NN Physical
Systolic NNP Physical
blood NN Physical
pressure NN Physical
self-recorded JJ Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
-DOCSTART- -X- N

doses NNS Physical
of IN Physical
peanut NN Physical
protein NN Physical
on IN Physical
re-challenge NN Physical
RAST NNP Physical
inhibition NN Physical
epitope DT Physical
recognition NN Physical
. . None
50 CD None
% NN None
inhibition NN None
. . None
-DOCSTART- -X- N

area NN Other
under IN Other
the DT Other
plasma JJ Other
concentration-time JJ Other
curve NN Other
terminal-phase JJ Other
half-life NN Other
magnitude NN Other
of IN Other
the DT Other
reduction NN Other
in IN Other
the DT Other
intrinsic JJ Other
clearance NN Other
of IN Other
caffeine NN Other
pharmacokinetics NNS Other
of IN Other
caffeine NN Other
methylxanthine JJ Other
clearance NN Other
. . Physical
-DOCSTART- -X- N

clinical JJ Physical
WSL-scores NNS Physical
number NN Other
of IN Other
sites NNS Other
that WDT Other
totally RB Other
disappeared VBD Other
LF NNP Physical
readings NNS Physical
-DOCSTART- -X- N

negative JJ Mental
mood NN Mental
symptoms NNS Mental
Pharmacodynamic NNP Other
response NN Other
saccadic JJ Physical
eye NN Physical
velocity NN Physical
( ( Physical
SEV NNP Physical
) ) Physical
, , Physical
saccade JJ Physical
acceleration NN Physical
, , Physical
saccade JJ Physical
latency NN Physical
and CC Physical
self-rated JJ Physical
sedation NN Physical
. . None
daily JJ Mental
symptom NN Mental
rating NN Mental
scales NNS Mental
daily JJ Mental
symptom NN Mental
rating NN Mental
scales NNS Mental
saccadic JJ Physical
eye NN Physical
movement NN Physical
parameters NNS Physical
self-rated JJ Physical
sedation NN Physical
saccade JJ Physical
acceleration NN Physical
and CC Physical
sedation NN Physical
responses NNS Physical
negative JJ Mental
mood NN Mental
symptoms NNS Mental
pregnanolone NN Physical
sensitivity NN Physical
-DOCSTART- -X- N

Cardiovascular JJ Physical
risk NN Physical
markers NNS Physical
cardiovascular JJ Physical
risk NN Physical
markers NNS Physical
Cardiovascular JJ Other
risk NN Other
markers NNS Other
Fibrinogen NNP None
Factor NNP None
VIIc NNP None
activity NN None
levels NNS None
Factor NNP Physical
VII NNP Physical
antigen NN Physical
Factor NNP None
VIIa NNP None
Plasminogen NN None
levels NNS None
lipid JJ Other
variables NNS Other
total JJ Physical
cholesterol NN Physical
and CC Physical
LDL NNP Physical
cholesterol NN Physical
factor NN Physical
VIIc NNP Physical
factor NN Physical
VIIc NNP Physical
bleeding NN None
pattern NN None
. . None
procoagulant JJ None
changes NNS None
in IN None
factor NN None
VIIa NNP None
factor NN None
VIIc NNP None
activity NN None
PAI-1 NNP None
activity NN None
androgenic JJ Other
properties NNS Other
fibrinogen NN None
level NN None
Lp NNP None
( ( None
a DT None
) ) None
-DOCSTART- -X- N

included VBD None
V?O NNP None
( ( None
2peak CD None
) ) None
, , None
peak JJ None
power NN None
output NN None
and CC None
muscle NN None
strength NN None
and CC None
endurance NN None
. . None
ACE NNP None
higher JJR None
V?O NNP None
( ( None
2peak CD None
) ) None
( ( None
p=0.02 NN None
) ) None
and CC None
peak JJ None
power NN None
( ( None
p=0.003 NN None
observed VBN None
in IN None
V?O NNP None
( ( None
2peak CD None
) ) None
, , None
muscle NN None
strength NN None
, , None
muscle NN None
endurance NN None
or CC None
lactate NN None
threshold NN None
. . None
CONCLUSION NNP None
-DOCSTART- -X- N

Depression NNP Mental
and CC None
anxiety NN Mental
psychological JJ Mental
quality NN Mental
of IN Mental
life NN Mental
( ( Mental
symptoms NNS Mental
of IN Mental
depression NN Mental
and CC Mental
anxiety NN Mental
) ) Mental
depression NN Mental
and CC None
anxiety NN Mental
symptoms NNS Mental
of IN Mental
depression NN Mental
women NNS Mental
's POS Mental
depressive JJ Mental
symptom NN Mental
scores NNS Mental
symptoms NNS Mental
of IN Mental
anxiety NN Mental
depression NN Mental
and CC Mental
anxiety NN Mental
data NNS None
. . None
depression NN Mental
and CC Mental
anxiety NN Mental
symptoms NNS Mental
of IN Mental
anxiety NN Mental
effective JJ Other
symptoms NNS None
of IN None
depression NN Mental
and CC None
anxiety NN Mental
psychological JJ Other
quality NN Other
of IN Other
life NN Other
-DOCSTART- -X- N

symptoms NNS Physical
, , None
knowledge NN Mental
, , None
quality NN Mental
of IN Mental
life NN Mental
, , None
and CC None
satisfaction NN Other
-DOCSTART- -X- N

behavioral JJ Mental
and CC Mental
neural JJ Mental
correlates NNS Mental
of IN Mental
social JJ Mental
processing NN Mental
. . Mental
neural JJ Mental
processing NN Mental
of IN Mental
social JJ Mental
stimuli NNS Mental
behavioral JJ Mental
and CC Mental
neuronal JJ Mental
measures NNS Mental
of IN Mental
social JJ Mental
processing NN Mental
. . Mental
slower JJR Mental
reaction NN Mental
times NNS Mental
( ( Mental
RT NNP Mental
) ) Mental
higher JJR Mental
activation NN Mental
of IN Mental
left JJ Mental
fusiform NN Mental
gyrus NN Mental
social JJ Mental
stimuli NNS Mental
. . None
activation NN Mental
differences NNS Mental
RT NNP None
rs3796863 NN Mental
mainly RB Mental
influences VBZ Mental
fusiform NN Mental
gyrus NN Mental
activation NN Mental
activation NN Mental
differences NNS Mental
genetic JJ Physical
makeup NN Physical
OT NNP Physical
availability NN Physical
fusiform NN Mental
gyrus NN Mental
activation NN Mental
. . None
-DOCSTART- -X- N

pharmacokinetics NNS Physical
of IN Physical
AmB NNP Physical
concentration NN Physical
of IN Physical
AmB NNP Physical
in IN Physical
plasma NN Physical
clearance NN Physical
( ( Physical
CL NNP Physical
) ) Physical
of IN Physical
AmB NNP Physical
in IN Physical
dextrose NN Physical
steady-state JJ Physical
volume NN Physical
of IN Physical
distribution NN Physical
for IN Physical
AmB NNP Physical
AmB NNP Physical
in IN Physical
lipid JJ Physical
emulsion NN Physical
AmB NNP Physical
in IN Physical
dextrose NN Physical
safety NN Other
and CC Other
tolerance NN Other
-DOCSTART- -X- N

initial JJ Physical
cure NN Physical
rate NN Physical
assessed VBN Physical
by IN Physical
clinical JJ Physical
criteria NNS Physical
and CC Physical
Gram-stained JJ Physical
smear JJ Physical
criteria NNS Physical
Recurrence NN Physical
rates NNS Physical
by IN Physical
Gram-stained JJ Physical
smear JJ Physical
criteria NNS Physical
bacterial JJ Physical
vaginosis NN Physical
cure NN Physical
rates NNS Physical
. . None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
number NN Other
of IN Other
patients NNS Other
with IN Other
a DT Other
modified JJ Other
Rankin NNP Other
score NN Other
of IN Other
2 CD Other
or CC Other
less JJR Other
. . None
mortality NN Mortality
, , None
frequency NN Physical
of IN Physical
symptomatic JJ Physical
intracranial JJ Physical
haemorrhage NN Physical
( ( Physical
SIH NNP Physical
) ) Physical
, , None
neurological JJ Other
and CC Other
functional JJ Other
scores NNS Other
. . None
-DOCSTART- -X- N

Recovery NNP Physical
from IN Physical
anesthesia NN Physical
mean JJ Physical
+/- JJ Physical
SD NNP Physical
time NN Physical
to TO Physical
eye NN Physical
opening NN Physical
mean JJ Physical
time NN Physical
to TO Physical
respond VB Physical
to TO Physical
verbal VB Physical
commands NNS Physical
time NN Physical
from IN Physical
arrival NN Physical
in IN Physical
the DT Physical
recovery NN Physical
room NN Physical
to TO Physical
sitting VBG Physical
, , Physical
tolerating VBG Physical
oral JJ Physical
fluids NNS Physical
, , Physical
walking VBG Physical
, , Physical
or CC Physical
being VBG Physical
judged VBN Physical
fit NN Physical
for IN Physical
discharge NN Physical
. . Physical
postoperative VB Pain
pain NN Pain
or CC Pain
analgesic JJ Pain
requirements NNS Pain
. . None
higher JJR Adverse
frequency NN Adverse
of IN Adverse
nausea NN Adverse
and CC Adverse
vomiting NN Adverse
more RBR Physical
rapid JJ Physical
emergence NN Physical
from IN Physical
anesthesia NN Physical
recovery NN Physical
frequency NN Adverse
of IN Adverse
postoperative JJ Adverse
nausea NN Adverse
and CC Adverse
vomiting NN Adverse
. . None
-DOCSTART- -X- N

[ JJ None
Efficacy NNP Physical
and CC None
safety NN Physical
efficacy NN Physical
and CC None
safety NN Physical
serums NNS Physical
lipid JJ Physical
profiles NNS Physical
and CC None
adverse JJ Adverse
effects NNS Adverse
serum JJ Physical
level NN Physical
of IN Physical
triglyceride NN Physical
( ( Physical
TG NNP Physical
) ) Physical
and CC None
high-density JJ Physical
lipoprotein NN Physical
cholesterol NN Physical
( ( Physical
HDL-C NNP Physical
) ) Physical
TC NNP Physical
, , None
low-density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
( ( Physical
LDL-C NNP Physical
) ) Physical
, , None
and CC None
TG NNP Physical
in IN None
the DT None
atorvastatin NN Physical
group NN None
TC NNP Physical
, , None
LDL-C NNP Physical
, , None
and CC None
TG NNP Physical
levels NNS Physical
HDL-C NNP Physical
level NN Physical
TC NNP Physical
and CC None
LDL-C NNP Physical
LDL-C JJ Physical
flushing NN Adverse
gastrointestinal JJ Adverse
symptoms NNS Adverse
effect NN None
in IN None
modulating VBG None
the DT None
blood NN None
lipid JJ None
profile NN None
reducing VBG Other
TG NNP Physical
and CC None
elevating VBG Other
HDL-C NNP Physical
. . None
global JJ Physical
and CC Physical
effective JJ Physical
improvement NN Physical
in IN Physical
lipid JJ Physical
blood NN Physical
levels NNS Physical
safe JJ Physical
and CC None
well RB Physical
tolerable JJ Physical
. . None
-DOCSTART- -X- N

Safety NNP Other
and CC None
efficacy NN Other
Electroneurographic JJ Other
assessments NNS Physical
with IN None
surface NN None
electrodes NNS None
reduction NN Physical
of IN Physical
the DT Physical
compound NN Physical
muscle NN Physical
action NN Physical
potential JJ Physical
M-wave NNP Physical
amplitude NN Physical
the DT None
EDB NNP None
muscle NN None
. . None
effective JJ Other
Duration NN Other
of IN Other
effect NN Other
mean JJ Physical
values NNS Physical
of IN Physical
compound NN Physical
muscle NN Physical
action NN Physical
potential JJ Physical
M-wave NNP Physical
amplitudes NNS Physical
in IN Physical
the DT Physical
adjacent JJ Physical
muscles NNS Physical
muscle NN Physical
activity NN Physical
. . None
tolerated VBN Other
. . None
-DOCSTART- -X- N

depressive JJ Mental
symptoms NNS Mental
depressive JJ Mental
symptoms NNS Mental
depressive JJ Mental
symptom NN Mental
Depressive NNP Mental
symptoms NNS Mental
biochemically RB Physical
verified JJ Physical
abstinence NN Physical
depressive JJ Mental
symptoms NNS Mental
level NN Mental
of IN Mental
depressive JJ Mental
symptoms NNS Mental
depressive JJ Mental
symptoms NNS Mental
depressive NN Mental
symptoms NNS Mental
depressive JJ Mental
symptoms NNS Mental
-DOCSTART- -X- N

electroencephalographic JJ Physical
vigilance NN Physical
number NN Physical
of IN Physical
epochs NN Physical
anterior-posterior JJ Physical
and CC Physical
left-right JJ Physical
relations NNS Physical
of IN Physical
absolute JJ Physical
alpha-power NN Physical
baseline-EEG NN Physical
forms NNS Other
non-A JJ Physical
epochs NN Physical
alpha-activity NN None
) ) None
non-A JJ Physical
epochs NN Physical
; : None
prevalence NN Physical
of IN Physical
A-epochs NNP Physical
( ( Physical
abundant JJ Physical
alpha-activity NN Physical
) ) Physical
left-right JJ Physical
relations NNS Physical
of IN Physical
alpha-power NN Physical
alpha-activity NN Physical
shift NN Other
to TO Other
the DT Other
left NN Other
; : None
alpha-activity NN Other
to TO Other
the DT Other
right NN Other
. . None
shift NN Physical
to TO Physical
the DT Physical
left NN Physical
. . None
electroencephalographic JJ Physical
vigilance NN Physical
-DOCSTART- -X- N

ADL NNP Mental
self-reported JJ Mental
health NN Mental
problems NNS Mental
activities NNS Mental
of IN Mental
daily JJ Mental
living NN Mental
( ( Mental
ADL NNP Mental
) ) Mental
ADL NNP Mental
level NN Mental
visual JJ Physical
acuity NN Physical
ADL NNP Mental
. . None
General NNP Physical
health NN Physical
fewer JJR Physical
health NN Physical
problems NNS Physical
. . None
fewer JJR None
reports NNS None
of IN None
tiredness NN Adverse
and CC Physical
dizziness NN Physical
disablement JJ Physical
process NN Physical
ADL NNP Physical
level NN Physical
reducing VBG Physical
self-reported JJ Physical
health NN Physical
problems NNS Physical
-DOCSTART- -X- N

Bronchoalveolar NNP Other
lavage NN Other
( ( Other
BAL NNP Other
) ) Other
measurement NN None
of IN None
total JJ Physical
protein NN Physical
, , None
ceruloplasmin NN Physical
, , None
and CC None
transferrin NN Physical
, , None
total JJ Physical
neutrophil NN Physical
count NN Physical
, , None
IL-8 NNP Physical
, , None
IL-6 NNP Physical
, , Physical
tumor NN Physical
necrosis NN Physical
factor-alpha NN Physical
, , None
and CC None
leukotriene JJ Physical
B4 NNP Physical
. . None
Oxygenation NNP Physical
BALF NNP Physical
ceruloplasmin NN Physical
and CC None
IL-8 NNP Physical
BALF NNP None
levels NNS None
of IN None
total JJ Physical
protein NN Physical
, , None
neutrophils NNS Physical
, , None
and CC None
leukotriene JJ Physical
B4 NNP Physical
BALF NNP None
levels NNS None
of IN None
IL-6 NNP Physical
BALF NNP None
tumor NN Physical
necrosis NN Physical
factor-alpha NN Physical
oxygenation NN Physical
neutrophil JJ Physical
leukotriene JJ Physical
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
systemic JJ Physical
and CC Physical
regional JJ Physical
hemodynamics NNS Physical
arterial JJ Physical
pressure NN Physical
and CC Physical
vascular JJ Physical
resistances NNS Physical
nitric JJ Mental
oxide JJ Mental
synthase NN Mental
mean JJ Other
arterial JJ Other
pressure NN Other
after IN Other
L-NMMA NNP Other
postexercise NN Physical
hypotension NN Physical
production NN Mental
of IN Mental
nitric JJ Mental
oxide NN Mental
-DOCSTART- -X- N

absolute JJ Physical
rate NN Physical
of IN Physical
sodium NN Physical
excretion NN Physical
, , Physical
fractional JJ Physical
sodium NN Physical
excretion NN Physical
, , Physical
urine JJ Physical
flow NN Physical
rate NN Physical
and CC Physical
effective JJ Physical
renal JJ Physical
plasma NN Physical
flow NN Physical
glomerular JJ Physical
filtration NN Physical
rate NN Physical
. . Physical
urine JJ Physical
flow NN Physical
rate NN Physical
falls NNS None
absolute JJ Physical
rate NN Physical
of IN Physical
sodium NN Physical
excretion NN Physical
, , Physical
fractional JJ Physical
sodium NN Physical
excretion NN Physical
, , Physical
urine JJ Physical
flow NN Physical
rate NN Physical
and CC Physical
effective JJ Physical
renal JJ Physical
plasma NN Physical
flow NN Physical
glomerular JJ Physical
filtration NN Physical
rate NN Physical
natriuresis NN Physical
. . Physical
renal JJ Physical
haemodynamic NN Physical
and CC Physical
natriuretic JJ Physical
effects NNS Physical
homeostatic JJ Physical
role NN Physical
renal JJ Physical
function NN Physical
, , Physical
particularly RB Physical
glomerular JJ Physical
filtration NN Physical
-DOCSTART- -X- N

Weights NNS Physical
and CC Physical
heights NNS Physical
rate NN Physical
of IN Physical
weight NN Physical
gain NN Physical
rate NN Physical
of IN Physical
weight NN Physical
gain NN Physical
rate NN Physical
of IN Physical
height NN Physical
gain NN Physical
-DOCSTART- -X- N

incidence NN None
of IN None
low JJ None
cardiac JJ None
output NN None
syndrome NN None
( ( None
standardized VBN None
death NN None
at IN None
30 CD None
days NNS None
, , None
interleukin-6 JJ None
levels NNS None
, , None
inotropic NN None
score NN None
, , None
fluid NN None
balance NN None
, , None
serum JJ None
creatinine NN None
, , None
and CC None
intensive JJ None
care NN None
unit NN None
and CC None
hospital NN None
stay NN None
. . None
RESULTS NNP None
Preoperative NNP None
plasma NN None
levels NNS None
of IN None
inflammatory JJ None
cytokine JJ None
interleukin-6 NN None
were VBD None
incidence NN None
of IN None
low JJ None
cardiac JJ None
output NN None
syndrome NN None
was VBD None
46 CD None
associated VBN None
with IN None
a DT None
higher JJR None
serum NN Physical
creatinine NN Physical
( ( None
0.61 CD None
? . None
and CC None
poorer $ None
postoperative JJ None
diuresis NN None
( ( None
-96 VB None
Inotropic NNP None
requirement NN None
, , None
duration NN None
of IN None
mechanical JJ None
ventilation NN None
, , None
intensive JJ None
care NN None
unit NN None
, , None
and CC None
hospital JJ None
stay NN None
-DOCSTART- -X- N

Edinburgh NNP Physical
Postnatal NNP Physical
Depression NNP Physical
Scale NNP Physical
( ( Physical
EPDS NNP Physical
) ) Physical
Montgomery-Asberg NNP Physical
Depression NNP Physical
Rating NNP Physical
Scale NNP Physical
( ( Physical
MADRS NNP Physical
) ) Physical
DSM-III-R NNP Physical
fully RB Physical
recovered VBN Physical
-DOCSTART- -X- N

Wound NNP Physical
progress NN Physical
wound NN Physical
improvement NN Physical
wound NN Physical
progress NN Physical
wound NN Physical
progression NN Physical
-DOCSTART- -X- N

feasibility NN Other
accuracy NN Other
hemodynamic JJ Physical
performance NN Physical
fluoroscopic NN Other
evaluation NN Other
hemodynamic JJ Physical
performance NN Physical
rate NN Other
of IN Other
success NN Other
of IN Other
the DT Other
fluoroscopic JJ Other
evaluation NN Other
feasibility NN Other
and CC Other
accuracy NN Other
of IN Other
fluoroscopy NN Other
valve NN Physical
's POS Physical
hemodynamic JJ Physical
performance NN Physical
fluoroscopic NN Physical
-DOCSTART- -X- N

pain NN Pain
relief NN Pain
( ( Pain
0- JJ Pain
to TO Pain
5-point JJ Pain
verbal JJ Pain
response NN Pain
scale NN Pain
) ) Pain
. . Pain
muscle NN Physical
stiffness NN Physical
( ( None
101-point JJ Physical
numeric NN Physical
rating NN Physical
scale NN Physical
) ) None
, , None
lateral JJ Physical
trunk NN Physical
flexibility NN Physical
( ( Physical
fingertip-floor JJ Physical
distance NN Physical
) ) Physical
, , None
and CC None
Roland-Morris NNP Physical
Disability NNP Physical
Questionnaire NNP Physical
therapeutic JJ Other
benefits NNS Other
pain NN Pain
relief NN Pain
muscle NN Physical
stiffness NN Physical
flexibility NN Other
Disability NN Physical
Adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

Assessment NNP Mental
of IN Mental
language NN Mental
skills NNS Mental
and CC Mental
parents NNS Mental
' POS Mental
behavioral JJ Mental
assessments NNS Mental
Raters NNS Other
' POS Other
assessments NNS Other
of IN Other
severity NN Mental
of IN Mental
autistic JJ Mental
symptoms NNS Mental
-DOCSTART- -X- N

( ( None
Fisher NNP Mental
's POS Mental
Exact NNP Mental
test NN Mental
Mania NNP Mental
ratings NNS Mental
-DOCSTART- -X- N

quality NN Physical
of IN Physical
bone NN Physical
apatite JJ Physical
crystals NNS Physical
: : Physical
mean JJ Other
rate NN Other
of IN Other
substitutions NNS Other
crystallinity NN Physical
, , Physical
apparent JJ Physical
length NN Physical
and CC Physical
width/thickness NN Physical
of IN Physical
crystals NNS Physical
, , Physical
interplanar NN Physical
distances NNS Physical
, , Physical
and CC Physical
lattice JJ Physical
parameters NNS Physical
of IN Physical
unit NN Physical
cells NNS Physical
not RB None
influenced VBN None
presence NN None
of IN None
Sr NNP None
similar JJ None
mean JJ Physical
rate NN Physical
of IN Physical
substitutions NNS Physical
of IN Physical
calcium NN Physical
by IN Physical
Sr NNP Physical
ions NNS Physical
quality NN Physical
of IN Physical
bone NN Physical
apatite JJ Physical
crystals NNS Physical
-DOCSTART- -X- N

H. NNP None
pylori JJ Other
eradication NN Other
: : None
Helicobacter NNP None
pylori NN None
eradication NN None
cure NN Other
rates NNS Other
Bacterial JJ Physical
eradication NN Physical
eradication NN Other
rates NNS Other
H. NNP None
pylori JJ Other
infection NN Other
cured VBN Other
eradication NN Other
rates NNS Other
. . None
success NN Other
rate NN Other
-DOCSTART- -X- N

clinical JJ Physical
remission NN Physical
. . None
five CD Mortality
year NN Mortality
cure NN Physical
rate NN Mortality
survival NN Mortality
-DOCSTART- -X- N

plasma VBP Physical
levels NNS Physical
of IN Physical
fibrinogen NN Physical
and CC Physical
factor NN Physical
VII NNP Physical
increased JJ Physical
protein NN Physical
C NNP Physical
and CC Physical
decreased VBN Physical
protein NN Physical
S NNP Physical
levels NNS Physical
. . Physical
fibrinolytic JJ Physical
capacity NN Physical
antigen NN Physical
levels NNS Physical
of IN Physical
tissue NN Physical
plasminogen NN Physical
activator NN Physical
concentration NN Physical
of IN Physical
tissue NN Physical
plasminogen NN Physical
activator NN Physical
inhibitor NN Physical
. . Physical
ratio NN Physical
between IN Physical
thrombin-antithrombin-III-complexes NNS Physical
and CC Physical
fibrin JJ Physical
degradation NN Physical
products NNS Physical
were VBD None
unchanged JJ None
-DOCSTART- -X- N

appropriate JJ Other
volume NN Other
needle JJ Other
location NN Other
effect NN None
associated JJ None
variables NNS None
knee NN None
circumference NN None
, , None
body NN None
mass NN None
index NN None
, , None
and CC None
sex NN None
. . None
diagnose VB Other
50 CD Other
% NN Other
of IN Other
the DT Other
arthrotomies NNS Other
volumes NNS Other
that WDT Other
were VBD Other
needed VBN Other
in IN Other
order NN Other
to TO Other
effectively RB Other
diagnose VB Other
75 CD None
% NN None
arthrotomies NNS None
mean JJ Physical
volumes NNS Physical
of IN Physical
injected JJ Physical
fluid NN Physical
needed VBN Physical
for IN Physical
a DT Physical
positive JJ Physical
result NN Physical
at IN Physical
the DT Physical
inferomedial JJ Physical
and CC Physical
superomedial JJ Physical
needle JJ Physical
locations NNS Physical
no DT None
correlation NN None
between IN None
necessary JJ None
injection NN None
volume NN None
and CC None
sex NN None
, , None
body NN None
mass NN None
index NN None
, , None
or CC None
knee VB None
circumference NN None
. . None
inferomedial JJ None
injection NN None
location NN None
significantly RB Other
less JJR Other
fluid NN Other
superomedial JJ None
injection NN None
location NN None
-DOCSTART- -X- N

pharmacokinetics NNS Physical
and CC Physical
pharmacodynamics NNS Physical
of IN Physical
racemic JJ Physical
warfarin NN Physical
. . None
no DT Physical
major JJ Physical
change NN Physical
in IN Physical
the DT Physical
pharmacokinetics NNS Physical
of IN Physical
( ( Physical
R NNP Physical
) ) Physical
- : Physical
or CC Physical
( ( Physical
S NNP Physical
) ) Physical
-warfarin NN Physical
. . None
did VBD Physical
not RB Physical
alter VB Physical
the DT Physical
pharmacodynamic JJ Physical
profile NN Physical
of IN Physical
racemic JJ Physical
warfarin NN Physical
. . None
increased VBD Physical
template VB Physical
bleeding NN Physical
time NN Physical
-DOCSTART- -X- N

prevention NN Physical
of IN Physical
preventive JJ Other
effect NN Other
recurrence NN Physical
of IN Physical
effectiveness NN Other
prevention NN Physical
of IN Physical
AF NNP Physical
. . Physical
Kaplan-Meier NNP Physical
recurrent JJ Physical
symptomatic JJ Physical
AF NNP Physical
freedom NN Other
from IN Other
recurrence NN Other
prevalent JJ Physical
significant JJ Physical
difference NN Physical
rate NN Adverse
of IN Adverse
adverse JJ Adverse
events NNS Adverse
significant JJ Physical
effect NN Physical
preventing VBG Other
relapse NN Other
of IN Other
symptomatic JJ Other
AF NNP Other
; : Physical
recurrence NN Other
of IN Other
AF NNP Other
later RBR Physical
-DOCSTART- -X- N

body NN Physical
weight NN Physical
. . Physical
Dietary JJ Other
compensation NN Other
body JJ Physical
weight NN Physical
highest JJS None
dietary JJ None
compensation NN None
( ( None
significant JJ None
weight NN None
change NN None
( ( None
lower JJR None
compensation NN None
and CC None
significant JJ None
weight JJ None
gain NN None
during IN None
incomplete JJ None
dietary JJ None
compensation NN None
and CC None
weight JJ None
gain NN None
occurred VBD None
problematic JJ None
for IN None
weight JJ None
gain NN None
. . None
promote VB None
weight NN None
gain NN None
, , None
-DOCSTART- -X- N

visual JJ Physical
acuity NN Physical
Visual JJ Physical
acuity NN Physical
was VBD None
assessed VBN None
crowded VBN None
and CC None
uncrowded JJ None
logMAR NN None
acuity NN None
tests NNS None
and CC None
the DT None
logMAR NN None
crowded VBD None
and CC None
uncrowded JJ None
Kay NNP None
picture NN None
tests NNS None
mean JJ Physical
visual JJ Physical
acuity NN Physical
outcome NN Physical
mean JJ Physical
acuity NN Physical
difference NN Physical
logMAR NN Physical
acuity NN Physical
visual JJ Physical
acuity NN Physical
logMAR NN Physical
crowded VBD Physical
Kay NNP Physical
picture NN Physical
visual JJ Physical
acuity NN Physical
-DOCSTART- -X- N

effective JJ Physical
dose NN Physical
. . None
adverse JJ Adverse
health NN Adverse
effects NNS Adverse
oronasal RP Physical
breathing VBG Physical
oronasal NN Physical
breathing NN Physical
. . None
lower JJR None
airways NNS None
duration NN Physical
of IN Physical
oronasal NN Physical
breathing NN Physical
( ( Physical
tON NN Physical
) ) Physical
ventilation NN Physical
rate NN Physical
during IN Physical
oronasal NN Physical
breathing NN Physical
( ( Physical
VE NNP Physical
( ( Physical
ON NNP Physical
) ) Physical
) ) Physical
; : None
inhaled VBN Physical
hydrogen NN Physical
ion NN Physical
concentration NN Physical
[ NNP Physical
H+ NNP Physical
] NNP Physical
-DOCSTART- -X- N

attention NN Mental
during IN Mental
the DT Mental
game NN Mental
ability NN Mental
to TO Mental
answer VB Mental
questions NNS Mental
Judgment NN Mental
during IN Mental
batting NN Mental
, , Mental
batting VBG Mental
skill NN Mental
during IN Mental
the DT Mental
game NN Mental
, , Mental
and CC Mental
performance NN Mental
on IN Mental
skill NN Mental
drills NNS Mental
prior RB Mental
to TO Mental
the DT Mental
game NN Mental
-DOCSTART- -X- N

efficacy NN Other
, , None
side NN Adverse
effects NNS Adverse
and CC None
acceptability NN Other
The DT None
success NN Other
rate NN Other
at IN Other
48 CD Other
hours NNS Other
, , None
induction-to-abortion NN Other
interval NN Other
and CC None
the DT None
side NN Physical
effects NNS Physical
. . Physical
the DT None
success NN Other
rate NN Other
at IN Other
48 CD Other
hours NNS Other
success NN Other
rate NN Other
at IN Other
24 CD Other
hours NNS Other
the DT None
median JJ Other
induction-to-abortion NN Other
interval NN Other
preferred VBD None
the DT None
route NN None
to TO None
which WDT None
they PRP None
were VBD None
assigned VBN None
The DT Adverse
incidence NN Adverse
of IN Adverse
fever NN Adverse
success NN Other
rate NN Other
abortion NN Other
rate NN Other
-DOCSTART- -X- N

HRV NNP Physical
hormone NN Physical
baseline NN Physical
HRV NNP Physical
. . None
time NN Physical
and CC Physical
frequency NN Physical
domain NN Physical
measurements NNS Physical
antidepressants NNS Physical
parasympathetic JJ Physical
index NN Physical
rMSSD NN Physical
-DOCSTART- -X- N

beneficial JJ None
effects NNS None
restoration NN Physical
of IN Physical
spontaneous JJ Physical
menses NNS Physical
, , Physical
ovulation NN Physical
induction NN Physical
( ( Physical
spontaneous JJ Physical
or CC Physical
clomiphene NN Physical
induced VBN Physical
) ) Physical
and CC Physical
pregnancy NN Physical
. . Physical
Secondary JJ Physical
endpoints NNS Physical
Spontaneous JJ Physical
menstruation NN Physical
spontaneously RB Physical
ovulated VBD Physical
efficacy NN Physical
of IN Physical
clomiphene NN Physical
ovulation NN Physical
being VBG Physical
induced VBN Physical
Pregnancy NN Physical
-DOCSTART- -X- N

pain NN Pain
, , None
edema NN Physical
, , None
hyperpigmentation NN Physical
ulceration NN Physical
. . None
Villalta-Prandoni NNP Physical
scale NN Physical
( ( Physical
VPS NNP Physical
) ) Physical
Venous JJ Physical
Clinical NNP Physical
Severity NNP Physical
Score NNP Physical
( ( Physical
VCSS NNP Physical
) ) Physical
-DOCSTART- -X- N

breast NN Physical
density NN Physical
behavioural JJ Mental
or CC Mental
psychological JJ Mental
measures NNS Mental
breast NN Physical
cancer NN Physical
risk NN Physical
. . None
-DOCSTART- -X- N

Efficacy NN Other
effective JJ Other
( ( Other
based VBN Other
on IN Other
egg NN Other
per IN Other
gram NN Other
method NN Other
) ) Other
in IN Other
eliminating VBG Other
S. NNP Other
muris JJ Physical
infection NN Physical
efficacy NN Other
of IN Other
the DT Other
treatment NN Other
-DOCSTART- -X- N

full JJ Pain
return NN Pain
to TO Pain
sports NNS Pain
at IN Pain
the DT Pain
same JJ Pain
level NN Pain
without IN Pain
groin NN Pain
pain NN Pain
. . None
-DOCSTART- -X- N

composite JJ Mortality
of IN Mortality
death NN Mortality
, , Physical
myocardial JJ Physical
infarction NN Physical
, , Physical
or CC Physical
ischemia-driven JJ Physical
revascularization NN Physical
at IN Physical
48 CD Physical
hours NNS Physical
. . Physical
rate NN Physical
of IN Physical
stent JJ Physical
thrombosis NN Physical
rate NN Mortality
of IN Mortality
death NN Mortality
from IN Mortality
any DT Mortality
cause NN Mortality
rate NN Physical
of IN Physical
blood NN Physical
transfusion NN Physical
major JJ Physical
bleeding VBG Physical
groin JJ Physical
hematomas NN Physical
. . Physical
-DOCSTART- -X- N

plasma JJ Physical
levels NNS Physical
of IN Physical
antioxidants NNS Physical
transferrin JJ Physical
and CC Physical
superoxide JJ Physical
dismutase NN Physical
Social NNP Mental
Responsiveness NNP Mental
Scale NNP Mental
and CC Mental
the DT Mental
Aberrant NNP Mental
Behavior NNP Mental
Checklist-Community NNP Mental
. . None
Aberrant NNP Mental
Behavior NNP Mental
Checklist-Community-measured NNP Mental
social JJ Mental
withdrawal NN Mental
Social NNP Mental
Responsiveness NNP Mental
Scale-measured JJ Mental
communication NN Mental
. . None
change NN Physical
in IN Physical
plasma NN Physical
transferrin NN Physical
levels NNS Physical
plasma JJ Physical
superoxide JJ Physical
dismutase NN Physical
levels NNS Physical
social JJ Physical
interaction NN Physical
-DOCSTART- -X- N

safety NN Other
and CC Other
feasibility NN Other
changes NNS Physical
in IN Physical
infarct NN Physical
size NN Physical
and CC Other
left VBD Physical
ventricular JJ Physical
ejection NN Physical
fraction NN Physical
3 CD Physical
months NNS Physical
after IN Physical
therapy NN Physical
. . None
mean JJ Physical
changes NNS Physical
in IN Physical
infarct JJ Physical
size NN Physical
at IN Physical
3 CD Physical
months NNS Physical
changes NNS Physical
in IN Physical
ejection NN Physical
fraction NN Physical
ejection NN Physical
fraction NN Physical
stem NN Physical
cells NNS Physical
number NN Physical
of IN Physical
cells NNS Physical
myocardial JJ Physical
infarct NN Physical
size NN Physical
and CC Other
left VBD Physical
ventricular JJ Physical
function NN Physical
. . None
-DOCSTART- -X- N

surgical JJ Physical
wound NN Physical
infection NN Physical
. . None
Any NNP Physical
surgical JJ Physical
site NN Physical
infection NN Physical
( ( Physical
SSI NNP Physical
) ) Physical
; : None
return NN Physical
of IN Physical
bowel NN Physical
function NN Physical
and CC None
ability NN Physical
to TO Physical
tolerate VB Physical
solid JJ Physical
food NN Physical
, , None
ambulation NN Physical
, , None
suture NN Physical
removal NN Physical
, , None
and CC None
duration NN Other
of IN Other
hospitalization NN Other
. . None
Surgical JJ Physical
site NN Physical
infection NN Physical
risk NN Physical
of IN Physical
SSI NNP Physical
risk NN Physical
of IN Physical
wound JJ Physical
infection NN Physical
. . None
SSI NNP Physical
-DOCSTART- -X- N

pathologic JJ Physical
stage NN Physical
and CC Physical
resection NN Physical
limit NN Physical
status NN Physical
of IN Physical
effect NN Physical
of IN Physical
NHT NNP Physical
on IN Physical
pathologic JJ Physical
stage NN Physical
of IN Physical
PCa NNP Physical
and CC Physical
resection NN Physical
limit NN Physical
status NN Physical
pathologic JJ Physical
stage NN Physical
and CC Physical
resection NN Physical
limit NN Physical
status NN Physical
. . None
pathological JJ Physical
stage NN Physical
B NNP Physical
percentage NN Physical
of IN Physical
cancers NNS Physical
with IN Physical
negative JJ Physical
margins NNS Physical
proportion NN Physical
of IN Physical
patients NNS Physical
with IN Physical
pathological JJ Physical
stage NN Physical
B NNP Physical
negative JJ Physical
margins NNS Physical
pathological JJ Physical
stage NN Physical
B NNP Physical
and CC Physical
negative JJ Physical
margins NNS Physical
pathological JJ Physical
downstaging NN Physical
positive JJ Physical
margins NNS Physical
in IN Physical
the DT Physical
RP NNP Physical
specimens NNS Physical
. . None
beneficial JJ Other
effects NNS Other
-DOCSTART- -X- N

T NNP Physical
cell NN Physical
subpopulations NNS Physical
, , Physical
NK NNP Physical
activity NN Physical
, , Physical
humoral JJ Physical
immunity NN Physical
and CC Physical
leukocyte NN Physical
count NN Physical
T NNP Physical
cell NN Physical
subpopulations NNS Physical
, , None
natural JJ Physical
killer NN Physical
cell NN Physical
( ( Physical
NK NNP Physical
) ) Physical
activity NN Physical
, , None
humoral JJ Physical
immunity NN Physical
and CC Physical
leukocyte NN Physical
count NN Physical
T NNP Physical
cell NN Physical
subpopulations NNS Physical
, , Physical
NK NNP Physical
activity NN Physical
, , None
humoral JJ Physical
immunity NN Physical
and CC None
leukocyte JJ Physical
count NN Physical
changes NNS Physical
T NNP Physical
cell NN Physical
subpopulations NNS Physical
, , None
NK NNP Physical
activity NN Physical
, , None
humoral JJ Physical
immunity NN Physical
and CC None
leukocyte NN Physical
count NN Physical
leukocyte NN Physical
count NN Physical
immunologic JJ Physical
damage NN Physical
-DOCSTART- -X- N

revised VBN Mental
Chinese JJ Mental
version NN Mental
of IN Mental
Psycho-Educational NNP Mental
Profile NNP Mental
for IN Mental
autistic JJ Mental
and CC Mental
developmentally RB Mental
disabled JJ Mental
children NNS Mental
( ( Mental
C-PEP NNP Mental
) ) Mental
. . None
effective JJ Other
rate NN Other
total JJ Mental
score NN Mental
of IN Mental
development NN Mental
, , Mental
imitation NN Mental
, , Mental
oral JJ Mental
cognition NN Mental
therapeutic JJ Physical
effect NN Physical
-DOCSTART- -X- N

Increased VBN Physical
growth NN Physical
hormone NN Physical
growth NN Physical
hormone NN Physical
response NN Physical
growth NN Physical
hormone NN Physical
diagnosisxdrugxtime JJ Physical
interaction NN Physical
growth NN Physical
hormone NN Physical
response NN Physical
-DOCSTART- -X- N

Differences NNS Other
on IN Other
magnetic JJ Other
resonance NN Other
imaging NN Other
( ( Other
MRI NNP Other
) ) Other
maximal JJ Physical
mouth NN Physical
opening NN Physical
. . None
-DOCSTART- -X- N

Between-group JJ Physical
comparisons NNS Physical
revealed VBD Physical
no DT Other
significant JJ Other
differences NNS Other
in IN Other
clinical JJ Other
outcome NN Other
variables NNS Other
. . None
Only RB Physical
a DT Physical
subgroup NN Physical
of IN Physical
patients NNS Physical
with IN Physical
pronounced JJ Physical
negative JJ Physical
symptoms NNS Physical
developed VBD Physical
some DT Physical
clinical JJ Other
improvement NN Other
as IN Other
indicated VBN Other
by IN Other
significant JJ Other
changes NNS Other
in IN Other
the DT Other
GAF-scale NNP Other
. . None
there EX Physical
is VBZ Physical
some DT Physical
evidence NN Physical
for IN Physical
a DT Physical
more RBR Other
favourable JJ Other
clinical JJ Other
outcome NN Other
within IN Physical
this DT Physical
subgroup NN Physical
after IN Physical
rTMS NN Physical
in IN Physical
the DT Physical
CGI-S NNP Physical
and CC Physical
PANSS NNP Physical
negative JJ Physical
scale NN Physical
, , Physical
too RB Physical
. . None
results NNS Physical
suggest VBP Physical
a DT Physical
moderate JJ Other
- : Other
potentially RB Other
clinically RB Other
relevant JJ Other
- : Other
treatment NN Other
effect NN Other
of IN Physical
prefrontal JJ Other
10 CD Other
Hz NNP Other
rTMS NN Other
stimulation NN Other
in IN Physical
-DOCSTART- -X- N

knowledge NN Mental
, , Mental
attitudes NNS Mental
and CC Mental
behavioural JJ Mental
intentions NNS Mental
the DT None
knowledge NN None
and CC None
attitudes NNS None
, , None
the DT None
behavioural JJ None
intentions NNS None
of IN None
autism NN None
. . None
Knowledge NNP None
and CC None
attitudinal JJ None
changes NNS None
were VBD None
spill-over JJ None
effects NNS None
of IN None
-DOCSTART- -X- N

prolactin NN Physical
elevation NN Physical
prolactin RB Physical
prolactin NN Physical
elevation NN Physical
efficacy NN Other
and CC Other
safety NN Other
serum NN Physical
prolactin NN Physical
Prolactin NNP Physical
prolactin NN Physical
prolactin NN Physical
Prolactin NNP Physical
Mean NNP Physical
prolactin NN Physical
mean JJ Physical
prolactin NN Physical
elevation NN Physical
-DOCSTART- -X- N

device NN Adverse
complications NNS Adverse
, , None
procedure NN Adverse
complications NNS Adverse
, , None
and CC None
intracranial JJ Physical
events/overall NN Physical
neurologic JJ Physical
outcomes NNS Physical
AVM NNP Physical
dimensions NNS Physical
mean JJ Physical
number NN Physical
of IN Physical
vessels NNS Physical
embolized VBN Physical
surgical JJ Other
resection NN Other
time NN Other
, , Physical
number NN Other
of IN Other
patients NNS Other
who WP Other
required VBD Other
transfusion NN Other
, , Physical
volume NN Other
and CC Other
number NN Other
of IN Other
transfusion NN Other
units NNS Other
, , Physical
or CC Physical
type NN Other
and CC Other
volume NN Other
of IN Other
fluid JJ Other
replacement NN Other
. . Physical
Glasgow NNP Physical
Outcome NNP Physical
Scale NNP Physical
scores NNS Physical
post-resection NN Adverse
hematoma NN Adverse
-DOCSTART- -X- N

occurrence NN Physical
of IN Physical
bacteroides NNS Physical
bacteremia VBP Physical
lymphocytopenia NN Physical
-DOCSTART- -X- N

presence NN Physical
of IN Physical
metabolic JJ Physical
syndrome NN Physical
and CC Physical
changes NNS Physical
in IN Physical
the DT Physical
mean NN Physical
of IN Physical
physiological JJ Physical
parameters NNS Physical
such JJ Physical
as IN Physical
Hba1c NNP Physical
, , Physical
P-glucose NNP Physical
, , Physical
P-insulin NNP Physical
, , Physical
lipids NNS Physical
, , Physical
blood NN Physical
pressure NN Physical
, , Physical
physical JJ Physical
working NN Physical
capacity NN Physical
, , Physical
body NN Physical
mass NN Physical
index NN Physical
, , Physical
Heart NNP Physical
Score NNP Physical
were VBD None
investigated VBN None
and CC None
participants NNS Other
' POS Other
satisfaction NN Other
mean NN Physical
of IN Physical
metabolic JJ Physical
syndrome JJ Physical
criteria NNS Physical
health-related JJ Physical
risk NN Physical
factors NNS Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
Morning VBG Physical
predosing VBG Physical
supine NN Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
DBP NNP Physical
) ) Physical
supine NN Physical
DBP NNP Physical
Blood NNP Physical
pressure NN Physical
adverse JJ Adverse
events NNS Adverse
antihypertensive JJ Physical
effect NN Physical
-DOCSTART- -X- N

mean NN Physical
postoperative NN Physical
Snore NNP Physical
Index NNP Physical
( ( Physical
SI NNP Physical
) ) Physical
SI NNP Physical
fall NN Physical
in IN Physical
the DT Physical
SI NNP Physical
. . None
effectiveness NN Other
of IN Other
snoring VBG Other
surgery NN Other
. . None
-DOCSTART- -X- N

patient JJ Other
satisfaction NN Other
, , None
Victorian NNP Physical
Institute NNP Physical
of IN Physical
Sport NNP Physical
Assessment-Achilles NNP Physical
questionnaire NN Physical
( ( Physical
VISA-A NNP Physical
) ) Physical
score NN Physical
and CC None
reported VBD Other
compliance NN Other
patient JJ Other
satisfaction NN Other
VISA-A NNP Physical
score NN Physical
VISA-A NNP Physical
score NN Physical
patient JJ Other
satisfaction NN Other
-DOCSTART- -X- N

the DT None
5-item JJ None
Marder NNP None
negative-symptoms JJ None
factor NN None
of IN None
the DT None
Positive NNP None
and CC None
Negative NNP None
Syndrome NNP None
Scale NNP None
( ( None
PANSS NNP None
) ) None
. . None
Cognition NN None
and CC None
functioning NN None
on IN None
negative JJ None
symptoms NNS None
, , None
other JJ None
PANSS NNP None
symptom NN None
factors NNS None
, , None
or CC None
the DT None
MATRICS NNP None
Cognitive NNP None
Consensus NNP None
Battery NNP None
. . None
in IN None
overall JJ None
functioning NN None
and CC None
a DT None
test NN None
of IN None
free JJ None
verbal JJ None
recall NN None
. . None
was VBD None
abdominal JJ None
pain NN None
; : None
was VBD None
headache NN None
and CC None
sweating NN None
. . None
-DOCSTART- -X- N

Porteus NNP Mental
Maze NNP Mental
test NN Mental
quotient NN Mental
scores NNS Mental
slowing NN Mental
of IN Mental
reaction NN Mental
time NN Mental
( ( Mental
RT NNP Mental
) ) Mental
qualitative JJ Mental
scores NNS Mental
on IN Mental
the DT Mental
Porteus NNP Mental
Maze NNP Mental
test NN Mental
. . None
Matching NNP Mental
Familiar NNP Mental
Figures NNP Mental
Test NNP Mental
, , Mental
short-term JJ Mental
recognition NN Mental
memory NN Mental
and CC Other
concept NN Mental
attainment NN Mental
tasks NNS Mental
, , Mental
or CC Mental
the DT Mental
Stroop NNP Mental
Test NNP Mental
. . None
-DOCSTART- -X- N

Metabolic NNP Physical
and CC Physical
cardiovascular JJ Physical
effects NNS Physical
Heart NNP Physical
rate NN Physical
and CC None
blood NN Physical
pressure NN Physical
blood NN Physical
samples NNS Physical
for IN Physical
measurement NN Physical
of IN Physical
plasma JJ Physical
cyclic JJ Physical
AMP NNP Physical
, , Physical
insulin NN Physical
, , Physical
C-peptide NNP Physical
, , Physical
glucose NN Physical
, , Physical
lactate NN Physical
, , Physical
glycerol NN Physical
, , Physical
non-esterified JJ Physical
fatty JJ Physical
acids NNS Physical
( ( Physical
NEFA NNP Physical
) ) Physical
and CC Physical
3-hydroxybutyrate JJ Physical
( ( Physical
3-HB JJ Physical
) ) Physical
cardiovascular JJ Physical
effects NNS Physical
increases NNS None
of IN None
glycogenolysis NN Physical
and CC Physical
lipolysis NN Physical
metabolic JJ Physical
responses NNS Physical
-DOCSTART- -X- N

Efficacy NN Other
quality NN Other
of IN Other
life NN Other
deterioration NN Other
of IN Other
quality NN Other
of IN Other
life NN Other
Quality NN Other
of IN Other
life NN Other
'Profile NN Mental
of IN Mental
Mood NNP Mental
States NNPS Mental
' POS Mental
scale NN Mental
and CC Other
the DT Other
'Everyday JJ Other
Life NNP Other
' POS Other
questionnaire NN Other
quality NN None
of IN None
life NN None
modalities NNS Physical
depression NN Physical
, , None
fatigue NN Physical
, , Physical
and CC Physical
vigor NN Physical
lower JJR Physical
deterioration NN Physical
of IN Physical
depression NN Physical
, , None
anger NN Physical
, , Mental
mind NN Physical
function NN Physical
, , Mental
everyday JJ Mental
life NN Mental
, , Mental
and CC Mental
zest JJS Mental
for IN Mental
life NN Mental
beneficial JJ Other
effects NNS Other
deterioration NN Physical
of IN Physical
depression NN Physical
, , None
fatigue NN Physical
, , None
and CC None
vigor NN Physical
quality NN Other
of IN Other
life NN Other
-DOCSTART- -X- N

total JJ Physical
body NN Physical
weight NN Physical
( ( Physical
TBW NNP Physical
) ) Physical
, , None
lean JJ Physical
body NN Physical
weight NN Physical
( ( Physical
LBW NNP Physical
) ) Physical
, , None
and CC None
estimated VBD Physical
blood NN Physical
volume NN Physical
( ( Physical
BV NNP Physical
) ) Physical
correlation NN Physical
coefficients NNS Physical
correlation NN Physical
of IN Physical
change NN Physical
in IN Physical
CT NNP Physical
number NN Physical
per IN Physical
gram NN Physical
TBW NNP Physical
Adjusted VBN Physical
MHE NNP Physical
LBW NNP Physical
TBW NNP Physical
TBW NNP Physical
BV NNP Physical
TBW NNP Physical
When WRB None
LBW NNP Physical
, , None
rather RB None
than IN None
TBW NNP Physical
or CC None
BV NNP Physical
, , None
is VBZ None
used VBN None
-DOCSTART- -X- N

efficacy NN Other
and CC None
morbidity NN Other
survival NN Mortality
Serious JJ Adverse
late JJ Adverse
complication NN Adverse
rates NNS Adverse
Late JJ Adverse
complication NN Adverse
rates NNS Adverse
-DOCSTART- -X- N

Pre-operative JJ Physical
and CC Physical
post-operative JJ Physical
peak NN Physical
expiratory NN Physical
flow NN Physical
rate NN Physical
, , None
inspiratory NN Physical
capacity NN Physical
, , None
post-operative JJ Other
ventilation NN Other
time NN Other
, , None
post-operative JJ Adverse
pulmonary JJ Adverse
complication NN Adverse
and CC None
hospital NN Other
stay NN Other
Peak NNP Physical
expiratory JJ Physical
flow NN Physical
rate NN Physical
inspiratory JJ Physical
capacity NN Physical
rise NN Physical
in IN Physical
post-operative JJ Physical
peak JJ Physical
expiratory NN Physical
flow NN Physical
rate NN Physical
and CC None
inspiratory NN Physical
capacity NN Physical
after IN Physical
surgery NN Physical
, , None
the DT None
post-operative JJ Physical
peak NN Physical
expiratory NN Physical
flow NN Physical
rate NN Physical
and CC None
inspiratory NN Physical
capacity NN Physical
post-operative JJ Other
ventilation NN Other
time NN Other
post-operative JJ Adverse
complications NNS Adverse
hospital JJ Other
stay NN Other
feasible JJ Other
effective JJ Other
surgical JJ Physical
morbidity NN Physical
and CC None
cost NN Other
of IN Other
medical JJ Other
care NN Other
-DOCSTART- -X- N

Cost-effectiveness NN Other
Cost NN Other
analysis NN Other
All DT Other
costs NNS Other
( ( Other
medical JJ Other
and CC Other
non-medical JJ Other
) ) Other
Costs NNS Other
data NNS Other
quality NN Other
adjusted VBN Other
life NN Other
years NNS Other
Total JJ Other
costs NNS Other
difference NN None
in IN None
QALYs NNP None
QALY NNP None
. . None
The DT None
per IN None
QALY NNP None
-DOCSTART- -X- N

Standardised VBD Mental
measures NNS Mental
of IN Mental
behaviour NNS Mental
short JJ Mental
term NN Mental
improvement NN Mental
ability NN Mental
of IN Mental
improvement NN Other
; : None
deterioration NN Mental
. . None
short JJ Mental
term NN Mental
behavioural JJ Mental
effects NNS Mental
-DOCSTART- -X- N

maximal JJ Other
plasma NN Other
concentration NN Other
( ( Other
Cmax NNP Other
) ) Other
time NN Other
to TO Other
reach VB Other
Cmax NNP Other
plasma NN Other
concentration NN Other
plasma NN Other
concentration-time JJ Other
-DOCSTART- -X- N

fall NN Physical
in IN Physical
intraocular JJ Physical
pressure NN Physical
fall NN Physical
in IN Physical
intraocular JJ Physical
pressure NN Physical
-DOCSTART- -X- N

Proteinuria NNP Physical
and CC Physical
urinary JJ Physical
NAG NNP Physical
excretion NN Physical
urinary JJ Physical
protein NN Physical
excretion NN Physical
and CC Physical
NAG-creatinine JJ Physical
ratios NNS Physical
proteinuria NNS Physical
and CC Physical
urinary JJ Physical
NAG NNP Physical
excretion NN Physical
urinary JJ Physical
NAG NNP Physical
excretion NN Physical
duration NN Physical
of IN Physical
DM NNP Physical
proteinuria NN Physical
Urinary NNP Physical
NAG NNP Physical
excretion NN Physical
proteinuria NN Physical
and CC Physical
urinary JJ Physical
NAG NNP Physical
excretion NN Physical
-DOCSTART- -X- N

total JJ Other
medical JJ Other
cost NN Other
at IN Other
3 CD Other
months NNS Other
diagnostic JJ Other
certainty NN Other
, , None
time NN Other
to TO Other
appropriate VB Other
therapy NN Other
, , None
functional JJ Other
capacity NN Other
, , None
hospitalization NN Adverse
and CC None
mortality NN Mortality
. . None
Heart NNP Physical
failure NN Physical
number NN Other
of IN Other
hospitalizations NNS Other
, , None
functional JJ Other
status NN Other
and CC None
total JJ Other
medical JJ Other
cost NN Other
at IN Other
3 CD Other
months NNS Other
BNP NNP Physical
diagnostic JJ Other
certainty NN Other
-DOCSTART- -X- N

individual JJ Other
effectiveness NN Other
-DOCSTART- -X- N

sputum VBP Physical
inflammatory JJ Physical
indices NNS Physical
inflammatory NN Physical
and CC Physical
infective JJ Physical
markers NNS Physical
spirometry NN None
, , None
24-h JJ None
sputum NN None
volume NN None
, , None
sputum NN None
leukocyte NN None
density NN None
, , None
bacterial JJ None
densities NNS None
concentrations NNS Physical
of IN Physical
interleukin NN Physical
( ( Physical
IL NNP Physical
) ) Physical
-1beta NN Physical
, , None
IL-8 NNP Physical
, , Physical
tumor NN Physical
necrosis NN Physical
factor-alpha JJ Physical
( ( Physical
TNF-alpha NNP Physical
) ) Physical
leukotriene JJ Physical
B4 NNP Physical
( ( Physical
LTB4 NNP Physical
) ) Physical
sputum NN Physical
leukocyte NN Physical
density NN Physical
IL-1beta NNP Physical
, , None
IL-8 NNP Physical
LTB4 NNP Physical
spirometry NN Physical
adverse JJ Adverse
reactions NNS Adverse
sputum NN Physical
inflammatory NN Physical
indices NNS Physical
-DOCSTART- -X- N

CIN NNP Physical
free JJ Physical
high-grade JJ Physical
CIN NNP Physical
-DOCSTART- -X- N

graft NN Physical
patency NN Physical
Vein NNP Physical
graft JJ Physical
occlusion NN Physical
rates NNS Physical
per IN Physical
distal JJ Physical
anastomoses NNS Physical
> VBN Other
or CC Other
= $ Other
1 CD Other
occluded VBN Other
vein NN Other
graft NN Other
( ( Other
s PRP Other
) ) Other
serum JJ Physical
phospholipid JJ Physical
n-3 JJ Physical
fatty JJ Physical
acids NNS Physical
serum JJ Physical
phospholipid JJ Physical
n-3 JJ Physical
fatty JJ Physical
acids NNS Physical
and CC Physical
vein NN Physical
graft NN Physical
occlusions NNS Physical
-DOCSTART- -X- N

self-efficacy NN Other
self-efficacy NN Mental
. . None
-DOCSTART- -X- N

social JJ Mental
functions NNS Mental
social JJ Mental
functions NNS Mental
positive JJ Mental
and CC Mental
negative JJ Mental
symptoms NNS Mental
scales NNS Mental
( ( Mental
PANSS NNP Mental
) ) Mental
, , Mental
social JJ Mental
disability NN Mental
screening VBG Mental
schedule NN Mental
( ( Mental
SDSS NNP Mental
) ) Mental
treatment NN Mental
emergent NN Mental
symptom NN Mental
scale NN Mental
( ( Mental
TESS NNP Mental
) ) Mental
factors NNS Mental
and CC Mental
total JJ Mental
scores NNS Mental
of IN Mental
PANSS NNP Mental
positive JJ Physical
factor NN Physical
, , Physical
negative JJ Physical
factor NN Physical
and CC Physical
total JJ Physical
scores NNS Physical
of IN Physical
PANSS NNP Physical
factors NNS Physical
and CC Physical
total JJ Physical
scores NNS Physical
of IN Physical
PANSS NNP Physical
scores NNS None
of IN None
SDSS NNP None
scores NNS None
of IN None
SDSS NNP None
scores NNS None
of IN None
SDSS NNP None
severe JJ None
adverse JJ None
effect NN None
social JJ None
functions NNS None
psychiatric JJ None
symptoms NNS None
-DOCSTART- -X- N

survival JJ Mortality
gain NN Mortality
toxicity NN Adverse
late JJ Physical
bowel NN Physical
, , Physical
urinary JJ Physical
sexual JJ Physical
functions NNS Physical
required VBN None
. . None
Self-reported JJ None
late JJ None
toxicity NN None
was VBD None
the DT None
LENT NNP None
SOMA NNP None
criteria NNS None
in IN None
structured JJ None
telephone NN None
interview NN None
and CC None
with IN None
questionnaires NNS None
European JJ None
Organisation NNP None
for IN None
Research NNP None
and CC None
Treatment NNP None
of IN None
Cancer NNP None
( ( None
EORTC NNP None
) ) None
Quality NN None
of IN None
Life NNP None
Questionnaire NNP None
( ( None
QLQ-C30 NNP None
) ) None
, , None
International NNP None
Index NNP None
of IN None
Erectile NNP None
Function NNP None
( ( None
IIEF NNP None
) ) None
, , None
and CC None
sexual JJ None
function-vaginal JJ None
changes NNS None
questionnaire VBP None
( ( None
SVQ NNP None
) ) None
. . None
stoma NN None
( ( None
stoma NN None
( ( None
for IN None
liquid NN None
stools NNS None
or CC None
gas NN None
. . None
No DT None
stoma NN None
and CC None
good JJ None
anal JJ None
function NN None
were VBD None
had VBN None
bowel VBN None
obstruction NN None
compared VBN None
reported VBD None
urinary JJ None
incontinence NN None
. . None
had VBD None
severe JJ None
erectile JJ None
dysfunction NN None
. . None
reported VBD None
sexual JJ None
activity NN None
during IN None
CONCLUSIONS NNP None
Fecal NNP None
incontinence NN None
and CC None
erectile JJ None
dysfunction NN None
are VBP None
-DOCSTART- -X- N

pharmacokinetic/pharmacodynamic JJ Physical
wakefulness NN Physical
plasma NN Physical
concentrations NNS Physical
Pooled VBN Physical
Multiple JJ Physical
Sleep NNP Physical
Latency NNP Physical
Test NNP Physical
( ( Physical
MSLT NNP Physical
) ) Physical
pharmacokinetic/pharmacodynamic JJ Physical
plasma JJ Physical
drug NN Physical
concentrations NNS Physical
pharmacokinetic JJ Physical
model NN Physical
nonlinear JJ None
mixed-effects NNS None
modeling VBG None
. . None
plasma JJ Physical
concentration NN Physical
armodafinil NN None
placebo-subtracted JJ None
MSLT NNP None
times NNS None
consistently RB None
increased VBD None
wakefulness RB None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
efficacy NN Other
and CC Other
safety NN Other
terms NNS Physical
of IN Physical
clinical JJ Physical
success NN Physical
rates NNS Physical
clinical JJ Physical
cure NN Physical
rates NNS Physical
Adverse JJ Adverse
events NNS Adverse
, , Adverse
mostly RB Adverse
gastrointestinal JJ Adverse
tolerated VBN Other
. . None
-DOCSTART- -X- N

clinical JJ Other
failure NN Other
on IN Other
or CC Other
before IN Other
day- JJ Other
4 CD Other
. . None
Clinical JJ Other
failures NNS Other
Adherence NN Mental
Clinical JJ Other
failure NN Other
placebo NN None
treatment NN None
excess JJ Physical
respiratory JJ Physical
rate NN Physical
of IN Physical
> $ Physical
10 CD Physical
breaths NNS Physical
per IN Physical
minute NN Physical
vomiting VBG Physical
at IN Physical
enrolment NN Physical
history NN Physical
of IN Physical
use NN Physical
of IN Physical
broncho-dilators NNS Physical
non-adherence NN Mental
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
in-segment JJ Physical
binary JJ Physical
restenosis NN Physical
rate NN Physical
at IN None
included VBD None
target NN Physical
vessel NN Physical
failure NN Physical
( ( Physical
TVF NNP Physical
; : Physical
including VBG Physical
cardiac JJ Physical
death NN Physical
, , Physical
myocardial JJ Physical
infarction NN Physical
, , Physical
and CC Physical
target VB Physical
vessel JJ Physical
revascularization NN Physical
) ) Physical
and CC None
Academic NNP Physical
Research NNP Physical
Consortium-defined NNP Physical
definite/probable JJ Physical
stent NN Physical
thrombosis NN Physical
( ( Physical
ST NNP Physical
) ) Physical
within IN None
endpoint NN None
, , None
which WDT None
rate NN None
of IN None
TVF NNP None
-DOCSTART- -X- N

healing NN Physical
and CC None
complications NNS None
Nonunions NNP Physical
, , None
time NN Other
to TO Other
fracture VB Other
healing NN Other
, , Other
and CC Other
rate NN Other
of IN Other
malunions NNS Other
. . None
average JJ Other
time NN Other
to TO Other
fracture VB Other
healing NN Other
nonunions NNS Physical
healed VBD Physical
after IN Physical
dynamization NN Physical
by IN Physical
removing VBG Physical
static JJ Physical
interlocking NN Physical
screws NNS Physical
. . None
heal VB Physical
malunions NNS Physical
malunions NNS Physical
rates NNS Other
of IN Other
secondary JJ Other
operations NNS Other
and CC Other
malunions NNS Other
time NN Other
to TO Other
fracture VB Other
healing NN Other
-DOCSTART- -X- N

incidence NN Physical
of IN Physical
reduction NN Physical
of IN Physical
aerobic JJ Physical
bacteria NNS Physical
reduction NN None
anaerobic JJ None
bacteria NNS None
Wound IN Physical
infection NN Physical
rate NN Physical
wound IN None
infections NNS None
staphylococci NNS Physical
of IN Physical
presumed JJ Physical
skin JJ Physical
origin NN Physical
. . Physical
wound VB None
infection NN None
wound JJ None
infection NN None
. . None
-DOCSTART- -X- N

weeks NNS None
, , None
American NNP None
College NNP None
of IN None
Rheumatology NNP None
20/50/70 CD None
responses NNS None
were VBD None
) ) None
. . None
European JJ None
League NNP None
Against NNP None
Rheumatism NNP None
good/moderate NN None
responses NNS None
were VBD None
) ) None
. . None
Rates NNS None
of IN None
adverse JJ Adverse
events NNS Adverse
( ( Adverse
AE NNP Adverse
) ) Adverse
, , None
serious JJ Adverse
AE NNP Adverse
, , None
and CC None
infections NNS Adverse
generally RB None
stable JJ None
. . None
Rate NNP None
of IN None
progressive JJ None
joint JJ None
damage NN None
( ( None
groups NNS None
. . None
Mean JJ None
change NN None
from IN None
baseline NN None
in IN None
PJD NNP None
over IN None
-DOCSTART- -X- N

social JJ Mental
disability NN Mental
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
Social NNP Mental
Withdrawal NNP Mental
subscale JJ Mental
social JJ Mental
disability NN Mental
-DOCSTART- -X- N

Language NNP Mental
outcome NN Mental
language NN Mental
outcome RB Mental
JA NNP Mental
skills NNS Mental
, , None
SP NNP Mental
skills NNS Mental
, , None
mother-child JJ Mental
interactions NNS Mental
, , None
and CC None
language NN Mental
development NN Mental
expressive JJ Mental
language NN Mental
gains NNS Mental
language NN Mental
outcome NN Mental
-DOCSTART- -X- N

metabolic JJ Physical
profile NN Physical
efficacy NN Other
metabolic JJ Other
profile NN Other
blood NN Other
pressure NN Other
fasting VBG Physical
glucose JJ Physical
levels NNS Physical
mg/dL NN None
, , None
HOMA-IR NNP None
index NN None
?3 NNP None
, , None
triglyceride NN None
levels NNS None
?150 VBP None
systolic NN None
and CC None
diastolic JJ None
blood NN None
pressure NN None
?140 NNP None
the DT None
mean NN None
of IN None
systolic NN None
diastolic JJ None
blood NN None
pressures NNS None
, , None
HOMA-IR NNP None
index NN None
( ( None
-46.5 NNP None
fasting VBG None
glucose NN None
( ( None
triglyceride JJ None
levels NNS None
( ( None
-47.4 CD None
the DT None
metabolic JJ None
profile NN None
and CC None
blood NN None
pressure NN None
-DOCSTART- -X- N

effect NN Other
quantity NN Other
of IN Other
milk NN Other
taken VBN Other
mean VB Physical
haemoglobin NN Physical
and CC None
median JJ Physical
serum NN Physical
ferritin NN Physical
iron NN Physical
deficiency NN Physical
anaemia NN Physical
serum NN Physical
ferritin NN Physical
levels NNS Physical
-DOCSTART- -X- N

Complications NNS Adverse
of IN Adverse
therapy NN Adverse
incontinence NN Physical
anal JJ Physical
stretch NN Physical
. . Physical
-DOCSTART- -X- N

assess VB Physical
the DT Physical
incidence NN Physical
and CC Physical
clinical JJ Physical
manifestations NNS Physical
disabling NN Physical
and CC Physical
mild JJ Physical
radiation-induced JJ Physical
brachial NN Physical
plexopathy NN Physical
Radiation-induced JJ Physical
brachial JJ Physical
plexopathy NN Physical
paraesthesia JJ Physical
hypaesthesia NN Physical
weakness NN Physical
decreased VBN Adverse
muscle NN Adverse
stretch NN Adverse
reflexes NNS Adverse
pain NN Pain
-DOCSTART- -X- N

postoperative JJ Physical
infections NNS Physical
, , Physical
length NN Physical
of IN Physical
stay NN Physical
and CC Physical
inflammatory JJ Physical
markers NNS Physical
. . Physical
duration NN Physical
of IN Physical
enteral JJ Physical
nutrition NN Physical
length NN Physical
of IN Physical
postoperative JJ Physical
stay NN Physical
Wound JJ Physical
infections NNS Physical
and CC Physical
general JJ Physical
infections NNS Physical
Fistula NNP None
rates NNS None
two CD None
plasma NN None
proteins NNS None
( ( None
albumin NN None
, , None
transferrin NN None
) ) None
, , None
lymphocytes VBZ None
, , None
weight NN None
, , None
IL-6 NNP None
, , None
CPR NNP None
and CC None
TNFalpha NNP None
TNFalpha NNP Other
Gastrointestinal JJ None
tolerance NN None
and CC None
diarrhoea NN None
rate NN None
infection NN None
rate NN None
fistula NN None
rates NNS None
-DOCSTART- -X- N

n=20 NN None
) ) None
. . None
Change NN None
in IN None
dysphagia NN None
and CC None
pain NN None
three CD None
outcome NN None
. . None
Dysphagia NNP None
, , None
improved VBN None
dysphagia NN None
at IN None
pain NN None
was VBD None
less JJR None
dysphagia JJ None
. . None
experienced VBD None
manageable JJ None
complications NNS None
, , None
no DT None
complications NNS None
occurred VBD None
-DOCSTART- -X- N

Middle NNP Physical
cerebral JJ Physical
arterial JJ Physical
blood NN Physical
flow NN Physical
velocity NN Physical
and CC Physical
hemodynamics NNS Physical
middle JJ Physical
cerebral JJ Physical
arterial JJ Physical
blood NN Physical
flow NN Physical
velocity NN Physical
Middle NNP Physical
cerebral JJ Physical
arterial JJ Physical
blood NN Physical
flow NN Physical
velocities NNS Physical
hemodynamics NNS Physical
Middle NNP Physical
cerebral JJ Physical
arterial JJ Physical
blood NN Physical
flow NN Physical
velocities NNS Physical
cerebral JJ Physical
blood NN Physical
flow NN Physical
increased VBD Physical
pulsatility NN Physical
index NN Physical
and CC Physical
resistivity NN Physical
index NN Physical
-DOCSTART- -X- N

incidence NN Adverse
of IN Adverse
postoperative JJ Adverse
infections NNS Adverse
changes NNS None
induced VBN None
immunological JJ Physical
parameters NNS Physical
. . None
frequency NN Adverse
of IN Adverse
early JJ Adverse
postoperative JJ Adverse
infections NNS Adverse
immunological JJ Physical
parameters NNS Physical
. . None
immunological JJ Physical
parameters NNS Physical
. . None
post-operative JJ Physical
sepsis NN Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
evaluation NN Other
efficacy NN Other
and CC Other
safety NN Other
median JJ Physical
number NN Physical
of IN Physical
angina JJ Physical
attacks NNS Physical
per IN Physical
week NN Physical
and CC Physical
the DT Physical
median JJ Physical
number NN Physical
of IN Physical
nitroglycerin NN Physical
( ( Physical
NTG NNP Physical
) ) Physical
tablets NNS Physical
consumed/week VBP Physical
frequency NN Physical
of IN Physical
angina JJ Physical
attacks/week NN Physical
angina VBN Physical
attacks NNS Physical
self-assessments NNS None
angina NNS Physical
control NN Physical
ability NN Physical
to TO Physical
perform VB Physical
usual JJ Physical
activities NNS Physical
adverse JJ Adverse
events NNS Adverse
adverse JJ Adverse
event NN Adverse
edema RB Adverse
. . None
incidence NN Physical
of IN Physical
angina NN Physical
attacks NNS Physical
need NN Physical
of IN Physical
nitroglycerin NN Physical
-DOCSTART- -X- N

hyperglycemic JJ Physical
symptoms NNS Physical
or CC Physical
acetonemia NN Physical
Failure NN Physical
criteria NNS Physical
Elevated VBN Physical
stimulated VBD Physical
glucose JJ Physical
levels NNS Physical
Hyperglycemia NNP Physical
baseline NN Physical
C NNP Physical
peptide NN Physical
values NNS Physical
( ( None
0.43 CD None
symptomatic JJ Physical
hyperglycemia NN Physical
. . None
-DOCSTART- -X- N

serum NN Physical
adiponectin NN Physical
and CC Physical
insulin NN Physical
resistance NN Physical
index NN Physical
. . Physical
serum NN Physical
adiponectin NN Physical
and CC Physical
insulin NN Physical
resistance NN Physical
index NN Physical
( ( Physical
SI NNP Physical
) ) Physical
Blood NN Physical
samples NNS Physical
serum NN Physical
adiponectin NN Physical
and CC Physical
body NN Physical
fat JJ Physical
percentage NN Physical
, , Physical
waist-to-hip JJ Physical
ratio NN Physical
, , Physical
body NN Physical
mass NN Physical
index NN Physical
and CC Physical
the DT Physical
insulin NN Physical
resistance NN Physical
index NN Physical
at IN Physical
baseline NN Physical
SI NNP Physical
serum JJ Physical
adiponectin NN Physical
-DOCSTART- -X- N

pain NN Pain
ease NN Other
of IN Other
injection NN Other
. . Other
injection NN Pain
pain NN Pain
Mean NNP Pain
pain NN Pain
assessment NN Pain
subject JJ Other
comfort NN Other
injection NN Physical
experience NN Physical
. . None
-DOCSTART- -X- N

No DT Other
significant JJ Other
difference NN Other
was VBD None
observed VBN None
after IN None
6 CD None
and CC None
12 CD None
months NNS None
of IN None
treatment NN None
in IN None
PEF NNP Physical
variability NN Physical
, , None
FEV1 NNP Physical
or CC None
bronchial JJ Physical
hyperreactivity NN Physical
in IN None
the DT None
NS NNP None
group NN None
compared VBN None
with IN None
baseline NN None
values NNS None
, , None
while IN None
a DT None
significant JJ None
difference NN None
was VBD None
observed VBN None
in IN None
symptom NN None
score NN None
. . None
BDP NNP None
group NN None
showed VBD None
a DT None
significant JJ None
improvement NN None
in IN None
FEV1 NNP Physical
and CC Physical
bronchial JJ Physical
reactivity NN Physical
to TO None
methacholine VB None
after IN None
6 CD None
and CC None
12 CD None
months NNS None
of IN None
treatment NN None
. . None
In IN None
the DT None
BDP NNP None
+ NNP None
S NNP None
group NN None
, , None
the DT None
improvement NN None
in IN None
symptoms NNS Physical
and CC Physical
pulmonary JJ Physical
function NN Physical
persisted VBN None
until IN None
the DT None
end NN None
of IN None
the DT None
study NN None
. . None
the DT None
combination NN None
of IN None
beclomethasone NN None
dipropionate NN None
and CC None
salmeterol NN None
improved VBD None
pulmonary JJ Physical
function NN Physical
and CC None
bronchial JJ Physical
reactivity NN Physical
earlier RBR None
than IN None
beclomethasone CD None
dipropionate NN None
alone RB None
, , None
while IN None
nedocromil JJ None
sodium NN None
improved VBD None
symptoms NNS None
but CC None
not RB None
pulmonary JJ None
function NN None
. . None
bronchial JJ Physical
reactivity NN Physical
overtreatment NN None
of IN None
asthma NN None
in IN None
relationship NN None
with IN None
the DT None
classification NN None
of IN None
asthma JJ None
severity NN None
of IN None
the DT None
International NNP None
Guidelines NNP None
could MD None
improve VB None
both DT None
airway JJ None
inflammation NN None
and CC None
the DT None
prognosis NN None
of IN None
airway JJ None
obstruction NN None
. . None
-DOCSTART- -X- N

vertebral JJ Physical
fractures NNS Physical
efficacy NN Other
and CC Other
safety NN Other
of IN Other
risedronate NN Other
vertebral JJ Physical
fractures NNS Physical
, , None
and CC None
bone RB Physical
mineral JJ Physical
density NN Physical
new JJ None
vertebral JJ Physical
fractures NNS Physical
fracture NN Physical
reduction NN Physical
nonvertebral JJ Physical
fractures NNS Physical
bone JJ Physical
mineral JJ Physical
density NN Physical
gastrointestinal JJ Adverse
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

efficacy NN Other
severity NN Mental
of IN Mental
autism NN Mental
symptoms NNS Mental
( ( Mental
a DT Mental
total NN Mental
score NN Mental
of IN Mental
social JJ Mental
communication NN Mental
algorithm NNS Mental
items NNS Mental
from IN Mental
ADOS-G NNP Mental
, , Mental
higher JJR Mental
score NN Mental
indicating VBG Mental
greater JJR Mental
severity NN Mental
) ) Mental
at IN Mental
13 CD Mental
months NNS Mental
. . Mental
measures NNS Mental
of IN Mental
interaction NN Mental
, , Mental
child JJ Mental
language NN Mental
, , Mental
and CC Mental
adaptive JJ Mental
functioning NN Mental
in IN Mental
school NN Mental
. . Mental
severity NN Mental
of IN Mental
symptoms NNS Mental
parental JJ Mental
synchronous JJ Mental
response NN Mental
directly RB Mental
assessed VBN Mental
language NN Mental
and CC Mental
adaptive JJ Mental
functioning NN Mental
parent-child JJ Mental
dyadic JJ Mental
social JJ Mental
communication NN Mental
. . Mental
-DOCSTART- -X- N

safety NN Other
profile NN Other
, , None
pharmacokinetics NNS Other
, , None
immunogenicity NN Physical
, , None
and CC None
clinical JJ Physical
effects NNS Physical
. . None
adverse JJ Adverse
events NNS Adverse
drug-related JJ Adverse
hypotensive JJ Adverse
infusion NN Adverse
reaction NN Adverse
myocardial JJ Physical
infarction NN Physical
half-life NN Other
clinical JJ None
activity NN None
. . None
-DOCSTART- -X- N

effect NN Physical
on IN Physical
the DT Physical
health NN Physical
birth NN Physical
weight NN Physical
, , None
treatment NN Physical
with IN Physical
antibiotics NNS Physical
, , None
and CC None
the DT None
starting JJ Physical
time NN Physical
of IN Physical
breast-feeding NN Physical
Bifidobacterium-predominant JJ None
flora NN None
Bifidobacterium NNP None
Bifidobacterium NNP None
detected VBN None
-DOCSTART- -X- N

antioxidant JJ Physical
status NN Physical
anthropometric JJ Physical
, , Physical
biochemical JJ Physical
and CC Physical
antioxidant JJ Physical
parameters NNS Physical
total JJ Physical
cholesterol NN Physical
( ( Physical
TC NNP Physical
) ) Physical
, , Physical
HDL NNP Physical
, , Physical
LDL NNP Physical
and CC Physical
TGs NNP Physical
total JJ Physical
antioxidant JJ Physical
capacity NN Physical
( ( Physical
TAC NNP Physical
) ) Physical
in IN Physical
plasma NN Physical
Plasma NNP Physical
hydroxytyrosol NN Physical
( ( Physical
OH-Tyr NNP Physical
) ) Physical
concentration NN Physical
lipid JJ Physical
profiles NNS Physical
, , None
OH-Tyr NNP Physical
levels NNS Physical
and CC None
TAC NNP Physical
. . None
catalase NN Physical
( ( Physical
CAT NNP Physical
) ) Physical
superoxide JJ Physical
dismutase NN Physical
( ( Physical
SOD NNP Physical
) ) Physical
and CC Physical
glutathione JJ Physical
peroxidase NN Physical
( ( Physical
GH-PX NNP Physical
) ) Physical
activity NN Physical
biochemical JJ Other
parameters NNS Other
, , None
antioxidant JJ Other
capacity NN Other
and CC None
antioxidant JJ Physical
enzyme NN Physical
activity NN Physical
-DOCSTART- -X- N

left NN Physical
ventricular JJ Physical
ejection NN Physical
fraction NN Physical
( ( Physical
EF NNP Physical
) ) Physical
cardiac JJ Physical
volumes NNS Physical
changes NNS Physical
in IN Physical
neurohormones NNS Physical
Temporal JJ Physical
changes NNS Physical
in IN Physical
plasma NN Physical
renin NN Physical
, , None
angiotensin-II JJ Physical
, , None
aldosterone NN Physical
, , None
epinephrine NN Physical
, , None
norepinephrine JJ Physical
, , None
B-type JJ Physical
natriuretic JJ Physical
peptide NN Physical
( ( Physical
BNP NNP Physical
) ) Physical
, , None
and CC None
N-terminal JJ Physical
atrial JJ Physical
natriuretic JJ Physical
peptide NN Physical
( ( Physical
NT-ANP NNP Physical
) ) Physical
EF NNP Physical
, , None
cardiac JJ Physical
volumes NNS Physical
, , None
and CC None
risk NN Physical
for IN Physical
subsequent JJ Physical
adverse JJ Physical
clinical JJ Physical
outcomes NNS Physical
. . None
BNP NNP Physical
NT-ANP NNP Physical
EF NNP Physical
end-diastolic JJ Physical
volume NN Physical
( ( Physical
EDV NNP Physical
) ) Physical
end-systolic JJ Physical
volume NN Physical
died VBD Mortality
or CC None
experienced JJ Physical
heart NN Physical
failure NN Physical
hospitalization NN Physical
NT-ANP NNP Physical
norepinephrine NN Physical
NT-ANP NNP Physical
death NN Mortality
or CC None
heart NN Physical
failure NN Physical
hospitalization NN Physical
. . None
EF NNP Physical
ventricular JJ Physical
dilatation NN Physical
mortality NN Mortality
and CC None
morbidity NN Physical
. . None
ventricular JJ Physical
remodeling NN Physical
-DOCSTART- -X- N

counting VBG Physical
active JJ Physical
PU NNP Physical
lesions NNS Physical
, , None
serum NN Physical
eosinophils NNS Physical
, , None
and CC None
IgE NNP Physical
-DOCSTART- -X- N

UVB-induced NNP None
erythema NN None
and CC None
pigmentation NN None
degree NN None
of IN None
ultraviolet NN None
B NNP None
( ( None
UVB NNP None
) ) None
-induced VBD None
inflammation NN None
degree NN Physical
of IN Physical
hyperpigmentation NN Physical
subsequent JJ Physical
pigmentation NN Physical
degree NN Physical
of IN Physical
induced JJ Physical
erythema NN Physical
( ( Physical
delta JJ Physical
erythema VBP Physical
index NN Physical
) ) Physical
pigmentation NN Physical
( ( Physical
delta JJ Physical
melanin NN Physical
index NN Physical
) ) Physical
delta NN Physical
melanin NN Physical
index NN Physical
against IN Physical
delta NN Physical
erythema NN Physical
index NN Physical
erythema NN Other
and CC Other
hyperpigmentation NN Other
post-inflammatory JJ Physical
hyperpigmentation NN Physical
UVB-induced JJ Physical
hyperpigmentation NN Physical
-DOCSTART- -X- N

safety NN Other
and CC Other
efficacy NN Other
Recurrence NNP Physical
rate NN Physical
, , None
vision NN Physical
, , None
and CC None
complications NNS Adverse
. . None
Uveitis NNP Physical
recurrence NN Physical
was VBD Physical
reduced VBN Physical
improved VBN Physical
visual JJ Physical
acuity NN Physical
Implanted VBN Physical
eyes NNS Physical
had VBD Physical
higher JJR Physical
incidences NNS Physical
of IN Physical
intraocular JJ Physical
pressure NN Physical
elevation NN Physical
glaucoma NN Physical
surgery NN Physical
Cataracts NNPS Physical
reduced VBN Physical
uveitis JJ Physical
recurrence NN Physical
and CC None
improved VBD Physical
or CC Physical
stabilized VBN Physical
visual JJ Physical
acuity NN Physical
cataract JJ Physical
extraction NN Physical
intraocular JJ Physical
pressure-lowering JJ Physical
surgery NN Physical
. . None
-DOCSTART- -X- N

regrowth NN Physical
of IN Physical
hair NN Physical
regrew NNS Physical
hair NN Physical
None NN Physical
regrew VBD Physical
hair NN Physical
Patient JJ Mental
acceptance NN Mental
-DOCSTART- -X- N

non-inferiority NN Physical
of IN Physical
lumiracoxib NN Physical
1-year JJ Mental
retention NN Mental
on IN Mental
treatment NN Mental
rate NN Mental
. . None
OA NNP Physical
pain NN Physical
in IN Physical
the DT Physical
target NN Physical
joint NN Physical
, , Physical
patient NN Physical
's POS Physical
and CC Physical
physician NN Physical
's POS Physical
global JJ Physical
assessments NNS Physical
of IN Physical
disease NN Physical
activity NN Physical
, , Physical
Short NNP Physical
Arthritis NNP Physical
assessment JJ Physical
Scale NNP Physical
( ( Physical
SAS NNP Physical
) ) Physical
total NN Physical
score NN Physical
, , Physical
rescue NN Physical
medication NN Physical
use NN Physical
, , Physical
and CC Physical
safety NN Physical
and CC Physical
tolerability NN Physical
. . Physical
Retention NN Physical
rates NNS Physical
retention NN Other
tolerated VBN Physical
. . Physical
tolerated VBN Physical
-DOCSTART- -X- N

negative JJ Mental
symptoms NNS Mental
negative JJ Mental
symptoms NNS Mental
negative JJ Mental
symptoms NNS Mental
negative JJ Mental
symptom JJ Mental
response NN Mental
rate NN Mental
more JJR Pain
reduction NN Pain
in IN Pain
scores NNS Pain
on IN Pain
the DT Pain
negative JJ Pain
subscale NN Pain
of IN Pain
the DT Pain
Positive NNP Other
and CC Other
Negative NNP Other
Syndrome NNP Other
Scale NNP Other
clinical JJ Mental
response NN Mental
on IN Mental
the DT Mental
negative JJ Mental
symptom NN Mental
subscale NN Mental
-DOCSTART- -X- N

appearance NN Physical
of IN Physical
the DT Physical
scar NN Physical
, , Physical
including VBG Physical
scar NN Physical
type NN Physical
and CC Physical
scar NN Physical
size NN Physical
as RB Physical
well RB Physical
as IN Physical
scar NN Physical
colour NN Physical
scar NN None
physiological JJ Physical
scars NNS Physical
and CC Physical
skin-coloured JJ Physical
scars NNS Physical
Hypertrophic NNP Physical
or CC Physical
keloidal VB Physical
scars NNS Physical
scar NN Physical
length NN Physical
and CC None
scar NN Physical
height NN Physical
scar NN Physical
development NN Physical
-DOCSTART- -X- N

satisfactory JJ Other
internal JJ Other
consistency NN Other
reliability NN Other
test-retest JJ Other
reliability NN Other
, , None
and CC None
discriminant JJ Other
validity NN Other
AQ-J NNP Physical
satisfactory JJ Other
sensitivity NN Other
, , None
specificity NN Other
, , None
and CC None
negative JJ Other
predictive JJ Other
value NN Other
low JJ Other
positive JJ Other
predictive NN Other
value NN Other
AQ-J-21 NNP Physical
( ( Physical
consisting VBG Physical
of IN Physical
21 CD Physical
items NNS Physical
significantly RB Physical
associated VBN Physical
with IN Physical
HPDD NNP Physical
diagnosis NN Physical
) ) Physical
AQ-J-10 NNP Physical
( ( Physical
consisting VBG Physical
of IN Physical
10 CD Physical
of IN Physical
the DT Physical
21 CD Physical
items NNS Physical
with IN Physical
an DT Physical
effect NN Physical
size NN Physical
> NNP Physical
0.17 CD Physical
) ) Physical
higher JJR None
not RB Physical
satisfactory JJ Physical
, , None
positive JJ Other
predictive JJ Other
values NNS Other
mild NN Physical
HPDD NNP Physical
-DOCSTART- -X- N

effectiveness NN Other
tolerability NN Other
efficacy NN Other
tolerability NN Other
pain NN Pain
intensity NN Pain
and CC Pain
pain NN Pain
relief NN Pain
4 CD Pain
point NN Pain
scale NN Pain
( ( Pain
VRS NNP Pain
safety NN Other
efficacy NN Other
pain VBP Pain
intensity NN Pain
rescue NN Other
analgesic JJ Other
drug NN Other
adverse JJ Adverse
events NNS Adverse
systemic JJ Other
and CC Other
local JJ Other
tolerability NN Other
-DOCSTART- -X- N

Lactational JJ Physical
amenorrhea NN Physical
proportion NN Mental
of IN Mental
women NNS Mental
who WP Mental
were VBD Mental
amenorrheic VBN Mental
total JJ Other
duration NN Other
of IN Other
LA NNP Other
LA NNP None
time NN Mental
spent VBN Mental
breast-feeding NN Mental
( ( Mental
min/d NN Mental
) ) Mental
infant NN Physical
's POS Physical
energy NN Physical
intake NN Physical
-DOCSTART- -X- N

esophageal NN Physical
sphincter NN Physical
pressure NN Physical
( ( Physical
LESP NNP Physical
) ) Physical
Acid NNP Physical
exposure NN Physical
for IN Physical
each DT Physical
hour NN Physical
upright JJ Physical
acid NN Physical
exposure NN Physical
acid NN Physical
exposure NN Physical
upright JJ Physical
GER NNP Physical
acid JJ Physical
exposure NN Physical
LESP NNP Physical
-DOCSTART- -X- N

5-year JJ Mortality
disease-free JJ Mortality
survival NN Mortality
Overall JJ Mortality
survival NN Mortality
occurrence NN Physical
of IN Physical
liver NN Physical
metastases NNS Physical
overall JJ Physical
recurrence NN Physical
rate NN Physical
. . Physical
-DOCSTART- -X- N

effects NNS Other
glucose JJ Physical
tolerance NN Physical
and CC Physical
insulin NN Physical
resistance NN Physical
The DT None
amount NN None
of IN None
glucose NN None
infused VBN None
at IN None
steady-state JJ None
to TO None
maintain VB None
stable JJ None
blood NN None
glucose JJ None
[ $ None
clamp NN None
, , None
whole JJ None
body NN None
glucose JJ None
disposal NN None
( ( None
M NNP None
) ) None
was VBD None
and CC None
M/I NNP None
ratio NN None
was VBD None
The DT None
insulin NN None
sensitivity NN None
index NN None
, , None
Si NNP None
, , None
impaired JJ None
insulin NN None
sensitivity NN None
in IN None
-DOCSTART- -X- N

was VBD None
maintenance NN None
of IN None
endoscopic JJ None
remission NN None
at IN None
month NN None
6 CD None
in IN None
the DT None
per-protocol NN None
( ( None
PP NNP None
) ) None
population NN None
. . None
maintained VBN None
endoscopic JJ None
remission NN None
compared VBN None
ITT NNP None
) ) None
) ) None
. . None
Time NN None
to TO None
relapse VB None
was VBD None
The DT None
proportion NN None
of IN None
patients NNS None
with IN None
adverse JJ None
events NNS None
was VBD None
-DOCSTART- -X- N

serum NN Physical
liver NN Physical
enzymes NNS Physical
serum NN Physical
liver NN Physical
enzyme NN Physical
levels NNS Physical
[ VBP Physical
alanine JJ Physical
aminotransferase NN Physical
( ( Physical
ALT NNP Physical
) ) Physical
and CC Physical
gamma-glutamyl JJ Physical
transferase NN Physical
( ( Physical
GGT NNP Physical
) ) Physical
] VBP Physical
serum NN Physical
ALT NNP Physical
and CC Physical
GGT NNP Physical
levels NNS Physical
ALT NNP Physical
values NNS Physical
mean JJ Physical
ALT NNP Physical
and CC Physical
GGT NNP Physical
levels NNS Physical
-DOCSTART- -X- N

means NNS Mental
of IN Mental
this DT Mental
cooperation NN Mental
results NNS Other
diagnostic JJ Other
whole JJ Other
body NN Other
scintigraphy NN Other
thyroglobulin JJ Physical
levels NNS Physical
WBSs NNP Physical
good JJ Other
treatment NN Other
results NNS Other
. . None
cost VBN Other
effective JJ Other
. . None
-DOCSTART- -X- N

in-hospital JJ Mortality
mortality NN Mortality
and CC None
neurological JJ Physical
outcome NN Physical
infection NN Physical
rate NN Physical
, , Physical
days NNS Other
in IN Other
NICU NNP Other
, , None
in-hospital JJ Mortality
mortality NN Mortality
and CC None
long-term JJ Physical
neurological JJ Physical
outcome NN Physical
glucose JJ Physical
levels NNS Physical
mortality NN Mortality
rate NN Mortality
ICU NNP Physical
infection NN Physical
rate NN Physical
, , None
duration NN Other
of IN Other
ICU NNP Other
stay NN Other
, , None
in-hospital JJ Mortality
mortality NN Mortality
rate NN Mortality
and CC None
neurologic JJ Physical
outcome NN Physical
Overall JJ Mortality
mortality NN Mortality
rates NNS Mortality
infection NN Physical
rate NN Physical
days NNS Other
stay VBP Other
in IN Other
NICU NNP Other
in-hospital JJ Mortality
mortality NN Mortality
neurologic JJ None
outcome NN None
Glasgow NNP Physical
Outcome NNP Physical
Score NNP Physical
( ( Physical
GOS NNP Physical
) ) Physical
Mortality NNP Mortality
rates NNS Mortality
infection NN Physical
rate NN Physical
and CC None
days NNS Other
in IN Other
NICU NNP Other
improves VBZ None
the DT None
neurological JJ Physical
outcome NN Physical
in-hospital JJ Mortality
mortality NN Mortality
-DOCSTART- -X- N

acceptance NN Mental
and CC Mental
the DT Mental
imparting NN Mental
of IN Mental
knowledge NN Mental
. . None
imparting NN Mental
of IN Mental
knowledge NN Mental
acceptance NN Mental
of IN Mental
this DT Mental
new JJ Mental
medium NN Mental
-DOCSTART- -X- N

frequency NN Other
function NN Mental
of IN Mental
communication NN Mental
non-verbal JJ Mental
communication NN Mental
, , Mental
including VBG Mental
early JJ Mental
and CC Mental
atypical JJ Mental
communication NN Mental
Overall JJ Mental
frequency NN Mental
of IN Mental
non-verbal JJ Mental
communicative JJ Mental
acts NNS Mental
form NN Mental
and CC Mental
complexity NN Mental
, , Mental
the DT Mental
function NN Mental
and CC Mental
the DT Mental
role NN Mental
frequency NN Mental
and CC Mental
function NN Mental
of IN Mental
communicative JJ Mental
acts NNS Mental
later JJ Mental
language NN Mental
ability NN Mental
: : Mental
social JJ Mental
acts NNS Mental
, , Mental
comments NNS Mental
and CC Mental
initiations NNS Mental
-DOCSTART- -X- N

maintaining NN Physical
or CC Physical
increasing VBG Physical
their PRP$ Physical
physical JJ Mental
activity NN Mental
to TO Physical
a DT Physical
moderate-intensity JJ Physical
level NN Physical
self-reported JJ Physical
disease NN Physical
symptoms NNS Physical
and CC None
treatment NN Adverse
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

severity NN Physical
of IN Physical
bronchial JJ Physical
hyperresponsiveness NN Physical
evaluate VB Other
the DT Other
effects NNS Other
bronchial JJ Physical
hyperresponsiveness NN Physical
Bronchial NNP Physical
hyperresponsiveness NN Physical
was VBD Physical
quantified VBN Physical
provocative JJ Other
dose NN Other
of IN Other
methacholine NN Other
20 CD Physical
% NN Physical
fall NN Physical
in IN Physical
forced JJ Physical
expiratory NN Physical
volume NN Physical
in IN Physical
one CD Physical
second NN Physical
( ( Physical
PD20 NNP Physical
) ) Physical
. . Physical
Median JJ Physical
( ( Physical
interquartile JJ Physical
range NN Physical
) ) Physical
PD20 NNP Physical
Serum NNP Physical
free JJ Physical
cortisol NN Physical
levels NNS Physical
degree NN Physical
of IN Physical
bronchial JJ Physical
hyperresponsiveness NN Physical
-DOCSTART- -X- N

the DT None
irritability NN Mental
subscale NN Mental
of IN Mental
Aberrant NNP Mental
Behavior NNP Mental
Checklist-Community NNP Mental
( ( Mental
ABC-C NNP Mental
) ) Mental
. . None
ABC-C NNP None
subscale NN None
scores NNS None
for IN None
irritability NN None
, , None
stereotypic VB None
behaviour NN None
and CC None
hyperactivity NN None
. . None
Eight CD None
side-effects NNS None
were VBD None
-DOCSTART- -X- N

discrimination NN Mental
learning NN Mental
and CC Mental
behavioral JJ Mental
symptoms NNS Mental
behavioral JJ Mental
symptoms NNS Mental
; : None
safety NN Other
effect NN Mental
on IN Mental
discrimination NN Mental
learning NN Mental
. . None
side JJ Adverse
effects NNS Adverse
; : None
variety NN Mental
of IN Mental
symptoms NNS Mental
. . None
-DOCSTART- -X- N

Dropout NNP Other
dropout NN Other
rate NN Other
of IN Other
overall JJ Other
dropout NN Other
rate NN Other
Dropout NN Other
poorer NN None
rating NN None
by IN None
the DT None
clinicians NNS None
parental JJ Other
dissatisfaction NN Other
with IN Other
the DT Other
treatment NN Other
service NN Other
perception NN None
that IN None
the DT None
treatment NN None
overall JJ Other
dropout NN Other
rate NN Other
parental JJ Other
perception NN Other
of IN Other
a DT Other
less RBR Other
organised JJ Other
treatment NN Other
. . None
dropout VBP Other
-DOCSTART- -X- N

information NN Other
medical JJ Other
condition NN Other
interested JJ Mental
, , Mental
friendly JJ Mental
, , Mental
responsive JJ Mental
, , Mental
interactive JJ Mental
, , Mental
and CC Mental
respectful JJ Mental
depressed JJ Mental
and CC Mental
distressed JJ Mental
visit NN Other
satisfaction NN Other
, , None
trust NN Mental
, , Mental
stress NN Mental
, , Mental
or CC Mental
mood NN Mental
. . None
Mean NNP Other
visit NN Other
duration NN Other
-DOCSTART- -X- N

Serum NNP Physical
IgG NNP Physical
anti-IgG JJ Physical
antibodies NNS Physical
IgG NNP Physical
anti-IgG NN Physical
titres NNS Physical
Reactions NNS Physical
to TO Physical
rabbit VB Physical
IgG NNP Physical
F NNP Physical
( ( Physical
ab IN Physical
' POS Physical
) ) Physical
2 CD Physical
anti-IgG JJ Physical
antibodies NNS Physical
symptoms NNS Physical
, , None
side NN Adverse
effects NNS Adverse
, , Adverse
or CC None
the DT Physical
level NN Physical
of IN Physical
allergen-specific JJ Physical
IgG NNP Physical
. . None
IgG NNP Physical
anti-IgG JJ Physical
titres NNS Physical
IgG NNP Physical
anti- JJ Physical
IgG NNP Physical
antibodies NNS Physical
. . None
-DOCSTART- -X- N

postoperative JJ Physical
adrenergic JJ Physical
analgesia NN Physical
and CC Physical
sedation NN Physical
postoperative JJ None
analgesia NN None
and CC None
sedation NN None
visual JJ Physical
analogue NN Physical
scale NN Physical
( ( Physical
VAS NNP Physical
) ) Physical
and CC None
Richmond NNP Physical
scale NN Physical
. . None
effective JJ Other
and CC Other
safer JJR Other
analgesia NN Physical
and CC Physical
sedation NN Physical
-DOCSTART- -X- N

endothelin-mediated JJ Physical
vasoconstriction NN Physical
. . None
NO DT Physical
bioactivity NN Physical
Insulin-mediated JJ Physical
vasodilation NN Physical
and CC None
insulin-stimulated JJ Physical
NO NNP Physical
bioavailability NN Physical
steady-state JJ Physical
insulin NN Physical
levels NNS Physical
insulin-mediated JJ Physical
vasodilation NN Physical
ET-1 JJ Physical
flux NN Physical
insulin-stimulated JJ Physical
NO NNP Physical
bioavailability NN Physical
and CC None
NOx NNP Physical
flux NN Physical
endothelin-mediated JJ Physical
vasoconstriction NN Physical
. . None
-DOCSTART- -X- N

catheter-related JJ Physical
infection NN Physical
incidence NN Physical
of IN Physical
catheter NN Physical
colonization NN Physical
incidence NN Physical
density NN Physical
catheter-related JJ Adverse
bloodstream NN Adverse
infection NN Adverse
incidence NN Physical
density NN Physical
catheter NN Physical
colonization NN Physical
catheter-related JJ Physical
infection NN Physical
. . None
-DOCSTART- -X- N

complete JJ Physical
response NN Physical
( ( Physical
CR NNP Physical
) ) Physical
rates NNS Physical
. . None
Remission NNP Physical
duration NN Physical
and CC None
survival NN Mortality
duration NN Other
of IN Other
CR NNP Other
survival NN Mortality
Leucocytosis NNP Physical
-DOCSTART- -X- N

pain VBP Pain
and CC None
disability NN Physical
pain NN Pain
and CC None
disability NN Physical
pain NN Pain
and CC None
disability NN Physical
pain NN Pain
and CC None
disability NN Physical
pain NN Pain
and CC None
disability NN Physical
effect NN Other
-DOCSTART- -X- N

rate NN Physical
of IN Physical
mild JJ Physical
reactions NNS Physical
-DOCSTART- -X- N

of IN None
survival NN None
curves NNS None
. . None
no DT None
benefit NN None
. . None
survival NN None
in IN None
survival NN None
-DOCSTART- -X- N

death NN Mortality
disability NN Physical
. . None
mortality NN Mortality
and CC None
disability NN Physical
mortality NN Mortality
in IN Mortality
myocardial JJ Mortality
infarction NN Mortality
recanalisation NN Physical
mortality NN Mortality
and CC None
severe JJ Physical
invalidity NN Physical
-DOCSTART- -X- N

serum JJ Physical
sICAM-1 JJ Physical
levels NNS Physical
sICAM-1 JJ Physical
levels NNS Physical
sICAM-1 JJ Physical
levels NNS Physical
sICAM-1 JJ Physical
liver JJ Physical
function NN Physical
tests NNS Physical
lymphocyte JJ Physical
activation NN Physical
marker NN Physical
, , Physical
soluble JJ Physical
interleukin-2 JJ Physical
receptor NN Physical
. . None
sICAM-1 JJ Physical
levels NNS Physical
hepatobiliary JJ Physical
excretion NN Physical
reduction NN None
in IN None
cellular JJ Physical
production NN Physical
of IN Physical
sICAM-1 NN Physical
. . Physical
-DOCSTART- -X- N

pain NN Pain
100-mm JJ Pain
patient NN Pain
visual JJ Pain
analog NN Pain
scale NN Pain
ratings NNS Pain
investigator NN Physical
's POS Physical
global JJ Physical
improvement NN Physical
scale NN Physical
Investigator-rated JJ Pain
pain NN Pain
and CC Pain
tenderness NN Pain
scores NNS Pain
tolerated VBN Other
symptoms NNS Physical
of IN Physical
epicondylitis NN Physical
-DOCSTART- -X- N

dramatic JJ Mental
and CC Mental
persistent JJ Mental
decreases NNS Mental
cocaine NN Mental
use NN Mental
, , Physical
craving VBG Mental
for IN Mental
cocaine NN Mental
, , Physical
and CC Physical
psychiatric JJ Mental
symptoms NNS Mental
dropouts NNS Other
retention NN Other
in IN Other
treatment NN Other
, , Physical
craving VBG Mental
for IN Mental
cocaine NN Mental
, , Physical
and CC Physical
decreased VBD Mental
cocaine NN Mental
use NN Mental
urine JJ Other
toxicology NN Other
. . Physical
cocaine NN Mental
abstinence NN Mental
. . Physical
Mean NNP Physical
plasma JJ Physical
concentration NN Physical
of IN Physical
desipramine NN Physical
-DOCSTART- -X- N

evaluations NNS None
, , None
mexameter NN None
measurements NNS None
, , None
and CC None
assessment NN None
of IN None
patients NNS None
' POS None
satisfaction NN None
and CC None
adverse JJ None
events NNS None
were VBD None
baseline NN None
KP NNP None
effective JJ None
and CC None
safe JJ None
-DOCSTART- -X- N

mean JJ Other
gain NN Other
of IN Other
knowledge NN Other
scores NNS Other
non-anaemic JJ Physical
-DOCSTART- -X- N

incidence NN Physical
of IN Physical
intact JJ Physical
perineum NN Physical
lower JJR Physical
episiotomy NN Physical
rates NNS Physical
incidence NN Physical
of IN Physical
perineal NN Physical
tears NNS Physical
, , Mental
duration NN Physical
of IN Physical
second JJ Physical
stage NN Physical
of IN Physical
labour NN Physical
, , None
use NN Pain
of IN Pain
pain NN Pain
relief NN Pain
and CC None
rate NN Physical
of IN Physical
vaginal JJ Physical
infection NN Physical
. . None
having VBG Physical
an DT Physical
intact JJ Physical
perineum NN Physical
and CC None
reduces VBZ Physical
the DT Physical
episiotomy NN Physical
rate NN Physical
. . None
-DOCSTART- -X- N

sustained JJ Mental
improvement NN Mental
in IN Mental
development NN Mental
and CC Mental
behaviour $ Mental
Bayley NNP Mental
Scales NNP Mental
of IN Mental
Infant NNP Mental
Development NNP Mental
and CC Mental
Wechsler NNP Mental
Preschool NNP Mental
and CC Mental
Primary NNP Mental
Scale NNP Mental
of IN Mental
Intelligence NNP Mental
Revised VBD Mental
, , None
Preschool NNP Mental
Behaviour NNP Mental
Checklist NNP Mental
, , Mental
Bayley NNP Mental
Behaviour NNP Mental
Rating NNP Mental
Scale NNP Mental
and CC Mental
Behaviour NNP Mental
Screening NNP Mental
Questionnaire NNP Mental
. . None
outcome NN Mental
measures NNS Mental
Family NNP Mental
stress NN Mental
, , Mental
support NN Mental
and CC Mental
empowerment NN Mental
. . Mental
improvement NN Mental
in IN Mental
aspects NNS Mental
of IN Mental
cognitive JJ Mental
development NN Mental
behavioural JJ Mental
differences NNS Mental
Reliable NNP Mental
Change NNP Mental
Index NNP Mental
non-verbal JJ Mental
areas NNS Mental
. . Mental
language NN Mental
skills NNS Mental
stress NN Mental
Improvements NNPS None
stressed JJ None
-DOCSTART- -X- N

aberrant JJ Mental
behavior NN Mental
in IN Mental
aberrant JJ Mental
behavior NN Mental
. . Mental
-DOCSTART- -X- N

ANOVA NNP Physical
and CC Physical
Fisher NNP Physical
's POS Physical
exact NN Physical
tests NNS Physical
Mean JJ Physical
failure NN Physical
loads NNS Physical
( ( None
kN NN None
) ) None
fracture NN Physical
strengths NNS Physical
root NN Physical
fracture NN Physical
patterns VBZ Physical
fracture NN Physical
strengths NNS Physical
-DOCSTART- -X- N

weight NN Physical
reduction NN Physical
mean JJ Physical
weight NN Physical
loss NN Physical
mean JJ Physical
weight NN Physical
loss NN Physical
weight NN Physical
weight NN Physical
difference NN Physical
weight JJ Physical
loss NN Physical
. . Physical
-DOCSTART- -X- N

effects NNS Other
of IN Other
treatment NN Other
condition NN Other
, , Physical
cohort NN Physical
, , Physical
and CC Physical
baseline NN Physical
distress NN Physical
and CC Physical
their PRP$ Physical
interactions NNS Physical
. . Physical
treatment NN Other
condition NN Other
greater JJR Other
benefit NN Other
distress NN Mental
-DOCSTART- -X- N

total JJ Physical
American NNP Physical
Urological NNP Physical
Association NNP Physical
( ( Physical
AUA NNP Physical
) ) Physical
symptom NN Physical
score NN Physical
and CC None
maximum JJ Physical
urinary JJ Physical
flow NN Physical
( ( Physical
Qmax NNP Physical
) ) Physical
. . None
AUA NNP Physical
symptom NN Physical
score NN Physical
Qmax NNP Physical
significant JJ Physical
improvements NNS Other
tolerated VBN Other
orthostatic JJ Physical
hypotension NN Physical
Vital JJ Physical
sign NN Physical
changes NNS Physical
-DOCSTART- -X- N

reading NN Mental
and CC Mental
spelling NN Mental
pseudoword NN Mental
reading NN Mental
, , Mental
phonological JJ Mental
awareness NN Mental
, , Mental
phonological JJ Mental
word NN Mental
decoding NN Mental
and CC Mental
orthographical JJ Mental
word NN Mental
decoding VBG Mental
tasks NNS Mental
. . Mental
learning NN Mental
effects NNS Mental
and CC Mental
transfer NN Mental
effects NNS Mental
on IN Mental
words NNS Mental
classified VBN Mental
as IN Mental
a DT Mental
function NN Mental
of IN Mental
length NN Mental
, , Mental
consistency NN Mental
, , Mental
and CC Mental
complexity NN Mental
of IN Mental
syllable JJ Mental
structure NN Mental
. . Mental
-DOCSTART- -X- N

efficacy NN Other
STEPP NNP Other
analyses VBZ Other
assessed JJ Other
chemotherapy NN Other
effect NN Other
. . None
relative JJ Mortality
risk NN Mortality
of IN Mortality
a DT Mortality
disease-free JJ Mortality
survival NN Mortality
event NN Mortality
levels NNS Mortality
of IN Mortality
ER NNP Mortality
expression NN Mortality
disease-free JJ Mortality
survival NN Mortality
for IN Other
-DOCSTART- -X- N

Cadence NN Physical
were VBD None
: : None
mean JJ None
cadence NN None
; : None
moderate-to-vigorous JJ None
physical JJ None
activity NN None
time NN None
accumulated VBN None
in IN None
bouts NNS None
lasting VBG None
? . None
10 CD None
min NN None
; : None
number NN None
of IN None
walking VBG None
breaks NNS None
; : None
and CC None
duration NN None
. . None
RESULTS VB None
mean JJ None
cadence NN None
for IN None
the DT None
whole JJ None
walk NN None
was VBD None
moderate-to-vigorous JJ None
physical JJ None
activity NN None
in IN None
? . None
10 CD None
minute NN None
bouts NNS None
difference NN None
in IN None
self-timed JJ None
duration NN None
between IN None
accumulated VBD None
more RBR None
moderate-to-vigorous JJ None
physical JJ None
activity NN None
in IN None
bouts NNS None
-DOCSTART- -X- N

Comparison NNP Physical
of IN Physical
isoniazid NN Physical
with IN Physical
placebo NN Physical
or CC Physical
no DT Physical
prophylaxis NN Physical
. . Physical
risk NN Other
ratio NN Other
death NN Mortality
. . None
risk NN Other
ratio NN Other
of IN Other
tuberculosis NN Other
difference NN Other
in IN Other
the DT Other
effectiveness NN Other
-DOCSTART- -X- N

cyclooxygenase NN Physical
and CC Physical
nitric JJ Physical
oxide JJ Physical
synthase NN Physical
of IN Physical
gastric JJ Physical
mucosa NN Physical
: : Physical
endoscopic JJ Physical
lesions NNS Physical
and CC None
adverse JJ Adverse
reactions NNS Adverse
. . None
gastric JJ Physical
mucosa NN Physical
and CC Physical
enzymes NNS Physical
involved VBN Physical
in IN Physical
gastroprotection NN Physical
clinical JJ Physical
adverse JJ Physical
reactions NNS Physical
gastric JJ Physical
lesions NNS Physical
COX-1 NNP Physical
, , Physical
COX-2 NNP Physical
, , Physical
eNOS NN Physical
, , Physical
and CC Physical
iNOS NNS Physical
-DOCSTART- -X- N

Nontarget NNP Physical
coronary JJ Physical
lesions NNS Physical
with IN Physical
mild NN Physical
to TO Physical
moderate VB Physical
stenosis NN Physical
examined JJ Physical
coronary JJ Physical
plaque NN Physical
volume NN Physical
difference NN None
of IN None
plaque JJ None
regression NN None
between IN None
in IN None
the DT None
coronary JJ None
plaque NN None
volume NN None
reduction NN None
of IN None
plaque NN None
volume NN None
-DOCSTART- -X- N

Serologically RB Physical
verified JJ Physical
influenza NN Physical
complement JJ Physical
fixation NN Physical
and/or NN Physical
haemagglutination NN Physical
inhibition NN Physical
-DOCSTART- -X- N

serum JJ Physical
level NN Physical
of IN Physical
CRP NNP Physical
serum JJ Physical
level NN Physical
of IN Physical
CRP NNP Physical
serum JJ Physical
level NN Physical
of IN Physical
CRP NNP Physical
-DOCSTART- -X- N

loss NN Physical
of IN Physical
renal JJ Physical
function NN Physical
least-squares JJ Physical
analyses NNS Physical
of IN Physical
reciprocal JJ Physical
serum NN Physical
creatinine NN Physical
pretreatment NN Physical
levels NNS Physical
or CC Physical
controls NNS Physical
; : None
erythrocyturia NN Physical
Histologic NNP Physical
activity NN Physical
and CC None
chronicity NN Physical
indexes NNS Physical
Multivariate NNP Other
analysis NN Other
mesangial JJ Physical
cell NN Physical
proliferation NN Physical
and CC Physical
matrix NN Physical
scores NNS Physical
morphologic JJ Physical
variable NN Physical
or CC Physical
residual JJ Physical
renal JJ Physical
function NN Physical
Mean NNP Physical
arterial JJ Physical
pressures NNS Physical
Morbidity NNP Physical
renal JJ Physical
failure NN Physical
benefits NNS Other
of IN Other
therapy NN Other
modulation NN Other
of IN Other
systemic JJ Other
immune JJ Other
response NN Other
or CC None
nephritic JJ Physical
injury NN Physical
side NN Adverse
effects NNS Adverse
. . None
-DOCSTART- -X- N

indicator NN None
engagement NN Mental
pre- JJ Physical
and CC Physical
post-treatment JJ Physical
joint JJ Mental
engagement NN Mental
and CC None
initiating VBG Mental
joint JJ Mental
attention NN Mental
play NN Mental
skills NNS Mental
symbolic JJ Mental
play NN Mental
functional JJ Mental
play NN Mental
skills NNS Mental
. . None
joint JJ Mental
attention NN Mental
caregiver-mediated JJ None
-DOCSTART- -X- N

defibrillation NN Other
efficacy NN Other
defibrillation NN Other
threshold NN Other
( ( Other
DFT NNP Other
) ) Other
DFT NNP Other
using VBG Other
monophasic JJ Other
waveforms NNS Other
mean JJ Other
DFT NNP Other
mean JJ None
DFT NNP Other
DFT NNP Other
DFT NNP Other
. . None
Defibrillation NNP Other
efficacy NN Other
effectiveness NN Other
of IN Other
ICD NNP Other
therapy NN Other
. . None
-DOCSTART- -X- N

memory NN Mental
loss NN Mental
. . Mental
efficacy NN Other
memory NN Mental
support NN Mental
system NN Mental
( ( Mental
MSS NNP Mental
) ) Mental
Measures NNS Other
of IN Other
adherence NN Other
, , None
activities NNS Mental
of IN Mental
daily JJ Mental
living NN Mental
, , Mental
and CC Mental
emotional JJ Mental
impact NN Mental
adherence NN None
Functional NNP Mental
ability NN Mental
and CC None
memory NN Mental
self-efficacy NN Mental
Change NN None
in IN None
functional JJ None
ability NN None
mood NN Mental
caregiver NN Mental
burden NN Mental
activities NNS None
of IN None
daily JJ None
living NN None
and CC None
sense NN None
of IN None
memory NN None
self-efficacy NN None
Improved VBN None
mood NN None
worsening VBG None
sense NN None
of IN None
caregiver NN None
burden NN None
-DOCSTART- -X- N

feasibility NN Other
, , None
speed NN Other
, , None
pain NN Pain
, , None
and CC None
acceptability NN Other
. . None
time NN Other
taken VBN Other
to TO Other
complete VB Other
the DT Other
endometrial JJ Other
polypectomy NN Other
completeness NN Other
of IN Other
polyp NN Other
removal NN Other
, , Other
acceptability NN Other
, , None
and CC None
pain NN Pain
measured VBN None
median JJ Other
time NN Other
taken VBN Other
to TO Other
complete VB Other
the DT Other
procedure NN Other
polyps NNS Other
were VBD Other
completely RB Other
removed VBN Other
mean JJ Pain
pain NN Pain
scores NNS Pain
acceptable JJ Other
unacceptable JJ Other
. . None
quicker JJR Other
painful JJ Pain
acceptable JJ Other
completely RB Physical
remove VB Physical
endometrial JJ Physical
polyps NNS Physical
-DOCSTART- -X- N

walking VBG Physical
onset NN Physical
gait NN Physical
patterns NNS Physical
walking VBG Physical
onset NN Physical
gait NN Physical
patterns NNS Physical
Mean JJ Physical
age NN Physical
at IN Physical
walking VBG Physical
onset NN Physical
walking VBG Physical
onset RP Physical
average JJ Physical
velocity NN Physical
, , Physical
stride JJ Physical
length NN Physical
, , Physical
step NN Physical
width NN Physical
, , Physical
stride JJ Physical
time NN Physical
, , Physical
stance NN Physical
time NN Physical
, , Physical
and CC Physical
dynamic JJ Physical
base NN Physical
. . None
stride JJ Physical
length NN Physical
stride JJ Physical
length NN Physical
walking JJ Physical
onset NN Physical
gait NN Physical
patterns NNS Physical
-DOCSTART- -X- N

platelet NN Physical
aggregation NN Physical
. . None
cardiovascular JJ Physical
events NNS Physical
. . None
platelet NN Physical
aggregation NN Physical
. . None
Primary JJ Physical
hemostasis NN Physical
the DT Other
closure NN Physical
time NN Physical
( ( Physical
CT NNP Physical
) ) Physical
of IN Other
a DT Other
collagen- JJ Other
and CC Other
epinephrine-coated JJ Other
pore NN Other
by IN Other
aggregating VBG Other
platelets NNS Other
in IN Other
flowing VBG Other
blood NN Other
. . None
anti-aggregatory JJ Physical
action NN Physical
( ( None
CT NNP Physical
anti-aggregatory JJ Physical
action NN Physical
CT NNP Physical
platelet NN Physical
aggregation NN Physical
platelet NN Physical
inhibition NN Physical
platelet NN Physical
inhibition NN Physical
-DOCSTART- -X- N

staining VBG Physical
of IN Physical
the DT Physical
oropharynx NN Physical
dye NN Physical
was VBD Physical
present JJ Physical
in IN Physical
the DT Physical
trachea NN Physical
and CC Physical
bronchi NN Physical
-DOCSTART- -X- N

level NN Physical
of IN Physical
ACTH NNP Physical
and CC Physical
CORT NNP Physical
in IN Physical
plasma NN Physical
lymphocyte JJ Physical
proliferative JJ Physical
reaction NN Physical
monoaminic JJ Physical
transmitters NNS Physical
weight NN Physical
of IN Physical
pituitary JJ Physical
, , Physical
adrenal JJ Physical
and CC Physical
thymus NN Physical
number NN Physical
of IN Physical
CRH NNP Physical
positive JJ Physical
neurons NNS Physical
in IN Physical
hypothalamic JJ Physical
paraventricular JJ Physical
nucleus NN Physical
, , Physical
CRH NNP Physical
positive JJ Physical
neurofibrilin NN Physical
median JJ Physical
eminence NN Physical
and CC Physical
anterior JJ Physical
pituitary JJ Physical
ACTH NNP Physical
positive JJ Physical
secretory NN Physical
cells NNS Physical
adrenal JJ Physical
fasciculate NN Physical
zone NN Physical
and CC Physical
thymus NN Physical
cortex NN Physical
atrophies NNS Physical
; : None
NK NNP Physical
cell VBP Physical
cytotoxicity NN Physical
and CC Physical
the DT Physical
level NN Physical
of IN Physical
IL-2 NNP Physical
and CC Physical
gamma-IFN NN Physical
neuroendocrino-immunological JJ Physical
effect NN Physical
-DOCSTART- -X- N

well RB Other
tolerated VBN Other
fewer JJR Adverse
adverse JJ Adverse
effects NNS Adverse
tumor NN Physical
regressed VBD Physical
significantly RB None
volume NN Physical
reduction NN Physical
rate NN Physical
of IN Physical
individual JJ Physical
tumor NN Physical
nodule NN Physical
volume NN None
reduction NN None
rate NN None
tumor NN Physical
shrinkage NN Physical
number NN Physical
of IN Physical
nodules NNS Physical
-DOCSTART- -X- N

long-term JJ None
sedation NN None
sedation NN Other
sedation NN Other
quality NN Other
and CC Physical
time NN Other
to TO Other
recovery NN Other
from IN Other
sedation NN Other
. . Physical
optimal JJ Other
sedation NN Other
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

Nurse NNP Other
and CC Other
patient JJ Other
communication NN Other
profiles NNS Other
communication NN Other
profiles NNS Other
longitudinal JJ Other
changes NNS Other
in IN Other
communication NN Other
, , Physical
nurse JJ Other
perceptions NNS Other
, , Physical
and CC Physical
patient JJ Other
satisfaction NN Other
. . Physical
Roter NNP Other
Interaction NNP Other
Analysis NNP Other
System NNP Other
. . Physical
use VB Other
open-ended JJ Other
questions NNS Other
, , Other
back-channel JJ Other
responses NNS Other
, , Physical
friendly JJ Other
jokes NNS Other
, , Physical
and CC Physical
checks NNS Other
for IN Other
understanding VBG Other
Compliments NNS Other
given VBN Other
and CC Other
partnership NN Other
give VB Mental
lifestyle JJ Mental
information NN Mental
and CC Mental
approval NN Mental
comments NNS Mental
closed-ended JJ Other
questions NNS Other
Nurses CC Other
perceptions NNS Other
of IN Other
the DT Other
interactions NNS Other
perceptions NNS Other
patient JJ Other
satisfaction NN Other
-DOCSTART- -X- N

effectiveness NN Other
and CC None
cost-effectiveness NN Other
modelled VBN Physical
cardiovascular JJ Physical
risk NN Physical
at IN Physical
one CD Physical
year NN Physical
, , Physical
and CC None
cardiovascular JJ Mortality
mortality NN Mortality
and CC Mortality
morbidity NN Mortality
at IN Mortality
five CD Mortality
years NNS Mortality
all-cause JJ Mortality
mortality NN Mortality
, , None
development NN Physical
of IN Physical
renal JJ Physical
and CC Physical
visual JJ Physical
impairment NN Physical
, , None
peripheral JJ Physical
neuropathy NN Physical
, , None
health NN Other
service NN Other
costs NNS Other
, , None
self-reported JJ Physical
quality NN Physical
of IN Physical
life NN Physical
, , None
functional JJ Physical
status NN Physical
and CC None
health NN Physical
utility NN Physical
. . None
mortality NN Mortality
, , None
cardiovascular JJ Physical
morbidity NN Physical
, , None
health NN None
status NN None
and CC None
health NN None
service NN None
use NN None
-DOCSTART- -X- N

cardiovascular JJ Physical
& CC Physical
pulmonary JJ Physical
function NN Physical
. . Physical
significant JJ Physical
cardiovascular JJ Physical
improvement NN Physical
vital JJ Physical
capacity NN Physical
and CC Physical
flow NN Physical
rates NNS Physical
. . Physical
ventilatory NN Other
efficiency NN Other
. . Physical
physical JJ Physical
fitness NN Physical
. . Physical
-DOCSTART- -X- N

( ( None
Digit NNP Mental
Span NNP Mental
, , Mental
Trail NNP Mental
Making NNP Mental
Test NNP Mental
, , Mental
and CC Mental
Symbol NNP Mental
Digit NNP Mental
Modalities NNP Mental
Test NNP Mental
) ) Mental
, , None
verbal JJ Mental
memory NN Mental
( ( Mental
Selective JJ Mental
Reminding NNP Mental
Test NNP Mental
) ) Mental
, , Mental
nonverbal JJ Mental
memory NN Mental
( ( Mental
Benton NNP Mental
Visual NNP Mental
Retention NNP Mental
Test NNP Mental
) ) Mental
, , Mental
and CC None
motor NN Mental
speed NN Mental
( ( Mental
Finger NNP Mental
Tapping NNP Mental
Test NNP Mental
) ) Mental
Fatigue NNP Mental
tests NNS Mental
of IN Mental
attention NN Mental
verbal JJ Mental
memory NN Mental
motor NN Mental
speed NN Mental
-DOCSTART- -X- N

Low JJ Mental
self-esteem NN Mental
Competitive NNP Mental
Memory NNP Mental
Training NNP Mental
( ( Mental
COMET NNP Mental
) ) Mental
effects NNS Mental
of IN Mental
COMET NNP Mental
significant JJ Other
improvement NN Other
large JJ Mental
effect NN Mental
sizes VBZ Mental
on IN Mental
indices NNS Mental
of IN Mental
self-esteem JJ Mental
, , Mental
depression NN Mental
, , Mental
and CC Mental
depressive JJ Mental
rumination NN Mental
. . Mental
therapeutic JJ Mental
effects NNS Mental
stable JJ Mental
-DOCSTART- -X- N

Achilles NNP Physical
tendon NNP Physical
force NN Physical
and CC Physical
strain NN Physical
Achilles NNP Physical
tendon NN Physical
( ( Physical
AT NNP Physical
) ) Physical
force NN Physical
and CC Physical
strain NN Physical
Kinematics NNS Physical
for IN Physical
the DT Physical
right JJ Physical
lower JJR Physical
limb NN Physical
AT NNP Physical
force NN Physical
AT NNP Physical
strain NN Physical
Peak NNP Physical
AT NNP Physical
strain NN Physical
0.35 CD None
) ) None
. . None
Peak NNP None
AT NNP None
force NN None
was VBD None
reduced VBD None
ankle JJ Physical
dorsiflexion NN Physical
but CC None
not RB None
flexion-extension JJ None
ankle NN None
moments NNS None
and CC None
increased VBD None
the DT None
AT NNP None
moment NN None
arm NN None
compared VBN None
reduced VBN None
force NN None
and CC None
strain NN None
on IN None
the DT None
reduction NN None
in IN None
dorsiflexion NN None
, , None
which WDT None
lengthened VBD None
the DT None
AT NNP None
moment NN None
arm NN None
. . None
AT NNP None
loading NN None
and CC None
strain NN None
during IN None
-DOCSTART- -X- N

Safety NN Other
and CC Other
tolerability NN Other
safety NN Other
and CC Other
tolerability NN Other
irritability NN Adverse
runny JJ Physical
nose NN Physical
or CC Physical
nasal JJ Physical
congestion NN Physical
reactogenicity NN Adverse
events NNS Adverse
or CC Adverse
adverse JJ Adverse
events NNS Adverse
mild JJ Adverse
reactogenicity NN Adverse
events NNS Adverse
-DOCSTART- -X- N

episodes NNS Mental
of IN Mental
self-harm NN Mental
parasuicide NN Mental
risk NN Mental
Parasuicide NNP Mental
risk NN Mental
-DOCSTART- -X- N

Multivariate NNP Other
end-of-treatment JJ Mental
abstinence NN Mental
quit NN Mental
smoking VBG Mental
six-month JJ Mental
abstinence NN Mental
quit NN Mental
smoking VBG Mental
levels NNS Mental
of IN Mental
depression NN Mental
symptoms NNS Mental
predictive NN Mental
of IN Mental
smoking VBG Mental
relapse NN Mental
. . Mental
-DOCSTART- -X- N

false JJ Physical
memories NNS Physical
: : Physical
false JJ Physical
memories NNS Physical
studying VBG Physical
pictures NNS Physical
critical JJ Physical
lures NNS Physical
reported VBD Physical
critical JJ Physical
lures NNS Physical
critical JJ Physical
lures NNS Physical
postrecall NN Physical
recognition NN Physical
-DOCSTART- -X- N

International NNP Physical
prostate JJ Physical
symptom NN Physical
scores NNS Physical
( ( Physical
I-PSS NNP Physical
) ) Physical
, , None
uroflowmetry UH Physical
, , None
measurement NN Other
of IN Other
residual JJ Physical
urine JJ Physical
amount NN Physical
and CC Other
ultrasonography NN Other
Operation NNP Other
times NNS Other
, , None
urethral JJ Other
catheterization NN Other
times NNS Other
, , None
preoperative JJ Physical
and CC Physical
postoperative JJ Physical
Hb NNP Physical
, , Other
Htc NNP Physical
and CC Physical
serum VB Physical
Na NNP Physical
values NNS Physical
statistical JJ None
difference NN None
I-PSS NNP Physical
, , None
maximum JJ Physical
flow NN Physical
rate NN Physical
, , None
average NN Physical
flow NN Physical
, , None
residual JJ Physical
urine NN Physical
and CC Physical
size NN Physical
of IN Physical
the DT Physical
prostate NN Physical
. . None
serum NN Physical
Na NNP Physical
level NN Physical
operation NN Other
times NNS Other
postoperative JJ Other
catheterization NN Other
time NN Other
catheterization NN Other
time NN Other
-DOCSTART- -X- N

achievement NN Mental
of IN Mental
learning VBG Mental
objectives NNS Mental
caregiver NN Mental
factors NNS Mental
, , Mental
such JJ Mental
as IN Mental
education NN Mental
, , Mental
presence NN Mental
of IN Mental
father NN Mental
or CC Mental
surrogate VB Mental
father NN Mental
in IN Mental
the DT Mental
household NN Mental
, , Mental
and CC Mental
safety NN Mental
of IN Mental
the DT Mental
neighborhood NN Mental
child JJ Physical
factors NNS Physical
, , None
such JJ None
as IN None
age NN Physical
or CC None
severity NN Physical
of IN Physical
asthma NN Physical
number NN Other
of IN Other
home NN Other
visits NNS Other
-DOCSTART- -X- N

presence NN Physical
of IN Physical
overt JJ Physical
emotional JJ Physical
disturbance NN Physical
new JJ Physical
psychological JJ Physical
or CC Physical
psychophysiological JJ Physical
symptoms NNS Physical
preceding VBG Physical
the DT Physical
rash NN Physical
high JJ Mental
motivation NN Mental
improves VBZ None
eczema NN Physical
worsen VB None
it PRP None
-DOCSTART- -X- N

incidence NN Physical
of IN Physical
severe JJ Physical
respiratory JJ Physical
failure NN Physical
and CC Mortality
mortality NN Mortality
. . None
severe JJ Physical
respiratory JJ Physical
failure NN Physical
plasma JJ Physical
suppressive JJ Physical
activity NN Physical
plasma JJ Physical
suppressive JJ Physical
activity NN Physical
-DOCSTART- -X- N

effect NN Other
anti-Xa JJ Physical
levels NNS Physical
anti-Xa JJ Physical
levels NNS Physical
Anti-Xa JJ Physical
levels NNS Physical
bleeding NN Adverse
and CC None
recurrent NN Physical
venous JJ Physical
thromboembolism NN Physical
. . None
died VBD Mortality
mean JJ Physical
anti-Xa JJ Physical
levels NNS Physical
accumulation NN Physical
of IN Physical
anti-Xa JJ Physical
effect NN Physical
anti-Xa JJ Physical
levels NNS Physical
-DOCSTART- -X- N

Type-4a NNP Physical
MI NNP Physical
PMI NNP Physical
type-4a JJ Physical
MI NNP Physical
cardiac JJ Mortality
mortality NN Mortality
PMI NNP Physical
events NNS Physical
-DOCSTART- -X- N

efficacy NN Other
field NN Other
efficacy NN Other
efficacy NN Other
field NN Other
efficacy NN Other
Response NN Physical
to TO Physical
treatment NN Physical
was VBD None
assessed VBN None
by IN None
periodic JJ Physical
mite NN Physical
count NN Physical
, , None
and CC None
skin JJ Physical
lesions NNS Physical
scored VBN Physical
. . None
localised VBD Adverse
or CC Adverse
systemic JJ Adverse
side NN Adverse
effects NNS Adverse
mite JJ Physical
counts NNS Physical
mite JJ Other
counts NNS Other
mite JJ Physical
counts NNS Physical
mite JJ Physical
counts NNS Physical
-DOCSTART- -X- N

Local NNP Adverse
septic JJ Adverse
complications NNS Adverse
stool NN None
frequency NN None
continence NN Physical
anal JJ None
manometry NN Physical
functional JJ Physical
outcome NN Physical
local JJ Adverse
septic NN Adverse
complications NNS Adverse
-DOCSTART- -X- N

initial JJ Other
cure NN Other
definitive JJ Other
cure NN Other
abatement NN Physical
of IN Physical
fever NN Physical
complete JJ Adverse
spleen JJ Adverse
regression NN Adverse
. . Physical
-DOCSTART- -X- N

rate NN Mental
of IN Mental
adherence NN Mental
hepatotoxicity NN Adverse
or CC Adverse
side NN Adverse
effects NNS Adverse
. . Adverse
screening VBG Other
illegal JJ Other
immigration NN Other
status NN Other
unemployment NN Other
illiteracy NN Other
lack NN Other
of IN Other
family NN Other
support NN Other
6-month JJ Other
treatment NN Other
regimen NNS Other
tuberculosis NN Adverse
. . Adverse
-DOCSTART- -X- N

pulp NN Other
vitality NN Other
, , None
recurrent NN Other
caries NNS Other
, , None
pain NN Pain
and CC Pain
discomfort NN Pain
, , None
and CC None
restoration NN Other
retention NN Other
. . None
discomfort NN Pain
levels NNS Pain
for IN Pain
the DT Pain
laser NN Pain
system NN Pain
-DOCSTART- -X- N

overall JJ Mental
on IN Mental
language NN Mental
and CC Mental
cognitive JJ Mental
outcome NN Mental
measures NNS Mental
. . Mental
progress NN Mental
overall NN Mental
in IN Mental
the DT Mental
software NN Mental
demonstrated VBD Mental
larger JJR Mental
gains NNS Mental
within IN Mental
the DT Mental
software NN Mental
and CC Mental
in IN Mental
outcome JJ Mental
measures NNS Mental
. . Mental
-DOCSTART- -X- N

confidence NN Mental
confidence NN Other
confidence NN Mental
inflation NN Mental
-DOCSTART- -X- N

depressive JJ Mental
symptoms NNS Mental
Patient NNP Other
Health NNP Other
Questionnaire-9 NNP Other
( ( Other
PHQ-9 NNP Other
) ) Other
depression NN Other
scale NN Other
PHQ-9 NNP Other
score NN Other
greater JJR Mental
rates NNS Mental
of IN Mental
depression NN Mental
treatment NN Mental
better JJR Other
quality-of-life JJ Other
outcomes NNS Other
emotional JJ Mental
functional JJ Physical
physical JJ Mental
well-being NN Mental
-DOCSTART- -X- N

patient NN Mental
's POS Mental
ability NN Mental
to TO Mental
correctly RB Mental
demonstrate VB Mental
dosing VBG Mental
instructions NNS Mental
. . None
adherence NN Mental
, , None
error NN Other
rates NNS Other
and CC None
health NN Physical
outcomes NNS Physical
. . None
understanding NN Mental
, , None
medication NN Mental
use NN Mental
-DOCSTART- -X- N

production NN Physical
of IN Physical
symptoms NNS Physical
( ( Physical
syncope NN Physical
, , Physical
pre-syncope NN Physical
) ) Physical
with IN Physical
development NN Physical
of IN Physical
hypotension NN Physical
. . Physical
sensitivity NN Physical
of IN Physical
glyceryl NN Physical
trinitrate NN Physical
vasovagal JJ Physical
syncope NN Physical
tolerated VBN Other
. . None
Isoprenaline NNP Other
sensitivity NN Other
specificity NN None
Side-effects NNS Adverse
development NN Physical
of IN Physical
hypertension NN Physical
or CC Adverse
tachycardia NN Physical
and CC Adverse
intolerable JJ Physical
flushing NN Physical
or CC Adverse
nausea NN Physical
. . Adverse
effective JJ Other
vasovagal JJ Physical
syncope NN Physical
and CC Physical
has VBZ Physical
a DT Physical
lower JJR Physical
incidence NN Physical
of IN Physical
adverse JJ Physical
events NNS Physical
. . Physical
-DOCSTART- -X- N

reflexes NNS Physical
and CC Physical
breathing VBG Physical
responses NNS Physical
sleep JJ Physical
state NN Physical
( ( Physical
active JJ Physical
and CC Physical
quiet JJ Physical
sleep NN Physical
by IN Physical
electroencephalogram NN Physical
, , Physical
eye NN Physical
movements NNS Physical
, , Physical
breathing NN Physical
, , Physical
and CC Physical
behavior NN Mental
) ) Physical
, , Physical
cardiorespiratory JJ Physical
measurements NNS Physical
( ( Physical
nasal JJ Physical
airflow NN Physical
, , Physical
chest VBP Physical
wall NN Physical
movements NNS Physical
, , Physical
heart NN Physical
rate NN Physical
, , Physical
and CC Physical
oxygen PRP Physical
saturation NN Physical
) ) Physical
, , Physical
swallowing VBG Physical
, , Physical
and CC Physical
esophageal JJ Physical
activity NN Physical
( ( Physical
solid JJ Physical
state NN Physical
pressure NN Physical
catheter NN Physical
) ) Physical
. . None
swallowing NN Physical
swallowing VBG Physical
arousal NN Physical
swallowing VBG Physical
and CC Physical
breathing VBG Physical
swallows/min NN Physical
breaths/min NN Physical
; : None
arousal NN Physical
swallowing VBG Physical
rate NN Physical
arousal NN Physical
. . None
airway RB Physical
protective JJ Physical
reflexes NNS Physical
-DOCSTART- -X- N

Non-haematological JJ Adverse
toxicity NN Adverse
toxicity NN Adverse
. . None
Haematological JJ Adverse
toxicity NN Adverse
cumulative JJ Adverse
anaemia NN Adverse
and CC Adverse
thrombocytopenia NN Adverse
response NN Other
rate NN Other
measurable JJ None
disease NN None
-DOCSTART- -X- N

postoperative JJ Adverse
complications NNS Adverse
postoperative JJ Adverse
complications NNS Adverse
anal JJ Adverse
stenosis NN Adverse
hemorrhage NN Adverse
anastomosis VBN Adverse
leak NN Adverse
thrombosis NN Adverse
complications NNS Adverse
. . Adverse
severe JJ Adverse
postoperative JJ Adverse
pain NN Adverse
fecal JJ Adverse
incontinence NN Adverse
overall JJ Other
difference NN Other
number NN Adverse
of IN Adverse
complications NNS Adverse
effective JJ Other
reducing VBG Adverse
postoperative JJ Adverse
complications NNS Adverse
. . Adverse
-DOCSTART- -X- N

Ultrastructure NN None
features NNS None
of IN None
sampling VBG None
devices NNS None
less JJR None
cell NN None
overlap NN None
and CC None
less JJR None
white JJ None
blood NN None
cells NNS None
( ( None
p JJ None
more RBR None
metaplastic JJ None
cells NNS None
( ( None
p JJ None
evaluation NN None
highlighted VBD None
-DOCSTART- -X- N

intensity NN Other
of IN Other
chemotherapy NN Other
duration NN Physical
of IN Physical
neutropenia NN Physical
pulmonary JJ Physical
infection NN Physical
pulmonary JJ Physical
infection NN Physical
incidence NN Physical
of IN Physical
ARDS NNP Physical
due JJ Physical
to TO Physical
pulmonary JJ Physical
infection NN Physical
per IN Physical
chemotherapy NN Physical
session NN Physical
incidence NN None
of IN None
ARDS NNP None
due JJ None
to TO None
pulmonary JJ None
infection NN None
per IN None
case NN None
incidence NN Physical
of IN Physical
ARDS NNP Physical
due JJ Physical
to TO Physical
pulmonary JJ Physical
infection NN Physical
was VBD Physical
higher RBR Physical
in IN Physical
the DT Physical
G-CSF NNP Physical
group NN Physical
-DOCSTART- -X- N

ridge JJ Physical
dimensions NNS Physical
and CC Physical
histologic JJ Physical
characteristics NNS Physical
of IN Physical
ridges NNS Physical
Horizontal NNP Physical
and CC Physical
vertical JJ Physical
ridge NN Physical
dimensions NNS Physical
were VBD None
determined VBN None
using VBG None
a DT None
digital JJ None
caliper NN None
and CC None
a DT None
template NN None
. . None
histologic JJ Physical
analysis NN Physical
. . None
ridge NN Physical
width NN Physical
midbuccal JJ Physical
vertical JJ Physical
change NN Physical
vital JJ Physical
bone NN Physical
vital JJ Physical
bone NN Physical
fill NN Physical
Ridge NNP Physical
width NN Physical
and CC Physical
height JJ Physical
dimensions NNS Physical
-DOCSTART- -X- N

The DT None
serum NN Physical
levels NNS Physical
of IN Physical
25-hydroxyvitamin JJ Physical
D3 NNP Physical
had VBD None
25-hydroxyvitamin JJ Physical
D3 NNP Physical
levels NNS Physical
had VBD None
higher JJR None
levels NNS None
of IN None
serum NN Physical
parathyroid NN Physical
hormone NN Physical
lower JJR Physical
dietary JJ Physical
intake NN Physical
of IN Physical
vitamin NN Physical
D NNP Physical
between IN None
outdoor JJ None
activity NN None
and CC None
serum JJ None
level NN None
of IN None
25-hydroxyvitamin JJ None
D3 NNP None
lower JJR None
intake NN None
of IN None
calcium NN None
-DOCSTART- -X- N

Efficacy NN Other
scores NNS Physical
of IN Physical
erythema NN Physical
, , None
scaling/hypertrophy NN Physical
and CC Physical
induration NN Physical
as RB None
well RB None
as IN None
pain NN Pain
and CC Physical
itching NN Physical
; : None
general JJ Other
improvement NN Other
scored VBN Physical
by IN Physical
the DT Physical
investigator NN Physical
and CC Physical
global JJ Physical
improvement NN Physical
scored VBN Physical
by IN Physical
patients NNS Physical
' POS Physical
assessment NN Physical
were VBD Physical
also RB Physical
evaluated VBN Physical
. . None
scaling/hypertrophy NN Physical
, , None
pain NN Physical
, , None
itching NN None
and CC None
global JJ Physical
patient NN Physical
assessment NN Physical
induration NN Physical
size NN Physical
of IN Physical
the DT Physical
lesional JJ Physical
area NN Physical
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

Survival NNP Mortality
presumptive JJ Other
diagnosis NN Other
hospital JJ Other
admission NN Other
total JJ Other
patient-hospital JJ Other
days NNS Other
Actuarial JJ Mortality
survival NN Mortality
survival JJ Mortality
free JJ Mortality
from IN Mortality
recurrent JJ Mortality
syncope NN Mortality
diagnostic JJ Other
yield NN Other
hospital NN Other
admission NN Other
total JJ Other
length NN Other
of IN Other
hospital NN Other
stay NN Other
mortality NN Mortality
-DOCSTART- -X- N

endotracheal JJ None
colonisation NN None
with IN None
ps NN None
. . None
aeruginosa NN Physical
incidence NN Physical
of IN Physical
secondary JJ Physical
pneumonia NN Physical
Systemic JJ Physical
administration NN Physical
of IN Physical
antibiotics NNS Physical
growth NN Physical
of IN Physical
fungi NN Physical
in IN Physical
the DT Physical
upper JJ Physical
respiratory NN Physical
tract NN Physical
incidence NN Physical
mainly RB Physical
of IN Physical
staph NN Physical
. . Physical
epidermidis NN Physical
. . None
tolerated VBN Other
allergic JJ Adverse
reactions NNS Adverse
respiratory NN Adverse
pressures NNS Adverse
bronchoconstrictions NNS Adverse
-DOCSTART- -X- N

intervention NN Physical
to TO Physical
significantly RB Physical
improve VB Physical
joint JJ Physical
engagement NN Physical
significant JJ Physical
increases NNS Physical
in IN Physical
joint JJ Physical
attention NN Physical
and CC Physical
symbolic JJ Physical
play NN Physical
skills NNS Physical
. . Physical
play NN Physical
and CC Physical
joint JJ Physical
attention NN Physical
skills NNS Physical
-DOCSTART- -X- N

Cytology NNP Other
and CC Other
histology NN Other
results NNS Other
from IN Other
endocervical JJ Other
sampling NN Other
compared VBN None
with IN None
cone NN Other
biopsy NN Other
histology NN Other
. . None
sensitivity NN Other
of IN Other
endocervical JJ Other
sampling NN Other
false JJ Other
negative JJ Other
rate NN Other
negative JJ Other
predictive JJ Other
value NN Other
-DOCSTART- -X- N

on IN None
lymphocyte JJ None
sensitization NN None
vaccination NN None
. . None
Lymphocyte JJ None
responses NNS None
to TO None
the DT None
PPD-SI NNP None
rose VBD None
The DT None
lymphocyte JJ None
responses NNS None
to TO None
raised VBN None
PPD-SI NN None
before IN None
affected VBD None
lymphocyte JJ None
sensitization NN None
by IN None
enhances NNS None
immunologic JJ None
sensitization NN None
to TO None
-DOCSTART- -X- N

Brief JJ Mental
Agitation NNP Mental
Rating NNP Mental
Scale NNP Mental
( ( Mental
BARS NNP Mental
) ) Mental
. . Mental
10-item JJ Mental
version NN Mental
of IN Mental
the DT Mental
Neuropsychiatric NNP Mental
Inventory NNP Mental
Questionnaire NNP Mental
( ( Mental
NPI-Q NNP Mental
) ) Mental
, , Mental
the DT Mental
Cornell NNP Mental
Scale NNP Mental
for IN Mental
Depression NNP Mental
in IN Mental
Dementia NNP Mental
( ( Mental
CSDD NNP Mental
) ) Mental
and CC Mental
the DT Mental
Quality NN Mental
of IN Mental
Life NNP Mental
in IN Mental
Late-Stage NNP Mental
Dementia NNP Mental
( ( Mental
QUALID NNP Mental
) ) Mental
scale NN Mental
. . Mental
BARS NNP Mental
score NN Mental
NPI-Q NNP Mental
sum NN Mental
score NN Mental
NPI-Q NNP Mental
agitation NN Mental
and CC Mental
NPI-Q JJ Mental
psychosis NN Mental
QUALID NNP Mental
score NN Mental
CSDD NNP Mental
score NN Mental
-DOCSTART- -X- N

intravenous JJ Physical
glucose JJ Physical
tolerance NN Physical
test NN Physical
insulin NN Physical
sensitivity NN Physical
( ( Physical
Si NNP Physical
) ) Physical
and CC None
glucose JJ Physical
effectiveness NN Physical
( ( Physical
Sg NNP Physical
) ) Physical
Si NNP Physical
and CC None
Sg NNP Physical
resolution NN Physical
of IN Physical
Si NNP Physical
and CC Physical
Sg NNP Physical
Si NNP Physical
Sg NNP Physical
-DOCSTART- -X- N

weakness NN Physical
progression NN Physical
disease NN Physical
progression NN Physical
Mean NNP Physical
change NN Physical
of IN Physical
quantitative JJ Physical
muscle NN Physical
strength NN Physical
testing VBG Physical
sum NN Physical
scores NNS Physical
Quantitative JJ None
muscle NN None
strength NN None
testing VBG None
sum NN None
scores NNS None
manual JJ Physical
muscle NN Physical
testing VBG Physical
sum JJ Physical
scores NNS Physical
, , Physical
activity NN Physical
scale NN Physical
scores NNS Physical
and CC Physical
patients NNS Physical
' POS Physical
own JJ Physical
assessments NNS Physical
Serum NNP Physical
creatine JJ Physical
kinase NN Physical
activity NN Physical
progression NN Physical
of IN Physical
muscle NN Physical
weakness NN Physical
serum JJ Physical
creatine JJ Physical
kinase NN Physical
activity NN Physical
-DOCSTART- -X- N

self- JJ Other
and CC Other
caregiver-report JJ Other
measures NNS Other
. . Physical
loneliness JJ Mental
improved VBN Mental
social JJ Mental
skills NNS Mental
knowledge VBP Mental
overall JJ Mental
social JJ Mental
skills NNS Mental
, , Other
social JJ Mental
responsiveness NN Mental
, , Other
empathy NN Mental
, , Other
and CC Other
frequency NN Mental
of IN Mental
get-togethers NNS Mental
. . Other
-DOCSTART- -X- N

Serum NNP Physical
and CC Physical
ascitic JJ Physical
levels NNS Physical
of IN Physical
tumor NN Physical
necrosis NN Physical
factor-alpha JJ Physical
, , Physical
interferon-gamma JJ Physical
, , None
interleukin-12 JJ Physical
, , Physical
and CC Physical
nitric JJ Physical
oxide NN Physical
serum NN Physical
norfloxacins NNS Physical
concentrations NNS Physical
and CC Physical
tumor NN Physical
necrosis NN Physical
factor-alpha NN Physical
interferon-gamma JJ Physical
interleukin-12 JJ Physical
nitric JJ Physical
oxide NN Physical
Serum NNP Physical
norfloxacin NN Physical
's POS Physical
highest JJS Physical
concentrations NNS Physical
cytokines NNS Physical
and CC Physical
nitric JJ Physical
oxide NN Physical
. . None
Intracellular NNP Physical
norfloxacin NN Physical
's POS Physical
highest JJS Physical
levels NNS Physical
cytokine JJ Physical
expression NN Physical
. . None
-DOCSTART- -X- N

Systolic NNP Physical
diastolic JJ Physical
sphericity NN Physical
index NN Physical
worsened JJ Physical
outcome NN Physical
. . None
systolic JJ Physical
SI NNP Physical
diastolic JJ Physical
SI NNP Physical
TEI NNP Physical
index NN Physical
changes NNS Physical
in IN Physical
BNP NNP Physical
changes NNS Physical
in IN Physical
dP/dt NN Physical
systemic JJ None
ventricular JJ None
dysfunction NN None
and CC None
heart NN None
failure NN None
. . None
-DOCSTART- -X- N

breathing NN Physical
frequency NN Physical
( ( Physical
f NN Physical
) ) Physical
mean JJ Physical
tidal NN Physical
volume NN Physical
( ( Physical
VT NNP Physical
) ) Physical
. . Physical
minute JJ Physical
ventilation NN Physical
( ( Physical
VE NNP Physical
) ) Physical
and CC None
f $ Physical
VT NNP Physical
VT NNP Physical
f NN Physical
changes NNS Physical
in IN Physical
VE NNP Physical
peak JJ Physical
inspiratory NN Physical
and CC Physical
expiratory NN Physical
flow NN Physical
rates NNS Physical
. . None
oxygen NN Physical
consumption NN Physical
( ( Physical
VO2 NNP Physical
) ) Physical
and CC Physical
carbon NN Physical
dioxide NN Physical
production NN Physical
( ( Physical
VCO2 NNP Physical
) ) Physical
-DOCSTART- -X- N

no DT Physical
myelosuppression NN Physical
mild JJ Physical
gastrointestinal JJ Physical
symptoms NNS Physical
. . Physical
shrinkage NN Physical
of IN Physical
tumor NN Physical
in IN Physical
the DT Physical
X-ray JJ Physical
films NNS Physical
histopathological JJ Physical
changes NNS Physical
excessive JJ Physical
keratinization NN Physical
in IN Physical
the DT Physical
squamous JJ Physical
component NN Physical
of IN Physical
the DT Physical
esophageal NN Physical
cancerous JJ Physical
tissue NN Physical
incidence NN Physical
of IN Physical
degeneration NN Physical
and CC Physical
necrosis NN Physical
in IN Physical
the DT Physical
squamous JJ Physical
epithelium NN Physical
adjacent NN Physical
to TO Physical
carcinoma VB Physical
-DOCSTART- -X- N

effect NN Other
reduction NN Physical
of IN Physical
fever NN Physical
duration NN Pain
of IN Pain
chest NN Pain
pain NN Pain
pericardial JJ Physical
friction NN Physical
rub NN Physical
pericardial JJ Physical
effusion NN Physical
. . Physical
need NN Physical
for IN Physical
invasive JJ Physical
surgical JJ Physical
procedures NNS Physical
for IN None
relief NN None
of IN None
tamponade NN Physical
mortality NN Mortality
rate NN Mortality
. . Mortality
Death NNP Mortality
mild JJ Physical
illness NN Physical
of IN Physical
several JJ Physical
days NNS Physical
duration NN Physical
painful JJ Physical
and CC Physical
debilitating JJ Physical
disease NN Physical
lasting JJ Physical
weeks NNS Physical
surgical JJ Other
intervention NN Other
. . None
illness NN Physical
-DOCSTART- -X- N

systolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
SBP NNP Physical
) ) Physical
and CC None
diastolic JJ Physical
blood NN Physical
pressure NN Physical
( ( Physical
DBP NNP Physical
) ) Physical
. . None
blood NN Physical
lipid NN Physical
, , None
fasting VBG Physical
glucose NN Physical
, , None
and CC None
insulin NN Physical
levels NNS Physical
and CC None
side NN Adverse
effects NNS Adverse
related VBN Adverse
to TO Adverse
elevated VBN Adverse
blood NN Adverse
pressure NN Adverse
and CC Adverse
increased VBD Adverse
dietary JJ Adverse
fiber NN Adverse
intake NN Adverse
. . None
SBP NNP Physical
DBP NNP Physical
total JJ Physical
insulin NN Physical
response NN Physical
total JJ Physical
cholesterol NN Physical
low-density JJ Physical
lipoprotein NN Physical
cholesterol NN Physical
SBP NNP Physical
and CC None
DBP NNP Physical
. . None
-DOCSTART- -X- N

moderation NN Other
impairment NN Mental
in IN Mental
higher-order NN Mental
, , Mental
executive NN Mental
skills NNS Mental
. . None
AX NNP Mental
continuous JJ Mental
performance NN Mental
test NN Mental
( ( Mental
AX-CPT NNP Mental
) ) Mental
AX-CPT JJ Mental
performance NN Mental
performed VBD Mental
attenuated VBN Mental
this DT Mental
impairment NN Mental
performing VBG Mental
Working VBG Mental
memory NN Mental
performance NN Mental
effects NNS Other
inhibition NN Mental
condition NN Mental
cognitive JJ Mental
impairments NNS Mental
-DOCSTART- -X- N

bone NN Other
metabolism NN Other
, , None
bone NN Other
density NN Other
, , None
and CC None
bone NN Other
quality NN Other
Subnormal NNP Physical
bone NN Physical
mineral NN Physical
density NN Physical
( ( Physical
BMD NNP Physical
) ) Physical
and CC None
increased JJ Physical
fracture NN Physical
risk NN Physical
effects NNS Physical
on IN Physical
bone NN Physical
bone NN Physical
metabolism NN Physical
, , None
BMD NNP Physical
, , None
and CC None
bone NN Physical
quality NN Physical
Bone NNP Physical
turnover NN Physical
BMD NNP Physical
Apparent JJ Physical
phalangeal NN Physical
ultrasound JJ Physical
transmission NN Physical
velocity NN Physical
( ( Physical
APU NNP Physical
) ) Physical
BMD NNP Physical
BMD NNP Physical
BMD NNP Physical
bone NN Physical
turnover NN Physical
, , None
first RB Other
ICTP NNP Other
marker NN None
of IN None
bone NN Other
resorption NN Other
marker NN None
of IN None
bone NN Physical
formation NN Physical
APU NNP Physical
BMD NNP Physical
bone CD Physical
turnover NN Physical
BMD NNP Physical
. . None
BMD NNP Physical
: : None
BMD NNP Physical
BMD NNP Physical
normal JJ None
bone NN Physical
elasticity NN Physical
. . None
-DOCSTART- -X- N

solar JJ Mental
protection NN Mental
behavior NN Mental
knowledge NN Mental
attitudes NNS Mental
. . None
significant JJ Other
increase NN Other
high JJ Mental
level NN Mental
of IN Mental
solar JJ Mental
protection NN Mental
no DT Other
change NN Other
improved VBN Other
knowledge NN Mental
score NN Mental
intervention NN Other
group NN Other
showed VBD Other
a DT Other
significantly RB Other
greater JJR Other
improvement NN Other
No DT Other
changes NNS Other
in IN Other
attitudes NNS Other
solar JJ Mental
protection NN Mental
-DOCSTART- -X- N

Efficacy NN Other
skin NN Physical
compatibility NN Physical
, , Physical
efficacy NN Physical
and CC Physical
resulting VBG Physical
acceptance NN Physical
. . None
clinical JJ Physical
skin NN Physical
status NN Physical
stratum JJ Physical
corneum NN Physical
hydration NN Physical
tolerated VBN Other
and CC Physical
accepted VBN Physical
well RB Physical
skin JJ Physical
protection NN Physical
and CC Physical
skin NN Physical
care NN Physical
. . Physical
-DOCSTART- -X- N

Knee NNP Physical
range NN Physical
of IN Physical
motion NN Physical
( ( Physical
ROM NNP Physical
) ) Physical
, , None
stretch JJ Physical
perception NN Physical
, , None
pressure NN Pain
pain NN Pain
threshold NN Pain
( ( Pain
PPT NNP Pain
) ) Pain
and CC Pain
subjective JJ Pain
pain NN Pain
intensity NN Pain
. . None
lower JJR Pain
pain NN Pain
intensity NN Pain
scores NNS Pain
clinical JJ Other
effect NN Other
ROM NNP Physical
-DOCSTART- -X- N

Modulation NN Physical
of IN Physical
human JJ Physical
motor NN Physical
cortex NN Physical
excitability NN Physical
N-methyl-D-aspartate NNP Physical
antagonism NN Mental
cortex NN Physical
Spinal NNP Physical
cord NN Physical
excitability NN Physical
M-amplitudes NNS Physical
ICF NNP Physical
L-ICI NNP Physical
ICF NNP Physical
L-ICI NNP Physical
ICI NNP Physical
motor NN Physical
thresholds NNS Physical
, , None
MEP NNP Physical
recruitment NN Physical
curves NNS Physical
, , None
CSP NNP Physical
, , None
or CC None
peripheral JJ Physical
excitability NN Physical
. . Physical
modulating VBG Physical
human JJ Physical
motor NN Physical
cortex NN Physical
excitability NN Physical
. . None
ICF NNP Physical
L-ICI NNP Physical
cortical JJ Physical
excitability NN Physical
. . None
L-ICI JJ Physical
-DOCSTART- -X- N

Reflux NNP Physical
, , Physical
total JJ Physical
, , Physical
and CC Physical
antacid JJ Physical
scores NNS Physical
symptom NN Physical
scores NNS Physical
reflux NN Physical
score NN Physical
total JJ Physical
score NN Physical
antacid VB Physical
score NN Physical
-DOCSTART- -X- N

vacuum-compression NN Physical
therapy NN Physical
vacuum-compression NN Physical
therapy NN Physical
( ( Physical
VCT NNP Physical
) ) Physical
foot NN Physical
ulcer JJ Physical
surface NN Physical
area NN Physical
VCT NNP Other
conventional JJ Physical
therapy NN Physical
conventional JJ Other
therapy NN Other
debridement NN Other
, , Other
blood NN Other
glucose NNS Other
control NN Other
agents NNS Other
, , None
systemic JJ Other
antibiotics NNS Other
, , None
wound IN Other
cleaning VBG Other
with IN Other
normal JJ Other
saline NN Other
, , None
offloading VBG Other
( ( None
pressure NN None
relief NN None
) ) None
daily RB Physical
wound JJ Physical
dressings NNS Physical
. . None
foot NN Physical
ulcer JJ Physical
surface NN Physical
area NN Physical
measures NNS Physical
of IN Physical
foot NN Physical
ulcer JJ Physical
surface NN Physical
area NN Physical
VCT NNP Other
diabetic JJ Physical
foot NN Physical
ulcer NN Physical
healing VBG Physical
-DOCSTART- -X- N

stability NN Other
fixation NN Physical
American JJ Physical
Knee NNP Physical
Society NNP Physical
score NN Physical
intraoperative JJ Adverse
complications NNS Adverse
, , None
and CC None
no DT Adverse
postoperative JJ Adverse
infections NNS Adverse
or CC None
revisions NNS Adverse
. . None
improved VBN Physical
function NN Physical
and CC Physical
regained VBD Physical
full JJ Physical
extension NN Physical
. . Physical
migrated VBN Mental
migration NN Physical
of IN Physical
the DT Physical
TM NNP Physical
components NNS Physical
long-term JJ Mortality
implant JJ Mortality
survival NN Mortality
-DOCSTART- -X- N

cumulative JJ Physical
dose NN Physical
of IN Physical
morphine NN Physical
no DT None
significant JJ None
reduction NN None
in IN None
the DT None
requirement NN Pain
for IN Pain
patient-controlled JJ Pain
analgesia NN Pain
-DOCSTART- -X- N

BMD NNP Physical
high JJ Physical
levels NNS Physical
of IN Physical
serum NN Physical
ionized VBN Physical
calcium NN Physical
and CC None
urinary JJ Physical
deoxypyridinoline NN Physical
. . None
serum NN Physical
calcium NN Physical
and CC None
urinary JJ Physical
deoxypyridinoline NN Physical
levels NNS Physical
BMD NNP Physical
on IN Physical
the DT Physical
hemiplegic JJ Physical
side NN Physical
hip JJ Adverse
fractures NNS Adverse
hip NN Adverse
fracture NN Adverse
BMD NNP Physical
-DOCSTART- -X- N

efficacy NN Physical
of IN Physical
hemostasis NN Physical
, , None
complication NN Adverse
rate NN Adverse
, , None
safety NN Other
of IN Other
early JJ Other
mobilization NN Other
, , None
and CC None
patient JJ Other
comfort NN Other
. . None
pain NN Pain
during IN Pain
sheath NN Pain
removal NN Pain
period NN Other
of IN Other
bed NN Other
rest NN Other
Oozing VBG Other
and CC Other
need VB Other
for IN Other
pressure NN Other
bandage NN Other
at IN Other
the DT Other
puncture NN Other
site NN Other
Hematoma NNP Adverse
safety NN Other
oozing VBG Physical
. . None
patient JJ Other
comfort NN Other
-DOCSTART- -X- N

Atrial NNP Physical
remodeling NN Physical
sinus JJ Physical
rhythm NN Physical
auricular JJ Physical
remodeling NN Physical
with IN Physical
size NN Physical
regression NN Physical
new JJ Physical
atrial JJ Physical
enlargement NN Physical
atrial JJ Physical
rhythm NN Physical
postoperative JJ Physical
surgical JJ Physical
volume NN Physical
. . None
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
survival NN Mortality
analyses NNS None
safety NN Other
antitumor NN Other
activity NN Other
safety NN Other
. . None
survival NN Mortality
median JJ Mortality
OS NNP Mortality
OS NNP Mortality
Grade $ Physical
3 CD Physical
or CC Physical
4 CD Physical
fatigue NN Physical
, , None
neutropenia NN Physical
, , Physical
and CC None
febrile JJ Physical
neutropenia NN Physical
-DOCSTART- -X- N

effects NNS Other
anthropometric JJ Physical
characteristics NNS Physical
, , Physical
the DT Physical
basal NN Physical
values NNS Physical
of IN Physical
the DT Physical
Lp NNP Physical
( ( Physical
a DT Physical
) ) Physical
, , Physical
the DT Physical
sex NN Physical
steroid NN Physical
and CC Physical
pituitary JJ Physical
hormone NN Physical
levels NNS Physical
. . Physical
levels NNS Physical
of IN Physical
Lp NNP Physical
( ( Physical
a DT Physical
) ) Physical
-DOCSTART- -X- N

pain RB Pain
measured VBN Pain
by IN None
visual JJ Other
analogue NN Other
scale NN Other
and CC Other
patient JJ Other
global JJ Other
change NN Other
. . Pain
WOMAC NNP Other
, , None
knee NN Pain
pain NN Pain
scale NN Pain
, , None
SF-36 NNP Other
, , None
assessment NN Other
of IN Other
quality NN Other
of IN Other
life NN Other
index NN Other
, , None
quadriceps JJ Other
strength NN Other
, , None
and CC None
balance NN Other
test NN Other
. . None
pain NN Pain
reductions NNS Pain
pain NN Pain
remained VBD Pain
reduced VBN Pain
Global JJ Other
improvement NN Other
global JJ Other
improvement NN Other
-DOCSTART- -X- N

nasal JJ Physical
potential JJ Physical
difference NN Physical
level NN Physical
of IN Physical
sweat NN Physical
chloride NN Physical
forced JJ Physical
expiratory NN Physical
volume NN Physical
severe JJ Adverse
adverse JJ Adverse
events NNS Adverse
( ( None
diffuse IN Physical
macular NN Physical
rash NN Physical
elevated VBN Physical
blood NN Physical
and CC Physical
urine JJ Physical
glucose NN Physical
levels NNS Physical
diabetes NNS Physical
) ) None
safety NN Other
and CC None
adverse-event JJ Adverse
profile NN Adverse
CFTR NNP Physical
and CC None
lung NN Physical
function NN Physical
. . None
-DOCSTART- -X- N

analgesic JJ Pain
efficacy NN Pain
, , Other
onset NN Other
of IN Other
action NN Other
tolerability NN Other
pharmacokinetic JJ Other
characteristics NNS Other
pain NN Pain
relief NN Pain
analgesic JJ Pain
efficacy NN Pain
, , Other
speed NN Other
of IN Other
onset NN Other
, , Other
and CC Other
tolerability NN Other
Pain NNP Pain
intensity NN Pain
and CC Pain
pain NN Pain
relief NN Pain
verbal JJ Pain
descriptor NN Pain
scales NNS Pain
; : Pain
onset VBN Pain
of IN Pain
analgesia NN Pain
time NN Pain
to TO Pain
achievement NN Pain
of IN Pain
specific JJ Pain
pain NN Pain
relief NN Pain
Baseline NNP Pain
pain NN Pain
pain NN Pain
relief NN Pain
pain NN Pain
relief NN Pain
pain NN Pain
relief NN Pain
pain NN Pain
relief NN Pain
pain NN Pain
reduction NN Pain
Median JJ Physical
remedication NN Physical
times NNS Physical
Adverse-event JJ Adverse
profiles NNS Adverse
pain NN Pain
relief NN Pain
tolerability NN Other
profiles NNS Other
. . Other
-DOCSTART- -X- N

Comparative JJ Other
effectiveness NN Other
was VBD None
2-year JJ None
incidence NN None
of IN None
major JJ None
adverse JJ None
cardiac NN None
events NNS None
, , None
defined VBN None
as IN None
CAD NNP None
death NN None
or CC None
hospitalization NN None
for IN None
an DT None
acute JJ None
coronary JJ None
syndrome NN None
or CC None
heart NN None
failure NN None
. . None
ETT NNP None
, , None
ECG NNP None
results NNS None
the DT None
exercise NN None
MPI NNP None
results NNS None
were VBD None
major JJ None
adverse JJ None
cardiac NN None
events NNS None
( ( None
ETT NNP None
, , None
index NN None
testing VBG None
costs NNS None
were VBD None
the DT None
cumulative JJ None
diagnostic JJ None
cost NN None
savings NNS None
was VBD None
-DOCSTART- -X- N

Median JJ Mental
time NN Mental
to TO Mental
recurrence VB Mental
of IN Mental
any DT Mental
mood NN Mental
symptoms NNS Mental
( ( Mental
primary JJ Mental
endpoint NN Mental
) ) Mental
Time NN Mental
to TO Mental
recurrence VB Mental
of IN Mental
any DT Mental
mood NN Mental
symptoms NNS Mental
recurrence NN Mental
of IN Mental
manic NN Mental
Treatment-emergent JJ Adverse
adverse JJ Adverse
events NNS Adverse
( ( Adverse
maintenance NN Adverse
phase NN Adverse
) ) Adverse
-DOCSTART- -X- N

responsive JJ Mental
parental JJ Mental
behaviors NNS Mental
and CC None
child JJ Mental
communication NN Mental
responsive JJ Mental
parental JJ Mental
behaviors NNS Mental
language NN Mental
gains NNS Mental
responsive JJ Mental
parental JJ Mental
communication NN Mental
responsive JJ Mental
parental JJ Mental
behaviors NNS Mental
. . None
children NNS Mental
's POS Mental
expressive JJ Mental
language NN Mental
outcomes NNS Mental
responsive JJ Mental
communication NN Mental
. . None
-DOCSTART- -X- N

subjects NNS None
. . None
Body NNP None
weight NN None
was VBD None
0.0001 CD None
) ) None
; : None
maximal JJ Physical
oxygen NN Physical
uptake NN Physical
( ( None
0.0001 CD None
) ) None
. . None
Glucose JJ None
tolerance NN None
was VBD None
accumulated JJ None
incidence NN None
of IN None
diabetes NNS None
was VBD None
remission NN None
after IN None
years NNS None
. . None
Blood NNP None
pressure NN None
, , None
lipids NNS None
, , None
and CC None
hyperinsulinaemia NN None
were VBD None
and CC None
early JJ None
insulin NN None
responsiveness NN None
to TO None
glucose VB None
loading VBG None
glucose JJ None
tolerance NN None
was VBD None
weight VB Physical
reduction NN Physical
( ( None
and CC None
increased JJ Physical
fitness NN Physical
( ( None
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
uroflowmetry NN Physical
scores NNS Physical
, , None
operative JJ Other
time NN Other
, , None
catheterization NN Other
duration NN Other
, , None
hospital NN Other
stay NN Other
complication NN Adverse
rates NNS Adverse
mean VBP Other
operative JJ Other
time NN Other
mean JJ Other
volume NN Other
of IN Other
saline JJ Other
irrigation NN Other
during IN Other
the DT Other
PlasmaKinetic JJ Other
procedure NN Other
mean JJ Physical
improvement NN Physical
rate NN Physical
International NNP Physical
Prostate NNP Physical
Symptom NNP Physical
Score NNP Physical
and CC None
the DT Physical
maximal JJ Physical
urinary JJ Physical
flow NN Physical
rate NN Physical
Severe NNP Mental
irritative JJ Mental
symptoms NNS Mental
Recatheterization NN Physical
urethral JJ Physical
stricture NN Physical
formation NN Physical
Reoperation NN None
operative JJ None
, , None
catheterization NN None
and CC None
hospitalization NN None
times NNS None
postoperative JJ Physical
irritative NN Physical
symptoms NNS Physical
urethral JJ Physical
stricture NN Physical
formation NN Physical
-DOCSTART- -X- N

complete JJ Physical
response NN Physical
partial JJ Physical
response NN Physical
CR NNP Physical
rates NNS Physical
3 CD Mortality
year NN Mortality
survival NN Mortality
rate NN Mortality
incidence NN Adverse
of IN Adverse
myelosuppression NN Adverse
and CC Adverse
alopecia NN Adverse
neuropathy NN Adverse
-DOCSTART- -X- N

substantial JJ Other
reduction NN Other
in IN Other
their PRP$ Other
symptoms NNS Other
and CC None
recommencement NN Other
of IN Other
work NN Other
, , Physical
leisure NN Other
, , Physical
and CC Physical
social JJ Mental
activities NNS Mental
. . None
effective JJ Other
in IN None
a DT None
significant JJ None
number NN None
of IN None
patients NNS None
with IN None
CFS NNP None
-DOCSTART- -X- N

bladder NN Physical
cancer NN Physical
recurrence NN Physical
long-term JJ Physical
recurrence NN Physical
rate NN Physical
. . None
Median JJ Physical
time NN Physical
to TO Physical
recurrence VB Physical
intravesical JJ Other
therapy NN Other
rate NN Other
long-term JJ Physical
bladder NN Physical
cancer NN Physical
time NN Physical
to TO Physical
recurrence VB Physical
-DOCSTART- -X- N

confidence NN Mental
confidence NN Mental
Wheelchair NNP Mental
Use NNP Mental
Confidence NNP Mental
Scale-Manual JJ Mental
( ( Mental
WheelCon-M NNP Mental
) ) Mental
evaluate VB Mental
confidence NN Mental
significant JJ Mental
difference NN Mental
postintervention NN Other
WheelCon-M JJ Other
scores NNS Other
effect NN Mental
size NN Mental
greater JJR None
effects NNS None
on IN None
confidence NN None
in IN None
areas NNS None
related VBN None
to TO None
maneuvering VBG None
around IN None
the DT None
physical JJ None
environment NN None
, , None
knowledge NN None
and CC None
problem NN None
solving NN None
, , None
advocacy NN None
, , None
and CC None
managing VBG None
emotions NNS None
than IN None
in IN None
areas NNS None
related VBN None
to TO None
performing VBG None
activities NNS None
and CC None
behaving VBG None
in IN None
social JJ None
situations NNS None
. . None
improve VBP None
confidence NN None
with IN None
using VBG None
a DT None
manual JJ None
wheelchair NN None
-DOCSTART- -X- N

Mann-Whitney NNP Mental
U NNP Mental
test NN Mental
communication NN Mental
and CC Mental
socialization NN Mental
skills NNS Mental
more RBR Mental
restricted JJ Mental
repetitive NN Mental
and CC Mental
stereotyped VBD Mental
patterns NNS Mental
of IN Mental
behaviors NNS Mental
, , Mental
interests NNS Mental
and CC Mental
activities NNS Mental
. . Mental
behavioral JJ Mental
phenomenon NN Mental
-DOCSTART- -X- N

whole-body NN Physical
protein NN Physical
turnover NN Physical
rates NNS Physical
of IN Physical
whole-body NN Physical
protein NN Physical
synthesis NN Physical
and CC Physical
breakdown NN Physical
blood NN Physical
glucose NN Physical
, , None
plasma JJ Physical
insulin NN Physical
and CC Physical
glucagon NN Physical
, , None
urinary JJ Physical
ammonia NN Physical
, , None
nitrogen NN Physical
, , None
creatinine NN Physical
and CC None
3-methylhistidine JJ Physical
. . None
Blood NNP Physical
glucose NN Physical
and CC None
plasma JJ Physical
insulin NN Physical
and CC Physical
glucagon NN Physical
concentrations NNS Physical
insulin NN Physical
concentration NN Physical
Apparent JJ Physical
nitrogen NN Physical
balance NN Physical
urinary JJ Physical
excretion NN Physical
of IN Physical
ammonia NN Physical
, , None
creatinine NN Physical
and CC Physical
3-methylhistidine JJ Physical
Protein NNP Physical
turnover NN Physical
ammonia JJ Physical
end-product NN Physical
whole-body NN Physical
protein NN Physical
turnover NN Physical
insulin NN Physical
-DOCSTART- -X- N

feasibility NN Other
efficacy NN Other
improved VBD None
their PRP$ None
HIV-related JJ Mental
knowledge NN Mental
motivation NN Mental
for IN Mental
risk NN Mental
reduction NN Mental
Effect JJ Other
reduced VBD Mental
several JJ Mental
risk NN Mental
behaviors NNS Mental
( ( None
e.g. NN None
vaginal JJ Mental
sex NN Mental
without IN Mental
a DT Mental
condom NN Mental
, , None
giving VBG Mental
oral JJ Mental
sex NN Mental
, , None
and CC None
alcohol NN Mental
and CC Mental
drug NN Mental
use NN Mental
before IN Mental
sex NN Mental
) ) None
-DOCSTART- -X- N

renal JJ Physical
function NN Physical
. . None
renal JJ Physical
hemodynamics NNS Physical
Systemic JJ Physical
hemodynamics NNS Physical
effective JJ Physical
renal JJ Physical
plasma NN Physical
flow NN Physical
( ( Physical
ERPF NNP Physical
) ) Physical
( ( Physical
131I-hippuran JJ Physical
clearance NN Physical
) ) Physical
and CC None
glomerular JJ Physical
filtration NN Physical
rate NN Physical
( ( Physical
GFR NNP Physical
) ) Physical
( ( Physical
99Tc-DTPA JJ Physical
clearance NN Physical
) ) Physical
renal JJ Physical
variables NNS Physical
ERPF NNP Physical
GFR NNP Physical
transient JJ Physical
renal JJ Physical
vasoconstriction NN Physical
renal JJ Physical
hemodynamic JJ Physical
impairment NN Physical
. . None
-DOCSTART- -X- N

Exercise NN Physical
tolerance NN Physical
exercise NN Physical
duration NN Physical
before IN Physical
the DT Physical
onset NN Physical
of IN Physical
angina NN Physical
Maximal JJ Physical
heart NN Physical
rate NN Physical
exercise NN Physical
tolerance NN Physical
-DOCSTART- -X- N

accuracy NN Other
Field NNP Mental
placement JJ Mental
errors NNS Mental
( ( Mental
FPEs NNP Mental
) ) Mental
overall JJ Mental
treatment NN Mental
simulator NN Mental
differences NNS Mental
, , Mental
the DT Mental
number NN Mental
of IN Mental
error JJ Mental
free JJ Mental
treatments NNS Mental
, , Mental
and CC Mental
mean VB Mental
treatment-simulator JJ Mental
position NN Mental
evaluate VB Mental
the DT Mental
role NN Mental
of IN Mental
systematic JJ Mental
versus NN Mental
random JJ Mental
errors NNS Mental
. . Mental
Age NNP Other
, , Other
weight NN Other
, , Other
disease NN Other
site NN Other
, , Other
position NN Other
of IN Other
treatment NN Other
, , Other
fractionation NN Other
, , Other
blocked VBD Other
versus JJ Other
conventional JJ Other
techniques NNS Other
mean JJ Mental
absolute NN Mental
error NN Mental
accurate JJ Other
Systematic JJ Mental
errors NNS Mental
-DOCSTART- -X- N

bioavailability NN Physical
of IN Physical
diflunisal-naproxen JJ Physical
fixed-dose JJ Physical
combination NN Physical
( ( Physical
FDC NNP Physical
) ) Physical
dissolution NN Physical
behavior NN Physical
of IN Physical
FDC NNP Physical
diflunisal NN Physical
and CC Physical
naproxen NN Physical
Cmax NNP None
, , None
AUC0-t NNP None
, , None
AUC0-? NNP None
, , None
tmax NN None
, , None
and CC None
t1/2 NNS None
were VBD None
determined VBN None
Cmax NNP None
, , None
AUC0-t NNP None
, , None
and CC None
AUCt-? NNP None
of IN None
-DOCSTART- -X- N

glycemic JJ Physical
control NN Physical
pancreatic JJ None
?-cell NN None
function NN None
efficacy NN None
of IN None
insulin NN None
secretion NN None
, , None
mixed-meal-stimulated JJ None
C-peptide JJ None
secretion NN None
glycosylated JJ None
hemoglobin NN None
( ( None
HbA1c NNP None
) ) None
, , None
continuous JJ None
glucose NN None
sensor NN None
data NNS None
, , None
insulin NN None
utilization NN None
, , None
anthropometric JJ None
measures NNS None
, , None
and CC None
patient JJ None
satisfaction NN None
mixed-meal JJ None
tolerance NN None
test-stimulated JJ None
C-peptide JJ None
values NNS None
glycemic JJ None
control NN None
HbA1c NNP None
satisfaction NN None
glycemic JJ None
control NN None
patient JJ None
satisfaction NN None
residual JJ None
?-cell NNP None
function NN None
-DOCSTART- -X- N

relapse-free JJ Mortality
survival NN Mortality
( ( Mortality
RFS NNP Mortality
) ) Mortality
overall JJ Mortality
survival NN Mortality
( ( Mortality
OS NNP Mortality
) ) Mortality
RFS NNP Mortality
OS NNP Mortality
RFS NNP Mortality
OS NNP Mortality
-DOCSTART- -X- N

drinking NN Mental
days NNS Mental
per IN Mental
week NN Mental
, , None
drinks NNS Mental
per IN Mental
drinking NN Mental
day NN Mental
, , None
maximum JJ Mental
drinks NNS Mental
per IN Mental
occasion NN Mental
, , None
and CC None
negative JJ Mental
consequences NNS Mental
of IN Mental
drinking NN Mental
. . None
-DOCSTART- -X- N

Transfer NNP Physical
factor NN Physical
of IN Physical
the DT Physical
lung NN Physical
for IN Physical
carbon NN Physical
monoxide NN Physical
( ( Physical
TLCO NNP Physical
) ) Physical
Exhalation NNP Physical
TLCO NNP Physical
( ( Physical
TLCO NNP Physical
, , Physical
ex NN Physical
) ) Physical
standard NN Physical
( ( Physical
Jones NNP Physical
and CC Physical
Meade NNP Physical
) ) Physical
10 CD Physical
second JJ Physical
breath NN Physical
holding VBG Physical
TLCO NNP Physical
( ( Physical
TLCO NNP Physical
, , Physical
bh NN Physical
) ) Physical
relation NN Physical
-DOCSTART- -X- N

included VBD None
ETDRS NNP Physical
best-corrected JJ Physical
visual JJ Physical
acuity NN Physical
( ( Physical
BCVA NNP Physical
) ) Physical
, , None
fluorescein JJ None
angiography NN None
( ( None
FLA NNP None
) ) None
and CC None
OCT NNP None
at IN None
was VBD None
BCVA NNP None
secondary JJ None
was VBD None
foveal JJ Physical
thickness NN Physical
. . None
Mean NNP None
BCVA NNP Physical
of IN None
foveal JJ Physical
thickness NN Physical
following VBG None
-DOCSTART- -X- N

efficacy NN Other
Diagnostic NNP Mental
and CC Mental
Statistical NNP Mental
Manual NNP Mental
of IN Mental
Mental NNP Mental
Disorders NNP Mental
, , Mental
4 CD Mental
( ( Mental
th NN Mental
) ) Mental
edition NN Mental
( ( Mental
DSM-IV NNP Mental
) ) Mental
ADHD NNP Mental
subscale NN Mental
of IN Mental
the DT Mental
Conners NNP Mental
' POS Mental
Parent NN Mental
Rating VBG Mental
Scale-Revised JJ Mental
parent-rated JJ Mental
ADHD NNP Mental
symptoms NNS Mental
CPRS-R-DSM-IV-ADHD JJ Mental
subscale NN Mental
side JJ Adverse
effects NNS Adverse
stereotypic NN Mental
behavior NN Mental
, , Mental
upset JJ Mental
stomach NN Mental
, , Mental
sleep-related JJ Mental
difficulties NNS Mental
, , Mental
and CC Mental
emotional JJ Mental
lability NN Mental
. . None
-DOCSTART- -X- N

systolic JJ Physical
and CC Physical
diastolic JJ Physical
left VBD Physical
ventricular JJ Physical
function NN Physical
diastolic NN Physical
and CC Physical
systolic JJ Physical
left VBD Physical
ventricular JJ Physical
function NN Physical
left VBD Physical
ventricular JJ Physical
dimensions NNS Physical
and CC Physical
ejection NN Physical
fraction NN Physical
, , Physical
and CC Physical
Doppler NNP Physical
mitral JJ Physical
inflow NN Physical
parameters NNS Physical
left VBD Physical
ventricular JJ Physical
ejection NN Physical
fraction NN Physical
time NN Physical
of IN Physical
the DT Physical
early JJ Physical
mitral JJ Physical
filling NN Physical
wave NN Physical
time NN Physical
velocity JJ Physical
integral JJ Physical
of IN Physical
E-wave NNP Physical
duration NN Physical
of IN Physical
the DT Physical
late JJ Physical
mitral JJ Physical
filling NN Physical
wave NN Physical
diastolic JJ Physical
and CC Physical
systolic JJ Physical
function NN Physical
-DOCSTART- -X- N

pharmacokinetics NNS Physical
and CC Physical
pharmacodynamics NNS Physical
Plasma NNP Physical
concentrations NNS Physical
times NNS Other
for IN Other
the DT Other
plasma NN Other
concentration NN Other
to TO Other
decrease VB Other
by IN Other
50 CD Other
% NN Other
Times NNS None
Total JJ Physical
dose NN Physical
and CC Physical
plasma JJ Physical
concentrations NNS Physical
Mean NNP Other
total JJ Other
doses NNS Other
Time NN Physical
to TO Physical
awakening VBG Physical
trachea NN Physical
extubated VBN Physical
t80 NN Physical
t80 NN Physical
time NN Other
to TO Other
tracheal VB Other
extubation NN Other
t50 NN Physical
values NNS Physical
recovery NN Other
time NN Other
. . None
mechanical JJ Other
ventilatory NN Other
support NN Other
time NN Other
to TO Other
tracheal VB Other
extubation NN Other
-DOCSTART- -X- N

Abstinence NNP Mental
incentive NN Mental
effects NNS Mental
drug-free JJ Mental
negative JJ None
modest JJ Mental
improvements NNS Mental
in IN Mental
abstinence NN Mental
initiation NN Mental
rates NNS Mental
-DOCSTART- -X- N

sleep JJ Physical
latency NN Physical
, , Physical
total JJ Physical
sleep JJ Physical
time NN Physical
, , Physical
wake VBP Physical
after IN Physical
sleep JJ Physical
onset NN Physical
and CC Physical
number NN Physical
of IN Physical
awakenings NNS Physical
. . Physical
insomnia NN Physical
symptoms NNS Physical
sleep JJ Physical
latency NN Physical
initial JJ Physical
insomnia NN Physical
. . Physical
-DOCSTART- -X- N

ameliorating VBG Mental
autistic JJ Mental
behaviors NNS Mental
Children NNP Mental
's POS Mental
Psychiatric NNP Mental
Rating NNP Mental
Scale NNP Mental
( ( Mental
CPRS NNP Mental
) ) Mental
, , None
the DT Mental
Clinical NNP Mental
Global NNP Mental
Impression NNP Mental
Scale NNP Mental
, , None
and CC None
the DT None
NIMH NNP Mental
Global NNP Mental
Obsessive NNP Mental
Compulsive NNP Mental
Scale NNP Mental
. . None
-DOCSTART- -X- N

Clinical JJ Adverse
effects NNS Adverse
clinical JJ Physical
effects NNS Physical
bleeding VBG Physical
on IN Physical
probing VBG Physical
( ( Physical
BOP NNP Physical
) ) Physical
and CC None
probing VBG Physical
pocket NN Physical
depth NN Physical
( ( Physical
PPD NNP Physical
) ) Physical
BOP NNP Physical
percentage NN Physical
BOP NNP Physical
and CC None
PPD NNP Physical
BOP NNP Physical
percentage NN Physical
BOP NNP Physical
BOP NNP Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

accuracy NN None
cardiovascular JJ Other
risk NN Other
assessment NN Other
accuracy NN Other
of IN Other
risk NN Other
assessments NNS Other
difference NN Other
between IN Other
the DT Other
10-year JJ Other
cardiovascular JJ Other
risk NN Other
percentage NN Other
calculated VBN Other
by IN Other
nurses NNS Other
and CC Other
an DT Other
independent JJ Other
assessor NN Other
the DT None
agreement NN Other
between IN Other
the DT Other
treatment NN Other
categories NNS Other
assigned VBN Other
by IN Other
the DT Other
nurses NNS Other
( ( Other
low JJ Other
, , Other
moderate JJ Other
or CC Other
high JJ Other
risk NN Other
) ) Other
and CC Other
those DT Other
assigned VBN Other
by IN Other
the DT Other
independent JJ Other
assessor NN Other
. . None
cardiovascular JJ Other
risk NN Other
miscalculated VBD None
. . None
-DOCSTART- -X- N

aortic JJ Physical
valve NN Physical
pathology NN Physical
, , Physical
left VBD Physical
ventricular JJ Physical
function NN Physical
, , Physical
and CC Physical
pressure NN Physical
gradients NNS Physical
patient NN Physical
annulus NN Physical
index NN Physical
left VBD Physical
ventricular JJ Physical
mass NN Physical
index NN Physical
Regression NN Physical
of IN Physical
left JJ Physical
ventricular JJ Physical
hypertrophy NN Physical
-DOCSTART- -X- N

effectiveness NN Other
( ( None
1 CD None
) ) None
Urinary JJ Physical
leakage NN Physical
( ( None
during IN None
a DT None
standardized JJ None
PAD NNP None
test NN None
) ) None
, , None
( ( None
2 CD None
) ) None
pelvic NN Physical
muscle NN Physical
strength NN Physical
( ( None
measured VBN None
by IN None
a DT None
perineometer NN None
) ) None
, , None
and CC None
( ( None
3 CD None
) ) None
detrusor NN Physical
instability NN Physical
( ( None
on IN None
ambulant NN Physical
urodynamic JJ Physical
registration NN Physical
) ) None
. . None
women NNS Mental
's POS Mental
subjective JJ Mental
assessment NN Mental
of IN Mental
change NN Mental
in IN Mental
urinary JJ Mental
symptoms NNS Mental
based VBN Mental
on IN Mental
the DT Mental
PRAFAB NNP Mental
score NN Mental
. . None
measured JJ Physical
urinary JJ Physical
leakage NN Physical
) ) None
amount NN None
of IN None
urinary JJ Physical
leakage NN Physical
. . None
effectiveness NN Other
-DOCSTART- -X- N

serum NN Physical
cholesterol NN Physical
and CC Physical
plasma NN Physical
fibrinogen NN Physical
coagulation NN Physical
time NN Physical
fibrinolytic JJ Physical
activity NN Physical
effects NNS Physical
-DOCSTART- -X- N

congestive JJ Physical
failure NN Physical
, , None
hypertension NN Physical
, , None
prior JJ Physical
CABG NNP Physical
, , None
and CC None
unstable JJ Physical
angina NN Physical
; : None
body NN Physical
mass NN Physical
index NN Physical
ejection NN Physical
fraction NN Physical
degree NN Physical
of IN Physical
multivessel NN Physical
disease NN Physical
type VBD Physical
C NNP Physical
lesions NNS Physical
Angiographic NNP Other
and CC Other
procedural JJ Other
success NN Other
rates NNS Other
in-hospital JJ Other
events NNS Other
death NN Mortality
, , None
myocardial JJ Physical
infarction NN Physical
, , None
or CC None
target VB Physical
vessel JJ Physical
revascularization NN Physical
( ( Physical
TVR NNP Physical
) ) Physical
death NN Mortality
TVR NNP Physical
death/myocardial JJ Physical
infarction/TVR NN Physical
-DOCSTART- -X- N

survival JJ Mortality
time NN Mortality
model NN Mortality
-DOCSTART- -X- N

beta-endorphin NN Physical
adrenocorticotropic NN Physical
hormone NN Physical
norepinephrine NN Physical
( ( Physical
60 CD Physical
% NN Physical
) ) Physical
, , Physical
arginine-vasopressin JJ Physical
( ( Physical
50 CD Physical
% NN Physical
) ) Physical
, , Physical
and CC Physical
serotonin NN Physical
plasma NN Physical
chemistries NNS Physical
-DOCSTART- -X- N

hemorrhage NN Physical
Recurrent JJ Physical
thromboembolism NN Physical
bleeding NN Physical
complications NNS Physical
recurrences NNS Physical
. . Physical
hemorrhagic JJ Physical
complications NNS Physical
. . Physical
rate NN Physical
of IN Physical
hemorrhagic JJ Physical
complications NNS Physical
-DOCSTART- -X- N

safe JJ Other
and CC Other
effective JJ Other
shorten VB Physical
the DT Physical
T2 NNP Physical
value NN Physical
sufficiently RB Physical
T1 NNP Physical
shortening NN Physical
and CC Other
leave VBP Physical
pathologic JJ Physical
lesions NNS Physical
hypointense VBP Physical
-DOCSTART- -X- N

Differential JJ Physical
inhibition NN Physical
of IN Physical
bronchoconstriction NN Physical
experimentally RB Physical
induced JJ Physical
bronchoconstriction NN Physical
bronchoconstrictor NN Physical
response NN Physical
to TO Physical
stimuli NNS Physical
of IN Physical
low JJ Physical
middle JJ None
effect NN Physical
of IN Physical
nifedipine NN Physical
protection NN Physical
from IN Physical
bronchoconstriction NN Physical
-DOCSTART- -X- N

fatigue NN Physical
Cancer-related-fatigue NNP Physical
( ( Physical
CRF NNP Physical
) ) Physical
Functional NNP Physical
Assessment NNP Physical
of IN Physical
Chronic NNP Physical
Illness NNP Physical
Therapy-Fatigue NNP Physical
( ( Physical
FACIT-F NNP Physical
) ) Physical
the DT None
median JJ None
difference NN None
in IN None
FACIT-F NNP None
fatigue NN None
at IN None
included VBD None
anxiety NN None
, , None
depression NN None
, , None
and CC None
sleep RB None
. . None
Median JJ None
FACIT-F NNP None
fatigue NN None
scores NNS None
improved VBN None
FACIT-F NNP None
fatigue NN None
between IN None
.16 NNP None
) ) None
. . None
Fatigue NNP None
( ( None
.001 NNP None
) ) None
, , None
nausea NN None
( ( None
.01 NNP None
) ) None
, , None
depression NN None
( ( None
.02 NNP None
) ) None
, , None
anxiety NN None
( ( None
.01 NNP None
) ) None
, , None
drowsiness NN None
( ( None
.001 NNP None
) ) None
, , None
appetite RB None
( ( None
.009 NNP None
) ) None
, , None
sleep JJ None
( ( None
and CC None
feeling NN None
of IN None
well-being NN None
( ( None
NTI NNP None
. . None
Grade NNP None
? . None
3 CD None
adverse JJ None
events NNS None
did VBD None
improving VBG None
CRF NNP None
-DOCSTART- -X- N

effectiveness NN Other
relieving VBG Pain
Ocular JJ Pain
postoperative JJ Pain
pain NN Pain
and CC None
discomfort NN Pain
on IN Pain
instillation NN Pain
of IN Pain
medication NN Pain
visual JJ Pain
analog NN Pain
scale NN Pain
and CC None
a DT None
questionnaire NN Pain
. . None
effective JJ Other
in IN Other
relieving VBG Other
pain NN Other
. . None
pain NN Pain
relief NN Pain
stinging VBG Pain
on IN Pain
instillation NN Pain
pain NN Pain
relief NN Pain
stinging VBG Pain
on IN Pain
instillation NN Pain
. . None
-DOCSTART- -X- N

cardiovascular JJ Physical
reflex NN Physical
tests NNS Physical
Valsalva NNP Physical
ratio NN Physical
values NNS Other
of IN Other
most JJS Other
standard JJ Other
cardiovascular JJ Other
reflex NN Other
tests NNS Other
deep JJ Physical
breathing NN Physical
tests NNS Physical
( ( None
expiration-inspiration NN Physical
ratio NN Physical
, , None
standard JJ Physical
deviation NN Physical
, , None
and CC None
mean VB Physical
circular JJ Physical
resultant NN Physical
of IN Physical
R-R NNP Physical
intervals NNS Physical
) ) None
, , None
postural JJ Physical
index NN Physical
, , None
and CC None
postural JJ Physical
hypotension NN Physical
high JJ Physical
transaminases NNS Physical
levels NNS Physical
autonomic RB Physical
nervous JJ Physical
system NN Physical
function NN Physical
-DOCSTART- -X- N

disability NN Physical
and CC None
managing VBG Physical
chronic JJ Physical
illness NN Physical
reduce VB None
disability NN None
risks NNS None
and CC None
improve VB None
self-management NN None
of IN None
chronic JJ Physical
illness NN Physical
chronic JJ Physical
illness NN Physical
self-management NN None
and CC None
disability NN None
prevention NN None
program NN None
on IN None
health NN None
, , None
functioning NN None
, , None
and CC None
healthcare JJ Physical
utilization NN Physical
Self-reported JJ None
Physical NNP None
function NN None
, , None
physical JJ None
performance NN None
tests NNS None
, , None
health NN Physical
care NN Physical
utilization NN Physical
, , None
and CC None
health NN None
behaviors NNS None
. . None
less JJR None
decline NN None
in IN None
function NN Physical
, , None
as IN None
measured VBN None
by IN None
disability NN None
days NNS None
lower JJR None
scores NNS None
on IN None
the DT None
Health NNP Physical
Assessment NNP Physical
Questionnaire NNP Physical
. . None
the DT None
SF-36 NNP Physical
and CC None
a DT None
battery NN None
of IN None
physical JJ None
performance NN None
tests NNS None
number NN Other
of IN Other
hospitalized JJ Other
participants NNS Other
total JJ Other
number NN Other
of IN Other
inpatient JJ Other
hospital NN Other
days NNS Other
higher JJR None
levels NNS None
of IN None
physical JJ Physical
activity NN Physical
and CC None
senior JJ Mental
center NN Mental
participation NN Mental
and CC None
significant JJ None
reductions NNS None
use NN Physical
of IN Physical
psychoactive JJ Physical
medications NNS Physical
. . None
improve VB None
function NN Physical
and CC None
reduce VB None
inpatient JJ Other
utilization NN Other
-DOCSTART- -X- N

clinical JJ Physical
improvement NN Physical
. . Physical
satisfactory JJ Physical
bacteriological JJ Physical
response NN Physical
mild JJ None
adverse JJ None
effects NNS None
( ( None
nausea NN None
, , None
vomiting VBG None
, , None
headache NN None
, , None
hypotension NN None
and CC None
rash NN None
) ) None
. . None
tolerated VBN Other
deaths NNS None
effective JJ None
and CC None
safe JJ None
-DOCSTART- -X- N

absolute JJ Physical
bioavailability NN Physical
Plasma NNP Physical
methylprednisolone NN Physical
concentrations NNS Physical
AUCi.v NNP Physical
. . Physical
and CC Physical
AUCtablet NNP Physical
absolute JJ Physical
bioavailability NN Physical
peripheral JJ Physical
blood NN Physical
neutrophil NN Physical
count NN Physical
clinically RB Physical
relevant JJ Physical
changes NNS Physical
in IN Physical
hematology NN Physical
or CC Physical
clinical JJ Physical
chemistry NN Physical
adverse JJ Physical
drug NN Physical
reactions NNS Physical
-DOCSTART- -X- N

influence NN Other
forearm JJ Other
pass NN Other
Analysis NN Mental
of IN Mental
covariance NN Mental
correct JJ Other
sets NNS Other
higher JJR Other
average JJ Other
daily JJ Other
success NN Other
rate NN Other
-DOCSTART- -X- N

Focal NNP Other
therapeutic JJ Other
efficacy NN Other
focal JJ Other
therapeutic JJ Other
effect NN Other
fever NN Adverse
( ( Adverse
maximum JJ Adverse
body NN Adverse
temperature NN Adverse
) ) Adverse
frequency NN Physical
of IN Physical
shaking VBG Physical
chills NNS Physical
and CC None
abdominal JJ Adverse
pain NN Adverse
, , None
and CC None
by IN None
biochemical JJ None
parameters NNS None
such JJ None
as IN None
albumin NN None
, , None
prothrombin JJ None
time NN None
, , None
and CC None
aspartate NN None
and CC None
alanine NN None
aminotransferases NNS None
. . None
Lipiodol NNP Physical
accumulation NN Physical
in IN Physical
the DT Physical
tumor NN Physical
tumor NN Physical
regression NN Physical
rate NN Physical
elevations NNS Physical
of IN Physical
aminotransferases NNS Physical
reductions NNS Physical
of IN Physical
cholinesterase NN Physical
shaking VBG Physical
chills NNS Physical
more RBR Other
favorable JJ Other
focal JJ Other
therapeutic JJ Other
effect NN Other
-DOCSTART- -X- N

pain NN Pain
scores NNS Pain
efficacy NN Other
efficacy NN Other
Premature NNP Pain
Infant NNP Pain
Pain NNP Pain
Profile NNP Pain
( ( Pain
PIPP NNP Pain
) ) Pain
Baseline NNP Physical
PIPP NNP Physical
scores NNS Physical
post-examination NN Physical
PIPP NNP Physical
scores VBZ Physical
pair VB None
pain NN None
scores NNS None
. . None
Mean NNP None
gestational JJ None
age NN None
( ( None
GA NNP None
) ) None
at IN None
lowered VBN None
mean JJ None
PIPP NNP None
scores NNS None
( ( None
and CC None
delta JJ None
scores NNS None
( ( None
mean JJ None
PIPP NNP None
scores NNS None
after IN None
significant JJ None
relief NN None
of IN None
pain NN None
that WDT None
Significantly NNP None
lower JJR None
PIPP NNP None
scores NNS None
at IN None
pain NN None
during IN None
ROP NNP None
-DOCSTART- -X- N

anaerobic JJ Physical
threshold NN Physical
and CC Physical
related JJ Physical
parameters NNS Physical
Peak NNP Physical
VO2 NNP Physical
anaerobic JJ Physical
threshold NN Physical
peak JJ None
VO2 NNP None
anaerobic JJ None
threshold NN None
peak JJ Physical
work NN Physical
rate NN Physical
or CC Physical
exercise NN Physical
time NN Physical
. . Physical
heart NN Physical
rate NN Physical
heart NN Physical
rate NN Physical
exercise NN Physical
capacity NN Physical
-DOCSTART- -X- N

artefacts VBZ Physical
artefacts NNS Physical
visibility NN Other
score NN Other
the DT Other
endoscopic NN Other
ultrasonography NN Other
score NN Other
endoscopic NN Other
ultrasonography NN Other
score NN Other
The DT Physical
numbers NNS Physical
of IN Physical
high-echo JJ Physical
spots NNS Physical
in IN Physical
the DT Physical
gastric JJ Physical
cavity NN Physical
and CC Physical
on IN Physical
the DT Physical
gastric NN Physical
wall NN Physical
surface NN Physical
no DT Adverse
complications NNS Adverse
artefacts NNS Physical
-DOCSTART- -X- N

depressant JJ Physical
effect NN Physical
Hemodynamic JJ Physical
responses NNS Physical
systemic JJ Physical
vascular JJ Physical
resistance NN Physical
( ( Physical
SVR NNP Physical
) ) Physical
and CC Physical
increases VBZ Physical
in IN Physical
cardiac JJ Physical
output NN Physical
( ( Physical
Q NNP Physical
) ) Physical
. . Physical
Myocardial JJ Physical
contractility NN Physical
Mean JJ Physical
arterial JJ Physical
pressure NN Physical
mean JJ Physical
pulmonary JJ Physical
arterial JJ Physical
pressure NN Physical
myocardial JJ Physical
contractility NN Physical
and CC None
hemodynamic JJ Physical
alterations NNS Physical
airway NN Physical
pressures NNS Physical
-DOCSTART- -X- N

incidence NN Physical
of IN Physical
clinical JJ Physical
sepsis NN Physical
. . None
incidence NN Adverse
of IN Adverse
positive JJ Adverse
blood NN Adverse
cultures NNS Adverse
, , None
necrotising VBG Physical
enterocolitis NN Physical
( ( Physical
NEC NNP Physical
) ) Physical
stage NN Physical
II NNP Physical
or CC Physical
III NNP Physical
, , None
or CC None
death NN Mortality
, , None
and CC None
the DT Other
duration NN Other
of IN Other
hospital NN Other
stay NN Other
. . None
incidence NN Adverse
of IN Adverse
clinical JJ Adverse
sepsis NN Adverse
Mortality NNP Mortality
blood NN Mental
cultures NNS Mental
incidence NN Physical
of IN Physical
NEC NNP Physical
and CC None
the DT Other
duration NN Other
of IN Other
hospital NN Other
stay NN Other
-DOCSTART- -X- N

HSV-1 NNP Physical
DNA NNP Physical
copy NN Physical
numbers NNS Physical
in IN Physical
the DT Physical
tears NNS Physical
or CC Physical
saliva NN Physical
mean JJ Physical
copy NN Physical
numbers NNS Physical
+/- JJ Physical
SE NNP Physical
of IN Physical
mean NN Physical
( ( Physical
SEM NNP Physical
) ) Physical
of IN Physical
HSV-1 NNP Physical
DNA NNP Physical
HSV-1 NNP Physical
shedding VBG Physical
-DOCSTART- -X- N

Pain VB Pain
pain NN Pain
intensity NN Pain
activity NN Physical
and CC Physical
return NN Physical
of IN Physical
bowel NN Physical
function NN Physical
side NN Adverse
effects NNS Adverse
bowel NN Physical
function NN Physical
oral JJ Physical
intake NN Physical
coughing VBG Physical
pain NN Pain
management NN Pain
complications NNS Adverse
-DOCSTART- -X- N

care NN Other
arrangements NNS Other
outlook NN Mental
on IN Mental
life NN Mental
. . Mental
effectiveness NN Other
of IN Other
the DT Other
CCDE NNP Other
program NN Other
Logistic JJ Mental
regression NN Mental
analyses NNS Mental
satisfaction NN Other
with IN Other
care NN Other
arrangements NNS Other
, , None
consumers NNS Mental
' POS Mental
perceptions NNS Mental
of IN Mental
paid JJ Mental
caregivers NNS Mental
' POS Mental
attitudes NNS Mental
, , None
unmet JJ None
needs NNS None
, , None
adverse JJ Adverse
events NNS Adverse
, , None
and CC None
satisfaction NN Other
with IN Other
life NN Other
-- : None
this DT None
positive JJ Other
effect NN Other
adverse JJ Adverse
events NNS Adverse
, , None
health NN Physical
problems NNS Physical
, , Physical
and CC Physical
general JJ Physical
health NN Physical
status NN Physical
-DOCSTART- -X- N

fasciculations NNS Physical
Fasciculations NNP Physical
emesis NN Physical
fasciculations NNS Physical
Fasciculations NNS Physical
graded JJ Other
visual JJ Other
scale NN Other
. . None
fasciculations NNS Physical
. . None
fasciculations NNS Physical
Complete JJ Physical
relaxation NN Physical
of IN Physical
the DT Physical
cords NNS Physical
emesis NN Physical
or CC None
significant JJ Physical
dysrhythmias NN Physical
. . None
fasciculations NNS Physical
-DOCSTART- -X- N

safety NN Other
, , None
tolerability NN Other
, , None
pharmacokinetics NNS Physical
and CC None
pharmacodynamics NNS Physical
well-absorbed JJ Other
and CC None
well-tolerated JJ Physical
Minimal JJ Adverse
treatment-related JJ Adverse
adverse JJ Adverse
events NNS Adverse
Serum NNP None
interferon NN None
( ( None
IFN NNP None
) ) None
-? NN None
Induction NNP None
of IN None
chemokines/cytokines NNS None
and CC None
IFN-stimulated JJ None
genes NNS None
were VBD None
demonstrates VBZ None
safety NN None
and CC None
pharmacodynamic JJ None
activity NN None
at IN None
doses VBZ None
-DOCSTART- -X- N

all-cause JJ Mortality
mortality NN Mortality
deaths NNS Mortality
cardiovascular JJ Physical
deaths NNS Physical
tolerated VBN Other
patients NNS Mental
discontinuing VBG Mental
medication NN Mental
acute JJ Physical
myocardial JJ Physical
infarction NN Physical
. . None
-DOCSTART- -X- N

neuropathic JJ Pain
pain NN Pain
and CC None
pain NN Pain
in IN Pain
intolerable JJ Pain
pain NN Pain
pain NN Pain
intensity NN Pain
numeric JJ Other
analog NN Other
scale NN Other
. . None
delay NN Pain
in IN Pain
pain JJ Pain
increase NN Pain
complete JJ Pain
pain NN Pain
relief NN Pain
neuropathic JJ Pain
pain NN Pain
. . None
-DOCSTART- -X- N

to TO None
first VB None
on-study JJ None
SRE NNP None
( ( None
defined VBN None
as IN None
pathologic JJ None
fracture NN None
, , None
radiation NN None
or CC None
surgery NN None
to TO None
bone VB None
, , None
or CC None
spinal JJ None
cord NN None
compression NN None
) ) None
. . None
in IN None
delaying VBG Physical
time NN Physical
to TO Physical
first VB Physical
on-study JJ Physical
SRE NNP Physical
and CC None
time NN Physical
to TO Physical
first RB Physical
and CC Physical
subsequent JJ Physical
( ( Physical
multiple JJ Physical
) ) Physical
on-study NN Physical
SREs NNP Physical
Reduction NN None
in IN None
bone NN None
turnover NN None
markers NNS None
Overall JJ None
survival NN None
, , None
disease NN Physical
progression NN Physical
, , None
and CC None
rates NNS None
of IN None
adverse JJ None
events NNS None
( ( None
AEs NNP None
) ) None
and CC None
serious JJ None
AEs NNP None
An DT None
excess NN None
of IN None
renal JJ None
AEs NNP None
and CC None
acute-phase JJ None
reactions NNS None
acid NN None
; : None
hypocalcemia NN None
Osteonecrosis NN None
of IN None
the DT None
jaw NN None
-DOCSTART- -X- N

non-vellus JJ Physical
hair NN Physical
count NN Physical
mean JJ Physical
increase NN Physical
in IN Physical
non-vellus JJ Physical
hair NN Physical
both DT Physical
clinical JJ Physical
and CC Physical
histological JJ Physical
cure NN Physical
erythemal JJ Other
index NN Other
-DOCSTART- -X- N

Serum NNP Physical
bactericidal NN Physical
activities NNS Physical
and CC Physical
comparative JJ Other
pharmacokinetics NNS Other
pharmacokinetics NNS Other
and CC Physical
serum NN Physical
bactericidal NN Physical
activities NNS Physical
( ( Physical
SBAs NNP Physical
) ) Physical
concentrations NNS Physical
of IN Physical
the DT Physical
drugs NNS Physical
in IN Physical
serum NN Physical
and CC Physical
urine NN Physical
bioassay NN Other
and CC Other
high-pressure NN Other
liquid NN Other
chromatography NN Other
. . Other
mean JJ Physical
concentrations NNS Physical
of IN Physical
imipenem NN Physical
and CC Physical
meropenem NN Physical
measured VBN Physical
in IN Physical
serum NN Physical
urinary JJ Physical
recoveries NNS Physical
areas NNS Physical
under IN Physical
the DT Physical
concentration-time JJ Physical
curve NN Physical
SBAs NNP Physical
microdilution NN Other
method NN Other
of IN Other
Reller NNP Other
and CC Other
Stratton NNP Other
Mean NNP Physical
reciprocal JJ Physical
bactericidal NN Physical
titers NNS Physical
SBAs NNP Physical
SBAs NNP Physical
against IN Physical
clinically RB Physical
important JJ Physical
pathogens NNS Physical
SBA NNP Physical
SBA NNP Physical
-DOCSTART- -X- N

efficacy NN Other
Patient-reported JJ Physical
outcome NN Physical
( ( Physical
PROs NNP Physical
) ) Physical
measures NNS Physical
improvement NN None
in IN None
dry JJ Physical
mouth NN Physical
. . None
saliva NN Other
measurements NNS Other
severe JJ Physical
dry JJ Physical
mouth NN Physical
sticky NN Physical
saliva NN Physical
needing VBG Physical
to TO Physical
sip VB Physical
fluids NNS Physical
to TO Physical
swallow VB Physical
food NN Physical
waking VBG Other
up RP Other
at IN Other
night NN Other
to TO Other
drink VB Other
stimulated VBD Other
or CC Other
unstimulated JJ Other
saliva NN Other
measurements NNS Other
-DOCSTART- -X- N

hypnosis NN Mental
( ( Mental
loss NN Mental
of IN Mental
response NN Mental
to TO Mental
verbal JJ Mental
command NN Mental
) ) Mental
anaesthesia $ Mental
( ( Mental
loss NN Mental
of IN Mental
response NN Mental
to TO Mental
a DT Mental
5-s JJ Mental
transcutaneous JJ Mental
tetanic JJ Mental
stimulus NN Mental
) ) Physical
hypnosis NN Mental
, , Mental
synergistic JJ Mental
interaction NN Mental
anaesthesia NN Pain
required VBN Mental
to TO Mental
produce VB Mental
anaesthesia NN Mental
arterial JJ Physical
pressure NN Physical
at IN Physical
induction NN Physical
-DOCSTART- -X- N

Onset NNP Other
of IN Other
action NN Other
evaluate VB Other
the DT Other
time NN Other
to TO Other
onset VB Other
of IN Other
action NN Other
of IN Other
ciclesonide NN Other
immunologic JJ Other
priming NN Other
total NN Physical
nasal NN Physical
symptom VBD Physical
score NN Physical
nasal JJ Physical
congestion NN Physical
or CC Physical
rhinorrhea VB Physical
score NN Physical
baseline NN Physical
total JJ Physical
nasal JJ Physical
symptom NN Physical
scores NNS Physical
Onset NNP Other
of IN Other
action NN Other
total JJ Physical
nasal JJ Physical
symptom NN Physical
score NN Physical
statistically RB Other
significant JJ Other
difference NN Other
. . None
onset NN Other
of IN Other
action NN Other
of IN Other
ciclesonide NN Other
total JJ Physical
nasal JJ Physical
symptom NN Physical
scores NNS Physical
-DOCSTART- -X- N

hormone NN Physical
receptor NN Physical
variations NNS Physical
biopsy NN Physical
Objective JJ Physical
regression NN Physical
Median JJ Physical
time NN Physical
to TO Physical
progression NN Physical
Overall NNP Mortality
survival NN Mortality
Metrorrhagia NNP Physical
PgR NNP Physical
content NN Physical
Plasma NNP Physical
level JJ Physical
variations NNS Physical
of IN Physical
TAM NNP Physical
, , Physical
N-desmethyl NNP Physical
TAM NNP Physical
and CC Physical
MPA NNP Physical
-DOCSTART- -X- N

sealing VBG Other
ability NN Other
mean JJ Physical
apical JJ Physical
leakage NN Physical
-DOCSTART- -X- N

metabolic JJ Physical
control NN Physical
, , None
knowledge NN Physical
of IN Physical
diabetes NNS Physical
, , None
health NN Physical
behaviours NNS Physical
quality NN Physical
of IN Physical
life NN Physical
3-monthly JJ Physical
HbA1c NNP Physical
, , None
fasting VBG Physical
blood NN Physical
glucose NN Physical
, , None
body NN Physical
weight VBD Physical
, , None
waist-hip JJ Physical
ratio NN Physical
, , None
yearly RB Physical
blood NN Physical
lipids NNS Physical
, , None
and CC None
bi-yearly JJ Physical
assessment NN Physical
of IN Physical
knowledge NN Physical
of IN Physical
diabetes NNS Physical
, , None
health NN Mental
behaviours NNS Mental
and CC None
quality NN Physical
of IN Physical
life NN Physical
. . None
systolic JJ Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
, , None
evaluation NN Physical
of IN Physical
ECG NNP Physical
for IN Physical
ischaemia NN Physical
and CC Physical
QT NNP Physical
interval NN Physical
, , None
hypoglycaemic JJ Physical
and CC Physical
anti-hypertensive JJ Physical
medication NN Physical
and CC None
cardiovascular JJ Physical
events NNS Physical
. . None
improve VB Mental
lifestyle NN Mental
outcomes NNS None
, , None
support NN Mental
team NN Mental
work NN Mental
, , None
enhance NN Mental
providers NNS Mental
' POS Mental
attitudes NNS Mental
competencies NNS Physical
-DOCSTART- -X- N

wrinkle NN Physical
and CC Physical
acne NN Physical
scar NN Physical
appearance NN Physical
subject NN Other
's POS Other
, , Other
evaluator NN Other
's POS Other
, , Other
and CC Other
independent JJ Other
photographic JJ Other
viewer NN Other
's POS Other
( ( Other
IPR NNP Other
) ) Other
assessment NN Other
of IN Other
acne NN Physical
scarring VBG Physical
appearance NN Physical
of IN Physical
depressed JJ Physical
distensible JJ Physical
acne NN Physical
scars NNS Physical
. . None
-DOCSTART- -X- N

glomerular JJ Adverse
filtration NN Adverse
rate NN Adverse
renal JJ Adverse
plasma NN Adverse
flow NN Adverse
lithium JJ Physical
clearance NN Physical
fractional JJ Physical
proximal JJ Physical
reabsorption NN Physical
fractional JJ Physical
distal JJ Physical
sodium NN Physical
reabsorption NN Physical
blood NN Physical
glucose NN Physical
control NN Physical
glomerular JJ Physical
filtration NN Physical
rate NN Physical
-DOCSTART- -X- N

Serum NNP Physical
levels NNS Physical
of IN Physical
N-acetylcysteine NNP Physical
serum NN Physical
acetaminophen NN Physical
level NN Physical
area NN None
under IN None
the DT None
curve NN None
for IN None
N-acetylcysteine NNP None
Peak VB Physical
N-acetylcysteine JJ Physical
and CC None
time NN Physical
to TO Physical
peak VB Physical
four-hour JJ Physical
serum NN Physical
acetaminophen NN Physical
level NN Physical
Diarrhea NNP Adverse
tolerated VBN Other
. . None
-DOCSTART- -X- N

bronchodilator NN None
effect NN None
The DT None
scores NNS None
of IN None
the DT None
three CD None
groups NNS None
-DOCSTART- -X- N

Behavioral NNP Mental
and CC Mental
physiological JJ Mental
effects NNS Mental
The DT None
subjective JJ Mental
and CC Mental
psychomotor JJ Mental
effects NNS Mental
prototypic VBN Mental
micro-like JJ Mental
opioid JJ Mental
subjective JJ Mental
effects NNS Mental
, , Mental
impaired JJ Mental
psychomotor NN Mental
performance NN Mental
, , Mental
and CC Mental
produced VBD Mental
analgesia NN Mental
. . None
analgesia NN Physical
pharmacodynamic JJ Mental
effects NNS Mental
psychomotor NN Mental
effects NNS Mental
-DOCSTART- -X- N

glucose JJ Physical
utilization NN Physical
blood NN Physical
glucose NN Physical
blood NN Physical
glucose NN Physical
insulin NN Physical
blood NN Physical
glucose NN Physical
blood NN Physical
glucose NN Physical
triglyceride NN Physical
and CC None
cholesterol NN Physical
blood NN Physical
glucose NN Physical
and CC None
insulin NN Physical
-DOCSTART- -X- N

antioxidant JJ Physical
activity NN Physical
serum NN Physical
trace NN Physical
elements NNS Physical
, , None
glutathione NN Physical
peroxidase NN Physical
activity NN Physical
and CC Physical
total JJ Physical
antioxidant JJ Physical
capacity NN Physical
, , None
and CC None
increased VBD None
malondialdehyde NN Physical
, , Physical
glutathion NN Physical
reductase NN Physical
concentration NN Physical
of IN Physical
serum NN Physical
Se NNP Physical
, , Physical
Zn NNP Physical
glutathione JJ Physical
peroxidase NN Physical
and CC Physical
total JJ Physical
antioxidant JJ Physical
capacity NN Physical
malondialdehyde NN Physical
and CC Physical
glutathion NN Physical
reductase NN Physical
levels NNS Physical
trace NN Physical
elements NNS Physical
levels NNS Physical
and CC Physical
antioxidant JJ Physical
activities NNS Physical
-DOCSTART- -X- N

Efficacy NN Other
skin JJ Physical
breakdown NN Physical
rectal JJ Physical
infections NNS Physical
; : Physical
severity NN Physical
of IN Physical
granulocytopenia NN Physical
incidence NN Physical
of IN Physical
rectal JJ Physical
infections NNS Physical
occurrence NN Physical
of IN Physical
perirectal JJ Physical
infections NNS Physical
skin JJ Physical
breakdown NN Physical
-DOCSTART- -X- N

relative NN Mental
's POS Mental
illness NN Mental
, , Mental
psychological JJ Mental
distress NN Mental
, , Mental
burden NN Mental
, , Mental
coping VBG Mental
skills NNS Mental
, , None
and CC None
expenditures NNS Other
improvement NN Other
relative NN Mental
's POS Mental
illness NN Mental
, , None
psychological JJ Mental
distress NN Mental
, , None
or CC None
caregiver RB Mental
burden NN Mental
decreased VBN None
psychological JJ Mental
distress NN Mental
improved VBN Mental
psychosocial JJ Mental
adjustment NN Mental
psychosocial JJ Mental
adjustment NN Mental
health NN Other
and CC Other
social JJ Other
services NNS Other
-DOCSTART- -X- N

Overt NNP Mental
Aggression NNP Mental
Scale NNP Mental
( ( Mental
OAS NNP Mental
) ) Mental
OAS NNP Mental
aggression NN Mental
scores NNS Mental
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
Community NNP Mental
Scale NNP Mental
irritability NN Mental
subscale NN Mental
. . None
OAS NNP Mental
-DOCSTART- -X- N

Erythrocyte NNP Physical
deformability NN Physical
, , None
endothelin NN Physical
levels NNS Physical
, , None
and CC None
renal JJ Physical
function NN Physical
Erythrocyte NNP Physical
deformability NN Physical
polyunsaturated JJ Physical
fatty JJ Physical
acid NN Physical
content NN Physical
glomerular JJ Physical
filtration NN Physical
rate NN Physical
, , None
effective JJ Physical
renal JJ Physical
plasma NN Physical
flow NN Physical
, , None
filtration NN Physical
fraction NN Physical
or CC Physical
blood NN Physical
pressure NN Physical
erythrocyte JJ Physical
deformability NN Physical
-DOCSTART- -X- N

anxiety NN Mental
, , None
knowledge NN Mental
, , None
and CC None
readiness NN Mental
for IN Mental
discharge NN Mental
anxiety NN Mental
and CC None
knowledge NN Mental
. . None
level NN Mental
of IN Mental
anxiety NN Mental
perceived JJ Mental
knowledge NN Mental
scores NNS Mental
in IN Mental
actual JJ Mental
knowledge NN Mental
. . None
anxiety NN Mental
-DOCSTART- -X- N

Safety NN Other
safety NN Other
adverse JJ Adverse
events NNS Adverse
, , None
laboratory NN Physical
tests NNS Physical
, , Physical
and CC Physical
vital JJ Physical
signs NNS Physical
. . None
incidence NN Adverse
of IN Adverse
related JJ Adverse
adverse JJ Adverse
events NNS Adverse
adverse JJ Adverse
events NNS Adverse
symptoms NNS Adverse
injection/infusion NN Adverse
site NN Adverse
, , Adverse
dizziness NN Adverse
, , Adverse
pruritus NN Adverse
, , Adverse
headache NN Adverse
, , Adverse
fatigue NN Adverse
, , Adverse
and CC Adverse
nausea NN Adverse
. . Adverse
Serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
Serious JJ Adverse
related JJ Adverse
adverse JJ Adverse
events NNS Adverse
blood NN Physical
pressure NN Physical
tolerated VBN Other
safety NN Other
profile NN Other
-DOCSTART- -X- N

Baseline NNP Physical
BP NNP Physical
and CC None
R-R NNP Physical
interval NN Physical
reflex JJ Physical
depressor NN Physical
and CC Physical
bradycardic JJ Physical
responses NNS Physical
to TO Physical
NS NNP Physical
spontaneous JJ Physical
baroreflex JJ Physical
sensitivity NN Physical
R-R NNP Physical
interval JJ Physical
total JJ Physical
variance NN Physical
heart NN Physical
rate NN Physical
variability NN Physical
-DOCSTART- -X- N

event-free JJ Mortality
survival NN Mortality
and CC None
total JJ Other
treatment NN Other
costs NNS Other
Twenty-eight-day JJ Mortality
mortality NN Mortality
and CC None
1-year JJ Mortality
mortality NN Mortality
rate NN Mortality
quality-of-life JJ Other
scores NNS Other
Event-free JJ Mortality
survival NN Mortality
total JJ Other
treatment NN Other
costs NNS Other
1-year JJ Other
outcome NN Other
and CC Other
quality NN Other
of IN Other
life NN Other
event-free JJ Mortality
survival NN Mortality
revascularization NN Physical
rate NN Physical
lower JJR Other
costs NNS Other
-DOCSTART- -X- N

-DOCSTART- -X- N

Operating NN Other
time NN Other
hospitalization NN Other
time NN Other
complications NNS Adverse
safe JJ Other
effective JJ Other
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
Antidepressant JJ Mental
response NN Mental
Hamilton NNP Mental
Depression NNP Mental
and CC Mental
Anxiety NNP Mental
Scales NNP Mental
, , None
Clinical NNP Mental
Global NNP Mental
Severity NNP Mental
and CC None
Improvement NNP Mental
Ratings NNP Mental
Zung NNP Mental
Self-Rating NNP Mental
Depression NNP Mental
Scale NNP Mental
efficacy NN Other
sleep JJ Mental
Hamilton NNP Mental
Depression NNP Mental
Scale NNP Mental
sleep NN None
anticholinergic JJ Adverse
side NN Adverse
effects NNS Adverse
dry JJ Adverse
mouth NN Adverse
, , None
constipation NN Adverse
, , None
sleepiness NN Adverse
, , None
and CC None
tiredness NN Adverse
appetite NN Adverse
and CC Adverse
weight JJ Adverse
gain NN Adverse
-DOCSTART- -X- N

Safety NN Other
and CC Other
efficacy NN Other
improvement NN Physical
assessment NN Other
measures NNS Other
excretion NN Physical
of IN Physical
toxic JJ Physical
metals NNS Physical
and CC Physical
changes NNS Physical
in IN Physical
glutathione NN Physical
safe JJ Other
-DOCSTART- -X- N

identification NN Mental
of IN Mental
dynamic JJ Mental
facial JJ Mental
expressions NNS Mental
: : Other
processing VBG Mental
the DT Mental
facial JJ Mental
expressions NNS Mental
recognition NN Mental
of IN Mental
dynamically RB Mental
emerging VBG Mental
facial JJ Mental
expressions NNS Mental
of IN Mental
others NNS Mental
. . None
recognition NN Mental
of IN Mental
dynamically RB Mental
emerging VBG Mental
facial JJ Mental
expression NN Mental
. . None
recognized VBD Mental
expressions NNS Mental
expression NN Mental
identification NN Mental
ability NN Mental
to TO Mental
recognize VB Mental
facial JJ Mental
expressions NNS Mental
-DOCSTART- -X- N

onset NN Physical
and CC Physical
average JJ Physical
root NN Physical
mean JJ Physical
square JJ Physical
amplitude NN Physical
of IN Physical
EMG NNP Physical
activity NN Physical
in IN Physical
the DT Physical
peroneal NN Physical
muscles NNS Physical
was VBD Physical
calculated VBN None
following VBG None
the DT None
release NN Other
of IN Other
a DT Other
trap NN Other
door NN Other
mechanism NN Other
causing VBG Other
inversion NN Other
. . None
peroneal JJ Physical
reaction NN Physical
time NN Physical
or CC Physical
average JJ Physical
peroneal JJ Physical
muscle NN Physical
activity NN Physical
-DOCSTART- -X- N

'fresh-start JJ Mental
' POS Mental
experiences NNS Mental
new JJ Physical
severe JJ Physical
events NNS Physical
and CC Mental
difficulties NNS Physical
. . None
Fresh-start JJ Mental
experiences NNS Mental
standard JJ Mental
attachment NN Mental
style NN Mental
remission NN Physical
-DOCSTART- -X- N

repeatedly RB Other
reusable JJ Other
and CC Other
considerably RB Other
cheaper JJR Other
-DOCSTART- -X- N

bulimic JJ Physical
episodes NNS Physical
relatively RB Physical
low JJ Physical
plasma NN Physical
levels NNS Physical
depression NN Mental
and CC Mental
other JJ Mental
psychopathologies NNS Mental
bulimic JJ Physical
behavior NN Physical
. . None
-DOCSTART- -X- N

incidence NN Physical
of IN Physical
nonunion NN Physical
-DOCSTART- -X- N

patients NNS None
underwent JJ None
MRA NNP None
without IN None
any DT None
difficulty NN None
. . None
an DT None
early JJ Other
visualization NN Other
of IN Other
the DT Other
transverse JJ Other
sinus NN Other
Cortical NNP None
venous JJ None
reflux NN None
( ( None
CVR NNP None
) ) None
-DOCSTART- -X- N

CD4 NNP Physical
counts NNS Physical
total JJ Physical
WBC NNP Physical
count NN Physical
% NN None
change NN None
in IN None
CD4 NNP Physical
count NN Physical
% NN None
change NN None
in IN None
CD4/CD8 NNP Physical
ratios NNS Physical
absolute JJ None
CD4 NNP Physical
count NN Physical
, , None
absolute JJ None
CD4/CD8 NNP Physical
ratio NN Physical
, , None
and CC None
total JJ None
and CC None
B-lymphocytes NNP None
toxicity NN Physical
immunostimulatory JJ Other
effect NN Other
-DOCSTART- -X- N

eradication NN Other
rate NN Other
Per-protocol JJ Other
eradication NN Other
rate NN Other
therapy NN None
. . None
Intention-to-treat JJ None
eradication NN None
rates NNS None
were VBD None
respectively RB None
. . None
The DT None
incidence NN None
of IN None
major JJ None
and CC None
minor JJ None
side NN None
effects NNS None
eradicating VBG None
H. NNP None
pylori JJ None
infection NN None
. . None
-DOCSTART- -X- N

on IN None
serum NN None
testosterone NN None
( ( None
T NNP None
) ) None
, , None
estradiol FW None
( ( None
F2 NNP None
) ) None
, , None
luteotropic VBZ None
hormone NN None
( ( None
LH NNP None
) ) None
, , None
follicle-stimulating JJ None
hormone NN None
( ( None
FSH NNP None
) ) None
, , None
progesterone NN None
( ( None
P NNP None
) ) None
, , None
and CC None
prolactin NN None
( ( None
PRL NNP None
) ) None
the DT None
levels NNS None
of IN None
serum NN None
T NNP None
, , None
E2 NNP None
, , None
LH NNP None
, , None
FSH NNP None
, , None
P NNP None
and CC None
PRL NNP None
( ( None
that IN None
serum NN None
EF NNP None
and CC None
T NNP None
contents NNS None
in IN None
and CC None
serum JJ None
LH NNP None
content NN None
decreased VBN None
only RB None
serum JJ None
LH NNP None
decreased VBD None
serum NN None
P NNP None
, , None
FSH NNP None
and CC None
PRL NNP None
levels NNS None
in IN None
regulating VBG None
multiple JJ None
sex NN None
hormones NNS None
. . None
-DOCSTART- -X- N

restenosis NN None
rate NN None
mean NN Physical
minimal JJ Physical
luminal JJ Physical
diameter NN Physical
mean JJ Physical
minimal JJ Physical
luminal JJ Physical
diameter NN Physical
mean JJ Physical
diameter NN Physical
stenosis NN Physical
Binary JJ Physical
angiographic JJ Physical
restenosis NN Physical
reocclusion NN Other
rates NNS Other
rate NN Other
of IN Other
target NN Other
lesion NN Other
revascularization NN Other
target NN Physical
lesion NN Physical
revascularization NN Physical
restenosis NN Physical
rate NN Physical
. . None
-DOCSTART- -X- N

Childhood NNP Mental
Autism NNP Mental
Rating NNP Mental
Scales NNP Mental
( ( Mental
CARS NNP Mental
) ) Mental
changes NNS Physical
in IN Physical
GI NNP Physical
symptoms NNS Physical
, , None
expressive JJ Mental
and/or NN Mental
receptive JJ Mental
language NN Mental
function NN Mental
, , Mental
and CC Mental
improved JJ Mental
awareness NN Mental
and CC Mental
social JJ Mental
interactions NNS Mental
. . None
adverse JJ Adverse
effects NNS Adverse
transient JJ Mental
changes NNS Mental
in IN Mental
speech NN Mental
and CC Mental
behavior NN Mental
-DOCSTART- -X- N

Total JJ Other
clearance NN Other
fractional JJ Mental
excretion NN Mental
of IN Mental
DMU NNP Mental
renal JJ Mental
clearance NN Mental
of IN Mental
3-MX JJ Mental
, , None
1-MU JJ Mental
and CC None
DMU NNP Mental
Theophylline NNP Mental
metabolic JJ Mental
clearance NN Mental
to TO Mental
3-MX JJ Mental
Michaelis-Menten NNP Other
parameters NNS Other
Km NNP Other
and CC Other
Vmax NNP Other
Km NNP Other
values NNS Other
for IN Other
theophylline JJ Other
metabolism NN Other
to TO Other
3-MX JJ Other
, , None
1-MU JJ Mental
and CC None
DMU NNP Mental
Vmax NNP Other
values NNS Other
Km NNP Other
values NNS Other
for IN Other
the DT Other
N-demethylation NNP Other
pathways NNS Other
( ( Other
3MX CD Other
and CC Other
1-MU JJ Other
) ) Other
serum JJ Physical
concenntrations NNS Physical
-DOCSTART- -X- N

[ JJ None
Prevention NNP None
of IN None
thromboembolism NN Physical
prevention NN None
of IN None
peri- NN Physical
and CC Physical
postoperative JJ Physical
thromboembolic NN Physical
disease NN Physical
DVT NNP Physical
symptoms NNS Physical
or CC Physical
signs NNS Physical
of IN Physical
pulmonary JJ Physical
embolism NN Physical
radiologically RB Physical
diagnosed VBD Physical
pulmonary JJ Physical
embolism NN Physical
cases NNS Physical
of IN Physical
DVT NNP Physical
postoperative JJ Physical
bleeding NN Physical
evaluated VBN Physical
scarring VBG Physical
scarring VBG Physical
clinical JJ Other
effectiveness NN Other
, , Other
tolerance NN Other
, , Other
handiness NN Other
and CC Other
lack NN Other
of IN Other
interference NN Other
with IN Other
clotting VBG Other
functions NNS Other
thromboembolic JJ Physical
-DOCSTART- -X- N

Protein NNP Physical
digestibility NN Physical
coefficients NNS Physical
of IN Physical
rapeseed NN Physical
products NNS Physical
Ileal NNP Physical
digestibility NN Physical
of IN Physical
protein NN Physical
ileal NN Physical
digestibility NN Physical
ileal JJ Physical
digestibility NN Physical
values NNS Physical
Total NNP None
tract JJ None
digestibility NN None
of IN None
protein NN None
total JJ Physical
tract JJ Physical
digestibility NN Physical
of IN Physical
protein NN Physical
liver NN Other
size NN Other
or CC Other
mortality NN Other
. . Other
-DOCSTART- -X- N

fixation NN Mental
duration NN Mental
time NN Mental
taken VBN Mental
to TO Mental
fixate VB Mental
on IN Mental
the DT Mental
Eye NNP Mental
and CC Mental
Mouth NNP Mental
regions NNS Mental
of IN Mental
familiar JJ Mental
, , None
unfamiliar JJ Mental
and CC Mental
Self NNP Mental
Faces NNP Mental
. . None
fixation NN Mental
patterns NNS Mental
to TO Mental
the DT Mental
Eye NNP Mental
and CC Mental
Mouth NNP Mental
areas NNS Mental
gaze VB Mental
patterns NNS Mental
on IN Mental
unfamiliar JJ Mental
and CC Mental
Self NNP Mental
Faces NNP Mental
ability NN Mental
and CC Mental
attention NN Mental
-DOCSTART- -X- N

blood NN Physical
folate VB Physical
concentrations NNS Physical
blood NN Physical
folate NN Physical
concentrations NNS Physical
and CC None
folate NN Physical
intakes NNS Physical
blood NN Physical
folate NN Physical
concentrations NNS Physical
dietary JJ Physical
folate NN Physical
intakes NNS Physical
blood NN Physical
folate NN Physical
concentrations NNS Physical
total JJ Physical
folate NN Physical
intakes NNS Physical
plasma NN Physical
folate NN Physical
concentrations NNS Physical
Plasma NNP Physical
and CC Physical
RBC NNP Physical
folate VBP Physical
values NNS Physical
RBC NNP Physical
folate NN Physical
concentration NN Physical
Folate NNP Physical
intakes NNS Physical
blood NN Physical
folate NN Physical
concentrations NNS Physical
folate NN Physical
. . None
blood NN Physical
folate NN Physical
concentration NN Physical
-DOCSTART- -X- N

coagulation NN Physical
index NN Physical
different JJ Other
anticoagulation NN Other
systems NNS Other
anticoagulation NN Physical
coagulation NN None
changes NNS None
of IN None
prothrombin NN None
time NN None
( ( None
PT NNP None
) ) None
, , None
PTA NNP None
, , None
thrombin JJ None
time NN None
( ( None
TT NNP None
) ) None
, , None
activated VBN None
partial JJ None
thromboplastin NN None
time NN None
( ( None
APTT NNP None
) ) None
and CC None
international JJ None
normalized VBN None
ratio NN None
( ( None
INR NNP None
) ) None
dynamically RB None
. . None
line NN None
/ VBP None
filter NN None
coagulation NN None
, , None
rupture NN None
and CC None
bleeding NN None
were VBD None
PT NNP None
, , None
PTA NNP None
, , None
INR NNP None
between IN None
APTT NNP None
and CC None
TT NNP None
and CC None
fibrinogen NN None
( ( None
Fbg NNP None
) ) None
. . None
APTT NNP None
and CC None
TT NNP None
levels NNS None
in IN None
the DT None
Fbg NNP None
level NN None
was VBD None
curve NN None
was VBD None
observed VBN None
after IN None
severe JJ None
bleeding NN None
after IN None
was VBD None
terminated VBN None
because IN None
degree JJ None
III NNP None
clotting NN None
in IN None
blood NN None
platelet NN None
count NN None
( ( None
BPC NNP None
) ) None
, , None
fibrin JJ None
degradation NN None
products NNS None
( ( None
FDP NNP None
) ) None
, , None
D-dimer NNP None
and CC None
clinical JJ None
symptoms NNS None
is VBZ None
the DT None
disorder NN None
of IN None
hypercoagulable JJ None
state NN None
during IN None
blood NN None
coagulation NN None
by IN None
-DOCSTART- -X- N

Cognitive JJ Mental
performance NN Mental
serotonergic JJ Mental
function NN Mental
neurotoxic JJ Physical
effects NNS Physical
Reaction NN Mental
time NN Mental
, , Mental
direct JJ Mental
recall NN Mental
recognition NN Mental
Serotonergic NNP Physical
function NN Physical
small JJ Mental
, , Mental
impairment NN Mental
of IN Mental
memory NN Mental
and CC Mental
prolonged JJ Mental
reaction NN Mental
times NNS Mental
. . None
Release NNP Physical
of IN Physical
cortisol NN Physical
prolactin NN Physical
impairment NN Mental
of IN Mental
memory NN Mental
and CC Mental
of IN Mental
serotonergic JJ Mental
function NN Mental
. . None
neurotoxicity NN Physical
-DOCSTART- -X- N

survival NN Mortality
, , None
quality NN Other
of IN Other
life NN Other
( ( Other
QOL NNP Other
) ) Other
, , None
and CC None
quality-adjusted JJ Other
life-years NNS Other
( ( Other
QALY NNP Other
) ) Other
; : None
mortality NN Mortality
, , None
days NNS Other
spent VBD Other
in IN Other
hospital NN Other
, , None
major JJ Physical
clinical JJ Physical
events NNS Physical
, , None
and CC None
drug NN Mental
use NN Mental
cost-effectiveness NN Other
quality NN Other
of IN Other
life NN Other
, , None
time NN Other
off RP Other
work NN Other
, , None
and CC None
resources NNS Other
used VBN Other
, , None
such JJ None
as IN None
time NN Other
in IN Other
hospital NN Other
, , None
procedures NNS Other
, , None
and CC None
medications NNS Other
taken VBN Other
. . None
-DOCSTART- -X- N

anti-ischaemic JJ Physical
effect NN Physical
rate NN Physical
x JJ Physical
pressure NN Physical
product NN Physical
coronary JJ Physical
blood NN Physical
flow NN Physical
. . None
anti-anginal JJ Other
efficacy NN Other
anginal JJ Physical
attack NN Physical
rate NN Physical
per IN Physical
week NN Physical
exercise NN Physical
duration NN Physical
ST NNP Physical
segment NN Physical
depression NN Physical
Heart NNP Physical
rate NN Physical
and CC Physical
rate NN Physical
x JJ Physical
pressure NN Physical
product NN Physical
at IN Physical
rest NN Physical
ischaemic JJ Physical
episodes NNS Physical
withdrawn VBN Other
-DOCSTART- -X- N

global JJ Other
improvement NN Other
scale NN Other
irritable JJ Physical
bowel NN Physical
syndrome JJ Physical
studies NNS Physical
) ) Physical
, , Physical
number NN Physical
of IN Physical
daily JJ Physical
bowel NN Physical
movements NNS Physical
, , Physical
days NNS Physical
of IN Physical
constipation NN Physical
, , Physical
or CC Physical
severity NN Physical
of IN Physical
problem NN Physical
behaviors NNS Physical
. . None
well-tolerated JJ Other
; : Other
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
. . Adverse
-DOCSTART- -X- N

neutropenia NN Physical
and CC Physical
neutropenic JJ Physical
fever NN Physical
. . None
average JJ Physical
leukocyte JJ Physical
count NN Physical
response NN Physical
rates NNS Physical
, , None
other JJ Physical
acute JJ Adverse
hematotoxicity NN Adverse
, , None
acute JJ Adverse
infection NN Adverse
rate NN Adverse
, , None
hospital NN Other
admission NN Other
, , None
remission NN Other
duration NN Other
, , None
event-free JJ Mortality
, , Mortality
and CC Mortality
overall JJ Mortality
survival NN Mortality
. . None
average JJ None
leukocyte JJ Physical
count NN Physical
. . None
Response JJ Physical
rate NN Physical
response NN Physical
rates NNS Physical
grade NN Physical
3+4 CD Physical
leukocytopenia NN Physical
grade VBD Physical
3+4 CD Physical
neutropenia NN Physical
acute JJ Physical
infection NN Physical
hospitalization NN Other
erythrocyte JJ Physical
support NN Physical
toxicity NN Other
and CC Other
efficacy NN Other
-DOCSTART- -X- N

Age-related JJ Physical
response NN Physical
efficacy NN Other
and CC Other
safety NN Other
Anti-PRP NNP Physical
antibody NN Physical
levels NNS Physical
Immunoresponsiveness NN Physical
increased VBD None
lower JJR Adverse
incidence NN Adverse
of IN Adverse
side NN Adverse
effects NNS Adverse
well RB Other
tolerated VBN Other
clinically RB Other
and CC Other
has VBZ Other
greater JJR Other
immunogenicity NN Other
-DOCSTART- -X- N

erosion NN Physical
and CC None
abrasion NN Physical
on IN None
enamel NN Physical
and CC Physical
dentine NN Physical
: : None
abrasion NN Physical
and CC None
erosion NN Physical
wear NN Physical
of IN Physical
enamel NN Physical
and CC Physical
dentine NN Physical
. . None
erosion NN Physical
and CC None
abrasion NN Physical
of IN None
dental JJ Physical
tissues NNS Physical
. . None
erosion NN Physical
and CC None
abrasion NN Physical
of IN None
enamel NN Physical
and CC None
dentine NN Physical
. . None
tissue NN Physical
loss NN Physical
tissue NN Physical
loss NN Physical
over IN Physical
time NN Physical
erosion NN Physical
abrasion NN Physical
erosion NN Physical
abrasion NN Physical
synergy JJ Physical
effect NN Physical
susceptibility NN Physical
of IN Physical
enamel NN Physical
toothpaste VB Physical
abrasion NN Physical
. . None
erosion NN Physical
and CC None
abrasion NN Physical
Dentine NNP Physical
loss NN Physical
-DOCSTART- -X- N

intraarterial JJ Physical
pressure NN Physical
Heart NNP Physical
rate NN Physical
, , Physical
stroke VBD Physical
index NN Physical
, , Physical
and CC Physical
cardiac JJ Physical
index NN Physical
total JJ Physical
peripheral JJ Physical
resistance NN Physical
index NN Physical
reduction NN None
arterial JJ Physical
pressure NN Physical
Cardiac NNP Physical
index NN Physical
and CC Physical
heart NN Physical
rate NN Physical
total JJ Physical
peripheral JJ Physical
resistance NN Physical
Twenty-four JJ Physical
hour NN Physical
ambulatory NN Physical
blood NN Physical
pressure NN Physical
achieved VBN None
blood NN Physical
pressure NN Physical
reduction NN None
reduction NN None
of IN None
heart NN Physical
rate NN Physical
and CC Physical
cardiac JJ Physical
output NN Physical
-DOCSTART- -X- N

performance NN Mental
on IN Mental
common JJ Mental
facts NNS Mental
in IN None
fame NN None
amount NN Mental
of IN Mental
memory NN Mental
priming NN Mental
positively RB Mental
related VBN Mental
to TO Mental
one CD Mental
of IN Mental
two CD Mental
measures NNS Mental
preoperative JJ Mental
anxiety NN Mental
. . None
-DOCSTART- -X- N

Operative NNP Other
data NN Other
, , None
postoperative JJ Other
stay NN Other
, , None
pain NN Pain
assessment NN Pain
and CC None
persistent NN Pain
symptoms NNS Pain
endoanal JJ Other
ultrasound NN Other
postoperative JJ Other
stay NN Other
and CC None
in-hospital JJ Other
analgesia NN Other
higher JJR Pain
pain NN Pain
scores NNS Pain
no DT Pain
pain NN Pain
median JJ Other
return NN Other
to TO Other
work VB Other
was VBD Other
significantly RB Other
shorter JJR Other
internal JJ Physical
sphincter NN Physical
damage NN Physical
. . None
less JJR Pain
pain NN Pain
-DOCSTART- -X- N

FEV NNP Physical
( ( Physical
1 CD Physical
) ) Physical
FEV NNP Physical
( ( Physical
1 CD Physical
) ) Physical
values NNS None
adverse JJ Adverse
events NNS Adverse
-DOCSTART- -X- N

abnormal JJ Physical
cytological JJ Physical
examinations NNS Physical
proportion NN Physical
of IN Physical
DNA NNP Physical
aneuploid JJ Physical
histograms NNS Physical
response NN Physical
biomarker NN Physical
Recurrence-free JJ Mortality
survival NN Mortality
dark NN Adverse
adaptability NN Adverse
mild JJ Physical
dermatological JJ Physical
alterations NNS Physical
. . None
content NN Physical
distribution NN Physical
morphology NN Physical
of IN Physical
urothelial JJ Physical
cells NNS Physical
Recurrence-free JJ Mortality
survival NN Mortality
-DOCSTART- -X- N

Total JJ Physical
cholesterol NN Physical
high JJ Physical
density NN Physical
lipoprotein VBP Physical
cholesterol NN Physical
Triacylglycerol NNP Physical
concentration NN Physical
of IN Physical
prothrombin JJ Physical
fragment JJ Physical
1 CD Physical
+ JJ Physical
2 CD Physical
fibrinogen NN Physical
or CC Physical
factor NN Physical
VIIc NNP Physical
Tumor NNP Physical
necrosis NN Physical
factor NN Physical
generation NN Physical
in IN Physical
lipopolysaccharide NN Physical
( ( Physical
LPS NNP Physical
) ) Physical
-stimulated VBD Physical
blood NN Physical
LPS-induced JJ Physical
tissue NN Physical
factor NN Physical
activity NN Physical
in IN Physical
monocytes NNS Physical
thromboxane NN Physical
B2 NNP Physical
-DOCSTART- -X- N

NCHS NNP Physical
weight NN Physical
& CC Physical
length NN Physical
for IN Physical
age NN Physical
at IN Physical
discharge NN Physical
Weight NNP Physical
advantage NN Physical
-DOCSTART- -X- N

assessment NN None
of IN None
arm NN Physical
function NN Physical
the DT None
Action NNP Physical
Research NNP Physical
Arm NNP Physical
Test NNP Physical
( ( Physical
ARAT NNP Physical
) ) Physical
and CC None
Wolf NNP Physical
Motor NNP Physical
Function NNP Physical
Test NNP Physical
( ( Physical
WMFT NNP Physical
) ) Physical
. . None
Motor NNP Physical
Activity NNP Physical
Log NNP Physical
, , None
Stroke NNP Physical
Impact NNP Physical
Scale NNP Physical
, , None
Carer NNP Physical
Strain NNP Physical
Index NNP Physical
, , None
and CC None
health NN Other
and CC Other
social JJ Other
care NN Other
resource NN Other
use NN Other
. . None
Recruitment NNP Other
, , Mental
adherence NN Mental
, , None
withdrawals NNS Other
, , None
adverse JJ Adverse
events NNS Adverse
( ( Adverse
AEs NNP Adverse
) ) Adverse
, , None
and CC None
completeness NN Other
of IN Other
data NNS Other
acceptability NN Other
-DOCSTART- -X- N

visual JJ Pain
analog NN Pain
scores NNS Pain
( ( Pain
VAS NNP Pain
) ) Pain
for IN Pain
pain NN Pain
; : None
duration NN Physical
of IN Physical
stiffness NN Physical
; : None
range NN Physical
of IN Physical
movement NN Physical
; : None
joint JJ Physical
effusion NN Physical
; : None
local JJ Physical
heat NN Physical
; : None
synovial JJ Physical
thickening NN Physical
; : None
joint-line JJ Physical
and CC Physical
periarticular JJ Physical
tenderness NN Physical
. . None
pain NN Pain
on IN Pain
a DT Pain
self-selected JJ Pain
activity NN Pain
assessed VBN Pain
by IN Pain
Vas NNP Pain
. . None
pain NN Pain
-DOCSTART- -X- N

microcirculatory JJ Physical
blood NN Physical
flow NN Physical
marker NN Physical
of IN Physical
endothelial JJ Physical
cell NN Physical
injury NN Physical
Abnormal JJ Physical
blood NN Physical
flow NN Physical
abnormal JJ Physical
blood NN Physical
flow NN Physical
in IN Physical
SCD NNP Physical
microvascular JJ Physical
blood NN Physical
flow NN Physical
microvascular JJ Other
blood NN Other
flow NN Other
plasma JJ None
levels NNS None
of IN None
sVCAM-1 NN None
microvascular JJ None
blood NN None
flow NN None
acute JJ Other
vascular NN Other
occlusion NN Other
and CC Other
chronically RB Other
impaired JJ Other
microvascular JJ Other
blood NN Other
flow NN Other
in IN Other
SCD NNP Other
. . Other
blood NN None
flow NN None
-DOCSTART- -X- N

Effects NNS Other
transfusion NN Other
requirements NNS Other
postoperative JJ None
anemia NN None
and CC None
transfusion NN None
requirements NNS None
in IN None
respectively RB None
) ) None
. . None
Perioperative JJ None
laboratory NN None
and CC None
clinical JJ None
outcomes NNS None
( ( None
Hb NNP None
, , None
iron NN None
variables NNS None
, , None
postoperative JJ None
bleeding NN None
amount NN None
, , None
and CC None
number NN None
of IN None
units NNS None
of IN None
RBCs NNP None
transfused VBD None
and CC None
incidences NNS None
) ) None
were VBD None
Although IN None
preoperative JJ None
Hb NNP None
amount NN None
of IN None
postoperative JJ None
bleeding NN None
were VBD None
groups NNS None
, , None
Hb NNP None
levels NNS None
at IN None
transfusion NN None
rate NN None
was VBD None
mean JJ None
number NN None
of IN None
red JJ None
blood NN None
cell NN None
units NNS None
transfused VBD None
was VBD None
p=0.005 NN None
) ) None
. . None
Postoperative NNP None
iron NN None
, , None
ferritin NN None
, , None
and CC None
transferrin JJ None
saturation NN None
levels NNS None
were VBD None
effectively RB None
attenuated VBD None
anemia NN None
and CC None
decreased VBN None
transfusion NN None
-DOCSTART- -X- N

otorrhea NN Physical
Physician-observed JJ Physical
otorrhea NN Physical
otorrhea NNS Physical
rate NN Physical
of IN Physical
clinically RB Physical
diagnosed VBN Physical
otitis NN Physical
media NNS Physical
( ( Physical
OM NNP Physical
) ) Physical
and CC None
effusion NN Physical
early JJ Physical
post-operative JJ Physical
otorrhea NN Physical
, , None
clinically RB Physical
diagnosed VBN Physical
OM NNP Physical
effusion NN Physical
otorrhea NN Physical
-DOCSTART- -X- N

percentage NN Physical
of IN Physical
, , None
defined VBD None
as IN None
discontinuation NN None
of IN None
steroid JJ None
therapy NN None
without IN None
a DT None
disease NN None
flare NN None
( ( None
Crohn NNP None
's POS None
Disease NNP None
Activity NNP None
Index NNP None
score VBD None
> NNP None
or CC None
=220 NNP None
points NNS None
) ) None
Steroid NNP Physical
sparing VBG Physical
Adverse JJ Adverse
events NNS Adverse
sparing VBG Adverse
steroids NNS Adverse
-DOCSTART- -X- N

Efficacy NN Other
efficacy NN Other
efficacy NN Other
similar JJ Other
, , Other
rapid JJ Other
resolution NN Other
of IN Other
clinical JJ Other
signs NNS Other
and CC Other
negative JJ Other
isolation NN Other
scores NNS Other
ineffective JJ Physical
in IN Physical
clearing VBG Physical
infection NN Physical
. . Physical
unsuccessful JJ Physical
in IN Physical
eliminating VBG Physical
the DT Physical
carriage NN Physical
of IN Physical
this DT Physical
strain NN Physical
of IN Physical
C NNP Physical
felis NN Physical
. . Physical
-DOCSTART- -X- N

failure NN Adverse
death NN Mortality
relapsed VBN Adverse
deaths NNS None
nonlymphocytic JJ Physical
leukemia NN Physical
the DT Mortality
actuarial JJ Mortality
probabilities NNS Mortality
for IN Mortality
survival NN Mortality
and CC Mortality
freedom NN Mortality
from IN Mortality
relapse NN Mortality
number NN Other
of IN Other
cycles NNS Other
of IN Other
chemotherapy NN Other
Bone NNP Adverse
growth NN Adverse
defects NNS Adverse
related VBN Adverse
to TO Adverse
radiotherapy VB Adverse
mediastinal JJ Physical
relapse NN Physical
. . Physical
Azoospermia NNP Physical
-DOCSTART- -X- N

antiinflammatory JJ None
effect NN None
compared VBN None
well RB None
tolerated VBN None
. . None
-DOCSTART- -X- N

Safety NN Other
, , Other
pharmacokinetics NNS Other
and CC Other
pharmocodynamics NNS Other
5-aminolevulinic JJ Physical
acid NN Physical
and CC Physical
porphobilinogen NN Physical
. . Physical
concentrations NNS Physical
of IN Physical
recombinant JJ Physical
human JJ Physical
porphobilinogen NN Physical
deaminase NN Physical
and CC Physical
titres NNS Physical
of IN Physical
antibodies NNS Physical
against IN Physical
recombinant JJ Physical
human JJ Physical
porphobilinogen NN Physical
deaminase NN Physical
Plasma NNP Physical
porphobilinogen NN Physical
and CC Physical
5-aminolevulinic JJ Physical
acid NN Physical
concentrations NNS Physical
Urinary JJ Physical
porphobilinogen NN Physical
, , Physical
5-aminolevulinic JJ Physical
acid NN Physical
and CC Physical
porphyrin NN Physical
concentrations NNS Physical
plasma NN Physical
porphyrin NN Physical
concentrations NNS Physical
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
antibodies NNS Adverse
against IN Adverse
recombinant JJ Adverse
human JJ Adverse
porphobilinogen NN Adverse
deaminase NN Adverse
allergic JJ Adverse
manifestations NNS Adverse
. . Adverse
mean JJ Physical
elimination NN Physical
half-lives NNS Physical
of IN Physical
the DT Physical
highest JJS Physical
doses NNS Physical
of IN Physical
recombinant JJ Physical
human JJ Physical
porphobilinogen NN Physical
deaminase NN Physical
area NN Physical
under IN Physical
the DT Physical
plasma JJ Physical
concentration-time JJ Physical
curve NN Physical
plasma NN Physical
porphobilinogen NN Physical
concentrations NNS Physical
plasma NN Physical
porphobilinogen NN Physical
concentration NN Physical
plasma NN Physical
5-aminolevulinic JJ Physical
acid NN Physical
concentrations NNS Physical
porphyrin JJ Physical
concentrations NNS Physical
. . Physical
corresponding JJ Physical
concentrations NNS Physical
of IN Physical
metabolites NNS Physical
in IN Physical
the DT Physical
urine NN Physical
therapeutic JJ Other
efficacy NN Other
-DOCSTART- -X- N

respiratory NN Physical
symptoms NNS Physical
of IN Physical
effect NN Other
extraesophageal NN Physical
symptoms NNS Physical
of IN Physical
gastroesophageal JJ Physical
reflux JJ Physical
disease NN Physical
extraesophageal NN Physical
symptoms NNS Physical
resolution NN Physical
of IN Physical
symptoms NNS Physical
; : None
symptom-free JJ Physical
. . None
complete JJ Physical
resolution NN Physical
of IN Physical
symptoms NNS Physical
partial JJ Physical
resolution NN Physical
of IN Physical
symptoms NNS Physical
complete JJ Physical
remission NN Physical
extraesophageal JJ Physical
reflux NN Physical
symptoms NNS Physical
. . None
efficacy NN Other
-DOCSTART- -X- N

patients NNS Mental
' POS Mental
disease-related JJ Mental
knowledge NN Mental
, , Other
active JJ Mental
coping VBG Mental
with IN Mental
illness NN Mental
, , Other
and CC Other
quality NN Mental
of IN Mental
life NN Mental
( ( Mental
QoL NNP Mental
) ) Mental
improved VBD Mental
their PRP$ Mental
knowledge NN Mental
and CC Other
QoL NNP Other
during IN Other
rehabilitation NN Other
; : None
knowledge NN Mental
active JJ Mental
coping NN Mental
with IN Mental
illness NN Mental
QoL NNP Mental
-DOCSTART- -X- N

total JJ Physical
serum NN Physical
bilirubin NN Physical
concentrations NNS Physical
. . Physical
TSB NNP Physical
concentrations NNS Physical
minimum JJ Physical
TSB NNP Physical
values NNS Physical
more RBR Physical
than IN Physical
doubled VBD Physical
TSB NNP Physical
concentration NN Physical
rise NN Physical
in IN Physical
TSB NNP Physical
TSB NNP Physical
-DOCSTART- -X- N

steroid JJ Other
requirements NNS Other
Symptom NNP Physical
scores NNS Physical
, , Physical
peak NN Physical
flow NN Physical
rates NNS Physical
, , Physical
spirometry NN Other
, , Physical
and CC Physical
beta-agonist JJ Physical
frequency NN Physical
daily JJ Other
steroid JJ Other
requirement NN Other
Symptom JJ Physical
scores NNS Physical
and CC None
spirometry NN Other
Complications NNS Adverse
from IN Adverse
MTX NNP Adverse
anorexia NN Adverse
, , Adverse
alopecia NN Adverse
, , Adverse
and CC Adverse
stomatitis NN Adverse
. . None
complications NNS Adverse
steroid JJ Other
requirement NN Other
reduction NN Other
in IN Other
steroid JJ Other
requirement NN Other
-DOCSTART- -X- N

life-style JJ Mental
, , None
and CC None
subsequent JJ Physical
changes NNS Physical
in IN Physical
risk NN Physical
factors NNS Physical
for IN Physical
CHD NNP Physical
. . None
fitness JJ Physical
level NN Physical
body NN Physical
weight NN Physical
CHD NNP Physical
risk NN Physical
factors NNS Physical
. . None
-DOCSTART- -X- N

cerebral JJ Physical
blood NN Physical
flow NN Physical
oxygen NN Physical
consumption NN Physical
Cerebral JJ Physical
blood NN Physical
flow NN Physical
( ( Physical
CBF NNP Physical
) ) Physical
cerebral JJ Physical
metabolic NN Physical
rate NN Physical
for IN Physical
oxygen NN Physical
( ( Physical
CMRO2 NNP Physical
) ) Physical
Plasma NNP Physical
concentrations NNS Physical
of IN Physical
midazolam NN Physical
plasma JJ Physical
concentration NN Physical
of IN Physical
midazolam NN Physical
, , None
CBF NNP Physical
or CC None
CMRO2 NNP Physical
. . None
no DT Physical
effect NN Physical
on IN Physical
CBF NNP Physical
CMRO2 NNP Physical
. . None
-DOCSTART- -X- N

ischemic JJ Physical
heart NN Physical
disease NN Physical
, , None
venous JJ Physical
thromboembolism NN Physical
, , None
cardiac JJ Physical
incompensation NN Physical
and CC None
cerebral JJ Physical
depression NN Physical
incidence NN Adverse
of IN Adverse
cardiovascular JJ Adverse
complications NNS Adverse
and CC None
a DT None
history NN None
of IN None
previous JJ None
cardiovascular JJ None
disease NN None
. . None
cardiovascular JJ Physical
complications NNS Physical
-DOCSTART- -X- N

glucosylated JJ Physical
hemoglobin NN Physical
amplitudes NNS Physical
of IN Physical
OP-2 NNP Physical
, , Physical
OP-3 NNP Physical
and CC Physical
OP-sum NNP Physical
were VBD None
reduced VBN None
retinopathy JJ Physical
worsened VBD None
intraocular JJ Physical
pressure NN Physical
decreased VBN None
systolic JJ Physical
blood NN Physical
pressure NN Physical
increased VBD None
glycemic JJ Physical
control NN Physical
OP-1 NNP Physical
, , Physical
OP-2 NNP Physical
, , Physical
OP-3 NNP Physical
, , Physical
OP-sum NNP Physical
change NN Physical
in IN Physical
glycemic JJ Physical
control NN Physical
or CC None
background NN Physical
variables NNS Physical
OPs NNP Physical
OP-3 NNP Physical
and CC None
duration NN Physical
counts NNS Physical
of IN Physical
microaneurysms NNS Physical
Reduced NNP Physical
neurosensory JJ Physical
retinal JJ Physical
function NN Physical
( ( Physical
OPs NNP Physical
) ) Physical
vascular JJ Physical
defects NNS Physical
of IN Physical
retinopathy JJ Physical
long-term JJ Physical
improvement NN Physical
in IN Physical
glucose JJ Physical
control NN Physical
. . Physical
-DOCSTART- -X- N

anxiety VB Mental
reduction NN Mental
. . None
anxiety NN Mental
symptom NN Mental
checklists NNS Mental
Clinical JJ Mental
Global NNP Mental
Impressions-Improvement NNP Mental
scale NN Mental
criteria NNS Mental
parent NN Mental
reports NNS Mental
of IN Mental
child NN Mental
anxiety NN Mental
anxiety NN Mental
disorders NNS None
-DOCSTART- -X- N

Safety NN Other
and CC Other
efficacy NN Other
Bronchodilator NNP Other
efficacy NN Other
serial JJ Physical
spirometry NN Physical
Safety NNP Physical
changes NNS Physical
in IN Physical
pulse JJ Physical
rate NN Physical
, , Physical
blood NN Physical
pressure NN Physical
, , Physical
and CC Physical
electrocardiogram NN Physical
( ( Physical
ECG NNP Physical
) ) Physical
intervals NNS Physical
monitoring VBG Physical
adverse JJ Physical
events NNS Physical
laboratory NN Physical
testing NN Physical
and CC Physical
physical JJ Physical
examinations NNS Physical
. . Physical
bronchodilator NN Other
efficacy NN Other
pulse JJ Physical
rate NN Physical
, , Physical
blood NN Physical
pressure NN Physical
, , Physical
and CC Physical
ECG NNP Physical
intervals NNS Physical
. . Physical
Adverse JJ Physical
event NN Physical
profiles NNS Physical
changes NNS Physical
-DOCSTART- -X- N

Autism NNP Mental
Relevant NNP Mental
Subscale NNP Mental
of IN Mental
the DT Mental
Children NNP Mental
's POS Mental
Psychiatric NNP Mental
Rating NNP Mental
Scale NNP Mental
, , None
the DT Mental
Modified NNP Mental
Comprehensive NNP Mental
Psychopathological NNP Mental
Rating NNP Mental
Scale-Obsessive-Compulsive JJ Mental
Disorder NNP Mental
Subscale NNP Mental
, , None
and CC None
the DT None
Clinical NNP Mental
Global NNP Mental
Impressions NNP Mental
Scale NNP Mental
. . None
autistic JJ Mental
symptoms NNS Mental
( ( Mental
including VBG Mental
stereotypies NNS Mental
) ) Mental
, , Mental
anger NN Mental
, , Mental
and CC Mental
compulsive JJ Mental
, , Mental
ritualized JJ Mental
behaviors NNS Mental
hyperactivity NN Mental
. . Mental
-DOCSTART- -X- N

better RBR Physical
rate NN Physical
of IN Physical
complete JJ Physical
response NN Physical
, , None
fewer JJR Physical
nodes NNS Physical
, , None
and CC None
better JJR Physical
overall JJ Physical
response NN Physical
3-year JJ Mortality
disease-free JJ Mortality
survival NN Mortality
, , None
progression NN Mortality
free JJ Mortality
survival NN Mortality
, , None
and CC None
overall JJ Mortality
survival NN Mortality
quality NN Physical
of IN Physical
life NN Physical
quality NN Physical
of IN Physical
life NN Physical
acute NN Adverse
and CC Adverse
late JJ Adverse
toxicity NN Adverse
-DOCSTART- -X- N

clinical JJ Other
benefit NN Other
RDAI NNP Physical
score NN Physical
oxygen JJ Physical
saturation NN Physical
, , None
respiratory NN Physical
rate NN Physical
, , None
RDAI NNP Physical
measurement NN Physical
twice RB Physical
daily RB Physical
length NN Other
of IN Other
hospitalization NN Other
. . None
mean JJ Other
change NN Other
( ( Other
SD NNP Other
) ) Other
RDAI NNP Physical
score NN Physical
oxygen NN Physical
saturation NN Physical
, , None
respiratory NN Physical
rate NN Physical
, , None
and CC None
RDAI NNP Physical
score NN Physical
median JJ Other
length NN Other
of IN Other
stay NN Other
clinical JJ None
course NN None
-DOCSTART- -X- N

efficacy NN Other
and CC None
tolerability NN Other
Adverse JJ Adverse
events NNS Adverse
lost VBN Physical
HCV NNP Physical
RNA NNP Physical
in IN Physical
serum NN Physical
HCV NNP Physical
RNA NNP Physical
negative JJ Physical
Sustained VBN Other
response NN Other
rates NNS Other
anaemia NN Physical
, , None
neutropenia NN Physical
, , None
nausea NN Physical
and CC None
depression NN Physical
sustained JJ Other
response NN Other
rates NNS Other
. . None
-DOCSTART- -X- N

Safety NN Other
and CC Other
efficacy NN Other
excretion NN Physical
of IN Physical
lead NN Physical
excretion NN Physical
of IN Physical
tin NN Physical
and CC Physical
bismuth NN Physical
excretion NN Physical
of IN Physical
thallium NN Physical
, , Physical
mercury NN Physical
, , Physical
antimony NN Physical
, , Physical
and CC Physical
tungsten RB Physical
. . None
urinary JJ Physical
excretion NN Physical
of IN Physical
essential JJ Physical
minerals NNS Physical
normalization NN Physical
of IN Physical
RBC NNP Physical
glutathione NN Physical
abnormal JJ Physical
platelet NN Physical
counts NNS Physical
inflammation NN Physical
. . None
safe JJ Other
, , Other
effective JJ Other
toxic JJ Physical
metals NNS Physical
normalizing VBG Physical
RBC NNP Physical
glutathione NN Physical
normalizing VBG Physical
platelet NN Physical
counts NNS Physical
. . None
glutathione NN Physical
and CC Physical
platelets NNS Physical
. . None
excretion NN Physical
of IN Physical
toxic JJ Physical
metals NNS Physical
. . None
-DOCSTART- -X- N

duration NN Other
assess VB Adverse
possible JJ Adverse
complications NNS Adverse
anesthetic JJ Other
technique NN Other
, , Physical
levels NNS Other
of IN Other
extension NN Other
of IN Other
motor NN Other
and CC Other
sensory JJ Other
blockades NNS Other
, , Physical
duration NN Other
of IN Other
blockades NNS Other
and CC Physical
complications NNS Physical
within IN Physical
the DT Physical
first JJ Physical
24 CD Physical
hours NNS Physical
duration NN Other
of IN Other
sensory JJ Other
blockade NN Other
motor NN Other
blockade NN Other
hypotension NN Adverse
bradycardia NN Adverse
surgical JJ Other
conditions NNS Other
complications NNS Adverse
. . None
sensory NN Other
and CC Physical
motor NN Other
blockade NN Other
-DOCSTART- -X- N

Index NN Physical
of IN Physical
biochemistry NN Physical
virology NN Physical
complete JJ Other
effective JJ Other
partial JJ Other
effective JJ Other
effective JJ Other
. . None
-DOCSTART- -X- N

fitness NN Physical
parameters NNS Physical
physical JJ Physical
fitness NN Physical
cardiovascular JJ Physical
endurance NN Physical
, , None
body NN Physical
composition NN Physical
, , None
muscular JJ Physical
strength NN Physical
and CC None
endurance NN Physical
and CC Physical
flexibility NN Physical
. . None
components NNS Physical
of IN Physical
physical JJ Physical
fitness NN Physical
functional JJ Physical
capacity NN Physical
ability NN Mental
to TO Mental
complete VB Mental
activities NNS Mental
of IN Mental
daily JJ Mental
living VBG Mental
primary JJ Physical
and CC Physical
secondary JJ Physical
physical JJ Physical
injuries NNS Physical
-DOCSTART- -X- N

outcome NN Physical
positive JJ Other
effect NN Other
advantage NN Other
disadvantage NN Other
-DOCSTART- -X- N

Mycological JJ Other
cure NN Other
rate NN Other
efficacy NN Other
cure NN Other
rates NNS Other
-DOCSTART- -X- N

metabolic JJ Physical
traits NNS Physical
, , None
organ JJ Physical
mass NN Physical
development NN Physical
and CC Physical
growth NN Physical
metabolic JJ Physical
disorders NNS Physical
post-weaning JJ Physical
diets NNS Physical
Dietary NNP Physical
protein NN Physical
content NN Physical
nitrogen NN None
retention NN None
liver NN Physical
, , Physical
pancreas NNS Physical
and CC Physical
kidney NN Physical
weight NN Physical
plasma NN Physical
IGF-1 JJ Physical
concentrations NNS Physical
hepatic JJ Physical
lipidosis NN Physical
higher JJR Physical
body NN Physical
fat JJ Physical
lower JJR Physical
body NN Physical
CP NNP Physical
content NN Physical
low JJ Physical
protein NN Physical
provision NN Physical
nutrient JJ Physical
supply NN Physical
post-partum NN Physical
. . None
growth NN Physical
potential NN Physical
and CC None
induces NNS Physical
transient JJ Physical
hepatic JJ Physical
lipidosis NN Physical
and CC Physical
modified VBD Physical
body NN Physical
composition NN Physical
. . None
-DOCSTART- -X- N

ATC-related JJ Physical
workload NN Physical
and CC Physical
the DT Physical
modality NN Physical
, , Physical
frequency NN Physical
, , Physical
and CC Physical
priority NN Physical
of IN Physical
interruption NN Physical
tasks NNS Physical
. . Physical
interruption NN Mental
task NN Mental
performance NN Mental
; : None
-DOCSTART- -X- N

interleukin JJ None
1 CD None
interleukin JJ None
1 CD None
( ( None
IL NNP None
= NNP None
1 CD None
) ) None
. . None
respiratory NN Physical
tract JJ Physical
infections NNS Physical
. . None
IL-1 JJ Physical
production NN Physical
in IN Physical
vitro JJ Physical
IL-1 JJ Physical
production NN Physical
IL-1 NNP Physical
production NN Physical
AM NNP Physical
IL-1 NNP Physical
production NN Physical
IL-1 JJ Physical
production NN Physical
IL-1 JJ Physical
production NN Physical
. . None
IL-1 NNP Physical
production NN Physical
LPS NNP Physical
concentration NN Physical
IL-1 JJ Physical
optimal JJ Physical
LPS NNP Physical
concentration NN Physical
IL-1 NNP Physical
low JJ Physical
LPS NNP Physical
concentration NN Physical
-DOCSTART- -X- N

Biochemical JJ Physical
markers NNS Physical
of IN Physical
bone NN Physical
turnover NN Physical
Bone NNP Physical
strength NN Physical
tibial JJ Physical
bone NN Physical
speed NN Physical
of IN Physical
sound NN Physical
Bone NNP Physical
SOS NNP Physical
main JJ Physical
beneficial JJ Physical
effect NN Physical
of IN Physical
exercise NN Physical
bone NN Physical
turnover NN Physical
marker NN Physical
changes NNS Physical
postnatal JJ Physical
decrease NN Physical
in IN Physical
bone NN Physical
SOS NNP Physical
decrease NN None
bone NN Physical
strength NN Physical
risk NN Physical
of IN Physical
osteopenia NN Physical
-DOCSTART- -X- N

favorable JJ Physical
cytogenetics NNS Physical
incidence NN Physical
of IN Physical
translocations NNS Physical
involving VBG Physical
chromosome NN Physical
11q23 CD Physical
FAB NNP Physical
types VBZ Physical
M5 NNP Physical
M7 NNP Other
FAB NNP Other
types NNS Other
M0 NNP Other
M2 NNP Other
M3 NNP Other
Involvement NN None
of IN None
the DT None
central JJ None
nervous JJ None
system NN None
severe JJ Physical
diarrhea NN Physical
nausea NN Physical
and CC Physical
vomiting NN Physical
complete JJ Physical
remission NN Physical
rates NNS Physical
deaths NNS Mortality
overall JJ Mortality
survival NN Mortality
event-free JJ Mortality
survival NN Mortality
disease-free JJ Mortality
survival NN Mortality
relapse NN Physical
rate NN Physical
-DOCSTART- -X- N

Humphrey NNP Physical
Field NNP Physical
Analyzer NNP Physical
visual JJ Physical
field NN Physical
sensitivity NN Physical
, , None
30-Hz JJ Other
electroretinogram NN Other
amplitude NN Other
, , None
and CC None
visual JJ Physical
acuity NN Physical
. . None
field NN Physical
sensitivity NN Physical
and CC Physical
electroretinogram NN Other
amplitude NN Other
total JJ Physical
field NN Physical
sensitivity NN Physical
total JJ Physical
field NN Physical
sensitivity NN Physical
duration NN Physical
of IN Physical
vitamin NN Physical
A DT Physical
supplementation NN Physical
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
and CC None
right JJ Physical
ventricular NN Physical
function NN Physical
blood NN Physical
pressure NN Physical
and CC None
right JJ Physical
ventricular NN Physical
function NN Physical
pulmonary JJ Physical
artery NN Physical
pressure NN Physical
groups NNS None
. . None
Duration NN None
on IN None
treadmill NN None
and CC None
right JJ None
ventricular NN None
ejection NN None
fraction NN None
post NN None
exercise NN None
increased VBD None
while IN None
diastolic JJ None
and CC None
systolic JJ None
artery NN None
pressure NN None
decreased VBN None
right JJ None
ventricular NN None
function NN None
by IN None
decreasing VBG None
systolic JJ None
pulmonary JJ None
artery NN None
pressure NN None
. . None
-DOCSTART- -X- N

ambulatory NN None
opioid JJ None
detoxification NN None
: : None
feasibility NN None
primary JJ Physical
care-based JJ Physical
ambulatory NN Physical
opioid JJ Physical
detoxification NN Physical
( ( Physical
AOD NNP Physical
) ) Physical
mean JJ Mental
admission NN Mental
opioid IN Mental
craving VBG Mental
score NN Mental
withdrawal NN Mental
symptom NN Mental
score NN Mental
AODs NNP None
-DOCSTART- -X- N

energy NN Physical
metabolism NN Physical
food NN Mental
intake NN Mental
energy NN Physical
metabolism NN Physical
food NN Mental
intake NN Mental
Energy NNP Physical
metabolism NN Physical
food NN Mental
intake NN Mental
urinary JJ Physical
norepinephrine NN Physical
excretion NN Physical
sympathetic JJ Physical
nervous JJ Physical
system NN Physical
activity NN Physical
. . None
energy NN Physical
expenditure NN Physical
24-h JJ Physical
NE NNP Physical
energy NN Physical
expenditure NN Physical
energy NN Physical
intake NN Physical
energy NN Physical
intake NN Physical
-DOCSTART- -X- N

bleeding NN Physical
rates NNS Physical
including VBG None
adherence NN None
to TO None
prasugrel VB None
therapy NN None
were VBD None
Major NNP None
minor NN None
, , None
and CC None
minimal JJ None
bleedings NNS None
( ( None
Thrombolysis NNP None
patients NNS None
. . None
Low JJ None
residual JJ None
platelet NN None
reactivity NN None
( ( None
p JJ None
= NNP None
was VBD None
epistaxis RB None
. . None
Only RB None
because IN None
of IN None
bleeding VBG None
events NNS None
( ( None
n JJ None
= NNP None
possible JJ None
side NN None
effects NNS None
( ( None
n JJ None
= NNP None
medical JJ None
decisions NNS None
not RB None
associated VBN None
with IN None
bleeding NN None
or CC None
side NN None
effects NNS None
( ( None
n JJ None
= NNP None
temporarily RB None
discontinued VBN None
prasugrel NN None
definite NN None
or CC None
probable JJ None
stent JJ None
thrombosis NN None
occurred VBD None
develop VB None
de FW None
novo FW None
myocardial JJ None
infarction NN None
and CC None
1 CD None
an DT None
ischemic JJ None
stroke NN None
. . None
There EX None
11 CD None
deaths NNS None
because IN None
of IN None
heart NN None
failure NN None
or CC None
refractory NN None
cardiogenic JJ None
shock NN None
pulmonary JJ None
embolism NN None
in IN None
1 CD None
, , None
cancer NN None
in IN None
1 CD None
. . None
practice NN None
, , None
major JJ None
and CC None
minor JJ None
bleeding NN None
event NN None
rates NNS None
. . None
The DT None
minimal JJ None
bleeding JJ None
event NN None
rate NN None
-DOCSTART- -X- N

carotid NNS Physical
arterial JJ Physical
wall JJ Physical
intima-media JJ Physical
thickness NN Physical
rate NN None
of IN None
progression NN None
of IN None
early JJ None
preintrusive JJ None
atherosclerosis NN Physical
less JJR Physical
carotid JJ Physical
IMT NNP Physical
progression NN Physical
vitamin NN Physical
reducing VBG None
progression NN Physical
of IN Physical
atherosclerosis NN Physical
-DOCSTART- -X- N

symptomatic JJ Physical
relief NN Physical
and CC Physical
intervals NNS Physical
between IN Physical
the DT Physical
operation NN Physical
and CC Physical
return NN Physical
to TO Physical
their PRP$ Physical
daily JJ Physical
activities NNS Physical
and CC Physical
work NN Physical
, , Physical
and CC Physical
examined VBD Physical
for IN Physical
scar NN Physical
tenderness NN Physical
and CC Physical
esthetic JJ Physical
outcome NN Physical
. . Physical
Distal NNP Physical
motor NN Physical
latency NN Physical
, , Physical
conduction NN Physical
velocity NN Physical
, , Physical
scar NN Physical
length NN Physical
, , Physical
scar NN Physical
width NN Physical
, , Physical
and CC Physical
operation NN Physical
time NN Physical
symptomatic JJ Physical
relief NN Physical
and CC Physical
electrophysiological JJ Physical
parameters NNS Physical
. . Physical
Intervals NNS Physical
between IN Physical
the DT Physical
operation NN Physical
and CC Physical
return NN Physical
to TO Physical
daily JJ Physical
activities NNS Physical
intervals NNS Physical
between IN Physical
the DT Physical
operation NN Physical
and CC Physical
return NN Physical
to TO Physical
work VB Physical
Scar/pillar JJ Physical
tenderness NN Physical
, , Physical
scar NN Physical
length NN Physical
and CC Physical
width NN Physical
, , Physical
esthetic JJ Physical
outcome NN Physical
, , Physical
and CC Physical
operation NN Physical
time NN Physical
-DOCSTART- -X- N

pulmonary NN Physical
gas NN Physical
exchange NN Physical
, , Physical
hemodynamics NNS Physical
, , Physical
and CC Physical
respiratory NN Physical
parameters NNS Physical
mean JJ Physical
airway NN Physical
pressure NN Physical
blood NN Physical
gas NN Physical
analyses NNS Physical
and CC Physical
measurements NNS Physical
of IN Physical
respiratory NN Physical
and CC Physical
hemodynamic JJ Physical
variables NNS Physical
. . None
normocapnia RB Physical
Pao2 NNP Physical
attributable JJ Physical
Mean NNP Physical
airway JJ Physical
pressure NN Physical
augmentation NN Physical
Pao2 NNP None
Peak NNP Physical
inspiratory JJ Physical
pressure NN Physical
normocapnia NN Physical
Pao2 NNP Physical
-DOCSTART- -X- N

composite JJ Mortality
of IN Mortality
death NN Mortality
or CC None
nonfatal JJ Physical
myocardial JJ Physical
infarction NN Physical
at IN Physical
30 CD Physical
days NNS Physical
. . None
primary JJ None
outcome NN None
Major JJ Physical
bleeding NN Physical
rate NN Mortality
of IN Mortality
a DT Mortality
composite NN Mortality
of IN Mortality
death NN Mortality
or CC None
nonfatal JJ Physical
myocardial JJ Physical
infarction NN Physical
risk NN Physical
of IN Physical
major JJ Physical
bleeding NN Physical
. . None
-DOCSTART- -X- N

survival JJ Mortality
median JJ Other
observation NN Other
time NN Other
Kaplan-Meier NNP Other
curves NNS Other
no DT Physical
lymph NN Physical
node RB Physical
involvement NN Physical
nodal JJ Physical
spread NN Physical
of IN Physical
tumor NN Physical
cells NNS Physical
long-term JJ Mortality
survival NN Mortality
improved JJ Mortality
overall JJ Mortality
survival NN Mortality
survival JJ Mortality
-DOCSTART- -X- N

increasing VBG None
physical JJ None
activity NN None
increase VB None
physical JJ None
activity NN None
( ( None
PA NNP None
) ) None
measure VB None
activity NN None
levels NNS None
, , None
other JJ None
student NN None
behaviors NNS None
, , None
and CC None
teacher NN None
behaviors NNS None
related VBN None
PA. NNP None
PA NNP None
increased VBD None
decreased VBD None
PA NNP None
from IN None
increased VBD None
PA NNP None
once RB None
exhibited VBD None
statistically RB None
significant JJ None
increases NNS None
in IN None
light NN None
( ( None
51 CD None
% NN None
) ) None
and CC None
moderate-intensity NN None
( ( None
16 CD None
% NN None
) ) None
PA NNP None
and CC None
increases NNS None
in IN None
time NN None
spent VBN None
in IN None
on-task JJ None
behavior NN None
( ( None
for IN None
increasing VBG None
PA NNP None
and CC None
improving VBG None
behavior NN None
-DOCSTART- -X- N

overall JJ Mortality
mortality NN Mortality
. . Mortality
survival NN Mortality
mortality NN Mortality
-DOCSTART- -X- N

cost-effectiveness NN Other
. . Other
effectiveness NN Other
and CC Other
the DT Other
costs NNS Other
validated JJ Mental
measures NNS Mental
of IN Mental
physical JJ Mental
and CC Mental
psychological JJ Mental
impairment NN Mental
and CC Mental
quality NN Mental
of IN Mental
life NN Mental
( ( Mental
SF-36 NNP Mental
health NN Mental
survey NN Mental
) ) Mental
. . Mental
costs NNS Other
to TO Other
the DT Other
National NNP Other
Health NNP Other
Service NNP Other
over IN Other
the DT Other
one CD Other
year NN Other
follow VBP Other
up RP Other
functional JJ Mental
status NN Mental
four CD Physical
SF-36 JJ Physical
health NN Physical
dimensions-general JJ Physical
health NN Physical
, , Physical
bodily RB Physical
pain NN Physical
, , Physical
role-emotional JJ Physical
, , Physical
and CC Physical
social JJ Physical
functioning NN Physical
cost NN Other
cost-effective JJ Other
quality NN Other
of IN Other
life NN Other
. . None
-DOCSTART- -X- N

toxic JJ Adverse
side-effects NNS Adverse
. . None
toxic NN Adverse
, , None
immunomodulatory NN Physical
, , None
and CC None
therapeutic JJ Physical
properties NNS Other
overall JJ Other
major JJ Other
response NN Physical
rate NN Physical
mean JJ Physical
maximal JJ Physical
temperature NN Physical
elevation NN Physical
incidence NN Physical
and CC Physical
severity NN Physical
of IN Physical
interferon-related JJ Physical
fatigue NN Physical
, , None
reduction NN Physical
in IN Physical
performance NN Physical
status NN Physical
, , None
headache NN Physical
, , None
depression NN Mental
, , None
confusion NN Mental
, , None
elevations NNS Physical
in IN Physical
liver JJ Physical
function NN Physical
tests NNS Physical
, , None
and CC None
myelosuppression NN Physical
frequency NN Adverse
of IN Adverse
dose JJ Adverse
reductions NNS Adverse
for IN Adverse
toxic JJ Adverse
side-effects NNS Adverse
administration NN Other
of IN Other
higher JJR Other
interferon NN Other
doses NNS Other
. . None
Peripheral NNP Physical
blood VBD Physical
natural JJ Physical
killer NN Physical
activity NN Physical
augmentation NN Physical
of IN Physical
natural JJ Physical
killer NN Physical
activity NN Physical
Immunological JJ Physical
changes NNS Physical
fever NN Physical
therapeutic JJ Physical
or CC Physical
chronic JJ Physical
immunomodulatory NN Physical
activities NNS Physical
. . None
fever NN Physical
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
metabolism NN Physical
systolic JJ Physical
and CC Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
postprandial JJ Physical
blood NN Physical
glucose JJ Physical
concentrations NNS Physical
blood NN Physical
kinin NN Physical
concentrations NNS Physical
Body NNP Physical
mass NN Physical
index NN Physical
, , Physical
fasting VBG Physical
plasma JJ Physical
insulin NN Physical
, , Physical
serum JJ Physical
electrolyte NN Physical
pattern NN Physical
, , Physical
uric JJ Physical
acid NN Physical
, , Physical
white JJ Physical
blood NN Physical
count NN Physical
, , Physical
lipid JJ Physical
profile NN Physical
hepatic JJ Physical
and CC Physical
renal JJ Physical
function NN Physical
-DOCSTART- -X- N

service NN Other
utilization NN Other
and CC Other
cost NN Other
. . None
clinical JJ Other
cost NN Other
effectiveness NN Other
functional JJ Other
cost NN Other
effectiveness NN Other
functional JJ None
outcomes NNS None
cost NN Other
effectiveness NN Other
Mental NNP Mental
health NN Mental
and CC None
physical JJ Physical
health NN Physical
functioning NN Physical
, , None
as RB None
well RB None
as IN None
work NN Mental
status NN Mental
cost NN Other
savings NNS Other
physical JJ Physical
functioning VBG Physical
Functional JJ None
outcomes NNS None
health-related JJ Other
quality NN Other
of IN Other
life NN Other
-DOCSTART- -X- N

improvement NN Physical
of IN Physical
overall JJ Physical
subjective JJ Physical
symptoms NNS Physical
myofascial JJ Pain
visual JJ Physical
analog NN Physical
scale NN Physical
frequency NN Pain
and CC Pain
intensity NN Pain
of IN Pain
myofascial JJ Pain
pain NN Pain
number NN Physical
of IN Physical
tender NN Physical
sites NNS Physical
on IN Physical
the DT Physical
masticatory NN Physical
muscles NNS Physical
overall JJ Physical
subjective JJ Physical
symptoms NNS Physical
-DOCSTART- -X- N

thrombocyte JJ Physical
aggregation NN Physical
, , None
blood NN Physical
viscosity NN Physical
, , None
hemodynamics NNS Physical
functional JJ Physical
activity NN Physical
of IN Physical
thrombocytes NNS Physical
high JJ Physical
blood NN Physical
viscosity NN Physical
syndrome NN Physical
low JJ Physical
density NN Physical
lipoprotein NN Physical
cholesterol NN Physical
level NN Physical
. . None
myocardial JJ Physical
perfusion NN Physical
strength NN Physical
and CC Physical
frequency NN Physical
of IN Physical
coronary JJ Physical
pain NN Physical
attacks NNS Physical
postinfarction NN Physical
left VBD Physical
ventricular JJ Physical
remodeling NN Physical
quality NN Other
of IN Other
life NN Other
of IN Other
-DOCSTART- -X- N

auditory NN Physical
processing NN Physical
disorders NNS Physical
. . None
University NNP Other
of IN Other
Canterbury NNP Other
Adaptive NNP Other
Speech NNP Other
Test-Filtered NNP Other
Words NNP Other
( ( Other
UCAST-FW NNP Other
) ) Other
significant JJ Physical
maturational JJ Physical
effect NN Physical
. . None
UCAST-FW NNP Other
UCAST-FW NNP Other
maturational JJ Physical
changes NNS Physical
in IN Physical
auditory NN Physical
processing NN Physical
ability NN Physical
. . None
-DOCSTART- -X- N

effects NNS Other
spine JJ Physical
BMD NNP Physical
increased VBN None
BMD NNP Physical
changes NNS Physical
from IN None
baseline NN None
inverse JJ Physical
changes NNS Physical
in IN Physical
BTM NNP Physical
number NN Physical
of IN Physical
fractures NNS Physical
occurred VBD Physical
fracture NN Physical
rates NNS Physical
adverse JJ Adverse
bone NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

analgesic JJ Other
efficacy NN Other
postoperative JJ Physical
motor NN Physical
block NN Physical
. . Physical
clinical JJ Other
efficacy NN Other
of IN Other
the DT Other
caudal JJ Other
block NN Other
during IN Other
the DT Other
operation NN Other
. . None
analgesic JJ Other
onset JJ Other
time NN Other
, , Other
pain NN Pain
relief NN Pain
after IN Pain
the DT Pain
operation NN Pain
and CC None
residual JJ Physical
motor NN Physical
blockade NN Physical
. . None
residual JJ Physical
motor NN Physical
block NN Physical
analgesic JJ Other
efficacy NN Other
. . None
incidence NN Physical
of IN Physical
residual JJ Physical
motor NN Physical
blockade NN Physical
analgesic JJ Physical
block NN Physical
-DOCSTART- -X- N

prevention NN Physical
of IN Physical
postoperative JJ Physical
nausea NN Physical
and CC Physical
vomiting NN Physical
. . Physical
postoperative JJ Physical
nausea NN Physical
and CC Physical
vomiting NN Physical
incidence NN Physical
of IN Physical
nausea NN Physical
and CC Physical
vomiting NN Physical
Side-effects NNS Adverse
constipation NN Adverse
, , Adverse
headache NN Adverse
, , Adverse
and CC Adverse
asymptomatic JJ Adverse
elevation NN Adverse
of IN Adverse
liver NN Adverse
enzymes NNS Adverse
. . None
side-effects NNS Adverse
clinically RB Other
important JJ Other
benefit NN Other
optimal JJ None
oral JJ None
dose NN None
postoperative JJ Physical
nausea NN Physical
and CC Physical
vomiting NN Physical
. . None
-DOCSTART- -X- N

ECG NNP Other
changes NNS Other
good JJ Other
reproducibility NN Other
. . None
ergometrine-induced JJ Physical
coronary JJ Physical
spasm NN Physical
. . None
-DOCSTART- -X- N

Maximal NNP Physical
oxygen NN Physical
uptake NN Physical
ventilatory NN Physical
threshold NN Physical
. . Physical
Peak NNP Physical
and CC Physical
mean JJ Physical
power NN Physical
output NN Physical
Trunk NNP Physical
muscle NN Physical
endurance NN Physical
arms NNS Physical
endurance NN Physical
Performance NN Mental
basketball NN Other
technical JJ Other
skills NNS Other
shooting NN Mental
and CC Mental
passing NN Mental
. . None
-DOCSTART- -X- N

Effectiveness NN Other
efficacy NN Other
and CC Other
tolerability NN Other
mean JJ Physical
supine VBP Physical
diastolic JJ Physical
blood NN Physical
pressure NN Physical
reductions NNS Physical
reduced VBN Physical
supine JJ Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
log NN Physical
of IN Physical
the DT Physical
dose NN Physical
blood NN Physical
pressure NN Physical
reduction NN Physical
Automated VBN Physical
ambulatory JJ Physical
blood NN Physical
pressure NN Physical
recordings NNS Physical
blood NN Physical
pressure NN Physical
was VBD None
lowered VBN None
-DOCSTART- -X- N

rate NN Physical
of IN Physical
surgical JJ Physical
reattachment NN Physical
of IN Physical
the DT Physical
retina NN Physical
-DOCSTART- -X- N

mortality NN Mortality
of IN Physical
'serious JJ Physical
' POS Physical
ventricular JJ Physical
arrhythmias NNS Physical
no DT Mortality
significant JJ Mortality
differences NNS Mortality
mortality NN Mortality
incidence NN Physical
of IN Physical
heart NN Physical
failure NN Physical
number NN Physical
of IN Physical
dysrhythmic JJ Physical
episodes NNS Physical
on IN Physical
24-hour JJ Physical
ECG NNP Physical
recordings NNS Physical
reduce VB Mortality
the DT Mortality
mortality NN Mortality
from IN Mortality
acute JJ Mortality
myocardial JJ Mortality
infarction NN Mortality
reduce VB Physical
the DT Physical
incidence NN Physical
of IN Physical
'serious JJ Physical
' POS Physical
ventriicular JJ Physical
arrhythmias NNS Physical
. . None
-DOCSTART- -X- N

[ JJ None
progression-free JJ Mortality
survival NN Mortality
( ( Mortality
PFS NNP Mortality
) ) Mortality
] NN None
Cardiac JJ Adverse
event NN Adverse
rates NNS Adverse
PFS NNP Mortality
confidence NN None
interval NN None
( ( None
CI NNP None
) ) None
Overall JJ Adverse
risk NN Adverse
of IN Adverse
cardiotoxicity NN Adverse
Overall JJ Mortality
survival NN Mortality
Alopecia NNP Adverse
nausea NN Adverse
vomiting VBG Adverse
neutropenia $ Adverse
Palmar-plantar NNP Adverse
erythrodysesthesia NN Adverse
stomatitis NN Adverse
mucositis NN Adverse
cardiotoxicity NN Adverse
, , None
myelosuppression NN Physical
, , None
vomiting VBG Adverse
and CC None
alopecia NN Adverse
. . None
-DOCSTART- -X- N

onset JJ Physical
time NN Physical
peak JJ Physical
effect NN Physical
relative JJ Physical
resistance NN Physical
delayed VBN Physical
onset NN Physical
time NN Physical
-DOCSTART- -X- N

toxicity NN Physical
and CC None
clinical JJ Physical
outcome NN Physical
Acute NNP Adverse
toxicity NN Adverse
Common NNP Adverse
Terminology NNP Adverse
Criteria NNP Adverse
for IN Adverse
Adverse NNP Adverse
Events NNP Adverse
, , Adverse
version NN Adverse
3.0 CD Adverse
, , Adverse
and CC Adverse
late JJ Adverse
toxicity NN Adverse
was VBD None
graded VBN None
according VBG None
to TO None
the DT None
Radiation NNP None
Therapy NNP None
Oncology NNP None
Group NNP None
system NN None
. . None
acute JJ Adverse
gastrointestinal JJ Adverse
toxicity NN Adverse
disease-free JJ Mortality
survival NN Mortality
disease-free JJ Mortality
survival NN Mortality
overall JJ Mortality
survival NN Mortality
grade NN None
?2 NNP None
acute VBZ None
gastrointestinal JJ None
toxicities NNS None
( ( None
gastrointestinal JJ None
toxicities NNS None
( ( None
4.5 CD None
chronic JJ None
gastrointestinal JJ None
toxicity NN None
( ( None
13.6 CD None
significantly RB None
less JJR None
toxicity NN None
compared VBN None
comparable JJ None
clinical JJ None
outcome NN None
. . None
Further JJ None
-DOCSTART- -X- N

effectiveness NN Other
safety NN Other
intraocular JJ Physical
pressure NN Physical
intraocular JJ Physical
pressure NN Physical
reduction NN Physical
success NN Other
rates NNS Other
qualified JJ Other
success NN Other
rate NN Other
( ( Adverse
choroidal JJ Adverse
detachment NN Adverse
, , Adverse
hyphema NN Adverse
, , Adverse
leakage NN Adverse
) ) Adverse
hemorrhagic JJ Physical
detachment NN Physical
of IN Physical
the DT Physical
Descemet NNP Physical
membrane NN Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
Efficacy NN Other
measurements NNS Other
tolerated VBN Other
. . Other
adverse JJ Adverse
experiences NNS Adverse
adverse JJ Adverse
experiences NNS Adverse
adverse JJ Adverse
experience NN Adverse
rash NN Adverse
-DOCSTART- -X- N

inflammatory JJ Physical
markers NNS Physical
inflammatory JJ Physical
markers NNS Physical
plasma NN Physical
levels NNS Physical
of IN Physical
25 CD Physical
( ( Physical
OH NNP Physical
) ) Physical
D NNP Physical
, , None
high-sensitivity JJ Physical
C-reactive JJ Physical
protein NN Physical
( ( Physical
CRP NNP Physical
) ) Physical
, , Physical
interleukin FW Physical
( ( Physical
IL NNP Physical
) ) Physical
-6 NN Physical
, , None
IL-10 NNP Physical
, , None
and CC None
soluble JJ None
TNF-? NNP None
receptor NN None
type NN None
2 CD None
( ( None
sTNF-R2 NN None
) ) None
in IN None
CRP NNP Physical
, , None
IL-6 NNP Physical
, , Physical
IL-10 NNP Physical
, , None
and CC None
sTNF-R2 NNS Physical
Baseline NNP None
CRP NNP None
the DT None
baseline NN Physical
25 CD Physical
( ( Physical
OH NNP Physical
) ) Physical
D NNP Physical
level NN Physical
baseline NN None
25 CD None
( ( None
OH NNP None
) ) None
D NNP None
and CC None
vitamin NNP None
D NNP None
supplementation NN None
in IN None
log NN None
CRP NNP None
in IN None
circulating VBG None
inflammatory JJ None
markers NNS None
. . None
of IN None
CRP NNP None
with IN None
25 CD None
( ( None
OH NNP None
) ) None
D NNP None
-DOCSTART- -X- N

insomnia NN Mental
: : Mental
nocturnal JJ Physical
sleep NN Physical
. . Mental
primary JJ Physical
insomnia NN Physical
total JJ Physical
sleep JJ Physical
time NN Physical
. . Mental
Mean NNP Physical
daily JJ Physical
sleep NN Physical
latency NN Physical
on IN Physical
the DT Physical
screening VBG Physical
MSLT NNP Physical
of IN Physical
insomniacs NN Physical
screening NN Physical
MSLTs NNP Physical
screening NN Physical
total JJ Physical
sleep JJ Physical
times NNS Physical
mean JJ Physical
MSLT NNP Physical
score NN Physical
hyperarousal NN Physical
wake NN Physical
drive NN Physical
-DOCSTART- -X- N

food NN Physical
intake NN Physical
and CC Physical
energy NN Physical
expenditure NN Physical
. . Physical
food NN Mental
intake NN Mental
, , None
energy NN Physical
expenditure NN Physical
and CC None
body NN Physical
weight NN Physical
Body-weight JJ Physical
loss NN Physical
total JJ Physical
energy NN Physical
intake NN Physical
macronutrient JJ Physical
composition NN Physical
, , Physical
hunger NN Physical
, , Physical
satiety NN Physical
and CC Physical
hedonic JJ Physical
scores NNS Physical
Energy NNP Other
expenditure NN Other
sleeping VBG Physical
and CC Physical
resting VBG Physical
metabolic JJ Physical
rate NN Physical
, , Physical
diet-induced JJ Physical
thermogenesis NN Physical
, , Physical
activity-induced JJ Physical
energy NN Physical
expenditure NN Physical
and CC Physical
24 CD Physical
h NN Physical
RQ NNP Physical
food NN Mental
intake NN Mental
, , None
energy NN Physical
expenditure NN Physical
or CC None
body NN Physical
weight NN Physical
-DOCSTART- -X- N

survival NN Mortality
, , None
toxicity NN Physical
, , None
and CC None
overall JJ Physical
response NN Physical
Toxicity NN Physical
leukopenia NN Physical
thrombocytopenia NN Physical
leukopenia NN Physical
thrombocytopenia NN Physical
response NN Other
rate NN Other
hematological JJ Physical
toxicity NN Physical
leukopenia VBN Physical
thrombocytopenia VBN Physical
Rates NNS Other
of IN Other
responses NNS Other
-DOCSTART- -X- N

Blood NN Physical
samples NNS Physical
Peak NNP Physical
concentrations NNS Physical
of IN Physical
RU NNP Physical
486 CD Physical
Plasma NNP Physical
concentrations NNS Physical
Plasma NNP Physical
concentrations NNS Physical
of IN Physical
RU NNP Physical
42633 CD Physical
plasma JJ Physical
concentrations NNS Physical
of IN Physical
the DT Physical
metabolites NNS Physical
RU NNP Physical
486 CD Physical
to TO Physical
RU NNP Physical
42633 CD Physical
; : None
-DOCSTART- -X- N

proportion NN Physical
of IN Physical
subjects NNS Physical
receiving VBG Physical
> NN Physical
or CC Physical
=85 CD Physical
% NN Physical
relative JJ Physical
dose JJ Physical
intensity NN Physical
adverse JJ Adverse
events NNS Adverse
diarrhoea VB Physical
haematological JJ Adverse
toxicities NNS Adverse
febrile JJ Adverse
neutropenia NN Adverse
liver NN Physical
enzymes NNS Physical
and CC Physical
gastrointestinal JJ Physical
events NNS Physical
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
( ( Adverse
vomiting VBG Adverse
and CC Adverse
throat VB Adverse
oedema NN Adverse
) ) Adverse
-DOCSTART- -X- N

expired NNP Physical
gas NN Physical
exchange NN Physical
and CC Physical
respiratory NN Physical
flow NN Physical
relation NN Physical
of IN Physical
pacing VBG Physical
rate NN Physical
to TO Physical
oxygen VB Physical
consumption NN Physical
( ( Physical
VO2 NNP Physical
) ) Physical
, , None
expired VBD Physical
carbon NN Physical
dioxide NN Physical
concentration NN Physical
( ( Physical
VCO2 NNP Physical
) ) Physical
, , None
respiratory JJ Physical
quotient NN Physical
, , None
tidal JJ Physical
volume NN Physical
, , None
respiratory NN Physical
rate NN Physical
and CC Physical
minute NN Physical
ventilation NN Physical
Pacing VBG Physical
rate NN Physical
minute JJ Other
ventilation NN Other
respiratory JJ Physical
quotient NN Physical
VCO2 NNP Physical
tidal JJ Physical
volume NN Physical
VO2 NNP Physical
respiratory JJ Physical
rate NN Physical
mean JJ Physical
exercise NN Physical
duration NN Physical
maximal JJ Physical
VO2 NNP Physical
-DOCSTART- -X- N

social JJ Mental
skills NNS Mental
( ( Mental
Gilliam NNP Mental
Autism NNP Mental
Rating NNP Mental
Scale NNP Mental
) ) Mental
Maladaptive JJ Mental
behaviour NN Mental
communication NN Mental
and CC Mental
socialisation NN Mental
skills NNS Mental
. . None
-DOCSTART- -X- N

Therapy NNP Other
effect NN Other
TP53 NNP Physical
status NN Physical
TP53 NNP Physical
status NN Physical
Therapy NNP Other
response NN Other
positive JJ Physical
response NN Physical
rate NN Physical
relapse-free JJ Mortality
survival NN Mortality
sequence NN Physical
alterations NNS Physical
in IN Physical
the DT Physical
TP53 NNP Physical
gene NN Physical
. . Physical
relapse-free JJ Mortality
survival NN Mortality
TP53 NNP Physical
alterations NNS Physical
TP53 NNP Physical
tumour NN Physical
status NN Physical
prognosis NN None
-DOCSTART- -X- N

CD19+ NNP Physical
B NNP Physical
cells NNS Physical
CD19+ NNP Physical
B NNP Physical
cells NNS Physical
levels NNS Physical
of IN Physical
circulating VBG Physical
CD19+ NNP Physical
B NNP Physical
cells NNS Physical
. . None
total JJ Physical
CD19+ NNP Physical
blood NN Physical
population NN Physical
CD19+ NNP Physical
blood NN Physical
cells NNS Physical
CD19+ NNP Physical
B NNP Physical
cells NNS Physical
CD19+ NNP Physical
B-cell NNP Physical
level NN Physical
clinical JJ Physical
stage NN Physical
III NNP Physical
CD19 NNP Physical
cells NNS Physical
longer JJR Mortality
overall JJ Mortality
survival NN Mortality
CD19 NNP Physical
levels NNS Physical
event-free JJ Mortality
survival NN Mortality
. . None
CD19 NNP Physical
values NNS Physical
number NN Mortality
of IN Mortality
deaths NNS Mortality
related VBN Mortality
to TO Mortality
infections NNS Mortality
levels NNS Physical
of IN Physical
CD19+ NNP Physical
cells NNS Physical
. . None
CD19+ NNP Physical
cell NN Physical
levels NNS Physical
blood NN Physical
levels NNS Physical
of IN Physical
CD19+ NNP Physical
CD19+ NNP Physical
cell NN Physical
-DOCSTART- -X- N

operative JJ Other
time NN Other
, , None
blood NN Physical
loss NN Physical
, , None
blood NN Other
transfusion NN Other
, , None
intraoperative JJ Adverse
complications NNS Adverse
, , None
postoperative JJ Adverse
complications NNS Adverse
, , None
duration NN Other
of IN Other
hospital NN Other
stay NN Other
, , None
and CC None
number NN Other
of IN Other
lymph JJ Other
nodes NNS Other
safe JJ None
blood JJ Adverse
loss NN Adverse
hospitalization NN Other
; : None
operating VBG Other
time NN Other
. . None
-DOCSTART- -X- N

aggressive JJ Mental
reactions NNS Mental
indicator NN Mental
of IN Mental
aggression NN Mental
. . None
autonomic JJ Mental
arousal NN Mental
, , Mental
as IN None
measured VBN None
by IN None
photoplethysmographic JJ None
sensors NNS None
speed NN Mental
of IN Mental
clenching VBG Mental
. . None
tendencies NNS Mental
to TO Mental
aggression NN Mental
. . None
-DOCSTART- -X- N

motor NN Physical
recovery NN Physical
( ( Physical
9-hole CD Physical
Peg NNP Physical
Test NNP Physical
[ VBD Physical
9HPT CD Physical
] NN Physical
, , Physical
Jebsen NNP Physical
Taylor NNP Physical
Test NNP Physical
[ NNP Physical
JTT NNP Physical
] NNP Physical
, , Physical
and CC Physical
grip NN Physical
and CC Physical
pinch-grip JJ Physical
dynamometry NN Physical
) ) Physical
were VBD Physical
assessed VBN Physical
improvements NNS Physical
-- : Physical
9HPT CD Physical
, , Physical
5 CD Physical
% NN Physical
of IN Physical
maximum NN Physical
JTT NNP Physical
grip VB Physical
strength NN Physical
-DOCSTART- -X- N

less JJR Other
titration JJ Other
steps NNS Other
BP NNP Physical
goal NN Physical
BP NNP Physical
control NN Physical
rates NNS Physical
reductions NNS Other
in IN Other
both DT Other
systolic JJ Other
and CC Other
diastolic JJ Other
BP NNP Other
drug-related JJ Adverse
AEs NNP Adverse
early JJ Other
, , Other
improved JJ Other
BP NNP Physical
efficacy NN Physical
tolerability NN Other
-DOCSTART- -X- N

clinical JJ Physical
stage NN Physical
I/II NNP Physical
HL NNP Physical
-DOCSTART- -X- N

weight JJ Physical
loss NN Physical
, , Physical
metabolic JJ Physical
markers NNS Physical
, , Physical
body NN Physical
composition NN Physical
cardiac JJ Physical
function NN Physical
tests NNS Physical
change NN Physical
in IN Physical
body NN Physical
mass NN Physical
index NN Physical
Z-score NNP Physical
( ( None
BMI-Z NNP Physical
) ) None
( ( None
BMI-Z NNP Physical
) ) None
BMI-Z JJ Physical
reduction NN Physical
lean JJ Physical
body NN Physical
mass NN Physical
serious JJ Adverse
adverse JJ Adverse
effects NNS Adverse
metabolic JJ Physical
profiles NNS Physical
, , None
cardiac JJ Physical
function NN Physical
subjective JJ None
complaints NNS None
. . None
-DOCSTART- -X- N

partial JJ Mental
decreases NNS Mental
in IN Mental
maladaptive JJ Mental
behaviors NNS Mental
reduce VB Mental
the DT Mental
self-injurious JJ Mental
and CC Mental
other JJ Mental
maladaptive JJ Mental
behaviors NNS Mental
-DOCSTART- -X- N

respiratory NN Physical
exacerbations NNS Physical
Clinical JJ Physical
improvement NN Physical
, , Physical
chest VBP Physical
radiograph NN Physical
changes NNS Physical
, , Physical
evidence NN Physical
of IN Physical
airway JJ Physical
obstruction NN Physical
, , Physical
and CC Physical
bacteriologic JJ Physical
flora NNS Physical
of IN Physical
sputum NN Physical
-DOCSTART- -X- N

Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
irritability NN Mental
subscale NN Mental
and CC None
the DT None
Clinical NNP Mental
Global NNP Mental
Impression NNP Mental
improvement NN Mental
scale NN Mental
. . None
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
irritability NN Mental
subscale NN Mental
loss NN Other
of IN Other
efficacy NN Other
adverse JJ Adverse
effects NNS Adverse
relapse NN Physical
rates NNS Physical
efficacy NN Other
tolerability NN Other
-DOCSTART- -X- N

Pain NNP Pain
visual JJ Physical
analogue NN Physical
scale NN Physical
time NN Pain
-DOCSTART- -X- N

effective JJ Mental
ventilation NN Mental
variations NNS Physical
in IN Physical
delivered JJ Physical
airway NN Physical
pressure NN Physical
, , Physical
tidal JJ Physical
volume NN Physical
( ( Physical
TV NN Physical
) ) Physical
, , Physical
minute JJ Physical
ventilation NN Physical
( ( Physical
MV NNP Physical
) ) Physical
and CC Physical
inspiratory JJ Physical
time NN Physical
variation NN Other
in IN Other
mechanical JJ Other
ventilation NN Other
peak JJ Physical
inspiratory NN Physical
pressure NN Physical
( ( Physical
PIP NNP Physical
) ) Physical
positive JJ Physical
end-expiratory JJ Physical
pressure NN Physical
( ( Physical
PEEP NNP Physical
) ) Physical
PIP NNP Physical
PEEP NNP Physical
TV NN Physical
MV NNP Physical
delivered JJ Other
ventilation NN Other
. . Other
TV NN Physical
MV NNP Physical
-DOCSTART- -X- N

Weight NNP Physical
and CC None
leptin JJ Physical
changes NNS Physical
weight NN Physical
change NN Physical
. . None
Weight NNP Physical
change NN Physical
Change NNP Physical
in IN Physical
serum NN Physical
leptin NN Physical
levels NNS Physical
final JJ Physical
weight NN Physical
gain NN Physical
weight NN Physical
increased VBD Physical
weight NN Physical
gained VBN Physical
Change NN Physical
in IN Physical
leptin NN Physical
levels NNS Physical
final JJ Physical
weight NN Physical
gain NN Physical
. . None
weight VBD Physical
gain NN Physical
Serum NNP Physical
leptin JJ Physical
change NN Physical
weight NN Physical
gain NN Physical
. . None
-DOCSTART- -X- N

reported VBN Physical
energy NN Physical
intake NN Physical
( ( Physical
rEI NN Physical
) ) Physical
Basal NNP Physical
metabolic JJ Physical
rate NN Physical
( ( Physical
BMR NNP Physical
) ) Physical
physical JJ Physical
activity NN Physical
( ( Physical
EEPA NNP Physical
) ) Physical
rEI NN Physical
and CC None
misreporting NN Other
. . None
Mean NNP Physical
reported VBD Physical
energy NN Physical
intake NN Physical
total JJ Physical
energy NN Physical
expenditure NN Physical
-DOCSTART- -X- N

QoL NNP Other
St NNP Other
George NNP Other
's POS Other
Respiratory NNP Other
Questionnaire NNP Other
( ( Other
SGRQ NNP Other
) ) Other
visual JJ Other
analogue NN Other
scale NN Other
( ( Other
VAS NNP Other
) ) Other
VAS NNP Other
SGRQ NNP Other
QoL NNP Other
data NN Other
. . None
QoL NNP Other
. . None
-DOCSTART- -X- N

symptomatic JJ Physical
response NN Physical
and CC None
rates NNS Physical
of IN Physical
clinical JJ Physical
failure NN Physical
. . None
initial JJ Physical
resolution NN Physical
of IN Physical
symptoms NNS Physical
Mean JJ Physical
symptom NN Physical
scores NNS Physical
rate NN Physical
of IN Physical
clinical JJ Physical
failure NN Physical
-- : Physical
defined VBD Physical
acute JJ Physical
infection NN Physical
on IN Physical
otoscopic JJ Physical
examination NN Physical
-- : None
was VBD None
Mastoiditis NNP Adverse
Diarrhea NNP Adverse
and CC Adverse
diaper-area JJ Adverse
dermatitis NN Adverse
nasopharyngeal JJ Physical
colonization NN Physical
-DOCSTART- -X- N

frequency NN Mental
of IN Mental
generalized JJ Mental
turn NN Mental
taking VBG Mental
and CC None
generalized VBN Mental
initiating NN Mental
joint JJ Mental
attention NN Mental
initiating VBG Mental
joint JJ Mental
attention NN Mental
. . None
generalized JJ Mental
requests NNS Mental
initiating VBG Mental
joint JJ Mental
attention NN Mental
effect NN Other
sizes NNS Other
large JJ Other
. . None
-DOCSTART- -X- N

vocabulary JJ Mental
difference NN Mental
score NN Mental
Parent NNP Mental
expansions NNS Mental
of IN Mental
child NN Mental
verbal JJ Mental
utterances NNS Mental
spoken JJ Mental
vocabulary JJ Mental
the DT Mental
number NN Mental
of IN Mental
parent NN Mental
utterances NNS Mental
following VBG Mental
into IN Mental
the DT Mental
child NN Mental
's POS Mental
focus NN Mental
of IN Mental
attention NN Mental
the DT Mental
number NN Mental
of IN Mental
parent NN Mental
utterances NNS Mental
responding VBG Mental
to TO Mental
child VB Mental
verbal JJ Mental
communication NN Mental
spoken JJ Mental
vocabulary NN Mental
-DOCSTART- -X- N

median JJ Pain
interval NN Pain
until IN Pain
the DT Pain
first JJ Pain
decrease NN Pain
in IN Pain
pain NN Pain
median JJ Pain
interval NN Pain
until IN Pain
the DT Pain
complete JJ Pain
resolution NN Pain
of IN Pain
pain NN Pain
and CC None
promoted VBN None
faster RBR Pain
complete JJ Physical
healing NN Physical
of IN Physical
skin NN Physical
lesions NNS Physical
-DOCSTART- -X- N

costs NNS Other
costs NNS Other
cost NN Other
predictors NNS Other
. . None
Multivariable JJ Other
analysis NN Other
costs NNS Other
and CC None
cost NN Other
data NNS Other
Total JJ Other
costs NNS Other
costs NNS Other
and CC None
baseline NN Physical
status NN Physical
. . None
transplant-related JJ Physical
complications NNS Physical
: : None
repeated VBD Physical
infections NNS Physical
actual JJ Other
costs NNS Other
. . None
actual JJ Other
cost NN Other
-DOCSTART- -X- N

safety NN Other
and CC Other
efficacy NN Other
decrease NN None
in IN None
Aberrant NNP Mental
Behavior NNP Mental
Checklist-Community NNP Mental
Irritability NNP Mental
subscale NNP Mental
score NN Mental
) ) None
decrease NN None
. . None
Increased VBN Physical
appetite NN Physical
and CC Physical
weight JJ Physical
gain NN Physical
effective JJ Mental
for IN None
aggressive JJ Mental
behavior NN Mental
-DOCSTART- -X- N

higher JJR Physical
contamination NN Physical
rate NN Physical
fever NN Adverse
> $ Adverse
37.5 CD Adverse
degrees NNS Adverse
C NNP Adverse
postoperative JJ Other
stay NN Other
antibiotic JJ Adverse
related JJ Adverse
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

major JJ Mental
behavior NN Mental
disturbances NNS Mental
Conners NNPS Mental
' POS Mental
Rating VBG Mental
Scales NNS Mental
Sleep JJ Mental
Diary NNP Mental
( ( Mental
SD NNP Mental
) ) Mental
Conners NNPS Mental
' POS Mental
Teacher NNP Mental
Questionnaire NNP Mental
and CC None
SD NNP Mental
conduct NN Mental
problem NN Mental
, , Mental
hyperactivity NN Mental
, , Mental
inattention-passivity NN Mental
, , Mental
hyperactivity NN Mental
index NN Mental
, , Mental
and CC Mental
sleeping VBG Mental
behavior NN Mental
. . None
Conners NNP Mental
' POS Mental
Parent NNP Mental
Questionnaire NNP Mental
anxiety NN Physical
conduct NN Mental
problem NN Mental
anxiety NN Physical
stereotypical JJ Mental
behaviors NNS Mental
-DOCSTART- -X- N

efficacy NN Other
RTOG NNP Other
grade VBD Other
3 CD Other
neutropenia NN Other
Late JJ Physical
morbidity NN Physical
in IN Physical
the DT Physical
form NN Physical
of IN Physical
ulcers NNS Physical
strictures NNS Physical
survival NN Mortality
modest JJ Physical
improvement NN Physical
in IN Physical
survival NN Physical
manageable JJ Physical
additional JJ Physical
acute NN Physical
and CC None
late JJ Mortality
morbidity NN Mortality
. . None
-DOCSTART- -X- N

decision NN Physical
fixated VBD Physical
manipulation NN Physical
knowledge NN Physical
of IN Physical
words NNS Physical
manipulation NN Physical
knowledge NN Physical
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
valve FW Physical
motion NN Physical
thrombi NNS Physical
mobile JJ None
mobile JJ None
complications NNS Adverse
thrombus JJ Physical
size NN Physical
stroke NN Adverse
efficient JJ Other
and CC Other
safe JJ Other
stroke NN Adverse
-DOCSTART- -X- N

-DOCSTART- -X- N

detrusor VBN Physical
overactivity NN Physical
bladder NN Physical
capacity NN Physical
response NN Other
response NN Other
number NN Other
of IN Other
wet JJ Other
nights NNS Other
urodynamic JJ Physical
parameters NNS Physical
wet JJ Other
nights NNS Other
and CC None
urodynamic JJ Physical
parameters NNS Physical
response NN Other
-DOCSTART- -X- N

blood NN Physical
lipids NNS Physical
Blood NNP Physical
isoflavone NN Physical
concentrations NNS Physical
Blood NNP Physical
lipid JJ Physical
levels NNS Physical
blood NN Physical
isoflavones NNS Physical
and CC None
lipid JJ Physical
levels NNS Physical
. . None
decreases NNS Other
total JJ Physical
cholesterol NN Physical
LDL-cholesterol NNP Physical
blood NN Physical
lipids NNS Physical
. . None
-DOCSTART- -X- N

response NN Other
exercise VB Physical
training NN Physical
Loss NNP Physical
of IN Physical
muscle NN Physical
mass NN Physical
and CC Physical
strength NN Physical
falls NNS Physical
, , Physical
disability NN Physical
, , Physical
and CC Physical
morbidity NN Physical
physical JJ Physical
function NN Physical
physical JJ Physical
function NN Physical
was VBD None
between-group JJ None
change NN None
in IN None
6-minute JJ None
walk NN None
distance NN None
from IN None
included VBD None
changes NNS None
in IN None
Short NNP None
Physical NNP None
Performance NNP None
Battery NNP None
, , None
handgrip NN None
and CC None
quadriceps JJ None
strength NN None
, , None
self-reported JJ None
quality NN None
of IN None
life NN None
using VBG None
the DT None
EQ-5D NNP None
, , None
and CC None
functional JJ None
impairment NN None
measured VBD None
using VBG None
the DT None
Functional NNP None
Limitations NNP None
Profile NNP None
. . None
Baseline NNP None
6-minute JJ None
walk NN None
distance NN None
was VBD None
their PRP$ None
walk NN Physical
distance NN Physical
( ( None
exercise NN None
training NN None
on IN None
physical JJ None
function NN None
in IN None
-DOCSTART- -X- N

immune NN Physical
immunity NN Physical
-DOCSTART- -X- N

extravasation NN Physical
rate NN Physical
of IN Physical
albumin NN Physical
and CC Physical
fluid NN Physical
. . None
albumin JJ Physical
diffusion NN Physical
space NN Physical
, , Physical
the DT Physical
colloid JJ Physical
oncotic JJ Physical
pressure NN Physical
, , None
the DT None
plasma NN Physical
albumin NN Physical
concentration NN Physical
and CC None
the DT None
electrical JJ Physical
impedance NN Physical
Urine NN Physical
total JJ Physical
blood NN Physical
volume NN Physical
albumin NN Physical
diffusion NN Physical
space NN Physical
body NN Physical
electrical JJ Physical
impedance NN Physical
extravasation NN Physical
rate NN Physical
of IN Physical
albumin NN Physical
value NN Physical
of IN Physical
calculated JJ Physical
plasma NN Physical
volume NN Physical
loss NN Physical
of IN Physical
plasma JJ Physical
volume NN Physical
Urine NNP Physical
output NN Physical
colloid JJ Physical
oncotic JJ Physical
pressure NN Physical
and CC Physical
in IN Physical
plasma JJ Physical
albumin JJ Physical
concentration NN Physical
-DOCSTART- -X- N

One CD Physical
year NN Physical
recurrence NN Physical
recurrences NNS Physical
blisters NNS Adverse
, , Adverse
teleangiectatic JJ Adverse
matting NN Adverse
, , Adverse
scar NN Adverse
formation NN Adverse
, , Adverse
and CC Adverse
bruising VBG Adverse
from IN Adverse
bandaging VBG Adverse
. . Adverse
-DOCSTART- -X- N

efficacy NN Other
no DT Other
effect NN Other
interaction NN Mental
skills NNS Mental
demonstrated JJ Mental
progress NN Other
. . None
stronger JJR Mental
working VBG Other
alliances NNS Other
therapists NNS None
intervention NN Other
hours NNS Other
number NN Other
of IN Other
intervention NN Other
hours NNS Other
-DOCSTART- -X- N

Airway NNP Physical
responses NNS Physical
and CC Physical
inflammation NN Physical
Pulmonary JJ Physical
function NN Physical
and CC Physical
exhaled VBD Physical
NO NNP Physical
Induced NNP Physical
sputum NN Physical
in IN None
pulmonary JJ None
function NN None
, , None
the DT None
development NN None
of IN None
a DT None
late JJ None
asthmatic JJ None
response NN None
and CC None
bronchial JJ None
hyperresponsiveness NN None
, , None
significant JJ None
induction NN None
of IN None
eNO NN None
, , None
eosinophils NNS None
, , None
and CC None
Th-2 NNP None
cytokines NNS None
. . None
Repeated VBN None
provocation NN None
had VBD None
severe JJ None
adverse JJ None
events NNS None
marked VBD None
Th-2-mediated NNP None
allergic JJ None
airway NN None
inflammation NN None
. . None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
acute JJ Physical
coronary JJ Physical
syndromes NNS Physical
. . Physical
acute JJ Physical
ST-segment JJ Physical
myocardial JJ Physical
infarction NN Physical
( ( Physical
PENTALYSE NNP Physical
) ) Physical
and CC Physical
unstable JJ Physical
angina NN Physical
( ( Physical
PENTUA NNP Physical
) ) Physical
. . Physical
targeted VBD Physical
inhibition NN Physical
of IN Physical
coagulation NN Physical
effective JJ Physical
advance NN Physical
in IN Physical
antithrombotic JJ Physical
therapy NN Physical
. . Physical
-DOCSTART- -X- N

Cancer NNP Physical
related VBN Physical
fatigue NN Physical
( ( Physical
CRF NNP Physical
) ) Physical
CRF NNP Physical
level NN Physical
. . None
Fatigue NNP Physical
score NN Physical
( ( Physical
CRF NNP Physical
) ) Physical
Functional NNP Physical
Assessment NNP Physical
of IN Physical
Cancer NNP Physical
Therapy-Anaemia NNP Physical
Questionnaire NNP Physical
( ( Physical
FACT-An- NNP Physical
) ) Physical
( ( Physical
FACT-G NNP Physical
score NN Physical
& CC Physical
FACT-An NNP Physical
Anemia NNP Physical
subscale NN Physical
) ) Physical
. . Physical
CRF NNP Physical
Fatigue NNP Physical
score NN Physical
reduction NN Physical
FACT-An NNP Physical
score NN Physical
FACT-An NNP Physical
Toi NNP Physical
Anaemia-ANS JJ Physical
General NNP Other
Quality NNP Other
of IN Other
Life NNP Other
score NN Other
individual JJ Physical
wellbeing NN Physical
scores NNS Physical
; : Physical
Physical NNP Physical
Emotional NNP Physical
Social NNP Physical
Functional NNP Physical
self-reported JJ Physical
-DOCSTART- -X- N

Family NNP Mental
communication NN Mental
and CC None
problem-solving JJ Mental
skills NNS Mental
communication NN Mental
of IN Mental
adolescents NNS Mental
and CC Mental
mothers NNS Mental
, , Mental
but CC Mental
not RB Mental
fathers NNS Mental
. . Mental
quality NN Mental
of IN Mental
family NN Mental
interaction NN Mental
glycemic JJ Physical
control NN Physical
, , None
adherence NN Mental
, , None
and CC None
family NN Mental
conflict NN Mental
. . None
family NN Mental
communication NN Mental
and CC None
problem NN Mental
solving VBG Mental
-DOCSTART- -X- N

5-year JJ Mental
survival NN Mental
rate NN Mental
and CC Mental
the DT Mental
5-year JJ Mental
recurrence-free JJ Mental
rate NN Mental
slightly RB Mental
longer RBR Mental
recurrence-free JJ Mental
period NN Mental
. . Physical
levels NNS Physical
of IN Physical
peripheral JJ Physical
leukocytes NNS Physical
and CC Physical
peripheral JJ Physical
lymphocytes NNS Physical
; : Physical
Inhibition NN Physical
of IN Physical
bone NN Physical
marrow NN Physical
function NN Physical
certain JJ Physical
level NN Physical
of IN Physical
immune JJ Physical
performance NN Physical
improve VB Mortality
survival NN Mortality
rate NN Mortality
. . None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
biopsy-confirmed JJ Physical
acute NN Physical
rejections NNS Physical
incidence NN Physical
of IN Physical
steroid-sensitive JJ Physical
acute JJ Physical
rejections NNS Physical
Steroid-resistant JJ Physical
acute JJ Physical
rejections NNS Physical
died VBD Mortality
. . Mortality
Patient NNP Mortality
survival NN Mortality
and CC Mortality
graft NN Mortality
survival NN Mortality
incidence NN Adverse
of IN Adverse
adverse JJ Adverse
events NNS Adverse
cytomegalovirus NN Adverse
( ( Adverse
CMV NNP Adverse
) ) Adverse
infection NN Adverse
leukopenia NN Physical
fever RB Physical
herpes VBZ Adverse
simplex JJ Adverse
thrombocytopenia NN Physical
serum NN Physical
sickness NN Physical
new JJ Physical
onset NN Physical
diabetes NNS Physical
mellitus NN Physical
acute JJ Physical
rejection NN Physical
adverse JJ Adverse
events NNS Adverse
CMV NNP None
infection NN None
. . None
-DOCSTART- -X- N

peripheral JJ Physical
neuropathy NN Physical
: : None
efficacy NN Other
and CC Other
safety NN Other
peripheral JJ Physical
neuropathy NN Physical
( ( Physical
PIPN NNP Physical
) ) Physical
. . None
detailed JJ Other
neurological JJ Other
examination NN Other
and CC Other
electrophysiological JJ Other
study NN Other
severity NN Physical
of IN Physical
PIPN NNP Physical
was VBD Adverse
summarized VBN Adverse
by IN None
means NNS None
of IN None
a DT Other
modified JJ Other
Peripheral NNP Other
Neuropathy NNP Other
( ( Other
PNP NNP Other
) ) Other
score NN Other
. . None
incidence NN Adverse
of IN Adverse
neurotoxicity NN Adverse
relative JJ Physical
risk NN Physical
( ( Physical
RR NNP Physical
) ) Physical
of IN Physical
developing VBG Physical
PIPN NNP Physical
Mean JJ Other
PNP NNP Other
scores NNS Other
tolerated VBN Mental
safety NN Other
profile NN Other
. . None
occurrence NN Physical
of IN Physical
paclitaxel-induced JJ Physical
peripheral JJ Physical
nerve NN Physical
damage NN Physical
. . None
-DOCSTART- -X- N

efficacy NN Other
mean JJ Physical
blood NN Physical
transfusion NN Physical
requirements NNS Physical
time NN Physical
of IN Physical
bleeding VBG Physical
stop NN Physical
rebleeding NN Physical
and CC None
the DT None
mortality NN Mortality
rates NNS Mortality
effective JJ Other
acute JJ Physical
non-variceal JJ Physical
gastrointestinal JJ Physical
bleeding NN Physical
additional JJ Other
benefit NN Other
-DOCSTART- -X- N

recall NN Mental
assess VB Mental
recall NN Mental
total JJ Mental
number NN Mental
of IN Mental
themes NNS Mental
recalled VBN Mental
per IN Mental
participant NN Mental
. . None
proportion NN Mental
of IN Mental
responses NNS Mental
recalled VBD Mental
individual JJ Mental
themes NNS None
proportion NN None
of IN None
responses NNS None
falsely RB Mental
recalled VBN Mental
or CC Mental
extraneous JJ Mental
information NN Mental
. . None
mean NN Mental
of IN Mental
the DT Mental
total JJ Mental
number NN Mental
of IN Mental
themes NNS Mental
recalled VBN Mental
proportion NN Mental
of IN Mental
responses NNS Mental
recall NN Mental
recall NN Mental
falsely RB Mental
recalled VBN Mental
or CC Mental
extraneous JJ Mental
information NN Mental
-DOCSTART- -X- N

MEASURES NNP None
Resting NNP Physical
blood NN Physical
pressure NN Physical
( ( Physical
BP NNP Physical
) ) Physical
, , None
HR NNP None
, , None
MSNA NNP None
, , None
spontaneous JJ None
arterial JJ None
baroreflex NN None
MSNA NNP None
and CC None
HR NNP None
modulation NN None
, , None
endothelium-dependent JJ None
and CC None
endothelium-independent JJ None
vasodilation NN None
, , None
and CC None
the DT None
homoeostatic JJ None
model NN None
assessment NN None
of IN None
insulin NN None
resistance NN None
( ( None
HOMA-IR NNP None
) ) None
. . None
lowered VBD None
MSNA NNP Physical
burst JJ Physical
frequency NN Physical
( ( None
MSNA NNP Physical
burst NN Physical
incidence NN Physical
( ( None
from IN None
affecting VBG None
BP NNP Physical
, , None
HR NNP Physical
, , None
baroreflex JJ Physical
modulation NN Physical
of IN Physical
either DT Physical
MSNA NNP Physical
or CC Physical
HR NNP Physical
, , Physical
or CC Physical
HR NNP Physical
variability NN Physical
( ( None
all DT None
) ) None
. . None
Plasma NNP None
glucose NN None
, , None
insulin NN None
, , None
HOMA-IR NNP None
and CC None
endothelium-dependent JJ None
vasodilation NN None
( ( None
all DT None
whereas JJ None
endothelium-independent JJ None
vasodilation NN None
increased VBD None
MSNA NNP None
in IN None
low-density NN None
lipoprotein NN None
cholesterol NN None
( ( None
r=0.41 NN None
-DOCSTART- -X- N

cure NN Other
rates NNS Other
cure NN Other
rates NNS Other
-DOCSTART- -X- N

eliciting VBG Mental
speech NN Mental
eliciting VBG Mental
speech NN Mental
progress NN Other
number NN Mental
of IN Mental
verbal JJ Mental
attempts NNS Mental
number NN Mental
of IN Mental
correct JJ Mental
words NNS Mental
number NN Mental
of IN Mental
verbal JJ Mental
attempts NNS Mental
or CC None
number NN Mental
of IN Mental
correct JJ Mental
words NNS Mental
number NN Mental
of IN Mental
new JJ Mental
words NNS Mental
imitative JJ Mental
attempts NNS Mental
-DOCSTART- -X- N

nausea NN Adverse
and CC Adverse
vomiting NN Adverse
nausea NN Adverse
and CC None
vomiting NN Adverse
vomiting VBG Adverse
and CC Adverse
nausea NN Adverse
Complete NNP Adverse
control NN Adverse
of IN Adverse
acute JJ Adverse
vomiting NN Adverse
acute JJ Adverse
nausea NN Adverse
Overall JJ Physical
response NN Physical
vomiting VBG Adverse
and CC None
nausea NN Adverse
more RBR None
effective JJ Other
The DT None
adverse JJ Adverse
reactions NNS Adverse
tolerability NN Other
antiemetic JJ None
therapy NN None
modalities NNS None
. . None
nausea NN Adverse
and CC None
vomiting NN Adverse
This DT None
increased VBD None
antiemetic JJ Other
efficacy NN Other
body NN Physical
weight NN Physical
. . None
-DOCSTART- -X- N

long-term JJ Physical
effect NN Physical
symptomatology NN Physical
, , None
exercise NN Physical
performance NN Physical
left VBD Physical
ventricular JJ Physical
function NN Physical
symptom NN Physical
scores NNS Physical
functional JJ Physical
classification NN Physical
maximal JJ Physical
exercise NN Physical
capacity NN Physical
resting VBG Physical
heart NN Physical
rate NN Physical
left JJ Physical
ventricular JJ Physical
systolic JJ Physical
function NN Physical
-DOCSTART- -X- N

response NN Physical
response NN None
to TO None
treatment NN None
( ( None
defined VBN None
as IN None
a DT None
platelet NN None
count NN None
of IN None
odds NNS Physical
of IN Physical
response NN Physical
responded VBD None
of IN None
responding VBG None
concomitant JJ Physical
treatment NN Physical
rescue NN Other
treatment NN Other
thromboembolic JJ None
events NNS None
alanine JJ None
aminotransferase NN None
concentration NN None
total JJ None
bilirubin NN None
serious JJ Adverse
bleeding VBG Adverse
events NNS Adverse
-DOCSTART- -X- N

reductions NNS Other
in IN Other
depressive JJ Other
symptoms NNS Other
. . None
mood NN Mental
, , None
coping VBG Mental
and CC None
social JJ Mental
support NN Mental
psychosocial JJ Other
questionnaires NNS Other
depressive NN Mental
symptoms NNS Mental
and CC None
perceived VBD Mental
social JJ Mental
support NN Mental
. . None
10-week JJ Mental
increases NNS Mental
in IN Mental
cognitive JJ Mental
coping NN Mental
changes NNS Mental
in IN Mental
positive JJ Mental
reframing NN Mental
reductions NNS Mental
in IN Mental
depressive JJ Mental
symptoms NNS Mental
-DOCSTART- -X- N

drug NN Mental
efficacy NN Mental
higher JJR Mental
no DT Mental
significant JJ Mental
difference NN Mental
patients NNS Mental
with IN Mental
adverse JJ Mental
drug NN Mental
effects NNS Mental
lowest JJS Mental
actuarial JJ Mental
probability NN Mental
of IN Mental
a DT Mental
recurrence NN Mental
of IN Mental
arrhythmia NN Mental
significantly RB Other
lower JJR Other
lower JJR Other
risks NNS Other
of IN Other
death NN Other
death NN Other
from IN Other
arrhythmia NN Other
effective JJ None
effective JJ None
and CC None
tolerated VBD None
higher JJR None
effective JJ None
preventing VBG None
death NN None
and CC None
recurrences NNS None
of IN None
arrhythmia NN None
. . None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
efficacy NN Other
and CC None
safety NN Other
Therapeutic JJ Physical
response NN Physical
heart NN Physical
rate NN Physical
, , None
heart NN Physical
rate NN Physical
less JJR Physical
than IN Physical
100 CD Physical
bpm NN Physical
, , None
or CC None
conversion NN Physical
to TO Physical
normal JJ Physical
sinus NN Physical
rhythm NN Physical
. . None
The DT Other
therapeutic JJ Other
response NN Other
normal JJ Physical
sinus JJ Physical
rhythm NN Physical
therapeutic JJ Other
response NN Other
adverse JJ Adverse
effect NN Adverse
hypotension NN Adverse
Hypotension NN Adverse
and CC Adverse
associated VBN Adverse
symptoms NNS Adverse
-DOCSTART- -X- N

diastolic JJ Physical
perfusion NN Physical
time NN Physical
. . Physical
Left NNP None
ventricular JJ Physical
time NN None
intervals NNS None
obtained VBN Physical
carotid NN None
thermistor NN None
plethysmography NN None
. . None
Diastolic NNP Physical
duration NN Physical
calculated VBN Other
by IN Other
subtracting VBG Other
the DT Other
electromechanical JJ Other
systole NN Other
from IN Other
the DT Other
R-R NNP Other
interval NN Other
and CC Other
expressed VBD Other
as IN Other
a DT Other
percentage NN Other
of IN Other
the DT Other
cardiac JJ Other
cycle NN Other
( ( Other
% NN Other
D NNP Other
) ) Other
. . Other
total JJ None
exercise NN None
duration NN None
time NN None
to TO None
0.1-mV JJ None
ST NNP None
segment NN None
depression NN None
induced VBD Physical
a DT Physical
reduction NN Physical
of IN Physical
the DT Physical
rate-pressure JJ Physical
product NN Physical
extent NN None
of IN None
ischemic JJ None
ST NNP None
segment NN None
depression NN None
% NN None
D NNP None
linear JJ Physical
regression NN Physical
no DT None
difference NN None
was VBD None
observed VBN None
between IN None
both DT None
slopes NNS None
and CC None
intercepts NNS None
. . None
relationship NN None
between IN None
R-R NNP None
interval NN None
and CC None
% NN None
D NNP None
diastolic JJ Other
duration NN Other
-DOCSTART- -X- N

language NN Mental
behavioral JJ Mental
symptoms NNS Mental
assessments NNS Mental
of IN Mental
language NN Mental
, , Mental
behavior NN Mental
, , Mental
and CC Mental
autism NN Mental
symptomatology NN Mental
. . None
mean JJ Mental
scores NNS Mental
on IN Mental
any DT Mental
measure NN Mental
of IN Mental
language NN Mental
, , Mental
behavior NN Mental
, , Mental
or CC Mental
autism NN Mental
symptom JJ Mental
severity NN Mental
-DOCSTART- -X- N

diagnostic JJ Other
quality NN Other
diagnostic JJ Other
diagnostic JJ Other
poorer NN Physical
bladder NN Physical
distension NN Physical
significantly RB Physical
less JJR Physical
discomfort NN Physical
-DOCSTART- -X- N

symptoms NNS Physical
, , Physical
range NN Physical
of IN Physical
motion NN Physical
at IN Physical
the DT Physical
wrist NN Physical
, , Physical
power NN Physical
of IN Physical
first JJ Physical
closure NN Physical
and CC Physical
radiographic JJ Physical
appearance NN Physical
. . Physical
range NN Other
of IN Other
movement NN Other
loss NN Physical
of IN Physical
power NN Physical
of IN Physical
first JJ Physical
clenching NN Physical
-DOCSTART- -X- N

acute JJ Pain
nociceptive JJ Pain
and CC Pain
inflammatory JJ Pain
pain NN Pain
postoperative JJ Pain
pain NN Pain
. . None
postoperative JJ Physical
need NN Physical
for IN Physical
additional JJ Physical
pain NN Physical
treatment NN Physical
postoperative JJ Pain
pain NN Pain
treatment NN Pain
pain VBP Pain
scores NNS Pain
at IN Pain
rest NN Pain
and CC None
worst JJS Pain
pain NN Pain
score NN Pain
degree NN Physical
of IN Physical
postoperative JJ Physical
nausea NN Adverse
and CC Adverse
incidence NN Adverse
of IN Adverse
vomiting/retching VBG Adverse
postoperative JJ Pain
pain NN Pain
effective JJ Other
preoperative JJ Physical
anxiety NN Physical
-DOCSTART- -X- N

response NN Physical
to TO Physical
treatment NN Physical
: : None
20 CD Physical
% NN Physical
improvement NN Physical
from IN Physical
basal JJ Physical
conditions NNS Physical
clinical JJ Physical
, , Physical
laboratory NN Physical
, , Physical
or CC Physical
specific JJ Physical
neurological JJ Physical
testing NN Physical
variables NNS Physical
. . None
response NN Physical
rate NN Physical
effective JJ Other
-DOCSTART- -X- N

efficacy NN Other
, , Other
safety NN Other
and CC Other
cost-effectiveness NN Other
percentage NN Other
patients NNS Other
who WP Other
quit VBP Other
cost-effectiveness NN Other
rate NN Physical
of IN Physical
symptom NN Physical
relief NN Physical
and CC Physical
the DT Physical
improvement NN Physical
of IN Physical
symptom NN Physical
score NN Physical
weekly JJ Mental
average NN Mental
number NN Mental
of IN Mental
days NNS Mental
quit VBD Other
( ( None
P NNP None
= NNP None
0.065 CD None
) ) None
. . None
Cost-effectiveness JJ None
calculated VBD None
achieved VBN None
symptom JJ None
relief NN None
in IN None
good JJ None
option NN None
of IN None
cost-effectiveness NN None
and CC None
speed NN None
of IN None
action NN None
. . None
-DOCSTART- -X- N

intramucosal NN Physical
pH VBZ Physical
value NN Physical
Heart NNP Physical
rate NN Physical
, , Physical
cardiac JJ Physical
index NN Physical
, , Physical
and CC Physical
mixed JJ Physical
venous JJ Physical
oxygen NN Physical
saturation NN Physical
systemic JJ Physical
vascular NN Physical
resistance NN Physical
splanchnic JJ Physical
blood NN Physical
flow NN Physical
, , Physical
cardiac JJ Physical
index NN Physical
venous JJ Physical
saturation NN Physical
. . None
-DOCSTART- -X- N

Pain VB Pain
detection NN Pain
and CC Pain
tolerance NN Pain
thresholds NNS Pain
for IN Pain
pressure NN Pain
and CC Pain
electric JJ Pain
stimuli NNS Pain
pain NN Pain
thresholds NNS Pain
pain NN Pain
modulation NN Pain
-DOCSTART- -X- N

smoking VBG Mental
severity NN Mental
and CC None
rsFC NN Physical
between IN Physical
insula NN Physical
Nicotine NNP Other
challenge NN Other
alter VB Physical
rsFC NN Physical
in IN Physical
insula-dACC-striatal JJ Physical
circuits NNS Physical
. . Physical
rsFC JJ Physical
strength NN Physical
-DOCSTART- -X- N

first JJ Physical
recurrence NN Physical
Endoscopic NNP Other
examination NN Other
urinary JJ Other
cytology NN Other
recurrence NN Physical
rate NN Physical
Toxicity NN Adverse
bladder VB Adverse
irritation NN Adverse
-DOCSTART- -X- N

plasma NN Physical
, , None
red JJ Physical
blood NN Physical
cells NNS Physical
( ( Physical
RBC NNP Physical
) ) Physical
, , None
platelets NNS Physical
( ( Physical
PLT NNP Physical
) ) Physical
, , Physical
and CC None
mononuclear JJ Physical
cells NNS Physical
( ( Physical
MN NNP Physical
) ) Physical
. . None
all-trans JJ Physical
beta-carotene JJ Physical
level NN Physical
plasma NN Physical
, , None
PLT NNP Physical
, , None
and CC None
MN NNP Physical
Basal NNP Physical
levels NNS Physical
of IN Physical
9-cis CD Physical
beta-carotene NN Physical
in IN Physical
plasma NN Physical
, , Physical
PLT NNP Physical
, , Physical
and CC Physical
MN NNP Physical
Plasma NNP Physical
and CC Physical
RBC NNP Physical
alpha-tocopherol NN Physical
levels NNS Physical
No DT Adverse
side NN Adverse
effects NNS Adverse
or CC Adverse
toxicities NNS Adverse
-DOCSTART- -X- N

assessed VBD None
the DT None
baseline NN None
prevalence NN None
of IN None
, , None
and CC None
risk NN None
factors NNS None
for IN None
trachoma NN Physical
ocular JJ None
C. NNP None
trachomatis NN None
infection NN None
World NNP Physical
Health NNP Physical
Organization NNP Physical
( ( Physical
WHO NNP Physical
) ) Physical
simplified VBD Physical
grading VBG Physical
system NN Physical
ocular JJ Physical
swab NN Physical
Amplicor NNP None
polymerase NN None
chain NN None
reaction NN None
Amplicor NNP Physical
positive JJ Physical
prevalences NNS Physical
ocular JJ Physical
or CC Physical
nasal JJ Physical
discharge NN Physical
low JJ Mental
level NN Mental
of IN Mental
household NN Mental
head NN Mental
education NN Mental
aged VBN None
? . None
1 CD None
year NN None
. . None
flies NNS None
on IN None
the DT None
child NN None
's POS None
face NN None
, , None
being VBG None
Amplicor NNP None
positive JJ None
, , None
and CC None
crowding NN None
( ( None
being VBG None
Amplicor NNP None
positive JJ None
in IN None
only RB None
ocular JJ None
discharge NN None
was VBD None
being VBG None
Amplicor NNP None
positive JJ None
. . None
and CC None
Amplicor NNP None
positives NNS None
were VBD None
being VBG None
Amplicor NNP None
positive JJ None
were VBD None
trachoma JJ None
clinical JJ None
signs NNS None
and CC None
evidence NN None
of IN None
C. NNP None
trachomatis NN None
infection NN None
in IN None
Only RB None
ocular JJ None
discharge NN None
was VBD None
-DOCSTART- -X- N

retinopathy NN Physical
, , None
nephropathy JJ Physical
, , None
and CC None
neuropathy JJ Physical
retinopathy NN Physical
nephropathy JJ Physical
mean NN Physical
glycosylated VBD Physical
hemoglobin NN Physical
( ( Physical
HbA NNP Physical
( ( Physical
1c CD Physical
) ) Physical
) ) Physical
level NN Physical
median JJ Physical
HbA NNP Physical
( ( Physical
1c CD Physical
) ) Physical
level NN Physical
difference NN Physical
in IN Physical
mean JJ Physical
HbA NNP Physical
( ( Physical
1c CD Physical
) ) Physical
levels NNS Physical
rate NN Physical
of IN Physical
progression NN Physical
of IN Physical
complications NNS Physical
target NN Physical
HbA NNP Physical
( ( Physical
1c CD Physical
) ) Physical
level NN Physical
-DOCSTART- -X- N

leptin NN Physical
and CC Physical
leptin NN Physical
receptor NN Physical
gene NN Physical
expression NN Physical
myoma NN Physical
volume NN Physical
, , None
changes NNS None
expression NN None
of IN None
leptin NN None
genes NNS None
and CC None
gene NN None
coding VBG None
leptin JJ Physical
receptor NN Physical
isoforms NNS Physical
Expression NNP Physical
of IN Physical
leptin NN Physical
genes NNS Physical
leptin NN Physical
proteins NNS Physical
and CC Physical
leptin JJ Physical
receptor NN Physical
proteins NNS Physical
effect NN None
expression NN Physical
pattern NN Physical
leptin NN Physical
genes NNS Physical
-DOCSTART- -X- N

? . None
value NN None
mean JJ None
sensitivity NN None
volume NN None
of IN None
total JJ None
agreement NN None
the DT None
union NN None
volume NN None
Rectal JJ None
and CC None
bladder VB None
wall NN None
DVH NNP None
parameters NNS None
of IN None
IMRT NNP None
and CC None
VMAT NNP None
vs VBP None
3D-CRT JJ None
plans NNS None
-DOCSTART- -X- N

8-oxo-dG JJ Physical
levels NNS Physical
in IN Physical
lymphocyte NN Physical
DNA NNP Physical
mean JJ Physical
8-oxo-dG JJ Physical
concentration NN Physical
8-oxo-dG NN Physical
Oxidative NNP Physical
DNA NNP Physical
damage NN Physical
mean JJ Physical
baseline NN Physical
levels NNS Physical
of IN Physical
antioxidants NNS Physical
premature NN Mortality
coronary JJ Mortality
heart NN Mortality
disease NN Mortality
mortality NN Mortality
coronary JJ Mortality
heart NN Mortality
disease NN Mortality
mortality NN Mortality
rates NNS Mortality
significant JJ Other
positive JJ Other
correlation NN Other
stomach NN Physical
cancer NN Physical
-DOCSTART- -X- N

significant JJ Other
improvement NN Other
free JJ None
of IN None
symptoms NNS Physical
lack NN Mental
of IN Mental
activity NN Mental
, , None
tiredness NN Physical
, , None
fatigue NN Mental
, , None
and CC None
disturbed JJ Mental
sleep NN Mental
no DT None
undesirable JJ Adverse
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

Efficacy NN Other
hemorrhoidal PRP$ Physical
symptoms NNS Physical
based VBN Physical
on IN Physical
a DT Physical
visual JJ Physical
analogue NN Physical
scale NN Physical
( ( Physical
VAS NNP Physical
) ) Physical
: : None
pain NN Pain
, , None
discharge NN Physical
, , Physical
bleeding NN Physical
, , Physical
inflammation NN Physical
, , Physical
and CC Physical
pruritus NN Physical
; : None
analgesic JJ Other
intake NN Other
, , Other
if IN Other
any DT Other
; : Other
time NN Other
to TO Other
restore VB Other
a DT Other
physiological JJ Other
defecation NN Other
; : None
edema CC None
evaluation NN None
( ( None
based VBN None
on IN None
a DT None
four-point JJ None
scale NN None
: : None
camera NN Physical
pictures VBZ Physical
taken VBN Physical
at IN Physical
T1 NNP Physical
and CC Physical
T4 NNP Physical
blood NN Physical
coagulation NN Physical
tests NNS Physical
. . Physical
significant JJ Physical
difference NN Physical
total JJ Other
VAS NNP Other
score NN Other
bleeding NN Physical
and CC None
pruritus NN Physical
inflammation NN Physical
and CC None
edema NN Physical
No DT Adverse
adverse JJ Adverse
events NNS Adverse
blood NN Physical
coagulation NN Physical
-DOCSTART- -X- N

Uterine JJ Physical
volume NN Physical
, , None
mean VB Other
operating NN Other
time NN Other
, , None
uterine JJ Physical
weight NN Physical
, , Physical
drop NN Physical
in IN Physical
hemoglobin NN Physical
, , None
intraoperative JJ Adverse
complications NNS Adverse
, , None
conversions NNS Physical
to TO Physical
laparotomy VB Physical
, , None
and CC None
hospital NN Other
stay NN Other
uterine JJ Physical
volume NN Physical
uterine JJ Physical
weight NN Physical
, , None
operating VBG Other
time NN Other
, , None
and CC None
drop NN Physical
in IN Physical
hemoglobin JJ Physical
level NN Physical
. . Physical
-DOCSTART- -X- N

improvement NN Mental
in IN Mental
mental JJ Mental
activity NN Mental
. . None
compensatory NN Other
effect NN Other
cerebral JJ Physical
haemodynamics NNS Physical
: : None
progressive JJ Physical
increase NN Physical
in IN Physical
cerebral JJ Physical
circulation NN Physical
time NN Physical
expression NN Physical
of IN Physical
decreased JJ Physical
cerebral JJ Physical
blood NN Physical
flow NN Physical
8-10 JJ Other
Hz NNP Other
pattern NN Other
performance NN Other
-DOCSTART- -X- N

-DOCSTART- -X- N

in IN None
weight NN None
, , None
BMI NNP None
, , None
and CC None
LBM NNP None
greater JJR None
weight NN None
and CC None
BMI NNP None
gain NN None
not RB None
LBM NNP None
baseline NN None
CD4 NNP None
cell NN None
count NN None
and CC None
higher JJR None
HIV-1 NNP None
RNA NNP None
were VBD None
weight NN None
, , None
BMI NNP None
, , None
or CC None
LBM NNP None
. . None
In IN None
increased VBD None
LBM NNP None
was VBD None
increased VBN None
hip NN None
BMD NNP None
. . None
CONCLUSION NNP None
weight NN None
, , None
BMI NNP None
, , None
or CC None
LBM NNP None
; : None
ATV/r NNP None
greater JJR None
weight NN None
and CC None
BMI NNP None
gain NN None
LBM NNP None
. . None
A NNP None
-DOCSTART- -X- N

final JJ Other
concentration NN Other
of IN Other
the DT Other
drugs NNS Other
were VBD None
measured VBN None
. . None
concentration NN Other
of IN Other
infusions NNS Other
Medication NNP Mental
errors NNS Mental
medication NN Mental
errors NNS Mental
and CC None
treatment NN Mental
delays NNS Mental
patient NN Other
safety NN Other
. . None
-DOCSTART- -X- N

Fat NNP Physical
absorption NN Physical
Beta-carotene NNP Physical
and CC Physical
vitamin VB Physical
A NNP Physical
in IN Physical
their PRP$ Physical
plasma NN Physical
-DOCSTART- -X- N

blood NN Physical
lipids NNS Physical
Total JJ Physical
cholesterol NN Physical
, , Physical
triglycerides NNS Physical
, , Physical
HDL NNP Physical
and CC Physical
LDL NNP Physical
cholesterol NN Physical
fractions NNS Physical
total JJ Physical
cholesterol NN Physical
triglycerides NNS Physical
LDL NNP Physical
HDL NNP Physical
triglycerides NNS Physical
HDL NNP Physical
cholesterol NN Physical
total JJ Physical
cholesterol NN Physical
or CC Physical
LDL NNP Physical
fraction NN Physical
total JJ Physical
triglycerides NNS Physical
( ( Physical
NS NNP Physical
) ) Physical
HDL NNP Physical
total JJ Physical
cholesterol NN Physical
and CC Physical
LDL NNP Physical
fraction NN Physical
. . Physical
blood NN Physical
lipids NNS Physical
blood NN Physical
lipids NNS Physical
. . None
-DOCSTART- -X- N

Arterial JJ Physical
blood NN Physical
samples NNS Physical
serum VBD Physical
propofol JJ Physical
concentrations NNS Physical
in IN Physical
equilibrium NN Physical
EC50 NNP Physical
+/- JJ Physical
SE NNP Physical
values NNS Physical
EC50 NNP Physical
additive JJ Physical
interaction NN Physical
loss NN Physical
of IN Physical
consciousness NN Physical
. . None
loss NN Physical
of IN Physical
consciousness NN Physical
. . None
-DOCSTART- -X- N

Anti-emetic JJ Other
efficacy NN Other
prevention NN Physical
efficacy NN Other
complete JJ Physical
response NN Physical
, , Physical
defined VBD Physical
as IN Physical
no DT Physical
emesis NN Physical
with IN Physical
no DT Physical
need NN Physical
for IN Physical
another DT Physical
rescue NN Physical
antiemetic JJ Physical
corresponding JJ Physical
incidence NN Physical
adverse JJ Adverse
events NNS Adverse
long-term JJ None
prevention NN None
post-operative JJ Physical
vomiting NN Physical
-DOCSTART- -X- N

effects NNS Other
dysfunctional JJ Other
parenting NN Other
, , Other
parental JJ Other
stress NN Other
and CC Other
child VB Other
behaviour NN Other
problems NNS Other
little JJ Adverse
side NN Adverse
effects NNS Adverse
positive JJ Mental
acceptance NN Mental
-DOCSTART- -X- N

safety NN Other
tolerability NN None
safety NN Other
tolerability NN Other
of IN Other
rotigotine NN Other
nausea JJ Adverse
and/or NN Adverse
vomiting NN Adverse
side-effect JJ Adverse
profile NN Adverse
adverse JJ Adverse
event NN Adverse
profile NN Adverse
-DOCSTART- -X- N

antitumor NN Physical
activity NN Physical
safety NN Other
Grades $ Adverse
3 CD Adverse
and CC Adverse
4 CD Adverse
toxicities NNS Adverse
neutropenia RB Adverse
fatigue NN Adverse
neuropathy JJ Adverse
ixabepilone NN None
arm NN None
, , None
and CC None
neutropenia NN Physical
febrile JJ Adverse
neutropenia NN Adverse
fatigue NN Physical
neuropathy JJ Physical
thrombosis NN Adverse
prostate-specific JJ Physical
antigen NN Physical
partial JJ Physical
responses NNS Physical
Time NN Physical
to TO Physical
prostate-specific JJ Physical
antigen NN Physical
progression NN Physical
well RB None
tolerated VBN Other
antitumor VBN Other
activity NN Other
-DOCSTART- -X- N

antiproteinuric JJ Physical
effect NN Physical
antiproteinuric JJ Physical
effect NN Physical
creatinine NN Physical
levels NNS Physical
. . None
Gastric NNP Physical
irritation NN Physical
short-term JJ Physical
antiproteinuric JJ Physical
action NN Physical
-DOCSTART- -X- N

Subjective JJ Mental
Significance NNP Mental
Questionnaire NNP Mental
changes NNS None
health-related JJ Mental
quality-of-life NN Mental
( ( Mental
HRQOL NNP Mental
) ) Mental
EORTC NNP Mental
Quality NNP Mental
of IN Mental
Life NNP Mental
Questionnaire NNP Mental
( ( Mental
QLQ-C30 NNP Mental
) ) Mental
Subjective NNP Mental
Significance NNP Mental
Questionnaire NNP Mental
( ( Mental
SSQ NNP Mental
) ) Mental
. . None
physical JJ Physical
functioning NN Physical
, , None
emotional JJ Mental
functioning NN Mental
, , None
social JJ Mental
functioning NN Mental
, , None
and CC None
overall/global JJ Mental
quality NN Mental
of IN Mental
life NN Mental
( ( Mental
QOL NNP Mental
) ) Mental
by IN None
completing VBG None
a DT None
seven-category JJ Other
SSQ NNP Other
fatigue NN Physical
, , None
pain NN Pain
, , None
appetite NN Physical
, , None
diarrhea NN Physical
, , None
and CC None
global JJ Other
QOL NNP Other
scores NNS Mental
global JJ Mental
QOL NNP Mental
SSQ NNP Mental
QLQ-C30 JJ Mental
change NN Mental
scores NNS Mental
QOL NNP Mental
scores VBZ Mental
-DOCSTART- -X- N

effect NN Mental
of IN Mental
proactive JJ Mental
learning NN Mental
post-hypnotic JJ Mental
suggestion NN Mental
test NN Mental
performance NN Mental
scholastic JJ Other
aptitude NN Other
impaired JJ Mental
test NN Mental
performance NN Mental
. . None
-DOCSTART- -X- N

adrenal JJ Physical
mass NN Physical
size NN Physical
operative JJ Other
time NN Other
estimated VBN Physical
blood NN Physical
loss NN Physical
specimen NNS Physical
weight VBD Physical
analgesic JJ Pain
requirements NNS Pain
hospital JJ Other
stay NN Other
complication NN Adverse
rate NN Adverse
open VB None
surgery NN None
. . None
convalescence NN Other
late JJ Adverse
complication NN Adverse
( ( Adverse
port JJ Adverse
site NN Adverse
hernia NN Adverse
) ) Adverse
. . None
Mortality NN Mortality
safely RB Other
effectively RB Other
-DOCSTART- -X- N

selective JJ Physical
serotonin NN Physical
reuptake NN Physical
inhibitor NN Physical
citalopram NN Physical
uncontrolled JJ Mental
crying NN Mental
Psychiatric NNP Mental
assessment NN Mental
Hamilton NNP Mental
depression NN Mental
scale NN Mental
unwanted JJ Adverse
effects NNS Adverse
UKU NNP Adverse
side-effect JJ Adverse
scale NN Adverse
. . None
number NN Mental
of IN Mental
daily JJ Mental
crying VBG Mental
episodes NNS Mental
decrease NN Mental
in IN Mental
depression NN Mental
rating NN Mental
-DOCSTART- -X- N

triglycerides NNS Physical
triglycerides/HDL NN Physical
cholesterol NN Physical
flow-mediated JJ Physical
dilation NN Physical
insulin NN Physical
, , None
plasma VBP Physical
adiponectin NN Physical
levels NNS Physical
, , None
and CC None
insulin NN Physical
sensitivity NN Physical
total JJ Physical
cholesterol NN Physical
, , None
triglycerides NNS Physical
triglycerides/HDL-cholesterol NN Physical
improved VBN Physical
flow-mediated JJ Physical
dilation NN Physical
non-HDL JJ Physical
cholesterol NN Physical
triglycerides/HDL $ Physical
cholesterol NN Physical
HDL NNP Physical
cholesterol NN Physical
apolipoprotein JJ Physical
AI NNP Physical
fasting JJ Physical
insulin NN Physical
plasma NN Physical
adiponectin NN Physical
insulin JJ Physical
sensitivity NN Physical
triglycerides NNS Physical
and CC None
endothelium-dependent JJ Physical
dilation NN Physical
. . None
lipoprotein NN Physical
and CC None
metabolic JJ Physical
profiles NNS Physical
-DOCSTART- -X- N

six CD Mental
cognitive JJ Mental
tests NNS Mental
beneficial JJ Other
or CC Other
harmful JJ Other
effect NN Other
of IN Other
antioxidants NNS Other
or CC Other
zinc NN Other
and CC Other
copper NN Other
cognition NN Mental
-DOCSTART- -X- N

A DT Other
significant JJ Other
difference NN Other
of IN Other
average JJ Physical
values NNS Physical
of IN Physical
CRP NNP Physical
between IN Other
the DT Other
3rd CD Other
and CC Other
21st CD Other
day NN Other
in IN Other
both DT Other
groups NNS Other
of IN Other
patients NNS Other
was VBD Other
established VBN Other
similarity NN Other
in IN Other
average JJ Physical
values NNS Physical
of IN Physical
CRP NNP Physical
infection NN Physical
-DOCSTART- -X- N

incidence NN None
and CC None
tracheal JJ Physical
acid JJ Physical
aspiration NN Physical
GER NNP Physical
. . None
GER NNP Physical
and CC None
tracheal JJ Physical
aspiration NN Physical
incidence NN Physical
of IN Physical
acid JJ Physical
GER NNP Physical
episodes NNS Physical
of IN Physical
GER NNP Physical
total JJ Physical
number NN Physical
of IN Physical
episodes NNS Physical
of IN Physical
GER NNP Physical
incidence NN Physical
of IN Physical
tracheal JJ Physical
acid JJ Physical
aspiration NN Physical
risk NN Physical
of IN Physical
acid JJ Physical
GER NNP Physical
tracheal VB Physical
acid JJ Physical
aspiration NN Physical
Gastroesophageal NNP Physical
reflux NN Physical
( ( Physical
GER NNP Physical
) ) Physical
and CC None
tracheal JJ Physical
aspiration NN Physical
of IN Physical
acid NN Physical
acid JJ Physical
GER NNP Physical
and CC None
tracheal JJ Physical
acid JJ Physical
aspiration NN Physical
-DOCSTART- -X- N

Helicobacter NNP Physical
pylori NN Physical
eradication NN Physical
immunosorbent NN None
assay NN None
and CC None
immunoblot NN None
Urea JJ None
Breath NNP None
Test NNP None
intention-to-treat JJ Other
eradication NN Other
rate NN Other
-DOCSTART- -X- N

maintenance NN Physical
of IN Physical
patency NN Physical
and CC None
subsequent JJ Physical
occlusion NN Physical
. . None
maintenance NN Physical
of IN Physical
perioperative JJ Physical
arterial JJ Physical
catheter NN Physical
patency NN Physical
and CC None
the DT None
incidence NN Physical
of IN Physical
subsequent JJ Physical
radial JJ Physical
arterial JJ Physical
occlusion NN Physical
. . None
Radial NNP Physical
and CC Physical
ulnar JJ Physical
blood NN Physical
flows NNS Physical
Doppler NNP Other
probe NN Other
and CC Other
pulse JJ Other
oximetry NN Other
decannulation NN Other
The DT None
cannulation NN None
site NN None
complications NNS Adverse
such JJ Adverse
as IN Adverse
hematoma NN Adverse
, , Adverse
nerve JJ Adverse
injury NN Adverse
, , Adverse
and CC Adverse
infection NN Adverse
. . None
cannulations NNS Other
manual JJ None
flushes NNS None
partial JJ Physical
or CC Physical
total JJ Physical
occlusion NN Physical
occlusion NN Physical
maintenance NN Other
of IN Other
perioperative JJ Other
radial JJ Other
artery NN Other
catheter NN Other
patency NN Other
. . None
-DOCSTART- -X- N

opioid JJ Physical
withdrawal NN Physical
syndrome NN Physical
subjective JJ Mental
symptoms NNS Mental
subjective NN Mental
symptoms NNS Mental
objective JJ Physical
signs NNS Physical
of IN Physical
opioid JJ Physical
withdrawal NN Physical
-DOCSTART- -X- N

end NN Physical
points NNS Physical
survival JJ Mortality
and CC Mortality
time NN Mortality
to TO Mortality
treatment NN Mortality
failure NN Mortality
( ( Mortality
TTF NNP Mortality
) ) Mortality
. . Mortality
complete JJ Physical
remission NN Physical
rate NN Physical
TTF NNP Other
overall JJ Mortality
survival NN Mortality
tolerated VBN Other
-DOCSTART- -X- N

calcium VBP Physical
absorption NN Physical
calcium NN Physical
absorption NN Physical
. . None
The DT None
mean JJ None
calcium NN None
intake NN None
in IN None
calcium JJ None
absorption NN None
adjusted VBN None
calcium JJ None
absorption NN None
Calcium NNP None
absorption NN None
in IN None
-DOCSTART- -X- N

development NN Physical
of IN Physical
deep JJ Physical
venous JJ Physical
thrombosis NN Physical
( ( Physical
DVT NNP Physical
) ) Physical
and CC None
haemorrhage NN Physical
. . None
clinical JJ None
significant JJ None
DVT NNP Physical
, , None
wound NN Physical
haematoma NN Physical
or CC None
intra-abdominal JJ Physical
bleeding NN Physical
. . None
bleeding VBG Physical
complications NNS Physical
antiFXa JJ Physical
level NN Physical
-DOCSTART- -X- N

airway NN Physical
responses NNS Physical
to TO Physical
salbutamol VB Physical
dose-response JJ Other
curves NNS Other
to TO Other
inhaled VB Other
salbutamol NN Other
dose-response JJ Other
curve NN Other
to TO Other
inhaled VB Other
salbutamol NN Other
forced JJ Other
expiratory NN Other
volume NN Other
in IN Other
one CD Other
second NN Other
( ( Other
FEV1 NNP Other
) ) Other
FEV1 NNP Physical
FEV1 NNP Other
and CC Other
forced VBD Other
vital JJ Other
capacity NN Other
( ( Other
FVC NNP Other
) ) Other
responses VBZ Other
bronchodilation NN Physical
-DOCSTART- -X- N

epidural JJ Physical
morphine-induced JJ Physical
pruritus NN Physical
occurrence NN Physical
and CC Physical
severity NN Physical
of IN Physical
pruritus NN Physical
other JJ Physical
untoward JJ Physical
symptoms NNS Physical
. . Physical
incidence NN Physical
of IN Physical
pruritus NN Physical
incidence NN Physical
of IN Physical
pruritus NN Physical
inhibitory JJ Adverse
effect NN Adverse
. . None
incidence NN Physical
of IN Physical
pruritus NN Physical
untoward JJ Adverse
effects NNS Adverse
Pruritus NNP Physical
-DOCSTART- -X- N

hypotensive JJ Physical
effect NN Physical
additive JJ Physical
antihypertensive JJ Physical
effect NN Physical
blood NN Physical
pressure NN Physical
heart NN Physical
rate NN Physical
or CC Physical
body NN Physical
weight NN Physical
. . Physical
absolute NN None
percentage NN None
decreases NNS None
mean JJ Physical
blood NN Physical
pressure NN Physical
additive JJ Physical
antihypertensive JJ Physical
effect NN Physical
clinical JJ Physical
significance NN Physical
-DOCSTART- -X- N

effectiveness NN Other
proportion NN Other
of IN Other
Intention NN Other
to TO Other
treat VB Other
( ( Other
ITT NNP Other
) ) Other
and CC None
per-protocol JJ Other
( ( Other
PP NNP Other
) ) Other
analyses NNS Other
risk NN None
ratios NNS None
( ( None
RR NNP None
) ) None
assistance NN Physical
; : None
admitted VBN Other
to TO Other
hospitals NNS Other
confirmed VBN Physical
strokes NNS Physical
. . None
confirmed JJ Physical
strokes NNS Physical
SU NNP Other
efficiency NN Other
and CC Other
feasibility NN Other
quality NN Other
of IN Other
care NN Other
-DOCSTART- -X- N

hot JJ Physical
flashes NNS Physical
and CC Physical
excessive JJ Physical
sweating NN Physical
weakness NN Physical
, , None
palpitations NNS Physical
, , None
limb NN Physical
paresthesia NN Physical
, , None
and CC None
total JJ Physical
symptoms NNS Physical
menopausal NN Physical
symptoms NNS Physical
-DOCSTART- -X- N

headache NN Physical
relief NN Physical
; : None
free JJ Pain
of IN Pain
headache NN Pain
pain NN Pain
. . Pain
Adverse JJ Adverse
events NNS Adverse
chest JJS Adverse
pain NN Adverse
QTc NNP Physical
prolongation NN Physical
-DOCSTART- -X- N

Childhood NNP Physical
Autism NNP Physical
Rating NNP Physical
Scale NNP Physical
, , Physical
the DT Physical
Gilliam NNP Physical
Autism NNP Physical
Rating NNP Physical
Scale NNP Physical
, , Physical
the DT Physical
Expressive NNP Physical
and CC Physical
Receptive NNP Physical
One-Word NNP Physical
Picture NNP Physical
Vocabulary NNP Physical
tests NNS Physical
, , None
and CC None
Clinical NNP None
Global NNP None
Impressions NNP None
of IN None
Change NNP None
. . None
Gilliam NNP Physical
Autism NNP Physical
Rating NNP Physical
Scale NNP Physical
( ( Physical
total JJ Physical
score NN Physical
and CC Physical
the DT Physical
Behavior NNP Physical
, , Physical
Socialization NNP Physical
, , Physical
and CC Physical
Communication NNP Physical
subscales NNS Physical
) ) Physical
and CC Physical
the DT Physical
Receptive JJ Physical
One-Word NNP Physical
Picture NNP Physical
Vocabulary NNP Physical
test NN Physical
-DOCSTART- -X- N

Patient NNP Other
Global NNP Other
Assessment NNP Other
of IN Other
Response NNP Other
to TO Other
Therapy NNP Other
( ( Other
PGART NNP Other
) ) Other
and CC None
Western JJ Other
Ontario NNP Other
and CC Other
McMaster NNP Other
Universities NNP Other
( ( Other
WOMAC NNP Other
) ) Other
Osteoarthritis NNP Other
Index NNP Other
. . None
median JJ Physical
time NN Physical
to TO Physical
good JJ Physical
or CC Physical
excellent JJ Physical
PGART NNP Physical
response NN Physical
WOMAC NNP Physical
response NN Physical
greater JJR Other
efficacy NN Other
PGART NNP Other
PGART NNP Other
WOMAC NNP Physical
subscales NNS Physical
. . Other
greater JJR Physical
PGART NNP Physical
greater JJR Physical
response NN Physical
to TO Physical
all DT Physical
other JJ Physical
PGART NNP Physical
and CC None
WOMAC NNP Physical
endpoints NNS Physical
tolerability NN Physical
good JJ Other
and CC Other
similar JJ Other
. . Other
clinical JJ Adverse
adverse JJ Adverse
experience NN Adverse
( ( None
AE NNP None
) ) None
. . None
discontinuations NNS Adverse
due JJ Adverse
to TO Adverse
an DT Adverse
AE NNP Adverse
Discontinuation NN Physical
rates NNS Physical
edema VB Adverse
and CC None
hypertension NN Adverse
related VBN Adverse
AE NNP Adverse
efficacy NN Other
response NN Other
efficacy NN Other
well RB Other
tolerated VBN Other
. . None
-DOCSTART- -X- N

toxicity NN Adverse
and CC None
PSA NNP Physical
response NN Physical
time NN Physical
to TO Physical
progression NN Physical
survival NN Mortality
Toxicity NNP Adverse
mean JJ Other
treatment NN Other
duration NN Other
median JJ Physical
time NN Physical
to TO Physical
PSA NNP Physical
progression NN Physical
median JJ Mortality
survival NN Mortality
time NN Mortality
PSA NNP Physical
response NN Physical
rate NN Physical
PSA NNP Physical
response NN Physical
and CC None
survival NN Mortality
. . None
PSA NNP Physical
response NN Physical
toxicity NN Adverse
of IN Adverse
EMP NNP Adverse
monotherapy NN Adverse
effective JJ Other
toxic JJ Adverse
-DOCSTART- -X- N

blood NN Physical
pressure NN Physical
, , None
plasma JJ Physical
renin NN Physical
activity NN Physical
and CC None
aldosterone NN Physical
blood NN Physical
pressure NN Physical
and CC None
heart NN Physical
rate NN Physical
blood NN Physical
pressure NN Physical
plasma NN Physical
renin NN Physical
activity NN Physical
Urinary JJ Physical
aldosterone NN Physical
basal NN Physical
values NNS Physical
nor CC Physical
changes NNS Physical
of IN Physical
renin NN Physical
and CC None
aldosterone NN Physical
urinary JJ Physical
sodium NN Physical
excretion NN Physical
fell VBD Physical
sodium NN None
blood NN Physical
pressure NN Physical
successive JJ Physical
sodium NN Physical
escape NN Physical
-DOCSTART- -X- N

healed VBN Physical
healing VBG Physical
rate NN Physical
Complaints NNS Other
upper JJ Pain
abdominal JJ Pain
pain NN Pain
pain VB Pain
relief NN Pain
or CC None
side NN Adverse
effects NNS Adverse
. . None
-DOCSTART- -X- N

attitudes NNS Mental
, , Mental
communication NN Mental
skills NNS Mental
and CC Mental
occupational JJ Mental
stress NN Mental
Attitudes NNS Mental
semantic JJ Mental
differential NN Mental
questionnaire NN Mental
, , None
occupational JJ Mental
stress NN Mental
the DT Mental
Nursing NNP Mental
Stress NNP Mental
Scale NNP Mental
communication NN Mental
skills NNS Mental
standardised JJ Mental
videotaped VBD Mental
role-playing NN Mental
exercises NNS Mental
. . Mental
attitudes NNS Mental
self VB Mental
concept NN Mental
level NN Mental
of IN Mental
occupational JJ Mental
stress NN Mental
-DOCSTART- -X- N

efficacy NN Other
and CC Other
tolerability NN Other
erythema RB Physical
, , Physical
scaling VBG Physical
and CC Physical
pruritus NN Physical
effective JJ Other
erythema NN Physical
, , None
scaling VBG Physical
and CC None
pruritus NN Physical
Relapses NNS Physical
pruritus NN Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

cough NN Physical
of IN None
cough NN None
had VBD None
cough VBN Physical
, , None
had VBD None
cough NN None
. . None
-DOCSTART- -X- N

total JJ Mental
sleep JJ Mental
time NN Mental
( ( Physical
TST NNP Physical
) ) Physical
actigraphically RB Physical
recorded VBN Physical
sleep-onset JJ Physical
latency NN Physical
, , Mental
sleep JJ Other
efficiency NN Other
, , None
assessments NNS Mental
of IN Mental
child NN Mental
behavior NN Mental
, , None
family NN Mental
functioning NN Mental
, , None
and CC None
adverse JJ Adverse
events NNS Adverse
. . None
TST NNP Mental
objective NN Other
or CC Other
subjective JJ Other
measure NN Other
of IN Other
sleep NN Other
well RB Other
tolerated VBN Other
-DOCSTART- -X- N

high-sensitivity NN Physical
C-reactive JJ Physical
protein NN Physical
, , None
CD40 NNP Physical
ligand NN Physical
, , None
P-selectin NNP Physical
, , None
and CC None
N-terminal JJ Physical
pro-brain JJ Physical
natriuretic JJ Physical
peptide NN Physical
model-adjusted JJ Physical
CD40-ligand NNP Physical
levels NNS Physical
high-sensitivity JJ Physical
C-reactive JJ Physical
protein NN Physical
, , None
P-selectin NNP Physical
, , None
and CC None
N-terminal JJ Physical
pro-brain JJ Physical
natriuretic JJ Physical
peptide NN Physical
. . None
deaths NNS Mortality
or CC None
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
expression NN Physical
of IN Physical
the DT Physical
CD40-ligand NNP Physical
biomarker NN Physical
. . None
-DOCSTART- -X- N

marginal JJ Physical
microleakage NN Physical
microleakage NN Physical
in IN Physical
microleakage NN Physical
was VBD None
scored VBN None
from IN None
0 CD None
to TO None
7 CD None
degree NN Physical
of IN Physical
leakage NN Physical
. . Physical
-DOCSTART- -X- N

Antibiotic-use JJ Mental
rates NNS Mental
antibiotic JJ Mental
prescribing NN Mental
overall JJ Mental
antibiotic JJ Mental
use NN Mental
-DOCSTART- -X- N

performance NN Mental
characteristics NNS Mental
four-cell NN Physical
or CC Physical
greater JJR Physical
stage NN Physical
early JJ Physical
embryonic JJ Physical
growth NN Physical
growth NN Physical
Excyte NNP Physical
IV NNP Physical
concentration NN Physical
accelerated VBN Physical
( ( Physical
P NNP Physical
< NNP Physical
0.01 CD Physical
) ) Physical
growth NN Physical
hatching VBG Physical
accelerated VBN Physical
growth NN Physical
-DOCSTART- -X- N

sustained JJ Physical
resting NN Physical
pressure NN Physical
( ( Physical
tone NN Physical
) ) Physical
and CC Physical
contractile JJ Physical
activity NN Physical
Baseline NNP Physical
tone NN Physical
and CC Other
activity NN Physical
tone NN Physical
and CC None
activity NN Physical
Tone NN Physical
rate NN Physical
of IN Physical
recovery NN Physical
tone NN Physical
or CC None
activity NN Physical
-DOCSTART- -X- N

Clinical JJ Physical
scores NNS Physical
effective JJ Other
-DOCSTART- -X- N

task NN Mental
performances NNS Mental
performance NN Mental
times NNS Mental
or CC None
number NN Mental
of IN Mental
completed VBN Mental
tasks NNS Mental
within IN Mental
a DT Mental
given VBN Mental
time NN Mental
frame NN Mental
. . None
performances NNS Mental
unsuccessful JJ Mental
attempts NNS Mental
and CC Mental
unwanted JJ Mental
interactions NNS Mental
of IN Mental
instruments NNS Mental
. . None
subjective JJ Other
questionnaires NNS Other
rated VBN Mental
difficulties NNS Mental
with IN Mental
two-dimensional JJ Mental
vision NN Mental
and CC Mental
coordination NN Mental
of IN Mental
instruments NNS Mental
. . None
Task NNP Mental
performances NNS Mental
performances NNS Other
instrument JJ Mental
interaction NN Mental
major JJ Adverse
problem NN Adverse
-DOCSTART- -X- N

no DT Physical
significant JJ Physical
differences NNS Physical
sleep JJ Physical
variables NNS Physical
improved VBD Physical
sleep JJ Physical
latency NN Physical
total JJ Physical
sleep NN Physical
side NN Adverse
effect NN Adverse
profile NN Adverse
low JJ None
and CC None
not RB None
significantly RB None
different JJ None
-DOCSTART- -X- N

the DT None
efficacy NN None
investigate VB None
efficacy NN None
, , None
safety NN None
and CC None
tolerability NN None
showed VBD None
greater JJR None
improvement NN None
in IN None
the DT None
sum NN None
score NN None
efficacy NN None
assessments NNS None
of IN None
single JJ None
symptoms NNS None
and CC None
ocular JJ None
discomfort NN None
measured VBN None
VAS NNP None
( ( None
visual JJ None
analogue NN None
scale NN None
) ) None
provided VBD None
favorable JJ None
tolerability NN Other
ratings NNS None
preferring VBG None
No DT None
safety NN None
issues NNS None
were VBD None
observed VBN None
to TO None
intraocular JJ None
pressure NN None
, , None
visual JJ None
acuity NN None
, , None
or CC None
occurrence NN None
of IN None
adverse JJ None
events NNS None
. . None
CONCLUSIONS NNP None
-DOCSTART- -X- N

Mortality NN Mortality
mortality NN Mortality
median JJ Physical
length NN Physical
died VBN Mortality
; : None
deaths NNS Mortality
metastatic JJ Physical
melanoma NN Physical
. . None
mortality NN Mortality
mortality NN Mortality
-DOCSTART- -X- N

progression NN Physical
of IN Physical
coronary JJ Physical
atherosclerosis NN Physical
atheroma JJ Physical
progression NN Physical
disease NN Physical
progression NN Physical
atheroma JJ Physical
burden NN Physical
characteristics NNS None
and CC None
disease NN None
progression NN None
high-density NN None
lipoprotein NN None
cholesterol NN None
levels NNS None
percent JJ None
atheroma NN None
volume NN None
( ( None
PAV NNP None
) ) None
total JJ None
atheroma NN None
volume NN None
progression NN None
of IN None
PAV NNP None
coronary JJ None
atherosclerosis NN None
-DOCSTART- -X- N

Gastric JJ Physical
contents NNS Physical
amount NN Physical
of IN Physical
gastric JJ Physical
content NN Physical
pH NN Physical
values NNS Physical
gastric JJ Physical
pH NN Physical
gastric JJ Physical
volume NN Physical
-DOCSTART- -X- N

cardiorespiratory JJ Physical
effects NNS Physical
Cardiorespiratory NNP Physical
and CC Physical
arterial JJ Physical
blood NN Physical
gas NN Physical
variables NNS Physical
cardiac JJ Physical
output NN Physical
, , Physical
oxygen NN Physical
delivery NN Physical
, , Physical
and CC Physical
heart NN Physical
rate NN Physical
mean JJ Physical
arterial JJ Physical
blood NN Physical
pressure NN Physical
or CC Physical
stroke NN Physical
volume NN Physical
and CC Physical
decreased JJ Physical
systemic JJ Physical
vascular JJ Physical
resistance NN Physical
. . Physical
mean JJ Physical
arterial JJ Physical
blood NN Physical
pressure NN Physical
and CC None
systemic JJ Physical
vascular JJ Physical
resistance NN Physical
heart NN Physical
rate NN Physical
, , None
cardiac JJ Physical
output NN Physical
, , None
or CC None
oxygen NN Physical
delivery NN Physical
. . None
degree NN Physical
of IN Physical
apnea NN Physical
, , Physical
hypoventilation NN Physical
, , Physical
and CC Physical
hypoxemia NN Physical
mean JJ Physical
arterial JJ Physical
blood NN Physical
pressure NN Physical
heart NN Physical
rate NN Physical
, , None
cardiac JJ Physical
output NN Physical
, , None
or CC None
oxygen NN Physical
delivery NN Physical
-DOCSTART- -X- N

MEASURE NNP None
( ( None
S NNP None
) ) None
Rate NNP Physical
of IN Physical
development NN Physical
of IN Physical
expanded JJ Physical
blastocysts NNS Physical
suitable JJ Physical
for IN Physical
transfer NN Physical
or CC Physical
vitrification NN Physical
( ( Physical
primary JJ Physical
outcome NN Physical
) ) Physical
, , None
fertilization NN Physical
, , Physical
aneuploidy NN Physical
, , Physical
and CC Physical
sustained VBD Physical
implantation NN Physical
. . None
RESULT NNP None
rate NN Physical
of IN Physical
usable JJ Physical
blastocyst NN Physical
formation NN Physical
per IN Physical
zygote NN Physical
at IN None
37?C CD None
Rates NNS None
of IN None
fertilization NN None
, , None
aneuploidy NN None
, , None
and CC None
sustained JJ None
implantation NN None
were VBD None
equivalent JJ None
-DOCSTART- -X- N

graft NN Physical
survival NN Physical
. . None
graft NN Physical
survival NN Physical
rates NNS Physical
. . None
both DT Physical
cytotoxic JJ Physical
and CC Physical
anti-idiotypic JJ Physical
antibodies NNS Physical
. . None
Anti-HLA JJ Physical
antibodies NNS Physical
Anti-idiotypic JJ Physical
antibody NN Physical
activity NN Physical
anti-HLA JJ Physical
antibody NN Physical
response NN Physical
promote VB Physical
an DT Physical
anti-idiotypic JJ Physical
response NN Physical
-DOCSTART- -X- N

cellular JJ Physical
immune NN Physical
status NN Physical
quantitative JJ Other
flow NN Other
cytometry NN Other
. . None
absolute JJ Physical
number NN Physical
of IN Physical
immunocompetent JJ Physical
cells NNS Physical
T NNP Physical
lymphocytes NNS Physical
helper/inducer NN Physical
type NN Physical
cytotoxic NN Physical
and CC Physical
natural JJ Physical
killer NN Physical
cells NNS Physical
. . Physical
activation NN Physical
state NN Physical
of IN Physical
T NNP Physical
lymphocytes NNS Physical
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

success NN Physical
therapist NN Other
's POS Other
performance NN Other
outcomes NNS None
of IN None
treatment NN None
. . None
patient JJ Other
factors NNS Other
; : Other
therapist JJ Other
factors NNS Other
; : None
patient-therapist JJ Mental
relationship NN Mental
factors NNS Mental
; : None
therapy NN Other
factors NNS Other
. . None
therapist NN Other
's POS Other
personal JJ Other
qualities NNS Other
patient-therapist JJ Mental
relationship NN Mental
, , Mental
the DT Mental
Helping NNP Mental
Alliance NNP Mental
Questionnaire NNP Mental
purity NN Other
-DOCSTART- -X- N

ADHD NNP Mental
Rating NNP Mental
Scale NNP Mental
( ( Mental
ADHD-RS NNP Mental
) ) Mental
score NN Mental
; : None
secondary JJ None
endpoints NNS None
were VBD None
the DT None
Clinical JJ Mental
Global NNP Mental
Impression NNP Mental
of IN Mental
ADHD-Improvement NNP Mental
( ( Mental
CGI-I NNP Mental
) ) Mental
and CC None
the DT None
Conners NNP Mental
Teacher NNP Mental
Rating VBG Mental
Scale-Revised JJ Mental
: : Mental
Short JJ Mental
Form NNP Mental
( ( Mental
CTRS-R JJ Mental
: : Mental
S NN Mental
) ) Mental
score NN Mental
. . None
ADHD-RS NNP Mental
CTRS-R JJ Mental
: : Mental
S NNP Mental
CTRS-R JJ Mental
: : Mental
S JJ Mental
nausea RB Adverse
appetite NN Adverse
, , Adverse
fatigue NN Adverse
, , Adverse
and CC Adverse
early JJ Adverse
morning NN Adverse
awakening VBG Adverse
) ) None
adverse JJ Adverse
events NNS Adverse
. . None
-DOCSTART- -X- N

ambiguous JJ Physical
genitalia NN Physical
, , Physical
impaired JJ Physical
prostate NN Physical
differentiation NN Physical
and CC Physical
development NN Physical
decreased VBD Physical
facial JJ Physical
and CC Physical
body JJ Physical
hair NN Physical
. . None
C19 NNP Physical
androgen NN Physical
and CC Physical
C21 NNP Physical
5 CD Physical
alpha-steroid JJ Physical
metabolism NN Physical
hepatic JJ Physical
and CC Physical
peripheral JJ Physical
5 CD Physical
alpha-metabolism NN Physical
. . None
alpha-steroid JJ Other
metabolite NN Other
profile NN Other
affinity NN Physical
for IN Physical
multiple JJ Physical
steroid JJ Physical
substrates NNS Physical
. . Physical
-DOCSTART- -X- N

gastrointestinal VB Physical
symptoms NNS Physical
frequency NN Physical
of IN Physical
GI NNP Physical
abnormalities NNS Physical
, , None
including VBG None
abnormal JJ Physical
stool NN Physical
consistency NN Physical
( ( None
e.g. JJ None
bulky NN Physical
or CC None
loose JJ Physical
) ) None
gastrointestinal JJ Physical
symptoms NNS Physical
-DOCSTART- -X- N

Efficacy NN Other
and CC Other
tolerability NN Other
eradication NN Physical
rates NNS Physical
incidence NN Adverse
of IN Adverse
side NN Adverse
effects NNS Adverse
eradicated VBN Physical
eradicated VBN Physical
prevalence NN Adverse
and CC Adverse
intensity NN Adverse
of IN Adverse
side NN Adverse
effects NNS Adverse
effective JJ Other
and CC Other
safe JJ Other
. . Other
side NN Adverse
effects NNS Adverse
-DOCSTART- -X- N

hospitalization NN Other
burden NN Other
CV NNP Mortality
mortality NN Mortality
quality NN Other
of IN Other
life NN Other
. . Other
efficacy NN Other
cardiovascular JJ Physical
Hospitalization NNP Physical
or CC None
death NN Mortality
CV NNP Other
hospitalization NN Other
clinical JJ Other
benefit NN Other
number NN None
and CC None
duration NN None
of IN None
CV NNP Other
hospitalizations NNS Other
reduced VBD Other
the DT Other
risk NN Other
of IN Other
first JJ Other
CV NNP Other
hospitalization NN Other
non-CV JJ Other
hospitalization NN Other
CV NNP Other
hospitalizations NNS Other
AF-related JJ Physical
hospital JJ Other
stay NN Other
hospital NN Other
stay NN Other
reduced VBD Other
total JJ Other
hospitalizations NNS Other
first JJ Mortality
AF/atrial NNP Mortality
flutter NN Mortality
recurrence NN Mortality
and CC Mortality
CV NNP Other
hospitalization/death NN Other
Hospitalization NNP Other
burden NN Other
CV NNP Other
hospitalization NN Other
hospitalization NN Other
burden NN Other
-DOCSTART- -X- N

HIV-1 NNP None
acquisition NN None
HIV-1 NNP None
transmission NN None
risk NN None
of IN None
HIV-1 NNP None
acquisition NN None
and CC None
transmission NN None
-DOCSTART- -X- N

spontaneous JJ Mental
imitation NN Mental
skills NNS Mental
spontaneously RB Mental
imitate VB Mental
play NN Mental
actions NNS Mental
and CC Mental
descriptive JJ Mental
gestures NNS Mental
spontaneous JJ Mental
imitation NN Mental
skills NNS Mental
effectiveness NN Other
learned VBD Mental
spontaneous JJ Mental
imitation NN Mental
. . None
imitation NN Mental
skills NNS Mental
-DOCSTART- -X- N

included VBD None
histologic JJ Physical
assessment NN Physical
of IN Physical
bowel NN Physical
biopsies NNS Physical
and CC None
assessment NN Physical
of IN Physical
serologic JJ Physical
markers NNS Physical
of IN Physical
inflammatory JJ Physical
bowel NN Physical
disease NN Physical
( ( Physical
IBD NNP Physical
) ) Physical
, , None
fecal JJ Physical
calprotectin NN Physical
levels NNS Physical
, , None
and CC None
polymorphisms NNS Physical
in IN Physical
immune-related JJ Physical
genes NNS Physical
. . None
Ipilimumab NNP None
levels NNS None
to TO None
enteric VB None
flora NNS None
, , None
inflammatory NN Physical
cell NN Physical
infiltration NN Physical
into IN None
gastrointestinal JJ None
mucosa NN None
, , None
and CC None
increased VBD None
fecal JJ Physical
calprotectin NN Physical
associated VBN None
with IN None
diarrhea NN Physical
and CC None
clinical JJ None
evidence NN None
of IN None
colitis NN Physical
. . None
The DT None
prevent VB None
ipilimumab-induced JJ None
bowel NN None
inflammation NN None
. . None
Despite IN None
diarrhea NN None
, , None
no DT None
-DOCSTART- -X- N

status NN None
. . None
At-home JJ None
exposure NN None
completion NN None
was VBD None
reduced VBD None
anxiety NN Mental
, , None
FCBT NNP None
-DOCSTART- -X- N

complete JJ Physical
response NN Physical
( ( Physical
CR NNP Physical
) ) Physical
partial JJ Physical
remission NN Physical
( ( Physical
PR NNP Physical
) ) Physical
. . Physical
the DT Mortality
overall JJ Mortality
response NN Mortality
rate NN Mortality
The DT Mortality
progression-free JJ Mortality
survival NN Mortality
( ( Mortality
PFS NNP Mortality
) ) Mortality
and CC Mortality
overall JJ Mortality
survival NN Mortality
at IN Mortality
5 CD Mortality
years NNS Mortality
relapsed VBN Physical
long-term JJ Mortality
survivors NNS Mortality
-DOCSTART- -X- N

rates NNS Physical
of IN Physical
recurrence NN Physical
, , None
disease-free JJ Mortality
and CC None
overall JJ Mortality
survival NN Mortality
1-year JJ Mortality
, , Mortality
2-year JJ Mortality
and CC Mortality
3-year JJ Mortality
disease-free JJ Mortality
survival NN Mortality
rates NNS Mortality
respective JJ None
overall JJ Mortality
survival NN Mortality
rates NNS Mortality
presence NN Physical
of IN Physical
vascular JJ Physical
permeation NN Physical
. . None
side-effects NNS Adverse
mild JJ None
and CC None
tolerable JJ None
. . None
survival NN Mortality
rates NNS Mortality
-DOCSTART- -X- N

effectiveness NN Other
effects NNS Mental
of IN Mental
ethnic JJ Mental
match NN Mental
on IN Mental
drinking NN Mental
outcomes NNS Mental
volume NN Mental
per IN Mental
week NN Mental
, , Mental
maximum JJ Mental
amount NN Mental
, , Mental
and CC Mental
frequency NN Mental
of IN Mental
5 CD Mental
or CC Mental
more JJR Mental
drinks NNS Mental
per IN Mental
occasion NN Mental
. . None
significant JJ Mental
reduction NN Mental
in IN Mental
drinking NN Mental
outcomes NNS Mental
most RBS None
beneficial JJ Other
less RBR Other
effectiveness NN Other
of IN None
brief JJ None
intervention NN None
effectiveness NN Other
-DOCSTART- -X- N

upright JJ Physical
mobility NN Physical
upright JJ Physical
mobility NN Physical
parameters NNS Physical
for IN Physical
weighting VBG Physical
upright JJ Physical
mobility NN Physical
timed VBN Physical
up RP Physical
and CC Physical
go VB Physical
( ( Physical
TUG NNP Physical
) ) Physical
, , None
sharpened VBD Physical
Romberg NNP Physical
, , None
360-degree JJ Physical
turns NNS Physical
, , None
25-foot JJ Physical
walk NN Physical
, , Physical
and CC None
computerized JJ Physical
platform NN Physical
posturography NN Physical
. . None
balance NN Physical
loss NN Physical
. . None
25-foot JJ Physical
walk NN Physical
TUG NNP Physical
kg NNS None
gait NN Physical
velocity NN Physical
functional JJ Physical
activity NN Physical
-DOCSTART- -X- N

left VBD Physical
ventricular JJ Physical
thrombosis NN Physical
left JJ Physical
ventricular JJ Physical
thrombosis NN Physical
larger JJR Physical
infarcts NNS Physical
depression NN Physical
of IN Physical
left JJ Physical
ventricular JJ Physical
ejection NN Physical
fraction NN Physical
at IN Physical
S1 NNP Physical
left VBD Physical
ventricular JJ Physical
volumes NNS Physical
at IN Physical
S1 NNP Physical
prevalence NN Physical
of IN Physical
moderate JJ Physical
to TO Physical
severe VB Physical
mitral JJ Physical
regurgitation NN Physical
on IN Physical
colour NN Physical
Doppler NNP Physical
at IN Physical
S1 NNP Physical
left VBN Physical
ventricular JJ Physical
thrombosis NN Physical
left JJ Physical
ventricular JJ Physical
thrombosis NN Physical
Left NNP Physical
ventricular JJ Physical
thrombosis NN Physical
-DOCSTART- -X- N

donepezil NN Physical
pharmacokinetics NNS Physical
( ( None
Cmax NNP None
, , None
tmax NN None
, , None
AUC NNP None
( ( None
0-120 JJ None
) ) None
, , None
AUC NNP None
( ( None
0-infinity NN None
) ) None
cardiac JJ Physical
conduction NN Physical
-DOCSTART- -X- N

induction NN Physical
apoptotic JJ Other
index NN Other
( ( Other
AI NNP Other
) ) Other
transferase-mediated JJ Other
deoxyuridine NN Other
triphosphate NN Other
biotin NN Other
nick JJ Other
end-labeling NN Other
( ( Other
TUNEL NNP Other
) ) Other
Expression NN Physical
of IN Physical
Ki-67 NNP Physical
immunohistochemical JJ Physical
staining NN Physical
. . None
concentration NN Physical
of IN Physical
5-fluorouracil JJ Physical
( ( Physical
5-FU JJ Physical
) ) Physical
in IN Physical
tumor NN Physical
tissue NN Physical
was VBD None
measured VBN None
by IN None
chemical NN Physical
assay NN Physical
. . None
AI NNP Physical
of IN Physical
lung NN Physical
adenocarcinoma NN Physical
cells NNS Physical
AI NNP Physical
and CC None
the DT Physical
5-FU JJ Physical
concentrations NNS Physical
apoptosis NN Physical
AI NNP Physical
and CC Physical
5-FU JJ Physical
-DOCSTART- -X- N

no DT Other
further JJ Other
treatment NN Other
. . None
Actuarial JJ Mortality
relapse-free JJ Mortality
survival NN Mortality
relapse-free JJ Mortality
survival NN Mortality
-DOCSTART- -X- N

efficacy NN Other
and CC Other
safety NN Other
efficacy NN Other
( ( Pain
postprandial JJ Physical
bloating NN Physical
, , None
epigastric JJ Pain
pain NN Pain
, , None
heartburn NN Physical
) ) None
galactorrhoea NN Physical
, , Physical
breast NN Physical
tenderness NN Physical
and CC Physical
menstrual JJ Physical
changes NNS Physical
. . None
-DOCSTART- -X- N

retarding VBG Physical
aging VBG Physical
effect NN Physical
in IN None
retarding VBG Physical
aging VBG Physical
. . None
symptoms NNS Physical
of IN Physical
aging VBG Physical
regulating VBG Physical
immune NN Physical
and CC Physical
endocrinal JJ Physical
function NN Physical
, , None
scavenging VBG Physical
free JJ Physical
radicals NNS Physical
and CC None
adjusting VBG Physical
coli JJ Physical
flora NNS Physical
. . None
retarding VBG Physical
aging NN Physical
. . None
-DOCSTART- -X- N

adiposity NN Physical
adiposity NN Physical
and CC None
metabolic JJ Physical
parameters NNS Physical
adiposity NN Physical
glucose/insulin NN Physical
indices NNS Physical
strength NN Physical
physical JJ Mental
activity NN Mental
by IN Mental
the DT Mental
7-d JJ Mental
accelerometry NN Mental
3-d JJ Mental
physical JJ Mental
activity NN Mental
recall NN Mental
, , None
dietary JJ Mental
intake NN Mental
by IN None
3-d JJ None
records NNS None
, , None
body NN Physical
composition NN Physical
glucose/insulin JJ Physical
indices NNS Physical
intravenous JJ None
glucose JJ None
tolerance NN None
test NN None
adiposity NN Physical
measures NNS None
( ( None
weight NN Physical
, , None
body NN Physical
mass NN Physical
index NN Physical
[ NNP Physical
BMI NNP Physical
] NNP Physical
, , None
BMI NNP Physical
z-scores NNS Physical
, , None
and CC None
DEXA NNP Physical
total VBP Physical
body NN Physical
fat NN Physical
) ) None
fasting VBG Physical
glucose NN Physical
multiple JJ Physical
adiposity NN Physical
outcomes NNS Physical
and CC None
fasting VBG Physical
glucose NN Physical
adiposity NN Physical
and CC None
insulin NN Physical
indices NNS Physical
-DOCSTART- -X- N

effectiveness NN Other
repetition NN Other
of IN Other
the DT Other
procedure NN Other
. . Other
decreased VBD None
the DT None
probability NN Other
of IN Other
therapeutic JJ Other
failure NN Other
and CC None
recurrence NN Physical
of IN Physical
urethral JJ Physical
strictures NNS Physical
-DOCSTART- -X- N

disability NN Physical
, , Physical
illness JJ Physical
perceptions NNS Physical
, , Physical
pain NN Physical
and CC Physical
coping NN Physical
depression NN None
clinical JJ Physical
outcome NN Physical
and CC Physical
process NN Physical
measures NNS Physical
predict VB Physical
depression NN Physical
depression NN Mental
, , None
disability NN Physical
, , None
pain NN Pain
, , None
beliefs VB Mental
about IN Mental
the DT Mental
consequences NNS Mental
of IN Mental
arthritis NN Mental
and CC Mental
coping VBG Mental
strategies NNS Mental
-DOCSTART- -X- N

plasma NN None
homovanillic JJ None
acid NN None
concentrations NNS None
plasma NN None
concentrations NNS None
of IN None
the DT None
dopamine NN None
metabolite NN None
, , None
homovanillic JJ None
acid NN None
. . None
mCPP RB Adverse
mCPP NNS Physical
raised VBD Physical
prolactin NN Physical
and CC Physical
temperature NN Physical
as IN Physical
compared VBN Physical
to TO Physical
placebo VB Physical
plasma NN Physical
homovanillic JJ Physical
acid JJ Physical
concentrations NNS Physical
. . Physical
mCPP NN Physical
does VBZ Physical
not RB Physical
alter VB Physical
dopamine NN Physical
function NN Physical
. . Physical
-DOCSTART- -X- N

Atrioventricular JJ Physical
risk NN Physical
of IN Physical
developing VBG Physical
AV NNP Physical
block NN Physical
PQ NNP Physical
interval NN Physical
atrial JJ Physical
stimulus-Q JJ Physical
intervals NNS Physical
at IN Physical
pacing VBG Physical
rates NNS Physical
of IN Physical
100 CD Physical
and CC Physical
120 CD Physical
bpm NN Physical
. . Other
occurrence NN Physical
of IN Physical
AV NNP Physical
block NN Physical
PQ NNP Physical
interval NN Physical
atrial JJ Physical
stimulus-Q JJ Physical
intervals NNS Physical
or CC Other
Wenckebach NNP Physical
block NN Physical
point NN Physical
grade $ Physical
2 CD Physical
to TO Physical
3 CD Physical
AV NNP Physical
block NN Physical
right JJ Physical
bundle-branch JJ Physical
block NN Physical
PQ NNP Physical
interval NN Physical
and CC Other
atrial JJ Physical
stimulus-Q JJ Physical
interval NN Physical
safe JJ Other
-DOCSTART- -X- N

modes NNS None
of IN None
failure NN None
-- : None
radiographic JJ None
stability NN None
of IN None
fixation NN None
modes NNS None
of IN None
failure NN None
Linear JJ None
and CC None
angular JJ None
displacements NNS None
implant JJ Physical
migration NN Physical
into IN Physical
the DT Physical
femoral JJ Physical
head NN Physical
adequacy NN None
of IN None
the DT None
reduction NN None
and CC None
the DT None
location NN None
of IN None
the DT None
implant NN None
fixation NN None
failure NN None
neck-shaft JJ None
angle NN None
incidence NN None
of IN None
varus NN None
angulation NN None
by IN None
10 CD None
degrees NNS None
or CC None
more JJR None
vertical JJ Physical
migration NN Physical
of IN Physical
the DT Physical
device NN Physical
into IN Physical
the DT Physical
femoral JJ Physical
head NN Physical
failure NN None
of IN None
the DT None
fixation NN None
and CC None
varus NN None
reduction NN None
screw/neck NN None
angle NN None
deviation NN None
fixation NN Physical
failure NN Physical
screw/neck NN None
angle NN None
deviation NN None
fixation NN None
failure NN None
. . None
-DOCSTART- -X- N

FEV1 NNP Physical
morning NN Physical
and CC Physical
evening NN Physical
PEF NNP Physical
number NN Physical
of IN Physical
daytime NN Physical
and CC Physical
nighttime JJ Physical
asthma NN Physical
symptoms NNS Physical
and CC None
the DT None
use NN Physical
of IN Physical
beta2-agonist NN Physical
concentrations NNS Physical
of IN Physical
serum NN Physical
eosinophil NN Physical
cationic JJ Physical
protein NN Physical
and CC Physical
exhaled VBD Physical
nitric JJ Physical
oxide NN Physical
-DOCSTART- -X- N

shivering VBG Physical
sedation NN Physical
tympanic JJ Physical
membrane NN Physical
temperature NN Physical
oxygen JJ Other
gain NN Physical
of IN Physical
shivering NN Physical
core NN Physical
temperature NN Physical
Sedation NN Physical
verbal JJ Other
rating NN Other
score NN Other
( ( Other
VRS NNP Other
) ) Other
bispectral JJ Physical
index NN Physical
( ( Physical
BIS NNP Physical
) ) Physical
of IN Physical
the DT Physical
EEG NNP Physical
. . None
Peripheral NNP Physical
muscle NN Physical
strength NN Physical
shivering NN Physical
threshold NN Physical
gain NN Physical
of IN Physical
shivering VBG Physical
sedation NN Physical
muscle NN Physical
strength NN Physical
. . None
shivering NN Physical
threshold NN Physical
. . None
-DOCSTART- -X- N

healing NN Physical
endoscopic NN Physical
healing VBG Physical
rates NNS Physical
healing VBG Physical
rate NN Physical
cumulative JJ Physical
relapse NN Physical
rate NN Physical
cumulative JJ Physical
relapse NN Physical
rate NN Physical
relapsed VBN Physical
duration NN Physical
of IN Physical
illness NN Physical
remission NN Physical
period NN Physical
, , Physical
long JJ Physical
symptomatic JJ Physical
spell NN Physical
, , Physical
and CC Physical
reluctance NN Physical
to TO Physical
give VB Physical
up RP Physical
smoking VBG Physical
. . None
-DOCSTART- -X- N

peripheral JJ Physical
blood NN Physical
pressure NN Physical
and CC Physical
central JJ Physical
blood NN Physical
pressure NN Physical
effects NNS Other
peripheral JJ Physical
blood NN Physical
pressure NN Physical
and CC Physical
the DT Physical
central JJ Physical
blood NN Physical
pressure NN Physical
parameters NNS Physical
of IN Physical
pulse JJ Physical
wave NN Physical
central JJ Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
, , Physical
augmentation NN Physical
and CC Physical
augmentation NN Physical
index NN Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
and CC Physical
pulse JJ Physical
pressure NN Physical
in IN Physical
central JJ Physical
aorta NNS Physical
difference NN Physical
peripheral JJ Physical
arterial JJ Physical
blood NN Physical
pressure NN Physical
. . None
central JJ Physical
systolic JJ Physical
pressure NN Physical
and CC Physical
augmentation NN Physical
index NN Physical
wave NN Physical
reflection NN Physical
-DOCSTART- -X- N

PaO2 NNP Physical
intrapulmonary JJ Physical
shunt NN Physical
alveolar-arterial JJ Other
oxygen NN Other
tension NN Other
gradient NN Other
AaDO2 NNP Other
PaO2 NNP Other
nor CC Other
intrapulmonary JJ Other
shunt NN Other
( ( Other
or CC Other
AaDO2 NNP Other
) ) Other
rate NN Physical
pressure NN Physical
product NN Physical
therapeutic JJ Physical
failure NN Physical
cumulative JJ Other
therapeutic JJ Other
failure NN Other
rate NN Other
-DOCSTART- -X- N

scheduled JJ None
visit NN None
number NN Physical
of IN Physical
symptom JJ Physical
days NNS Physical
emergency NN Other
department NN Other
visits NNS Other
emergency NN Other
department NN Other
visits NNS Other
-DOCSTART- -X- N

hot JJ None
flashes NNS None
Hot NNP Physical
flashes NNS Physical
hot JJ Physical
flashes NNS Physical
hot JJ Physical
flashes NNS Physical
hot JJ Physical
flashes NNS Physical
; : None
hot JJ Physical
flashes NNS Physical
. . None
hot JJ Physical
flashes NNS Physical
relief NN Other
postmenopausal NN Physical
hot JJ Physical
flashes NNS Physical
-DOCSTART- -X- N

H-reflex NNP Physical
hamsting NN Physical
( ( Physical
HS NNP Physical
) ) Physical
or CC Physical
bone-patellar JJ Physical
tendon-bone NN Physical
( ( Physical
BTB NNP Physical
) ) Physical
autograft NN Physical
, , None
on IN None
VM NNP Physical
and CC Physical
SOL NNP Physical
H-reflex NNP Physical
latency NN Physical
and CC Physical
amplitude NN Physical
VM NNP Physical
and CC Physical
SOL NNP Physical
H-reflexes NNP Physical
visual JJ Other
analog NN Other
scales NNS Other
and CC None
knee VB Physical
girth NN Physical
VM NNP Physical
H-reflex NNP Physical
amplitude NN Physical
visual JJ Pain
analog NN Pain
pain NN Pain
and CC None
functional JJ Physical
scales NNS Physical
and CC Physical
the DT Physical
mid-patella JJ Physical
girth NN Physical
. . None
VM NNP Physical
H-reflex NNP Physical
amplitude NN Physical
VM NNP Physical
neuromuscular JJ Physical
excitability NN Physical
. . None
VM NNP Physical
neuromuscular JJ Physical
excitability NN Physical
neuromuscular JJ Physical
excitability NN Physical
-DOCSTART- -X- N

masticatory JJ Physical
performance NN Physical
, , Physical
and CC Physical
the DT Physical
subjective JJ Physical
chewing NN Physical
experience NN Physical
. . Physical
Masticatory JJ Physical
performance NN Physical
as RB Physical
well RB Physical
as IN Physical
chewing VBG Physical
experience NN Physical
masticatory NN Physical
performance NN Physical
and CC Physical
the DT Physical
variables NNS Physical
of IN Physical
chewing VBG Physical
experience NN Physical
. . Physical
masticatory JJ Physical
performance NN Physical
and CC Physical
functional JJ Other
complaints NNS Other
mandibular JJ Other
denture NN Other
. . Physical
-DOCSTART- -X- N

Injection NN Pain
pain NN Pain
pain NN Pain
reducing VBG Pain
pain NN Pain
on IN Pain
injection NN Pain
effective JJ Other
-DOCSTART- -X- N

early JJ Other
and CC Other
significant JJ Other
improvement NN Other
PEFR NNP Physical
and CC None
SaO2 NNP Physical
clinical JJ Physical
asthma NN Physical
score NN Physical
improvement NN Physical
in IN Physical
clinical JJ Physical
signs NNS Physical
and CC None
symptoms NNS Physical
of IN Physical
asthma NN Physical
and CC None
PEFR NNP Physical
-DOCSTART- -X- N

rescue JJ Physical
medication NN Physical
Pain NNP Pain
relief NN Pain
rescue NN Physical
medication NN Physical
overall JJ Pain
pain NN Pain
relief NN Pain
incidence NN Adverse
of IN Adverse
adverse JJ Adverse
events NNS Adverse
pain NN Pain
relief NN Pain
-DOCSTART- -X- N

safety NN Other
and CC Other
efficacy NN Other
safety NN Other
and CC Other
efficacy NN Other
tumour JJ Physical
clearance NN Physical
measures NNS Other
of IN Other
patients NNS Other
' POS Other
acceptability NN Other
. . None
clearance NN Physical
rate NN Physical
clearance NN Physical
rates NNS Physical
acceptability NN Other
of IN Other
treatment NN Other
effective JJ Other
well RB Other
tolerated VBN Other
-DOCSTART- -X- N

plasma JJ Physical
chronobiologic JJ Physical
rhythms NN Physical
phases NNS None
. . None
Circadian JJ None
rhythms NN None
in IN None
dietary JJ None
and CC None
water NN None
intake NN None
and CC None
levels NNS Physical
of IN Physical
plasma NN Physical
total JJ Physical
fatty JJ Physical
acids NNS Physical
and CC None
lipid JJ Physical
fractions NNS Physical
remained VBD None
light NN None
. . None
Circadian JJ None
patterns NNS None
of IN None
plasma NN None
melatonin NN None
, , None
glucose NN None
, , None
lactic JJ None
acid NN None
, , None
and CC None
corticosterone NN None
were VBD None
normal JJ None
circadian JJ None
rhythms NN None
of IN None
-DOCSTART- -X- N

Extinction NN Physical
of IN Physical
over-selected JJ Physical
stimuli JJ Physical
emergence NN Other
under-selected JJ Other
cues NNS Other
post-acquisition JJ Mental
performance NN Mental
deficit NN Mental
over-selected JJ Physical
stimulus NN Physical
behavioral JJ Mental
control NN Mental
over-selectivity NN Mental
extinction NN Physical
of IN Physical
over-selected JJ Physical
stimuli NNS Physical
-DOCSTART- -X- N

TOM NNP Other
test NN Other
TOM NNP Other
test NN Other
TOM NNP Other
test NN Other
interrater NN Other
reliability NN Other
TOM NNP Other
test NN Other
TOM NNP Other
test NN Other
scores NNS Other
intelligence NN Mental
Wechsler NNP Other
Intelligence NNP Other
Scale NNP Other
for IN Other
Children NNP Other
TOM NNP Other
test NN Other
scores NNS Other
. . None
TOM NNP Other
test NN Other
-DOCSTART- -X- N

thromboembolism NN None
ischaemic JJ None
stroke NN None
systemic JJ None
embolism NN None
absolute JJ Physical
rate NN Physical
of IN Physical
primary JJ Physical
events NNS Physical
primary JJ Physical
event NN Physical
rate NN Physical
per IN Physical
year NN Physical
absolute JJ None
rate NN None
of IN None
primary JJ None
events NNS None
absolute JJ None
rate NN None
of IN None
primary JJ None
events NNS None
primary JJ None
event NN None
rate NN None
per IN None
year NN None
rate NN None
of IN None
all DT None
stroke NN None
with IN None
residual JJ None
deficit NN None
ischaemic JJ None
stroke NN None
absolute JJ None
reduction NN None
stroke NN None
rate NN None
rate NN None
of IN None
stroke NN None
rate NN None
of IN None
stroke NN None
-DOCSTART- -X- N

Analgesia NN Physical
analgesia NN Physical
Analgesia NNP Physical
( ( None
Mann-Whitney NNP Other
test NN Other
Mantel-Haentszel NNP Other
further RBR Physical
analgesia NN Physical
no DT Physical
further JJ Physical
analgesia NN Physical
Pain NNP Pain
VAS NNP Pain
and CC None
overall JJ Physical
assessment NN Physical
of IN Physical
analgesia NN Physical
( ( None
nausea NN Adverse
, , None
dizziness NN Physical
) ) None
-DOCSTART- -X- N

posttraumatic JJ Physical
seizures NNS Physical
posttraumatic JJ Physical
seizure NN Physical
. . None
survival NN Mortality
or CC None
neurologic JJ Physical
outcome NN Physical
rate NN Physical
of IN Physical
early JJ Physical
posttraumatic JJ Physical
seizures NNS Physical
prophylactic JJ Other
efficacy NN Other
posttraumatic JJ Physical
seizures NNS Physical
-DOCSTART- -X- N

autism NN Physical
: : None
Severity NNP Physical
of IN Physical
autism NN Physical
Childhood NNP Other
Autism NNP Other
Rating NNP Other
Scale NNP Other
clear JJ Other
improvement NN Other
in IN Other
cognition NN Other
ameliorating VBG Other
some DT Other
of IN Other
the DT Other
symptoms NNS Other
of IN Other
autism NN Other
-DOCSTART- -X- N

erectile JJ None
function NN None
health-related JJ None
quality NN None
of IN None
life NN None
the DT None
effectiveness NN None
and CC None
cost-effectiveness NN None
of IN None
erectile JJ None
function NN None
and CC None
health-related JJ None
quality NN None
of IN None
life NN None
in IN None
was VBD None
erectile JJ Physical
function NN Physical
( ( None
International NNP None
Index NNP None
of IN None
Erectile NNP None
Function-5 NNP None
score NN None
) ) None
. . None
male JJ Physical
ED-specific JJ Physical
quality NN Physical
of IN Physical
life NN Physical
( ( Physical
MED-QoL NNP Physical
) ) Physical
, , None
quality-adjusted JJ None
life NN None
years NNS None
( ( None
QALYs NNP None
) ) None
using VBG None
the DT None
generic JJ None
Euroqol NNP None
measure NN None
( ( None
EQ-5D NNP None
) ) None
, , None
endothelial JJ Physical
function NN Physical
, , None
cardiovascular JJ None
risk NN None
, , None
cholesterol NN Physical
and CC None
health NN None
service NN None
costs NNS None
. . None
difference NN None
in IN None
erectile JJ Physical
function NN Physical
between IN None
improvement NN None
in IN None
MED-QoL NNP Physical
Both DT None
10-year JJ None
cardiovascular NN None
risk NN None
and CC None
low-density NN None
lipoprotein NN None
were VBD None
reduced VBN None
in IN None
endothelial JJ None
function NN None
. . None
The DT None
frequency NN None
of IN None
sexual JJ None
encounters NNS None
is VBZ None
correlated VBN None
with IN None
improved JJ None
erectile JJ None
function NN None
. . None
The DT None
joint JJ None
distribution NN None
of IN None
costs NNS None
and CC None
QALY NNP None
benefits NNS None
indicates VBZ None
simvastatin NN None
being VBG None
cost-effective JJ None
for IN None
willingness-to-pay JJ None
of IN None
costs NNS None
QALY NNP None
benefits NNS None
-DOCSTART- -X- N

the DT None
visual JJ Pain
analogue NN Pain
scale NN Pain
( ( Pain
VAS NNP Pain
) ) Pain
score NN Pain
of IN Pain
rest NN Pain
pain NN Pain
, , Pain
uterine JJ Pain
contration NN Pain
pain NN Pain
and CC Pain
dynamic JJ Pain
pain NN Pain
at IN None
the DT None
time NN None
of IN None
postoperation NN None
for IN None
6 CD None
, , None
12 CD None
, , None
24 CD None
and CC None
48 CD None
hours NNS None
( ( None
T NNP None
( ( None
1 CD None
) ) None
-T NN None
( ( None
4 CD None
) ) None
) ) None
; : None
the DT None
total JJ None
number NN None
and CC None
effective JJ None
compressions NNS None
number NN None
of IN None
patient-controlled JJ Physical
epidural JJ Physical
analgesia NN Physical
( ( Physical
PCEA NNP Physical
) ) Physical
; : None
the DT None
dose NN Other
of IN Other
analgesia JJ Other
mixture NN Other
; : None
the DT None
anal JJ Physical
exhaust JJ Physical
time NN Physical
; : None
the DT None
volume NN Physical
of IN Physical
postoperative JJ Physical
bleeding NN Physical
for IN Physical
6 CD Physical
hours NNS Physical
of IN Physical
postoperation NN Physical
and CC None
the DT None
other JJ Adverse
side NN Adverse
effects NNS Adverse
. . None
incidence NN Physical
of IN Physical
PONV NNP Physical
, , None
the DT None
rate NN Other
of IN Other
metoclopramide NN Other
, , None
the DT None
VAS NNP Physical
score NN Physical
total JJ Physical
number NN Physical
and CC Physical
effective JJ Physical
compressions NNS Physical
number NN Physical
of IN Physical
PCEA NNP Physical
, , None
the DT None
ratio NN Physical
of IN Physical
the DT Physical
total JJ Physical
number NN Physical
with IN Physical
effective JJ Physical
compressions NNS Physical
number NN Physical
and CC None
the DT None
dose NN Physical
of IN Physical
analgesia JJ Physical
mixture NN Physical
anal JJ Physical
exhaust NN Physical
time NN Physical
and CC None
the DT Adverse
volume NN Physical
of IN Physical
postoperative JJ Physical
bleeding NN Physical
side NN Adverse
effects NNS Adverse
incidence NN Physical
of IN Physical
PONV NNP Physical
and CC None
improves VBZ None
analgesia JJ Pain
effect NN Pain
of IN Pain
PCEA NNP Pain
in IN None
postoperation NN None
of IN None
cesarean JJ None
section NN None
. . None
-DOCSTART- -X- N

established VBN Physical
immunity NN Physical
. . Physical
protective JJ Other
antibody NN Other
titer NN Other
Post-immunization NN Other
titers NNS Other
post-vaccination JJ Other
protective JJ Other
titers NNS Other
-DOCSTART- -X- N

glycemic JJ Physical
control NN Physical
and CC None
health-related JJ Other
quality NN Other
of IN Other
life NN Other
quality NN Mental
of IN Mental
life NN Mental
mean JJ Physical
HbA NNP Physical
( ( Physical
1c CD Physical
) ) Physical
Stability NN Physical
of IN Physical
blood NN Physical
glucose JJ Physical
self-measurement JJ Physical
values NNS Physical
number NN Mental
of IN Mental
mild JJ Mental
hypoglycemic JJ Mental
episodes NNS Mental
Weight NNP Physical
gain NN Physical
Scores NNS Physical
on IN Physical
the DT Physical
Short-Form JJ Physical
36-Item JJ Physical
subscales NNS Physical
'general POS Physical
health NN Physical
' '' Other
and CC Other
'mental JJ Mental
health NN Mental
' '' Other
-DOCSTART- -X- N

on IN None
early JJ None
virological JJ None
response NN None
increases NNS None
early RB None
virological JJ None
response NN None
( ( None
EVR NNP None
) ) None
HCV NNP None
RNA NNP None
was VBD None
. . None
Ribavirin NNP None
plasma VBD None
trough JJ None
concentrations NNS None
were VBD None
received VBD None
nucleoside JJ None
reverse NN None
transcriptase NN None
inhibitor NN None
( ( None
NRTI NNP None
) ) None
-sparing VBG None
regimens NNS None
. . None
More JJR None
achieved VBD None
an DT None
HCV NNP None
RNA NNP None
decrease NN None
?1 NNP None
log NN None
, , None
but CC None
EVR NNP None
rates NNS None
were VBD None
faster NN None
HCV NNP None
RNA NNP None
decrease NN None
at IN None
12 CD None
weeks NNS None
age NN None
. . None
RBV-C NNP None
( ( None
4 CD None
were VBD None
higher JJR None
decrease NN None
in IN None
HCV NNP None
RNA NNP None
higher JJR None
EVR NN None
rates NNS None
. . None
Higher JJR None
improve VB None
HCV NNP None
treatment NN None
efficacy NN None
-DOCSTART- -X- N

effective JJ None
regimen NNS None
of IN None
tranexamic JJ None
acid NN None
drain NN Physical
loss NN Physical
and CC None
total JJ Physical
blood NN Physical
loss NN Physical
, , None
calculated VBN None
by IN None
the DT None
hemoglobin NN None
balance NN None
method NN None
drain NN Physical
loss NN Physical
blood NN Physical
loss NN Physical
drain JJ Physical
loss NN Physical
blood NN Physical
loss NN Physical
drain NN Physical
loss NN Physical
total JJ Physical
blood NN Physical
loss NN Physical
. . None
reduction NN None
of IN None
drain NN Physical
loss NN Physical
and CC None
total JJ Physical
blood NN Physical
loss NN Physical
drain NN Physical
loss NN Physical
and CC None
total JJ Physical
blood NN Physical
loss NN Physical
. . None
-DOCSTART- -X- N

VEGF NNP Physical
and CC Physical
VEGFR2 NNP Physical
changes NNS Physical
in IN Physical
VEGF NNP Physical
expression NN Physical
VEGF NNP Physical
expression NN Physical
baseline NN Physical
VEGF NNP Physical
VEGFR2 NNP Physical
expression NN Physical
VEGFR2 NNP Physical
expression NN Physical
response NN Physical
rate NN Physical
suppression NN Other
of IN Other
a DT Other
key JJ Other
angiogenic JJ Other
pathway NN Other
. . None
-DOCSTART- -X- N

no DT Other
differences NNS Other
on IN Other
climacteric NN Other
symptoms NNS Other
relief NN Other
between IN Other
the DT Other
two CD Other
groups NNS Other
. . None
improvement NN Other
in IN Other
urinary JJ Other
symptoms NNS Other
at IN Other
the DT Other
end NN Other
of IN Other
the DT Other
study NN Other
was VBD None
similar JJ None
for IN None
both DT None
groups NNS None
women NNS None
in IN None
group NN None
E NNP None
reached VBD None
significant JJ Other
improvement NN Other
on IN Other
urinary JJ Other
complaints NNS Other
since IN None
the DT None
first JJ None
month NN None
of IN None
treatment NN None
. . None
significant JJ None
difference NN None
between IN None
E NNP None
and CC None
P NNP None
was VBD None
observed VBN None
at IN None
months NNS None
2 CD None
and CC None
3 CD None
, , None
although IN None
no DT None
differences NNS None
were VBD None
detected VBN None
at IN None
the DT None
end NN None
of IN None
the DT None
study NN None
. . None
Papanicolaou NNP None
smear JJ None
showed VBD None
reactive JJ Other
or CC None
reparative JJ Other
changes NNS Other
and CC None
karyopyknotic JJ Other
index NN Other
exhibited VBD Other
a DT Other
significant JJ Other
increase NN Other
in IN Other
superficial JJ Physical
cells NNS Physical
in IN Other
both DT Other
groups NNS Other
and CC Other
at IN Other
the DT Other
end NN Other
of IN Other
the DT Other
study NN Other
. . None
-DOCSTART- -X- N

effective JJ Other
effective JJ Physical
protection NN Physical
of IN Physical
the DT Physical
lower JJR Physical
airways NNS Physical
safety NN Other
postoperative JJ Mortality
morbidity NN Mortality
-DOCSTART- -X- N

Tetrahydrobiopterin NNP None
the DT None
Clinical JJ Mental
Global NNP Mental
Impressions NNP Mental
Improvement NNP Mental
and CC Mental
Severity NNP Mental
Scales NNP Mental
( ( Mental
CGI-I NNP Mental
and CC Mental
CGI-S NNP Mental
) ) Mental
; : None
secondary JJ None
the DT None
Preschool NNP Mental
Language NNP Mental
Scale-4 NNP Mental
( ( Mental
PLS-4 NNP Mental
) ) None
, , None
Social NNP Mental
Responsiveness NNP Mental
Scale NNP Mental
( ( Mental
SRS NNP Mental
) ) Mental
, , None
Aberrant NNP Mental
Behavior NNP Mental
Checklist NNP Mental
( ( Mental
ABC NNP Mental
) ) Mental
, , None
and CC None
Vineland NNP Mental
Adaptive NNP Mental
Behavior NNP Mental
Scales NNP Mental
( ( Mental
Vineland NNP Mental
) ) Mental
. . None
the DT None
CGI-I NNP None
or CC None
CGI-S NNP None
. . None
for IN None
BH4 NNP None
relative NN None
social JJ Mental
awareness NN Mental
, , Mental
autism NN Mental
mannerisms NNS Mental
, , Mental
hyperactivity NN Mental
, , Mental
and CC Mental
inappropriate JJ Mental
speech NN Mental
. . None
that IN None
BH4 NNP None
offers VBZ None
-DOCSTART- -X- N

bone JJ Physical
mineral JJ Physical
density NN Physical
bone NN Physical
turnover NN Physical
bone JJ Physical
mineral JJ Physical
density NN Physical
( ( Physical
BMD NNP Physical
) ) Physical
BMD NNP Physical
BMD NNP Physical
bone RB None
mineral JJ None
density NN None
( ( None
BMD NNP None
) ) None
bone NN Physical
turnover NN Physical
BMD NNP Physical
bone NN Physical
turnover NN Physical
BMD NNP Physical
BMD NNP Physical
Alkphase NNP Physical
B NNP Physical
serum JJ Physical
NTx NNP Physical
BMD NNP Physical
Alkphase NNP Physical
B NNP Physical
Serum NNP Physical
NTx NNP Physical
BMD NNP Physical
and CC None
bone NN Physical
turnover NN Physical
BMD NNP Physical
BMD NNP Physical
-DOCSTART- -X- N

feasibility NN Physical
and CC Physical
morbidity NN Physical
examinations NNS Other
mean JJ Other
operative JJ Other
times NNS Other
feasibility NN Physical
of IN Physical
the DT Physical
procedures NNS Physical
average JJ Other
hospitalizations NNS Other
feasible JJ Other
effective JJ Other
operative JJ Other
time NN Other
. . None
length NN Other
of IN Other
stay NN Other
. . None
-DOCSTART- -X- N

completion NN Mental
of IN Mental
theory NN Mental
of IN Mental
mind NN Mental
and CC Mental
emotion NN Mental
understanding NN Mental
tasks NNS Mental
, , None
and CC None
parent NN Mental
and CC Mental
teacher NN Mental
questionnaires NNS Mental
on IN Mental
children NNS Mental
's POS Mental
social JJ Mental
skills NNS Mental
. . None
efficacy NN Other
Hypotheses NNP Other
, , None
strengths NNS Other
, , None
and CC None
limitations NNS Other
-DOCSTART- -X- N

Drug-induced NNP None
, , None
or CC None
chemical NN None
cystitis NN None
groups NNS None
bacterial JJ Physical
cystitis NN Physical
had VBD None
recurrent JJ Physical
tumors NNS Physical
, , None
recurrence NN None
. . None
The DT None
recurrence NN None
rate NN None
to TO None
toxicity NN None
and CC None
recurrence NN None
of IN None
tumors NNS None
. . None
-DOCSTART- -X- N

Comparison NNP None
Pain NNP Pain
intensity NN Pain
measurements NNS Pain
degree NN Pain
of IN Pain
analgesia NN Pain
setting VBG Other
up RP Other
the DT Other
infusion NN Other
system NN Other
time NN Other
between IN Other
requesting VBG Other
analgesia NN Other
and CC Other
vaginal JJ Other
delivery NN Other
Maternal JJ Adverse
oversedation NN Adverse
and CC Adverse
vomiting VBG Adverse
Neonatal NNP Other
naloxone NN Other
therapy NN Other
umbilical JJ Other
serum NN Other
levels NNS Other
of IN Other
fentanyl NN Other
postnatal JJ Physical
neuroadaptive JJ Physical
testing NN Physical
drug NN Other
use NN Other
, , None
improving VBG Pain
pain NN Pain
relief NN Pain
, , None
or CC None
avoiding VBG Physical
drowsiness NN Adverse
. . None
-DOCSTART- -X- N

efficacy NN Other
safety NN Other
efficacy NN Other
safety NN Other
percent NN Physical
improvement NN Physical
of IN Physical
the DT Physical
RP NNP Physical
attack NN Physical
rate NN Physical
serious JJ Adverse
adverse JJ Adverse
events NNS Adverse
adverse JJ Adverse
events NNS Adverse
effective JJ Other
tolerable JJ Other
-DOCSTART- -X- N

posttreatment JJ Mental
Hamilton NNP Mental
ratings NNS Mental
of IN Mental
depression NN Mental
reduced VBN Other
risk-benefit JJ Other
ratio NN Other
depression NN Mental
favorable JJ Other
. . None
-DOCSTART- -X- N

remission NN Physical
of IN Physical
treatment NN None
outcomes NNS None
outcome NN None
outcome NN Physical
of IN Physical
pharmacotherapy NN Physical
outcomes NNS None
high JJ Physical
remission NN Physical
rate NN Physical
low JJ Physical
remission NN Physical
rate NN Physical
low JJ Physical
remission NN Physical
rate NN Physical
impact NN Physical
of IN Physical
prior JJ Physical
pharmacotherapy NN Physical
treatment NN None
outcomes NNS None
-DOCSTART- -X- N

ringing JJ Other
voice NN Other
quality NN Other
with IN Other
strong JJ Other
overtones NNS Other
at IN Other
3-5 JJ Other
kHz NN Other
. . None
Fundamental JJ Other
frequency NN Other
( ( Other
F0 NNP Other
) ) Other
, , Other
sound JJ Other
pressure NN Other
level NN Other
( ( Other
SPL NNP Other
) ) Other
and CC None
long-term-average JJ Other
spectrum NN Other
( ( Other
LTAS NNP Other
) ) Other
analyses NNS Other
Voice NNP Other
quality NN Other
Sound NNP Other
energy NN Other
at IN Other
3-5 JJ Other
kHz NNS Other
increased VBN None
by IN None
3-4 JJ None
dB NN None
SPL NNP Other
. . None
F0 NNP Other
increased VBD None
slightly RB None
decreased VBN None
relative JJ Other
dB NN Other
level NN Other
of IN Other
fundamental JJ Other
Voice NNP Other
quality NN Other
efficacy NN Other
-DOCSTART- -X- N

EBER-ISH NNP Physical
tumor NN Physical
status NN Physical
EBER-ISH NNP Physical
. . Physical
with IN None
EBER-ISH NNP None
. . None
had VBD None
inferior JJ None
failure-free JJ Mortality
survival NN Mortality
( ( Mortality
FFS NNP Mortality
) ) Mortality
in IN None
FFS NNP None
by IN None
EBER-ISH NNP None
. . None
plasma NN None
EBV NNP None
( ( None
+ NNP None
) ) None
had VBD None
inferior JJ None
FFS NNP None
with IN None
plasma NN None
EBV NNP None
( ( None
- : None
) ) None
with IN None
EBER-ISH NNP None
-DOCSTART- -X- N

Efficacy NNP Other
, , Other
safety NN Other
, , Other
and CC Other
durability NN Other
ulcers NNS Physical
healed VBD Physical
or CC Physical
were VBD Physical
significantly RB Physical
improved VBN Physical
ulcers NNS Physical
failed VBD Physical
to TO Physical
heal VB Physical
operation NN None
. . None
recurrent JJ Physical
ulceration NN Physical
or CC Physical
skin JJ Physical
deterioration NN Physical
AVP NNP Physical
transient NN Adverse
neurologic NN Adverse
disorders NNS Adverse
paradysthesia NN None
) ) None
, , None
but CC None
deep RB Adverse
venous JJ Adverse
thrombosis NN Adverse
deaths NNS Mortality
durability NN Other
. . None
-DOCSTART- -X- N

joint JJ Mental
attention NN Mental
spent VBD Mental
more JJR Mental
time NN Mental
in IN Mental
supported JJ Mental
engagement NN Mental
and CC Mental
less JJR Mental
time NN Mental
in IN Mental
object JJ Mental
engagement NN Mental
core NN Mental
deficit NN Mental
of IN Physical
-DOCSTART- -X- N

Effect NN Physical
lactate NN Physical
levels NNS Physical
recovery NN Physical
from IN Physical
intense JJ Physical
exercise NN Physical
activity NN Physical
pattern NN Physical
, , Physical
rate NN Physical
of IN Physical
perceived VBN Physical
exertion NN Physical
( ( Physical
RPE NNP Physical
) ) Physical
, , Physical
and CC Physical
blood NN Physical
lactate NN Physical
concentration NN Physical
. . Physical
The DT None
mean JJ None
heart NN None
rate NN None
( ( None
HR NNP None
) ) None
, , None
RPE NNP None
, , None
number NN None
of IN None
steps NNS None
( ( None
determined VBN None
by IN None
step NN None
counter NN None
) ) None
, , None
and CC None
blood NN None
lactate NN None
concentrations NNS None
the DT None
mean JJ None
HR NNP None
increased JJ None
voluntary JJ None
activity NN None
increased JJ None
number NN None
of IN None
steps NNS None
number NN None
of IN None
steps NNS None
during IN None
decrease NN None
in IN None
blood NN None
lactate NN None
concentration NN None
percentage NN None
in IN None
RPE NNP None
( ( None
-DOCSTART- -X- N

efficacy NN Other
recurrence NN Physical
rate NN Physical
after IN Physical
TUR NNP Physical
. . Physical
tolerated VBN Other
. . Other
Systemic JJ Physical
absorption NN Physical
no DT Adverse
severe JJ Adverse
drug-related JJ Adverse
side NN Adverse
effects NNS Adverse
Chemical NNP Adverse
cystitis NN Adverse
-DOCSTART- -X- N

Children NNP Mental
's POS Mental
communication NN Mental
and CC Mental
parental JJ Mental
responsivity NN Mental
Children NNP Mental
's POS Mental
object JJ Mental
interest NN Mental
, , Mental
a DT Mental
putative JJ Mental
moderator NN Mental
parental JJ Mental
responsivity NN Mental
children NNS Mental
's POS Mental
communication NN Mental
. . None
parental JJ Mental
responsivity NN Mental
on IN None
child JJ None
communication NN None
object JJ None
interest NN None
in IN None
communication NN None
; : None
of IN None
object JJ None
interest NN None
exhibited VBD None
growth NN None
attenuation NN None
. . None
on IN None
child NN None
communication NN None
facilitated VBD None
communication NN None
-DOCSTART- -X- N

rate NN Physical
of IN Physical
eradication NN Physical
of IN Physical
H. NNP Physical
pylori NN Physical
Complete JJ Other
relief NN Other
of IN Other
symptoms NNS Other
therapeutic JJ Other
success NN Other
-DOCSTART- -X- N

very RB None
slight JJ None
increase NN None
skin NN Physical
flora NN Physical
no DT None
significant JJ None
differences NNS None
perioral JJ Physical
dermatitis NN Physical
and CC Physical
steroid JJ Physical
acne NN Physical
. . None
-DOCSTART- -X- N

efficacy NN Other
and CC Other
toxicity NN Other
recurrences NNS Physical
recurrence NN Physical
ocular JJ Adverse
complications NNS Adverse
nor CC Adverse
systemic JJ Adverse
toxicity NN Adverse
-DOCSTART- -X- N

plasma JJ Physical
lipids NNS Physical
and CC Physical
glucose VB Physical
plasma JJ Physical
triglyceride NN Physical
plasma NN Physical
triglyceride NN Physical
levels NNS Physical
tolerated VBN Other
-DOCSTART- -X- N

predict VB Physical
response NN Physical
overall JJ Physical
response NN Physical
to TO Physical
first-line JJ Physical
treatment NN Physical
TS NN Physical
levels NNS Physical
response NN Physical
to TO Physical
FUFA NNP Physical
and CC Physical
FOLFIRI NNP Physical
-DOCSTART- -X- N

coronary JJ Physical
aneurysm NN Physical
formation NN Physical
-DOCSTART- -X- N

radiation NN Other
burden NN Other
efficacy NN Other
. . Other
goiter NN Physical
volume NN Physical
reduction NN Physical
( ( Physical
GVR NNP Physical
) ) Physical
. . Physical
relative JJ Physical
GVR NNP Physical
131I-activity NN Physical
hospitalization NN Other
goiter-related JJ Physical
symptoms NNS Physical
myxedema NN Physical
thyroid JJ Physical
131I CD Physical
uptake NN Physical
131I-activity NN Physical
efficacy NN Other
. . Other
posttherapeutic JJ Other
restrictions NNS Other
radiation-induced JJ Physical
malignancy NN Physical
-DOCSTART- -X- N

Beneficial JJ Other
effects NNS Other
insulin NN Physical
sensitivity NN Physical
and CC None
free JJ Physical
fatty NN Physical
acid NN Physical
insulin NN Physical
sensitivity NN Physical
, , None
serum JJ Physical
C NNP Physical
peptide NN Physical
, , None
serum JJ Physical
lipids NNS Physical
and CC None
free JJ Physical
fatty NN Physical
acid NN Physical
( ( Physical
FFA NNP Physical
) ) Physical
Plasma NNP Physical
glucose NN Physical
, , None
serum JJ Physical
insulin NN Physical
, , None
C NNP Physical
peptide NN Physical
and CC None
lipids NNS Physical
postprandial JJ Physical
rise NN Physical
in IN Physical
blood NN Physical
glucose JJ Physical
concentrations NNS Physical
peak JJ Physical
height NN Physical
of IN Physical
plasma NN Physical
glucose NN Physical
plasma NN Physical
insulin NN Physical
concentrations NNS Physical
plasma NN Physical
insulin NN Physical
peak NN Physical
glucose NN Physical
and CC Physical
insulin JJ Physical
C NNP Physical
peptide NN Physical
level NN Physical
glycemic JJ Physical
control NN Physical
. . None
insulin NN Physical
sensitivity NN Physical
( ( Physical
HOMA-IS NNP Physical
) ) Physical
-DOCSTART- -X- N

plaque NN Physical
characteristics NNS Physical
plaque NN Physical
characteristics NNS Physical
cardiovascular JJ Physical
events NNS Physical
characterize VB Physical
plaque JJ Physical
echogenicity NN Physical
death NN Mortality
or CC None
nonfatal JJ Physical
myocardial JJ Physical
infarction NN Physical
or CC Physical
nonfatal JJ Physical
stroke NN Physical
) ) None
corresponding JJ None
numbers NNS None
echogenic JJ Physical
plaques NNS Physical
beneficial JJ Other
effect NN Other
-DOCSTART- -X- N

Efficacy NN Other
tolerance NN Physical
for IN Physical
bowel NN Physical
preparation NN Physical
efficacy NN Other
tolerability NN Other
colon NN Other
cleansing VBG Other
efficacy NN Other
Ottawa NNP Physical
bowel NN Physical
preparation NN Physical
scale NN Physical
. . None
Ottawa NNP Physical
cleansing VBG Physical
scale JJ Physical
overall JJ Physical
tolerability NN Physical
adverse JJ Adverse
events NNS Adverse
cleansing VBG Other
efficacy NN Other
improved JJ Physical
tolerability NN Physical
-DOCSTART- -X- N

maximum JJ Other
diameter NN Other
of IN Other
the DT Other
resection NN Other
specimen NNS Other
and CC Other
of IN Other
the DT Other
resection NN Other
area NN Other
, , None
and CC None
the DT None
complication NN Adverse
rate NN Adverse
. . None
maximum JJ Other
diameters NNS Other
and CC Other
calculated JJ Other
area NN Other
of IN Other
the DT Other
resected VBN Other
specimens NNS Other
maximum JJ Other
diameters NNS Other
and CC Other
calculated JJ Other
area NN Other
of IN Other
the DT Other
endoscopic NN Other
resection NN Other
ulcers NNS Other
bleeding VBG Adverse
residual JJ Physical
neoplasia NN Physical
-DOCSTART- -X- N

Pain NN Pain
and CC None
fatigue JJ Pain
management NN Pain
: : None
physical JJ Physical
functioning NN Physical
and CC None
emotional JJ Mental
health NN Mental
Pain NNP Pain
and CC None
fatigue NN Physical
, , None
numbers NNS Pain
of IN Pain
other JJ Pain
symptoms NNS Pain
, , None
and CC None
physical JJ Physical
role NN Physical
impact NN Physical
and CC None
social-functioning JJ Pain
subscales NNS Pain
number NN Physical
of IN Physical
symptoms NNS Physical
experienced VBN Physical
physical JJ Physical
and CC None
social JJ Physical
functioning NN Physical
. . None
pain NN Pain
and CC None
fatigue NN Physical
pain NN Pain
and CC None
fatigue NN Physical
symptom JJ Physical
burden NN Physical
quality NN Physical
of IN Physical
the DT Physical
daily JJ Physical
life NN Physical
improved JJ Physical
quality NN Physical
of IN Physical
life NN Physical
-DOCSTART- -X- N

baseline NN Other
exercise NN Other
capacity NN Other
and CC None
measures NNS Other
of IN Other
quality NN Other
of IN Other
life NN Other
. . None
measures NNS Other
of IN Other
symptoms NNS Other
, , None
limitation NN Other
of IN Other
activity NN Other
and CC Other
quality NN Other
of IN Other
life NN Other
. . None
exercise NN Other
capacity NN Other
quality NN Other
of IN Other
life NN Other
. . None
